data_2jzi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jzi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.833 0.349 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -100.95 -170.21 1.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.827 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -117.23 83.93 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.574 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.6 164.73 12.3 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.58 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.417 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.6 p -98.6 162.8 12.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.465 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -47.43 -51.33 20.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.879 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -64.42 -27.66 69.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.157 0.503 . . . . 0.0 110.065 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.443 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -72.51 -51.43 20.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.706 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.588 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 37.9 pt -73.08 -28.85 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.849 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.37 -27.45 9.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 11.0 mt-10 -75.23 -28.53 59.95 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.207 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.36 -58.41 3.22 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.218 0.532 . . . . 0.0 111.004 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.855 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.5 pttt -54.45 -23.03 14.34 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.273 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.45 -27.85 56.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.27 -39.78 62.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.072 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.855 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.64 -51.89 67.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.845 0.831 . . . . 0.0 109.458 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.401 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 p -74.46 -24.45 59.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.101 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -82.06 -23.5 35.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.261 0.553 . . . . 0.0 110.28 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.9 t80 -95.4 -0.76 52.17 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.554 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.7 t70 -103.48 142.64 33.91 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.971 0.891 . . . . 0.0 111.039 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.44 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 3.7 mmtt -59.11 -53.38 59.04 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.604 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.93 -5.42 59.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.77 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.51 47.69 44.03 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.303 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -92.06 18.86 7.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.867 0.365 . . . . 0.0 110.685 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.36 5.11 89.06 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.577 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.8 p -150.34 148.86 29.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.18 140.51 19.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.847 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.17 176.46 8.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.004 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.426 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.1 p -70.52 -37.5 74.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.145 0.497 . . . . 0.0 110.332 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.536 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.23 -41.12 92.46 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.15 178.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -69.4 -53.41 19.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.26 -179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -54.69 44.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.724 0.773 . . . . 0.0 109.326 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.49 -45.83 92.63 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.456 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.7 m -62.39 -30.9 71.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.845 0.322 . . . . 0.0 110.495 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 72.5 t -68.2 -57.26 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.87 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.405 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -71.95 -35.63 69.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.389 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -68.13 -42.74 79.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.848 0.356 . . . . 0.0 110.667 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 t -78.94 -8.14 58.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.806 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tt -90.97 -54.82 3.8 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.88 34.94 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.937 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.543 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp-100 -137.56 -178.95 5.46 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.381 0.61 . . . . 0.0 111.163 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -159.64 56.46 0.88 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.927 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.4 Cg_endo -80.37 -175.7 2.83 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.56 2.173 . . . . 0.0 112.101 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.612 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.94 152.5 32.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.956 0.408 . . . . 0.0 110.18 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.55 ' N ' HG23 ' A' ' 44' ' ' THR . 3.7 mm-40 -57.22 -49.58 75.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.58 75.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.713 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -54.33 33.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.673 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.612 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.85 -34.77 78.9 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.379 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.39 -42.7 95.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.909 0.385 . . . . 0.0 110.228 179.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.76 -45.52 93.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.23 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -30.69 61.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.412 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.555 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.69 -38.29 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.524 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -44.91 -28.68 0.69 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.351 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.6 -38.78 47.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.891 0.376 . . . . 0.0 110.803 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 52' ' ' ILE . 4.6 m -81.07 -11.39 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.18 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.9 t0 -103.73 155.68 18.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.754 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.57 -29.1 26.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -116.43 -9.66 11.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.416 0.627 . . . . 0.0 110.471 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.44 63.53 5.14 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.517 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -112.26 18.13 18.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.846 0.355 . . . . 0.0 110.193 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.67 19.91 55.31 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.453 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.413 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.1 p -147.16 176.41 9.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.418 HG23 ' CG ' ' A' ' 68' ' ' PHE . 13.8 mt -115.7 136.52 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.562 0.22 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.9 m-20 -87.28 -178.06 6.11 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.28 0.562 . . . . 0.0 111.931 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.5 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.03 -56.06 11.99 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.622 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.7 Cg_endo -65.65 -34.8 40.07 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.21 1.94 . . . . 0.0 111.166 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.91 -52.35 63.41 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.268 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.0 -56.63 19.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.867 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -57.51 -46.12 84.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.696 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.5 m -60.06 -31.15 69.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.041 0.448 . . . . 0.0 109.966 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.43 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 2.8 tpp -64.54 -61.8 1.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.908 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.7 mtt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.803 179.957 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.735 0.303 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.85 -54.48 37.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.76 -29.43 27.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.375 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.9 mt -64.76 -51.23 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.772 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -75.58 -50.57 15.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.043 0.449 . . . . 0.0 110.685 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -53.79 -30.84 46.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.682 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -71.08 -38.55 72.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.781 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 24.2 t80 -67.03 -56.02 11.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.579 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.62 -30.65 43.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.866 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.7 t -88.4 -22.92 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.211 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' HD12 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -55.18 -32.05 61.87 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.046 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -102.16 148.84 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.438 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -69.61 -37.71 76.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.332 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -112.27 -9.78 13.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.66 30.55 32.37 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.119 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.41 -13.73 62.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.96 0.38 . . . . 0.0 110.757 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.24 -13.46 55.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.857 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.446 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.7 m-85 -127.14 145.41 50.76 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.967 0.413 . . . . 0.0 111.284 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.1 109.97 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.885 179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 p -83.39 177.38 8.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.311 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.18 -28.97 70.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.083 0.468 . . . . 0.0 110.405 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.46 -57.67 9.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.426 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.41 -42.96 42.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.273 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.426 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 56.0 tp -56.9 -31.14 64.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.08 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.401 ' HD2' ' HG ' ' A' ' 116' ' ' LEU . 5.4 ttt180 -72.54 -49.27 33.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.937 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -60.85 -36.5 79.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 110.539 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.475 HG12 ' CZ ' ' B' ' 20' ' ' PHE . 54.5 t -72.82 -44.14 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.301 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 24.8 mmt -73.99 -54.05 8.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.727 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m -55.59 -45.55 77.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.367 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -60.27 -29.85 69.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.792 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.9 mp -123.49 38.66 4.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.647 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.95 -116.81 0.4 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.781 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -132.2 170.77 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 110.864 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -74.97 99.7 3.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.257 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.416 ' CD1' ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.7 114.39 26.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.384 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.7 175.34 5.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.429 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -48.09 -35.93 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.755 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -77.4 -35.09 54.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -72.62 -33.67 66.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.977 0.417 . . . . 0.0 110.106 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.6 t -74.69 -48.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.899 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.21 -52.87 63.82 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.843 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -56.97 -28.85 62.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.857 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.426 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 6.6 tpt -76.35 -38.64 55.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.146 0.498 . . . . 0.0 110.169 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.87 -48.42 79.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.563 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -60.25 -40.27 89.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.946 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.86 -37.1 30.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 0.0 110.598 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.403 ' HB1' ' CE ' ' A' ' 124' ' ' MET . . . -66.93 -36.18 81.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 22.3 t0 -101.37 147.58 26.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.013 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.523 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.6 pt -84.84 -40.67 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.047 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.95 -10.98 60.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.65 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.68 1.09 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.405 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.9 p-10 -96.33 -12.84 23.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.317 -0.941 . . . . 0.0 112.379 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.93 20.1 10.21 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.754 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.9 146.54 30.19 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.899 0.38 . . . . 0.0 110.06 179.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.64 107.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.246 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.21 174.84 11.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.304 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.581 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.96 -67.01 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.523 0.677 . . . . 0.0 111.464 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.88 -34.15 72.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.839 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -40.63 73.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.45 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.2 OUTLIER -78.83 -32.88 46.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.064 178.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 64.0 t -55.35 -46.93 78.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.626 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -57.81 -45.32 86.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.1 -33.12 65.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.409 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 18.0 ttp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.72 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.3 mmm180 -52.3 -51.25 59.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.66 -53.17 33.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.638 0.256 . . . . 0.0 111.289 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -57.24 -37.52 72.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.007 0.432 . . . . 0.0 110.347 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.405 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 15.6 t -63.27 -33.68 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.348 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.72 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.6 mt -71.58 -55.46 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.995 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.3 mmm-85 -50.36 -37.79 38.92 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.215 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -44.44 66.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -57.9 -55.01 40.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.43 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 3.8 mt -51.27 -57.28 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.906 0.384 . . . . 0.0 111.228 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -58.36 -51.18 70.9 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.424 0.631 . . . . 0.0 110.656 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.567 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.5 -39.38 64.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.81 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.3 mt -54.28 -48.31 67.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.233 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.27 -38.22 95.58 Favored Glycine 0 CA--C 1.498 -1.022 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.495 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.661 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -64.76 -61.8 1.96 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.743 -0.729 . . . . 0.0 110.504 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.642 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -60.32 -27.59 67.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -67.32 -48.64 66.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.038 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 0.7 OUTLIER -63.78 -43.74 95.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.642 HG23 ' O ' ' B' ' 16' ' ' MET . 1.7 m -62.09 -34.65 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.472 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.539 ' N ' HG23 ' B' ' 19' ' ' VAL . 0.3 OUTLIER -75.37 -44.11 46.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.639 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 18.8 p -60.84 -25.8 66.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.474 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.428 HG21 ' N ' ' B' ' 23' ' ' LEU . 26.8 m -90.07 -46.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.991 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.12 -33.34 75.26 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.18 0.514 . . . . 0.0 110.444 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.508 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.121 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.98 -169.95 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -119.24 84.49 2.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.574 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.93 164.82 12.21 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.51 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.401 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.58 162.08 13.47 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.46 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.68 -51.71 20.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.789 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.51 -27.68 69.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.035 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.94 -51.41 22.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.614 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.589 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 39.2 pt -73.06 -28.9 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.706 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.62 -27.31 10.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.3 mt-10 -75.28 -28.56 59.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.269 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.589 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.28 -58.44 3.21 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.207 0.527 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.86 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.9 pttt -54.77 -22.93 15.73 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.203 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.28 -27.74 56.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.091 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.63 -39.77 61.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.074 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.86 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.04 -51.83 68.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.816 0.817 . . . . 0.0 109.463 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -25.04 59.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.073 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.498 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -82.02 -25.75 34.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.148 0.499 . . . . 0.0 110.451 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.504 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 5.6 t80 -87.75 -15.08 37.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.448 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR . 32.0 t70 -90.28 146.24 24.37 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.977 0.894 . . . . 0.0 111.23 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -63.33 -53.41 53.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -81.83 -6.8 59.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.846 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.56 45.27 59.68 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.402 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -90.42 17.75 6.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.822 0.344 . . . . 0.0 110.759 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.47 89.36 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 46.4 p -150.18 150.52 31.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.504 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.77 140.58 20.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.968 0.413 . . . . 0.0 111.952 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.34 176.34 8.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.974 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.425 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.0 OUTLIER -70.42 -38.0 74.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.03 0.443 . . . . 0.0 110.251 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.543 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.75 -40.99 89.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.22 178.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.543 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.08 -53.47 20.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.234 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.408 ' CD1' ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -58.43 -54.85 42.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.718 0.77 . . . . 0.0 109.463 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.59 -45.85 92.74 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.508 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.2 m -62.2 -31.39 71.91 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.818 0.342 . . . . 0.0 110.581 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.08 -57.25 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.429 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -71.91 -35.36 69.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.436 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -42.13 79.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.945 0.402 . . . . 0.0 110.645 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -79.02 -7.61 58.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.648 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.03 -54.43 3.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.042 0.448 . . . . 0.0 110.754 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.67 34.81 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.552 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.13 -178.97 5.44 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.368 0.604 . . . . 0.0 111.134 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -159.58 56.49 0.89 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.902 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.4 -176.76 3.36 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.502 2.134 . . . . 0.0 112.076 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.608 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -113.53 152.48 30.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.962 0.41 . . . . 0.0 110.199 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.548 ' N ' HG21 ' A' ' 44' ' ' THR . 3.6 mm-40 -57.51 -49.33 76.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.404 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.69 72.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.75 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.06 -54.33 27.18 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.559 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.608 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.92 -34.74 78.82 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.369 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.401 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.46 -42.6 95.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.873 0.368 . . . . 0.0 110.172 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -61.76 -45.38 94.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.245 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -30.77 61.83 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.419 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.549 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.75 -38.32 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.511 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -44.98 -28.6 0.69 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.387 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.04 -38.85 51.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.914 0.388 . . . . 0.0 110.758 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 52' ' ' ILE . 5.1 m -81.38 -11.89 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.227 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.514 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.8 t0 -103.57 155.35 18.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.748 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.61 -28.8 26.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.124 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -116.42 -9.68 11.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.452 0.644 . . . . 0.0 110.5 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.514 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.35 63.48 5.2 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.488 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -112.06 18.1 19.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.81 0.338 . . . . 0.0 110.225 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.41 19.86 55.91 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.483 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.407 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 3.9 p -147.09 176.32 10.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.408 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 2.1 mp -115.54 136.55 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 120.6 0.238 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.0 m-20 -86.11 -178.6 6.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.272 0.558 . . . . 0.0 111.885 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.5 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -67.65 -56.32 12.35 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.557 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.0 Cg_endo -65.93 -35.4 35.23 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.3 2.0 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -61.85 -52.45 64.1 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.192 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.09 -56.42 21.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.758 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -57.16 -45.47 83.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.733 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.0 m -60.58 -31.57 70.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.069 0.462 . . . . 0.0 110.049 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.435 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.5 tpp -63.49 -61.76 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.01 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.9 mtm . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.716 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.799 0.333 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -50.45 -30.59 12.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.232 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 2.0 mt-10 -68.88 -30.54 69.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.481 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.1 mt -79.49 -51.1 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -74.65 -51.54 14.12 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -53.52 -25.32 16.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.929 0.395 . . . . 0.0 110.755 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.454 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.67 -36.43 43.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.248 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 28.1 t80 -67.94 -51.33 48.84 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.053 0.454 . . . . 0.0 110.142 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -32.62 58.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.773 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.7 -22.73 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.616 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -52.93 -34.22 54.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.231 -179.388 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -99.36 147.87 24.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.487 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -67.48 -38.27 84.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.374 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.25 -9.74 13.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.796 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.03 28.07 32.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.327 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -67.5 -13.98 62.52 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.165 0.482 . . . . 0.0 110.757 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.441 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.85 -10.73 55.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.146 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.8 m-85 -127.12 145.28 50.8 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.014 0.435 . . . . 0.0 111.458 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.442 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.17 110.03 26.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.699 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -82.97 176.89 8.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.602 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.06 71.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.077 0.465 . . . . 0.0 110.487 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -57.76 11.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.286 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -45.81 29.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.093 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.414 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 38.0 tp -53.0 -31.15 39.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -73.36 -49.09 29.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.952 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -59.06 -42.04 89.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.207 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -72.99 -40.01 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.598 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.456 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 27.7 mmt -73.97 -54.2 8.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.521 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 m -56.92 -47.75 79.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.241 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -59.67 -28.42 67.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.28 37.09 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.99 -113.18 0.29 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.722 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.58 167.22 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 0.0 110.849 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -72.55 99.88 2.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.237 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.05 114.42 26.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.435 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.85 175.39 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.381 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.03 -36.0 12.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.782 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -77.34 -35.01 55.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.761 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -72.82 -33.26 66.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.993 0.425 . . . . 0.0 110.178 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.414 ' HA ' HD13 ' A' ' 116' ' ' LEU . 2.5 t -74.88 -47.92 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.898 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.54 -52.81 63.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.788 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -57.44 -28.72 63.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.829 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.414 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 7.5 tpt -76.25 -38.06 56.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.137 0.494 . . . . 0.0 110.108 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.53 -43.33 80.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.476 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -64.98 -39.18 93.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.786 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.42 -36.28 29.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.945 0.402 . . . . 0.0 110.449 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.402 ' HB1' ' CE ' ' A' ' 124' ' ' MET . . . -67.88 -37.55 81.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.544 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 22.2 t0 -100.35 146.35 27.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.04 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.524 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.72 -40.6 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.077 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.98 -10.99 60.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.701 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.81 32.93 1.01 Allowed Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -176.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.409 ' N ' ' C ' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.28 -12.63 24.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.311 -0.944 . . . . 0.0 112.46 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.87 20.12 10.24 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.86 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -146.67 146.91 30.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.66 107.28 13.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.348 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -79.36 174.84 11.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.323 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.573 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -45.88 -67.36 0.29 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.518 0.675 . . . . 0.0 111.461 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -30.38 70.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.884 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -55.82 -44.43 77.88 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -31.79 46.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.208 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 55.3 t -53.68 -47.79 61.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.487 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -57.82 -42.26 83.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.717 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.24 -37.93 66.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.967 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 6.4 ttp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.978 -179.856 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.821 0.343 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.718 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.31 -51.15 60.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.538 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.59 -53.31 31.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.668 0.271 . . . . 0.0 111.295 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -57.07 -37.57 72.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.46 . . . . 0.0 110.332 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.429 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 14.7 t -63.38 -34.2 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.364 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.718 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.5 mt -71.01 -54.7 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.988 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -51.08 -37.2 44.24 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.159 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -48.37 63.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.492 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -55.51 -54.4 44.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.203 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.435 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.21 -57.46 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.545 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.501 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.93 -51.17 70.82 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.177 0.513 . . . . 0.0 110.96 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.3 -40.55 64.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.747 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.474 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 2.8 mt -54.64 -49.32 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.484 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.4 -36.99 94.12 Favored Glycine 0 CA--C 1.498 -1.011 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.934 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.677 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.47 -61.68 2.07 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.381 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.64 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.36 -27.54 69.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.668 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -65.9 -50.37 64.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.204 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 0.5 OUTLIER -64.25 -43.63 94.29 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.625 HG23 ' O ' ' B' ' 16' ' ' MET . 2.0 m -64.25 -33.12 60.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.479 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.64 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -74.55 -45.75 43.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.839 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.489 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.9 p -59.55 -26.11 65.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.483 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.424 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.2 m -90.47 -46.64 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.148 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.9 pp -63.18 -32.98 74.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.189 0.519 . . . . 0.0 110.511 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.489 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.051 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.853 0.359 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.44 -169.78 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.811 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -120.96 84.36 2.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.96 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -97.63 164.74 12.29 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.485 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.413 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.14 162.71 13.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.481 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -47.46 -51.3 20.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.856 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -64.43 -27.65 69.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.04 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.52 -51.43 20.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.734 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.59 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 37.6 pt -73.2 -28.73 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.854 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.39 -27.38 9.86 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 2.7 mm-40 -75.18 -28.51 60.08 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.253 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.43 -58.5 3.17 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 121.253 0.549 . . . . 0.0 111.015 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.854 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -54.64 -22.84 14.81 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.205 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.3 -28.1 56.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.23 -39.87 62.8 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.11 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.854 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.94 -51.81 68.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.861 0.838 . . . . 0.0 109.487 178.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 p -74.51 -24.43 58.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.122 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.484 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.15 -23.35 35.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.202 0.525 . . . . 0.0 110.347 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.505 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.7 t80 -95.74 -1.02 50.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.608 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.2 t70 -103.12 144.27 31.52 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 122.036 0.922 . . . . 0.0 111.09 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 12.6 mmtt -60.55 -53.42 57.69 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.571 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.01 -4.65 59.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.876 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.46 45.55 45.93 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.391 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -90.43 17.57 7.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.836 0.35 . . . . 0.0 110.722 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.46 6.2 87.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.508 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.45 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 61.6 p -150.29 149.05 29.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.47 140.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.747 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.485 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 1.3 t -87.49 -179.74 6.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.122 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 p -70.42 -44.14 68.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 0.0 110.897 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.538 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -55.5 -40.23 71.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.327 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -69.63 -53.83 16.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.424 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -55.15 38.59 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.781 0.801 . . . . 0.0 109.42 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.62 -45.99 92.62 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.594 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.3 m -62.1 -31.22 71.65 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.939 0.37 . . . . 0.0 110.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 71.5 t -68.02 -57.2 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.842 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.415 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 1.3 tpt -71.97 -35.87 69.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.428 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -42.44 80.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.76 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.0 t -78.93 -8.36 58.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.7 tt -90.54 -54.72 3.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.761 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.15 35.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.889 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp-100 -137.3 -178.91 5.42 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.362 0.601 . . . . 0.0 111.207 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -159.64 56.59 0.9 Allowed Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.891 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.9 Cg_endo -80.37 -177.11 3.56 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.501 2.134 . . . . 0.0 112.059 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -113.66 152.54 30.28 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 110.263 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.55 ' N ' HG21 ' A' ' 44' ' ' THR . 3.8 mm-40 -57.14 -49.52 75.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.442 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.1 -33.12 74.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.764 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -54.28 33.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.692 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.613 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.6 -35.82 81.94 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.429 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -42.69 98.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.875 0.369 . . . . 0.0 110.238 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -61.83 -45.61 93.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.338 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -30.72 61.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.492 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.57 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.524 -179.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -45.0 -28.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.328 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.46 -38.78 48.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.92 0.391 . . . . 0.0 110.838 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 52' ' ' ILE . 4.8 m -81.14 -11.48 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.157 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.52 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.9 t0 -103.61 155.51 18.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.727 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.59 -29.09 26.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.079 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -116.4 -9.74 11.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.392 0.615 . . . . 0.0 110.485 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.8 63.93 4.76 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.008 -0.997 . . . . 0.0 113.491 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 -112.66 18.31 18.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.88 0.371 . . . . 0.0 110.217 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.09 19.81 56.63 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.474 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.409 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 5.3 p -146.65 176.37 9.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.41 HG22 ' CG ' ' A' ' 68' ' ' PHE . 35.5 mt -115.8 136.5 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.595 0.236 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.6 m-20 -86.94 -178.3 6.26 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.329 0.585 . . . . 0.0 111.935 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.499 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.96 -55.96 12.38 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.672 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.6 Cg_endo -65.62 -34.71 40.72 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.245 1.963 . . . . 0.0 111.197 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -52.45 62.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.476 ' CD2' ' CD1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -56.97 -56.88 15.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.83 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.488 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -57.04 -46.56 82.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.9 m -60.67 -31.84 71.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.107 0.479 . . . . 0.0 110.041 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.434 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.3 tpp -62.34 -61.75 2.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.97 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.7 mtp . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.826 179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.771 0.32 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -57.89 -52.2 66.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.986 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.68 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.73 -29.21 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.432 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.7 mt -65.89 -51.35 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.822 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.448 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -75.68 -50.43 15.42 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.774 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -53.79 -31.92 50.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.644 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -69.84 -38.74 76.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.774 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.529 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.1 t80 -66.82 -55.85 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.967 0.413 . . . . 0.0 110.549 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -53.73 -30.54 44.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.876 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.9 t -88.46 -22.85 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.214 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.437 ' CE2' HD13 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -55.36 -31.85 62.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.047 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -102.44 148.66 25.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.439 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -69.59 -37.67 77.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.385 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -112.28 -9.79 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.53 30.69 32.39 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.08 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.44 -13.46 62.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.992 0.396 . . . . 0.0 110.856 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.444 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.2 -13.66 55.32 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.853 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.433 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.2 m-85 -127.21 145.87 50.61 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.971 0.415 . . . . 0.0 111.268 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.437 HD13 ' CE2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.06 109.97 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.853 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.1 m -83.53 177.28 8.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.393 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.16 -28.64 69.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.044 0.449 . . . . 0.0 110.427 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.1 -57.67 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.422 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.42 -42.38 44.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.434 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 52.9 tp -56.93 -31.24 64.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 6.0 ttt180 -72.57 -49.3 33.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -60.81 -36.15 78.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.012 0.434 . . . . 0.0 110.437 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG11 ' CZ ' ' B' ' 20' ' ' PHE . 60.3 t -72.94 -44.83 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.178 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 24.4 mmt -74.12 -54.06 8.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.556 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.6 m -55.57 -45.86 77.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.73 0.3 . . . . 0.0 111.267 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -60.04 -30.06 68.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.805 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.63 38.92 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.578 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.38 -116.1 0.38 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.798 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.13 169.53 16.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.889 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -74.22 100.07 3.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.417 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.5 114.91 26.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.322 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.67 175.08 5.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.417 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.02 -36.01 12.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.809 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -77.32 -34.76 55.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.774 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -72.86 -34.18 66.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.056 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.414 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.5 t -74.2 -48.59 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.968 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -59.2 -52.83 63.99 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.874 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.56 -28.96 64.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.843 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.434 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 6.6 tpt -76.32 -37.72 57.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.129 0.49 . . . . 0.0 110.177 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.64 -42.86 83.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.455 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -65.1 -39.54 93.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.858 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -81.85 -35.44 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.56 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.68 80.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.5 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 22.8 t0 -100.44 147.44 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.99 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.523 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.6 pt -84.84 -40.75 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.039 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.91 -10.95 59.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.709 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.07 32.67 1.09 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.405 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.4 p-10 -96.25 -12.87 23.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.264 -0.968 . . . . 0.0 112.462 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.19 10.17 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.822 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -146.98 146.37 30.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.962 0.41 . . . . 0.0 109.998 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.68 107.38 14.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.185 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.36 174.83 11.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.338 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.581 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.95 -67.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.494 0.664 . . . . 0.0 111.393 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -34.03 72.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.789 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -40.53 73.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.447 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.79 -33.15 46.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.046 178.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 64.8 t -55.11 -46.92 77.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.661 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.8 -45.65 85.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.13 -32.87 65.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.413 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 16.6 ttp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.873 0.368 . . . . 0.0 111.01 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.718 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.33 -51.28 59.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.538 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.63 -53.26 32.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.678 0.275 . . . . 0.0 111.257 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -57.22 -37.46 72.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.0 0.429 . . . . 0.0 110.346 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.415 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 16.3 t -63.31 -33.72 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.403 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.718 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.5 mt -71.7 -55.36 13.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.046 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.6 mmm-85 -50.34 -38.11 40.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.239 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.71 -44.7 66.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.409 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -57.24 -55.19 38.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.98 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.434 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.12 -57.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.309 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -58.23 -51.16 70.91 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.379 0.609 . . . . 0.0 110.65 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.52 -39.56 64.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.822 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.5 mt -54.31 -48.23 67.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.221 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.27 -38.37 95.79 Favored Glycine 0 CA--C 1.498 -1.002 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.517 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -64.81 -61.66 2.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.683 -0.759 . . . . 0.0 110.506 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.641 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.08 -27.76 67.26 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -67.14 -48.89 66.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.005 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.1 ppt_? -63.45 -43.6 96.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.13 0.49 . . . . 0.0 109.77 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.641 HG23 ' O ' ' B' ' 16' ' ' MET . 1.6 m -62.42 -34.83 66.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.476 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.54 ' N ' HG23 ' B' ' 19' ' ' VAL . 0.3 OUTLIER -74.98 -43.86 51.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.7 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 17.3 p -60.46 -25.68 66.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.511 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.417 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.7 m -90.83 -46.71 14.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.055 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.54 -33.01 74.07 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.171 0.51 . . . . 0.0 110.362 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.498 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.114 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.98 -170.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -121.2 86.78 2.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.583 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -98.73 164.75 12.1 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.662 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.4 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.8 p -97.96 162.71 13.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.506 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -47.43 -51.47 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.878 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -64.27 -27.73 69.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.147 0.499 . . . . 0.0 109.985 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.455 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.4 mm-40 -72.51 -51.36 20.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.736 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.581 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 37.4 pt -73.22 -28.78 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.898 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.36 -27.32 9.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.516 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 13.2 mm-40 -75.17 -28.46 60.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.264 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.583 ' CZ ' ' CD1' ' A' ' 4' ' ' LEU . 3.2 m-85 -79.51 -58.48 3.18 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-O 121.275 0.56 . . . . 0.0 111.014 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.857 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.52 -22.96 14.49 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.209 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.27 -27.78 56.8 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.75 -39.68 61.68 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.051 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.857 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.09 -51.73 68.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 109.43 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 p -74.45 -24.91 59.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.083 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.498 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.0 -25.1 35.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.129 0.49 . . . . 0.0 110.438 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.504 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 5.1 t80 -89.38 -14.53 35.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.498 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.1 t70 -90.61 145.84 24.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.963 0.887 . . . . 0.0 111.24 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.8 mmtt -63.76 -53.43 51.17 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.575 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.44 -7.07 59.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.772 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.52 45.91 58.94 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.394 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -90.9 18.13 6.99 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.894 0.378 . . . . 0.0 110.732 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.37 5.01 89.14 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.542 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.9 p -150.21 151.92 33.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.504 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -102.67 140.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.977 0.418 . . . . 0.0 111.772 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.453 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.11 176.42 8.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.006 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.425 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.1 p -70.4 -38.32 74.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.126 0.489 . . . . 0.0 110.198 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.61 -41.05 89.52 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.176 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -68.98 -53.71 19.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.264 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.28 -55.37 35.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.725 0.774 . . . . 0.0 109.393 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.1 -45.96 91.98 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.536 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.21 -31.11 71.6 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.883 0.342 . . . . 0.0 110.589 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.25 -57.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.424 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.9 OUTLIER -71.95 -35.51 69.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.474 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -42.98 80.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.625 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 t -79.03 -7.14 57.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.761 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.14 -54.51 3.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.27 34.49 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.839 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.561 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.36 -178.4 5.2 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.329 0.585 . . . . 0.0 111.106 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -159.59 56.62 0.9 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.901 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.9 Cg_endo -80.41 -176.27 3.11 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.516 2.144 . . . . 0.0 112.118 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.603 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.68 152.49 31.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.942 0.401 . . . . 0.0 110.27 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.547 ' N ' HG23 ' A' ' 44' ' ' THR . 3.7 mm-40 -57.21 -49.65 75.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.41 75.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.761 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -54.33 33.84 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.626 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.603 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -66.03 -34.57 78.39 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.378 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.46 -43.12 95.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.894 0.378 . . . . 0.0 110.193 179.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.58 -45.37 94.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.265 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.52 -30.67 61.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.37 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.552 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.65 -39.2 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.604 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -45.12 -28.58 0.76 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.373 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.452 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.89 -38.74 53.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.952 0.406 . . . . 0.0 110.698 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' A' ' 52' ' ' ILE . 4.8 m -80.39 -12.75 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.5 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 43.5 t0 -103.53 155.07 18.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.763 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.14 26.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.182 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -116.42 -9.8 11.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.419 0.628 . . . . 0.0 110.402 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.81 61.49 7.31 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.261 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -109.43 18.38 20.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.758 0.313 . . . . 0.0 110.472 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.76 19.79 59.15 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.402 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 p -147.95 176.28 10.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.0 mt -113.28 136.61 49.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.64 0.257 . . . . 0.0 110.846 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -85.87 -179.38 6.8 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.178 0.513 . . . . 0.0 111.77 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.3 m-85 -68.26 -55.94 11.65 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.455 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.3 Cg_endo -65.94 -35.27 35.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.181 1.921 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.25 -52.37 64.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.211 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.02 -56.6 19.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.779 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.83 -47.71 73.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.2 m -59.34 -32.18 69.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.146 0.498 . . . . 0.0 109.713 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.413 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 2.9 tpp -67.73 -61.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.93 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 31.8 mtp . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.599 179.917 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -50.46 -30.53 12.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.316 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.7 OUTLIER -77.17 -29.57 54.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.809 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.8 mt -79.3 -51.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.37 -51.97 11.87 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -53.74 -25.92 20.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 110.71 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.444 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.07 -36.59 48.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.257 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 25.6 t80 -67.82 -52.02 41.82 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.043 0.449 . . . . 0.0 110.181 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -54.55 -32.26 58.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.847 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.72 -22.72 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.577 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.459 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -53.45 -33.45 54.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.207 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -100.19 147.83 25.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.44 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -67.47 -38.35 84.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.403 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.26 -9.75 13.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.835 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.5 28.67 32.12 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.407 -0.901 . . . . 0.0 113.238 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -67.45 -13.9 62.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 117.161 0.481 . . . . 0.0 110.774 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.446 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.09 -11.57 55.58 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.085 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.4 m-85 -127.09 145.34 50.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.993 0.425 . . . . 0.0 111.434 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.429 HD13 ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.16 109.93 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.686 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -83.29 177.29 8.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.541 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.32 -28.62 69.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.059 0.457 . . . . 0.0 110.509 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.31 -57.69 9.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.337 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -43.6 39.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.181 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.409 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 35.5 tp -54.95 -31.18 60.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.081 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 3.3 ttt-85 -73.7 -49.3 26.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -61.28 -36.42 80.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.036 0.446 . . . . 0.0 110.369 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.445 HG12 ' CZ ' ' B' ' 20' ' ' PHE . 41.4 t -72.95 -44.79 56.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.229 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.6 mmt -74.05 -54.33 8.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.45 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.1 m -55.63 -46.2 77.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.32 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -59.51 -30.48 68.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.8 mp -123.47 38.87 4.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.32 -115.69 0.36 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.817 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.21 168.87 17.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.93 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -74.06 100.62 3.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.313 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.419 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.79 115.43 27.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.279 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.83 175.05 6.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.404 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.03 -35.91 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 110.821 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -77.36 -35.07 54.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -72.49 -33.92 67.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.994 0.426 . . . . 0.0 110.08 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.408 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.5 t -74.54 -48.46 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.935 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -59.33 -52.75 64.31 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.847 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.47 -28.81 63.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.819 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.418 ' CE ' HD13 ' B' ' 23' ' ' LEU . 7.7 tpt -76.33 -37.88 56.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.127 0.489 . . . . 0.0 110.182 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -43.6 79.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.56 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -64.94 -39.2 93.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.837 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.22 -36.14 30.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.518 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.22 81.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.666 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.7 t0 -99.76 147.6 25.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.09 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.529 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.8 -40.69 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.102 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.529 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.93 -10.98 60.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.698 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.68 1.09 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.415 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.2 p-10 -95.99 -12.83 24.39 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.302 -0.949 . . . . 0.0 112.455 -176.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.94 20.15 10.15 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.817 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 1.1 pt20 -146.48 146.8 30.68 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.953 0.406 . . . . 0.0 109.983 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.73 107.35 13.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.278 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -79.27 174.6 11.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.285 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.585 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -45.87 -67.07 0.32 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.527 0.68 . . . . 0.0 111.441 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.434 ' HA ' HG21 ' A' ' 142' ' ' VAL . 0.6 OUTLIER -60.5 -34.1 73.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.865 -178.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.17 -41.89 76.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.306 0.574 . . . . 0.0 109.53 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.75 -31.81 46.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.132 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.585 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 62.2 t -55.95 -47.11 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -56.62 -44.33 81.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.07 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.13 -32.31 64.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.5 ttp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.865 0.364 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.717 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.24 -50.96 61.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.538 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.66 -53.26 32.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.701 0.286 . . . . 0.0 111.289 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.14 -37.63 72.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.028 0.442 . . . . 0.0 110.252 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.424 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 13.4 t -63.51 -33.69 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.384 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.717 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.6 mt -71.43 -55.4 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.966 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.8 mmm-85 -50.61 -37.24 39.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.117 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -47.57 62.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.523 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -55.93 -55.34 33.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.989 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.423 ' HA ' HD11 ' B' ' 13' ' ' ILE . 3.8 mt -51.36 -57.48 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.23 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -56.89 -51.2 70.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.93 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.52 -41.53 66.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.3 mt -54.39 -49.58 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.47 -37.18 94.4 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.017 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.674 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.96 -61.62 2.05 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.723 -0.738 . . . . 0.0 110.354 -179.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.666 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.81 -27.73 68.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.615 177.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -64.95 -51.58 61.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.273 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.508 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.5 OUTLIER -63.89 -43.72 95.14 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 16' ' ' MET . 1.7 m -64.56 -32.92 59.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.666 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.02 -45.93 46.64 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.783 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.49 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.7 -26.11 65.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.534 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.425 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.0 m -90.24 -45.9 14.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.171 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.63 -32.67 74.21 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.127 0.489 . . . . 0.0 110.483 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.093 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.835 0.35 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.18 -169.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.68 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -114.6 93.58 4.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.564 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -96.42 164.63 12.55 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.471 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 6.3 p -98.93 162.58 13.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.464 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -47.73 -51.33 22.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.761 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.74 -27.7 69.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.029 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.03 -51.54 21.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.62 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.589 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 39.0 pt -72.67 -28.98 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.592 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.41 11.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.7 mt-10 -75.1 -28.63 60.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.126 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.589 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.22 -58.42 3.23 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.332 0.587 . . . . 0.0 110.927 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.858 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 11.0 ptmt -54.44 -23.31 15.47 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.231 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.11 -27.92 57.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.226 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.41 -39.59 62.53 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.052 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.858 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.78 -51.76 68.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.789 0.804 . . . . 0.0 109.452 178.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.51 -24.8 59.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.99 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.3 tt -82.05 -24.16 35.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.501 . . . . 0.0 110.269 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.497 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 4.2 t80 -92.77 -2.72 55.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.567 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.5 t70 -102.41 144.02 31.41 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.988 0.899 . . . . 0.0 111.032 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.2 mmtt -60.93 -53.44 57.29 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.512 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.31 -4.64 59.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.823 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.9 47.33 39.82 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.292 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 p30 -91.81 18.54 7.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.824 0.345 . . . . 0.0 110.685 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.52 4.85 88.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.57 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.1 p -150.17 149.97 30.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.66 0.266 . . . . 0.0 110.349 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.497 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.72 140.4 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.955 0.407 . . . . 0.0 111.822 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.448 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -85.96 176.99 7.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.131 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.442 HG22 ' CA ' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -69.84 -38.28 76.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.108 0.48 . . . . 0.0 110.315 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.81 -41.36 91.09 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.251 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.546 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.46 -52.16 29.34 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.41 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -55.1 37.89 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.836 0.827 . . . . 0.0 109.364 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.81 -45.15 91.69 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.431 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.5 m -62.52 -31.24 71.98 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.469 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 71.6 t -67.59 -57.31 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.833 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.442 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 3.4 tpt -71.92 -36.17 69.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.539 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -42.01 81.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.647 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.4 t -78.97 -8.44 58.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.675 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tt -89.64 -53.93 4.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.103 0.477 . . . . 0.0 110.694 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.97 35.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.803 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.541 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.8 tp-100 -137.47 179.99 6.08 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.374 0.607 . . . . 0.0 111.212 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -159.76 56.46 0.87 Allowed Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.831 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.1 Cg_endo -80.38 -175.13 2.54 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.469 2.113 . . . . 0.0 112.195 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.594 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -112.98 152.63 29.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.886 0.374 . . . . 0.0 110.272 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 44' ' ' THR . 3.4 mm-40 -57.3 -49.18 76.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.03 74.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.821 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -54.58 28.33 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.639 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.594 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -62.12 -44.65 96.18 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.93 179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -58.2 -49.15 78.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.351 . . . . 0.0 110.751 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -53.25 -47.52 68.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.399 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.413 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.2 mmt -74.77 -30.55 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.767 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -53.62 -35.11 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.868 0.366 . . . . 0.0 111.522 -179.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -44.99 -28.63 0.7 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.267 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -78.05 -38.86 43.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.914 0.387 . . . . 0.0 110.764 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG21 ' HA ' ' A' ' 52' ' ' ILE . 4.5 m -80.49 -11.17 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.6 t0 -103.69 155.79 18.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.735 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.63 -29.17 25.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -116.5 -9.65 11.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.444 0.64 . . . . 0.0 110.468 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.525 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.61 63.51 5.15 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.484 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -112.11 17.9 19.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.857 0.36 . . . . 0.0 110.268 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.07 19.91 54.47 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.554 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.411 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 3.2 p -147.64 176.42 10.1 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.421 HG22 ' CG ' ' A' ' 68' ' ' PHE . 12.1 mt -115.49 136.57 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.569 0.223 . . . . 0.0 111.068 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.4 m-20 -88.05 -178.05 5.89 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.219 0.533 . . . . 0.0 111.964 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.86 -55.97 12.61 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.77 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.9 Cg_endo -65.63 -34.91 39.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.237 1.958 . . . . 0.0 111.186 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -52.28 63.64 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.206 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -56.97 -56.72 18.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.887 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -56.94 -46.25 82.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.653 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.0 m -60.05 -31.91 70.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.092 0.473 . . . . 0.0 110.037 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.43 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.3 tpp -62.24 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.105 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.8 mtm . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.011 -179.897 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.854 0.359 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -50.35 -30.43 12.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 6.4 mt-10 -77.68 -29.47 51.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.713 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.41 HG23 ' CZ ' ' A' ' 141' ' ' PHE . 16.2 mt -79.15 -51.13 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -72.55 -48.85 36.86 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -53.61 -25.49 17.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.807 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.434 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.99 -36.83 48.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.284 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.545 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 25.2 t80 -68.29 -51.68 42.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 110.146 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -54.96 -32.2 61.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.772 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.4 t -88.77 -22.72 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.55 -33.6 55.26 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.073 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -101.8 147.21 26.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.407 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -69.59 -36.59 76.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.448 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.18 -9.69 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.824 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.64 29.82 34.56 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.251 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -67.51 -13.85 62.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.109 0.455 . . . . 0.0 110.732 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.18 -12.7 55.47 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.906 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 20.5 m-85 -127.3 146.91 50.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.86 0.362 . . . . 0.0 111.25 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.408 HG12 ' CD2' ' A' ' 92' ' ' PHE . 1.1 pt -121.11 110.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.854 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m -82.31 178.42 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.644 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.72 -29.69 70.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 110.638 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.56 -57.2 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.147 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.43 -45.26 32.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.251 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.03 -32.7 48.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.936 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -73.4 -49.36 27.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -59.7 -42.67 93.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.877 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.436 HG12 ' CZ ' ' B' ' 20' ' ' PHE . 3.4 t -73.0 -40.14 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.73 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 30.1 mmt -73.95 -54.19 8.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.529 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m -57.01 -48.94 77.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.256 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -57.87 -28.4 64.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -123.6 36.6 4.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.44 -116.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.734 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -130.49 168.75 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.85 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -74.1 100.52 3.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.233 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.78 114.53 26.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.455 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.83 175.39 5.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.358 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -48.11 -35.93 12.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.746 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -77.37 -35.74 54.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.701 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -71.81 -33.51 68.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.966 0.412 . . . . 0.0 110.063 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.431 ' HA ' HD13 ' A' ' 116' ' ' LEU . 2.6 t -73.92 -48.61 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.745 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -58.41 -52.82 64.03 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.544 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -60.24 -28.67 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.577 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.5 tpt -72.42 -37.74 68.56 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.253 0.549 . . . . 0.0 110.085 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.63 -41.25 77.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.501 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -64.78 -40.16 94.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.6 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -81.84 -34.67 30.03 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.002 0.429 . . . . 0.0 110.374 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -34.75 76.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.517 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.418 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.3 t0 -105.19 146.67 28.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.992 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.527 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -83.69 -40.83 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.08 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.527 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.96 -11.0 60.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.678 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.96 32.6 1.02 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.408 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.4 p-10 -96.0 -12.78 24.47 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.332 -0.934 . . . . 0.0 112.432 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.22 10.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.828 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.443 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -146.68 147.4 30.97 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.6 t -130.76 107.3 13.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.354 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.53 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -81.01 174.51 11.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.239 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.545 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -45.96 -67.23 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.583 0.706 . . . . 0.0 111.471 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -60.81 -29.14 69.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.989 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.83 -44.26 77.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.069 0.461 . . . . 0.0 109.814 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.41 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -78.7 -32.01 46.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.175 178.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.519 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 68.5 t -53.84 -48.14 62.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -58.15 -44.16 87.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.21 -32.63 64.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.789 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 15.3 ttp . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.41 ' O ' ' CG2' ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.786 0.327 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.712 ' O ' HG13 ' B' ' 6' ' ' ILE . 2.1 mmm180 -52.15 -51.54 57.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.76 -53.43 31.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.612 0.244 . . . . 0.0 111.417 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.05 -37.0 71.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.139 0.495 . . . . 0.0 110.174 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.437 ' HB ' ' CZ ' ' B' ' 2' ' ' ARG . 21.6 t -63.7 -34.4 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.417 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.712 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.8 mt -71.47 -53.87 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.979 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -50.81 -39.77 53.8 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.238 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -48.32 65.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 13.9 mtmt -55.01 -54.25 45.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.273 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.438 ' HA ' HD11 ' B' ' 13' ' ' ILE . 4.7 mt -51.04 -55.04 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.297 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 5.9 tpt180 -61.44 -46.46 89.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.224 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.13 -40.58 64.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.076 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 1.8 mt -54.55 -51.71 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.512 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.46 -36.72 93.54 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.386 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.68 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.15 -61.58 2.16 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.954 -0.623 . . . . 0.0 110.474 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.667 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -63.38 -27.77 69.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.658 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -66.62 -50.91 61.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.203 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.5 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 3.9 ppt_? -63.38 -43.5 97.42 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.65 HG23 ' O ' ' B' ' 16' ' ' MET . 2.5 m -66.94 -31.85 55.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 0.0 110.609 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.667 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.7 OUTLIER -72.65 -51.15 20.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.814 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.435 ' HA ' ' NE ' ' B' ' 24' ' ' ARG . 50.6 p -57.27 -35.34 69.64 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.116 0.484 . . . . 0.0 110.781 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.461 HG23 ' C ' ' B' ' 19' ' ' VAL . 27.2 m -73.43 -45.81 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.976 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 20' ' ' PHE . 3.6 pp -65.15 -24.9 67.53 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.916 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 11.2 ptt85 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.901 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.866 0.365 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.48 -169.9 1.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.76 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -116.96 83.98 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.566 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -97.51 164.77 12.3 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.019 0.438 . . . . 0.0 110.475 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 p -97.7 161.97 13.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.438 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -47.68 -51.67 20.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.752 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -64.56 -27.69 69.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.033 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.7 mm-40 -71.88 -51.41 22.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.644 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.59 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 39.1 pt -73.01 -28.95 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.72 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.31 10.81 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 4.0 mt-10 -75.25 -28.55 59.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.281 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.38 -58.52 3.17 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.299 0.571 . . . . 0.0 110.946 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.856 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.5 pttt -54.52 -23.48 16.61 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.183 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -75.65 -28.03 58.59 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.174 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.17 -39.77 63.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.094 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.856 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.04 -51.84 68.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.803 0.811 . . . . 0.0 109.544 178.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.49 -24.7 59.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.124 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.483 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -82.13 -23.13 35.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.165 0.507 . . . . 0.0 110.405 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.48 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 3.6 t80 -94.46 -2.82 51.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.639 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 26' ' ' THR . 23.9 t70 -100.83 142.81 31.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.946 0.879 . . . . 0.0 111.096 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -59.84 -53.45 57.78 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.501 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.17 -6.27 59.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.714 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.5 47.37 51.66 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.36 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -92.01 18.8 7.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.882 0.372 . . . . 0.0 110.688 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.42 5.03 89.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.619 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.8 p -150.28 150.27 31.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.688 0.28 . . . . 0.0 110.26 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.78 140.54 20.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.79 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -84.89 176.35 8.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.024 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.427 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.9 OUTLIER -70.49 -37.97 74.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.128 0.49 . . . . 0.0 110.271 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.87 -41.06 90.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.162 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.1 -53.82 18.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.264 -179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -55.13 39.05 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.695 0.76 . . . . 0.0 109.365 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.12 -45.88 92.1 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.514 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.2 m -62.34 -32.3 73.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.874 0.337 . . . . 0.0 110.488 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 70.9 t -66.45 -57.18 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.418 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -71.91 -34.61 69.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.376 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -68.97 -42.62 76.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.666 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.5 t -78.91 -7.75 58.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.751 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.21 -54.91 3.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.806 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.11 34.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.9 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.544 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 tp-100 -137.59 -178.73 5.37 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.295 0.569 . . . . 0.0 111.223 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -159.56 56.57 0.9 Allowed Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.933 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.0 Cg_endo -80.33 -177.38 3.75 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.538 2.159 . . . . 0.0 112.065 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -112.86 152.36 29.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.955 0.407 . . . . 0.0 110.306 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.552 ' N ' HG23 ' A' ' 44' ' ' THR . 3.4 mm-40 -57.51 -49.24 76.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.39 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.65 -31.82 72.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.783 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -54.31 27.68 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.611 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.611 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.97 -34.53 78.31 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.34 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.403 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.49 -42.68 95.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.909 0.385 . . . . 0.0 110.172 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.74 -45.45 93.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.186 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.6 mmt -74.52 -30.77 61.91 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.46 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.74 -38.29 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.606 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -45.03 -28.53 0.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.369 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.437 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.72 -38.33 47.39 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 52' ' ' ILE . 4.7 m -81.58 -11.36 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.239 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.526 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.9 t0 -103.52 155.6 18.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.761 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.61 -28.8 26.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -116.46 -9.75 11.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.399 0.618 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.53 63.23 5.42 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.402 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -112.23 18.42 18.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.863 0.363 . . . . 0.0 110.188 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.32 19.9 56.0 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.49 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.417 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.0 p -146.85 176.49 9.85 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mt -116.27 136.53 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.528 0.204 . . . . 0.0 110.92 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.1 m-20 -87.33 -178.36 6.17 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.328 0.585 . . . . 0.0 112.002 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.496 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.78 -56.37 11.94 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.534 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.4 Cg_endo -65.81 -34.61 39.4 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.285 1.99 . . . . 0.0 111.114 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -52.4 63.67 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.226 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.47 -56.64 19.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.842 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -57.73 -46.26 84.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.3 m -60.69 -31.01 70.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.075 0.464 . . . . 0.0 110.046 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.446 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.5 tpp -62.43 -61.84 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.163 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 66.9 mtp . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.92 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.797 0.332 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -75.35 -44.4 45.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.68 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.76 -29.3 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.455 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.2 mt -65.97 -51.33 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.828 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.442 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -75.68 -51.11 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.828 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -53.91 -30.78 47.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.666 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -69.92 -38.78 76.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 22.6 t80 -67.38 -55.17 14.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.969 0.414 . . . . 0.0 110.431 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -54.47 -30.33 52.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.866 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.4 t -88.38 -22.83 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.148 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.436 ' CD2' HG12 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -55.53 -30.55 60.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.036 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -107.69 142.82 37.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.621 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -38.01 88.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.631 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -110.58 -9.58 14.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.43 31.74 36.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.367 -0.921 . . . . 0.0 113.076 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -67.38 -13.61 62.17 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.962 0.381 . . . . 0.0 110.747 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.444 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.19 -13.73 55.32 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.847 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.451 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.8 m-85 -127.28 147.42 50.23 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.899 0.381 . . . . 0.0 111.292 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -120.17 110.02 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.949 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.9 p -83.93 176.09 9.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.462 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.7 -29.98 71.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.08 0.467 . . . . 0.0 110.471 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.03 -57.01 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.287 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.43 -46.49 26.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.323 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.0 tp -53.13 -31.08 40.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.047 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 6.0 ttt180 -73.82 -49.2 26.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.11 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -57.44 -43.7 84.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.292 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -72.99 -43.0 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.574 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.477 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 31.3 mmt -70.21 -54.22 13.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.569 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.4 m -55.56 -45.25 77.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.15 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -61.64 -29.61 70.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.35 37.59 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.62 -112.95 0.28 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.723 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -136.61 170.27 16.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.771 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -73.59 98.35 2.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.416 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -88.86 113.42 24.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.74 175.26 5.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.376 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -48.09 -36.05 12.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -77.34 -34.13 55.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.795 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -73.91 -33.3 63.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.971 0.415 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.411 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.5 t -74.92 -48.4 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.808 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.09 -52.8 64.18 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.736 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.52 -28.71 63.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.798 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.2 tpt -76.18 -37.9 57.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.142 0.496 . . . . 0.0 110.244 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -42.68 88.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.4 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -62.87 -41.54 99.42 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.1 -32.79 30.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 110.48 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.54 78.45 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.451 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 18.5 t0 -105.46 149.38 26.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.934 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.544 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.5 pt -84.79 -40.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.26 0.552 . . . . 0.0 109.986 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.544 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.88 -10.93 59.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.67 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.12 32.77 1.13 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.412 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.5 p-10 -96.55 -12.9 23.41 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.296 -0.952 . . . . 0.0 112.391 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.09 10.28 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.753 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.451 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.81 146.43 30.24 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.925 0.393 . . . . 0.0 110.094 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.76 107.38 13.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.224 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.514 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.16 174.24 11.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.41 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.58 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.91 -67.07 0.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.5 0.667 . . . . 0.0 111.539 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.78 -33.51 71.79 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.981 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -41.36 75.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.432 ' CD1' HD23 ' B' ' 23' ' ' LEU . 0.2 OUTLIER -78.77 -32.03 46.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.226 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.58 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 61.8 t -55.78 -51.13 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.722 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -58.25 -47.41 83.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.3 tpp -68.44 -31.66 71.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.79 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.429 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 26.5 ttp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.786 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.847 0.356 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.72 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.3 mmm180 -52.26 -51.17 59.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.67 -53.21 32.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.681 0.277 . . . . 0.0 111.302 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -57.06 -37.6 72.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.373 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.418 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 14.9 t -63.38 -33.69 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.37 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.72 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.4 mt -71.76 -55.09 14.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.993 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 27.5 mmm-85 -50.2 -37.9 37.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.2 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.19 -46.57 64.33 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.492 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -56.14 -53.57 55.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.127 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.446 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.21 -57.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.662 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.1 tpt180 -61.67 -51.38 68.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.328 0.585 . . . . 0.0 111.028 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.556 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.37 -38.94 63.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.719 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.475 HG12 ' CZ ' ' A' ' 19' ' ' PHE . 3.1 mt -54.41 -49.24 66.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.275 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.95 -37.76 95.09 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.55 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -64.9 -61.62 2.05 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.707 -0.747 . . . . 0.0 110.507 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.661 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -60.51 -27.73 67.83 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.494 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -67.51 -48.99 65.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.04 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.1 ppt_? -63.29 -43.95 96.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.661 HG23 ' O ' ' B' ' 16' ' ' MET . 1.8 m -61.85 -35.4 67.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.715 0.769 . . . . 0.0 110.234 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.703 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 0.3 OUTLIER -72.49 -46.66 53.75 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.408 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.479 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 59.1 p -59.73 -37.2 78.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.756 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' B' ' 19' ' ' VAL . 27.2 m -72.28 -45.2 62.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' B' ' 20' ' ' PHE . 3.3 pp -64.17 -28.18 69.58 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.893 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.703 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 6.8 ptt85 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.931 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.815 0.34 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.59 -169.7 1.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.796 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.52 83.06 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.57 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -96.1 164.68 12.59 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.407 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.429 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.95 162.77 12.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.491 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -47.48 -51.22 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -64.56 -27.64 69.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.057 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.5 -51.46 19.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.681 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.592 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.1 pt -73.1 -28.89 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.666 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.57 -27.31 10.66 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.54 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 7.3 mt-10 -75.24 -28.6 59.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.289 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.592 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.0 m-85 -79.53 -58.6 3.12 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.24 0.543 . . . . 0.0 110.981 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.85 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.8 15.13 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.198 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.25 -27.99 56.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.31 -39.71 62.7 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.053 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.85 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.88 -51.8 68.46 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.82 0.819 . . . . 0.0 109.387 178.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.411 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 1.8 p -74.42 -23.95 59.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.064 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -81.99 -26.15 34.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.285 0.564 . . . . 0.0 110.04 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.488 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.5 t80 -92.91 0.63 57.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.349 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 26' ' ' THR . 27.7 t70 -105.52 144.07 32.8 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.99 0.9 . . . . 0.0 111.025 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 2.3 mmtt -59.6 -53.41 58.43 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.601 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.63 -3.61 59.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.785 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.08 46.83 33.38 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.322 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.2 p30 -91.1 17.96 7.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.845 0.355 . . . . 0.0 110.759 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.411 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 84.2 4.9 87.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.668 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.431 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.7 p -150.29 147.82 28.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.639 0.257 . . . . 0.0 110.337 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.488 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -99.61 140.39 19.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.825 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.452 ' OG1' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -86.19 179.07 7.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.346 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.452 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.7 OUTLIER -70.19 -41.94 73.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.181 0.515 . . . . 0.0 110.277 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -57.44 -41.12 79.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.467 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.77 -53.79 16.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.405 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.454 ' HB3' ' NZ ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -56.24 -55.69 30.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.882 0.849 . . . . 0.0 109.581 178.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.407 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -58.74 -48.0 87.36 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.485 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.413 ' CB ' ' O ' ' A' ' 30' ' ' LYS . 54.9 m -64.38 -31.11 72.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.858 0.329 . . . . 0.0 110.458 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 18.9 t -63.2 -58.03 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.925 0.393 . . . . 0.0 110.486 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.598 ' HB2' ' HD2' ' B' ' 9' ' ' LYS . 0.0 OUTLIER -72.65 -40.66 66.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.238 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.61 -39.62 88.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.554 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -78.83 -12.2 60.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.597 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.02 -53.75 4.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.108 0.48 . . . . 0.0 110.553 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.53 36.33 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.654 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.539 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 2.0 tp-100 -133.7 178.73 6.71 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.403 0.62 . . . . 0.0 111.267 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -159.87 56.29 0.84 Allowed Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.696 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.4 Cg_endo -80.54 -168.24 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.527 2.151 . . . . 0.0 112.37 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.577 HG23 ' N ' ' A' ' 45' ' ' GLU . 1.2 m -117.37 152.96 33.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.891 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.577 ' N ' HG23 ' A' ' 44' ' ' THR . 2.8 mm-40 -60.37 -48.53 81.34 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.75 76.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.705 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -53.95 46.42 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.484 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -57.65 -51.27 70.19 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.947 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.418 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -53.62 -49.42 67.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.744 0.307 . . . . 0.0 111.289 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -53.11 -48.7 67.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.73 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.406 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.2 mmt -74.71 -30.48 61.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.986 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -53.64 -36.44 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.843 -178.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -45.66 -28.58 1.03 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.271 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -78.04 -38.34 44.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.932 0.396 . . . . 0.0 110.7 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 52' ' ' ILE . 4.1 m -81.21 -12.32 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.063 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.518 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 42.5 t0 -103.59 155.24 18.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.744 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.71 -28.27 26.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.156 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -116.39 -9.72 11.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.443 0.64 . . . . 0.0 110.423 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.89 61.2 7.64 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.278 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -109.37 18.42 20.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.759 0.314 . . . . 0.0 110.447 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.9 19.78 58.92 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.493 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 p -147.81 176.35 10.2 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.7 mt -114.11 136.69 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.582 0.229 . . . . 0.0 110.955 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -87.54 -179.61 6.37 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.218 0.532 . . . . 0.0 111.958 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.5 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.3 m-85 -67.7 -55.77 13.48 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.54 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.73 -35.35 37.2 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.204 1.936 . . . . 0.0 111.166 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.12 -52.48 63.68 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.319 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.64 -56.31 23.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.773 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -58.66 -46.66 86.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.75 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 m -60.68 -30.66 70.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.147 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.435 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 4.6 tpp -59.94 -61.75 2.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.166 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mtm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.918 -179.933 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.862 0.363 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -59.46 -50.75 72.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.662 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.7 -29.27 25.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.518 -179.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 mt -66.61 -51.33 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.829 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -75.62 -50.67 14.79 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -53.81 -32.11 51.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.648 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -68.68 -39.35 80.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.683 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 22.9 t80 -66.73 -56.38 10.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.555 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -53.87 -29.93 43.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.905 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.41 -23.03 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.19 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.435 ' CE2' HD11 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -55.7 -31.94 62.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.061 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -102.69 148.41 25.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.389 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -69.62 -37.51 76.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -112.34 -9.73 13.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.877 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.24 30.83 32.92 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.136 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.41 -13.32 61.91 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.971 0.386 . . . . 0.0 110.813 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.446 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.27 -13.86 55.04 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.826 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.442 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.8 m-85 -127.14 145.69 50.66 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.976 0.417 . . . . 0.0 111.258 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.435 HD11 ' CE2' ' A' ' 92' ' ' PHE . 1.1 pt -121.15 109.94 26.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.814 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 56.0 m -83.73 177.41 8.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.405 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.13 -28.87 70.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.071 0.463 . . . . 0.0 110.494 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.94 -57.67 9.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.436 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -42.37 44.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.257 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.428 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 54.5 tp -57.3 -31.12 65.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.082 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 5.9 ttt180 -72.37 -49.28 35.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -60.6 -36.54 78.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 110.533 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG11 ' CZ ' ' B' ' 20' ' ' PHE . 56.6 t -72.93 -44.56 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.243 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 23.4 mmt -74.05 -53.95 8.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.7 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 m -55.42 -45.58 76.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 111.262 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.44 -25.7 68.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.838 0.351 . . . . 0.0 110.728 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mp -125.37 37.41 4.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.755 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -172.3 -113.77 0.31 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.775 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.72 169.88 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.36 . . . . 0.0 110.877 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -74.09 100.07 3.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.252 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.416 ' CD1' ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.39 114.76 26.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.285 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.74 175.1 5.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.412 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -48.11 -36.02 12.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.939 0.4 . . . . 0.0 110.775 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -77.35 -34.4 55.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.777 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -73.29 -34.05 65.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.002 0.43 . . . . 0.0 110.093 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.5 t -74.4 -48.82 34.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.943 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -58.99 -52.89 63.82 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.908 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.31 -29.02 63.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.839 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.428 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 6.4 tpt -76.32 -38.07 56.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.091 0.472 . . . . 0.0 110.223 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.14 -42.46 84.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.553 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -65.78 -39.2 90.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.923 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.03 -35.54 28.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.402 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.24 -38.58 81.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.517 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 22.6 t0 -98.96 147.48 24.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.078 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.526 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.6 pt -84.79 -40.68 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.307 0.575 . . . . 0.0 110.053 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.92 -11.02 60.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.713 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.72 1.1 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.408 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.3 p-10 -96.28 -12.92 23.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.296 -0.952 . . . . 0.0 112.42 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.96 20.08 10.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.804 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.97 146.31 30.04 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.962 0.41 . . . . 0.0 110.029 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.67 107.44 14.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.229 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.25 174.7 11.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.339 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.586 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.99 -66.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.513 0.673 . . . . 0.0 111.479 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -34.01 72.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.909 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.05 -40.54 73.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.442 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.75 -33.62 46.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.082 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.586 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.4 t -54.68 -46.83 73.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.666 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.98 -45.49 86.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.11 -33.21 65.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.419 ' HG3' ' CE1' ' A' ' 141' ' ' PHE . 14.7 ttp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.846 0.355 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.717 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.2 mmm180 -52.24 -50.78 61.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.526 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.63 -53.36 31.4 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.628 0.252 . . . . 0.0 111.323 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.96 -37.1 71.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.129 0.49 . . . . 0.0 109.998 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.401 ' O ' ' HD3' ' B' ' 9' ' ' LYS . 21.9 t -63.42 -34.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.341 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.717 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.5 mt -71.99 -55.59 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.253 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 27.6 mmm-85 -49.79 -40.56 41.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.414 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -43.72 70.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.224 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 36' ' ' MET . 0.0 OUTLIER -54.84 -55.49 29.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.189 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.439 ' HA ' HD11 ' B' ' 13' ' ' ILE . 3.5 mt -51.6 -57.49 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.835 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.498 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.2 tpt180 -60.56 -51.29 70.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.321 0.582 . . . . 0.0 110.912 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.4 -40.0 64.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.652 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.0 mt -54.51 -47.57 71.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.236 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.08 -38.33 95.84 Favored Glycine 0 CA--C 1.497 -1.056 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.546 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -64.97 -61.69 2.01 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.637 -0.782 . . . . 0.0 110.495 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.647 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.03 -27.75 67.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -67.68 -48.73 65.77 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.935 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.5 ppt_? -62.27 -43.45 98.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.133 0.492 . . . . 0.0 109.692 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.647 HG23 ' O ' ' B' ' 16' ' ' MET . 1.6 m -63.89 -34.9 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.866 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.535 ' N ' HG23 ' B' ' 19' ' ' VAL . 0.3 OUTLIER -74.8 -45.74 41.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.929 -179.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.509 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 12.6 p -59.81 -24.98 64.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.567 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.413 HG21 ' N ' ' B' ' 23' ' ' LEU . 29.5 m -90.73 -46.72 14.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.972 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.31 -32.76 73.55 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.147 0.498 . . . . 0.0 110.335 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.131 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.792 0.33 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.96 -169.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -116.97 90.56 3.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.001 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.577 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.2 mt -98.64 164.75 12.11 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.542 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.4 p -96.77 161.78 13.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.493 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -47.7 -51.78 20.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.781 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -64.35 -27.72 69.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.031 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.87 -51.52 21.93 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.592 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.582 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 39.0 pt -72.98 -28.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.742 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.51 -27.36 10.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.513 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 37.3 mt-10 -75.28 -28.47 59.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.203 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.28 -58.51 3.18 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.281 0.562 . . . . 0.0 110.983 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.855 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.49 -23.05 14.65 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.285 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.513 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.33 -27.87 56.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.49 -39.8 62.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.074 177.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.855 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.74 -51.68 68.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.899 0.857 . . . . 0.0 109.445 178.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.3 p -74.37 -24.89 59.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.049 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.48 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.06 -24.64 35.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.172 0.51 . . . . 0.0 110.278 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.504 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 3.9 t80 -92.66 -2.33 56.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.599 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.9 t70 -102.36 143.37 32.2 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.97 0.891 . . . . 0.0 111.154 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -59.94 -53.42 58.11 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.58 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -84.81 -6.11 59.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.811 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.54 46.27 53.31 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.188 -0.529 . . . . 0.0 113.375 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -90.99 18.15 7.06 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.798 0.333 . . . . 0.0 110.727 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.5 5.7 88.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 48.3 p -150.28 149.9 30.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.504 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.88 140.5 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.944 0.402 . . . . 0.0 111.834 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.446 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.35 176.56 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.02 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.427 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.2 p -70.49 -37.76 74.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.133 0.492 . . . . 0.0 110.268 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.03 -41.11 91.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.155 178.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.23 -53.43 19.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.282 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -54.93 41.46 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.771 0.796 . . . . 0.0 109.402 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.46 -45.89 92.52 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.516 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -62.21 -31.34 71.86 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.851 0.326 . . . . 0.0 110.574 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -68.0 -57.24 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.853 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.427 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 1.1 tpt -71.91 -35.5 69.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.427 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -68.05 -42.15 80.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.595 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 t -78.97 -7.79 58.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.731 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -90.73 -54.31 4.03 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.109 0.48 . . . . 0.0 110.776 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.22 35.19 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.836 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.0 -178.98 5.44 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 111.16 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -159.65 56.43 0.87 Allowed Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.909 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.0 Cg_endo -80.42 -175.72 2.84 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.519 2.146 . . . . 0.0 112.076 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.605 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.89 152.47 32.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.941 0.401 . . . . 0.0 110.23 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.547 ' N ' HG23 ' A' ' 44' ' ' THR . 3.7 mm-40 -57.18 -49.64 75.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.43 75.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.765 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -54.26 34.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.657 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.605 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.87 -34.57 78.44 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.322 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' CA ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.54 -43.07 95.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.926 0.393 . . . . 0.0 110.185 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.33 -45.52 94.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.189 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.4 mmt -74.57 -30.73 61.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.403 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.74 -38.02 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.55 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -45.05 -28.55 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.372 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.59 -38.75 47.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.915 0.388 . . . . 0.0 110.84 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 52' ' ' ILE . 5.0 m -81.17 -11.43 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.157 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.7 t0 -103.63 155.63 18.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.62 -29.09 26.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -116.45 -9.64 11.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.416 0.626 . . . . 0.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.47 63.56 5.12 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.488 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -112.28 18.16 18.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 0.0 110.241 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.93 55.13 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.475 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.411 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.4 p -147.09 176.4 9.97 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -115.77 136.48 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.546 0.212 . . . . 0.0 110.86 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.0 m-20 -87.46 -178.18 6.09 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.318 0.58 . . . . 0.0 111.916 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.1 -55.9 12.13 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.648 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.4 Cg_endo -65.68 -34.39 41.31 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.251 1.967 . . . . 0.0 111.193 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -52.46 61.97 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.209 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.02 -57.04 14.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.867 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -57.1 -47.14 81.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.0 m -60.23 -30.92 69.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 110.077 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.433 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.7 tpp -62.08 -61.84 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.144 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 8.4 mtt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.992 -179.869 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.859 0.361 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -50.44 -30.48 12.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 4.6 mt-10 -77.31 -29.55 53.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.73 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.3 mt -79.24 -51.13 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -48.48 38.34 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.897 0.379 . . . . 0.0 111.863 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -53.5 -26.42 20.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.357 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.56 -33.99 58.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.964 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 13.1 t80 -68.96 -50.42 49.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.002 0.43 . . . . 0.0 110.149 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -54.42 -33.21 59.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.767 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.99 -22.7 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.557 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -52.81 -36.82 59.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.342 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -100.09 147.13 25.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.753 0.311 . . . . 0.0 110.525 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -67.94 -37.71 81.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.434 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -112.2 -9.76 13.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.847 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.41 28.36 33.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.365 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -67.51 -13.96 62.51 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.163 0.481 . . . . 0.0 110.769 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -11.49 55.44 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.084 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.7 m-85 -127.21 146.94 50.24 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.925 0.393 . . . . 0.0 111.53 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.428 HD11 ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.14 109.92 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.633 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 m -82.66 176.78 9.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.14 -29.88 70.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.097 0.475 . . . . 0.0 110.457 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.24 -57.74 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.23 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.44 -45.46 31.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.157 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.402 ' CD1' ' CD1' ' A' ' 100' ' ' ILE . 28.6 tp -53.04 -31.44 41.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -72.46 -49.13 35.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -59.9 -42.0 92.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.115 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.9 t -73.06 -40.17 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.404 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.46 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.7 mmt -73.92 -54.16 8.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 m -59.03 -48.9 79.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.202 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -57.26 -28.56 63.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.414 ' CD2' ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -124.33 37.0 4.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.731 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.43 -115.88 0.36 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.808 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.7 167.52 18.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 110.883 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -73.59 100.07 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.291 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.418 HD11 ' HA ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.55 114.43 26.64 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.393 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.78 175.26 5.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.385 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -48.01 -35.92 11.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.363 . . . . 0.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.4 -35.44 54.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.698 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -72.29 -33.3 67.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.959 0.409 . . . . 0.0 110.116 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.418 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.6 t -74.65 -48.51 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.846 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -59.41 -52.87 63.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.724 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -57.76 -28.67 64.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.807 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.407 ' CE ' HD13 ' B' ' 23' ' ' LEU . 6.6 tpt -76.12 -37.88 57.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.147 0.499 . . . . 0.0 110.248 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.14 -40.65 80.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -66.46 -39.19 88.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.952 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.41 -36.13 29.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.61 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.17 80.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.413 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.435 ' HA ' ' HG2' ' A' ' 140' ' ' GLU . 22.4 t0 -101.36 145.53 28.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.033 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.52 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.0 pt -83.06 -40.8 16.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.165 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.92 -11.02 60.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.747 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.87 32.65 0.99 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 131' ' ' ASP . 42.3 p-10 -95.53 -12.41 25.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.304 -0.948 . . . . 0.0 112.568 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.18 10.19 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.89 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.443 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.99 147.37 31.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.74 107.25 13.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.39 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.529 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -78.81 174.79 11.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.227 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.584 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 1.1 t80 -45.93 -67.08 0.31 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.635 0.731 . . . . 0.0 111.788 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.474 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.4 mt-10 -65.28 -25.3 67.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.42 -1.263 . . . . 0.0 112.554 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 129' ' ' ASP . 0.3 OUTLIER -55.62 -48.51 74.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.822 0.344 . . . . 0.0 110.271 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.8 p90 -78.91 -30.99 45.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.243 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.49 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.4 t -52.83 -44.5 48.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.121 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -60.34 -37.16 79.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.125 0.488 . . . . 0.0 109.809 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.46 -42.21 62.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.721 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.2 ttp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.026 -179.836 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.801 0.334 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.716 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.23 -51.08 60.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.65 -53.27 32.36 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.677 0.275 . . . . 0.0 111.302 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.1 -37.54 72.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.015 0.436 . . . . 0.0 110.339 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 14.2 t -63.46 -34.12 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.387 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.716 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.6 mt -70.84 -54.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.969 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -51.51 -37.24 48.25 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.097 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.63 -48.31 64.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.472 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -55.8 -54.38 45.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.433 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 4.5 mt -51.17 -57.45 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.465 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.8 tpt180 -59.79 -51.23 70.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.237 0.541 . . . . 0.0 111.094 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.502 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.19 -40.1 64.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.819 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 2.8 mt -54.58 -50.37 59.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.418 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.93 -36.82 93.96 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.056 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.679 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.28 -61.69 2.08 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.539 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.686 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.98 -27.62 69.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.599 177.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.484 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -66.04 -50.68 63.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.225 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.504 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.4 OUTLIER -63.64 -43.55 96.46 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.02 0.438 . . . . 0.0 109.847 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.627 HG23 ' O ' ' B' ' 16' ' ' MET . 2.2 m -65.9 -32.69 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.839 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.686 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.66 -48.13 27.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.219 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.519 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 13.5 p -58.46 -25.9 62.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.454 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.405 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.5 m -89.93 -47.62 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.161 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.429 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -62.84 -33.02 74.37 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.139 0.495 . . . . 0.0 110.507 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.519 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.107 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.79 0.328 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.17 -170.16 1.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -116.77 83.95 2.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.71 164.71 12.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.539 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.32 162.73 13.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.48 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -47.39 -51.38 19.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.902 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -64.39 -27.71 69.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.034 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.453 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.5 -51.39 20.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.705 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.586 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 37.4 pt -73.18 -28.79 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.809 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.38 -27.32 9.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 35.0 mm-40 -75.25 -28.51 59.88 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.166 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.42 -58.31 3.27 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.228 0.537 . . . . 0.0 111.042 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.856 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 11.2 ptmt -54.56 -22.99 14.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.235 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.27 -28.02 56.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.33 -39.83 62.58 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.07 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.856 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.01 -51.66 69.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.774 0.797 . . . . 0.0 109.5 178.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 p -74.42 -24.78 59.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.072 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -82.04 -24.29 35.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.177 0.513 . . . . 0.0 110.285 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.5 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 3.6 t80 -93.4 -1.71 55.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.563 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.7 t70 -102.7 143.56 32.19 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 122.005 0.907 . . . . 0.0 111.125 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.2 mmtt -59.65 -53.47 57.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.56 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.51 -5.72 59.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.744 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.3 46.31 51.98 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.356 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -90.97 18.15 7.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.799 0.333 . . . . 0.0 110.73 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.72 5.57 88.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.564 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 47.5 p -150.34 149.58 30.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.65 140.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.879 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.21 176.37 8.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.002 179.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.426 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.1 p -70.49 -37.77 74.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.126 0.488 . . . . 0.0 110.257 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.09 -41.13 91.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.143 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.546 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -69.09 -53.79 18.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.221 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.16 -55.62 32.61 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.73 0.776 . . . . 0.0 109.362 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.76 -46.18 90.1 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.62 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.7 m -62.5 -32.13 72.99 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.951 0.376 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 71.8 t -67.03 -57.22 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.922 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.417 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.6 OUTLIER -71.9 -36.37 69.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.471 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -67.07 -41.9 85.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.4 . . . . 0.0 110.552 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.7 t -79.04 -7.94 58.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.698 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.2 tt -91.42 -55.41 3.52 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.97 33.1 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.946 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -134.18 -179.66 5.7 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.337 0.589 . . . . 0.0 111.125 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -159.66 56.33 0.86 Allowed Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.819 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.8 Cg_endo -80.62 -172.78 1.61 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.577 2.185 . . . . 0.0 112.086 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.37 152.42 35.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.884 0.373 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.548 ' N ' HG21 ' A' ' 44' ' ' THR . 3.6 mm-40 -56.7 -50.15 73.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 -33.33 75.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.709 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -54.39 31.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.687 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.61 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.83 -34.63 78.61 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.399 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -42.75 95.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 110.226 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.65 -45.5 93.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.25 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -30.76 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.424 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.73 -38.01 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.529 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -44.93 -28.59 0.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.417 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.439 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.45 -38.96 48.34 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 120.89 0.376 . . . . 0.0 110.819 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 52' ' ' ILE . 5.0 m -81.23 -11.47 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.182 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.7 t0 -103.61 155.65 18.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.788 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -29.01 26.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.095 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -116.49 -9.67 11.39 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.407 0.623 . . . . 0.0 110.481 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.31 63.77 4.94 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.481 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -112.39 18.11 18.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.831 0.348 . . . . 0.0 110.216 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.84 19.85 55.11 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.469 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.408 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.6 p -147.1 176.42 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.418 HG22 ' CG ' ' A' ' 68' ' ' PHE . 14.6 mt -115.77 136.52 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.836 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.9 m-20 -87.28 -178.27 6.16 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.218 0.533 . . . . 0.0 111.859 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.08 -55.83 12.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.727 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -65.67 -34.77 40.03 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.272 1.981 . . . . 0.0 111.12 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -52.45 62.95 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.232 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -56.93 -56.83 16.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.815 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -56.75 -45.75 81.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.679 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.8 m -60.07 -31.33 69.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.085 0.469 . . . . 0.0 109.954 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.424 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 2.9 tpp -64.68 -61.8 1.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.949 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 43.0 mtm . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.787 179.901 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.81 0.338 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.48 -30.64 13.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.397 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 2.1 mt-10 -65.94 -29.78 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 110.342 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -79.45 -50.64 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.308 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.2 OUTLIER -74.99 -51.24 14.13 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -53.5 -25.19 15.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.742 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.428 ' CB ' HG22 ' B' ' 19' ' ' VAL . . . -78.43 -36.61 45.32 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 24.0 t80 -68.12 -52.26 36.92 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.012 0.434 . . . . 0.0 110.091 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -32.05 59.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.807 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.74 -22.74 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.522 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.455 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.85 -31.64 50.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.144 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -103.25 147.44 27.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.431 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -69.24 -37.03 77.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.432 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.15 -9.75 13.92 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.75 29.89 33.95 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.232 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.37 -13.95 62.48 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.078 0.439 . . . . 0.0 110.779 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.14 -12.12 55.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.969 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.6 m-85 -127.26 146.85 50.28 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.953 0.406 . . . . 0.0 111.247 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.42 HD11 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.03 110.01 26.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.875 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -84.09 176.9 8.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.522 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.55 70.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.08 0.467 . . . . 0.0 110.484 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.73 -57.18 12.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.209 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.32 -46.11 29.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.309 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.42 HD13 HD11 ' A' ' 100' ' ' ILE . 20.0 tp -53.14 -31.11 40.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.996 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 2.8 ttt-85 -73.35 -49.13 28.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -58.87 -42.87 90.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.142 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' B' ' 20' ' ' PHE . 2.2 t -72.91 -40.37 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.529 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.464 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 30.0 mmt -73.87 -54.21 8.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.353 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.3 m -56.96 -48.84 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 0.0 111.147 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -58.8 -29.33 66.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.6 mp -122.88 37.62 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.802 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 109' ' ' MET . . . -171.2 -113.86 0.31 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.783 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.07 166.85 21.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 110.886 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -72.39 99.68 2.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.244 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.413 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.81 114.51 26.25 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.421 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.77 175.24 5.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.37 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -48.02 -36.0 12.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 110.77 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.37 -34.88 54.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.723 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -73.0 -33.23 65.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.973 0.416 . . . . 0.0 110.079 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.41 HG22 HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.95 -48.51 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.839 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -59.01 -52.81 64.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.746 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.7 -28.65 64.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.765 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 12.8 tpt -76.15 -37.5 57.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.172 0.51 . . . . 0.0 110.163 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.21 -39.16 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.342 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -64.77 -41.94 95.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.418 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -82.08 -32.45 30.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.937 0.398 . . . . 0.0 110.431 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.77 -34.71 76.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.54 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.0 t0 -107.95 148.07 30.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.014 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.526 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.7 pt -84.91 -40.71 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.013 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.95 -10.98 60.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.693 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.06 32.8 1.1 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.35 -12.69 24.02 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.332 -0.934 . . . . 0.0 112.493 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.79 20.14 10.28 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.832 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.77 146.44 30.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.959 0.409 . . . . 0.0 110.0 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 38.4 t -130.79 107.41 13.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.213 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -79.86 174.22 11.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.259 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.573 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.82 -67.07 0.32 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.554 0.692 . . . . 0.0 111.448 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -60.11 -33.41 72.09 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.903 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -42.09 75.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.36 0.6 . . . . 0.0 109.496 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.438 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.69 -31.87 46.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.114 178.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.573 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 55.5 t -55.38 -48.75 76.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.655 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -55.15 -49.67 71.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -70.57 -30.38 67.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.783 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.42 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.848 0.356 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.717 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.1 mmm180 -52.38 -51.0 61.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.076 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.68 -53.24 32.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.679 0.276 . . . . 0.0 111.29 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -57.06 -37.64 72.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.997 0.427 . . . . 0.0 110.34 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.417 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 13.9 t -63.37 -34.15 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.361 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.717 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.6 mt -71.07 -55.28 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.967 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.4 mmm-85 -50.73 -36.84 38.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.098 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -48.28 63.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.466 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -55.56 -54.96 37.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.222 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.424 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 4.0 mt -51.13 -57.43 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.431 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.519 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -58.92 -51.05 71.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.27 0.557 . . . . 0.0 111.051 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.27 -40.58 64.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.831 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.474 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 2.9 mt -54.61 -49.7 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.493 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.43 -36.95 94.06 Favored Glycine 0 CA--C 1.499 -0.961 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.068 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.681 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.14 -61.73 2.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.789 -0.705 . . . . 0.0 110.357 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.667 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.75 -28.08 69.72 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.659 177.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.484 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -65.5 -51.48 59.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.227 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.511 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.5 OUTLIER -63.31 -43.44 97.82 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.037 0.446 . . . . 0.0 109.831 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.635 HG21 ' O ' ' B' ' 16' ' ' MET . 2.1 m -66.45 -32.55 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.639 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.667 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -71.82 -50.15 32.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.986 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.451 ' HA ' ' NE ' ' B' ' 24' ' ' ARG . 52.7 p -58.27 -35.56 71.96 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.023 0.439 . . . . 0.0 110.836 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.453 HG22 ' C ' ' B' ' 19' ' ' VAL . 26.9 m -73.04 -45.22 55.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.09 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' B' ' 20' ' ' PHE . 2.7 pp -64.62 -27.98 69.31 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.933 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.645 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 10.9 ptt85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.904 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.773 0.321 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.09 -169.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.824 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -117.49 89.09 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.002 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.579 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.78 164.81 12.24 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.459 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 p -98.28 162.4 13.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.488 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -47.25 -51.35 19.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.845 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.29 -27.72 69.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.115 0.484 . . . . 0.0 110.034 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.0 OUTLIER -72.64 -51.38 19.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.694 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.582 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 35.5 pt -73.27 -28.83 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.931 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.44 -27.37 10.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 49.6 mt-10 -75.43 -28.49 59.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.272 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.33 -58.57 3.15 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.242 0.544 . . . . 0.0 111.163 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.857 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -54.75 -23.3 17.22 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.175 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -75.64 -28.26 58.73 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.96 -40.02 63.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.072 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.857 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.11 -51.9 68.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.796 0.808 . . . . 0.0 109.608 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -24.79 59.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.042 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.486 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -82.15 -26.9 33.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.117 0.484 . . . . 0.0 110.401 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.498 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 4.6 t80 -87.2 -14.3 41.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.579 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.8 t70 -90.79 145.27 24.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.931 0.872 . . . . 0.0 111.175 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.8 mmtt -63.36 -53.39 53.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.578 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -83.09 -7.07 59.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.735 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.3 46.94 56.99 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.398 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -91.73 18.59 7.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.854 0.359 . . . . 0.0 110.659 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.21 5.11 89.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.539 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.7 p -150.28 152.07 33.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -103.04 140.53 21.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.924 0.392 . . . . 0.0 111.712 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.462 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -84.72 176.14 8.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.008 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.423 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.0 OUTLIER -70.39 -38.45 74.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.085 0.469 . . . . 0.0 110.159 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.48 -40.92 88.51 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.144 178.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.542 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.07 -53.68 19.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.272 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.41 -54.91 41.64 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.761 0.791 . . . . 0.0 109.47 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.46 -46.01 92.39 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.581 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.12 -31.16 71.59 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.806 0.336 . . . . 0.0 110.587 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -68.18 -57.23 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.427 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.8 OUTLIER -71.89 -35.53 69.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.412 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -42.46 80.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.641 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.7 t -78.95 -7.46 58.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.749 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.11 -54.43 3.95 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.056 0.455 . . . . 0.0 110.796 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.45 34.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.871 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.556 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.02 -178.78 5.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.291 0.567 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -159.59 56.49 0.89 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.884 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.0 Cg_endo -80.37 -176.09 3.02 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.552 2.168 . . . . 0.0 112.065 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.606 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.61 152.45 31.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.94 0.4 . . . . 0.0 110.236 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.549 ' N ' HG21 ' A' ' 44' ' ' THR . 3.7 mm-40 -57.13 -49.68 75.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.386 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.24 75.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.72 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.7 -54.32 33.4 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.682 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.606 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.89 -34.69 78.7 Favored 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.405 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.52 -42.92 95.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.886 0.374 . . . . 0.0 110.162 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.52 -45.44 94.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.233 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -30.71 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.41 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.75 -38.31 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.527 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -45.03 -28.55 0.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.377 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.76 -38.56 46.58 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.886 0.374 . . . . 0.0 110.841 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 52' ' ' ILE . 4.8 m -81.2 -11.27 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.167 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.4 t0 -103.66 155.62 18.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.759 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.65 -28.93 26.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.034 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -116.45 -9.73 11.41 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.408 0.623 . . . . 0.0 110.501 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.45 63.58 5.1 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.476 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -112.32 18.12 18.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.854 0.359 . . . . 0.0 110.19 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.75 19.9 55.18 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.491 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.411 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 3.8 p -147.32 176.46 9.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.2 mt -115.85 136.51 52.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.557 0.218 . . . . 0.0 110.91 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.7 m-20 -87.11 -178.08 6.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.298 0.571 . . . . 0.0 111.959 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.499 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.99 -56.12 11.98 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.674 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.8 -34.44 40.06 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.254 1.969 . . . . 0.0 111.175 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.07 -52.38 62.96 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.166 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.03 -56.92 15.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.893 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.488 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -56.6 -47.13 80.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.7 m -60.21 -30.76 69.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.07 0.462 . . . . 0.0 110.078 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.424 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.1 tpp -64.43 -61.83 1.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.124 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 mtt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.976 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.806 0.336 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -50.45 -30.55 12.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.183 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.481 ' CB ' ' HB3' ' B' ' 15' ' ' LYS . 0.6 OUTLIER -77.24 -29.3 53.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.789 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.2 mt -79.08 -51.04 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -73.7 -51.11 17.71 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.839 0.352 . . . . 0.0 111.901 -178.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -53.56 -24.61 14.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -78.67 -35.73 44.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.058 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.545 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.8 t80 -69.03 -52.43 28.79 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.108 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -55.7 -31.9 62.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.895 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.94 -22.73 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.571 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -54.53 -32.24 57.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.081 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -102.75 147.42 26.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.434 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -69.64 -36.83 76.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -112.18 -9.66 13.91 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.55 30.08 34.1 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.204 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -67.37 -13.82 62.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.004 0.402 . . . . 0.0 110.797 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.437 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.18 -11.71 55.28 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.011 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.433 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.0 m-85 -127.3 145.83 50.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 120.959 0.409 . . . . 0.0 111.354 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -120.68 110.03 27.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.828 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -83.41 176.4 9.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.525 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.403 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -63.32 -29.84 71.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.065 0.459 . . . . 0.0 110.432 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.13 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.222 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.37 -46.1 28.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.35 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.8 tp -53.1 -31.06 40.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.09 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 3.5 ttt-85 -74.21 -49.26 24.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.182 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -58.32 -42.39 86.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.057 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.406 HG12 ' CZ ' ' B' ' 20' ' ' PHE . 2.5 t -72.87 -40.68 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.563 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 30.0 mmt -73.91 -54.34 8.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.351 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 m -57.32 -48.92 77.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.21 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -58.38 -28.61 65.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -123.89 36.63 4.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.802 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.35 -113.47 0.29 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.844 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.31 166.24 22.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 110.931 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -73.12 99.91 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.332 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.416 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.43 114.52 26.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.292 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.62 174.97 6.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.439 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -48.08 -36.01 12.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 0.0 110.767 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -77.39 -34.27 54.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.734 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -73.5 -33.43 64.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.972 0.415 . . . . 0.0 110.029 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.412 HG22 ' CD ' ' A' ' 106' ' ' ARG . 2.5 t -75.14 -49.32 28.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.871 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.19 -52.83 63.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.708 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -57.34 -28.65 63.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.679 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.9 tpt -75.42 -38.41 59.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.294 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.403 HD13 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.98 -41.91 81.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.559 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -65.9 -39.61 90.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.647 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.09 -36.41 27.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.55 83.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.487 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 23.7 t0 -100.35 147.26 26.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.004 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.529 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.79 -40.69 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.086 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.529 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.97 -10.94 60.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.647 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.6 1.08 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.2 p-10 -96.16 -12.87 24.06 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.269 -0.965 . . . . 0.0 112.363 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.93 20.2 10.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.816 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.436 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -147.05 146.66 30.08 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.954 0.407 . . . . 0.0 109.969 179.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 37.7 t -130.73 107.42 14.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.266 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.537 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.18 174.58 11.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.235 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.574 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.96 -66.96 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.448 0.642 . . . . 0.0 111.332 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.83 -33.85 72.31 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.775 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.15 -40.11 73.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.458 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.74 -34.69 45.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.047 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.574 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 78.8 t -54.3 -46.02 68.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.786 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -57.43 -46.82 83.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.13 -31.54 64.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.412 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.719 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.29 -51.05 60.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.537 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.7 -53.22 33.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.654 0.264 . . . . 0.0 111.284 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -57.16 -37.74 72.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.003 0.43 . . . . 0.0 110.31 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 14.5 t -63.14 -34.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.356 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.719 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.6 mt -70.75 -55.05 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.919 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 mmm-85 -50.55 -37.24 38.38 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.127 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -68.98 -48.32 63.42 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.61 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -55.78 -55.1 36.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.262 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.424 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.24 -57.49 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.56 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.483 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.72 -50.41 73.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.211 0.529 . . . . 0.0 111.028 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.525 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.23 -41.06 65.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.809 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.0 mt -54.57 -47.68 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.485 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.401 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.53 -37.1 93.98 Favored Glycine 0 CA--C 1.498 -1.006 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.671 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.672 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.94 -61.52 2.11 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.728 -0.736 . . . . 0.0 110.275 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.738 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.26 -28.17 68.98 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.616 177.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -64.8 -52.14 58.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.241 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.51 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.5 OUTLIER -63.56 -43.34 97.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.026 0.441 . . . . 0.0 109.922 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.69 HG22 ' O ' ' B' ' 16' ' ' MET . 2.2 m -65.79 -35.09 74.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.668 0.747 . . . . 0.0 110.424 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.738 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.3 OUTLIER -71.37 -45.75 62.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.363 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.492 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 57.2 p -60.13 -36.66 77.99 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.723 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' B' ' 19' ' ' VAL . 27.1 m -72.92 -44.35 57.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.171 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' B' ' 20' ' ' PHE . 3.4 pp -64.1 -29.53 70.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.779 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.856 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.75 -170.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -120.87 89.74 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.585 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.4 mt -99.52 164.81 11.93 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.622 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.9 p -96.87 161.99 13.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.511 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -47.5 -51.75 19.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.806 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -64.36 -27.65 69.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.973 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.452 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.11 -51.55 20.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.643 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.579 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.1 pt -72.8 -28.76 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.882 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.27 -27.33 9.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.0 mt-10 -75.27 -28.42 59.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.314 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.585 ' CZ ' ' CD1' ' A' ' 4' ' ' LEU . 3.3 m-85 -79.48 -58.51 3.16 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.221 0.534 . . . . 0.0 111.078 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.855 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.54 14.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.218 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.56 -28.01 56.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.45 -39.87 62.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.059 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.855 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.63 -51.77 68.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.851 0.834 . . . . 0.0 109.416 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -74.46 -24.45 59.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.087 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.482 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.2 tt -82.04 -24.88 35.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.233 0.539 . . . . 0.0 110.249 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.514 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 3.2 t80 -93.05 -1.74 56.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.561 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.2 t70 -103.14 143.64 32.35 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.966 0.888 . . . . 0.0 111.114 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -60.2 -53.47 57.31 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.54 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -84.9 -5.95 59.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.801 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.34 46.64 51.95 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.367 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 p30 -91.35 18.44 7.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.83 0.348 . . . . 0.0 110.706 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.33 88.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.611 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.0 p -150.24 150.07 31.04 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.514 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -102.0 140.49 20.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.959 0.409 . . . . 0.0 111.939 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.25 176.48 8.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.009 179.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.426 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.2 p -70.43 -37.88 74.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.058 0.456 . . . . 0.0 110.312 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.0 -41.26 91.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.134 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.546 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -68.91 -53.79 19.1 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.27 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -55.83 29.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.711 0.767 . . . . 0.0 109.357 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.45 -45.77 88.75 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.562 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.4 m -62.74 -32.09 73.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.78 0.324 . . . . 0.0 110.585 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 71.0 t -66.68 -57.24 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.416 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -71.88 -36.94 70.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.436 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -66.13 -41.3 90.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 110.537 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -79.06 -8.72 59.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.65 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -90.63 -54.28 4.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.084 0.468 . . . . 0.0 110.746 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.73 34.45 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.891 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.559 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.63 179.99 5.88 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.301 0.572 . . . . 0.0 111.12 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -159.69 56.22 0.84 Allowed Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.812 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.3 Cg_endo -80.67 -172.23 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.538 2.159 . . . . 0.0 112.116 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -119.08 152.41 36.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.926 0.393 . . . . 0.0 110.142 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.547 ' N ' HG23 ' A' ' 44' ' ' THR . 3.7 mm-40 -56.91 -50.08 73.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.41 75.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.462 0.649 . . . . 0.0 110.681 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -54.29 33.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.702 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.61 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -66.05 -34.54 78.3 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.366 179.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.64 -42.59 95.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.911 0.386 . . . . 0.0 110.149 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -61.87 -45.46 93.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.218 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.1 mmt -74.54 -30.7 61.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.47 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.28 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.587 -179.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -45.01 -28.6 0.7 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.378 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.43 -39.35 47.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.972 0.415 . . . . 0.0 110.792 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 52' ' ' ILE . 4.7 m -80.59 -11.68 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.143 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.513 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 38.8 t0 -103.61 155.56 18.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.738 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -29.08 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.061 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -116.52 -9.66 11.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.429 0.633 . . . . 0.0 110.42 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.2 64.04 4.69 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.445 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -112.45 17.7 19.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.872 0.368 . . . . 0.0 110.214 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.29 19.9 53.85 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.512 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.403 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 3.9 p -147.62 176.36 10.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.407 HG21 ' CG ' ' A' ' 68' ' ' PHE . 54.1 mt -115.03 136.49 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 120.609 0.242 . . . . 0.0 110.853 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.4 m-20 -86.91 -178.42 6.3 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.256 0.551 . . . . 0.0 111.836 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.87 -55.74 13.06 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.769 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.7 Cg_endo -65.56 -35.14 39.58 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.291 1.994 . . . . 0.0 111.244 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.37 -52.34 62.1 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.242 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -56.9 -56.92 15.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.907 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.491 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.73 -48.18 72.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.5 m -58.74 -32.3 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.203 0.525 . . . . 0.0 109.716 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.417 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 2.7 tpp -67.86 -61.6 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.938 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 mtt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.742 179.963 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.795 0.331 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -50.42 -30.48 12.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.241 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.506 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 4.6 mt-10 -73.77 -29.45 62.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.718 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.408 HG21 ' CZ ' ' A' ' 141' ' ' PHE . 14.4 mt -79.04 -51.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.409 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -71.95 -50.46 28.76 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -53.51 -25.22 15.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 110.779 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.443 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.72 -36.77 50.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.271 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.9 t80 -68.46 -51.4 43.94 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.014 0.435 . . . . 0.0 110.097 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -55.03 -32.17 61.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.799 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.78 -22.73 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.617 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.469 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.38 -30.11 38.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.049 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -109.13 139.47 43.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.449 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.02 -38.54 91.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.591 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -107.85 -9.64 15.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.18 31.03 39.72 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.144 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -67.53 -13.82 62.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.041 0.421 . . . . 0.0 110.756 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.442 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 100.91 -12.15 59.11 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.976 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 20.3 m-85 -127.35 146.15 50.56 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.914 0.387 . . . . 0.0 111.338 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' CD2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.15 110.01 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.807 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t -83.07 178.24 8.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.43 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.83 -28.12 69.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.093 0.473 . . . . 0.0 110.557 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.96 -56.8 12.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.291 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -76.35 -42.49 44.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.232 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.6 tp -56.55 -33.61 66.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 2.3 ttt-85 -71.79 -49.47 38.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.945 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -61.87 -38.43 88.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 110.376 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.475 HG12 ' CZ ' ' B' ' 20' ' ' PHE . 39.9 t -73.06 -43.97 57.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.403 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.451 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 25.4 mmt -73.99 -54.02 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.465 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -55.38 -46.87 76.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.478 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.88 -29.77 68.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.0 38.21 4.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.678 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.42 -113.96 0.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.773 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -135.21 169.21 17.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -73.83 99.75 3.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.0 115.25 27.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.373 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.81 175.21 5.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.41 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -48.0 -35.89 11.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.397 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -77.4 -35.91 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.71 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -71.66 -33.31 68.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.951 0.405 . . . . 0.0 110.065 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.422 ' HA ' HD13 ' A' ' 116' ' ' LEU . 2.6 t -74.86 -49.12 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.56 . . . . 0.0 109.849 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -59.46 -52.76 64.22 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.758 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -57.33 -28.7 63.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.2 tpt -76.19 -39.43 54.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.121 0.486 . . . . 0.0 110.241 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -41.11 87.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.369 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -64.21 -41.59 96.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.444 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.73 -33.13 27.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.476 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.39 -35.25 77.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.454 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.42 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 20.9 t0 -106.09 146.1 30.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.029 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.527 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.0 pt -82.73 -40.95 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.147 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.527 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.95 -11.05 60.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.675 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.74 33.11 1.0 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.408 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.2 p-10 -96.58 -12.62 23.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.307 -0.946 . . . . 0.0 112.466 -176.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.21 10.18 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.777 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.443 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.5 147.21 30.94 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.134 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.5 t -130.73 107.25 13.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.364 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.57 174.57 11.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.222 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.559 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -45.95 -67.15 0.31 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.54 0.686 . . . . 0.0 111.488 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.75 -29.54 69.45 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.563 -1.198 . . . . 0.0 111.913 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -44.05 77.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.08 0.467 . . . . 0.0 109.762 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.408 ' CZ ' HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -78.74 -31.91 46.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.134 178.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.527 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.5 t -54.03 -48.29 64.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.132 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.625 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -57.99 -44.99 87.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.7 tpp -73.14 -32.92 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.7 ttp . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.919 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.718 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.3 -50.89 61.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.056 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.538 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.72 -53.26 32.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.678 0.275 . . . . 0.0 111.241 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -57.07 -37.68 72.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.051 0.453 . . . . 0.0 110.365 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.406 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 12.4 t -63.45 -33.64 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.415 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.718 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.6 mt -71.52 -55.43 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.026 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.2 mmm-85 -50.58 -37.61 40.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.214 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -69.76 -47.17 63.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.543 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -56.0 -55.41 33.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.417 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.52 -57.34 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.049 0.452 . . . . 0.0 111.059 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.54 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -56.16 -51.19 68.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.954 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.39 -40.24 64.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.094 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.1 mt -54.44 -51.52 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.506 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.27 93.19 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.08 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.678 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.73 -61.44 2.18 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.812 -0.694 . . . . 0.0 110.413 -178.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.676 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -62.97 -27.84 69.68 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.647 177.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.492 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -66.05 -51.31 59.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.226 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.502 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 3.7 ppt_? -63.49 -43.48 97.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.977 0.418 . . . . 0.0 109.918 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.644 HG23 ' O ' ' B' ' 16' ' ' MET . 2.4 m -66.61 -32.29 57.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.679 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.676 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -71.65 -50.94 25.95 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.955 -179.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.432 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 54.7 p -57.85 -36.24 72.05 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.45 HG22 ' C ' ' B' ' 19' ' ' VAL . 26.8 m -72.55 -45.25 59.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.102 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' B' ' 20' ' ' PHE . 3.1 pp -65.71 -26.42 67.75 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.084 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 12.7 ptt180 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.926 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.765 0.317 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.87 -169.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -117.28 89.42 3.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.02 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.572 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.93 164.72 12.25 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.482 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -97.84 162.47 13.24 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.527 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -47.51 -51.42 20.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.831 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.39 -27.62 69.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.022 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.4 -51.43 20.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.72 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.582 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 37.9 pt -73.24 -28.9 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.862 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.47 -27.39 10.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.513 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 17.9 mt-10 -75.21 -28.57 60.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.256 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.35 -58.5 3.18 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.853 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 10.9 ptmt -54.52 -23.01 14.64 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.206 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.513 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.37 -27.93 56.58 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.39 -39.9 62.41 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.106 177.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.853 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.8 -51.94 67.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.79 0.805 . . . . 0.0 109.398 178.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.43 -24.14 59.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.089 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.14 -26.29 33.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.22 0.533 . . . . 0.0 110.147 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.5 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.9 t80 -91.24 -1.4 57.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.356 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.9 t70 -103.09 144.11 31.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.004 0.907 . . . . 0.0 111.072 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -60.37 -53.4 58.02 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 113.859 -1.519 . . . . 0.0 111.68 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.29 -6.51 59.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.75 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.06 46.16 56.23 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.169 -0.538 . . . . 0.0 113.371 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.3 p30 -90.88 17.95 7.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.831 0.348 . . . . 0.0 110.732 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.55 88.65 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 49.6 p -150.29 148.98 29.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -100.54 140.52 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.016 0.436 . . . . 0.0 111.907 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.443 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -85.52 178.07 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.131 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.434 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -70.46 -40.45 73.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.107 0.479 . . . . 0.0 110.382 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -58.48 -40.87 83.94 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.402 178.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.61 -53.86 16.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.378 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.408 ' HB3' ' NZ ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.33 -54.17 49.85 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.785 0.802 . . . . 0.0 109.583 178.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.69 -46.78 92.87 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.27 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.9 m -66.25 -30.14 70.52 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.757 0.313 . . . . 0.0 110.493 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.424 ' CG2' ' CE2' ' A' ' 19' ' ' PHE . 16.7 t -64.03 -57.89 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.06 0.457 . . . . 0.0 110.635 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.47 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -72.48 -40.38 66.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.255 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -61.09 -38.87 87.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 110.378 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -78.8 -12.23 60.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.526 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 tt -87.46 -53.48 4.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.0 110.544 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 180.0 35.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.568 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -131.31 -179.96 5.66 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.287 0.565 . . . . 0.0 111.245 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -159.71 56.17 0.84 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.783 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.3 Cg_endo -80.72 -173.52 1.88 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.588 2.192 . . . . 0.0 112.202 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -119.7 152.39 37.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 110.075 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 44' ' ' THR . 3.5 mm-40 -56.71 -50.14 73.07 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.85 76.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.711 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -54.37 31.91 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.76 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.613 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.65 -38.18 90.12 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.313 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -61.79 -42.57 99.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.884 0.373 . . . . 0.0 110.428 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -61.73 -46.09 91.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.5 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -30.6 61.73 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.606 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.542 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -53.66 -40.19 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.761 -178.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -45.11 -28.68 0.77 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.383 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.84 -38.0 47.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.977 0.418 . . . . 0.0 110.734 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 52' ' ' ILE . 3.8 m -80.8 -12.63 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.498 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 43.2 t0 -103.46 155.25 18.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.699 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.09 26.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.179 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -116.44 -9.72 11.42 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.402 0.62 . . . . 0.0 110.415 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.72 61.52 7.29 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.295 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -109.74 18.49 20.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.758 0.313 . . . . 0.0 110.411 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.32 19.96 59.65 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.303 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.4 p -147.48 176.23 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.2 mt -113.47 136.66 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.644 0.259 . . . . 0.0 110.717 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -86.24 -179.96 6.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.208 0.528 . . . . 0.0 111.876 -179.384 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.89 -55.88 12.71 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.471 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.7 Cg_endo -65.76 -35.04 38.28 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.186 1.924 . . . . 0.0 111.18 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -52.51 63.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.35 -56.66 19.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.816 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.488 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -56.73 -47.92 78.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.813 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.3 m -59.39 -30.66 68.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.473 . . . . 0.0 110.102 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.421 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.1 tpp -63.61 -61.79 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.112 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 40.3 mtm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.145 -179.801 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.791 0.329 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -50.72 -30.67 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' CB ' ' HB3' ' B' ' 15' ' ' LYS . 0.6 OUTLIER -78.16 -29.44 48.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.678 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.4 mt -79.21 -51.13 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.32 -52.04 11.77 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -53.85 -25.63 20.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.754 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.418 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.46 -35.75 46.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.265 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 27.6 t80 -68.58 -51.38 43.2 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 110.026 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -54.76 -32.61 60.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.796 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.6 t -88.75 -22.67 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.631 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.468 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -53.05 -33.33 51.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.271 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -100.64 148.85 24.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.519 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.27 -37.69 78.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.22 -9.77 13.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.782 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.59 28.47 32.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.313 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -67.51 -13.97 62.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.183 0.491 . . . . 0.0 110.752 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.441 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.27 -10.27 56.53 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.187 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.5 m-85 -127.08 145.42 50.74 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.988 0.423 . . . . 0.0 111.5 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.18 109.9 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.843 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -83.84 175.18 9.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.329 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.05 70.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.001 0.429 . . . . 0.0 110.37 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -56.81 14.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.252 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -46.54 26.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.279 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.414 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 15.5 tp -52.99 -36.07 59.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -68.05 -49.1 63.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.877 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -58.17 -44.52 88.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.232 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -73.01 -42.28 59.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.552 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.477 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 26.6 mmt -70.16 -54.06 14.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.514 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 m -58.39 -48.36 80.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -58.48 -29.29 66.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.84 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.416 ' CD2' ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -122.98 37.52 4.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.75 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -168.85 -116.17 0.36 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.708 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -131.51 172.23 12.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.72 0.295 . . . . 0.0 110.777 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -75.78 98.77 4.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.288 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 121' ' ' VAL . 0.4 OUTLIER -91.47 112.72 24.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.551 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.8 174.9 6.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.328 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.11 -36.13 12.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 0.0 110.757 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -77.38 -33.91 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.757 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -73.64 -34.72 65.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.023 0.439 . . . . 0.0 110.023 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.435 ' HA ' HD12 ' A' ' 116' ' ' LEU . 2.6 t -72.73 -47.99 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.872 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -58.81 -52.87 63.89 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.837 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -56.64 -28.91 61.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.928 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.414 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 7.8 tpt -76.31 -38.73 55.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.182 0.515 . . . . 0.0 110.111 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -67.51 -48.51 76.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.521 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -60.26 -40.32 89.9 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.85 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -80.55 -37.13 32.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 110.604 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.47 82.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.555 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.4 t0 -101.57 147.87 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.062 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.528 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.7 pt -84.88 -40.74 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.048 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.528 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.98 -10.9 59.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.692 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.09 32.68 1.1 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.4 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.1 -12.79 24.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.303 -0.949 . . . . 0.0 112.482 -176.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.89 20.12 10.22 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.813 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -146.51 146.83 30.66 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.928 0.395 . . . . 0.0 110.029 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 t -130.74 107.39 14.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.307 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -79.18 174.69 11.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.337 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.579 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -45.84 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.548 0.69 . . . . 0.0 111.421 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.431 ' HA ' HG21 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -60.3 -34.77 74.26 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.839 -178.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -41.55 75.24 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.444 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.77 -31.85 46.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.022 178.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.579 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 53.6 t -55.54 -47.23 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.596 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -56.07 -45.15 79.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.966 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.16 -32.11 64.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.406 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.693 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.47 -52.17 55.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.214 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.521 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.78 -53.32 32.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 111.394 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.94 -36.89 70.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 0.0 110.295 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.487 ' O ' ' HD3' ' B' ' 9' ' ' LYS . 39.6 t -62.05 -39.19 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.1 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.693 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.8 mt -65.92 -55.48 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.166 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -50.91 -37.31 43.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.022 0.439 . . . . 0.0 110.202 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -73.32 -45.86 52.86 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.718 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' B' ' 5' ' ' VAL . 0.4 OUTLIER -55.02 -55.47 30.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.999 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.422 ' HA ' HD11 ' B' ' 13' ' ' ILE . 3.5 mt -51.49 -57.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.421 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.487 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -57.8 -51.33 70.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.218 0.532 . . . . 0.0 111.021 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.46 -42.47 67.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.779 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.488 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.3 mt -54.57 -48.07 71.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.577 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.26 96.18 Favored Glycine 0 CA--C 1.499 -0.954 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.077 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.674 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.14 -61.75 2.06 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.831 -0.685 . . . . 0.0 110.445 -178.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.658 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.7 OUTLIER -61.8 -27.84 69.04 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.65 177.799 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -65.19 -50.89 64.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.258 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 0.5 OUTLIER -63.89 -43.65 95.37 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.633 HG23 ' O ' ' B' ' 16' ' ' MET . 1.7 m -64.34 -33.68 64.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.532 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.658 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.4 OUTLIER -74.3 -45.04 50.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.737 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.48 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.8 p -59.85 -25.96 65.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.457 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.42 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.5 -46.15 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.134 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.83 -34.23 76.88 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.164 0.507 . . . . 0.0 110.323 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.48 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.064 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.827 0.346 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.69 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.762 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -123.78 89.36 3.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.107 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.564 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.03 164.71 12.41 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.354 179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.407 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.2 p -97.89 162.31 13.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.482 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -47.53 -51.4 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.819 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -64.48 -27.66 69.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.018 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.22 -51.52 20.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.683 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.588 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.0 pt -73.31 -28.89 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.806 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.31 10.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 13.8 mt-10 -75.38 -28.62 59.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.369 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.1 m-85 -79.25 -58.69 3.09 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.174 0.511 . . . . 0.0 111.189 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.85 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -55.37 -21.89 17.33 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.249 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -77.23 -28.03 53.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.18 -40.1 62.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.082 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.85 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.46 -51.95 67.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.853 0.835 . . . . 0.0 109.448 178.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 p -74.35 -24.27 59.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.161 -1.382 . . . . 0.0 112.149 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.482 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.14 -25.85 34.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.31 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.7 t80 -92.16 -1.99 56.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.632 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.9 t70 -101.77 143.5 31.62 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.963 0.887 . . . . 0.0 111.152 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -60.16 -53.38 58.44 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.552 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.15 -5.6 59.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.791 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.22 46.45 51.42 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.349 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -91.11 18.17 7.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.82 0.343 . . . . 0.0 110.704 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.52 5.1 88.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.605 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 47.0 p -150.29 149.25 29.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.8 140.51 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.895 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.45 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.29 177.01 7.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.124 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.432 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -70.35 -39.05 74.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.102 0.477 . . . . 0.0 110.301 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.35 -40.78 87.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.285 178.81 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.534 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.57 -53.83 17.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.329 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.7 -54.38 47.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.786 0.803 . . . . 0.0 109.531 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.33 -46.63 92.69 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.296 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.1 m -66.76 -30.06 70.18 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.749 0.309 . . . . 0.0 110.479 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.419 ' CG2' ' CE2' ' A' ' 19' ' ' PHE . 13.0 t -63.51 -57.95 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 0.0 110.534 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.48 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -72.44 -40.94 66.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.196 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -39.26 86.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.982 0.42 . . . . 0.0 110.494 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -78.81 -12.14 60.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.537 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.73 -54.07 4.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 0.0 110.596 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.02 36.87 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.752 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.551 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 tp-100 -134.9 -179.46 5.62 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.332 0.587 . . . . 0.0 111.22 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -159.68 56.35 0.86 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.892 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.49 -176.71 3.32 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.583 2.189 . . . . 0.0 112.153 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.604 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -115.89 152.5 33.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 110.203 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 44' ' ' THR . 1.0 OUTLIER -57.11 -49.64 75.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -34.19 77.57 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -54.35 31.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.657 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.604 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.7 -38.17 90.08 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 120.246 -0.581 . . . . 0.0 110.329 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.403 ' CA ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.36 -42.15 99.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.891 0.377 . . . . 0.0 110.405 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.09 -47.34 86.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.431 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.9 mmt -74.51 -30.32 61.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.732 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.42 -38.64 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.584 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -45.52 -28.53 0.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.298 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.74 -38.03 47.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.935 0.398 . . . . 0.0 110.833 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 52' ' ' ILE . 4.2 m -81.92 -11.78 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.218 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.9 t0 -103.46 155.48 18.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.729 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.58 -28.73 26.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.084 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -116.38 -9.72 11.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.387 0.613 . . . . 0.0 110.458 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.525 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.38 63.08 5.56 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.467 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -112.19 18.45 18.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.835 0.35 . . . . 0.0 110.194 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.9 19.95 56.71 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.445 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.419 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 5.0 p -146.5 176.44 9.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.418 HG22 ' CG ' ' A' ' 68' ' ' PHE . 15.1 mt -116.44 136.48 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.522 0.201 . . . . 0.0 110.883 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 8.7 m-20 -86.67 -178.95 6.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.273 0.558 . . . . 0.0 111.908 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.84 -55.94 12.72 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.607 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -65.6 -35.05 39.63 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.22 1.947 . . . . 0.0 111.223 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.64 -52.38 63.57 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.199 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.06 -56.86 16.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.844 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -57.11 -47.5 80.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.729 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.3 m -59.06 -30.76 68.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.055 0.455 . . . . 0.0 110.061 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.415 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.1 tpp -65.54 -61.75 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.229 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.1 mtm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.104 -179.785 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.77 0.319 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -77.22 -42.07 38.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.274 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.655 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.71 -29.32 26.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.541 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 mt -66.07 -51.42 60.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.794 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -75.81 -50.65 14.58 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.774 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.87 -30.69 46.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.661 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -71.16 -38.62 72.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.792 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.6 t80 -67.08 -55.92 12.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 0.0 110.541 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.85 -30.51 45.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.832 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.6 t -88.36 -22.86 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.309 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.433 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.25 -32.54 62.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.982 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -102.08 148.64 25.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -69.62 -37.53 76.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.375 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -112.26 -9.76 13.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.5 30.65 32.61 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.119 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -67.42 -13.52 62.1 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.928 0.364 . . . . 0.0 110.823 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.45 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.16 -13.61 55.44 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.846 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.45 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.5 m-85 -127.22 145.9 50.61 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.961 0.41 . . . . 0.0 111.3 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.423 HD11 HD11 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.09 109.99 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.85 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -82.19 177.71 8.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.17 69.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.009 0.433 . . . . 0.0 110.559 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.35 -57.72 9.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.314 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -38.74 54.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.006 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.459 HD13 ' HG3' ' A' ' 124' ' ' MET . 5.5 tt -56.5 -33.15 65.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 6.7 ttt180 -74.77 -49.4 21.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.172 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -36.72 79.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.064 0.459 . . . . 0.0 110.321 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.486 HG13 ' CZ ' ' B' ' 20' ' ' PHE . 45.6 t -72.9 -45.69 54.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.242 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.453 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 22.3 mmt -73.93 -54.14 8.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.818 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 m -55.46 -43.11 75.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 111.362 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -61.21 -31.81 71.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.788 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.17 38.76 4.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.31 -116.96 0.39 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.782 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -133.61 171.88 13.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.821 0.343 . . . . 0.0 110.944 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -75.38 100.08 4.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.294 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.445 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.41 115.48 26.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.29 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.76 174.99 6.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.404 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.0 -35.76 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.92 0.391 . . . . 0.0 110.734 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.29 -36.15 54.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.699 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -71.13 -34.56 71.14 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.056 0.455 . . . . 0.0 110.084 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.417 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.6 t -73.62 -50.02 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.351 0.596 . . . . 0.0 109.776 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -59.76 -52.85 63.7 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.859 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.84 -28.83 62.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.938 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.459 ' HG3' HD13 ' A' ' 105' ' ' LEU . 7.4 tpt -76.35 -38.75 55.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.151 0.5 . . . . 0.0 110.13 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.15 -49.07 78.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.521 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -60.13 -40.12 88.66 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.967 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.01 -37.31 29.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 110.647 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.406 ' HB3' ' CE ' ' A' ' 124' ' ' MET . . . -66.33 -36.96 84.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.518 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.1 t0 -100.39 148.1 25.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.025 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.527 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.8 -40.8 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.297 0.57 . . . . 0.0 110.073 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.527 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.83 -11.03 60.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.682 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.14 32.59 1.1 Allowed Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.04 -12.94 24.16 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.309 -0.946 . . . . 0.0 112.434 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.88 20.18 10.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.81 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.45 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -146.74 146.69 30.38 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.905 0.383 . . . . 0.0 110.061 179.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.7 t -130.67 107.47 14.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.24 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.523 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.01 174.65 11.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.426 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.582 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.97 -67.06 0.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.479 0.657 . . . . 0.0 111.531 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -34.15 72.9 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.913 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -40.34 73.61 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.451 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.79 -33.67 46.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.114 178.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.582 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.6 t -54.86 -47.43 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.688 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -58.13 -45.2 87.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.12 -32.5 64.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.416 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 14.1 ttp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.696 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.44 -52.37 54.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.209 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.527 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.83 -53.2 34.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.291 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -56.84 -37.02 70.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.009 0.433 . . . . 0.0 110.256 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' B' ' 9' ' ' LYS . 40.7 t -61.94 -39.16 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.081 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.696 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.8 mt -66.03 -55.53 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.15 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -50.96 -37.16 42.88 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.2 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.22 -45.55 55.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.622 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' B' ' 5' ' ' VAL . 0.3 OUTLIER -55.33 -55.32 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.129 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.447 ' HA ' HD13 ' B' ' 13' ' ' ILE . 3.5 mt -51.29 -57.5 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.802 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.8 tpt180 -60.3 -51.32 70.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.273 0.559 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.35 -40.13 64.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.679 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.483 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.1 mt -54.46 -47.75 70.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.27 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.92 -38.25 95.81 Favored Glycine 0 CA--C 1.497 -1.06 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.493 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.656 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -64.93 -61.61 2.06 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.646 -0.777 . . . . 0.0 110.507 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.65 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.19 -27.49 67.19 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -67.81 -48.57 65.89 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.017 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.7 ppt_? -63.28 -43.57 97.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.127 0.489 . . . . 0.0 109.798 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.65 HG23 ' O ' ' B' ' 16' ' ' MET . 1.7 m -61.78 -34.82 64.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.348 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.541 ' N ' HG23 ' B' ' 19' ' ' VAL . 0.3 OUTLIER -74.95 -43.94 51.27 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.633 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.505 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 18.7 p -60.74 -25.77 66.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.495 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.417 HG23 ' N ' ' B' ' 23' ' ' LEU . 29.3 m -90.25 -46.5 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.09 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.37 -34.47 76.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.184 0.516 . . . . 0.0 110.348 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.505 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.092 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.821 0.343 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.65 -169.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -117.5 90.65 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.975 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.575 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.2 mt -98.72 164.88 12.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.557 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 p -96.94 161.82 13.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.494 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.52 -51.91 19.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.798 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -64.28 -27.73 69.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.015 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.94 -51.52 21.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.662 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.582 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.6 pt -72.84 -28.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.816 -179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.36 -27.29 9.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.51 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 7.9 mt-10 -74.88 -28.5 60.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.171 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.6 -58.34 3.24 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.198 0.523 . . . . 0.0 110.994 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.85 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -54.45 -23.01 14.3 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.188 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.24 -27.94 56.96 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.48 -39.8 62.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.079 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.85 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.93 -51.82 68.39 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.85 0.834 . . . . 0.0 109.416 178.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.43 -24.26 59.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.096 -1.411 . . . . 0.0 112.134 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.491 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.2 tt -82.08 -24.24 35.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.248 0.547 . . . . 0.0 110.191 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.524 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.6 t80 -95.61 0.82 53.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.434 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.9 t70 -105.58 145.13 31.37 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.013 0.911 . . . . 0.0 111.123 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.43 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.0 mmtt -60.54 -53.39 58.07 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.587 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.43 -6.09 59.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.06 47.23 55.12 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.194 -0.526 . . . . 0.0 113.515 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -92.66 17.8 9.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.871 0.367 . . . . 0.0 110.469 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.16 9.25 86.34 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.258 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.462 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 72.8 p -150.16 147.23 27.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.6 mt -101.96 140.39 20.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.904 0.383 . . . . 0.0 111.927 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.456 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 1.4 t -87.27 -179.29 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.123 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -70.49 -45.51 65.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 110.899 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.545 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -54.54 -40.54 68.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.449 178.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -69.52 -53.83 17.14 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.467 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -56.07 26.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.78 0.8 . . . . 0.0 109.379 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -56.86 -46.2 90.73 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.64 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.2 m -62.05 -35.01 77.31 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.047 0.423 . . . . 0.0 110.542 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 70.0 t -64.0 -57.19 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.417 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.6 OUTLIER -71.82 -36.05 70.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.404 -179.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 2.8 ttt-85 -67.25 -41.22 85.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.999 0.428 . . . . 0.0 110.48 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 t -79.0 -8.32 58.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.627 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -90.82 -54.33 4.02 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.762 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.91 34.57 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.837 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.76 -179.37 5.49 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.317 0.58 . . . . 0.0 111.141 -179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -159.67 56.39 0.87 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.815 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.8 Cg_endo -80.56 -174.85 2.41 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.568 2.179 . . . . 0.0 112.117 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -116.87 152.45 34.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.945 0.402 . . . . 0.0 110.159 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 44' ' ' THR . 3.6 mm-40 -56.69 -50.03 73.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.14 74.94 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.75 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -54.3 32.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.733 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.611 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.71 -35.57 81.12 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.419 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -42.95 98.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.868 0.366 . . . . 0.0 110.224 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.85 -45.36 94.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.373 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.56 -30.68 61.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.449 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.72 -39.51 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.637 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -44.99 -28.64 0.7 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.387 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.65 -38.52 54.47 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.954 0.407 . . . . 0.0 110.73 179.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 52' ' ' ILE . 5.5 m -80.99 -12.77 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.049 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.492 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 42.9 t0 -103.5 154.88 18.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.815 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.68 -28.03 26.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.227 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -116.42 -9.72 11.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.386 0.612 . . . . 0.0 110.423 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.91 61.66 7.11 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.315 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -109.52 18.4 20.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 110.475 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.75 18.93 60.66 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.407 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.2 p -146.54 176.12 10.06 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.0 mt -112.91 136.49 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.585 0.231 . . . . 0.0 110.675 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -85.12 179.56 7.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.243 0.544 . . . . 0.0 111.824 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 6.3 m-85 -67.45 -56.52 12.32 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.285 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.82 -36.11 33.03 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.326 2.017 . . . . 0.0 111.071 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.61 -52.32 65.67 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.135 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CD2' ' CD1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -56.94 -56.29 23.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.657 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.49 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -57.34 -46.67 83.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.706 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.1 m -61.2 -31.79 71.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.013 0.435 . . . . 0.0 110.11 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.441 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 4.5 tpp -60.86 -61.77 2.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.125 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.8 mtp . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.991 -179.871 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -50.47 -30.51 12.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 4.7 mt-10 -76.49 -29.59 56.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.685 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -79.26 -51.13 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -48.41 39.04 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.893 0.378 . . . . 0.0 111.87 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -53.6 -26.31 21.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.344 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.448 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.4 -34.31 58.83 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.052 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.589 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 12.8 t80 -68.79 -50.05 53.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.12 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -54.5 -33.17 59.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.778 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.8 t -88.95 -22.79 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.542 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.518 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.28 -33.63 53.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.206 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -106.18 139.24 41.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.521 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -64.74 -34.77 79.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -112.15 -9.7 13.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.97 29.26 38.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.36 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.68 -13.92 62.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.134 0.467 . . . . 0.0 110.745 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.468 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 100.48 -11.6 59.75 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.004 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.3 m-85 -127.19 147.3 50.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.038 0.447 . . . . 0.0 111.438 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.42 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.19 109.96 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.721 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 t -82.62 176.52 9.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.46 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.71 70.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.075 0.464 . . . . 0.0 110.477 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.26 -57.8 10.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.236 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.45 -45.38 31.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.126 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.402 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 31.9 tp -52.95 -31.24 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.191 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 2.9 ttt-85 -73.47 -49.17 28.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -58.67 -42.48 88.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.074 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.99 -40.04 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.546 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.7 mmt -73.99 -54.18 8.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.528 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 m -55.5 -46.96 76.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.376 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -59.9 -30.7 69.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.6 mp -121.54 37.52 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.49 -113.97 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.688 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.87 170.61 15.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.824 0.345 . . . . 0.0 110.805 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -73.73 98.22 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.152 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.416 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.14 113.52 24.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.385 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.79 175.45 5.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.368 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -48.13 -35.93 12.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.896 0.379 . . . . 0.0 110.766 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.4 -34.51 54.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -73.44 -33.5 64.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.009 0.433 . . . . 0.0 110.096 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 116' ' ' LEU . 2.5 t -74.47 -48.16 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.819 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.62 -52.85 63.77 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.735 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -57.48 -28.72 63.65 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.779 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.408 ' CE ' HD11 ' B' ' 23' ' ' LEU . 6.9 tpt -76.2 -38.02 57.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.121 0.486 . . . . 0.0 110.137 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -41.84 81.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.494 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -66.08 -38.92 89.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.933 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.54 -35.94 29.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.512 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.47 79.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.416 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 22.2 t0 -100.5 145.61 28.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.979 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.52 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.7 pt -83.17 -40.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.248 0.547 . . . . 0.0 110.101 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.9 -11.06 60.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.781 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.79 32.88 0.99 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -176.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.04 -12.48 24.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.341 -0.93 . . . . 0.0 112.53 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.2 10.18 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.84 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.444 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.31 146.76 30.82 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.75 107.22 13.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.354 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.533 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.3 t30 -78.25 175.2 10.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.206 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.589 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 1.1 t80 -45.91 -67.12 0.31 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.612 0.72 . . . . 0.0 111.635 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.3 mt-10 -64.96 -25.85 68.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.553 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 129' ' ' ASP . 0.4 OUTLIER -55.57 -48.47 74.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 110.35 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.0 p90 -78.81 -31.03 45.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.24 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.497 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 65.7 t -52.8 -44.49 48.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.094 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -59.26 -38.74 80.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 109.828 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.49 -40.71 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.704 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.8 ttp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.009 -179.872 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.815 0.34 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.711 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.26 -51.22 59.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.061 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.68 -53.28 32.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.261 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.95 -37.54 71.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.999 0.428 . . . . 0.0 110.31 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.417 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 15.3 t -63.35 -34.44 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.436 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.711 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.2 mt -71.32 -54.89 15.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.039 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -50.94 -37.63 45.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.154 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.85 -48.32 63.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.404 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -54.25 -54.08 44.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.067 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.441 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 4.9 mt -51.13 -57.5 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.4 tpt180 -60.06 -51.41 69.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.28 0.562 . . . . 0.0 111.089 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.39 -40.38 65.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.763 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.1 mt -54.57 -50.8 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.462 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.52 -37.06 94.08 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.235 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.679 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.02 -61.82 2.03 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.861 -0.669 . . . . 0.0 110.529 -178.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.7 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -63.17 -27.59 69.47 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.673 177.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -65.89 -50.48 64.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.28 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.505 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.4 OUTLIER -64.63 -43.63 93.08 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.623 HG23 ' O ' ' B' ' 16' ' ' MET . 2.3 m -64.98 -33.02 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.543 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.7 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -74.68 -45.92 41.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.944 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.46 -26.34 65.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.505 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.406 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.3 -47.41 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.229 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.429 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -62.79 -33.54 75.4 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.254 0.549 . . . . 0.0 110.511 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.498 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.071 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.819 0.343 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.83 -169.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.785 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -118.65 89.26 3.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.994 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.57 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.29 164.7 12.37 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.9 p -98.29 162.67 13.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.48 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -47.56 -51.31 21.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.845 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.48 -27.66 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.994 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.6 OUTLIER -72.4 -51.46 20.32 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.696 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.581 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.2 pt -73.19 -28.89 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.822 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.43 -27.45 10.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.515 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 15.2 mm-40 -75.34 -28.55 59.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.327 178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.36 -58.64 3.11 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.228 0.537 . . . . 0.0 111.083 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.854 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.56 -23.26 15.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.243 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -75.86 -28.08 58.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.123 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.07 -39.83 63.18 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.149 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.854 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.81 -51.81 68.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.762 0.791 . . . . 0.0 109.515 178.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.38 -24.41 59.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.044 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -82.1 -25.34 34.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.217 0.532 . . . . 0.0 110.279 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.492 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 3.1 t80 -92.23 -2.37 56.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.0 t70 -102.42 143.45 32.14 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.959 0.885 . . . . 0.0 111.026 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 3.7 mmtt -60.01 -53.36 58.77 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.626 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.46 -5.19 59.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.777 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.55 47.0 45.96 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.331 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.6 p30 -91.47 18.22 7.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.905 0.383 . . . . 0.0 110.711 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.54 5.27 88.6 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.589 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.9 p -150.38 148.61 29.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.32 140.55 19.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.975 0.416 . . . . 0.0 111.763 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.442 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -86.21 178.21 7.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.374 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.441 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.6 OUTLIER -69.62 -41.2 75.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 110.353 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -58.11 -41.24 83.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.439 179.127 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.79 -53.75 16.79 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.407 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.411 ' HB3' ' NZ ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.07 -54.15 50.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.81 0.814 . . . . 0.0 109.555 178.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -58.8 -47.08 92.29 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.384 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.4 m -65.33 -30.79 71.67 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.448 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 16.7 t -63.88 -57.91 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.481 ' HB2' ' HD2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER -72.57 -40.25 66.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.31 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 20.5 ttt180 -61.21 -38.56 87.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 110.447 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.3 t -78.84 -12.08 60.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.539 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 tt -87.46 -53.12 4.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.178 0.514 . . . . 0.0 110.52 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.74 36.16 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.606 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -131.07 179.39 6.03 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.342 0.591 . . . . 0.0 111.257 -179.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -159.78 56.11 0.82 Allowed Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.773 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.7 Cg_endo -80.67 -173.74 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.615 2.21 . . . . 0.0 112.226 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.618 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.91 152.42 36.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.87 0.367 . . . . 0.0 110.093 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' N ' HG21 ' A' ' 44' ' ' THR . 3.5 mm-40 -56.41 -50.14 72.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.0 -32.01 72.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.602 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.49 -54.45 23.77 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.648 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.618 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -62.26 -47.05 86.06 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.108 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.435 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -55.85 -44.94 78.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 110.806 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.4 -47.51 81.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -74.68 -30.61 61.64 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.968 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.482 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -54.15 -36.26 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.667 -178.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -45.02 -28.64 0.72 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.282 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.427 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -79.39 -39.03 33.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.898 0.38 . . . . 0.0 110.731 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 52' ' ' ILE . 3.6 m -80.01 -11.16 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.089 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.521 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 37.2 t0 -103.58 155.93 18.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.74 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.6 -29.38 25.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.1 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -116.51 -9.61 11.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.428 0.632 . . . . 0.0 110.442 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.4 63.86 4.85 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.519 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -112.49 17.84 18.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.807 0.337 . . . . 0.0 110.186 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.3 19.94 53.69 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.413 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.1 p -147.56 176.35 10.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.0 mt -115.03 136.48 51.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.554 0.216 . . . . 0.0 110.95 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.7 m-20 -88.18 -178.14 5.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.29 0.567 . . . . 0.0 112.001 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.75 -55.86 13.15 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.713 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.8 Cg_endo -65.66 -34.32 41.78 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.226 1.95 . . . . 0.0 111.267 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.72 -52.47 60.37 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.219 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.11 -57.15 13.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.88 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.49 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -57.23 -47.92 80.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.689 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.6 m -58.83 -30.54 67.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.066 0.46 . . . . 0.0 110.05 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.418 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.0 tpp -63.76 -61.71 2.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.234 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.5 mtm . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.243 -179.777 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.811 0.338 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -51.5 -30.53 20.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.7 OUTLIER -78.0 -29.41 49.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 mt -79.14 -51.26 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.3 -51.91 12.11 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -53.76 -25.47 19.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.786 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.433 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.62 -36.21 44.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.214 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.5 t80 -68.2 -52.13 37.84 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.0 0.429 . . . . 0.0 110.1 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -54.73 -31.98 59.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.821 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.7 t -88.69 -22.74 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.514 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.466 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.36 -34.32 57.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.26 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -99.19 147.93 24.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.467 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -67.54 -38.22 83.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.375 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.29 -9.84 13.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.804 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.93 28.29 31.9 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.246 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -67.48 -13.9 62.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.211 0.505 . . . . 0.0 110.764 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.442 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -11.0 55.35 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.146 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.9 m-85 -127.09 145.0 50.89 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.011 0.434 . . . . 0.0 111.414 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.439 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pt -121.15 109.97 26.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.726 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -83.7 177.15 8.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.582 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.2 -29.92 71.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.084 0.469 . . . . 0.0 110.449 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.3 -57.68 11.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.28 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.48 -45.66 30.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.135 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.41 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 37.4 tp -53.06 -31.15 40.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -72.94 -49.06 31.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.976 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -58.9 -42.58 89.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -72.85 -40.96 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.456 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.462 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 27.0 mmt -72.54 -54.08 10.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.431 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 m -58.95 -47.81 83.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.203 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -58.76 -30.18 67.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.805 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.407 ' CD2' ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -123.04 38.48 4.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.651 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.6 -114.75 0.33 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.852 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -133.17 166.89 21.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.334 . . . . 0.0 110.908 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -72.68 99.85 2.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.359 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.24 114.33 26.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.371 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.75 175.28 5.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.429 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -48.14 -35.94 12.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.763 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -77.34 -34.82 55.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.774 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -73.06 -33.49 65.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.988 0.423 . . . . 0.0 110.099 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.41 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.6 t -74.73 -48.03 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.854 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.62 -52.87 63.66 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.758 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -57.51 -28.8 63.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.842 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.41 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 7.5 tpt -76.26 -37.73 57.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.139 0.495 . . . . 0.0 110.134 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.91 -43.58 79.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.552 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -64.99 -39.09 92.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.812 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -81.17 -36.43 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.984 0.421 . . . . 0.0 110.545 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.25 82.57 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.635 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.8 t0 -99.39 147.67 25.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.029 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.529 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.85 -40.73 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.06 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.529 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.91 -11.01 60.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.706 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.1 32.72 1.11 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -176.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -96.11 -12.75 24.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.318 -0.941 . . . . 0.0 112.471 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.88 20.21 10.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.824 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.438 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 0.6 OUTLIER -146.59 146.64 30.51 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.78 107.4 13.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.266 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -79.12 174.66 11.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.302 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.578 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -45.83 -67.12 0.31 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.489 0.661 . . . . 0.0 111.444 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.424 ' HA ' HG21 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -60.57 -34.22 73.85 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.892 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -41.73 75.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 109.504 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.44 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.72 -31.92 46.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.086 178.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.575 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 61.3 t -56.06 -46.73 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.657 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -56.53 -43.92 80.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.084 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.15 -35.31 66.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.0 ttp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.839 0.352 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.691 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.5 mmm180 -52.38 -52.15 55.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.52 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.9 -53.31 33.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.365 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.03 -36.87 70.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.033 0.444 . . . . 0.0 110.287 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.493 ' O ' ' HD3' ' B' ' 9' ' ' LYS . 39.1 t -62.09 -39.57 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.047 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.691 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.9 mt -65.47 -55.49 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.1 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -50.72 -37.66 42.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.171 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.55 -45.97 56.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.66 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' B' ' 5' ' ' VAL . 0.3 OUTLIER -55.42 -55.57 30.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.015 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.42 ' HA ' HD13 ' B' ' 13' ' ' ILE . 3.4 mt -51.53 -57.42 3.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.343 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -57.44 -51.15 70.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.512 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.37 -42.51 66.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.481 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.2 mt -54.48 -48.24 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.583 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.19 -38.24 96.19 Favored Glycine 0 CA--C 1.498 -0.987 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.079 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.675 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.17 -61.79 2.03 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.847 -0.676 . . . . 0.0 110.445 -178.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.665 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.79 -27.75 68.97 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.594 177.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -64.98 -51.36 62.17 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.258 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.508 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.5 OUTLIER -63.88 -43.55 95.7 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.626 HG23 ' O ' ' B' ' 16' ' ' MET . 1.7 m -64.51 -33.39 62.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.503 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.665 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -74.15 -45.48 48.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.788 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.487 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.0 p -59.68 -26.17 65.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.477 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.422 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.1 m -90.32 -46.16 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.172 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.38 -32.85 74.39 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.15 0.5 . . . . 0.0 110.468 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.063 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.794 0.331 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.27 -169.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.8 90.34 3.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.573 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.18 164.73 12.37 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.968 0.413 . . . . 0.0 110.375 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.0 p -98.07 162.55 13.16 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.508 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -47.47 -51.4 20.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.831 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.46 -27.7 69.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.015 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.31 -51.45 20.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.741 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.586 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.0 pt -73.21 -28.99 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.753 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.44 -27.39 10.16 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.2 mt-10 -75.24 -28.57 59.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.235 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.1 m-85 -79.35 -58.55 3.15 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.351 0.596 . . . . 0.0 110.995 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.858 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.86 -22.9 16.13 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.219 -179.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -76.08 -27.6 57.25 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.119 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -75.08 -39.66 60.61 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.071 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.858 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.12 -51.9 68.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.875 0.845 . . . . 0.0 109.386 178.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.38 -24.82 59.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.104 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.512 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.02 -26.6 33.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.127 0.489 . . . . 0.0 110.409 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.492 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 5.3 t80 -86.07 -21.63 27.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.226 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 31.8 t70 -83.33 146.54 28.45 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.896 0.855 . . . . 0.0 111.129 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.5 mmtt -65.39 -53.37 44.18 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.969 -1.468 . . . . 0.0 111.6 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.19 -8.0 59.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.786 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.27 46.6 63.19 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.537 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -91.8 18.19 8.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.832 0.349 . . . . 0.0 110.583 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.18 5.7 89.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.425 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 54.3 p -150.19 151.06 32.49 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -102.36 140.42 20.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.915 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.44 176.53 8.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.97 179.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.42 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.9 OUTLIER -70.42 -39.05 74.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.149 0.499 . . . . 0.0 110.209 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.63 -40.49 87.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.133 178.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.542 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.6 mm-40 -68.15 -53.88 21.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.04 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -56.27 24.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.747 0.784 . . . . 0.0 109.462 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.05 -45.49 87.03 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.553 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.9 m -62.85 -32.35 73.55 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.906 0.353 . . . . 0.0 110.562 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.47 -57.26 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.412 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.7 OUTLIER -71.96 -37.05 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.495 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -41.4 88.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.914 0.387 . . . . 0.0 110.603 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.8 t -78.95 -8.58 59.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.682 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -90.85 -54.86 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.682 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.28 33.64 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.87 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.561 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.78 -179.98 5.87 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.314 0.578 . . . . 0.0 111.159 -179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -159.71 56.27 0.85 Allowed Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.831 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.8 Cg_endo -80.58 -173.9 2.03 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.535 2.157 . . . . 0.0 112.113 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.612 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -117.06 152.38 34.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.954 0.407 . . . . 0.0 110.19 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 44' ' ' THR . 1.2 mm-40 -56.94 -49.94 74.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.99 -31.9 72.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.734 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.16 -54.33 26.7 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.667 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.612 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -66.06 -34.5 78.22 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.447 179.642 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.02 -42.16 94.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.92 0.391 . . . . 0.0 110.138 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.65 -45.78 92.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.154 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.5 mmt -74.53 -30.88 61.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.477 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.72 -36.4 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.382 -179.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -44.87 -28.7 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.34 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.424 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.73 -39.44 44.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.923 0.392 . . . . 0.0 110.744 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 52' ' ' ILE . 4.3 m -81.61 -11.56 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.115 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.533 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 44.1 t0 -103.45 155.31 18.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.475 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.64 -28.77 26.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.036 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -116.51 -9.82 11.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.435 0.636 . . . . 0.0 110.473 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 59.45 61.0 7.77 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.467 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -111.18 18.16 19.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.869 0.366 . . . . 0.0 110.309 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.53 19.8 53.45 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.763 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.421 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 5.6 p -146.09 176.35 9.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.499 0.19 . . . . 0.0 110.501 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.417 HG22 ' CG ' ' A' ' 68' ' ' PHE . 25.4 mt -117.59 136.58 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.57 0.224 . . . . 0.0 110.777 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 1.8 m-20 -87.77 -178.14 5.99 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.338 0.589 . . . . 0.0 112.13 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.7 m-85 -67.11 -56.2 13.94 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.638 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -65.68 -35.64 36.34 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.355 2.037 . . . . 0.0 111.307 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.28 -52.49 63.5 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.246 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.1 -56.87 16.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.776 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.489 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -57.07 -47.22 81.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.756 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.0 m -59.16 -30.65 68.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.461 . . . . 0.0 110.124 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.441 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 4.4 tpp -60.3 -61.74 2.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.234 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.7 mtt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.103 -179.86 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -50.43 -30.45 12.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 4.6 mt-10 -76.04 -29.62 58.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.775 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.0 mt -79.22 -50.99 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.78 -48.43 38.34 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.904 0.383 . . . . 0.0 111.85 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -53.47 -26.52 20.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.396 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.454 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.61 -34.0 58.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.037 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 12.8 t80 -68.92 -50.55 48.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.04 0.448 . . . . 0.0 110.14 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -54.39 -33.18 58.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.727 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.8 t -88.94 -22.78 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.518 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -52.74 -36.83 58.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.364 -179.242 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -100.09 147.21 25.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 0.0 110.5 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -68.3 -37.49 80.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.33 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -112.23 -9.78 13.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.815 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.43 28.28 33.5 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.354 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -67.54 -14.0 62.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.206 0.503 . . . . 0.0 110.721 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.93 -11.35 55.96 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.126 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.5 m-85 -127.2 146.93 50.23 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 120.989 0.423 . . . . 0.0 111.482 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.422 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.14 109.97 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.652 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.92 177.04 8.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.539 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.22 -30.14 71.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.111 0.482 . . . . 0.0 110.484 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.88 -57.81 11.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.239 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.48 -45.45 31.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.155 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.5 tp -52.95 -31.2 39.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.185 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 2.7 ttt-85 -73.01 -49.1 30.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -58.78 -42.66 89.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.118 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.6 t -73.07 -39.74 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 29.0 mmt -74.0 -54.14 8.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.538 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -55.62 -48.9 74.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.35 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -58.87 -29.68 67.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.934 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.5 mp -121.85 36.6 4.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.29 -113.2 0.28 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.716 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -136.24 170.35 16.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.792 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -73.39 98.07 2.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.141 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.38 113.56 24.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.409 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.77 175.42 5.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.363 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.07 -35.87 12.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 0.0 110.742 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.41 -34.99 54.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.89 -33.32 65.96 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.026 0.441 . . . . 0.0 110.145 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.41 HG21 HD13 ' A' ' 116' ' ' LEU . 2.6 t -74.53 -48.62 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.342 0.591 . . . . 0.0 109.786 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.46 -52.91 63.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.775 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.25 -28.68 63.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.808 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.411 ' CE ' HD13 ' B' ' 23' ' ' LEU . 7.0 tpt -76.13 -38.1 57.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.131 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.22 -43.77 84.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.506 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -62.32 -40.82 97.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.971 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -80.64 -36.37 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.834 0.35 . . . . 0.0 110.652 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.53 -35.04 78.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.421 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.426 ' HA ' ' HG2' ' A' ' 140' ' ' GLU . 22.4 t0 -104.37 145.54 30.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.983 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.521 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.9 pt -83.03 -40.83 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.165 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.85 -11.1 60.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.78 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.81 32.74 0.98 Allowed Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -176.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 131' ' ' ASP . 42.9 p-10 -95.7 -12.38 25.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.351 -0.924 . . . . 0.0 112.548 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.78 20.27 10.16 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.903 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -146.09 147.35 31.48 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.9 t -130.7 107.21 13.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.395 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.529 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -78.71 174.87 10.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.256 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.587 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 1.1 t80 -45.91 -67.15 0.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.636 0.731 . . . . 0.0 111.695 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 3.5 mt-10 -65.19 -25.49 67.73 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.583 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 129' ' ' ASP . 0.3 OUTLIER -55.52 -48.56 74.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.829 0.347 . . . . 0.0 110.333 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.9 p90 -78.88 -31.06 45.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.219 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.49 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.6 t -52.87 -44.34 48.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.136 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -59.73 -38.51 81.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.147 0.498 . . . . 0.0 109.879 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.47 -41.04 63.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.714 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 8.5 ttp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.974 -179.807 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.712 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.26 -51.21 59.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.021 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.541 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.62 -53.3 31.85 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.232 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.43 -37.58 70.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.069 0.462 . . . . 0.0 110.292 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.412 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 12.1 t -64.07 -33.67 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.408 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.712 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.5 mt -71.71 -52.73 23.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.114 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -53.16 -37.36 61.8 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.081 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.03 -48.35 63.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.363 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -55.11 -52.92 61.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.762 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.441 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 6.1 mt -51.08 -57.44 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.053 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.558 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -58.85 -51.46 69.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.287 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.545 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.26 -40.1 64.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 2.4 mt -54.48 -52.38 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.537 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.63 -36.47 93.3 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.284 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.677 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.59 -61.75 2.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.526 -178.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.707 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -63.2 -27.55 69.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.658 177.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -65.58 -50.91 63.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.294 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.504 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.4 OUTLIER -64.58 -43.73 92.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.618 HG23 ' O ' ' B' ' 16' ' ' MET . 2.3 m -64.95 -32.83 59.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.56 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.707 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.69 -46.13 39.81 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.897 -179.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.503 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.33 -26.32 64.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.446 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.409 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.22 -47.4 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.227 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -63.1 -33.25 75.04 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.2 0.524 . . . . 0.0 110.453 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.092 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.787 0.327 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.63 -169.74 2.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -121.34 85.88 2.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.4 mt -98.29 164.79 12.16 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.479 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 p -96.85 161.87 13.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.519 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -47.65 -51.74 20.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.739 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -64.43 -27.69 69.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.96 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.94 -51.55 21.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.63 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.585 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 39.0 pt -72.95 -28.85 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.775 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.43 -27.35 9.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 29.7 mt-10 -75.32 -28.57 59.72 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.251 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.34 -58.53 3.17 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.197 0.522 . . . . 0.0 111.121 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.855 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -54.68 -22.75 14.71 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.246 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.38 -28.03 56.59 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.046 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.44 -39.52 62.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.127 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.855 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.91 -51.61 69.32 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.825 0.821 . . . . 0.0 109.367 178.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 p -74.32 -24.65 59.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.143 -1.389 . . . . 0.0 112.029 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 1.9 tt -81.93 -25.36 34.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.273 0.559 . . . . 0.0 110.194 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.501 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 3.6 t80 -92.63 -0.74 57.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.456 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.2 t70 -104.26 144.08 32.09 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.038 0.923 . . . . 0.0 111.108 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 11.5 mmtt -59.99 -53.4 58.28 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.519 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.59 -4.0 59.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.849 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.51 47.06 36.96 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.354 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -91.52 18.4 7.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.857 0.36 . . . . 0.0 110.693 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.32 88.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.615 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.4 p -150.26 148.78 29.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.647 0.261 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.501 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.41 140.46 20.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.99 0.424 . . . . 0.0 111.82 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -86.13 177.56 7.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.172 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.442 HG23 ' CA ' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -70.33 -38.75 74.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.16 0.505 . . . . 0.0 110.32 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.548 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.39 -41.34 89.17 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 178.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.4 -53.59 18.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.349 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -55.62 32.75 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.79 0.805 . . . . 0.0 109.342 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.38 -45.73 88.45 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.519 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.9 m -62.72 -31.83 72.83 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.556 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 73.7 t -66.56 -57.38 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.438 . . . . 0.0 110.838 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.437 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 2.3 tpt -72.0 -37.22 69.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.506 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -66.23 -40.94 90.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 110.613 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -79.01 -9.14 59.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.639 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -89.8 -54.02 4.24 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.634 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.92 34.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.788 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.547 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -132.89 178.78 6.61 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.344 0.593 . . . . 0.0 111.219 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -159.83 56.06 0.81 Allowed Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.709 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.3 Cg_endo -80.65 -170.25 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.552 2.168 . . . . 0.0 112.297 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.603 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.58 152.6 35.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.099 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.546 ' N ' HG21 ' A' ' 44' ' ' THR . 3.4 mm-40 -56.63 -50.05 73.18 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.81 -32.62 74.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.783 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -54.6 26.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.727 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.603 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -62.1 -44.66 96.17 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.893 179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' CA ' HG23 ' A' ' 29' ' ' THR . 0.0 OUTLIER -58.06 -49.03 78.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.715 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -53.27 -47.6 69.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.409 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 0.5 OUTLIER -74.7 -30.57 61.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.85 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.473 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -53.76 -35.0 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.524 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -45.05 -28.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.24 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -78.1 -39.12 42.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.922 0.391 . . . . 0.0 110.79 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 52' ' ' ILE . 4.6 m -80.22 -11.02 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.182 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 37.6 t0 -103.65 155.73 18.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.787 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.6 -29.34 25.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.072 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -116.54 -9.57 11.38 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.41 0.624 . . . . 0.0 110.428 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.61 63.74 4.94 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.495 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -112.32 17.77 19.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.799 0.333 . . . . 0.0 110.195 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.25 19.99 53.71 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.553 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.41 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 3.3 p -147.88 176.45 10.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.419 HG23 ' CG ' ' A' ' 68' ' ' PHE . 12.0 mt -115.03 136.52 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.594 0.235 . . . . 0.0 111.064 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.0 m-20 -88.41 -177.85 5.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.281 0.562 . . . . 0.0 111.901 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.91 -55.9 12.63 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.809 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.4 Cg_endo -65.48 -34.39 43.1 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.243 1.962 . . . . 0.0 111.266 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.87 -52.43 60.03 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.308 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.04 -56.97 14.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.879 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.49 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -56.83 -46.54 81.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.6 m -61.26 -31.66 71.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.071 0.462 . . . . 0.0 110.09 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.428 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.9 tpp -60.47 -61.78 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.101 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.8 mtt . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.88 179.876 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.834 0.35 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -50.36 -30.66 12.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.317 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -71.1 -29.45 65.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.934 0.397 . . . . 0.0 110.494 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 mt -79.05 -49.06 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.197 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -45.45 54.3 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.945 0.402 . . . . 0.0 111.645 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -53.68 -26.07 21.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.283 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.0 -33.41 51.31 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.046 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 13.4 t80 -69.33 -51.98 31.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.958 0.408 . . . . 0.0 110.283 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.32 -32.3 56.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.723 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.82 -22.91 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.624 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.29 -36.02 60.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.028 -179.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -101.34 148.48 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.445 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -69.18 -37.65 78.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.377 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.16 -9.76 13.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.57 29.4 32.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.258 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.45 -13.88 62.43 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.089 0.444 . . . . 0.0 110.754 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -12.79 55.66 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.94 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.6 m-85 -127.13 145.84 50.6 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.956 0.408 . . . . 0.0 111.448 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.423 HD11 ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pt -121.16 109.89 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.763 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.5 m -81.06 178.34 8.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.409 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.8 -29.63 70.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.002 0.429 . . . . 0.0 110.447 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.24 -57.82 10.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.244 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.51 -39.65 52.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.03 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.9 tt -55.42 -41.25 72.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.024 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 5.9 ttt180 -65.3 -49.49 69.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -60.46 -39.31 87.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.088 0.471 . . . . 0.0 110.184 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' B' ' 20' ' ' PHE . 37.1 t -73.21 -42.14 58.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.32 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 30.6 mmt -74.1 -54.31 8.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.688 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -55.42 -43.92 75.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.445 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.54 -31.43 70.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.347 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.7 mp -122.91 37.23 4.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.736 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -167.1 -117.37 0.4 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.819 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.8 177.92 7.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -78.27 97.7 5.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.299 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.86 114.84 26.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.327 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.72 174.97 6.1 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.956 -0.297 . . . . 0.0 110.363 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -48.03 -35.78 11.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.366 . . . . 0.0 110.749 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -77.32 -36.21 54.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.759 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -71.06 -33.89 70.68 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.994 0.426 . . . . 0.0 109.985 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 116' ' ' LEU . 2.6 t -73.86 -50.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.402 0.62 . . . . 0.0 109.681 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.91 -52.85 63.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.717 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -28.49 64.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.777 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.7 tpt -76.2 -37.57 57.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.152 0.501 . . . . 0.0 110.242 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -39.94 78.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.287 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -70.61 -34.57 72.27 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.411 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -82.92 -39.79 21.02 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.429 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 144' ' ' MET . . . -66.6 -41.79 87.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.474 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.2 t0 -91.48 147.18 23.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.07 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.52 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.03 -40.68 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.015 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.92 -10.98 60.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.756 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.88 33.03 1.05 Allowed Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.31 -12.57 24.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.357 -0.922 . . . . 0.0 112.48 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.11 10.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.863 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -146.47 146.76 30.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.71 107.24 13.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.281 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.53 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.3 t30 -78.31 175.4 10.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.368 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.591 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 1.1 t80 -45.95 -67.1 0.31 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.674 0.75 . . . . 0.0 111.709 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.473 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.3 mt-10 -65.32 -25.28 67.54 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.568 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.56 -48.61 74.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.813 0.34 . . . . 0.0 110.369 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.6 p90 -78.89 -31.31 45.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.347 178.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.496 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 73.8 t -53.07 -44.3 50.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.098 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -61.03 -35.5 77.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.095 0.474 . . . . 0.0 109.779 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.4 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 9.5 mmt -73.58 -42.3 61.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.091 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.407 ' CG ' HG23 ' B' ' 22' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.946 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.412 ' O ' ' CG2' ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.777 0.322 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.713 ' O ' HG13 ' B' ' 6' ' ' ILE . 2.1 mmm180 -52.18 -51.52 57.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.039 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.71 -53.36 31.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.591 0.234 . . . . 0.0 111.458 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -57.2 -36.98 71.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.086 0.47 . . . . 0.0 110.115 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.44 ' HB ' ' CZ ' ' B' ' 2' ' ' ARG . 21.4 t -63.77 -34.45 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.393 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.713 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.7 mt -71.3 -53.65 20.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.054 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -50.97 -39.92 56.42 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.236 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.84 -48.12 67.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.418 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -55.01 -54.53 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.196 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.452 ' HA ' HD11 ' B' ' 13' ' ' ILE . 4.7 mt -51.11 -56.91 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.298 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.6 OUTLIER -59.54 -47.95 83.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.199 0.523 . . . . 0.0 111.155 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.11 -39.87 63.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.025 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 1.7 mt -54.5 -52.03 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.502 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.51 -36.38 93.09 Favored Glycine 0 CA--C 1.499 -0.931 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.301 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.686 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -63.8 -61.73 2.11 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.863 -0.668 . . . . 0.0 110.468 -178.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.661 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -64.32 -27.43 69.02 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.789 177.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -67.12 -49.66 64.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.144 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.514 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.5 OUTLIER -64.69 -43.93 91.94 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.549 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.637 HG23 ' O ' ' B' ' 16' ' ' MET . 2.6 m -65.07 -32.28 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.579 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.661 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.8 OUTLIER -74.57 -48.41 26.9 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.074 -179.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.51 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.7 p -58.43 -26.26 63.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.475 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.407 HG23 ' CG ' ' A' ' 145' ' ' MET . 27.7 m -90.24 -48.05 14.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.258 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.43 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 4.1 pp -62.54 -32.9 73.93 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.202 0.525 . . . . 0.0 110.442 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.51 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.111 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.797 0.332 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.1 -169.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -117.68 90.72 3.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.572 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.2 mt -98.63 164.86 12.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.4 p -96.82 161.67 13.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.479 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -47.61 -51.81 20.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.744 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -64.46 -27.63 69.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.973 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.92 -51.49 21.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.58 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.588 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 39.0 pt -73.03 -28.9 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.801 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.49 -27.37 10.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.0 mt-10 -75.27 -28.45 59.81 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.314 178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.29 -58.5 3.19 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.301 0.572 . . . . 0.0 111.04 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.854 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.6 pttt -54.58 -22.94 14.74 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.285 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.39 -27.94 56.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.24 -39.95 62.72 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.027 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.854 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.82 -52.1 67.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.829 0.823 . . . . 0.0 109.483 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -24.21 58.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.145 -1.388 . . . . 0.0 112.117 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.492 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.3 tt -82.05 -24.68 35.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.282 0.563 . . . . 0.0 110.202 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.8 t80 -93.66 -0.83 55.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.522 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.4 t70 -102.87 143.64 32.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.997 0.904 . . . . 0.0 111.026 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.1 mmtt -60.17 -53.38 58.43 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.594 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.66 -5.9 59.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.773 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.59 45.91 53.83 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.425 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -90.83 18.05 7.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.832 0.349 . . . . 0.0 110.705 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.07 5.95 88.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.503 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.451 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 52.7 p -150.1 149.54 30.42 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -102.04 140.51 20.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.934 0.397 . . . . 0.0 112.018 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.445 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -85.6 176.84 7.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.929 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.43 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.0 OUTLIER -70.49 -38.16 74.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.142 0.496 . . . . 0.0 110.36 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.67 -40.96 89.53 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.22 178.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.43 -53.73 17.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.324 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -54.83 42.52 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.755 0.788 . . . . 0.0 109.422 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.57 -45.97 92.58 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 114.552 -1.203 . . . . 0.0 112.484 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.57 -31.1 71.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.86 0.33 . . . . 0.0 110.572 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 72.1 t -67.86 -57.22 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.414 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -71.98 -35.98 69.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.46 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -42.62 80.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.953 0.406 . . . . 0.0 110.776 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 t -78.96 -8.59 59.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.753 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.7 tt -90.57 -55.09 3.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.766 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.5 34.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.955 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.546 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.6 tp-100 -137.66 -178.86 5.43 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.3 0.571 . . . . 0.0 111.219 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -159.65 56.59 0.89 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.913 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.41 -177.49 3.81 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.457 2.104 . . . . 0.0 112.076 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -112.44 152.45 28.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.952 0.406 . . . . 0.0 110.224 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.551 ' N ' HG23 ' A' ' 44' ' ' THR . 3.5 mm-40 -57.7 -49.09 77.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.401 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.64 -31.93 72.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.774 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.83 -54.3 28.59 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.586 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.611 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.98 -34.52 78.28 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.373 179.606 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.52 -42.6 95.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.882 0.372 . . . . 0.0 110.148 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -61.83 -45.5 93.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.219 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 mmt -74.5 -30.75 61.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.428 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.42 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.624 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -44.99 -28.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.373 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -77.57 -38.6 48.09 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.905 0.383 . . . . 0.0 110.816 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 52' ' ' ILE . 4.5 m -81.43 -11.64 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.244 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 41.0 t0 -103.63 155.62 18.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.692 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.59 -28.89 26.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.05 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -116.45 -9.67 11.41 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.435 0.636 . . . . 0.0 110.459 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.525 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.14 63.37 5.31 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.446 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -112.37 18.26 18.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.808 0.337 . . . . 0.0 110.183 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.66 20.02 55.04 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.515 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.417 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.4 p -146.88 176.36 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.6 mt -116.12 136.54 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.581 0.229 . . . . 0.0 110.803 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.2 m-20 -86.97 -178.49 6.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.268 0.556 . . . . 0.0 111.948 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.499 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -67.82 -56.17 12.28 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.589 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.75 -34.81 39.18 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.248 1.965 . . . . 0.0 111.198 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.65 -52.38 63.57 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.204 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.22 -56.86 16.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.85 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -56.83 -46.96 81.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.7 m -60.26 -30.99 69.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 0.0 110.064 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.447 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.3 tpp -63.68 -61.89 2.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.104 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mtm . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.039 -179.848 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -53.47 -53.72 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.29 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.71 -29.56 27.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.486 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 mt -65.46 -51.29 65.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.38 -49.62 18.44 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 110.405 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -54.1 -30.22 47.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.243 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -69.88 -37.91 76.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.625 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 11.3 t80 -67.3 -53.93 25.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.519 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -54.08 -31.01 50.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.784 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.0 t -88.63 -22.85 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.291 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.495 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -55.2 -37.21 66.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.096 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -101.48 147.23 26.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.506 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -69.64 -36.75 76.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.362 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.2 -9.74 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.4 30.14 34.48 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.245 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -67.43 -13.79 62.34 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.01 0.405 . . . . 0.0 110.782 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.19 -13.42 55.38 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.951 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 25.5 m-85 -127.19 145.49 50.74 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.01 0.433 . . . . 0.0 111.353 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.432 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pp -121.1 109.89 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.705 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.68 178.9 8.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.508 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.67 -29.94 70.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.055 0.455 . . . . 0.0 110.511 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.44 -57.77 11.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.168 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.46 -41.47 47.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.951 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 tt -54.19 -37.46 64.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.936 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.418 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 3.2 ttt-85 -70.06 -49.4 51.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.925 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.51 -37.56 86.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.058 0.456 . . . . 0.0 110.139 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.472 HG11 ' CZ ' ' B' ' 20' ' ' PHE . 47.1 t -73.03 -45.33 54.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.232 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.455 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 21.5 mmt -74.03 -54.27 8.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.701 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 m -55.57 -44.6 77.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.264 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -58.4 -28.44 65.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.789 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.423 ' CD2' ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -126.06 35.88 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -164.04 -120.46 0.52 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.764 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -127.78 -176.84 3.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 0.0 110.907 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -83.84 97.07 8.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.418 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -90.28 114.0 25.95 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.426 179.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.78 175.36 5.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -48.06 -35.9 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.947 0.403 . . . . 0.0 110.733 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -77.41 -35.44 54.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.841 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -72.12 -33.22 67.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.998 0.427 . . . . 0.0 110.094 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.7 t -75.08 -50.61 24.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.395 0.617 . . . . 0.0 109.679 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -59.08 -52.83 64.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.717 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -28.73 58.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.767 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 6.4 tpt -76.16 -39.26 55.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.207 0.527 . . . . 0.0 110.044 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -46.83 87.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.392 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -62.7 -38.28 89.78 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.911 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 124' ' ' MET . 18.5 pt-20 -81.12 -39.81 25.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.724 0.297 . . . . 0.0 110.814 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 144' ' ' MET . . . -65.42 -39.35 92.03 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.547 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.6 t0 -94.94 146.4 24.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.518 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.4 -40.63 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.06 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.518 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.91 -10.98 60.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.769 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.68 33.03 0.95 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.2 p-10 -96.27 -12.49 24.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.369 -0.916 . . . . 0.0 112.56 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.8 20.2 10.23 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.808 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.443 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.63 147.29 30.89 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.68 107.27 13.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.258 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.528 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.3 t30 -77.83 175.23 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.445 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.591 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 1.1 t80 -46.05 -67.04 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.654 0.74 . . . . 0.0 111.811 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.3 mm-40 -65.57 -25.13 67.28 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.63 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.56 -48.9 74.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.382 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.465 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 9.3 p90 -79.21 -31.32 43.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.364 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.515 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 72.0 t -52.9 -43.3 46.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.341 -0.39 . . . . 0.0 109.963 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -62.71 -34.79 77.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.81 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 9.5 mmt -73.48 -44.29 58.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.424 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.1 ttp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.159 -179.625 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.721 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.31 -51.1 60.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.65 -53.23 32.63 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.655 0.264 . . . . 0.0 111.299 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.17 -37.57 72.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.019 0.438 . . . . 0.0 110.317 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 15.0 t -63.36 -33.73 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.388 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.721 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.5 mt -71.64 -55.08 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.011 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 26.2 mmm-85 -50.42 -37.88 40.16 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.178 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -46.1 65.15 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.503 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -56.6 -54.12 49.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.447 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.2 -57.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.548 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.54 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.0 OUTLIER -60.92 -51.41 69.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.361 0.601 . . . . 0.0 110.938 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.565 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.42 -38.81 63.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.859 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.48 HG12 ' CZ ' ' A' ' 19' ' ' PHE . 3.1 mt -54.31 -50.66 55.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.351 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.44 -37.28 94.56 Favored Glycine 0 CA--C 1.498 -0.977 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.544 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -65.0 -61.77 1.95 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.716 -0.742 . . . . 0.0 110.552 -179.11 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.636 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.69 -27.51 67.92 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.47 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.486 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -68.36 -46.41 70.17 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.794 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 1.1 ppt_? -63.58 -44.1 95.06 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.636 HG23 ' O ' ' B' ' 16' ' ' MET . 1.8 m -62.78 -35.42 70.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.934 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.554 ' N ' HG23 ' B' ' 19' ' ' VAL . 0.3 OUTLIER -75.18 -47.2 29.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.064 -179.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.522 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 12.1 p -59.4 -25.15 64.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.598 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.434 HG21 ' O ' ' B' ' 18' ' ' ARG . 30.3 m -90.29 -48.52 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.196 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -61.91 -33.78 74.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.228 0.537 . . . . 0.0 110.44 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.083 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.801 0.334 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.82 -169.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.782 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -120.59 90.68 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.566 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.66 164.75 12.28 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.004 0.43 . . . . 0.0 110.424 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 p -97.44 161.93 13.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.467 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -47.69 -51.68 20.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.766 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -64.5 -27.7 69.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.045 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.85 -51.5 22.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.619 179.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.587 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.9 pt -73.0 -28.97 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.64 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.54 -27.33 10.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.527 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 4.6 mm-40 -75.34 -28.55 59.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.281 178.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.34 -58.61 3.13 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.214 0.531 . . . . 0.0 111.033 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.851 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.76 15.04 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.249 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.52 -27.95 56.2 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.08 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.23 -39.92 62.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.043 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.851 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.55 -51.95 67.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.802 0.811 . . . . 0.0 109.363 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.405 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 p -74.51 -24.05 58.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.074 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.481 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.07 -24.74 35.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.261 0.553 . . . . 0.0 110.166 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CZ ' HG12 ' B' ' 13' ' ' ILE . 2.5 t80 -94.64 0.21 54.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.571 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.4 t70 -104.27 142.35 34.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.942 0.877 . . . . 0.0 110.997 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.7 mmtt -58.4 -53.35 59.33 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.572 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -86.62 -4.88 59.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.765 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.15 47.23 42.13 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.356 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -91.64 18.53 7.36 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.805 0.336 . . . . 0.0 110.673 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.85 5.12 88.25 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.592 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.9 p -150.33 148.65 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.668 0.27 . . . . 0.0 110.344 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.72 140.46 19.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.801 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -86.41 178.66 7.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.294 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.447 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.6 OUTLIER -69.96 -41.8 74.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.056 0.455 . . . . 0.0 110.411 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.537 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -57.28 -40.88 78.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.365 179.07 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.537 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -70.15 -53.82 15.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.47 -179.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.405 ' HB3' ' NZ ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.5 -54.14 50.26 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.838 0.828 . . . . 0.0 109.572 178.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.33 91.32 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.462 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 30' ' ' LYS . 53.3 m -65.48 -30.74 71.55 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 120.813 0.339 . . . . 0.0 110.432 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.441 ' CG2' ' CE2' ' A' ' 19' ' ' PHE . 13.9 t -63.62 -57.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.037 0.446 . . . . 0.0 110.568 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.481 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 1.7 tpt -72.35 -40.53 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.273 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -61.13 -39.66 90.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.945 0.402 . . . . 0.0 110.489 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.5 t -78.86 -11.48 59.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.578 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.4 tt -88.0 -53.43 4.74 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.075 0.464 . . . . 0.0 110.552 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.72 37.21 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.624 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.553 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 tp-100 -134.83 -179.8 5.83 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.338 0.589 . . . . 0.0 111.279 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -159.75 56.41 0.86 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.792 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.7 Cg_endo -80.57 -174.29 2.19 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.546 2.164 . . . . 0.0 112.291 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.602 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -117.32 152.64 34.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.873 0.368 . . . . 0.0 110.124 179.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.544 ' N ' HG23 ' A' ' 44' ' ' THR . 3.7 mm-40 -56.49 -49.99 73.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.26 -32.59 74.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.638 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -54.52 23.75 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.596 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.602 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -61.22 -48.36 81.87 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.929 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.434 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -54.6 -49.97 69.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 110.952 179.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.27 -47.23 69.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.682 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -74.68 -30.61 61.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.831 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.474 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -54.68 -36.03 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.588 -178.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -45.23 -28.64 0.82 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.213 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.433 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -79.6 -38.21 34.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.929 0.395 . . . . 0.0 110.778 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 52' ' ' ILE . 3.7 m -81.07 -10.98 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.14 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.532 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.6 t0 -103.59 155.87 18.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.72 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.58 -29.17 26.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.065 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -116.46 -9.72 11.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.397 0.617 . . . . 0.0 110.452 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.532 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.68 63.48 5.17 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.498 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -112.47 18.41 18.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.842 0.353 . . . . 0.0 110.201 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.39 19.98 55.68 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.424 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.3 p -146.71 176.49 9.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.4 mt -116.3 136.46 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.544 0.212 . . . . 0.0 110.959 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.5 m-20 -88.24 -178.02 5.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.25 0.548 . . . . 0.0 111.938 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.5 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.82 -55.91 12.83 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.659 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -65.67 -34.54 40.94 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.25 1.967 . . . . 0.0 111.241 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.44 -52.47 61.31 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.26 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.19 -56.99 14.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.789 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -57.89 -47.09 83.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.795 -179.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.5 m -59.69 -30.46 68.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.074 0.464 . . . . 0.0 110.129 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.424 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.2 tpp -62.71 -61.84 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.083 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.2 mtt . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.001 -179.934 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.804 0.335 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -56.82 -51.44 68.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.221 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.648 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.68 -29.24 25.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.477 -179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.403 ' CG1' ' OE1' ' A' ' 84' ' ' GLU . 19.8 mt -66.7 -51.45 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.919 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -50.08 16.64 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.075 0.464 . . . . 0.0 110.55 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -53.91 -29.19 40.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.252 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -70.83 -38.25 73.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 10.8 t80 -67.35 -54.15 23.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.966 0.412 . . . . 0.0 110.545 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -54.08 -30.67 49.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.791 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.7 -22.88 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.216 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -55.3 -38.38 68.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.176 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -100.64 146.87 26.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.503 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -69.72 -36.39 75.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.373 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.27 -9.79 13.87 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.43 30.02 34.75 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.23 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -67.43 -13.62 62.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 117.102 0.451 . . . . 0.0 110.787 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.22 -13.39 55.29 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.914 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.442 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 25.1 m-85 -127.16 145.95 50.57 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.988 0.423 . . . . 0.0 111.425 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.428 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pp -121.13 109.94 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.729 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.1 p -83.55 176.97 8.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.53 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.7 -30.91 71.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 110.396 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.25 -57.66 11.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.322 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.43 -45.73 30.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.228 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.426 ' HB2' HD13 ' A' ' 100' ' ' ILE . 17.6 tp -53.13 -33.24 51.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -68.79 -49.15 60.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -59.14 -43.51 92.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.194 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.6 t -72.96 -39.02 57.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.51 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.499 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.6 mmt -73.97 -54.27 8.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.511 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.4 m -56.99 -46.9 81.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.088 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -60.0 -26.67 66.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.841 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.8 mp -124.21 36.19 4.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.36 -116.46 0.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.688 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -131.31 172.51 12.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.805 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -75.05 98.58 3.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.163 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.417 ' CD1' ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.88 113.13 24.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.461 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.83 175.28 5.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.32 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -48.06 -36.04 12.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 110.759 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -77.41 -34.35 54.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -73.64 -33.04 64.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.024 0.44 . . . . 0.0 110.074 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.417 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.6 t -74.96 -48.56 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.829 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.25 -52.87 63.83 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.844 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.08 -28.72 62.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.82 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.414 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 5.8 tpt -76.23 -38.47 56.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 110.113 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -67.15 -44.95 87.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.559 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -61.75 -40.55 95.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.97 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 124' ' ' MET . 8.6 pt-20 -81.0 -37.39 29.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.787 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.84 81.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.338 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.3 t0 -102.06 146.34 28.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.937 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.519 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.5 -40.61 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.093 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.98 -11.07 60.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.713 -179.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.85 32.77 1.0 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.3 p-10 -95.99 -12.53 24.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.351 -0.924 . . . . 0.0 112.52 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.16 10.23 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.817 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.442 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.54 147.19 30.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 t -130.71 107.32 13.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.232 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.53 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -78.05 175.0 10.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.339 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.591 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 1.1 t80 -45.95 -67.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.653 0.74 . . . . 0.0 111.84 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.7 mt-10 -66.02 -24.54 66.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.644 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.73 -48.86 74.47 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.393 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 10.7 p90 -79.32 -31.21 43.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.399 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.506 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 75.7 t -52.91 -44.85 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.44 -35.45 79.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.137 0.494 . . . . 0.0 109.826 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.47 -43.35 60.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.81 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 24.5 ttp . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.012 -179.771 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.847 0.356 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.717 ' O ' HG13 ' B' ' 6' ' ' ILE . 11.6 mmm180 -52.5 -50.73 62.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.232 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.523 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.79 -53.43 32.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.281 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.69 -36.11 71.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.149 0.5 . . . . 0.0 110.007 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.526 ' O ' ' HD3' ' B' ' 9' ' ' LYS . 45.1 t -62.84 -41.43 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.997 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.717 HG13 ' O ' ' B' ' 2' ' ' ARG . 3.2 mt -63.16 -55.42 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.098 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' B' ' 3' ' ' LYS . 24.1 mmm-85 -50.16 -40.43 46.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.031 0.444 . . . . 0.0 110.247 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.88 -44.95 68.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.667 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' B' ' 5' ' ' VAL . 0.6 OUTLIER -56.34 -55.07 37.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.05 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.449 ' HA ' HD13 ' B' ' 13' ' ' ILE . 3.7 mt -51.21 -57.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.751 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.506 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.7 tpt180 -61.32 -51.34 69.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.252 0.548 . . . . 0.0 111.028 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.541 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.33 -39.23 63.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.701 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.484 HG12 ' CZ ' ' A' ' 19' ' ' PHE . 3.1 mt -54.47 -48.94 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.225 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.77 -37.64 95.0 Favored Glycine 0 CA--C 1.497 -1.041 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.521 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.656 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -65.06 -61.68 2.0 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.741 -0.73 . . . . 0.0 110.555 -179.246 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.642 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.6 -27.46 67.76 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -68.25 -47.53 67.5 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.978 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.5 ppt_? -63.8 -43.61 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.105 0.479 . . . . 0.0 109.754 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.642 HG23 ' O ' ' B' ' 16' ' ' MET . 1.8 m -61.86 -35.48 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.529 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.545 ' N ' HG23 ' B' ' 19' ' ' VAL . 0.3 OUTLIER -75.97 -43.1 46.17 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.785 -179.599 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.531 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 21.8 p -61.01 -26.63 67.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.495 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.413 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.4 m -90.42 -48.43 14.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.163 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 4.2 pp -63.09 -32.6 74.02 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.199 0.524 . . . . 0.0 110.535 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.531 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.176 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.817 0.341 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.86 -170.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -121.15 87.73 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -98.48 164.79 12.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.544 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 p -97.98 162.84 13.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.494 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -47.35 -51.42 19.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.875 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -64.27 -27.72 69.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.991 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.9 mm-40 -72.68 -51.36 19.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.707 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.58 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 36.7 pt -73.07 -28.74 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.895 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.34 -27.26 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.507 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 5.6 mm-40 -74.99 -28.39 60.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.227 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.581 ' CZ ' ' CD1' ' A' ' 4' ' ' LEU . 3.2 m-85 -79.63 -58.33 3.24 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.293 0.568 . . . . 0.0 111.002 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.855 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 13.1 ptmt -54.41 -23.0 14.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.216 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.21 -28.28 57.15 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.102 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.99 -39.81 63.4 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.07 177.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.855 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.26 -52.04 67.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.806 0.812 . . . . 0.0 109.501 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -23.9 58.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.183 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.498 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.1 -25.09 34.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.273 0.558 . . . . 0.0 110.215 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.522 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.4 t80 -94.42 -0.27 54.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.47 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.7 t70 -103.87 144.88 30.92 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.959 0.885 . . . . 0.0 111.051 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.5 mmtt -61.13 -53.43 57.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.644 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -83.91 -5.94 59.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.814 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.13 45.31 57.24 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.451 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.9 p30 -90.47 17.23 7.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.832 0.348 . . . . 0.0 110.68 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.37 7.46 87.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.386 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 69.0 p -150.38 148.23 28.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.7 mt -101.57 140.68 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.808 0.337 . . . . 0.0 111.829 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.449 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 1.5 t -85.52 179.37 7.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.117 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.411 HG22 ' CA ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -70.43 -45.78 65.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.935 -179.201 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.51 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -54.36 -38.93 66.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.335 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 3.4 mm-40 -71.64 -53.75 12.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.395 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.408 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -56.11 -52.52 64.02 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.733 0.778 . . . . 0.0 109.51 178.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.82 -45.5 96.08 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.371 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 m -62.87 -35.88 81.46 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.917 0.389 . . . . 0.0 110.156 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 60.1 t -61.76 -56.87 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.652 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.438 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -71.6 -40.78 69.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.306 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -41.2 99.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 0.0 110.656 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 t -78.88 -10.08 59.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.629 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 tt -88.76 -53.88 4.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.585 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.04 34.59 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.819 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -135.86 -179.94 5.96 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.362 0.601 . . . . 0.0 111.306 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -159.75 56.5 0.87 Allowed Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.754 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 96.0 Cg_endo -80.44 -173.58 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.527 2.151 . . . . 0.0 112.273 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.615 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.39 152.54 31.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.846 0.355 . . . . 0.0 110.166 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.551 ' N ' HG21 ' A' ' 44' ' ' THR . 3.3 mm-40 -57.68 -49.21 77.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.12 -31.17 71.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.742 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.16 -54.39 21.7 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.575 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.615 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -63.45 -37.84 88.84 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.209 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.411 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.42 -49.9 73.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.842 0.353 . . . . 0.0 110.588 179.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.25 -46.25 76.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.496 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.42 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.4 mmt -74.74 -30.54 61.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.704 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -53.5 -38.0 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.498 -179.079 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -44.98 -28.59 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.373 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.463 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.83 -39.58 50.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.944 0.402 . . . . 0.0 110.767 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.461 HG23 ' HA ' ' A' ' 52' ' ' ILE . 5.0 m -80.57 -11.96 12.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.099 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.509 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.4 t0 -103.69 155.15 18.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.74 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.63 -28.86 26.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.152 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -116.46 -9.68 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.44 0.638 . . . . 0.0 110.468 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.509 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.5 63.89 4.82 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.519 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -112.71 18.38 18.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.855 0.359 . . . . 0.0 110.133 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.88 19.93 56.79 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.467 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.4 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 6.1 p -146.1 176.12 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.9 mt -115.21 136.38 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.551 0.215 . . . . 0.0 110.725 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.4 m-20 -87.05 -178.17 6.2 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.16 0.505 . . . . 0.0 111.828 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.97 -55.46 13.41 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.831 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.2 Cg_endo -65.72 -35.37 37.17 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.234 1.956 . . . . 0.0 111.348 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -63.84 -52.31 60.69 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.305 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -56.9 -56.78 17.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.834 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.494 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -53.56 -49.51 67.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.83 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.6 m -58.57 -32.42 68.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.226 0.536 . . . . 0.0 109.685 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.461 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 2.7 tpp -67.19 -61.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.899 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.4 mtm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 179.896 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.847 0.356 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -52.24 -30.55 28.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.311 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' CB ' ' HB3' ' B' ' 15' ' ' LYS . 1.1 mt-10 -70.54 -29.58 66.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.745 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 mt -79.45 -51.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.27 -51.82 12.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -53.72 -25.53 18.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.884 0.373 . . . . 0.0 110.733 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.429 ' CB ' HG23 ' B' ' 19' ' ' VAL . . . -77.67 -37.13 50.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.204 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.564 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.2 t80 -68.04 -52.12 39.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.034 0.445 . . . . 0.0 110.087 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -54.77 -32.05 59.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.803 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -88.63 -22.8 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.55 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.45 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.93 -32.96 55.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.114 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -102.34 148.05 25.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.496 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -69.58 -37.21 76.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.351 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.16 -9.72 13.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.83 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.15 29.64 33.32 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.228 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -67.4 -13.93 62.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.079 0.439 . . . . 0.0 110.75 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.2 -12.23 55.3 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.992 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.1 m-85 -127.25 146.99 50.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.906 0.384 . . . . 0.0 111.378 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.414 HG12 ' CD2' ' A' ' 92' ' ' PHE . 1.1 pt -121.11 109.98 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.816 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.2 m -83.99 177.07 8.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.466 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.25 -30.09 71.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.097 0.475 . . . . 0.0 110.528 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.35 -57.11 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.205 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.32 -46.83 25.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.377 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.2 tp -53.19 -31.23 41.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.938 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -72.54 -49.15 34.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -59.22 -42.8 91.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.144 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.42 HG11 ' CZ ' ' B' ' 20' ' ' PHE . 2.2 t -72.95 -41.03 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.565 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.454 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 30.3 mmt -72.61 -54.17 9.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.536 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.4 m -57.12 -48.9 77.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.225 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -58.04 -29.9 65.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.796 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.6 mp -121.58 37.13 4.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.35 -116.43 0.39 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.744 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.02 168.72 16.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 110.835 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -73.71 100.11 3.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.36 114.13 26.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.86 175.25 5.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.364 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.04 -35.98 12.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 110.779 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.36 -34.98 55.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -72.87 -33.03 65.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.973 0.415 . . . . 0.0 110.091 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.411 ' HA ' HD12 ' A' ' 116' ' ' LEU . 2.6 t -75.06 -48.76 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.817 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -58.81 -52.77 64.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.788 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -28.74 63.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.791 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 11.7 tpt -76.13 -37.77 57.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.135 0.493 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -39.55 81.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.407 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -65.2 -41.41 94.56 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.489 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -82.62 -32.84 28.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 110.483 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.87 78.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.484 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 20.1 t0 -105.83 148.6 27.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.974 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.535 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.84 -40.8 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.024 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.535 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.94 -10.93 59.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.691 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.0 32.83 1.08 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.411 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.4 p-10 -96.36 -12.79 23.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.291 -0.954 . . . . 0.0 112.451 -176.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.21 10.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.808 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.6 146.95 30.62 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.043 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.0 t -130.75 107.5 14.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.202 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.35 174.16 11.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.327 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.599 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.88 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.471 0.653 . . . . 0.0 111.433 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.429 ' HA ' HG23 ' A' ' 142' ' ' VAL . 1.2 mt-10 -59.95 -32.58 70.94 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.045 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -43.44 78.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.258 0.551 . . . . 0.0 109.65 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 145' ' ' MET . 0.0 OUTLIER -78.69 -31.76 46.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.213 178.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.599 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 62.1 t -54.95 -51.83 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.683 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -56.87 -46.88 81.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.2 tpp -68.72 -31.09 69.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.8 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.431 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 11.3 ttp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.825 0.345 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.714 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.2 mmm180 -52.24 -51.41 58.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.53 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.73 -53.45 31.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.632 0.253 . . . . 0.0 111.391 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.81 -36.61 70.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.136 0.493 . . . . 0.0 110.09 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.438 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 21.7 t -64.27 -34.3 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.32 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.714 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.8 mt -71.56 -49.79 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.235 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 21.9 mmm-85 -58.01 -33.14 68.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.119 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.07 -49.19 47.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.187 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' B' ' 6' ' ' ILE . 1.6 ptpt -61.38 -50.52 72.52 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.657 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.461 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 10.6 mt -51.29 -57.37 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.091 0.472 . . . . 0.0 110.766 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.98 -50.79 72.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.93 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.11 -39.97 63.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.892 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.481 HG12 ' CZ ' ' A' ' 19' ' ' PHE . 2.6 mt -54.51 -52.11 43.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.612 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.74 -36.27 93.08 Favored Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.21 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.674 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.96 -61.67 2.02 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.847 -0.676 . . . . 0.0 110.389 -178.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' MET . . . . . 0.671 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -62.43 -27.92 69.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.652 177.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -65.27 -51.55 60.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.209 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.51 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.5 OUTLIER -63.45 -43.56 97.02 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.627 HG22 ' O ' ' B' ' 16' ' ' MET . 1.9 m -66.3 -32.36 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.599 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.672 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 0.6 OUTLIER -71.73 -50.08 33.44 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.006 -179.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.432 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 54.7 p -58.49 -36.22 73.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.058 0.456 . . . . 0.0 110.765 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.448 HG21 ' C ' ' B' ' 19' ' ' VAL . 28.4 m -72.54 -45.01 60.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.071 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 20' ' ' PHE . 3.0 pp -65.29 -27.53 68.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.022 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 13.0 ptt180 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.921 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.833 0.349 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -100.95 -170.21 1.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.827 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -117.23 83.93 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.574 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.6 164.73 12.3 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.58 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.417 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.6 p -98.6 162.8 12.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.465 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -47.43 -51.33 20.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.879 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -64.42 -27.66 69.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.157 0.503 . . . . 0.0 110.065 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.443 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -72.51 -51.43 20.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.706 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.588 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 37.9 pt -73.08 -28.85 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.849 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.37 -27.45 9.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 11.0 mt-10 -75.23 -28.53 59.95 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.207 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.36 -58.41 3.22 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.218 0.532 . . . . 0.0 111.004 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.855 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.5 pttt -54.45 -23.03 14.34 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.273 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.45 -27.85 56.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.27 -39.78 62.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.072 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.855 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.64 -51.89 67.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.845 0.831 . . . . 0.0 109.458 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.401 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 p -74.46 -24.45 59.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.101 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -82.06 -23.5 35.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.261 0.553 . . . . 0.0 110.28 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.9 t80 -95.4 -0.76 52.17 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.554 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.7 t70 -103.48 142.64 33.91 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.971 0.891 . . . . 0.0 111.039 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.44 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 3.7 mmtt -59.11 -53.38 59.04 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.604 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.93 -5.42 59.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.77 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.51 47.69 44.03 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.303 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -92.06 18.86 7.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.867 0.365 . . . . 0.0 110.685 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.36 5.11 89.06 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.577 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.8 p -150.34 148.86 29.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.18 140.51 19.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.847 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.17 176.46 8.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.004 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.426 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.1 p -70.52 -37.5 74.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.145 0.497 . . . . 0.0 110.332 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.536 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.23 -41.12 92.46 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.15 178.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -69.4 -53.41 19.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.26 -179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -54.69 44.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.724 0.773 . . . . 0.0 109.326 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.49 -45.83 92.63 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.456 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.7 m -62.39 -30.9 71.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.845 0.322 . . . . 0.0 110.495 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 72.5 t -68.2 -57.26 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.87 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.405 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -71.95 -35.63 69.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.389 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -68.13 -42.74 79.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.848 0.356 . . . . 0.0 110.667 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 t -78.94 -8.14 58.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.806 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tt -90.97 -54.82 3.8 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.88 34.94 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.937 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.543 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp-100 -137.56 -178.95 5.46 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.381 0.61 . . . . 0.0 111.163 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -159.64 56.46 0.88 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.927 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.4 Cg_endo -80.37 -175.7 2.83 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.56 2.173 . . . . 0.0 112.101 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.612 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.94 152.5 32.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.956 0.408 . . . . 0.0 110.18 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.55 ' N ' HG23 ' A' ' 44' ' ' THR . 3.7 mm-40 -57.22 -49.58 75.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.58 75.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.713 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.52 -54.33 33.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.673 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.612 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.85 -34.77 78.9 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.379 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.39 -42.7 95.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.909 0.385 . . . . 0.0 110.228 179.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.76 -45.52 93.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.23 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -30.69 61.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.412 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.555 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.69 -38.29 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.524 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -44.91 -28.68 0.69 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.351 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.6 -38.78 47.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.891 0.376 . . . . 0.0 110.803 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.465 HG23 ' HA ' ' A' ' 52' ' ' ILE . 4.6 m -81.07 -11.39 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.18 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.9 t0 -103.73 155.68 18.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.754 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.57 -29.1 26.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -116.43 -9.66 11.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.416 0.627 . . . . 0.0 110.471 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.44 63.53 5.14 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.517 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -112.26 18.13 18.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.846 0.355 . . . . 0.0 110.193 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.67 19.91 55.31 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.453 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.413 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.1 p -147.16 176.41 9.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.418 HG23 ' CG ' ' A' ' 68' ' ' PHE . 13.8 mt -115.7 136.52 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.562 0.22 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.9 m-20 -87.28 -178.06 6.11 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.28 0.562 . . . . 0.0 111.931 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.03 -56.06 11.99 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.622 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.7 Cg_endo -65.65 -34.8 40.07 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.21 1.94 . . . . 0.0 111.166 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.91 -52.35 63.41 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.268 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.0 -56.63 19.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.867 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -57.51 -46.12 84.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.696 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.5 m -60.06 -31.15 69.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.041 0.448 . . . . 0.0 109.966 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.43 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 2.8 tpp -64.54 -61.8 1.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.908 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.7 mtt -66.04 -29.19 69.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.803 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.77 -21.54 42.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.308 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -51.0 95.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 111.103 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -62.61 -18.82 62.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.231 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -29.61 66.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.963 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -88.94 79.33 7.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.68 -167.3 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.32 -167.41 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 63.87 30.51 14.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.1 p -77.53 -30.17 52.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.63 -29.11 36.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.85 -54.48 37.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.76 -29.43 27.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.375 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.9 mt -64.76 -51.23 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.772 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -75.58 -50.57 15.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.043 0.449 . . . . 0.0 110.685 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -53.79 -30.84 46.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.682 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -71.08 -38.55 72.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.781 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.533 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 24.2 t80 -67.03 -56.02 11.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.579 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.62 -30.65 43.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.866 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.7 t -88.4 -22.92 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.211 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' HD12 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -55.18 -32.05 61.87 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.046 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -102.16 148.84 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.438 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -69.61 -37.71 76.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.332 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -112.27 -9.78 13.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.66 30.55 32.37 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.119 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.41 -13.73 62.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.96 0.38 . . . . 0.0 110.757 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.24 -13.46 55.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.857 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.446 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.7 m-85 -127.14 145.41 50.76 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.967 0.413 . . . . 0.0 111.284 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.1 109.97 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.885 179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 p -83.39 177.38 8.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.311 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.18 -28.97 70.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.083 0.468 . . . . 0.0 110.405 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.46 -57.67 9.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.426 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.41 -42.96 42.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.273 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.426 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 56.0 tp -56.9 -31.14 64.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.08 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.401 ' HD2' ' HG ' ' A' ' 116' ' ' LEU . 5.4 ttt180 -72.54 -49.27 33.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.937 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -60.85 -36.5 79.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 110.539 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.475 HG12 ' CZ ' ' B' ' 20' ' ' PHE . 54.5 t -72.82 -44.14 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.301 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 24.8 mmt -73.99 -54.05 8.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.727 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m -55.59 -45.55 77.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.367 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -60.27 -29.85 69.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.792 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.9 mp -123.49 38.66 4.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.647 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.95 -116.81 0.4 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.781 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -132.2 170.77 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 110.864 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -74.97 99.7 3.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.257 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.416 ' CD1' ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.7 114.39 26.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.384 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.7 175.34 5.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.429 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -48.09 -35.93 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.755 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -77.4 -35.09 54.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -72.62 -33.67 66.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.977 0.417 . . . . 0.0 110.106 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.6 t -74.69 -48.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.899 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.21 -52.87 63.82 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.843 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -56.97 -28.85 62.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.857 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.426 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 6.6 tpt -76.35 -38.64 55.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.146 0.498 . . . . 0.0 110.169 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.87 -48.42 79.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.563 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -60.25 -40.27 89.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.946 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.86 -37.1 30.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 0.0 110.598 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.403 ' HB1' ' CE ' ' A' ' 124' ' ' MET . . . -66.93 -36.18 81.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 22.3 t0 -101.37 147.58 26.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.013 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.523 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.6 pt -84.84 -40.67 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.047 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.95 -10.98 60.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.65 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.68 1.09 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.405 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.9 p-10 -96.33 -12.84 23.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.317 -0.941 . . . . 0.0 112.379 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.93 20.1 10.21 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.754 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.9 146.54 30.19 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.899 0.38 . . . . 0.0 110.06 179.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.64 107.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.246 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.21 174.84 11.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.304 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.581 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.96 -67.01 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.523 0.677 . . . . 0.0 111.464 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.88 -34.15 72.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.839 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.01 -40.63 73.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.45 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.2 OUTLIER -78.83 -32.88 46.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.064 178.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 64.0 t -55.35 -46.93 78.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.626 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -57.81 -45.32 86.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.1 -33.12 65.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.409 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 18.0 ttp -59.41 -41.93 90.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 t -78.71 -31.25 46.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.67 151.32 25.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.72 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.3 mmm180 -52.3 -51.25 59.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.66 -53.17 33.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.638 0.256 . . . . 0.0 111.289 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -57.24 -37.52 72.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.007 0.432 . . . . 0.0 110.347 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.405 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 15.6 t -63.27 -33.68 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.348 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.72 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.6 mt -71.58 -55.46 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.995 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.3 mmm-85 -50.36 -37.79 38.92 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.215 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -44.44 66.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -57.9 -55.01 40.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.43 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 3.8 mt -51.27 -57.28 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.906 0.384 . . . . 0.0 111.228 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -58.36 -51.18 70.9 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.424 0.631 . . . . 0.0 110.656 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.567 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.5 -39.38 64.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.81 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.3 mt -54.28 -48.31 67.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.233 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.27 -38.22 95.58 Favored Glycine 0 CA--C 1.498 -1.022 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.495 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.661 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -64.76 -61.8 1.96 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.743 -0.729 . . . . 0.0 110.504 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.642 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -60.32 -27.59 67.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -67.32 -48.64 66.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.038 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 0.7 OUTLIER -63.78 -43.74 95.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.642 HG23 ' O ' ' B' ' 16' ' ' MET . 1.7 m -62.09 -34.65 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.472 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.539 ' N ' HG23 ' B' ' 19' ' ' VAL . 0.3 OUTLIER -75.37 -44.11 46.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.639 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 18.8 p -60.84 -25.8 66.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.474 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.428 HG21 ' N ' ' B' ' 23' ' ' LEU . 26.8 m -90.07 -46.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.991 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.12 -33.34 75.26 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.18 0.514 . . . . 0.0 110.444 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.508 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.121 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.98 -169.95 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -119.24 84.49 2.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.574 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.93 164.82 12.21 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.51 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.401 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.58 162.08 13.47 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.46 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.68 -51.71 20.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.789 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.51 -27.68 69.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.035 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.428 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.94 -51.41 22.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.614 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.589 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 39.2 pt -73.06 -28.9 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.706 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.62 -27.31 10.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.3 mt-10 -75.28 -28.56 59.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.269 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.589 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.28 -58.44 3.21 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.207 0.527 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.86 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.9 pttt -54.77 -22.93 15.73 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.203 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.28 -27.74 56.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.091 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.63 -39.77 61.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.074 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.86 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.04 -51.83 68.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.816 0.817 . . . . 0.0 109.463 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -25.04 59.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.073 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.498 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -82.02 -25.75 34.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.148 0.499 . . . . 0.0 110.451 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.504 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 5.6 t80 -87.75 -15.08 37.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.448 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR . 32.0 t70 -90.28 146.24 24.37 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.977 0.894 . . . . 0.0 111.23 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -63.33 -53.41 53.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -81.83 -6.8 59.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.846 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.56 45.27 59.68 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.402 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -90.42 17.75 6.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.822 0.344 . . . . 0.0 110.759 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.47 89.36 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 46.4 p -150.18 150.52 31.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.504 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.77 140.58 20.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.968 0.413 . . . . 0.0 111.952 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.34 176.34 8.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.974 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.425 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.0 OUTLIER -70.42 -38.0 74.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.03 0.443 . . . . 0.0 110.251 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.543 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.75 -40.99 89.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.22 178.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.543 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.08 -53.47 20.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.234 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.408 ' CD1' ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -58.43 -54.85 42.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.718 0.77 . . . . 0.0 109.463 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.59 -45.85 92.74 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.508 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.2 m -62.2 -31.39 71.91 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.818 0.342 . . . . 0.0 110.581 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.08 -57.25 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.429 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -71.91 -35.36 69.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.436 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -42.13 79.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.945 0.402 . . . . 0.0 110.645 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -79.02 -7.61 58.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.648 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.03 -54.43 3.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.042 0.448 . . . . 0.0 110.754 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.67 34.81 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.552 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.13 -178.97 5.44 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.368 0.604 . . . . 0.0 111.134 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -159.58 56.49 0.89 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.902 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.4 -176.76 3.36 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.502 2.134 . . . . 0.0 112.076 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.608 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -113.53 152.48 30.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.962 0.41 . . . . 0.0 110.199 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.548 ' N ' HG21 ' A' ' 44' ' ' THR . 3.6 mm-40 -57.51 -49.33 76.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.404 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.69 72.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.75 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.06 -54.33 27.18 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.559 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.608 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.92 -34.74 78.82 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.369 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.401 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.46 -42.6 95.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.873 0.368 . . . . 0.0 110.172 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -61.76 -45.38 94.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.245 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -30.77 61.83 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.419 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.549 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.75 -38.32 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.511 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -44.98 -28.6 0.69 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.387 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.04 -38.85 51.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.914 0.388 . . . . 0.0 110.758 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 52' ' ' ILE . 5.1 m -81.38 -11.89 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.227 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.514 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.8 t0 -103.57 155.35 18.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.748 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.61 -28.8 26.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.124 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -116.42 -9.68 11.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.452 0.644 . . . . 0.0 110.5 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.514 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.35 63.48 5.2 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.488 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -112.06 18.1 19.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.81 0.338 . . . . 0.0 110.225 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.41 19.86 55.91 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.483 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.407 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 3.9 p -147.09 176.32 10.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.408 ' CD1' ' CD1' ' A' ' 32' ' ' LEU . 2.1 mp -115.54 136.55 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 120.6 0.238 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.0 m-20 -86.11 -178.6 6.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.272 0.558 . . . . 0.0 111.885 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -67.65 -56.32 12.35 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.557 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.0 Cg_endo -65.93 -35.4 35.23 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.3 2.0 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -61.85 -52.45 64.1 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.192 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.09 -56.42 21.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.758 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -57.16 -45.47 83.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.733 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.0 m -60.58 -31.57 70.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.069 0.462 . . . . 0.0 110.049 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.435 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.5 tpp -63.49 -61.76 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.01 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.9 mtm -66.63 -27.56 67.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.716 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.9 -20.59 52.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.355 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -47.88 96.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.361 . . . . 0.0 111.141 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -20.12 60.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.157 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.6 ttm -65.28 -28.93 69.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.005 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -87.8 54.85 3.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.926 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.14 -167.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.58 -165.8 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.3 35.73 5.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.3 m -77.48 -42.96 33.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.6 -29.14 36.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.827 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -50.45 -30.59 12.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.232 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 2.0 mt-10 -68.88 -30.54 69.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.481 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.1 mt -79.49 -51.1 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -74.65 -51.54 14.12 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -53.52 -25.32 16.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.929 0.395 . . . . 0.0 110.755 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.454 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.67 -36.43 43.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.248 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 28.1 t80 -67.94 -51.33 48.84 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.053 0.454 . . . . 0.0 110.142 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -32.62 58.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.773 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.1 t -88.7 -22.73 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.616 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -52.93 -34.22 54.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.231 -179.388 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -99.36 147.87 24.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.487 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -67.48 -38.27 84.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.374 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.25 -9.74 13.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.796 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.03 28.07 32.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.327 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -67.5 -13.98 62.52 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.165 0.482 . . . . 0.0 110.757 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.441 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.85 -10.73 55.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.146 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.427 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.8 m-85 -127.12 145.28 50.8 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.014 0.435 . . . . 0.0 111.458 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.442 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.17 110.03 26.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.699 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -82.97 176.89 8.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.602 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.06 71.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.077 0.465 . . . . 0.0 110.487 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -57.76 11.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.286 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -45.81 29.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.093 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.414 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 38.0 tp -53.0 -31.15 39.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -73.36 -49.09 29.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.952 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -59.06 -42.04 89.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.207 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -72.99 -40.01 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.598 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.456 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 27.7 mmt -73.97 -54.2 8.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.521 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 m -56.92 -47.75 79.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.241 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -59.67 -28.42 67.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.28 37.09 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.99 -113.18 0.29 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.722 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.58 167.22 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 0.0 110.849 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -72.55 99.88 2.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.237 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.05 114.42 26.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.435 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.85 175.39 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.381 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.03 -36.0 12.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.782 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -77.34 -35.01 55.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.761 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -72.82 -33.26 66.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.993 0.425 . . . . 0.0 110.178 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.414 ' HA ' HD13 ' A' ' 116' ' ' LEU . 2.5 t -74.88 -47.92 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.898 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.54 -52.81 63.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.788 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -57.44 -28.72 63.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.829 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.414 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 7.5 tpt -76.25 -38.06 56.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.137 0.494 . . . . 0.0 110.108 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.53 -43.33 80.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.476 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -64.98 -39.18 93.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.786 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.42 -36.28 29.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.945 0.402 . . . . 0.0 110.449 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.402 ' HB1' ' CE ' ' A' ' 124' ' ' MET . . . -67.88 -37.55 81.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.544 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 22.2 t0 -100.35 146.35 27.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.04 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.524 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.72 -40.6 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.077 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.524 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.98 -10.99 60.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.701 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.81 32.93 1.01 Allowed Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -176.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.409 ' N ' ' C ' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.28 -12.63 24.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.311 -0.944 . . . . 0.0 112.46 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.87 20.12 10.24 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.86 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -146.67 146.91 30.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 38.3 t -130.66 107.28 13.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.348 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -79.36 174.84 11.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.323 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.573 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -45.88 -67.36 0.29 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.518 0.675 . . . . 0.0 111.461 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -30.38 70.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.884 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -55.82 -44.43 77.88 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -31.79 46.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.208 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 55.3 t -53.68 -47.79 61.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.487 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -57.82 -42.26 83.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.717 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.24 -37.93 66.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.967 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 6.4 ttp -57.11 -41.32 78.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.978 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.9 t -80.18 -31.32 38.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.74 146.63 40.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.821 0.343 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.718 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.31 -51.15 60.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.538 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.59 -53.31 31.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.668 0.271 . . . . 0.0 111.295 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -57.07 -37.57 72.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.46 . . . . 0.0 110.332 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.429 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 14.7 t -63.38 -34.2 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.364 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.718 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.5 mt -71.01 -54.7 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.988 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -51.08 -37.2 44.24 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.159 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -48.37 63.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.492 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -55.51 -54.4 44.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.203 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.435 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.21 -57.46 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.545 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.501 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.93 -51.17 70.82 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.177 0.513 . . . . 0.0 110.96 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.3 -40.55 64.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.747 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.474 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 2.8 mt -54.64 -49.32 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.484 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.4 -36.99 94.12 Favored Glycine 0 CA--C 1.498 -1.011 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.934 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.677 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.47 -61.68 2.07 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.381 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.64 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.36 -27.54 69.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.668 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -65.9 -50.37 64.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.204 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 0.5 OUTLIER -64.25 -43.63 94.29 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.625 HG23 ' O ' ' B' ' 16' ' ' MET . 2.0 m -64.25 -33.12 60.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.479 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.64 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -74.55 -45.75 43.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.839 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.489 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.9 p -59.55 -26.11 65.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.483 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.424 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.2 m -90.47 -46.64 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.148 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.9 pp -63.18 -32.98 74.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.189 0.519 . . . . 0.0 110.511 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.489 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.051 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.853 0.359 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.44 -169.78 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.811 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -120.96 84.36 2.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.96 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.578 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -97.63 164.74 12.29 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.485 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.413 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.14 162.71 13.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.481 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -47.46 -51.3 20.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.856 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -64.43 -27.65 69.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.04 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.52 -51.43 20.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.734 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.59 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 37.6 pt -73.2 -28.73 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.854 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.39 -27.38 9.86 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 2.7 mm-40 -75.18 -28.51 60.08 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.253 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.43 -58.5 3.17 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 121.253 0.549 . . . . 0.0 111.015 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.854 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -54.64 -22.84 14.81 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.205 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.3 -28.1 56.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.23 -39.87 62.8 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.11 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.854 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.94 -51.81 68.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.861 0.838 . . . . 0.0 109.487 178.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 p -74.51 -24.43 58.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.122 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.484 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.15 -23.35 35.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.202 0.525 . . . . 0.0 110.347 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.505 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.7 t80 -95.74 -1.02 50.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.608 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.2 t70 -103.12 144.27 31.52 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 122.036 0.922 . . . . 0.0 111.09 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 12.6 mmtt -60.55 -53.42 57.69 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.571 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.01 -4.65 59.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.876 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.46 45.55 45.93 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.391 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -90.43 17.57 7.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.836 0.35 . . . . 0.0 110.722 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.46 6.2 87.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.508 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.45 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 61.6 p -150.29 149.05 29.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.47 140.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.747 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.485 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 1.3 t -87.49 -179.74 6.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.122 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 p -70.42 -44.14 68.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 0.0 110.897 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.538 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -55.5 -40.23 71.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.327 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -69.63 -53.83 16.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.424 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -55.15 38.59 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.781 0.801 . . . . 0.0 109.42 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.62 -45.99 92.62 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.594 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.3 m -62.1 -31.22 71.65 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.939 0.37 . . . . 0.0 110.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 71.5 t -68.02 -57.2 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.842 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.415 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 1.3 tpt -71.97 -35.87 69.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.428 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -42.44 80.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.76 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.0 t -78.93 -8.36 58.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.7 tt -90.54 -54.72 3.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.761 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.15 35.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.889 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp-100 -137.3 -178.91 5.42 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.362 0.601 . . . . 0.0 111.207 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -159.64 56.59 0.9 Allowed Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.891 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.9 Cg_endo -80.37 -177.11 3.56 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.501 2.134 . . . . 0.0 112.059 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -113.66 152.54 30.28 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 110.263 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.55 ' N ' HG21 ' A' ' 44' ' ' THR . 3.8 mm-40 -57.14 -49.52 75.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.442 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.1 -33.12 74.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.764 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -54.28 33.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.692 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.613 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.6 -35.82 81.94 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.429 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -42.69 98.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.875 0.369 . . . . 0.0 110.238 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -61.83 -45.61 93.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.338 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -30.72 61.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.492 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.57 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.524 -179.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -45.0 -28.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.328 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.46 -38.78 48.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.92 0.391 . . . . 0.0 110.838 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 52' ' ' ILE . 4.8 m -81.14 -11.48 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.157 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.52 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.9 t0 -103.61 155.51 18.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.727 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.59 -29.09 26.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.079 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -116.4 -9.74 11.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.392 0.615 . . . . 0.0 110.485 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.52 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.8 63.93 4.76 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.008 -0.997 . . . . 0.0 113.491 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 -112.66 18.31 18.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.88 0.371 . . . . 0.0 110.217 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.09 19.81 56.63 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.474 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.409 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 5.3 p -146.65 176.37 9.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.41 HG22 ' CG ' ' A' ' 68' ' ' PHE . 35.5 mt -115.8 136.5 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.595 0.236 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.6 m-20 -86.94 -178.3 6.26 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.329 0.585 . . . . 0.0 111.935 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.499 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.96 -55.96 12.38 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.672 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.6 Cg_endo -65.62 -34.71 40.72 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.245 1.963 . . . . 0.0 111.197 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -52.45 62.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.476 ' CD2' ' CD1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -56.97 -56.88 15.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.83 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.488 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -57.04 -46.56 82.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.9 m -60.67 -31.84 71.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.107 0.479 . . . . 0.0 110.041 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.434 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.3 tpp -62.34 -61.75 2.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.97 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.7 mtp -67.62 -28.1 67.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.826 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.21 -20.7 59.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.374 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.56 125.36 20.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.363 . . . . 0.0 111.045 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -87.64 -21.44 25.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.095 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 35.0 tpp -60.76 -29.9 69.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -94.06 135.62 35.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -176.39 -166.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.72 63.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.61 30.84 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.0 t -77.52 -30.44 52.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.958 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -80.22 -31.93 38.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -57.89 -52.2 66.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.986 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.68 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.73 -29.21 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.432 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.7 mt -65.89 -51.35 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.822 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.448 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -75.68 -50.43 15.42 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.774 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -53.79 -31.92 50.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.644 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -69.84 -38.74 76.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.774 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.529 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.1 t80 -66.82 -55.85 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.967 0.413 . . . . 0.0 110.549 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -53.73 -30.54 44.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.876 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.9 t -88.46 -22.85 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.214 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.437 ' CE2' HD13 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -55.36 -31.85 62.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.047 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -102.44 148.66 25.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.439 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -69.59 -37.67 77.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.385 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -112.28 -9.79 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.53 30.69 32.39 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.08 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.44 -13.46 62.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.992 0.396 . . . . 0.0 110.856 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.444 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.2 -13.66 55.32 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.853 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.433 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.2 m-85 -127.21 145.87 50.61 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.971 0.415 . . . . 0.0 111.268 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.437 HD13 ' CE2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.06 109.97 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.853 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.1 m -83.53 177.28 8.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.393 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.16 -28.64 69.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.044 0.449 . . . . 0.0 110.427 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.1 -57.67 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.422 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.42 -42.38 44.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.434 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 52.9 tp -56.93 -31.24 64.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 6.0 ttt180 -72.57 -49.3 33.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -60.81 -36.15 78.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.012 0.434 . . . . 0.0 110.437 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG11 ' CZ ' ' B' ' 20' ' ' PHE . 60.3 t -72.94 -44.83 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.178 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 24.4 mmt -74.12 -54.06 8.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.556 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.6 m -55.57 -45.86 77.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.73 0.3 . . . . 0.0 111.267 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -60.04 -30.06 68.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.805 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.63 38.92 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.578 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.38 -116.1 0.38 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.798 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.13 169.53 16.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.889 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -74.22 100.07 3.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.417 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.5 114.91 26.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.322 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.67 175.08 5.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.417 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.02 -36.01 12.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.809 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -77.32 -34.76 55.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.774 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -72.86 -34.18 66.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.056 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.414 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.5 t -74.2 -48.59 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.968 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -59.2 -52.83 63.99 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.874 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.56 -28.96 64.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.843 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.434 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 6.6 tpt -76.32 -37.72 57.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.129 0.49 . . . . 0.0 110.177 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.64 -42.86 83.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.455 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -65.1 -39.54 93.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.858 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -81.85 -35.44 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.56 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.68 80.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.5 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 22.8 t0 -100.44 147.44 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.99 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.523 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.6 pt -84.84 -40.75 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.039 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.523 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.91 -10.95 59.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.709 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.07 32.67 1.09 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.405 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.4 p-10 -96.25 -12.87 23.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.264 -0.968 . . . . 0.0 112.462 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.19 10.17 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.822 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -146.98 146.37 30.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.962 0.41 . . . . 0.0 109.998 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.68 107.38 14.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.185 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.36 174.83 11.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.338 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.581 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.95 -67.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.494 0.664 . . . . 0.0 111.393 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -34.03 72.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.789 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -40.53 73.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.447 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.79 -33.15 46.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.046 178.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 64.8 t -55.11 -46.92 77.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.661 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.8 -45.65 85.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.13 -32.87 65.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.413 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 16.6 ttp -59.42 -42.03 90.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 t -78.71 -31.19 46.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.12 7.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.873 0.368 . . . . 0.0 111.01 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.718 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.33 -51.28 59.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.538 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.63 -53.26 32.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.678 0.275 . . . . 0.0 111.257 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -57.22 -37.46 72.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.0 0.429 . . . . 0.0 110.346 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.415 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 16.3 t -63.31 -33.72 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.403 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.718 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.5 mt -71.7 -55.36 13.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.046 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.6 mmm-85 -50.34 -38.11 40.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.239 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.71 -44.7 66.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.409 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -57.24 -55.19 38.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.98 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.434 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.12 -57.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.309 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -58.23 -51.16 70.91 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.379 0.609 . . . . 0.0 110.65 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.52 -39.56 64.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.822 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.5 mt -54.31 -48.23 67.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.221 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.27 -38.37 95.79 Favored Glycine 0 CA--C 1.498 -1.002 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.517 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -64.81 -61.66 2.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.683 -0.759 . . . . 0.0 110.506 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.641 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.08 -27.76 67.26 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -67.14 -48.89 66.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.005 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.1 ppt_? -63.45 -43.6 96.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.13 0.49 . . . . 0.0 109.77 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.641 HG23 ' O ' ' B' ' 16' ' ' MET . 1.6 m -62.42 -34.83 66.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.476 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.54 ' N ' HG23 ' B' ' 19' ' ' VAL . 0.3 OUTLIER -74.98 -43.86 51.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.7 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 17.3 p -60.46 -25.68 66.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.511 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.417 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.7 m -90.83 -46.71 14.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.055 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.54 -33.01 74.07 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.171 0.51 . . . . 0.0 110.362 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.498 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.114 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -72.98 -170.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -121.2 86.78 2.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.583 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -98.73 164.75 12.1 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.662 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.4 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.8 p -97.96 162.71 13.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.506 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -47.43 -51.47 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.878 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -64.27 -27.73 69.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.147 0.499 . . . . 0.0 109.985 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.455 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.4 mm-40 -72.51 -51.36 20.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.736 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.581 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 37.4 pt -73.22 -28.78 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.898 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.36 -27.32 9.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.516 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 13.2 mm-40 -75.17 -28.46 60.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.264 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.583 ' CZ ' ' CD1' ' A' ' 4' ' ' LEU . 3.2 m-85 -79.51 -58.48 3.18 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-O 121.275 0.56 . . . . 0.0 111.014 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.857 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.52 -22.96 14.49 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.209 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.27 -27.78 56.8 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.164 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.75 -39.68 61.68 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.051 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.857 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.09 -51.73 68.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 109.43 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 p -74.45 -24.91 59.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.083 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.498 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.0 -25.1 35.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.129 0.49 . . . . 0.0 110.438 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.504 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 5.1 t80 -89.38 -14.53 35.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.498 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.1 t70 -90.61 145.84 24.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.963 0.887 . . . . 0.0 111.24 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.8 mmtt -63.76 -53.43 51.17 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.575 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.44 -7.07 59.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.772 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.52 45.91 58.94 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.394 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -90.9 18.13 6.99 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.894 0.378 . . . . 0.0 110.732 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.37 5.01 89.14 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.542 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.9 p -150.21 151.92 33.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.504 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -102.67 140.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.977 0.418 . . . . 0.0 111.772 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.453 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.11 176.42 8.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.006 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.425 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.1 p -70.4 -38.32 74.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.126 0.489 . . . . 0.0 110.198 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.61 -41.05 89.52 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.176 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -68.98 -53.71 19.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.264 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.28 -55.37 35.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.725 0.774 . . . . 0.0 109.393 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.1 -45.96 91.98 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.536 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.21 -31.11 71.6 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.883 0.342 . . . . 0.0 110.589 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.1 t -68.25 -57.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.424 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.9 OUTLIER -71.95 -35.51 69.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.474 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -42.98 80.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.625 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 t -79.03 -7.14 57.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.761 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.14 -54.51 3.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.27 34.49 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.839 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.561 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.36 -178.4 5.2 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.329 0.585 . . . . 0.0 111.106 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -159.59 56.62 0.9 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.901 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.9 Cg_endo -80.41 -176.27 3.11 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.516 2.144 . . . . 0.0 112.118 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.603 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.68 152.49 31.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.942 0.401 . . . . 0.0 110.27 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.547 ' N ' HG23 ' A' ' 44' ' ' THR . 3.7 mm-40 -57.21 -49.65 75.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.41 75.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.761 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -54.33 33.84 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.626 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.603 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -66.03 -34.57 78.39 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.378 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.46 -43.12 95.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.894 0.378 . . . . 0.0 110.193 179.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.58 -45.37 94.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.265 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.52 -30.67 61.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.37 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.552 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.65 -39.2 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.604 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -45.12 -28.58 0.76 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.373 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.452 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.89 -38.74 53.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.952 0.406 . . . . 0.0 110.698 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' A' ' 52' ' ' ILE . 4.8 m -80.39 -12.75 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.5 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 43.5 t0 -103.53 155.07 18.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.763 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.14 26.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.182 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -116.42 -9.8 11.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.419 0.628 . . . . 0.0 110.402 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.81 61.49 7.31 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.261 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -109.43 18.38 20.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.758 0.313 . . . . 0.0 110.472 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.76 19.79 59.15 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.402 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 p -147.95 176.28 10.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.0 mt -113.28 136.61 49.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.64 0.257 . . . . 0.0 110.846 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -85.87 -179.38 6.8 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.178 0.513 . . . . 0.0 111.77 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.3 m-85 -68.26 -55.94 11.65 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.455 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.3 Cg_endo -65.94 -35.27 35.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.181 1.921 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.25 -52.37 64.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.211 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.02 -56.6 19.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.779 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.83 -47.71 73.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.2 m -59.34 -32.18 69.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.146 0.498 . . . . 0.0 109.713 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.413 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 2.9 tpp -67.73 -61.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.93 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 31.8 mtp -64.71 -29.01 69.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.599 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.63 -24.86 15.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.927 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -60.84 -29.64 69.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.721 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.4 ' CD ' ' O ' ' A' ' 75' ' ' LYS . 1.6 tptp -60.29 -21.29 61.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.023 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -23.16 27.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.232 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -56.68 -77.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 178.3 -177.94 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.946 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.83 -173.28 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.72 27.76 16.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.136 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -77.57 -49.43 14.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.66 -29.06 36.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.993 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -50.46 -30.53 12.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.316 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.7 OUTLIER -77.17 -29.57 54.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.809 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.8 mt -79.3 -51.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.37 -51.97 11.87 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -53.74 -25.92 20.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 110.71 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.444 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.07 -36.59 48.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.257 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 25.6 t80 -67.82 -52.02 41.82 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.043 0.449 . . . . 0.0 110.181 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -54.55 -32.26 58.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.847 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.72 -22.72 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.577 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.459 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -53.45 -33.45 54.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.207 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -100.19 147.83 25.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.44 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -67.47 -38.35 84.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.403 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.26 -9.75 13.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.835 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.5 28.67 32.12 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.407 -0.901 . . . . 0.0 113.238 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -67.45 -13.9 62.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 117.161 0.481 . . . . 0.0 110.774 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.446 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.09 -11.57 55.58 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.085 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.4 m-85 -127.09 145.34 50.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.993 0.425 . . . . 0.0 111.434 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.429 HD13 ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.16 109.93 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.686 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -83.29 177.29 8.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.541 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.32 -28.62 69.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.059 0.457 . . . . 0.0 110.509 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.31 -57.69 9.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.337 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -43.6 39.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.181 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.409 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 35.5 tp -54.95 -31.18 60.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.081 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 3.3 ttt-85 -73.7 -49.3 26.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -61.28 -36.42 80.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.036 0.446 . . . . 0.0 110.369 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.445 HG12 ' CZ ' ' B' ' 20' ' ' PHE . 41.4 t -72.95 -44.79 56.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.229 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.6 mmt -74.05 -54.33 8.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.45 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.1 m -55.63 -46.2 77.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.32 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -59.51 -30.48 68.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.8 mp -123.47 38.87 4.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.32 -115.69 0.36 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.817 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.21 168.87 17.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.93 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -74.06 100.62 3.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.313 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.419 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.79 115.43 27.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.279 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.83 175.05 6.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.404 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.03 -35.91 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 110.821 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -77.36 -35.07 54.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -72.49 -33.92 67.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.994 0.426 . . . . 0.0 110.08 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.408 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.5 t -74.54 -48.46 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.935 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -59.33 -52.75 64.31 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.847 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.47 -28.81 63.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.819 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.418 ' CE ' HD13 ' B' ' 23' ' ' LEU . 7.7 tpt -76.33 -37.88 56.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.127 0.489 . . . . 0.0 110.182 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.75 -43.6 79.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.56 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -64.94 -39.2 93.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.837 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.22 -36.14 30.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.518 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.15 -38.22 81.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.666 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.7 t0 -99.76 147.6 25.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.09 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.529 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.8 -40.69 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.102 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.529 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.93 -10.98 60.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.698 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.68 1.09 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.415 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.2 p-10 -95.99 -12.83 24.39 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.302 -0.949 . . . . 0.0 112.455 -176.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.94 20.15 10.15 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.817 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 1.1 pt20 -146.48 146.8 30.68 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.953 0.406 . . . . 0.0 109.983 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.73 107.35 13.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.278 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -79.27 174.6 11.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.285 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.585 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -45.87 -67.07 0.32 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.527 0.68 . . . . 0.0 111.441 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.434 ' HA ' HG21 ' A' ' 142' ' ' VAL . 0.6 OUTLIER -60.5 -34.1 73.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.865 -178.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.17 -41.89 76.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.306 0.574 . . . . 0.0 109.53 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.75 -31.81 46.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.132 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.585 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 62.2 t -55.95 -47.11 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -56.62 -44.33 81.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.07 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.13 -32.31 64.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.5 ttp -60.1 -43.12 95.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 t -77.25 -31.24 54.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.96 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 160.71 7.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.874 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.865 0.364 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.717 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.24 -50.96 61.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.538 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.66 -53.26 32.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.701 0.286 . . . . 0.0 111.289 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.14 -37.63 72.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.028 0.442 . . . . 0.0 110.252 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.424 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 13.4 t -63.51 -33.69 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.384 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.717 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.6 mt -71.43 -55.4 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.966 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.8 mmm-85 -50.61 -37.24 39.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.117 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -47.57 62.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.523 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -55.93 -55.34 33.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.989 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.423 ' HA ' HD11 ' B' ' 13' ' ' ILE . 3.8 mt -51.36 -57.48 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.23 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -56.89 -51.2 70.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.93 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.52 -41.53 66.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.3 mt -54.39 -49.58 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.47 -37.18 94.4 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.017 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.674 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.96 -61.62 2.05 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.723 -0.738 . . . . 0.0 110.354 -179.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.666 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.81 -27.73 68.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.615 177.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -64.95 -51.58 61.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.273 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.508 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.5 OUTLIER -63.89 -43.72 95.14 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 16' ' ' MET . 1.7 m -64.56 -32.92 59.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.666 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.02 -45.93 46.64 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.783 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.49 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.7 -26.11 65.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.534 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.425 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.0 m -90.24 -45.9 14.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.171 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.63 -32.67 74.21 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.127 0.489 . . . . 0.0 110.483 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.093 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.835 0.35 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.18 -169.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.68 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -114.6 93.58 4.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.564 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -96.42 164.63 12.55 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.471 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 6.3 p -98.93 162.58 13.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.464 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -47.73 -51.33 22.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.761 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.74 -27.7 69.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.029 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.03 -51.54 21.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.62 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.589 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 39.0 pt -72.67 -28.98 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.592 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.41 11.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.7 mt-10 -75.1 -28.63 60.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.126 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.589 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.22 -58.42 3.23 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.332 0.587 . . . . 0.0 110.927 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.858 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 11.0 ptmt -54.44 -23.31 15.47 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.231 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.11 -27.92 57.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.226 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.41 -39.59 62.53 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.052 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.858 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.78 -51.76 68.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.789 0.804 . . . . 0.0 109.452 178.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.51 -24.8 59.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.99 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.3 tt -82.05 -24.16 35.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.501 . . . . 0.0 110.269 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.497 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 4.2 t80 -92.77 -2.72 55.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.567 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.5 t70 -102.41 144.02 31.41 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.988 0.899 . . . . 0.0 111.032 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.2 mmtt -60.93 -53.44 57.29 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.512 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.31 -4.64 59.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.823 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.9 47.33 39.82 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.292 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 p30 -91.81 18.54 7.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.824 0.345 . . . . 0.0 110.685 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.52 4.85 88.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.57 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.1 p -150.17 149.97 30.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.66 0.266 . . . . 0.0 110.349 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.497 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.72 140.4 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.955 0.407 . . . . 0.0 111.822 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.448 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -85.96 176.99 7.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.131 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.442 HG22 ' CA ' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -69.84 -38.28 76.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.108 0.48 . . . . 0.0 110.315 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.81 -41.36 91.09 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.251 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.546 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.46 -52.16 29.34 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.41 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -55.1 37.89 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.836 0.827 . . . . 0.0 109.364 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.81 -45.15 91.69 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.431 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.5 m -62.52 -31.24 71.98 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.469 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 71.6 t -67.59 -57.31 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.833 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.442 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 3.4 tpt -71.92 -36.17 69.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.539 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -42.01 81.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.647 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.4 t -78.97 -8.44 58.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.675 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.8 tt -89.64 -53.93 4.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.103 0.477 . . . . 0.0 110.694 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.97 35.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.803 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.541 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.8 tp-100 -137.47 179.99 6.08 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.374 0.607 . . . . 0.0 111.212 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -159.76 56.46 0.87 Allowed Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.831 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.1 Cg_endo -80.38 -175.13 2.54 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.469 2.113 . . . . 0.0 112.195 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.594 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -112.98 152.63 29.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.886 0.374 . . . . 0.0 110.272 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 44' ' ' THR . 3.4 mm-40 -57.3 -49.18 76.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.03 74.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.821 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -54.58 28.33 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.639 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.594 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -62.12 -44.65 96.18 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.93 179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -58.2 -49.15 78.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.351 . . . . 0.0 110.751 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -53.25 -47.52 68.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.399 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.413 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.2 mmt -74.77 -30.55 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.767 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -53.62 -35.11 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.868 0.366 . . . . 0.0 111.522 -179.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -44.99 -28.63 0.7 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.267 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -78.05 -38.86 43.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.914 0.387 . . . . 0.0 110.764 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG21 ' HA ' ' A' ' 52' ' ' ILE . 4.5 m -80.49 -11.17 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.6 t0 -103.69 155.79 18.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.735 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.63 -29.17 25.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -116.5 -9.65 11.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.444 0.64 . . . . 0.0 110.468 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.525 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.61 63.51 5.15 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.484 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -112.11 17.9 19.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.857 0.36 . . . . 0.0 110.268 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.07 19.91 54.47 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.554 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.411 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 3.2 p -147.64 176.42 10.1 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.421 HG22 ' CG ' ' A' ' 68' ' ' PHE . 12.1 mt -115.49 136.57 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.569 0.223 . . . . 0.0 111.068 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.4 m-20 -88.05 -178.05 5.89 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.219 0.533 . . . . 0.0 111.964 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.86 -55.97 12.61 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.77 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.9 Cg_endo -65.63 -34.91 39.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.237 1.958 . . . . 0.0 111.186 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -52.28 63.64 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.206 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -56.97 -56.72 18.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.887 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -56.94 -46.25 82.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.653 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.0 m -60.05 -31.91 70.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.092 0.473 . . . . 0.0 110.037 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.43 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.3 tpp -62.24 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.105 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.8 mtm -71.26 -30.9 66.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.011 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.79 0.09 40.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.584 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 tpt85 -56.98 150.14 17.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.808 0.337 . . . . 0.0 111.009 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -72.55 -12.72 61.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.304 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.5 mmt -93.55 -30.83 14.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 110.965 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 100.44 6.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -156.24 -176.35 5.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.59 -167.51 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 64.25 65.01 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -77.54 -58.09 3.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.41 -31.01 72.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -50.35 -30.43 12.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 6.4 mt-10 -77.68 -29.47 51.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.713 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.41 HG23 ' CZ ' ' A' ' 141' ' ' PHE . 16.2 mt -79.15 -51.13 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -72.55 -48.85 36.86 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -53.61 -25.49 17.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.807 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.434 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.99 -36.83 48.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.284 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.545 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 25.2 t80 -68.29 -51.68 42.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 110.146 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -54.96 -32.2 61.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.772 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.4 t -88.77 -22.72 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.55 -33.6 55.26 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.073 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -101.8 147.21 26.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.407 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -69.59 -36.59 76.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.448 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.18 -9.69 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.824 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.64 29.82 34.56 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.251 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -67.51 -13.85 62.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.109 0.455 . . . . 0.0 110.732 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.18 -12.7 55.47 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.906 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 20.5 m-85 -127.3 146.91 50.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.86 0.362 . . . . 0.0 111.25 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.408 HG12 ' CD2' ' A' ' 92' ' ' PHE . 1.1 pt -121.11 110.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.854 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m -82.31 178.42 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.644 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.72 -29.69 70.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 110.638 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.56 -57.2 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.147 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.43 -45.26 32.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.251 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.03 -32.7 48.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.936 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -73.4 -49.36 27.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -59.7 -42.67 93.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.877 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.436 HG12 ' CZ ' ' B' ' 20' ' ' PHE . 3.4 t -73.0 -40.14 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.73 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 30.1 mmt -73.95 -54.19 8.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.529 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m -57.01 -48.94 77.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.256 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -57.87 -28.4 64.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -123.6 36.6 4.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.44 -116.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.734 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -130.49 168.75 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.85 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -74.1 100.52 3.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.233 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.78 114.53 26.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.455 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.83 175.39 5.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.358 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -48.11 -35.93 12.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.746 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -77.37 -35.74 54.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.701 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -71.81 -33.51 68.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.966 0.412 . . . . 0.0 110.063 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.431 ' HA ' HD13 ' A' ' 116' ' ' LEU . 2.6 t -73.92 -48.61 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.745 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -58.41 -52.82 64.03 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.544 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -60.24 -28.67 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.577 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.5 tpt -72.42 -37.74 68.56 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.253 0.549 . . . . 0.0 110.085 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.63 -41.25 77.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.501 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -64.78 -40.16 94.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.6 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -81.84 -34.67 30.03 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.002 0.429 . . . . 0.0 110.374 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -34.75 76.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.517 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.418 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.3 t0 -105.19 146.67 28.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.992 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.527 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -83.69 -40.83 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.08 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.527 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.96 -11.0 60.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.678 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.96 32.6 1.02 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.4 p-10 -96.0 -12.78 24.47 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.332 -0.934 . . . . 0.0 112.432 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.22 10.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.828 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.443 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -146.68 147.4 30.97 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.6 t -130.76 107.3 13.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.354 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.53 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -81.01 174.51 11.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.239 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.545 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -45.96 -67.23 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.583 0.706 . . . . 0.0 111.471 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -60.81 -29.14 69.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.989 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.83 -44.26 77.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.069 0.461 . . . . 0.0 109.814 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.41 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -78.7 -32.01 46.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.175 178.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.519 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 68.5 t -53.84 -48.14 62.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -58.15 -44.16 87.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.21 -32.63 64.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.789 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 15.3 ttp -60.01 -45.56 92.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 t -74.69 -30.96 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.61 148.87 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.876 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.41 ' O ' ' CG2' ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.786 0.327 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.712 ' O ' HG13 ' B' ' 6' ' ' ILE . 2.1 mmm180 -52.15 -51.54 57.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.76 -53.43 31.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.612 0.244 . . . . 0.0 111.417 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.05 -37.0 71.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.139 0.495 . . . . 0.0 110.174 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.437 ' HB ' ' CZ ' ' B' ' 2' ' ' ARG . 21.6 t -63.7 -34.4 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.417 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.712 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.8 mt -71.47 -53.87 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.979 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -50.81 -39.77 53.8 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.238 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -48.32 65.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 13.9 mtmt -55.01 -54.25 45.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.273 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.438 ' HA ' HD11 ' B' ' 13' ' ' ILE . 4.7 mt -51.04 -55.04 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.297 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 5.9 tpt180 -61.44 -46.46 89.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.224 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.13 -40.58 64.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.076 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.467 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 1.8 mt -54.55 -51.71 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.512 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.46 -36.72 93.54 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.386 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.68 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.15 -61.58 2.16 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.954 -0.623 . . . . 0.0 110.474 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.667 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -63.38 -27.77 69.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.658 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -66.62 -50.91 61.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.203 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.5 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 3.9 ppt_? -63.38 -43.5 97.42 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.65 HG23 ' O ' ' B' ' 16' ' ' MET . 2.5 m -66.94 -31.85 55.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 0.0 110.609 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.667 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.7 OUTLIER -72.65 -51.15 20.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.814 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.435 ' HA ' ' NE ' ' B' ' 24' ' ' ARG . 50.6 p -57.27 -35.34 69.64 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.116 0.484 . . . . 0.0 110.781 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.461 HG23 ' C ' ' B' ' 19' ' ' VAL . 27.2 m -73.43 -45.81 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.976 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 20' ' ' PHE . 3.6 pp -65.15 -24.9 67.53 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.916 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.639 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 11.2 ptt85 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.901 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.866 0.365 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.48 -169.9 1.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.76 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -116.96 83.98 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.566 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -97.51 164.77 12.3 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.019 0.438 . . . . 0.0 110.475 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 p -97.7 161.97 13.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.438 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -47.68 -51.67 20.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.752 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -64.56 -27.69 69.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.033 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.7 mm-40 -71.88 -51.41 22.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.644 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.59 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 39.1 pt -73.01 -28.95 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.72 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.31 10.81 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 4.0 mt-10 -75.25 -28.55 59.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.281 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.59 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.38 -58.52 3.17 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.299 0.571 . . . . 0.0 110.946 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.856 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.5 pttt -54.52 -23.48 16.61 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.183 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -75.65 -28.03 58.59 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.174 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.17 -39.77 63.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.094 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.856 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.04 -51.84 68.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.803 0.811 . . . . 0.0 109.544 178.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.49 -24.7 59.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.124 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.483 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -82.13 -23.13 35.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.165 0.507 . . . . 0.0 110.405 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.48 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 3.6 t80 -94.46 -2.82 51.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.639 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 26' ' ' THR . 23.9 t70 -100.83 142.81 31.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.946 0.879 . . . . 0.0 111.096 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.433 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -59.84 -53.45 57.78 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.501 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.17 -6.27 59.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.714 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.5 47.37 51.66 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.36 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -92.01 18.8 7.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.882 0.372 . . . . 0.0 110.688 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.42 5.03 89.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.619 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.8 p -150.28 150.27 31.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.688 0.28 . . . . 0.0 110.26 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.78 140.54 20.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.79 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -84.89 176.35 8.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.024 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.427 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.9 OUTLIER -70.49 -37.97 74.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.128 0.49 . . . . 0.0 110.271 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.87 -41.06 90.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.162 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.1 -53.82 18.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.264 -179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -55.13 39.05 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.695 0.76 . . . . 0.0 109.365 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.12 -45.88 92.1 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.514 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.2 m -62.34 -32.3 73.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.874 0.337 . . . . 0.0 110.488 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 70.9 t -66.45 -57.18 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.418 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -71.91 -34.61 69.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.376 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -68.97 -42.62 76.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.666 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.5 t -78.91 -7.75 58.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.751 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.21 -54.91 3.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.806 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.11 34.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.9 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.544 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 tp-100 -137.59 -178.73 5.37 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.295 0.569 . . . . 0.0 111.223 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -159.56 56.57 0.9 Allowed Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.933 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.0 Cg_endo -80.33 -177.38 3.75 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.538 2.159 . . . . 0.0 112.065 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -112.86 152.36 29.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.955 0.407 . . . . 0.0 110.306 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.552 ' N ' HG23 ' A' ' 44' ' ' THR . 3.4 mm-40 -57.51 -49.24 76.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.39 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.65 -31.82 72.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.783 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.0 -54.31 27.68 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.611 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.611 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.97 -34.53 78.31 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.34 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.403 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.49 -42.68 95.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.909 0.385 . . . . 0.0 110.172 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.74 -45.45 93.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.186 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.6 mmt -74.52 -30.77 61.91 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.46 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.74 -38.29 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.606 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -45.03 -28.53 0.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.369 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.437 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.72 -38.33 47.39 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 52' ' ' ILE . 4.7 m -81.58 -11.36 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.239 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.526 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.9 t0 -103.52 155.6 18.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.761 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.61 -28.8 26.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -116.46 -9.75 11.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.399 0.618 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.526 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.53 63.23 5.42 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.402 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -112.23 18.42 18.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.863 0.363 . . . . 0.0 110.188 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.32 19.9 56.0 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.49 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.417 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.0 p -146.85 176.49 9.85 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mt -116.27 136.53 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.528 0.204 . . . . 0.0 110.92 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.1 m-20 -87.33 -178.36 6.17 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.328 0.585 . . . . 0.0 112.002 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.496 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.78 -56.37 11.94 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.534 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.4 Cg_endo -65.81 -34.61 39.4 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.285 1.99 . . . . 0.0 111.114 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -52.4 63.67 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.226 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.47 -56.64 19.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.842 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -57.73 -46.26 84.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.3 m -60.69 -31.01 70.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.075 0.464 . . . . 0.0 110.046 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.446 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.5 tpp -62.43 -61.84 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.163 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 66.9 mtp -62.18 -33.43 74.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.1 -19.29 61.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.399 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -53.56 141.55 25.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.841 0.353 . . . . 0.0 111.134 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 2.1 tptp -87.53 -21.79 25.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.1 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 37.4 ttm -60.01 -23.2 63.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.104 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -57.53 153.66 12.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -105.09 27.38 8.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.05 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 m 68.3 -67.52 0.2 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.037 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.53 36.66 8.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.886 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.1 t -77.49 -28.88 52.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.034 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -80.61 -29.18 36.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -75.35 -44.4 45.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.68 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.76 -29.3 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.455 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.2 mt -65.97 -51.33 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.828 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.442 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -75.68 -51.11 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.828 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -53.91 -30.78 47.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.666 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -69.92 -38.78 76.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 22.6 t80 -67.38 -55.17 14.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.969 0.414 . . . . 0.0 110.431 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -54.47 -30.33 52.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.866 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.4 t -88.38 -22.83 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.148 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.436 ' CD2' HG12 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -55.53 -30.55 60.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.036 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -107.69 142.82 37.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.621 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -38.01 88.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.631 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -110.58 -9.58 14.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.43 31.74 36.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.367 -0.921 . . . . 0.0 113.076 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -67.38 -13.61 62.17 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.962 0.381 . . . . 0.0 110.747 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.444 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.19 -13.73 55.32 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.847 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.451 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.8 m-85 -127.28 147.42 50.23 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.899 0.381 . . . . 0.0 111.292 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.436 HG12 ' CD2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -120.17 110.02 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.949 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.9 p -83.93 176.09 9.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.462 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.7 -29.98 71.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.08 0.467 . . . . 0.0 110.471 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.03 -57.01 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.287 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.43 -46.49 26.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.323 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.0 tp -53.13 -31.08 40.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.047 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 6.0 ttt180 -73.82 -49.2 26.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.11 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -57.44 -43.7 84.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.292 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -72.99 -43.0 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.574 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.477 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 31.3 mmt -70.21 -54.22 13.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.569 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.4 m -55.56 -45.25 77.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.15 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -61.64 -29.61 70.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.8 mp -122.35 37.59 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.62 -112.95 0.28 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.723 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -136.61 170.27 16.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.771 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -73.59 98.35 2.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.416 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -88.86 113.42 24.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.74 175.26 5.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.376 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -48.09 -36.05 12.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -77.34 -34.13 55.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.795 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -73.91 -33.3 63.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.971 0.415 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.411 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.5 t -74.92 -48.4 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.808 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.09 -52.8 64.18 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.736 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.52 -28.71 63.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.798 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.2 tpt -76.18 -37.9 57.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.142 0.496 . . . . 0.0 110.244 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -42.68 88.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.4 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -62.87 -41.54 99.42 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.1 -32.79 30.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 110.48 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.54 78.45 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.451 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 18.5 t0 -105.46 149.38 26.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.934 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.544 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.5 pt -84.79 -40.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.26 0.552 . . . . 0.0 109.986 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.544 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.88 -10.93 59.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.67 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.12 32.77 1.13 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.412 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.5 p-10 -96.55 -12.9 23.41 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.296 -0.952 . . . . 0.0 112.391 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.09 10.28 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.753 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.451 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.81 146.43 30.24 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.925 0.393 . . . . 0.0 110.094 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.76 107.38 13.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.224 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.514 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.16 174.24 11.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.41 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.58 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.91 -67.07 0.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.5 0.667 . . . . 0.0 111.539 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.78 -33.51 71.79 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.981 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -41.36 75.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.432 ' CD1' HD23 ' B' ' 23' ' ' LEU . 0.2 OUTLIER -78.77 -32.03 46.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.226 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.58 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 61.8 t -55.78 -51.13 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.722 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -58.25 -47.41 83.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.3 tpp -68.44 -31.66 71.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.79 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.429 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 26.5 ttp -61.11 -46.48 90.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.786 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.3 t -76.96 -30.84 56.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.907 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.64 153.6 19.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.079 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.847 0.356 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.72 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.3 mmm180 -52.26 -51.17 59.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.67 -53.21 32.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.681 0.277 . . . . 0.0 111.302 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -57.06 -37.6 72.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.373 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.418 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 14.9 t -63.38 -33.69 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.37 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.72 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.4 mt -71.76 -55.09 14.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.993 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 27.5 mmm-85 -50.2 -37.9 37.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.2 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.19 -46.57 64.33 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.492 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -56.14 -53.57 55.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.127 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.446 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.21 -57.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.662 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.1 tpt180 -61.67 -51.38 68.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.328 0.585 . . . . 0.0 111.028 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.556 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.37 -38.94 63.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.719 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.475 HG12 ' CZ ' ' A' ' 19' ' ' PHE . 3.1 mt -54.41 -49.24 66.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.275 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.95 -37.76 95.09 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.55 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -64.9 -61.62 2.05 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.707 -0.747 . . . . 0.0 110.507 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.661 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -60.51 -27.73 67.83 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.494 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -67.51 -48.99 65.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.04 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.1 ppt_? -63.29 -43.95 96.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.661 HG23 ' O ' ' B' ' 16' ' ' MET . 1.8 m -61.85 -35.4 67.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.715 0.769 . . . . 0.0 110.234 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.703 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 0.3 OUTLIER -72.49 -46.66 53.75 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.408 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.479 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 59.1 p -59.73 -37.2 78.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.756 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' B' ' 19' ' ' VAL . 27.2 m -72.28 -45.2 62.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' B' ' 20' ' ' PHE . 3.3 pp -64.17 -28.18 69.58 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.893 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.703 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 6.8 ptt85 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.931 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.815 0.34 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.59 -169.7 1.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.796 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.52 83.06 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.57 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -96.1 164.68 12.59 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.407 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.429 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.95 162.77 12.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.491 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -47.48 -51.22 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -64.56 -27.64 69.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.057 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.5 -51.46 19.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.681 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.592 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.1 pt -73.1 -28.89 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.666 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.57 -27.31 10.66 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.54 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 7.3 mt-10 -75.24 -28.6 59.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.289 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.592 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.0 m-85 -79.53 -58.6 3.12 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.24 0.543 . . . . 0.0 110.981 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.85 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.8 15.13 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.198 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.54 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.25 -27.99 56.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.31 -39.71 62.7 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.053 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.85 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.88 -51.8 68.46 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.82 0.819 . . . . 0.0 109.387 178.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.411 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 1.8 p -74.42 -23.95 59.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.064 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -81.99 -26.15 34.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.285 0.564 . . . . 0.0 110.04 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.488 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.5 t80 -92.91 0.63 57.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.349 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 26' ' ' THR . 27.7 t70 -105.52 144.07 32.8 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.99 0.9 . . . . 0.0 111.025 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 2.3 mmtt -59.6 -53.41 58.43 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.601 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.63 -3.61 59.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.785 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.08 46.83 33.38 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.322 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.2 p30 -91.1 17.96 7.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.845 0.355 . . . . 0.0 110.759 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.411 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 84.2 4.9 87.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.668 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.431 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.7 p -150.29 147.82 28.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.639 0.257 . . . . 0.0 110.337 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.488 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -99.61 140.39 19.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.825 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.452 ' OG1' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -86.19 179.07 7.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.346 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.452 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.7 OUTLIER -70.19 -41.94 73.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.181 0.515 . . . . 0.0 110.277 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -57.44 -41.12 79.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.467 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.77 -53.79 16.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.405 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.454 ' HB3' ' NZ ' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -56.24 -55.69 30.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.882 0.849 . . . . 0.0 109.581 178.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.407 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -58.74 -48.0 87.36 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.485 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.413 ' CB ' ' O ' ' A' ' 30' ' ' LYS . 54.9 m -64.38 -31.11 72.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.858 0.329 . . . . 0.0 110.458 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 18.9 t -63.2 -58.03 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.925 0.393 . . . . 0.0 110.486 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.598 ' HB2' ' HD2' ' B' ' 9' ' ' LYS . 0.0 OUTLIER -72.65 -40.66 66.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.238 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.61 -39.62 88.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.554 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -78.83 -12.2 60.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.597 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.02 -53.75 4.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.108 0.48 . . . . 0.0 110.553 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -178.53 36.33 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.654 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.539 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 2.0 tp-100 -133.7 178.73 6.71 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.403 0.62 . . . . 0.0 111.267 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -159.87 56.29 0.84 Allowed Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.696 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.4 Cg_endo -80.54 -168.24 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.527 2.151 . . . . 0.0 112.37 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.577 HG23 ' N ' ' A' ' 45' ' ' GLU . 1.2 m -117.37 152.96 33.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.891 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.577 ' N ' HG23 ' A' ' 44' ' ' THR . 2.8 mm-40 -60.37 -48.53 81.34 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.75 76.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.705 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -53.95 46.42 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.484 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -57.65 -51.27 70.19 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.947 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.418 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -53.62 -49.42 67.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.744 0.307 . . . . 0.0 111.289 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -53.11 -48.7 67.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.73 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.406 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.2 mmt -74.71 -30.48 61.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.986 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -53.64 -36.44 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.843 -178.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -45.66 -28.58 1.03 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.271 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -78.04 -38.34 44.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.932 0.396 . . . . 0.0 110.7 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 52' ' ' ILE . 4.1 m -81.21 -12.32 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.063 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 42.5 t0 -103.59 155.24 18.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.744 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.71 -28.27 26.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.156 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -116.39 -9.72 11.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.443 0.64 . . . . 0.0 110.423 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.89 61.2 7.64 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.278 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -109.37 18.42 20.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.759 0.314 . . . . 0.0 110.447 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.9 19.78 58.92 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.493 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 p -147.81 176.35 10.2 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.7 mt -114.11 136.69 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.582 0.229 . . . . 0.0 110.955 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -87.54 -179.61 6.37 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.218 0.532 . . . . 0.0 111.958 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.3 m-85 -67.7 -55.77 13.48 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.54 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.73 -35.35 37.2 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.204 1.936 . . . . 0.0 111.166 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.12 -52.48 63.68 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.319 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.64 -56.31 23.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.773 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -58.66 -46.66 86.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.75 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.8 m -60.68 -30.66 70.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.147 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.435 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 4.6 tpp -59.94 -61.75 2.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.166 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mtm -62.89 -36.2 82.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.01 -21.46 59.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.352 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -54.94 151.2 9.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.858 0.361 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -87.62 -14.85 38.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.221 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.0 ttm -82.86 -30.78 28.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.939 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.51 105.45 17.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.898 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -176.43 -173.23 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m 64.25 81.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.78 37.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.58 -31.57 53.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -80.67 -36.82 31.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.996 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -59.46 -50.75 72.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.662 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.7 -29.27 25.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.518 -179.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 mt -66.61 -51.33 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.829 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -75.62 -50.67 14.79 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -53.81 -32.11 51.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.648 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -68.68 -39.35 80.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.683 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 22.9 t80 -66.73 -56.38 10.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.555 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -53.87 -29.93 43.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.905 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -88.41 -23.03 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.19 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.435 ' CE2' HD11 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -55.7 -31.94 62.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.061 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -102.69 148.41 25.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.389 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -69.62 -37.51 76.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -112.34 -9.73 13.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.877 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.24 30.83 32.92 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.136 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.41 -13.32 61.91 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.971 0.386 . . . . 0.0 110.813 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.446 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.27 -13.86 55.04 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.826 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.442 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.8 m-85 -127.14 145.69 50.66 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.976 0.417 . . . . 0.0 111.258 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.435 HD11 ' CE2' ' A' ' 92' ' ' PHE . 1.1 pt -121.15 109.94 26.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.814 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 56.0 m -83.73 177.41 8.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.405 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.13 -28.87 70.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.071 0.463 . . . . 0.0 110.494 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.94 -57.67 9.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.436 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -42.37 44.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.257 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.428 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 54.5 tp -57.3 -31.12 65.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.082 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 5.9 ttt180 -72.37 -49.28 35.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -60.6 -36.54 78.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 110.533 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG11 ' CZ ' ' B' ' 20' ' ' PHE . 56.6 t -72.93 -44.56 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.243 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 23.4 mmt -74.05 -53.95 8.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.7 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 m -55.42 -45.58 76.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 111.262 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.44 -25.7 68.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.838 0.351 . . . . 0.0 110.728 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.4 mp -125.37 37.41 4.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.755 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -172.3 -113.77 0.31 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.775 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.72 169.88 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.36 . . . . 0.0 110.877 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -74.09 100.07 3.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.252 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.416 ' CD1' ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.39 114.76 26.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.285 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.74 175.1 5.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.412 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -48.11 -36.02 12.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.939 0.4 . . . . 0.0 110.775 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -77.35 -34.4 55.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.777 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -73.29 -34.05 65.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.002 0.43 . . . . 0.0 110.093 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.5 t -74.4 -48.82 34.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.943 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -58.99 -52.89 63.82 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.908 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.31 -29.02 63.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.839 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.428 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 6.4 tpt -76.32 -38.07 56.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.091 0.472 . . . . 0.0 110.223 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.14 -42.46 84.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.553 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -65.78 -39.2 90.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.923 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.03 -35.54 28.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.402 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.24 -38.58 81.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.517 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.435 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 22.6 t0 -98.96 147.48 24.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.078 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.526 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.6 pt -84.79 -40.68 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.307 0.575 . . . . 0.0 110.053 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.92 -11.02 60.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.713 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.72 1.1 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.3 p-10 -96.28 -12.92 23.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.296 -0.952 . . . . 0.0 112.42 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.96 20.08 10.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.804 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.97 146.31 30.04 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.962 0.41 . . . . 0.0 110.029 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.67 107.44 14.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.229 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.25 174.7 11.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.339 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.586 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.99 -66.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.513 0.673 . . . . 0.0 111.479 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -34.01 72.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.909 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.05 -40.54 73.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.442 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.75 -33.62 46.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.082 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.586 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.4 t -54.68 -46.83 73.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.666 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.98 -45.49 86.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.11 -33.21 65.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.419 ' HG3' ' CE1' ' A' ' 141' ' ' PHE . 14.7 ttp -59.25 -41.76 89.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.4 t -79.23 -30.88 43.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.63 161.87 5.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.119 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.846 0.355 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.717 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.2 mmm180 -52.24 -50.78 61.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.526 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.63 -53.36 31.4 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.628 0.252 . . . . 0.0 111.323 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.96 -37.1 71.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.129 0.49 . . . . 0.0 109.998 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.401 ' O ' ' HD3' ' B' ' 9' ' ' LYS . 21.9 t -63.42 -34.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.341 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.717 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.5 mt -71.99 -55.59 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.253 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 27.6 mmm-85 -49.79 -40.56 41.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.414 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -43.72 70.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.224 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 36' ' ' MET . 0.0 OUTLIER -54.84 -55.49 29.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.189 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.439 ' HA ' HD11 ' B' ' 13' ' ' ILE . 3.5 mt -51.6 -57.49 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.835 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.498 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.2 tpt180 -60.56 -51.29 70.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.321 0.582 . . . . 0.0 110.912 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.4 -40.0 64.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.652 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.0 mt -54.51 -47.57 71.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.236 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.08 -38.33 95.84 Favored Glycine 0 CA--C 1.497 -1.056 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.546 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -64.97 -61.69 2.01 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.637 -0.782 . . . . 0.0 110.495 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.647 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.03 -27.75 67.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -67.68 -48.73 65.77 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.935 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.5 ppt_? -62.27 -43.45 98.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.133 0.492 . . . . 0.0 109.692 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.647 HG23 ' O ' ' B' ' 16' ' ' MET . 1.6 m -63.89 -34.9 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.866 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.535 ' N ' HG23 ' B' ' 19' ' ' VAL . 0.3 OUTLIER -74.8 -45.74 41.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.929 -179.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.509 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 12.6 p -59.81 -24.98 64.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.567 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.413 HG21 ' N ' ' B' ' 23' ' ' LEU . 29.5 m -90.73 -46.72 14.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.972 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.31 -32.76 73.55 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.147 0.498 . . . . 0.0 110.335 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.509 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.131 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.792 0.33 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.96 -169.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -116.97 90.56 3.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.001 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.577 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.2 mt -98.64 164.75 12.11 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.542 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.4 p -96.77 161.78 13.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.493 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -47.7 -51.78 20.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.781 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -64.35 -27.72 69.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.031 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.87 -51.52 21.93 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.592 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.582 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 39.0 pt -72.98 -28.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.742 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.51 -27.36 10.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.513 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 37.3 mt-10 -75.28 -28.47 59.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.203 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.28 -58.51 3.18 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.281 0.562 . . . . 0.0 110.983 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.855 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.49 -23.05 14.65 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.285 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.513 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.33 -27.87 56.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.49 -39.8 62.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.074 177.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.855 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.74 -51.68 68.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.899 0.857 . . . . 0.0 109.445 178.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.3 p -74.37 -24.89 59.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.049 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.48 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.06 -24.64 35.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.172 0.51 . . . . 0.0 110.278 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.504 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 3.9 t80 -92.66 -2.33 56.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.599 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.9 t70 -102.36 143.37 32.2 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.97 0.891 . . . . 0.0 111.154 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -59.94 -53.42 58.11 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.58 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -84.81 -6.11 59.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.811 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.54 46.27 53.31 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.188 -0.529 . . . . 0.0 113.375 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -90.99 18.15 7.06 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.798 0.333 . . . . 0.0 110.727 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.5 5.7 88.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 48.3 p -150.28 149.9 30.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.504 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.88 140.5 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.944 0.402 . . . . 0.0 111.834 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.446 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.35 176.56 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.02 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.427 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.2 p -70.49 -37.76 74.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.133 0.492 . . . . 0.0 110.268 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.03 -41.11 91.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.155 178.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.23 -53.43 19.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.282 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -54.93 41.46 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.771 0.796 . . . . 0.0 109.402 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.46 -45.89 92.52 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.516 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -62.21 -31.34 71.86 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.851 0.326 . . . . 0.0 110.574 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -68.0 -57.24 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.853 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.427 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 1.1 tpt -71.91 -35.5 69.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.427 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -68.05 -42.15 80.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.595 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 t -78.97 -7.79 58.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.731 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -90.73 -54.31 4.03 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.109 0.48 . . . . 0.0 110.776 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.22 35.19 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.836 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.0 -178.98 5.44 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 111.16 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -159.65 56.43 0.87 Allowed Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.909 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.0 Cg_endo -80.42 -175.72 2.84 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.519 2.146 . . . . 0.0 112.076 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.605 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.89 152.47 32.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.941 0.401 . . . . 0.0 110.23 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.547 ' N ' HG23 ' A' ' 44' ' ' THR . 3.7 mm-40 -57.18 -49.64 75.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.43 75.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.765 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -54.26 34.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.657 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.605 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.87 -34.57 78.44 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.322 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' CA ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.54 -43.07 95.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.926 0.393 . . . . 0.0 110.185 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.33 -45.52 94.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.189 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.4 mmt -74.57 -30.73 61.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.403 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.74 -38.02 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.55 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -45.05 -28.55 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.372 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.59 -38.75 47.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.915 0.388 . . . . 0.0 110.84 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG22 ' HA ' ' A' ' 52' ' ' ILE . 5.0 m -81.17 -11.43 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.157 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.7 t0 -103.63 155.63 18.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.62 -29.09 26.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -116.45 -9.64 11.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.416 0.626 . . . . 0.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.47 63.56 5.12 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.488 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -112.28 18.16 18.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 0.0 110.241 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.93 55.13 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.475 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.411 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.4 p -147.09 176.4 9.97 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -115.77 136.48 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.546 0.212 . . . . 0.0 110.86 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.0 m-20 -87.46 -178.18 6.09 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.318 0.58 . . . . 0.0 111.916 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.1 -55.9 12.13 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.648 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.4 Cg_endo -65.68 -34.39 41.31 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.251 1.967 . . . . 0.0 111.193 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -52.46 61.97 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.209 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.02 -57.04 14.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.867 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -57.1 -47.14 81.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.0 m -60.23 -30.92 69.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 110.077 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.433 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.7 tpp -62.08 -61.84 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.144 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 8.4 mtt -72.77 -31.64 65.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.76 0.04 40.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.602 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -55.68 153.46 8.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.809 0.338 . . . . 0.0 111.062 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tptm -69.64 -12.64 61.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.299 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.2 tpp -93.18 -30.52 15.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.34 . . . . 0.0 110.989 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.74 115.86 20.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -176.53 179.5 1.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.46 -167.27 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.864 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 63.45 65.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 110.864 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.45 -46.09 23.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -68.87 -36.6 78.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -50.44 -30.48 12.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 4.6 mt-10 -77.31 -29.55 53.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.73 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.3 mt -79.24 -51.13 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -48.48 38.34 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.897 0.379 . . . . 0.0 111.863 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -53.5 -26.42 20.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.357 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.56 -33.99 58.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.964 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 13.1 t80 -68.96 -50.42 49.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.002 0.43 . . . . 0.0 110.149 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -54.42 -33.21 59.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.767 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.99 -22.7 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.557 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -52.81 -36.82 59.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.342 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -100.09 147.13 25.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.753 0.311 . . . . 0.0 110.525 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -67.94 -37.71 81.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.434 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -112.2 -9.76 13.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.847 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.41 28.36 33.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.365 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -67.51 -13.96 62.51 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.163 0.481 . . . . 0.0 110.769 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -11.49 55.44 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.084 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.7 m-85 -127.21 146.94 50.24 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.925 0.393 . . . . 0.0 111.53 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.428 HD11 ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.14 109.92 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.633 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 m -82.66 176.78 9.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.14 -29.88 70.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.097 0.475 . . . . 0.0 110.457 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.24 -57.74 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.23 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.44 -45.46 31.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.157 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.402 ' CD1' ' CD1' ' A' ' 100' ' ' ILE . 28.6 tp -53.04 -31.44 41.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.2 ttt-85 -72.46 -49.13 35.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -59.9 -42.0 92.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.115 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.9 t -73.06 -40.17 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.404 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.46 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.7 mmt -73.92 -54.16 8.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 m -59.03 -48.9 79.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.202 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -57.26 -28.56 63.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.414 ' CD2' ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -124.33 37.0 4.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.731 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.43 -115.88 0.36 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.808 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.7 167.52 18.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 110.883 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -73.59 100.07 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.291 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.418 HD11 ' HA ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.55 114.43 26.64 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.393 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.78 175.26 5.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.385 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -48.01 -35.92 11.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.363 . . . . 0.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.4 -35.44 54.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.698 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -72.29 -33.3 67.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.959 0.409 . . . . 0.0 110.116 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.418 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.6 t -74.65 -48.51 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.846 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -59.41 -52.87 63.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.724 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -57.76 -28.67 64.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.807 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.407 ' CE ' HD13 ' B' ' 23' ' ' LEU . 6.6 tpt -76.12 -37.88 57.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.147 0.499 . . . . 0.0 110.248 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.14 -40.65 80.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -66.46 -39.19 88.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.952 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.41 -36.13 29.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.61 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.17 80.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.413 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.435 ' HA ' ' HG2' ' A' ' 140' ' ' GLU . 22.4 t0 -101.36 145.53 28.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.033 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.52 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.0 pt -83.06 -40.8 16.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.165 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.92 -11.02 60.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.747 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.87 32.65 0.99 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 131' ' ' ASP . 42.3 p-10 -95.53 -12.41 25.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.304 -0.948 . . . . 0.0 112.568 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.18 10.19 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.89 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.443 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.99 147.37 31.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.74 107.25 13.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.39 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.529 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -78.81 174.79 11.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.227 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.584 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 1.1 t80 -45.93 -67.08 0.31 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.635 0.731 . . . . 0.0 111.788 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.474 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.4 mt-10 -65.28 -25.3 67.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.42 -1.263 . . . . 0.0 112.554 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 129' ' ' ASP . 0.3 OUTLIER -55.62 -48.51 74.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.822 0.344 . . . . 0.0 110.271 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.8 p90 -78.91 -30.99 45.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.243 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.49 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.4 t -52.83 -44.5 48.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.121 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -60.34 -37.16 79.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.125 0.488 . . . . 0.0 109.809 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.46 -42.21 62.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.721 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.2 ttp -52.74 -44.21 66.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.026 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.2 t -78.33 -31.25 48.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 146.84 40.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.801 0.334 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.716 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.23 -51.08 60.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.65 -53.27 32.36 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.677 0.275 . . . . 0.0 111.302 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.1 -37.54 72.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.015 0.436 . . . . 0.0 110.339 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 14.2 t -63.46 -34.12 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.387 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.716 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.6 mt -70.84 -54.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.969 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -51.51 -37.24 48.25 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.097 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.63 -48.31 64.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.472 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -55.8 -54.38 45.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.433 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 4.5 mt -51.17 -57.45 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.465 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.8 tpt180 -59.79 -51.23 70.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.237 0.541 . . . . 0.0 111.094 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.502 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.19 -40.1 64.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.819 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 2.8 mt -54.58 -50.37 59.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.418 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.93 -36.82 93.96 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.056 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.679 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.28 -61.69 2.08 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.539 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.686 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.98 -27.62 69.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.599 177.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.484 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -66.04 -50.68 63.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.225 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.504 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.4 OUTLIER -63.64 -43.55 96.46 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.02 0.438 . . . . 0.0 109.847 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.627 HG23 ' O ' ' B' ' 16' ' ' MET . 2.2 m -65.9 -32.69 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.839 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.686 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.66 -48.13 27.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.219 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.519 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 13.5 p -58.46 -25.9 62.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.454 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.405 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.5 m -89.93 -47.62 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.161 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.429 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -62.84 -33.02 74.37 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.139 0.495 . . . . 0.0 110.507 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.519 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.107 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.79 0.328 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.17 -170.16 1.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -116.77 83.95 2.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.71 164.71 12.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.539 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.32 162.73 13.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.48 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -47.39 -51.38 19.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.902 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -64.39 -27.71 69.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.034 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.453 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.5 -51.39 20.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.705 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.586 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 37.4 pt -73.18 -28.79 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.809 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.38 -27.32 9.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 35.0 mm-40 -75.25 -28.51 59.88 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.166 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.42 -58.31 3.27 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.228 0.537 . . . . 0.0 111.042 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.856 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 11.2 ptmt -54.56 -22.99 14.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.235 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.27 -28.02 56.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.33 -39.83 62.58 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.07 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.856 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.01 -51.66 69.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.774 0.797 . . . . 0.0 109.5 178.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 p -74.42 -24.78 59.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.072 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -82.04 -24.29 35.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.177 0.513 . . . . 0.0 110.285 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.5 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 3.6 t80 -93.4 -1.71 55.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.563 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.7 t70 -102.7 143.56 32.19 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 122.005 0.907 . . . . 0.0 111.125 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.2 mmtt -59.65 -53.47 57.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.56 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.51 -5.72 59.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.744 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.3 46.31 51.98 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.356 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -90.97 18.15 7.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.799 0.333 . . . . 0.0 110.73 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.72 5.57 88.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.564 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 47.5 p -150.34 149.58 30.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.65 140.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.879 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.21 176.37 8.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.002 179.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.426 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.1 p -70.49 -37.77 74.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.126 0.488 . . . . 0.0 110.257 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.09 -41.13 91.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.143 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.546 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -69.09 -53.79 18.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.221 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.16 -55.62 32.61 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.73 0.776 . . . . 0.0 109.362 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.76 -46.18 90.1 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.62 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.7 m -62.5 -32.13 72.99 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.951 0.376 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 71.8 t -67.03 -57.22 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.922 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.417 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.6 OUTLIER -71.9 -36.37 69.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.471 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -67.07 -41.9 85.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.4 . . . . 0.0 110.552 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.7 t -79.04 -7.94 58.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.698 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.2 tt -91.42 -55.41 3.52 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.97 33.1 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.946 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -134.18 -179.66 5.7 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.337 0.589 . . . . 0.0 111.125 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -159.66 56.33 0.86 Allowed Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.819 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.8 Cg_endo -80.62 -172.78 1.61 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.577 2.185 . . . . 0.0 112.086 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.37 152.42 35.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.884 0.373 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.548 ' N ' HG21 ' A' ' 44' ' ' THR . 3.6 mm-40 -56.7 -50.15 73.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 -33.33 75.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.709 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -54.39 31.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.687 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.61 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.83 -34.63 78.61 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.399 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.48 -42.75 95.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 110.226 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.65 -45.5 93.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.25 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -30.76 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.424 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.73 -38.01 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.529 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -44.93 -28.59 0.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.417 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.439 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.45 -38.96 48.34 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 120.89 0.376 . . . . 0.0 110.819 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.466 HG22 ' HA ' ' A' ' 52' ' ' ILE . 5.0 m -81.23 -11.47 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.182 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.7 t0 -103.61 155.65 18.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.788 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -29.01 26.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.095 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -116.49 -9.67 11.39 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.407 0.623 . . . . 0.0 110.481 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.31 63.77 4.94 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.481 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -112.39 18.11 18.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.831 0.348 . . . . 0.0 110.216 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.84 19.85 55.11 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.469 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.408 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.6 p -147.1 176.42 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.418 HG22 ' CG ' ' A' ' 68' ' ' PHE . 14.6 mt -115.77 136.52 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.836 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.9 m-20 -87.28 -178.27 6.16 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.218 0.533 . . . . 0.0 111.859 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.08 -55.83 12.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.727 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -65.67 -34.77 40.03 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.272 1.981 . . . . 0.0 111.12 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -52.45 62.95 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.232 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -56.93 -56.83 16.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.815 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -56.75 -45.75 81.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.679 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.8 m -60.07 -31.33 69.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.085 0.469 . . . . 0.0 109.954 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.424 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 2.9 tpp -64.68 -61.8 1.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.949 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 43.0 mtm -68.86 -29.16 67.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.26 -25.66 59.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.231 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.01 89.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -83.03 -19.83 36.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.104 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 6.8 ttm -68.25 -28.45 67.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.951 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -132.82 42.23 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -90.42 -76.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.72 -164.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.976 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 63.28 63.01 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.071 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.0 p -77.54 -45.83 24.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -80.73 -29.04 36.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.006 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.48 -30.64 13.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.397 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 2.1 mt-10 -65.94 -29.78 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 110.342 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.4 mt -79.45 -50.64 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.308 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.2 OUTLIER -74.99 -51.24 14.13 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -53.5 -25.19 15.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.742 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.428 ' CB ' HG22 ' B' ' 19' ' ' VAL . . . -78.43 -36.61 45.32 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 24.0 t80 -68.12 -52.26 36.92 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.012 0.434 . . . . 0.0 110.091 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -32.05 59.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.807 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.4 t -88.74 -22.74 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.522 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.455 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.85 -31.64 50.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.144 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -103.25 147.44 27.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.431 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -69.24 -37.03 77.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.432 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.15 -9.75 13.92 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.75 29.89 33.95 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.232 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.37 -13.95 62.48 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.078 0.439 . . . . 0.0 110.779 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.14 -12.12 55.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.969 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.6 m-85 -127.26 146.85 50.28 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.953 0.406 . . . . 0.0 111.247 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.42 HD11 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.03 110.01 26.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.875 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -84.09 176.9 8.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.522 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -29.55 70.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.08 0.467 . . . . 0.0 110.484 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.73 -57.18 12.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.209 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.32 -46.11 29.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.309 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.42 HD13 HD11 ' A' ' 100' ' ' ILE . 20.0 tp -53.14 -31.11 40.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.996 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 2.8 ttt-85 -73.35 -49.13 28.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -58.87 -42.87 90.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.142 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' B' ' 20' ' ' PHE . 2.2 t -72.91 -40.37 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.529 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.464 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 30.0 mmt -73.87 -54.21 8.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.353 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.3 m -56.96 -48.84 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 0.0 111.147 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -58.8 -29.33 66.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.6 mp -122.88 37.62 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.802 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 109' ' ' MET . . . -171.2 -113.86 0.31 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.783 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.07 166.85 21.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 110.886 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -72.39 99.68 2.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.244 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.413 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.81 114.51 26.25 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.421 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.77 175.24 5.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.37 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -48.02 -36.0 12.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 110.77 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.37 -34.88 54.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.723 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -73.0 -33.23 65.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.973 0.416 . . . . 0.0 110.079 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.41 HG22 HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.95 -48.51 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.839 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -59.01 -52.81 64.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.746 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.7 -28.65 64.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.765 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 12.8 tpt -76.15 -37.5 57.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.172 0.51 . . . . 0.0 110.163 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.21 -39.16 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.342 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -64.77 -41.94 95.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.418 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -82.08 -32.45 30.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.937 0.398 . . . . 0.0 110.431 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.77 -34.71 76.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.54 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.0 t0 -107.95 148.07 30.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.014 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.526 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.7 pt -84.91 -40.71 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.013 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.526 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.95 -10.98 60.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.693 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.06 32.8 1.1 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.35 -12.69 24.02 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.332 -0.934 . . . . 0.0 112.493 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.79 20.14 10.28 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.832 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.77 146.44 30.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.959 0.409 . . . . 0.0 110.0 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 38.4 t -130.79 107.41 13.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.213 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -79.86 174.22 11.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.259 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.573 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.82 -67.07 0.32 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.554 0.692 . . . . 0.0 111.448 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -60.11 -33.41 72.09 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.903 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.03 -42.09 75.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.36 0.6 . . . . 0.0 109.496 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.438 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.69 -31.87 46.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.114 178.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.573 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 55.5 t -55.38 -48.75 76.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.655 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -55.15 -49.67 71.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -70.57 -30.38 67.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.783 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.42 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -60.6 -46.06 91.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 t -73.48 -31.32 63.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.83 163.39 4.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.897 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.848 0.356 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.717 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.1 mmm180 -52.38 -51.0 61.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.076 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.68 -53.24 32.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.679 0.276 . . . . 0.0 111.29 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -57.06 -37.64 72.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.997 0.427 . . . . 0.0 110.34 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.417 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 13.9 t -63.37 -34.15 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.361 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.717 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.6 mt -71.07 -55.28 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.967 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.4 mmm-85 -50.73 -36.84 38.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.098 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -48.28 63.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.466 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -55.56 -54.96 37.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.222 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.424 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 4.0 mt -51.13 -57.43 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.431 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.519 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -58.92 -51.05 71.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.27 0.557 . . . . 0.0 111.051 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.505 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.27 -40.58 64.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.831 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.474 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 2.9 mt -54.61 -49.7 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.493 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.43 -36.95 94.06 Favored Glycine 0 CA--C 1.499 -0.961 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.068 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.681 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.14 -61.73 2.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.789 -0.705 . . . . 0.0 110.357 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.667 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.75 -28.08 69.72 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.659 177.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.484 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -65.5 -51.48 59.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.227 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.511 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.5 OUTLIER -63.31 -43.44 97.82 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.037 0.446 . . . . 0.0 109.831 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.635 HG21 ' O ' ' B' ' 16' ' ' MET . 2.1 m -66.45 -32.55 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.639 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.667 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -71.82 -50.15 32.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.986 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.451 ' HA ' ' NE ' ' B' ' 24' ' ' ARG . 52.7 p -58.27 -35.56 71.96 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.023 0.439 . . . . 0.0 110.836 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.453 HG22 ' C ' ' B' ' 19' ' ' VAL . 26.9 m -73.04 -45.22 55.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.09 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' B' ' 20' ' ' PHE . 2.7 pp -64.62 -27.98 69.31 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.933 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.645 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 10.9 ptt85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.904 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.773 0.321 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.09 -169.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.824 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -117.49 89.09 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.002 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.579 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.78 164.81 12.24 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.459 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 p -98.28 162.4 13.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.488 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -47.25 -51.35 19.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.845 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.29 -27.72 69.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.115 0.484 . . . . 0.0 110.034 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.0 OUTLIER -72.64 -51.38 19.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.694 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.582 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 35.5 pt -73.27 -28.83 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.931 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.44 -27.37 10.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 49.6 mt-10 -75.43 -28.49 59.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.272 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.33 -58.57 3.15 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.242 0.544 . . . . 0.0 111.163 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.857 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -54.75 -23.3 17.22 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.175 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -75.64 -28.26 58.73 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.96 -40.02 63.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.072 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.857 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.11 -51.9 68.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.796 0.808 . . . . 0.0 109.608 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -24.79 59.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.042 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.486 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -82.15 -26.9 33.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.117 0.484 . . . . 0.0 110.401 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.498 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 4.6 t80 -87.2 -14.3 41.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.579 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.8 t70 -90.79 145.27 24.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.931 0.872 . . . . 0.0 111.175 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.8 mmtt -63.36 -53.39 53.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.578 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -83.09 -7.07 59.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.735 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.3 46.94 56.99 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.398 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -91.73 18.59 7.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.854 0.359 . . . . 0.0 110.659 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.21 5.11 89.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.539 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.7 p -150.28 152.07 33.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -103.04 140.53 21.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.924 0.392 . . . . 0.0 111.712 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.462 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -84.72 176.14 8.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.008 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.423 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.0 OUTLIER -70.39 -38.45 74.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.085 0.469 . . . . 0.0 110.159 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.48 -40.92 88.51 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.144 178.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.542 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.07 -53.68 19.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.272 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.41 -54.91 41.64 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.761 0.791 . . . . 0.0 109.47 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.46 -46.01 92.39 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.581 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.12 -31.16 71.59 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.806 0.336 . . . . 0.0 110.587 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -68.18 -57.23 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.427 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.8 OUTLIER -71.89 -35.53 69.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.412 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -42.46 80.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.641 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.7 t -78.95 -7.46 58.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.749 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -91.11 -54.43 3.95 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.056 0.455 . . . . 0.0 110.796 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.45 34.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.871 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.556 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.02 -178.78 5.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.291 0.567 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -159.59 56.49 0.89 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.884 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.0 Cg_endo -80.37 -176.09 3.02 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.552 2.168 . . . . 0.0 112.065 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.606 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.61 152.45 31.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.94 0.4 . . . . 0.0 110.236 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.549 ' N ' HG21 ' A' ' 44' ' ' THR . 3.7 mm-40 -57.13 -49.68 75.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.386 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.24 75.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.72 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.7 -54.32 33.4 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.682 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.606 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.89 -34.69 78.7 Favored 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.405 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.52 -42.92 95.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.886 0.374 . . . . 0.0 110.162 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.52 -45.44 94.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.233 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -30.71 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.41 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.75 -38.31 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.527 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -45.03 -28.55 0.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.377 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.76 -38.56 46.58 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.886 0.374 . . . . 0.0 110.841 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 52' ' ' ILE . 4.8 m -81.2 -11.27 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.167 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.4 t0 -103.66 155.62 18.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.759 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.65 -28.93 26.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.034 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -116.45 -9.73 11.41 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.408 0.623 . . . . 0.0 110.501 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.45 63.58 5.1 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.476 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -112.32 18.12 18.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.854 0.359 . . . . 0.0 110.19 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.75 19.9 55.18 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.491 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.411 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 3.8 p -147.32 176.46 9.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.2 mt -115.85 136.51 52.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.557 0.218 . . . . 0.0 110.91 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.7 m-20 -87.11 -178.08 6.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.298 0.571 . . . . 0.0 111.959 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.499 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.99 -56.12 11.98 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.674 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.8 -34.44 40.06 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.254 1.969 . . . . 0.0 111.175 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.07 -52.38 62.96 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.166 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.03 -56.92 15.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.893 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.488 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -56.6 -47.13 80.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.7 m -60.21 -30.76 69.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.07 0.462 . . . . 0.0 110.078 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.424 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.1 tpp -64.43 -61.83 1.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.124 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 mtt -68.78 -31.15 69.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.976 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.98 0.13 41.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.631 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -55.08 141.25 35.21 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.858 0.361 . . . . 0.0 111.075 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.62 -16.37 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.246 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 8.5 tpp -76.43 -30.76 57.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.943 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.49 144.71 31.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.86 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -174.75 -166.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.4 m 63.29 88.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -166.01 53.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -77.54 -56.63 4.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.54 -29.64 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -50.45 -30.55 12.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.183 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.481 ' CB ' ' HB3' ' B' ' 15' ' ' LYS . 0.6 OUTLIER -77.24 -29.3 53.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.789 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.2 mt -79.08 -51.04 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -73.7 -51.11 17.71 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.839 0.352 . . . . 0.0 111.901 -178.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -53.56 -24.61 14.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 92' ' ' PHE . . . -78.67 -35.73 44.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.058 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.545 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.8 t80 -69.03 -52.43 28.79 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.108 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -55.7 -31.9 62.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.895 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -88.94 -22.73 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.571 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -54.53 -32.24 57.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.081 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -102.75 147.42 26.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.434 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -69.64 -36.83 76.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -112.18 -9.66 13.91 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.55 30.08 34.1 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.204 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -67.37 -13.82 62.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.004 0.402 . . . . 0.0 110.797 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.437 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.18 -11.71 55.28 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.011 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.433 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.0 m-85 -127.3 145.83 50.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 120.959 0.409 . . . . 0.0 111.354 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -120.68 110.03 27.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.828 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -83.41 176.4 9.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.525 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.403 ' N ' HD13 ' A' ' 125' ' ' ILE . . . -63.32 -29.84 71.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.065 0.459 . . . . 0.0 110.432 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.13 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.222 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.37 -46.1 28.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.35 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.8 tp -53.1 -31.06 40.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.09 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 3.5 ttt-85 -74.21 -49.26 24.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.182 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -58.32 -42.39 86.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.057 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.406 HG12 ' CZ ' ' B' ' 20' ' ' PHE . 2.5 t -72.87 -40.68 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.563 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 30.0 mmt -73.91 -54.34 8.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.351 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 m -57.32 -48.92 77.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.21 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -58.38 -28.61 65.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt -123.89 36.63 4.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.802 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.35 -113.47 0.29 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.844 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.31 166.24 22.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 110.931 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -73.12 99.91 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.332 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.416 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.43 114.52 26.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.292 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.62 174.97 6.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.439 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -48.08 -36.01 12.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 0.0 110.767 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -77.39 -34.27 54.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.734 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -73.5 -33.43 64.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.972 0.415 . . . . 0.0 110.029 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.412 HG22 ' CD ' ' A' ' 106' ' ' ARG . 2.5 t -75.14 -49.32 28.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.871 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.19 -52.83 63.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.708 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -57.34 -28.65 63.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.679 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.9 tpt -75.42 -38.41 59.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.294 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.403 HD13 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.98 -41.91 81.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.559 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -65.9 -39.61 90.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.647 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.09 -36.41 27.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.55 83.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.487 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 23.7 t0 -100.35 147.26 26.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.004 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.529 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.79 -40.69 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.086 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.529 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.97 -10.94 60.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.647 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.6 1.08 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.2 p-10 -96.16 -12.87 24.06 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.269 -0.965 . . . . 0.0 112.363 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.93 20.2 10.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.816 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.436 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -147.05 146.66 30.08 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.954 0.407 . . . . 0.0 109.969 179.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 37.7 t -130.73 107.42 14.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.266 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.537 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.18 174.58 11.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.235 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.574 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.96 -66.96 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.448 0.642 . . . . 0.0 111.332 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.83 -33.85 72.31 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.775 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.15 -40.11 73.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.458 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.74 -34.69 45.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.047 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.574 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 78.8 t -54.3 -46.02 68.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.786 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -57.43 -46.82 83.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.13 -31.54 64.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.412 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -60.3 -42.33 95.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.3 t -78.07 -30.88 49.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.62 148.97 31.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.932 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.719 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.29 -51.05 60.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.537 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.7 -53.22 33.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.654 0.264 . . . . 0.0 111.284 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -57.16 -37.74 72.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.003 0.43 . . . . 0.0 110.31 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 14.5 t -63.14 -34.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.356 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.719 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.6 mt -70.75 -55.05 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.919 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 mmm-85 -50.55 -37.24 38.38 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.127 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -68.98 -48.32 63.42 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.61 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -55.78 -55.1 36.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.262 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.424 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.24 -57.49 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.56 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.483 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.72 -50.41 73.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.211 0.529 . . . . 0.0 111.028 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.525 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.23 -41.06 65.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.809 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.0 mt -54.57 -47.68 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.485 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.401 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.53 -37.1 93.98 Favored Glycine 0 CA--C 1.498 -1.006 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.671 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.672 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.94 -61.52 2.11 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.728 -0.736 . . . . 0.0 110.275 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.738 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.26 -28.17 68.98 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.616 177.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -64.8 -52.14 58.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.241 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.51 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.5 OUTLIER -63.56 -43.34 97.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.026 0.441 . . . . 0.0 109.922 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.69 HG22 ' O ' ' B' ' 16' ' ' MET . 2.2 m -65.79 -35.09 74.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.668 0.747 . . . . 0.0 110.424 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.738 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.3 OUTLIER -71.37 -45.75 62.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.363 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.492 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 57.2 p -60.13 -36.66 77.99 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.723 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' B' ' 19' ' ' VAL . 27.1 m -72.92 -44.35 57.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.171 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' B' ' 20' ' ' PHE . 3.4 pp -64.1 -29.53 70.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.779 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.856 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.75 -170.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -120.87 89.74 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.585 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.4 mt -99.52 164.81 11.93 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.622 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.9 p -96.87 161.99 13.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.511 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -47.5 -51.75 19.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.806 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -64.36 -27.65 69.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.973 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.452 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.11 -51.55 20.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.643 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.579 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.1 pt -72.8 -28.76 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.882 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.27 -27.33 9.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.506 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.0 mt-10 -75.27 -28.42 59.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.314 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.585 ' CZ ' ' CD1' ' A' ' 4' ' ' LEU . 3.3 m-85 -79.48 -58.51 3.16 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.221 0.534 . . . . 0.0 111.078 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.855 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.54 14.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.218 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.56 -28.01 56.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.45 -39.87 62.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.059 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.855 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.63 -51.77 68.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.851 0.834 . . . . 0.0 109.416 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -74.46 -24.45 59.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.087 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.482 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.2 tt -82.04 -24.88 35.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.233 0.539 . . . . 0.0 110.249 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.514 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 3.2 t80 -93.05 -1.74 56.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.561 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.2 t70 -103.14 143.64 32.35 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.966 0.888 . . . . 0.0 111.114 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -60.2 -53.47 57.31 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.54 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -84.9 -5.95 59.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.801 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.34 46.64 51.95 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.367 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 p30 -91.35 18.44 7.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.83 0.348 . . . . 0.0 110.706 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.33 88.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.611 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.0 p -150.24 150.07 31.04 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.514 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -102.0 140.49 20.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.959 0.409 . . . . 0.0 111.939 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.25 176.48 8.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.009 179.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.426 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.2 p -70.43 -37.88 74.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.058 0.456 . . . . 0.0 110.312 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.0 -41.26 91.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.134 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.546 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -68.91 -53.79 19.1 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.27 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -55.83 29.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.711 0.767 . . . . 0.0 109.357 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.45 -45.77 88.75 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.562 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.4 m -62.74 -32.09 73.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.78 0.324 . . . . 0.0 110.585 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 71.0 t -66.68 -57.24 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.416 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -71.88 -36.94 70.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.436 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -66.13 -41.3 90.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 110.537 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -79.06 -8.72 59.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.65 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -90.63 -54.28 4.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.084 0.468 . . . . 0.0 110.746 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.73 34.45 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.891 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.559 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.63 179.99 5.88 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.301 0.572 . . . . 0.0 111.12 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -159.69 56.22 0.84 Allowed Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.812 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.3 Cg_endo -80.67 -172.23 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.538 2.159 . . . . 0.0 112.116 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -119.08 152.41 36.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.926 0.393 . . . . 0.0 110.142 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.547 ' N ' HG23 ' A' ' 44' ' ' THR . 3.7 mm-40 -56.91 -50.08 73.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.41 75.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.462 0.649 . . . . 0.0 110.681 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -54.29 33.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.702 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.61 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -66.05 -34.54 78.3 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.366 179.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.64 -42.59 95.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.911 0.386 . . . . 0.0 110.149 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -61.87 -45.46 93.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.218 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.1 mmt -74.54 -30.7 61.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.47 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.28 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.587 -179.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -45.01 -28.6 0.7 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.378 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.43 -39.35 47.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.972 0.415 . . . . 0.0 110.792 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 52' ' ' ILE . 4.7 m -80.59 -11.68 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.143 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.513 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 38.8 t0 -103.61 155.56 18.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.738 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -29.08 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.061 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -116.52 -9.66 11.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.429 0.633 . . . . 0.0 110.42 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.2 64.04 4.69 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.445 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -112.45 17.7 19.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.872 0.368 . . . . 0.0 110.214 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.29 19.9 53.85 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.512 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.403 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 3.9 p -147.62 176.36 10.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.407 HG21 ' CG ' ' A' ' 68' ' ' PHE . 54.1 mt -115.03 136.49 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 120.609 0.242 . . . . 0.0 110.853 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.4 m-20 -86.91 -178.42 6.3 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.256 0.551 . . . . 0.0 111.836 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.87 -55.74 13.06 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.769 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.7 Cg_endo -65.56 -35.14 39.58 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.291 1.994 . . . . 0.0 111.244 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.37 -52.34 62.1 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.242 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -56.9 -56.92 15.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.907 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.491 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -54.73 -48.18 72.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.5 m -58.74 -32.3 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.203 0.525 . . . . 0.0 109.716 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.417 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 2.7 tpp -67.86 -61.6 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.938 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 mtt -63.53 -29.89 71.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.742 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.31 -24.61 12.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.964 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.99 -29.37 67.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' CD ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -58.58 -22.24 55.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.077 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 28.7 mmt -56.81 -23.03 40.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.205 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -55.93 -81.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.985 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 177.72 -178.71 0.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.351 . . . . 0.0 110.956 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.99 -179.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.041 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 63.25 31.7 15.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.006 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 77.3 p -77.51 -51.93 9.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.847 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -80.72 -29.22 36.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.983 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -50.42 -30.48 12.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.241 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.506 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 4.6 mt-10 -73.77 -29.45 62.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.718 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.408 HG21 ' CZ ' ' A' ' 141' ' ' PHE . 14.4 mt -79.04 -51.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.409 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -71.95 -50.46 28.76 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -53.51 -25.22 15.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 110.779 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.443 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.72 -36.77 50.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.271 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.9 t80 -68.46 -51.4 43.94 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.014 0.435 . . . . 0.0 110.097 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -55.03 -32.17 61.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.799 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.78 -22.73 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.617 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.469 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.38 -30.11 38.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.049 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -109.13 139.47 43.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.449 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.02 -38.54 91.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.591 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -107.85 -9.64 15.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.18 31.03 39.72 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.144 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -67.53 -13.82 62.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.041 0.421 . . . . 0.0 110.756 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.442 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 100.91 -12.15 59.11 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.976 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 20.3 m-85 -127.35 146.15 50.56 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.914 0.387 . . . . 0.0 111.338 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' CD2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.15 110.01 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.807 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t -83.07 178.24 8.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.43 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.83 -28.12 69.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.093 0.473 . . . . 0.0 110.557 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.96 -56.8 12.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.291 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -76.35 -42.49 44.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.232 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.6 tp -56.55 -33.61 66.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.916 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 2.3 ttt-85 -71.79 -49.47 38.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.945 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -61.87 -38.43 88.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 110.376 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.475 HG12 ' CZ ' ' B' ' 20' ' ' PHE . 39.9 t -73.06 -43.97 57.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.403 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.451 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 25.4 mmt -73.99 -54.02 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.465 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.0 m -55.38 -46.87 76.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.478 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.88 -29.77 68.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.0 38.21 4.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.678 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.42 -113.96 0.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.773 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -135.21 169.21 17.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -73.83 99.75 3.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.0 115.25 27.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.373 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.81 175.21 5.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.41 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -48.0 -35.89 11.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.397 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -77.4 -35.91 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.71 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -71.66 -33.31 68.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.951 0.405 . . . . 0.0 110.065 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.422 ' HA ' HD13 ' A' ' 116' ' ' LEU . 2.6 t -74.86 -49.12 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.56 . . . . 0.0 109.849 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -59.46 -52.76 64.22 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.758 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -57.33 -28.7 63.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 10.2 tpt -76.19 -39.43 54.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.121 0.486 . . . . 0.0 110.241 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -41.11 87.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.369 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -64.21 -41.59 96.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.444 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.73 -33.13 27.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.476 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.39 -35.25 77.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.454 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 20.9 t0 -106.09 146.1 30.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.029 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.527 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.0 pt -82.73 -40.95 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.147 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.527 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.95 -11.05 60.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.675 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.74 33.11 1.0 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.408 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.2 p-10 -96.58 -12.62 23.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.307 -0.946 . . . . 0.0 112.466 -176.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.21 10.18 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.777 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.443 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.5 147.21 30.94 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.134 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.5 t -130.73 107.25 13.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.364 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.57 174.57 11.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.222 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.559 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -45.95 -67.15 0.31 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.54 0.686 . . . . 0.0 111.488 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.75 -29.54 69.45 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.563 -1.198 . . . . 0.0 111.913 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -44.05 77.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.08 0.467 . . . . 0.0 109.762 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.408 ' CZ ' HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -78.74 -31.91 46.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.134 178.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.527 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.5 t -54.03 -48.29 64.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.132 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.625 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -57.99 -44.99 87.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.7 tpp -73.14 -32.92 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.7 ttp -59.89 -43.05 95.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.2 t -77.59 -30.9 52.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.59 149.3 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.89 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.718 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.3 -50.89 61.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.056 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.538 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.72 -53.26 32.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.678 0.275 . . . . 0.0 111.241 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -57.07 -37.68 72.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.051 0.453 . . . . 0.0 110.365 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.406 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 12.4 t -63.45 -33.64 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.415 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.718 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.6 mt -71.52 -55.43 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.026 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.2 mmm-85 -50.58 -37.61 40.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.214 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -69.76 -47.17 63.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.543 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -56.0 -55.41 33.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.417 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.52 -57.34 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.049 0.452 . . . . 0.0 111.059 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.54 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -56.16 -51.19 68.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.954 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.534 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.39 -40.24 64.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.094 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.1 mt -54.44 -51.52 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.506 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.27 93.19 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.08 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.678 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.73 -61.44 2.18 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.812 -0.694 . . . . 0.0 110.413 -178.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.676 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -62.97 -27.84 69.68 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.647 177.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.492 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -66.05 -51.31 59.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.226 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.502 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 3.7 ppt_? -63.49 -43.48 97.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.977 0.418 . . . . 0.0 109.918 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.644 HG23 ' O ' ' B' ' 16' ' ' MET . 2.4 m -66.61 -32.29 57.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.679 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.676 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -71.65 -50.94 25.95 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.955 -179.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.432 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 54.7 p -57.85 -36.24 72.05 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.45 HG22 ' C ' ' B' ' 19' ' ' VAL . 26.8 m -72.55 -45.25 59.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.102 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' B' ' 20' ' ' PHE . 3.1 pp -65.71 -26.42 67.75 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.084 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 12.7 ptt180 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.926 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.765 0.317 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.87 -169.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -117.28 89.42 3.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.02 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.572 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.93 164.72 12.25 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.482 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -97.84 162.47 13.24 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.527 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -47.51 -51.42 20.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.831 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.39 -27.62 69.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.022 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.4 -51.43 20.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.72 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.582 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 37.9 pt -73.24 -28.9 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.862 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.47 -27.39 10.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.513 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 17.9 mt-10 -75.21 -28.57 60.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.256 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.35 -58.5 3.18 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.853 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 10.9 ptmt -54.52 -23.01 14.64 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.206 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.513 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.37 -27.93 56.58 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.143 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.39 -39.9 62.41 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.106 177.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.853 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.8 -51.94 67.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.79 0.805 . . . . 0.0 109.398 178.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.43 -24.14 59.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.089 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.14 -26.29 33.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.22 0.533 . . . . 0.0 110.147 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.5 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.9 t80 -91.24 -1.4 57.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.356 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.9 t70 -103.09 144.11 31.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.004 0.907 . . . . 0.0 111.072 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -60.37 -53.4 58.02 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 113.859 -1.519 . . . . 0.0 111.68 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.29 -6.51 59.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.75 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.06 46.16 56.23 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.169 -0.538 . . . . 0.0 113.371 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.3 p30 -90.88 17.95 7.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.831 0.348 . . . . 0.0 110.732 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.55 88.65 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 49.6 p -150.29 148.98 29.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -100.54 140.52 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.016 0.436 . . . . 0.0 111.907 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.443 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -85.52 178.07 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.131 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.434 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -70.46 -40.45 73.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.107 0.479 . . . . 0.0 110.382 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -58.48 -40.87 83.94 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.402 178.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.61 -53.86 16.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.378 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.408 ' HB3' ' NZ ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.33 -54.17 49.85 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.785 0.802 . . . . 0.0 109.583 178.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.69 -46.78 92.87 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.27 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.9 m -66.25 -30.14 70.52 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.757 0.313 . . . . 0.0 110.493 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.424 ' CG2' ' CE2' ' A' ' 19' ' ' PHE . 16.7 t -64.03 -57.89 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.06 0.457 . . . . 0.0 110.635 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.47 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -72.48 -40.38 66.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.255 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -61.09 -38.87 87.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 110.378 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -78.8 -12.23 60.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.526 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 tt -87.46 -53.48 4.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.0 110.544 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 180.0 35.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.568 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -131.31 -179.96 5.66 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.287 0.565 . . . . 0.0 111.245 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -159.71 56.17 0.84 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.783 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.3 Cg_endo -80.72 -173.52 1.88 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.588 2.192 . . . . 0.0 112.202 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -119.7 152.39 37.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 110.075 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 44' ' ' THR . 3.5 mm-40 -56.71 -50.14 73.07 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.85 76.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.711 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -54.37 31.91 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.76 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.613 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.65 -38.18 90.12 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.313 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -61.79 -42.57 99.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.884 0.373 . . . . 0.0 110.428 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -61.73 -46.09 91.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.5 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -30.6 61.73 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.606 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.542 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -53.66 -40.19 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.761 -178.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -45.11 -28.68 0.77 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.383 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.84 -38.0 47.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.977 0.418 . . . . 0.0 110.734 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 52' ' ' ILE . 3.8 m -80.8 -12.63 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.498 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 43.2 t0 -103.46 155.25 18.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.699 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.09 26.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.179 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -116.44 -9.72 11.42 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.402 0.62 . . . . 0.0 110.415 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.72 61.52 7.29 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.295 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -109.74 18.49 20.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.758 0.313 . . . . 0.0 110.411 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.32 19.96 59.65 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.303 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.4 p -147.48 176.23 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.2 mt -113.47 136.66 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.644 0.259 . . . . 0.0 110.717 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -86.24 -179.96 6.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.208 0.528 . . . . 0.0 111.876 -179.384 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.89 -55.88 12.71 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.471 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.7 Cg_endo -65.76 -35.04 38.28 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.186 1.924 . . . . 0.0 111.18 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -52.51 63.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.35 -56.66 19.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.816 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.488 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -56.73 -47.92 78.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.813 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.3 m -59.39 -30.66 68.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.473 . . . . 0.0 110.102 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.421 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.1 tpp -63.61 -61.79 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.112 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 40.3 mtm -72.12 -29.65 64.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.145 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.09 0.07 37.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.687 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -53.2 121.14 6.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.835 0.35 . . . . 0.0 111.067 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -16.6 63.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.217 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 32.9 mtt -76.88 -29.61 55.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.964 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -100.16 144.56 29.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -177.05 -169.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.17 -167.27 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 63.96 60.6 1.01 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.46 -33.39 54.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -76.86 -29.22 55.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.933 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -50.72 -30.67 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' CB ' ' HB3' ' B' ' 15' ' ' LYS . 0.6 OUTLIER -78.16 -29.44 48.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.678 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.4 mt -79.21 -51.13 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.32 -52.04 11.77 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -53.85 -25.63 20.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.754 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.418 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.46 -35.75 46.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.265 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 27.6 t80 -68.58 -51.38 43.2 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 110.026 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -54.76 -32.61 60.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.796 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.6 t -88.75 -22.67 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.631 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.468 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -53.05 -33.33 51.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.271 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -100.64 148.85 24.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.519 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.27 -37.69 78.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.22 -9.77 13.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.782 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.59 28.47 32.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.313 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -67.51 -13.97 62.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.183 0.491 . . . . 0.0 110.752 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.441 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.27 -10.27 56.53 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.187 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.5 m-85 -127.08 145.42 50.74 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.988 0.423 . . . . 0.0 111.5 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.42 HG12 ' CD2' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.18 109.9 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.843 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -83.84 175.18 9.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.329 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.63 -29.05 70.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.001 0.429 . . . . 0.0 110.37 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -56.81 14.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.252 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.37 -46.54 26.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.279 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.414 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 15.5 tp -52.99 -36.07 59.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -68.05 -49.1 63.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.877 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -58.17 -44.52 88.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.232 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -73.01 -42.28 59.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.552 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.477 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 26.6 mmt -70.16 -54.06 14.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.514 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 m -58.39 -48.36 80.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.3 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -58.48 -29.29 66.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.84 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.416 ' CD2' ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -122.98 37.52 4.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.75 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -168.85 -116.17 0.36 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.708 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -131.51 172.23 12.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.72 0.295 . . . . 0.0 110.777 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -75.78 98.77 4.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.288 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 121' ' ' VAL . 0.4 OUTLIER -91.47 112.72 24.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.551 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.8 174.9 6.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.328 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.11 -36.13 12.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 0.0 110.757 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -77.38 -33.91 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.757 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -73.64 -34.72 65.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.023 0.439 . . . . 0.0 110.023 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.435 ' HA ' HD12 ' A' ' 116' ' ' LEU . 2.6 t -72.73 -47.99 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.872 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -58.81 -52.87 63.89 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.837 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -56.64 -28.91 61.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.928 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.414 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 7.8 tpt -76.31 -38.73 55.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.182 0.515 . . . . 0.0 110.111 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -67.51 -48.51 76.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.521 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -60.26 -40.32 89.9 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.85 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -80.55 -37.13 32.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 110.604 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.47 82.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.555 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.4 t0 -101.57 147.87 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.062 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.528 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.7 pt -84.88 -40.74 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.048 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.528 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.98 -10.9 59.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.692 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.09 32.68 1.1 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.4 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.1 -12.79 24.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.303 -0.949 . . . . 0.0 112.482 -176.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.89 20.12 10.22 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.813 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.433 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -146.51 146.83 30.66 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.928 0.395 . . . . 0.0 110.029 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 t -130.74 107.39 14.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.307 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.527 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -79.18 174.69 11.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.337 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.579 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -45.84 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.548 0.69 . . . . 0.0 111.421 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.431 ' HA ' HG21 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -60.3 -34.77 74.26 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.839 -178.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -41.55 75.24 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.444 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.77 -31.85 46.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.022 178.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.579 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 53.6 t -55.54 -47.23 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.596 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -56.07 -45.15 79.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.966 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.16 -32.11 64.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.406 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -59.95 -42.92 95.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 t -76.97 -31.3 56.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.76 152.24 23.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.693 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.47 -52.17 55.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.214 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.521 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.78 -53.32 32.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 111.394 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.94 -36.89 70.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 0.0 110.295 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.487 ' O ' ' HD3' ' B' ' 9' ' ' LYS . 39.6 t -62.05 -39.19 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.1 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.693 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.8 mt -65.92 -55.48 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.166 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -50.91 -37.31 43.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.022 0.439 . . . . 0.0 110.202 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -73.32 -45.86 52.86 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.718 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' B' ' 5' ' ' VAL . 0.4 OUTLIER -55.02 -55.47 30.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.999 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.422 ' HA ' HD11 ' B' ' 13' ' ' ILE . 3.5 mt -51.49 -57.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.421 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.487 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -57.8 -51.33 70.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.218 0.532 . . . . 0.0 111.021 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.46 -42.47 67.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.779 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.488 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.3 mt -54.57 -48.07 71.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.577 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.26 -38.26 96.18 Favored Glycine 0 CA--C 1.499 -0.954 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.077 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.674 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.14 -61.75 2.06 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.831 -0.685 . . . . 0.0 110.445 -178.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.658 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.7 OUTLIER -61.8 -27.84 69.04 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.65 177.799 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -65.19 -50.89 64.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.258 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 0.5 OUTLIER -63.89 -43.65 95.37 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.633 HG23 ' O ' ' B' ' 16' ' ' MET . 1.7 m -64.34 -33.68 64.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.532 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.658 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.4 OUTLIER -74.3 -45.04 50.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.737 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.48 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.8 p -59.85 -25.96 65.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.457 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.42 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.5 -46.15 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.134 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.83 -34.23 76.88 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.164 0.507 . . . . 0.0 110.323 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.48 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.064 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.827 0.346 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.69 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.762 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -123.78 89.36 3.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.107 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.564 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.03 164.71 12.41 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.354 179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.407 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.2 p -97.89 162.31 13.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.482 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -47.53 -51.4 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.819 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -64.48 -27.66 69.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.018 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.22 -51.52 20.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.683 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.588 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.0 pt -73.31 -28.89 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.806 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.31 10.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 13.8 mt-10 -75.38 -28.62 59.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.369 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.1 m-85 -79.25 -58.69 3.09 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.174 0.511 . . . . 0.0 111.189 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.85 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -55.37 -21.89 17.33 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.249 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -77.23 -28.03 53.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.18 -40.1 62.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.082 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.85 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.46 -51.95 67.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.853 0.835 . . . . 0.0 109.448 178.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 p -74.35 -24.27 59.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.161 -1.382 . . . . 0.0 112.149 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.482 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.14 -25.85 34.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.31 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.7 t80 -92.16 -1.99 56.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.632 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.9 t70 -101.77 143.5 31.62 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.963 0.887 . . . . 0.0 111.152 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -60.16 -53.38 58.44 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.552 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.15 -5.6 59.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.791 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.22 46.45 51.42 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.349 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -91.11 18.17 7.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.82 0.343 . . . . 0.0 110.704 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.52 5.1 88.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.605 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 47.0 p -150.29 149.25 29.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.8 140.51 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.895 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.45 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.29 177.01 7.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.124 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.432 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.8 OUTLIER -70.35 -39.05 74.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.102 0.477 . . . . 0.0 110.301 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.35 -40.78 87.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.285 178.81 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.534 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.57 -53.83 17.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.329 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.7 -54.38 47.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.786 0.803 . . . . 0.0 109.531 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.33 -46.63 92.69 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.296 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.1 m -66.76 -30.06 70.18 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.749 0.309 . . . . 0.0 110.479 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.419 ' CG2' ' CE2' ' A' ' 19' ' ' PHE . 13.0 t -63.51 -57.95 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 0.0 110.534 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.48 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -72.44 -40.94 66.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.196 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -39.26 86.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.982 0.42 . . . . 0.0 110.494 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -78.81 -12.14 60.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.537 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.73 -54.07 4.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 0.0 110.596 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.02 36.87 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.752 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.551 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 tp-100 -134.9 -179.46 5.62 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.332 0.587 . . . . 0.0 111.22 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -159.68 56.35 0.86 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.892 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.49 -176.71 3.32 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.583 2.189 . . . . 0.0 112.153 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.604 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -115.89 152.5 33.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 110.203 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 44' ' ' THR . 1.0 OUTLIER -57.11 -49.64 75.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -34.19 77.57 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -54.35 31.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.657 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.604 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.7 -38.17 90.08 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 120.246 -0.581 . . . . 0.0 110.329 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.403 ' CA ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.36 -42.15 99.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.891 0.377 . . . . 0.0 110.405 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.09 -47.34 86.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.431 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.9 mmt -74.51 -30.32 61.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.732 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.42 -38.64 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.584 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -45.52 -28.53 0.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.298 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.74 -38.03 47.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.935 0.398 . . . . 0.0 110.833 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 52' ' ' ILE . 4.2 m -81.92 -11.78 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.218 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.9 t0 -103.46 155.48 18.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.729 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.58 -28.73 26.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.084 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -116.38 -9.72 11.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.387 0.613 . . . . 0.0 110.458 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.525 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.38 63.08 5.56 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.467 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -112.19 18.45 18.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.835 0.35 . . . . 0.0 110.194 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.9 19.95 56.71 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.445 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.419 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 5.0 p -146.5 176.44 9.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.418 HG22 ' CG ' ' A' ' 68' ' ' PHE . 15.1 mt -116.44 136.48 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.522 0.201 . . . . 0.0 110.883 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 8.7 m-20 -86.67 -178.95 6.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.273 0.558 . . . . 0.0 111.908 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.84 -55.94 12.72 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.607 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -65.6 -35.05 39.63 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.22 1.947 . . . . 0.0 111.223 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.64 -52.38 63.57 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.199 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.06 -56.86 16.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.844 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -57.11 -47.5 80.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.729 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.3 m -59.06 -30.76 68.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.055 0.455 . . . . 0.0 110.061 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.415 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.1 tpp -65.54 -61.75 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.229 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.1 mtm -69.35 -37.32 77.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.104 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -21.08 43.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.432 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.33 105.9 0.13 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.88 0.372 . . . . 0.0 111.083 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -19.14 62.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 tpp -68.63 -29.34 67.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.985 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.02 117.82 21.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.956 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -136.75 -177.46 4.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 m 59.88 102.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 178.04 -33.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -53.21 -31.15 41.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.233 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -80.74 -31.78 35.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.021 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -77.22 -42.07 38.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.274 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.655 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.71 -29.32 26.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.541 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 mt -66.07 -51.42 60.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.794 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -75.81 -50.65 14.58 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.774 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -53.87 -30.69 46.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.661 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -71.16 -38.62 72.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.792 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.6 t80 -67.08 -55.92 12.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 0.0 110.541 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.85 -30.51 45.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.832 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.6 t -88.36 -22.86 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.309 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.433 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.25 -32.54 62.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.982 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -102.08 148.64 25.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -69.62 -37.53 76.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.375 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -112.26 -9.76 13.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.5 30.65 32.61 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.119 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -67.42 -13.52 62.1 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.928 0.364 . . . . 0.0 110.823 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.16 -13.61 55.44 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.846 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.45 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.5 m-85 -127.22 145.9 50.61 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.961 0.41 . . . . 0.0 111.3 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.423 HD11 HD11 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.09 109.99 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.85 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -82.19 177.71 8.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.17 69.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.009 0.433 . . . . 0.0 110.559 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.35 -57.72 9.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.314 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -38.74 54.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.006 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.459 HD13 ' HG3' ' A' ' 124' ' ' MET . 5.5 tt -56.5 -33.15 65.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 6.7 ttt180 -74.77 -49.4 21.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.172 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -36.72 79.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.064 0.459 . . . . 0.0 110.321 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.486 HG13 ' CZ ' ' B' ' 20' ' ' PHE . 45.6 t -72.9 -45.69 54.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.242 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.453 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 22.3 mmt -73.93 -54.14 8.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.818 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 m -55.46 -43.11 75.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 111.362 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -61.21 -31.81 71.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.788 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.17 38.76 4.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.31 -116.96 0.39 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.782 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -133.61 171.88 13.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.821 0.343 . . . . 0.0 110.944 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -75.38 100.08 4.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.294 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.445 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.41 115.48 26.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.29 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.76 174.99 6.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.404 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.0 -35.76 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.92 0.391 . . . . 0.0 110.734 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.29 -36.15 54.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.699 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -71.13 -34.56 71.14 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.056 0.455 . . . . 0.0 110.084 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.417 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.6 t -73.62 -50.02 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.351 0.596 . . . . 0.0 109.776 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -59.76 -52.85 63.7 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.859 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.84 -28.83 62.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.938 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.459 ' HG3' HD13 ' A' ' 105' ' ' LEU . 7.4 tpt -76.35 -38.75 55.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.151 0.5 . . . . 0.0 110.13 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.15 -49.07 78.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.521 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -60.13 -40.12 88.66 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.967 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -81.01 -37.31 29.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 110.647 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.406 ' HB3' ' CE ' ' A' ' 124' ' ' MET . . . -66.33 -36.96 84.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.518 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.1 t0 -100.39 148.1 25.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.025 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.527 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.8 -40.8 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.297 0.57 . . . . 0.0 110.073 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.527 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.83 -11.03 60.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.682 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.14 32.59 1.1 Allowed Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.04 -12.94 24.16 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.309 -0.946 . . . . 0.0 112.434 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.88 20.18 10.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.81 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.45 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -146.74 146.69 30.38 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.905 0.383 . . . . 0.0 110.061 179.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.7 t -130.67 107.47 14.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.24 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.523 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.01 174.65 11.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.426 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.582 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.97 -67.06 0.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.479 0.657 . . . . 0.0 111.531 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -34.15 72.9 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.913 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.12 -40.34 73.61 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.451 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.79 -33.67 46.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.114 178.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.582 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.6 t -54.86 -47.43 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.688 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -58.13 -45.2 87.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.12 -32.5 64.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.416 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 14.1 ttp -59.81 -43.63 94.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 t -76.81 -31.19 56.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.923 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.71 160.79 6.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.91 179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.696 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.44 -52.37 54.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.209 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.527 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.83 -53.2 34.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.291 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -56.84 -37.02 70.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.009 0.433 . . . . 0.0 110.256 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' B' ' 9' ' ' LYS . 40.7 t -61.94 -39.16 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.081 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.696 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.8 mt -66.03 -55.53 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.15 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -50.96 -37.16 42.88 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.2 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.22 -45.55 55.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.622 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' B' ' 5' ' ' VAL . 0.3 OUTLIER -55.33 -55.32 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.129 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.447 ' HA ' HD13 ' B' ' 13' ' ' ILE . 3.5 mt -51.29 -57.5 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.802 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.8 tpt180 -60.3 -51.32 70.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.273 0.559 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.35 -40.13 64.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.679 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.483 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.1 mt -54.46 -47.75 70.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.27 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.92 -38.25 95.81 Favored Glycine 0 CA--C 1.497 -1.06 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.493 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.656 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -64.93 -61.61 2.06 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.646 -0.777 . . . . 0.0 110.507 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.65 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.19 -27.49 67.19 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -67.81 -48.57 65.89 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.017 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.7 ppt_? -63.28 -43.57 97.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.127 0.489 . . . . 0.0 109.798 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.65 HG23 ' O ' ' B' ' 16' ' ' MET . 1.7 m -61.78 -34.82 64.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.348 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.541 ' N ' HG23 ' B' ' 19' ' ' VAL . 0.3 OUTLIER -74.95 -43.94 51.27 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.633 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.505 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 18.7 p -60.74 -25.77 66.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.495 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.417 HG23 ' N ' ' B' ' 23' ' ' LEU . 29.3 m -90.25 -46.5 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.09 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.37 -34.47 76.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.184 0.516 . . . . 0.0 110.348 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.505 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.092 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.821 0.343 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.65 -169.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -117.5 90.65 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.975 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.575 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.2 mt -98.72 164.88 12.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.557 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.3 p -96.94 161.82 13.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.494 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.52 -51.91 19.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.798 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -64.28 -27.73 69.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.015 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.94 -51.52 21.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.662 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.582 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.6 pt -72.84 -28.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.816 -179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.36 -27.29 9.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.51 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 7.9 mt-10 -74.88 -28.5 60.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.171 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.6 -58.34 3.24 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.198 0.523 . . . . 0.0 110.994 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.85 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -54.45 -23.01 14.3 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.188 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.24 -27.94 56.96 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.48 -39.8 62.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.079 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.85 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.93 -51.82 68.39 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.85 0.834 . . . . 0.0 109.416 178.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.43 -24.26 59.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.096 -1.411 . . . . 0.0 112.134 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.491 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.2 tt -82.08 -24.24 35.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.248 0.547 . . . . 0.0 110.191 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.524 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.6 t80 -95.61 0.82 53.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.434 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.9 t70 -105.58 145.13 31.37 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.013 0.911 . . . . 0.0 111.123 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.0 mmtt -60.54 -53.39 58.07 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.587 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.43 -6.09 59.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.06 47.23 55.12 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.194 -0.526 . . . . 0.0 113.515 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -92.66 17.8 9.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.871 0.367 . . . . 0.0 110.469 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.16 9.25 86.34 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.258 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.462 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 72.8 p -150.16 147.23 27.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.6 mt -101.96 140.39 20.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.904 0.383 . . . . 0.0 111.927 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.456 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 1.4 t -87.27 -179.29 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.123 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 p -70.49 -45.51 65.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 110.899 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.545 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -54.54 -40.54 68.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.449 178.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -69.52 -53.83 17.14 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.467 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.92 -56.07 26.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.78 0.8 . . . . 0.0 109.379 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -56.86 -46.2 90.73 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.64 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.2 m -62.05 -35.01 77.31 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.047 0.423 . . . . 0.0 110.542 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 70.0 t -64.0 -57.19 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.417 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.6 OUTLIER -71.82 -36.05 70.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.404 -179.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 2.8 ttt-85 -67.25 -41.22 85.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.999 0.428 . . . . 0.0 110.48 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 t -79.0 -8.32 58.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.627 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -90.82 -54.33 4.02 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.762 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.91 34.57 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.837 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.76 -179.37 5.49 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.317 0.58 . . . . 0.0 111.141 -179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -159.67 56.39 0.87 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.815 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.8 Cg_endo -80.56 -174.85 2.41 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.568 2.179 . . . . 0.0 112.117 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -116.87 152.45 34.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.945 0.402 . . . . 0.0 110.159 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.546 ' N ' HG23 ' A' ' 44' ' ' THR . 3.6 mm-40 -56.69 -50.03 73.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.14 74.94 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.75 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -54.3 32.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.733 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.611 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.71 -35.57 81.12 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.419 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -42.95 98.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.868 0.366 . . . . 0.0 110.224 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.85 -45.36 94.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.373 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.56 -30.68 61.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.449 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.72 -39.51 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.637 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -44.99 -28.64 0.7 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.387 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.65 -38.52 54.47 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.954 0.407 . . . . 0.0 110.73 179.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 52' ' ' ILE . 5.5 m -80.99 -12.77 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.049 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.492 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 42.9 t0 -103.5 154.88 18.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.815 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.68 -28.03 26.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.227 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -116.42 -9.72 11.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.386 0.612 . . . . 0.0 110.423 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.91 61.66 7.11 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.315 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -109.52 18.4 20.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 110.475 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.75 18.93 60.66 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.407 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.2 p -146.54 176.12 10.06 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 61.0 mt -112.91 136.49 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.585 0.231 . . . . 0.0 110.675 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -85.12 179.56 7.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.243 0.544 . . . . 0.0 111.824 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 6.3 m-85 -67.45 -56.52 12.32 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.285 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.82 -36.11 33.03 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.326 2.017 . . . . 0.0 111.071 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.61 -52.32 65.67 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.135 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.491 ' CD2' ' CD1' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -56.94 -56.29 23.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.657 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.49 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -57.34 -46.67 83.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.706 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.1 m -61.2 -31.79 71.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.013 0.435 . . . . 0.0 110.11 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.441 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 4.5 tpp -60.86 -61.77 2.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.125 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.8 mtp -72.2 -31.59 66.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.991 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.76 0.04 40.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.638 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -56.02 152.62 10.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.875 0.369 . . . . 0.0 110.982 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -69.6 -12.68 61.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.295 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.5 mtt -93.49 -30.65 14.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.821 0.343 . . . . 0.0 110.962 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.01 116.56 21.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -176.6 -178.47 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.75 -166.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.792 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 63.94 65.87 0.68 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.57 -52.31 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.858 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -66.13 -35.52 80.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -50.47 -30.51 12.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 4.7 mt-10 -76.49 -29.59 56.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.685 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 mt -79.26 -51.13 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -48.41 39.04 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.893 0.378 . . . . 0.0 111.87 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -53.6 -26.31 21.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.344 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.448 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.4 -34.31 58.83 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.052 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.589 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 12.8 t80 -68.79 -50.05 53.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.12 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -54.5 -33.17 59.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.778 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.8 t -88.95 -22.79 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.542 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.518 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.28 -33.63 53.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.206 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -106.18 139.24 41.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.521 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -64.74 -34.77 79.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -112.15 -9.7 13.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.97 29.26 38.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.36 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.68 -13.92 62.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.134 0.467 . . . . 0.0 110.745 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.468 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 100.48 -11.6 59.75 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.004 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.3 m-85 -127.19 147.3 50.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.038 0.447 . . . . 0.0 111.438 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.42 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.19 109.96 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.721 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 t -82.62 176.52 9.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.46 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.71 70.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.075 0.464 . . . . 0.0 110.477 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.26 -57.8 10.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.236 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.45 -45.38 31.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.126 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.402 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 31.9 tp -52.95 -31.24 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.191 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 2.9 ttt-85 -73.47 -49.17 28.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -58.67 -42.48 88.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.074 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.99 -40.04 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.546 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.7 mmt -73.99 -54.18 8.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.528 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.4 m -55.5 -46.96 76.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.376 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -59.9 -30.7 69.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.6 mp -121.54 37.52 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.49 -113.97 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.688 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.87 170.61 15.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.824 0.345 . . . . 0.0 110.805 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -73.73 98.22 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.152 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.416 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.14 113.52 24.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.385 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.79 175.45 5.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.368 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -48.13 -35.93 12.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.896 0.379 . . . . 0.0 110.766 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.4 -34.51 54.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -73.44 -33.5 64.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.009 0.433 . . . . 0.0 110.096 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.41 HG22 HD11 ' A' ' 116' ' ' LEU . 2.5 t -74.47 -48.16 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.819 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.62 -52.85 63.77 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.735 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -57.48 -28.72 63.65 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.779 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.408 ' CE ' HD11 ' B' ' 23' ' ' LEU . 6.9 tpt -76.2 -38.02 57.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.121 0.486 . . . . 0.0 110.137 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -41.84 81.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.494 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -66.08 -38.92 89.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.933 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.54 -35.94 29.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.512 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.54 -37.47 79.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.416 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 22.2 t0 -100.5 145.61 28.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.979 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.52 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.7 pt -83.17 -40.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.248 0.547 . . . . 0.0 110.101 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.9 -11.06 60.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.781 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.79 32.88 0.99 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -176.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.04 -12.48 24.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.341 -0.93 . . . . 0.0 112.53 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.2 10.18 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.84 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.444 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.31 146.76 30.82 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.75 107.22 13.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.354 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.533 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.3 t30 -78.25 175.2 10.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.206 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.589 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 1.1 t80 -45.91 -67.12 0.31 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.612 0.72 . . . . 0.0 111.635 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.3 mt-10 -64.96 -25.85 68.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.553 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 129' ' ' ASP . 0.4 OUTLIER -55.57 -48.47 74.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 110.35 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.0 p90 -78.81 -31.03 45.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.24 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.497 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 65.7 t -52.8 -44.49 48.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.094 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -59.26 -38.74 80.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 109.828 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.49 -40.71 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.704 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 3.8 ttp -53.41 -43.58 68.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.009 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 t -78.89 -31.31 45.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 146.87 40.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.076 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.815 0.34 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.711 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.26 -51.22 59.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.061 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.68 -53.28 32.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.261 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.95 -37.54 71.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.999 0.428 . . . . 0.0 110.31 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.417 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 15.3 t -63.35 -34.44 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.436 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.711 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.2 mt -71.32 -54.89 15.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.039 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -50.94 -37.63 45.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.154 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.85 -48.32 63.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.404 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -54.25 -54.08 44.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.067 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.441 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 4.9 mt -51.13 -57.5 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.4 tpt180 -60.06 -51.41 69.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.28 0.562 . . . . 0.0 111.089 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.39 -40.38 65.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.763 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.1 mt -54.57 -50.8 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.462 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.52 -37.06 94.08 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.235 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.679 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.02 -61.82 2.03 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.861 -0.669 . . . . 0.0 110.529 -178.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.7 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -63.17 -27.59 69.47 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.673 177.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -65.89 -50.48 64.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.28 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.505 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.4 OUTLIER -64.63 -43.63 93.08 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.623 HG23 ' O ' ' B' ' 16' ' ' MET . 2.3 m -64.98 -33.02 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.543 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.7 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -74.68 -45.92 41.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.944 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.46 -26.34 65.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.505 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.406 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.3 -47.41 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.229 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.429 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -62.79 -33.54 75.4 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.254 0.549 . . . . 0.0 110.511 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.498 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.071 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.819 0.343 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.83 -169.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.785 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -118.65 89.26 3.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.994 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.57 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.29 164.7 12.37 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.9 p -98.29 162.67 13.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.48 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -47.56 -51.31 21.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.845 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.48 -27.66 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.994 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.6 OUTLIER -72.4 -51.46 20.32 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.696 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.581 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.2 pt -73.19 -28.89 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.822 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.43 -27.45 10.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.515 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 15.2 mm-40 -75.34 -28.55 59.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.327 178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.36 -58.64 3.11 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.228 0.537 . . . . 0.0 111.083 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.854 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.56 -23.26 15.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.243 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -75.86 -28.08 58.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.123 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.07 -39.83 63.18 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.149 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.854 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.81 -51.81 68.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.762 0.791 . . . . 0.0 109.515 178.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.38 -24.41 59.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.044 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.5 tt -82.1 -25.34 34.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.217 0.532 . . . . 0.0 110.279 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.492 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 3.1 t80 -92.23 -2.37 56.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.0 t70 -102.42 143.45 32.14 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.959 0.885 . . . . 0.0 111.026 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 3.7 mmtt -60.01 -53.36 58.77 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.626 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.46 -5.19 59.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.777 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.55 47.0 45.96 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.331 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.6 p30 -91.47 18.22 7.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.905 0.383 . . . . 0.0 110.711 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.54 5.27 88.6 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.589 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.9 p -150.38 148.61 29.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.32 140.55 19.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.975 0.416 . . . . 0.0 111.763 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.442 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -86.21 178.21 7.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.374 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.441 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.6 OUTLIER -69.62 -41.2 75.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 110.353 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -58.11 -41.24 83.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.439 179.127 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.79 -53.75 16.79 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.407 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.411 ' HB3' ' NZ ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.07 -54.15 50.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.81 0.814 . . . . 0.0 109.555 178.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -58.8 -47.08 92.29 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.384 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.4 m -65.33 -30.79 71.67 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.448 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 16.7 t -63.88 -57.91 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.481 ' HB2' ' HD2' ' B' ' 9' ' ' LYS . 0.9 OUTLIER -72.57 -40.25 66.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.31 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 20.5 ttt180 -61.21 -38.56 87.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 110.447 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.3 t -78.84 -12.08 60.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.539 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 tt -87.46 -53.12 4.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.178 0.514 . . . . 0.0 110.52 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.74 36.16 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.606 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -131.07 179.39 6.03 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.342 0.591 . . . . 0.0 111.257 -179.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -159.78 56.11 0.82 Allowed Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.773 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.7 Cg_endo -80.67 -173.74 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.615 2.21 . . . . 0.0 112.226 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.618 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.91 152.42 36.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.87 0.367 . . . . 0.0 110.093 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' N ' HG21 ' A' ' 44' ' ' THR . 3.5 mm-40 -56.41 -50.14 72.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.0 -32.01 72.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.602 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.49 -54.45 23.77 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.648 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.618 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -62.26 -47.05 86.06 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.108 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -55.85 -44.94 78.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 110.806 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.4 -47.51 81.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -74.68 -30.61 61.64 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.968 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.482 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -54.15 -36.26 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.667 -178.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -45.02 -28.64 0.72 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.282 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -79.39 -39.03 33.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.898 0.38 . . . . 0.0 110.731 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 52' ' ' ILE . 3.6 m -80.01 -11.16 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.089 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.521 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 37.2 t0 -103.58 155.93 18.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.74 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.6 -29.38 25.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.1 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -116.51 -9.61 11.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.428 0.632 . . . . 0.0 110.442 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.4 63.86 4.85 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.519 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -112.49 17.84 18.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.807 0.337 . . . . 0.0 110.186 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.3 19.94 53.69 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.413 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.1 p -147.56 176.35 10.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.0 mt -115.03 136.48 51.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.554 0.216 . . . . 0.0 110.95 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.7 m-20 -88.18 -178.14 5.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.29 0.567 . . . . 0.0 112.001 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.502 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.75 -55.86 13.15 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.713 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.8 Cg_endo -65.66 -34.32 41.78 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.226 1.95 . . . . 0.0 111.267 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.72 -52.47 60.37 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.219 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.11 -57.15 13.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.88 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.49 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -57.23 -47.92 80.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.689 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.6 m -58.83 -30.54 67.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.066 0.46 . . . . 0.0 110.05 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.418 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.0 tpp -63.76 -61.71 2.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.234 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.5 mtm -72.84 -28.53 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.243 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.18 0.14 37.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.706 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -54.83 122.88 11.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.823 0.344 . . . . 0.0 110.989 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -65.0 -16.68 63.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.229 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 74.8 mtp -76.5 -29.47 56.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.807 0.337 . . . . 0.0 111.03 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -99.33 143.38 29.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.74 -173.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.84 -165.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 65.5 59.97 0.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 t -77.5 -33.52 54.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -76.03 -29.84 58.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -51.5 -30.53 20.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.7 OUTLIER -78.0 -29.41 49.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 mt -79.14 -51.26 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.3 -51.91 12.11 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -53.76 -25.47 19.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.786 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.433 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.62 -36.21 44.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.214 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.5 t80 -68.2 -52.13 37.84 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.0 0.429 . . . . 0.0 110.1 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -54.73 -31.98 59.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.821 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.7 t -88.69 -22.74 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.514 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.466 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.36 -34.32 57.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.26 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -99.19 147.93 24.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.467 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -67.54 -38.22 83.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.375 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.29 -9.84 13.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.804 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.93 28.29 31.9 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.246 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -67.48 -13.9 62.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.211 0.505 . . . . 0.0 110.764 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.442 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -11.0 55.35 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.146 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.9 m-85 -127.09 145.0 50.89 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.011 0.434 . . . . 0.0 111.414 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.439 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pt -121.15 109.97 26.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.726 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -83.7 177.15 8.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.582 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.2 -29.92 71.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.084 0.469 . . . . 0.0 110.449 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.3 -57.68 11.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.28 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.48 -45.66 30.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.135 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.41 ' CD2' ' HG3' ' A' ' 124' ' ' MET . 37.4 tp -53.06 -31.15 40.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -72.94 -49.06 31.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.976 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -58.9 -42.58 89.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 t -72.85 -40.96 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.456 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.462 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 27.0 mmt -72.54 -54.08 10.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.431 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.9 m -58.95 -47.81 83.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.203 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -58.76 -30.18 67.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.805 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.407 ' CD2' ' CD1' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -123.04 38.48 4.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.651 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.6 -114.75 0.33 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.852 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -133.17 166.89 21.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.334 . . . . 0.0 110.908 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -72.68 99.85 2.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.359 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.24 114.33 26.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.371 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.75 175.28 5.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.429 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -48.14 -35.94 12.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.763 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -77.34 -34.82 55.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.774 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -73.06 -33.49 65.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.988 0.423 . . . . 0.0 110.099 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.41 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.6 t -74.73 -48.03 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.854 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.62 -52.87 63.66 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.758 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -57.51 -28.8 63.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.842 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.41 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 7.5 tpt -76.26 -37.73 57.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.139 0.495 . . . . 0.0 110.134 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.91 -43.58 79.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.552 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -64.99 -39.09 92.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.812 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -81.17 -36.43 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.984 0.421 . . . . 0.0 110.545 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.25 82.57 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.635 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.8 t0 -99.39 147.67 25.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.029 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.529 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.85 -40.73 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.06 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.529 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.91 -11.01 60.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.706 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.1 32.72 1.11 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -176.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -96.11 -12.75 24.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.318 -0.941 . . . . 0.0 112.471 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.88 20.21 10.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.824 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.438 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 0.6 OUTLIER -146.59 146.64 30.51 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.78 107.4 13.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.266 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -79.12 174.66 11.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.302 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.578 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -45.83 -67.12 0.31 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.489 0.661 . . . . 0.0 111.444 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.424 ' HA ' HG21 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -60.57 -34.22 73.85 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.892 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -41.73 75.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 109.504 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.44 ' CE1' ' CD2' ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.72 -31.92 46.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.086 178.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.575 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 61.3 t -56.06 -46.73 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.657 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -56.53 -43.92 80.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.084 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.15 -35.31 66.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.0 ttp -59.87 -41.5 91.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.3 t -79.02 -31.0 44.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.6 155.09 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.839 0.352 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.691 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.5 mmm180 -52.38 -52.15 55.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.52 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.9 -53.31 33.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.365 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.03 -36.87 70.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.033 0.444 . . . . 0.0 110.287 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.493 ' O ' ' HD3' ' B' ' 9' ' ' LYS . 39.1 t -62.09 -39.57 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.047 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.691 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.9 mt -65.47 -55.49 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.1 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -50.72 -37.66 42.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.171 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.55 -45.97 56.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.66 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' B' ' 5' ' ' VAL . 0.3 OUTLIER -55.42 -55.57 30.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.015 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.42 ' HA ' HD13 ' B' ' 13' ' ' ILE . 3.4 mt -51.53 -57.42 3.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.343 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -57.44 -51.15 70.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.512 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.37 -42.51 66.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.481 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 3.2 mt -54.48 -48.24 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.583 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.19 -38.24 96.19 Favored Glycine 0 CA--C 1.498 -0.987 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.079 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.675 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.17 -61.79 2.03 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.847 -0.676 . . . . 0.0 110.445 -178.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.665 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.79 -27.75 68.97 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.594 177.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -64.98 -51.36 62.17 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.258 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.508 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.5 OUTLIER -63.88 -43.55 95.7 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.626 HG23 ' O ' ' B' ' 16' ' ' MET . 1.7 m -64.51 -33.39 62.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.503 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.665 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -74.15 -45.48 48.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.788 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.487 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.0 p -59.68 -26.17 65.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.477 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.422 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.1 m -90.32 -46.16 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.172 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.38 -32.85 74.39 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.15 0.5 . . . . 0.0 110.468 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.063 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.794 0.331 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.27 -169.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.8 90.34 3.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.573 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.18 164.73 12.37 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.968 0.413 . . . . 0.0 110.375 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.0 p -98.07 162.55 13.16 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.508 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -47.47 -51.4 20.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.831 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.46 -27.7 69.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.015 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.31 -51.45 20.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.741 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.586 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.0 pt -73.21 -28.99 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.753 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.44 -27.39 10.16 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.2 mt-10 -75.24 -28.57 59.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.235 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.1 m-85 -79.35 -58.55 3.15 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.351 0.596 . . . . 0.0 110.995 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.858 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.86 -22.9 16.13 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.219 -179.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -76.08 -27.6 57.25 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.119 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -75.08 -39.66 60.61 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.071 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.858 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.12 -51.9 68.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.875 0.845 . . . . 0.0 109.386 178.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.38 -24.82 59.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.104 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.512 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.02 -26.6 33.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.127 0.489 . . . . 0.0 110.409 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.492 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 5.3 t80 -86.07 -21.63 27.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.226 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 31.8 t70 -83.33 146.54 28.45 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.896 0.855 . . . . 0.0 111.129 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.479 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.5 mmtt -65.39 -53.37 44.18 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.969 -1.468 . . . . 0.0 111.6 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.19 -8.0 59.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.786 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.27 46.6 63.19 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.537 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -91.8 18.19 8.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.832 0.349 . . . . 0.0 110.583 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.18 5.7 89.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.425 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 54.3 p -150.19 151.06 32.49 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -102.36 140.42 20.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.915 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' HB2' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -85.44 176.53 8.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.97 179.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.42 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.9 OUTLIER -70.42 -39.05 74.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.149 0.499 . . . . 0.0 110.209 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.63 -40.49 87.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.133 178.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.542 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.6 mm-40 -68.15 -53.88 21.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.04 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -56.27 24.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.747 0.784 . . . . 0.0 109.462 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.05 -45.49 87.03 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.553 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.9 m -62.85 -32.35 73.55 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.906 0.353 . . . . 0.0 110.562 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.47 -57.26 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.412 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.7 OUTLIER -71.96 -37.05 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.495 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -41.4 88.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.914 0.387 . . . . 0.0 110.603 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.8 t -78.95 -8.58 59.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.682 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.0 tt -90.85 -54.86 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.682 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.28 33.64 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.87 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.561 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.78 -179.98 5.87 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.314 0.578 . . . . 0.0 111.159 -179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -159.71 56.27 0.85 Allowed Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.831 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.8 Cg_endo -80.58 -173.9 2.03 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.535 2.157 . . . . 0.0 112.113 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.612 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -117.06 152.38 34.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.954 0.407 . . . . 0.0 110.19 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 44' ' ' THR . 1.2 mm-40 -56.94 -49.94 74.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.99 -31.9 72.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.734 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.16 -54.33 26.7 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.667 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.612 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -66.06 -34.5 78.22 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.447 179.642 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.02 -42.16 94.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.92 0.391 . . . . 0.0 110.138 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.65 -45.78 92.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.154 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.5 mmt -74.53 -30.88 61.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.477 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.72 -36.4 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.382 -179.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -44.87 -28.7 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.34 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.424 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.73 -39.44 44.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.923 0.392 . . . . 0.0 110.744 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 52' ' ' ILE . 4.3 m -81.61 -11.56 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.115 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.533 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 44.1 t0 -103.45 155.31 18.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.475 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.64 -28.77 26.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.036 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -116.51 -9.82 11.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.435 0.636 . . . . 0.0 110.473 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 59.45 61.0 7.77 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.467 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -111.18 18.16 19.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.869 0.366 . . . . 0.0 110.309 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.53 19.8 53.45 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.763 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.421 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 5.6 p -146.09 176.35 9.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.499 0.19 . . . . 0.0 110.501 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.417 HG22 ' CG ' ' A' ' 68' ' ' PHE . 25.4 mt -117.59 136.58 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.57 0.224 . . . . 0.0 110.777 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 1.8 m-20 -87.77 -178.14 5.99 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.338 0.589 . . . . 0.0 112.13 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.7 m-85 -67.11 -56.2 13.94 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.638 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -65.68 -35.64 36.34 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.355 2.037 . . . . 0.0 111.307 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.28 -52.49 63.5 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.246 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.1 -56.87 16.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.776 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.489 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -57.07 -47.22 81.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.756 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.0 m -59.16 -30.65 68.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.461 . . . . 0.0 110.124 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.441 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 4.4 tpp -60.3 -61.74 2.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.234 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.7 mtt -75.34 -36.98 60.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.103 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.82 -13.33 62.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.568 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.23 149.46 1.5 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.867 0.365 . . . . 0.0 111.088 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -68.0 -13.39 62.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.398 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -94.81 -27.58 15.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.782 0.325 . . . . 0.0 111.001 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.21 82.19 3.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.978 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -143.15 -178.43 5.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.45 -167.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 65.41 61.6 0.7 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.877 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.4 m -77.61 -58.18 3.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -63.6 -34.59 78.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -50.43 -30.45 12.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 4.6 mt-10 -76.04 -29.62 58.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.775 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.0 mt -79.22 -50.99 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.78 -48.43 38.34 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.904 0.383 . . . . 0.0 111.85 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -53.47 -26.52 20.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.396 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.454 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.61 -34.0 58.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.037 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 12.8 t80 -68.92 -50.55 48.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.04 0.448 . . . . 0.0 110.14 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -54.39 -33.18 58.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.727 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.8 t -88.94 -22.78 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.518 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -52.74 -36.83 58.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.364 -179.242 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -100.09 147.21 25.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 0.0 110.5 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -68.3 -37.49 80.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.33 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -112.23 -9.78 13.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.815 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.43 28.28 33.5 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.354 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -67.54 -14.0 62.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.206 0.503 . . . . 0.0 110.721 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.93 -11.35 55.96 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.126 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.5 m-85 -127.2 146.93 50.23 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 120.989 0.423 . . . . 0.0 111.482 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.422 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -121.14 109.97 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.652 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.92 177.04 8.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.539 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.22 -30.14 71.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.111 0.482 . . . . 0.0 110.484 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.88 -57.81 11.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.239 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.48 -45.45 31.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.155 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.5 tp -52.95 -31.2 39.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.185 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 2.7 ttt-85 -73.01 -49.1 30.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -58.78 -42.66 89.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.118 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.6 t -73.07 -39.74 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 29.0 mmt -74.0 -54.14 8.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.538 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -55.62 -48.9 74.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.35 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -58.87 -29.68 67.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.934 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.5 mp -121.85 36.6 4.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.29 -113.2 0.28 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.716 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -136.24 170.35 16.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.792 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -73.39 98.07 2.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.141 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.38 113.56 24.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.409 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.77 175.42 5.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.363 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.07 -35.87 12.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 0.0 110.742 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.41 -34.99 54.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -72.89 -33.32 65.96 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.026 0.441 . . . . 0.0 110.145 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.41 HG21 HD13 ' A' ' 116' ' ' LEU . 2.6 t -74.53 -48.62 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.342 0.591 . . . . 0.0 109.786 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.46 -52.91 63.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.775 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.25 -28.68 63.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.808 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.411 ' CE ' HD13 ' B' ' 23' ' ' LEU . 7.0 tpt -76.13 -38.1 57.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.131 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.22 -43.77 84.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.506 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -62.32 -40.82 97.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.971 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -80.64 -36.37 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.834 0.35 . . . . 0.0 110.652 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.53 -35.04 78.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.421 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.426 ' HA ' ' HG2' ' A' ' 140' ' ' GLU . 22.4 t0 -104.37 145.54 30.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.983 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.521 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.9 pt -83.03 -40.83 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.165 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.521 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.85 -11.1 60.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.78 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.81 32.74 0.98 Allowed Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -176.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.406 ' N ' ' C ' ' A' ' 131' ' ' ASP . 42.9 p-10 -95.7 -12.38 25.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.351 -0.924 . . . . 0.0 112.548 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.78 20.27 10.16 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.903 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -146.09 147.35 31.48 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.9 t -130.7 107.21 13.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.395 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.529 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -78.71 174.87 10.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.256 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.587 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 1.1 t80 -45.91 -67.15 0.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.636 0.731 . . . . 0.0 111.695 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.477 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 3.5 mt-10 -65.19 -25.49 67.73 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.583 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 129' ' ' ASP . 0.3 OUTLIER -55.52 -48.56 74.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.829 0.347 . . . . 0.0 110.333 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.9 p90 -78.88 -31.06 45.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.219 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.49 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.6 t -52.87 -44.34 48.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.136 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -59.73 -38.51 81.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.147 0.498 . . . . 0.0 109.879 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.47 -41.04 63.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.714 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 8.5 ttp -53.38 -43.62 67.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.974 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 t -78.82 -31.36 45.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.72 159.03 9.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.712 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.26 -51.21 59.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.021 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.541 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.62 -53.3 31.85 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.232 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.43 -37.58 70.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.069 0.462 . . . . 0.0 110.292 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.412 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 12.1 t -64.07 -33.67 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.408 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.712 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.5 mt -71.71 -52.73 23.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.114 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -53.16 -37.36 61.8 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.081 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.03 -48.35 63.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.363 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -55.11 -52.92 61.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.762 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.441 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 6.1 mt -51.08 -57.44 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.053 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.558 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -58.85 -51.46 69.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.287 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.545 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.26 -40.1 64.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 2.4 mt -54.48 -52.38 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.537 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.63 -36.47 93.3 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.284 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.677 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.59 -61.75 2.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.526 -178.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.707 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -63.2 -27.55 69.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.658 177.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -65.58 -50.91 63.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.294 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.504 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.4 OUTLIER -64.58 -43.73 92.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.618 HG23 ' O ' ' B' ' 16' ' ' MET . 2.3 m -64.95 -32.83 59.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.56 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.707 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.69 -46.13 39.81 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.897 -179.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.503 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.33 -26.32 64.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.446 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.409 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.22 -47.4 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.227 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -63.1 -33.25 75.04 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.2 0.524 . . . . 0.0 110.453 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.092 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.787 0.327 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.63 -169.74 2.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -121.34 85.88 2.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.4 mt -98.29 164.79 12.16 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.479 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 p -96.85 161.87 13.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.519 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -47.65 -51.74 20.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.739 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -64.43 -27.69 69.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.96 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.94 -51.55 21.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.63 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.585 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 39.0 pt -72.95 -28.85 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.775 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.43 -27.35 9.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 29.7 mt-10 -75.32 -28.57 59.72 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.251 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.34 -58.53 3.17 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.197 0.522 . . . . 0.0 111.121 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.855 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -54.68 -22.75 14.71 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.246 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.38 -28.03 56.59 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.046 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.44 -39.52 62.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.127 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.855 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.91 -51.61 69.32 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.825 0.821 . . . . 0.0 109.367 178.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 p -74.32 -24.65 59.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.143 -1.389 . . . . 0.0 112.029 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 1.9 tt -81.93 -25.36 34.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.273 0.559 . . . . 0.0 110.194 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.501 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 3.6 t80 -92.63 -0.74 57.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.456 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.2 t70 -104.26 144.08 32.09 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.038 0.923 . . . . 0.0 111.108 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 11.5 mmtt -59.99 -53.4 58.28 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.519 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.59 -4.0 59.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.849 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.51 47.06 36.96 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.354 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -91.52 18.4 7.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.857 0.36 . . . . 0.0 110.693 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.32 88.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.615 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.4 p -150.26 148.78 29.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.647 0.261 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.501 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.41 140.46 20.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.99 0.424 . . . . 0.0 111.82 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -86.13 177.56 7.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.172 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.442 HG23 ' CA ' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -70.33 -38.75 74.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.16 0.505 . . . . 0.0 110.32 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.548 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.39 -41.34 89.17 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 178.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.4 -53.59 18.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.349 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -55.62 32.75 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.79 0.805 . . . . 0.0 109.342 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.38 -45.73 88.45 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.519 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.9 m -62.72 -31.83 72.83 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.556 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 73.7 t -66.56 -57.38 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.438 . . . . 0.0 110.838 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.437 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 2.3 tpt -72.0 -37.22 69.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.506 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -66.23 -40.94 90.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 110.613 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -79.01 -9.14 59.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.639 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 tt -89.8 -54.02 4.24 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.634 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.92 34.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.788 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.547 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -132.89 178.78 6.61 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.344 0.593 . . . . 0.0 111.219 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -159.83 56.06 0.81 Allowed Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.709 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.3 Cg_endo -80.65 -170.25 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.552 2.168 . . . . 0.0 112.297 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.603 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.58 152.6 35.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.099 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.546 ' N ' HG21 ' A' ' 44' ' ' THR . 3.4 mm-40 -56.63 -50.05 73.18 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.81 -32.62 74.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.783 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -54.6 26.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.727 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.603 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -62.1 -44.66 96.17 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.893 179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' CA ' HG23 ' A' ' 29' ' ' THR . 0.0 OUTLIER -58.06 -49.03 78.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.715 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -53.27 -47.6 69.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.409 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 0.5 OUTLIER -74.7 -30.57 61.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.85 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.473 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -53.76 -35.0 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.524 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -45.05 -28.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.24 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -78.1 -39.12 42.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.922 0.391 . . . . 0.0 110.79 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 52' ' ' ILE . 4.6 m -80.22 -11.02 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.182 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 37.6 t0 -103.65 155.73 18.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.787 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.6 -29.34 25.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.072 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -116.54 -9.57 11.38 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.41 0.624 . . . . 0.0 110.428 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.61 63.74 4.94 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.495 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -112.32 17.77 19.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.799 0.333 . . . . 0.0 110.195 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.25 19.99 53.71 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.553 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.41 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 3.3 p -147.88 176.45 10.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.419 HG23 ' CG ' ' A' ' 68' ' ' PHE . 12.0 mt -115.03 136.52 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.594 0.235 . . . . 0.0 111.064 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.0 m-20 -88.41 -177.85 5.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.281 0.562 . . . . 0.0 111.901 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.91 -55.9 12.63 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.809 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.4 Cg_endo -65.48 -34.39 43.1 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.243 1.962 . . . . 0.0 111.266 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.87 -52.43 60.03 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.308 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.04 -56.97 14.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.879 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.49 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -56.83 -46.54 81.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.6 m -61.26 -31.66 71.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.071 0.462 . . . . 0.0 110.09 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.428 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.9 tpp -60.47 -61.78 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.101 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.8 mtt -67.44 -27.95 67.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.23 -20.13 57.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.408 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -53.95 113.49 1.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.832 0.349 . . . . 0.0 111.067 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -21.61 60.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.048 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -28.89 69.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -82.73 59.23 4.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.847 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.99 -174.59 4.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.24 -167.82 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 64.82 41.39 5.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.9 m -69.09 -51.31 40.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.809 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -80.6 -28.98 36.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -50.36 -30.66 12.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.317 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -71.1 -29.45 65.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.934 0.397 . . . . 0.0 110.494 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 mt -79.05 -49.06 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.197 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -45.45 54.3 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.945 0.402 . . . . 0.0 111.645 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -53.68 -26.07 21.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.283 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.0 -33.41 51.31 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.046 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 13.4 t80 -69.33 -51.98 31.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.958 0.408 . . . . 0.0 110.283 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.32 -32.3 56.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.723 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.82 -22.91 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.624 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.29 -36.02 60.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.028 -179.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -101.34 148.48 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.445 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -69.18 -37.65 78.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.377 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.16 -9.76 13.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.57 29.4 32.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.258 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.45 -13.88 62.43 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.089 0.444 . . . . 0.0 110.754 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -12.79 55.66 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.94 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.6 m-85 -127.13 145.84 50.6 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.956 0.408 . . . . 0.0 111.448 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.423 HD11 ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pt -121.16 109.89 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.763 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.5 m -81.06 178.34 8.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.409 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.8 -29.63 70.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.002 0.429 . . . . 0.0 110.447 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.24 -57.82 10.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.244 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.51 -39.65 52.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.03 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.9 tt -55.42 -41.25 72.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.024 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 5.9 ttt180 -65.3 -49.49 69.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -60.46 -39.31 87.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.088 0.471 . . . . 0.0 110.184 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.444 HG11 ' CE2' ' B' ' 20' ' ' PHE . 37.1 t -73.21 -42.14 58.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.32 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 30.6 mmt -74.1 -54.31 8.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.688 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -55.42 -43.92 75.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.445 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -60.54 -31.43 70.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.347 . . . . 0.0 110.825 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.7 mp -122.91 37.23 4.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.736 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -167.1 -117.37 0.4 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.819 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.8 177.92 7.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -78.27 97.7 5.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.299 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -89.86 114.84 26.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.327 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.72 174.97 6.1 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.956 -0.297 . . . . 0.0 110.363 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -48.03 -35.78 11.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.366 . . . . 0.0 110.749 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -77.32 -36.21 54.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.759 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -71.06 -33.89 70.68 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.994 0.426 . . . . 0.0 109.985 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.416 HG22 HD13 ' A' ' 116' ' ' LEU . 2.6 t -73.86 -50.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.402 0.62 . . . . 0.0 109.681 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.91 -52.85 63.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.717 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -28.49 64.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.777 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 6.7 tpt -76.2 -37.57 57.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.152 0.501 . . . . 0.0 110.242 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -39.94 78.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.287 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -70.61 -34.57 72.27 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.411 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -82.92 -39.79 21.02 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.429 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 144' ' ' MET . . . -66.6 -41.79 87.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.474 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.2 t0 -91.48 147.18 23.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.07 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.52 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.03 -40.68 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.015 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.52 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.92 -10.98 60.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.756 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.88 33.03 1.05 Allowed Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.31 -12.57 24.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.357 -0.922 . . . . 0.0 112.48 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.11 10.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.863 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -146.47 146.76 30.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.71 107.24 13.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.281 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.53 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.3 t30 -78.31 175.4 10.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.368 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.591 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 1.1 t80 -45.95 -67.1 0.31 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.674 0.75 . . . . 0.0 111.709 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.473 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.3 mt-10 -65.32 -25.28 67.54 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.568 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.56 -48.61 74.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.813 0.34 . . . . 0.0 110.369 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.6 p90 -78.89 -31.31 45.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.347 178.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.496 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 73.8 t -53.07 -44.3 50.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.098 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -61.03 -35.5 77.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.095 0.474 . . . . 0.0 109.779 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.4 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 9.5 mmt -73.58 -42.3 61.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.091 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.407 ' CG ' HG23 ' B' ' 22' ' ' VAL . 0.2 OUTLIER -51.29 -48.64 62.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.946 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 t -74.36 -31.22 62.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.73 146.72 40.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.412 ' O ' ' CG2' ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.777 0.322 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.713 ' O ' HG13 ' B' ' 6' ' ' ILE . 2.1 mmm180 -52.18 -51.52 57.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.039 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.71 -53.36 31.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.591 0.234 . . . . 0.0 111.458 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -57.2 -36.98 71.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.086 0.47 . . . . 0.0 110.115 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.44 ' HB ' ' CZ ' ' B' ' 2' ' ' ARG . 21.4 t -63.77 -34.45 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.393 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.713 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.7 mt -71.3 -53.65 20.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.054 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -50.97 -39.92 56.42 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.236 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.84 -48.12 67.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.418 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -55.01 -54.53 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.196 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.452 ' HA ' HD11 ' B' ' 13' ' ' ILE . 4.7 mt -51.11 -56.91 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.298 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.6 OUTLIER -59.54 -47.95 83.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.199 0.523 . . . . 0.0 111.155 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.11 -39.87 63.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.025 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' B' ' 17' ' ' ALA . 1.7 mt -54.5 -52.03 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.502 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.51 -36.38 93.09 Favored Glycine 0 CA--C 1.499 -0.931 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.301 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.686 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -63.8 -61.73 2.11 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.863 -0.668 . . . . 0.0 110.468 -178.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.661 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -64.32 -27.43 69.02 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.789 177.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' B' ' 13' ' ' ILE . . . -67.12 -49.66 64.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.144 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.514 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.5 OUTLIER -64.69 -43.93 91.94 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.549 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.637 HG23 ' O ' ' B' ' 16' ' ' MET . 2.6 m -65.07 -32.28 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.579 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.661 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.8 OUTLIER -74.57 -48.41 26.9 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.074 -179.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.51 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.7 p -58.43 -26.26 63.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.475 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.407 HG23 ' CG ' ' A' ' 145' ' ' MET . 27.7 m -90.24 -48.05 14.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.258 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.43 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 4.1 pp -62.54 -32.9 73.93 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.202 0.525 . . . . 0.0 110.442 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.51 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.111 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.797 0.332 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.1 -169.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -117.68 90.72 3.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.572 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.2 mt -98.63 164.86 12.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.4 p -96.82 161.67 13.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.479 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -47.61 -51.81 20.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.744 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -64.46 -27.63 69.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.973 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.92 -51.49 21.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.58 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.588 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 39.0 pt -73.03 -28.9 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.801 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.49 -27.37 10.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.0 mt-10 -75.27 -28.45 59.81 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.314 178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.588 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.29 -58.5 3.19 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.301 0.572 . . . . 0.0 111.04 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.854 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.6 pttt -54.58 -22.94 14.74 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.285 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.39 -27.94 56.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.24 -39.95 62.72 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.027 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.854 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.82 -52.1 67.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.829 0.823 . . . . 0.0 109.483 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -24.21 58.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.145 -1.388 . . . . 0.0 112.117 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.492 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.3 tt -82.05 -24.68 35.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.282 0.563 . . . . 0.0 110.202 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.8 t80 -93.66 -0.83 55.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.522 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.4 t70 -102.87 143.64 32.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.997 0.904 . . . . 0.0 111.026 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.1 mmtt -60.17 -53.38 58.43 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.594 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.66 -5.9 59.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.773 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.59 45.91 53.83 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.425 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -90.83 18.05 7.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.832 0.349 . . . . 0.0 110.705 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.07 5.95 88.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.503 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.451 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 52.7 p -150.1 149.54 30.42 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -102.04 140.51 20.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.934 0.397 . . . . 0.0 112.018 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.445 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -85.6 176.84 7.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.929 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.43 ' N ' ' OG1' ' A' ' 28' ' ' THR . 1.0 OUTLIER -70.49 -38.16 74.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.142 0.496 . . . . 0.0 110.36 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.67 -40.96 89.53 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.22 178.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -69.43 -53.73 17.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.324 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.96 -54.83 42.52 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.755 0.788 . . . . 0.0 109.422 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.57 -45.97 92.58 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 114.552 -1.203 . . . . 0.0 112.484 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.57 -31.1 71.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.86 0.33 . . . . 0.0 110.572 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 72.1 t -67.86 -57.22 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.414 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.0 OUTLIER -71.98 -35.98 69.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.46 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -42.62 80.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.953 0.406 . . . . 0.0 110.776 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 t -78.96 -8.59 59.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.753 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.7 tt -90.57 -55.09 3.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.766 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.5 34.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.955 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.546 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.6 tp-100 -137.66 -178.86 5.43 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.3 0.571 . . . . 0.0 111.219 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -159.65 56.59 0.89 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.913 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.41 -177.49 3.81 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.457 2.104 . . . . 0.0 112.076 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -112.44 152.45 28.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.952 0.406 . . . . 0.0 110.224 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.551 ' N ' HG23 ' A' ' 44' ' ' THR . 3.5 mm-40 -57.7 -49.09 77.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.401 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.64 -31.93 72.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.774 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.83 -54.3 28.59 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.586 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.611 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.98 -34.52 78.28 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.373 179.606 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.52 -42.6 95.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.882 0.372 . . . . 0.0 110.148 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -61.83 -45.5 93.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.219 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 mmt -74.5 -30.75 61.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.428 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.42 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.624 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -44.99 -28.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.373 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -77.57 -38.6 48.09 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.905 0.383 . . . . 0.0 110.816 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 52' ' ' ILE . 4.5 m -81.43 -11.64 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.244 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 41.0 t0 -103.63 155.62 18.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.692 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.59 -28.89 26.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.05 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -116.45 -9.67 11.41 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.435 0.636 . . . . 0.0 110.459 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.525 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.14 63.37 5.31 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.446 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -112.37 18.26 18.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.808 0.337 . . . . 0.0 110.183 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.66 20.02 55.04 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.515 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.417 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.4 p -146.88 176.36 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 54.6 mt -116.12 136.54 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.581 0.229 . . . . 0.0 110.803 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 9.2 m-20 -86.97 -178.49 6.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.268 0.556 . . . . 0.0 111.948 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.499 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -67.82 -56.17 12.28 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.589 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.75 -34.81 39.18 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.248 1.965 . . . . 0.0 111.198 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.65 -52.38 63.57 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.204 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.22 -56.86 16.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.85 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.487 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -56.83 -46.96 81.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.7 m -60.26 -30.99 69.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 0.0 110.064 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.447 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.3 tpp -63.68 -61.89 2.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.104 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mtm -70.49 -30.2 66.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.039 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.47 0.08 39.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.674 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -56.41 158.01 4.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.837 0.351 . . . . 0.0 111.008 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -86.5 -12.69 48.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.304 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.1 ttt -95.02 -30.79 13.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.786 0.327 . . . . 0.0 110.973 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -77.3 124.31 27.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -168.64 -170.87 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.39 -166.02 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 66.6 36.29 4.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 p -77.55 -45.23 26.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -80.74 -29.15 36.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -53.47 -53.72 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.29 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.71 -29.56 27.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.486 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.8 mt -65.46 -51.29 65.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.38 -49.62 18.44 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 110.405 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -54.1 -30.22 47.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.243 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -69.88 -37.91 76.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.625 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 11.3 t80 -67.3 -53.93 25.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.519 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -54.08 -31.01 50.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.784 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.0 t -88.63 -22.85 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.291 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.495 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -55.2 -37.21 66.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.096 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -101.48 147.23 26.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.506 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -69.64 -36.75 76.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.362 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.2 -9.74 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.4 30.14 34.48 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.245 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -67.43 -13.79 62.34 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.01 0.405 . . . . 0.0 110.782 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.467 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.19 -13.42 55.38 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.951 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 25.5 m-85 -127.19 145.49 50.74 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.01 0.433 . . . . 0.0 111.353 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.432 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pp -121.1 109.89 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.705 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.68 178.9 8.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.508 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.67 -29.94 70.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.055 0.455 . . . . 0.0 110.511 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.44 -57.77 11.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.168 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.46 -41.47 47.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.951 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 tt -54.19 -37.46 64.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.936 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.418 ' HD2' ' O ' ' A' ' 116' ' ' LEU . 3.2 ttt-85 -70.06 -49.4 51.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.925 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.51 -37.56 86.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.058 0.456 . . . . 0.0 110.139 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.472 HG11 ' CZ ' ' B' ' 20' ' ' PHE . 47.1 t -73.03 -45.33 54.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.232 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.455 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 21.5 mmt -74.03 -54.27 8.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.701 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 m -55.57 -44.6 77.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.264 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -58.4 -28.44 65.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.789 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.423 ' CD2' ' CD1' ' A' ' 19' ' ' PHE . 1.1 mp -126.06 35.88 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -164.04 -120.46 0.52 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.764 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -127.78 -176.84 3.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 0.0 110.907 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -83.84 97.07 8.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.418 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -90.28 114.0 25.95 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.426 179.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.78 175.36 5.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -48.06 -35.9 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.947 0.403 . . . . 0.0 110.733 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -77.41 -35.44 54.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.841 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -72.12 -33.22 67.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.998 0.427 . . . . 0.0 110.094 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.7 t -75.08 -50.61 24.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.395 0.617 . . . . 0.0 109.679 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -59.08 -52.83 64.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.717 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -28.73 58.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.767 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 6.4 tpt -76.16 -39.26 55.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.207 0.527 . . . . 0.0 110.044 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -46.83 87.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.392 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -62.7 -38.28 89.78 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.911 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 124' ' ' MET . 18.5 pt-20 -81.12 -39.81 25.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.724 0.297 . . . . 0.0 110.814 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 144' ' ' MET . . . -65.42 -39.35 92.03 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.547 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.6 t0 -94.94 146.4 24.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.518 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.4 -40.63 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.06 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.518 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.91 -10.98 60.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.769 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.68 33.03 0.95 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.411 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.2 p-10 -96.27 -12.49 24.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.369 -0.916 . . . . 0.0 112.56 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.8 20.2 10.23 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.808 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.443 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.63 147.29 30.89 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.68 107.27 13.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.258 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.528 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.3 t30 -77.83 175.23 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.445 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.591 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 1.1 t80 -46.05 -67.04 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.654 0.74 . . . . 0.0 111.811 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.3 mm-40 -65.57 -25.13 67.28 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.63 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.56 -48.9 74.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.382 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.465 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 9.3 p90 -79.21 -31.32 43.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.364 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.515 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 72.0 t -52.9 -43.3 46.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.341 -0.39 . . . . 0.0 109.963 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -62.71 -34.79 77.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.81 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 9.5 mmt -73.48 -44.29 58.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.424 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 7.1 ttp -51.12 -46.97 62.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.159 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.1 t -75.89 -31.24 59.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.71 162.37 5.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.911 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.721 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.31 -51.1 60.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.65 -53.23 32.63 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.655 0.264 . . . . 0.0 111.299 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.17 -37.57 72.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.019 0.438 . . . . 0.0 110.317 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 15.0 t -63.36 -33.73 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.388 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.721 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.5 mt -71.64 -55.08 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.011 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 26.2 mmm-85 -50.42 -37.88 40.16 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.178 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -46.1 65.15 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.503 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -56.6 -54.12 49.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.447 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.2 -57.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.548 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.54 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.0 OUTLIER -60.92 -51.41 69.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.361 0.601 . . . . 0.0 110.938 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.565 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.42 -38.81 63.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.859 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.48 HG12 ' CZ ' ' A' ' 19' ' ' PHE . 3.1 mt -54.31 -50.66 55.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.351 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.44 -37.28 94.56 Favored Glycine 0 CA--C 1.498 -0.977 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.544 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.66 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -65.0 -61.77 1.95 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.716 -0.742 . . . . 0.0 110.552 -179.11 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.636 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.69 -27.51 67.92 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.47 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.486 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -68.36 -46.41 70.17 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.794 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 1.1 ppt_? -63.58 -44.1 95.06 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.636 HG23 ' O ' ' B' ' 16' ' ' MET . 1.8 m -62.78 -35.42 70.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.934 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.554 ' N ' HG23 ' B' ' 19' ' ' VAL . 0.3 OUTLIER -75.18 -47.2 29.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.064 -179.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.522 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 12.1 p -59.4 -25.15 64.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.598 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.434 HG21 ' O ' ' B' ' 18' ' ' ARG . 30.3 m -90.29 -48.52 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.196 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -61.91 -33.78 74.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.228 0.537 . . . . 0.0 110.44 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.083 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.801 0.334 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.82 -169.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.782 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -120.59 90.68 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.566 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -97.66 164.75 12.28 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.004 0.43 . . . . 0.0 110.424 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 p -97.44 161.93 13.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.467 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -47.69 -51.68 20.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.766 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -64.5 -27.7 69.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.045 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.85 -51.5 22.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.619 179.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.587 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 38.9 pt -73.0 -28.97 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.64 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.54 -27.33 10.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.527 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 4.6 mm-40 -75.34 -28.55 59.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.281 178.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.34 -58.61 3.13 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.214 0.531 . . . . 0.0 111.033 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.851 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.76 15.04 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.249 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.52 -27.95 56.2 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.08 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.23 -39.92 62.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.043 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.851 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.55 -51.95 67.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.802 0.811 . . . . 0.0 109.363 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.405 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 p -74.51 -24.05 58.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.074 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.481 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.07 -24.74 35.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.261 0.553 . . . . 0.0 110.166 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.484 ' CZ ' HG12 ' B' ' 13' ' ' ILE . 2.5 t80 -94.64 0.21 54.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.571 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.4 t70 -104.27 142.35 34.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.942 0.877 . . . . 0.0 110.997 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.7 mmtt -58.4 -53.35 59.33 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.572 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -86.62 -4.88 59.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.765 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.15 47.23 42.13 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.356 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -91.64 18.53 7.36 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.805 0.336 . . . . 0.0 110.673 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.85 5.12 88.25 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.592 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.9 p -150.33 148.65 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.668 0.27 . . . . 0.0 110.344 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.72 140.46 19.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.801 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -86.41 178.66 7.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.294 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.447 ' N ' ' OG1' ' A' ' 28' ' ' THR . 0.6 OUTLIER -69.96 -41.8 74.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.056 0.455 . . . . 0.0 110.411 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.537 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -57.28 -40.88 78.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.365 179.07 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.537 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -70.15 -53.82 15.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.47 -179.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.405 ' HB3' ' NZ ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.5 -54.14 50.26 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.838 0.828 . . . . 0.0 109.572 178.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.33 91.32 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.462 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 30' ' ' LYS . 53.3 m -65.48 -30.74 71.55 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 120.813 0.339 . . . . 0.0 110.432 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.441 ' CG2' ' CE2' ' A' ' 19' ' ' PHE . 13.9 t -63.62 -57.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.037 0.446 . . . . 0.0 110.568 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.481 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 1.7 tpt -72.35 -40.53 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.273 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -61.13 -39.66 90.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.945 0.402 . . . . 0.0 110.489 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.5 t -78.86 -11.48 59.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.578 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.4 tt -88.0 -53.43 4.74 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.075 0.464 . . . . 0.0 110.552 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.72 37.21 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.624 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.553 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 tp-100 -134.83 -179.8 5.83 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.338 0.589 . . . . 0.0 111.279 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -159.75 56.41 0.86 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.792 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.7 Cg_endo -80.57 -174.29 2.19 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.546 2.164 . . . . 0.0 112.291 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.602 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -117.32 152.64 34.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.873 0.368 . . . . 0.0 110.124 179.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.544 ' N ' HG23 ' A' ' 44' ' ' THR . 3.7 mm-40 -56.49 -49.99 73.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.26 -32.59 74.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.638 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -54.52 23.75 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.596 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.602 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -61.22 -48.36 81.87 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.929 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.434 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -54.6 -49.97 69.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 110.952 179.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.27 -47.23 69.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.682 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -74.68 -30.61 61.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.831 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.474 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -54.68 -36.03 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.588 -178.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -45.23 -28.64 0.82 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.213 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.433 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -79.6 -38.21 34.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.929 0.395 . . . . 0.0 110.778 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 52' ' ' ILE . 3.7 m -81.07 -10.98 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.14 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.532 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.6 t0 -103.59 155.87 18.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.72 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.58 -29.17 26.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.065 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -116.46 -9.72 11.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.397 0.617 . . . . 0.0 110.452 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.532 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.68 63.48 5.17 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.498 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -112.47 18.41 18.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.842 0.353 . . . . 0.0 110.201 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.39 19.98 55.68 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.424 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 4.3 p -146.71 176.49 9.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.4 mt -116.3 136.46 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.544 0.212 . . . . 0.0 110.959 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.5 m-20 -88.24 -178.02 5.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.25 0.548 . . . . 0.0 111.938 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.5 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.82 -55.91 12.83 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.659 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -65.67 -34.54 40.94 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.25 1.967 . . . . 0.0 111.241 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.44 -52.47 61.31 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.26 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -57.19 -56.99 14.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.789 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.484 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -57.89 -47.09 83.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.795 -179.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.5 m -59.69 -30.46 68.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.074 0.464 . . . . 0.0 110.129 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.424 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 3.2 tpp -62.71 -61.84 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.083 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.2 mtt -70.1 -41.39 74.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.001 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.63 -18.51 64.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.367 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.43 147.62 13.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.806 0.336 . . . . 0.0 111.096 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.18 -14.33 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.22 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.7 mtp -84.71 -30.6 24.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.762 0.315 . . . . 0.0 110.971 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -85.26 122.48 29.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.04 -169.13 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.06 -167.15 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.37 37.68 8.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.53 -38.23 49.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -80.77 -30.65 36.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.0 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -56.82 -51.44 68.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.221 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.648 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.68 -29.24 25.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.477 -179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.403 ' CG1' ' OE1' ' A' ' 84' ' ' GLU . 19.8 mt -66.7 -51.45 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.919 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -50.08 16.64 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.075 0.464 . . . . 0.0 110.55 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -53.91 -29.19 40.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.252 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -70.83 -38.25 73.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 10.8 t80 -67.35 -54.15 23.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.966 0.412 . . . . 0.0 110.545 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -54.08 -30.67 49.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.791 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.7 -22.88 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.216 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -55.3 -38.38 68.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.176 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -100.64 146.87 26.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.503 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -69.72 -36.39 75.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.373 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.27 -9.79 13.87 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.43 30.02 34.75 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.23 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -67.43 -13.62 62.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 117.102 0.451 . . . . 0.0 110.787 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.22 -13.39 55.29 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.914 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.442 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 25.1 m-85 -127.16 145.95 50.57 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.988 0.423 . . . . 0.0 111.425 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.428 HD12 ' CZ ' ' A' ' 92' ' ' PHE . 1.1 pp -121.13 109.94 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.729 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.1 p -83.55 176.97 8.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.53 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.7 -30.91 71.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 110.396 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.25 -57.66 11.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.322 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.43 -45.73 30.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.228 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.426 ' HB2' HD13 ' A' ' 100' ' ' ILE . 17.6 tp -53.13 -33.24 51.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -68.79 -49.15 60.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -59.14 -43.51 92.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.194 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.6 t -72.96 -39.02 57.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.51 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.499 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.6 mmt -73.97 -54.27 8.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.511 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.4 m -56.99 -46.9 81.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.088 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -60.0 -26.67 66.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.841 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.8 mp -124.21 36.19 4.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.36 -116.46 0.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.688 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -131.31 172.51 12.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.805 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -75.05 98.58 3.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.163 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.417 ' CD1' ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.88 113.13 24.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.461 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.83 175.28 5.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.32 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -48.06 -36.04 12.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 110.759 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -77.41 -34.35 54.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -73.64 -33.04 64.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.024 0.44 . . . . 0.0 110.074 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.417 ' CG2' ' CD1' ' A' ' 116' ' ' LEU . 2.6 t -74.96 -48.56 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.829 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.25 -52.87 63.83 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.844 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.08 -28.72 62.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.82 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.414 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 5.8 tpt -76.23 -38.47 56.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 110.113 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -67.15 -44.95 87.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.559 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -61.75 -40.55 95.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.97 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 124' ' ' MET . 8.6 pt-20 -81.0 -37.39 29.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.787 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.84 81.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.338 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 21.3 t0 -102.06 146.34 28.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.937 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.519 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.5 -40.61 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.093 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.519 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.98 -11.07 60.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.713 -179.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.85 32.77 1.0 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 131' ' ' ASP . 43.3 p-10 -95.99 -12.53 24.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.351 -0.924 . . . . 0.0 112.52 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.16 10.23 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.817 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.442 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.54 147.19 30.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 t -130.71 107.32 13.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.232 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.53 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -78.05 175.0 10.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.339 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.591 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . 1.1 t80 -45.95 -67.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.653 0.74 . . . . 0.0 111.84 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.7 mt-10 -66.02 -24.54 66.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.644 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.73 -48.86 74.47 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.393 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 10.7 p90 -79.32 -31.21 43.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.399 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.506 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 75.7 t -52.91 -44.85 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.44 -35.45 79.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.137 0.494 . . . . 0.0 109.826 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.47 -43.35 60.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.81 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 24.5 ttp -52.77 -45.15 66.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.012 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 t -77.79 -31.17 51.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.962 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.81 147.3 38.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.096 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.847 0.356 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.717 ' O ' HG13 ' B' ' 6' ' ' ILE . 11.6 mmm180 -52.5 -50.73 62.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.232 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.523 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.79 -53.43 32.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.281 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.69 -36.11 71.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.149 0.5 . . . . 0.0 110.007 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.526 ' O ' ' HD3' ' B' ' 9' ' ' LYS . 45.1 t -62.84 -41.43 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.997 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.717 HG13 ' O ' ' B' ' 2' ' ' ARG . 3.2 mt -63.16 -55.42 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.098 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' B' ' 3' ' ' LYS . 24.1 mmm-85 -50.16 -40.43 46.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.031 0.444 . . . . 0.0 110.247 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.88 -44.95 68.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.667 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' B' ' 5' ' ' VAL . 0.6 OUTLIER -56.34 -55.07 37.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.05 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.449 ' HA ' HD13 ' B' ' 13' ' ' ILE . 3.7 mt -51.21 -57.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.751 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.506 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.7 tpt180 -61.32 -51.34 69.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.252 0.548 . . . . 0.0 111.028 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.541 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.33 -39.23 63.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.701 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.484 HG12 ' CZ ' ' A' ' 19' ' ' PHE . 3.1 mt -54.47 -48.94 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.225 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.77 -37.64 95.0 Favored Glycine 0 CA--C 1.497 -1.041 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.521 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.656 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -65.06 -61.68 2.0 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.741 -0.73 . . . . 0.0 110.555 -179.246 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.642 ' O ' HG23 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.6 -27.46 67.76 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -68.25 -47.53 67.5 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.978 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.61 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.5 ppt_? -63.8 -43.61 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.105 0.479 . . . . 0.0 109.754 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.642 HG23 ' O ' ' B' ' 16' ' ' MET . 1.8 m -61.86 -35.48 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.529 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.545 ' N ' HG23 ' B' ' 19' ' ' VAL . 0.3 OUTLIER -75.97 -43.1 46.17 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.785 -179.599 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.531 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 21.8 p -61.01 -26.63 67.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.495 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.413 HG21 ' N ' ' B' ' 23' ' ' LEU . 27.4 m -90.42 -48.43 14.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.163 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' B' ' 24' ' ' ARG . 4.2 pp -63.09 -32.6 74.02 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.199 0.524 . . . . 0.0 110.535 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.531 ' HG2' ' HA ' ' B' ' 21' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.176 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.817 0.341 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.86 -170.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -121.15 87.73 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -98.48 164.79 12.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.544 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 p -97.98 162.84 13.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.494 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -47.35 -51.42 19.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.875 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -64.27 -27.72 69.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.991 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.9 mm-40 -72.68 -51.36 19.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.707 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.58 ' HA ' ' CD1' ' A' ' 12' ' ' PHE . 36.7 pt -73.07 -28.74 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.895 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.34 -27.26 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.507 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 5.6 mm-40 -74.99 -28.39 60.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.227 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.581 ' CZ ' ' CD1' ' A' ' 4' ' ' LEU . 3.2 m-85 -79.63 -58.33 3.24 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.293 0.568 . . . . 0.0 111.002 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.855 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 13.1 ptmt -54.41 -23.0 14.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.216 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.21 -28.28 57.15 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.102 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.99 -39.81 63.4 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.07 177.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.855 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.26 -52.04 67.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.806 0.812 . . . . 0.0 109.501 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -23.9 58.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.183 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.498 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 2.4 tt -82.1 -25.09 34.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.273 0.558 . . . . 0.0 110.215 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.522 ' HB3' ' CD1' ' A' ' 27' ' ' ILE . 2.4 t80 -94.42 -0.27 54.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.47 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.7 t70 -103.87 144.88 30.92 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.959 0.885 . . . . 0.0 111.051 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.5 mmtt -61.13 -53.43 57.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.644 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -83.91 -5.94 59.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.814 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.13 45.31 57.24 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.451 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.9 p30 -90.47 17.23 7.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.832 0.348 . . . . 0.0 110.68 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.37 7.46 87.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.386 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 69.0 p -150.38 148.23 28.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 19' ' ' PHE . 3.7 mt -101.57 140.68 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.808 0.337 . . . . 0.0 111.829 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.449 ' CG2' ' HG3' ' A' ' 30' ' ' LYS . 1.5 t -85.52 179.37 7.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.117 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.411 HG22 ' CA ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -70.43 -45.78 65.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.935 -179.201 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.51 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -54.36 -38.93 66.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.335 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 3.4 mm-40 -71.64 -53.75 12.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.395 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.408 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -56.11 -52.52 64.02 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.733 0.778 . . . . 0.0 109.51 178.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.82 -45.5 96.08 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.371 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 m -62.87 -35.88 81.46 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.917 0.389 . . . . 0.0 110.156 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 60.1 t -61.76 -56.87 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.652 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.438 ' HG2' ' CG1' ' B' ' 5' ' ' VAL . 0.2 OUTLIER -71.6 -40.78 69.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.306 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -41.2 99.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 0.0 110.656 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 t -78.88 -10.08 59.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.629 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.6 tt -88.76 -53.88 4.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.585 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.04 34.59 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.819 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.542 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -135.86 -179.94 5.96 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.362 0.601 . . . . 0.0 111.306 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -159.75 56.5 0.87 Allowed Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.754 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 96.0 Cg_endo -80.44 -173.58 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.527 2.151 . . . . 0.0 112.273 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.615 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.39 152.54 31.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.846 0.355 . . . . 0.0 110.166 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.551 ' N ' HG21 ' A' ' 44' ' ' THR . 3.3 mm-40 -57.68 -49.21 77.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.12 -31.17 71.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.742 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.16 -54.39 21.7 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.575 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.615 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -63.45 -37.84 88.84 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.209 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' CA ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.42 -49.9 73.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.842 0.353 . . . . 0.0 110.588 179.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.25 -46.25 76.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.496 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.42 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.4 mmt -74.74 -30.54 61.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.704 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -53.5 -38.0 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.498 -179.079 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -44.98 -28.59 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.373 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.463 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.83 -39.58 50.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.944 0.402 . . . . 0.0 110.767 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.461 HG23 ' HA ' ' A' ' 52' ' ' ILE . 5.0 m -80.57 -11.96 12.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.099 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.509 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.4 t0 -103.69 155.15 18.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.74 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.63 -28.86 26.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.152 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -116.46 -9.68 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.44 0.638 . . . . 0.0 110.468 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.509 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.5 63.89 4.82 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.519 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -112.71 18.38 18.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.855 0.359 . . . . 0.0 110.133 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.88 19.93 56.79 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.467 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.4 ' O ' ' CG ' ' A' ' 56' ' ' ASP . 6.1 p -146.1 176.12 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.9 mt -115.21 136.38 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.551 0.215 . . . . 0.0 110.725 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.4 m-20 -87.05 -178.17 6.2 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.16 0.505 . . . . 0.0 111.828 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.97 -55.46 13.41 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.831 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.2 Cg_endo -65.72 -35.37 37.17 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.234 1.956 . . . . 0.0 111.348 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -63.84 -52.31 60.69 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.305 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -56.9 -56.78 17.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.834 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.494 ' CD2' ' CD2' ' A' ' 12' ' ' PHE . 0.3 OUTLIER -53.56 -49.51 67.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.83 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.6 m -58.57 -32.42 68.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.226 0.536 . . . . 0.0 109.685 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.461 ' HG2' ' CD1' ' B' ' 10' ' ' ILE . 2.7 tpp -67.19 -61.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.899 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.4 mtm -64.2 -29.12 70.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.01 -24.11 15.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -28.08 52.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.008 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -58.99 -21.86 59.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.033 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.69 -23.06 26.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.325 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 45.14 1.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 111.193 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 t0 53.58 -165.55 0.08 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.22 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 69.15 155.67 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.022 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.18 30.71 13.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.096 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -77.55 -51.81 10.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.817 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -80.79 -29.15 36.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.006 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -52.24 -30.55 28.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.311 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' CB ' ' HB3' ' B' ' 15' ' ' LYS . 1.1 mt-10 -70.54 -29.58 66.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.745 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 mt -79.45 -51.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.27 -51.82 12.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -53.72 -25.53 18.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.884 0.373 . . . . 0.0 110.733 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.429 ' CB ' HG23 ' B' ' 19' ' ' VAL . . . -77.67 -37.13 50.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.204 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.564 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.2 t80 -68.04 -52.12 39.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.034 0.445 . . . . 0.0 110.087 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -54.77 -32.05 59.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.803 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -88.63 -22.8 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.55 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.45 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.93 -32.96 55.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.114 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -102.34 148.05 25.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.496 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -69.58 -37.21 76.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.351 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.16 -9.72 13.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.83 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.15 29.64 33.32 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.228 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -67.4 -13.93 62.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.079 0.439 . . . . 0.0 110.75 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.447 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.2 -12.23 55.3 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.992 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.1 m-85 -127.25 146.99 50.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.906 0.384 . . . . 0.0 111.378 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.414 HG12 ' CD2' ' A' ' 92' ' ' PHE . 1.1 pt -121.11 109.98 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.816 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.2 m -83.99 177.07 8.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.466 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.25 -30.09 71.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.097 0.475 . . . . 0.0 110.528 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.35 -57.11 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.205 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.32 -46.83 25.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.377 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.2 tp -53.19 -31.23 41.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.938 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -72.54 -49.15 34.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -59.22 -42.8 91.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.144 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.42 HG11 ' CZ ' ' B' ' 20' ' ' PHE . 2.2 t -72.95 -41.03 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.565 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.454 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 30.3 mmt -72.61 -54.17 9.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.536 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.4 m -57.12 -48.9 77.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.225 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -58.04 -29.9 65.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.796 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.6 mp -121.58 37.13 4.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.35 -116.43 0.39 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.744 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.02 168.72 16.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 110.835 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -73.71 100.11 3.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.36 114.13 26.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.86 175.25 5.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.364 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -48.04 -35.98 12.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 110.779 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.36 -34.98 55.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -72.87 -33.03 65.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.973 0.415 . . . . 0.0 110.091 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.411 ' HA ' HD12 ' A' ' 116' ' ' LEU . 2.6 t -75.06 -48.76 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.817 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -58.81 -52.77 64.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.788 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -28.74 63.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.791 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 11.7 tpt -76.13 -37.77 57.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.135 0.493 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.23 -39.55 81.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.407 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -65.2 -41.41 94.56 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.489 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -82.62 -32.84 28.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 110.483 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.87 78.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.484 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 135' ' ' GLN . 20.1 t0 -105.83 148.6 27.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.974 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.535 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.84 -40.8 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.024 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.535 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.94 -10.93 59.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.691 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.0 32.83 1.08 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.411 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.4 p-10 -96.36 -12.79 23.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.291 -0.954 . . . . 0.0 112.451 -176.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.21 10.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.808 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.6 146.95 30.62 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.043 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.0 t -130.75 107.5 14.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.202 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.35 174.16 11.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.327 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.599 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -45.88 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.471 0.653 . . . . 0.0 111.433 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.429 ' HA ' HG23 ' A' ' 142' ' ' VAL . 1.2 mt-10 -59.95 -32.58 70.94 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.045 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -43.44 78.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.258 0.551 . . . . 0.0 109.65 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 145' ' ' MET . 0.0 OUTLIER -78.69 -31.76 46.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.213 178.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.599 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 62.1 t -54.95 -51.83 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.683 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -56.87 -46.88 81.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.2 tpp -68.72 -31.09 69.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.8 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.431 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 11.3 ttp -61.61 -46.19 90.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.2 t -77.06 -30.96 55.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.59 154.24 18.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.825 0.345 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.714 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.2 mmm180 -52.24 -51.41 58.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.53 ' HA ' ' CD1' ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.73 -53.45 31.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.632 0.253 . . . . 0.0 111.391 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.81 -36.61 70.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.136 0.493 . . . . 0.0 110.09 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.438 ' CG1' ' HG2' ' A' ' 36' ' ' MET . 21.7 t -64.27 -34.3 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.32 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.714 HG13 ' O ' ' B' ' 2' ' ' ARG . 2.8 mt -71.56 -49.79 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.235 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 21.9 mmm-85 -58.01 -33.14 68.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.119 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.07 -49.19 47.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.187 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' B' ' 6' ' ' ILE . 1.6 ptpt -61.38 -50.52 72.52 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.657 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.461 ' CD1' ' HG2' ' A' ' 71' ' ' MET . 10.6 mt -51.29 -57.37 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.091 0.472 . . . . 0.0 110.766 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.98 -50.79 72.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.93 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.11 -39.97 63.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.892 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.481 HG12 ' CZ ' ' A' ' 19' ' ' PHE . 2.6 mt -54.51 -52.11 43.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.612 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.74 -36.27 93.08 Favored Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.21 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.674 ' CE ' ' N ' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -64.96 -61.67 2.02 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.847 -0.676 . . . . 0.0 110.389 -178.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' MET . . . . . 0.671 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -62.43 -27.92 69.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.652 177.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' B' ' 16' ' ' MET . . . -65.27 -51.55 60.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.209 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.51 ' HD2' ' C ' ' B' ' 18' ' ' ARG . 0.5 OUTLIER -63.45 -43.56 97.02 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.627 HG22 ' O ' ' B' ' 16' ' ' MET . 1.9 m -66.3 -32.36 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.599 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.672 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 0.6 OUTLIER -71.73 -50.08 33.44 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.006 -179.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.432 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 54.7 p -58.49 -36.22 73.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.058 0.456 . . . . 0.0 110.765 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.448 HG21 ' C ' ' B' ' 19' ' ' VAL . 28.4 m -72.54 -45.01 60.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.071 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 20' ' ' PHE . 3.0 pp -65.29 -27.53 68.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.022 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 13.0 ptt180 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.921 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.474 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.833 0.349 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.534 ' HB2' HD21 ' A' ' 4' ' ' LEU . 2.1 m-20 -100.95 -170.21 1.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -117.23 83.93 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.633 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.6 164.73 12.3 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.58 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.517 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.6 p -98.6 162.8 12.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.465 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -47.43 -51.33 20.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.879 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -64.42 -27.66 69.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.157 0.503 . . . . 0.0 110.065 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.517 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.2 OUTLIER -72.51 -51.43 20.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.706 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.701 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.9 pt -73.08 -28.85 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.849 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.37 -27.45 9.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.535 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 11.0 mt-10 -75.23 -28.53 59.95 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.207 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.36 -58.41 3.22 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.218 0.532 . . . . 0.0 111.004 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.875 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.5 pttt -54.45 -23.03 14.34 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.273 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.45 -27.85 56.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.134 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.27 -39.78 62.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.072 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.64 -51.89 67.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.845 0.831 . . . . 0.0 109.458 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 p -74.46 -24.45 59.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.101 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.845 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.06 -23.5 35.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.261 0.553 . . . . 0.0 110.28 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.822 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.9 t80 -95.4 -0.76 52.17 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.554 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.7 t70 -103.48 142.64 33.91 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.971 0.891 . . . . 0.0 111.039 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 3.7 mmtt -59.11 -53.38 59.04 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.604 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.93 -5.42 59.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.77 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.51 47.69 44.03 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.303 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -92.06 18.86 7.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.867 0.365 . . . . 0.0 110.685 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.36 5.11 89.06 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.577 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.8 p -150.34 148.86 29.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.755 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.18 140.51 19.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.847 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.575 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.17 176.46 8.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.004 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.819 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -70.52 -37.5 74.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.145 0.497 . . . . 0.0 110.332 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.536 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.23 -41.12 92.46 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.15 178.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.914 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -69.4 -53.41 19.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.26 -179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.828 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -58.24 -54.69 44.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.724 0.773 . . . . 0.0 109.326 178.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.49 -45.83 92.63 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.456 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.7 m -62.39 -30.9 71.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.845 0.322 . . . . 0.0 110.495 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 31' ' ' GLU . 72.5 t -68.2 -57.26 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.87 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.457 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.95 -35.63 69.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.389 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -68.13 -42.74 79.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.848 0.356 . . . . 0.0 110.667 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 t -78.94 -8.14 58.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.806 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.8 tt -90.97 -54.82 3.8 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.468 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -175.88 34.94 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.937 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp-100 -137.56 -178.95 5.46 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.381 0.61 . . . . 0.0 111.163 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -159.64 56.46 0.88 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.927 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.4 Cg_endo -80.37 -175.7 2.83 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.56 2.173 . . . . 0.0 112.101 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.612 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.94 152.5 32.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.956 0.408 . . . . 0.0 110.18 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.22 -49.58 75.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.58 75.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.713 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.52 -54.33 33.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.673 -179.495 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.819 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.85 -34.77 78.9 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.379 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.69 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.39 -42.7 95.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.909 0.385 . . . . 0.0 110.228 179.247 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.76 -45.52 93.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.23 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -30.69 61.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.412 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.555 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.69 -38.29 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.524 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -44.91 -28.68 0.69 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.351 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.6 -38.78 47.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.891 0.376 . . . . 0.0 110.803 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.939 HG11 HG21 ' B' ' 6' ' ' ILE . 4.6 m -81.07 -11.39 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.18 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.549 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.9 t0 -103.73 155.68 18.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.754 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.485 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.57 -29.1 26.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -116.43 -9.66 11.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.416 0.627 . . . . 0.0 110.471 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.44 63.53 5.14 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.517 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -112.26 18.13 18.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.846 0.355 . . . . 0.0 110.193 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.67 19.91 55.31 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.453 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.1 p -147.16 176.41 9.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.768 HD12 HD11 ' A' ' 32' ' ' LEU . 13.8 mt -115.7 136.52 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.562 0.22 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.485 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.9 m-20 -87.28 -178.06 6.11 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.28 0.562 . . . . 0.0 111.931 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.514 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.03 -56.06 11.99 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.622 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.7 Cg_endo -65.65 -34.8 40.07 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.21 1.94 . . . . 0.0 111.166 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.91 -52.35 63.41 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.268 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.718 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.0 -56.63 19.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.867 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.701 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.51 -46.12 84.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.696 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 56.5 m -60.06 -31.15 69.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.041 0.448 . . . . 0.0 109.966 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.929 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.8 tpp -64.54 -61.8 1.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.908 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.7 mtt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.803 179.957 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.735 0.303 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.85 -54.48 37.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.713 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.76 -29.43 27.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.375 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.723 HG22 ' HE1' ' A' ' 138' ' ' TYR . 17.9 mt -64.76 -51.23 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.772 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -75.58 -50.57 15.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.043 0.449 . . . . 0.0 110.685 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 91' ' ' VAL . 7.1 mt-10 -53.79 -30.84 46.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.682 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -71.08 -38.55 72.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.781 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 24.2 t80 -67.03 -56.02 11.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.579 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.62 -30.65 43.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.866 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 87' ' ' GLU . 66.7 t -88.4 -22.92 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.211 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.462 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.18 -32.05 61.87 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.046 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -102.16 148.84 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.438 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -69.61 -37.71 76.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.332 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -112.27 -9.78 13.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.66 30.55 32.37 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.119 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.41 -13.73 62.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.96 0.38 . . . . 0.0 110.757 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.24 -13.46 55.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.857 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.7 m-85 -127.14 145.41 50.76 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.967 0.413 . . . . 0.0 111.284 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.949 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.1 109.97 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.885 179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 p -83.39 177.38 8.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.311 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.548 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.18 -28.97 70.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.083 0.468 . . . . 0.0 110.405 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.46 -57.67 9.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.426 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.41 -42.96 42.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.273 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.949 HD13 HD13 ' A' ' 100' ' ' ILE . 56.0 tp -56.9 -31.14 64.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.08 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.794 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.4 ttt180 -72.54 -49.27 33.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.937 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -60.85 -36.5 79.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 110.539 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 104' ' ' GLU . 54.5 t -72.82 -44.14 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.301 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 24.8 mmt -73.99 -54.05 8.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.727 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.648 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.3 m -55.59 -45.55 77.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.367 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.473 ' C ' HD12 ' A' ' 112' ' ' LEU . 7.8 m-20 -60.27 -29.85 69.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.792 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.845 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.9 mp -123.49 38.66 4.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.647 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.95 -116.81 0.4 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.781 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.409 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.8 pt-20 -132.2 170.77 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 110.864 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.648 ' HA ' HG23 ' A' ' 110' ' ' THR . 9.5 ttmm -74.97 99.7 3.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.257 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.953 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.7 114.39 26.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.384 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.934 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.7 175.34 5.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.429 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.411 ' H ' HG22 ' A' ' 117' ' ' THR . 79.3 m-20 -48.09 -35.93 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.755 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -77.4 -35.09 54.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -72.62 -33.67 66.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.977 0.417 . . . . 0.0 110.106 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.953 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.69 -48.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.899 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.21 -52.87 63.82 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.843 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -56.97 -28.85 62.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.857 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.841 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.6 tpt -76.35 -38.64 55.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.146 0.498 . . . . 0.0 110.169 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.491 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -66.87 -48.42 79.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.563 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -60.25 -40.27 89.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.946 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 124' ' ' MET . 12.7 pt-20 -80.86 -37.1 30.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 0.0 110.598 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.451 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.93 -36.18 81.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.764 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.3 t0 -101.37 147.58 26.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.013 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.56 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.6 pt -84.84 -40.67 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.047 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.56 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.95 -10.98 60.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.65 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.68 1.09 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.9 p-10 -96.33 -12.84 23.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.317 -0.941 . . . . 0.0 112.379 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.93 20.1 10.21 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.754 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.9 146.54 30.19 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.899 0.38 . . . . 0.0 110.06 179.211 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.764 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.1 t -130.64 107.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.246 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -80.21 174.84 11.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.304 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.723 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.96 -67.01 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.523 0.677 . . . . 0.0 111.464 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.88 -34.15 72.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.839 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.531 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.01 -40.63 73.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.83 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.2 OUTLIER -78.83 -32.88 46.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.064 178.648 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 64.0 t -55.35 -46.93 78.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.626 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -57.81 -45.32 86.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.1 -33.12 65.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.4 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 18.0 ttp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.953 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.736 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.3 mmm180 -52.3 -51.25 59.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.729 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.66 -53.17 33.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.638 0.256 . . . . 0.0 111.289 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -57.24 -37.52 72.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.007 0.432 . . . . 0.0 110.347 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.953 HG23 ' O ' ' B' ' 1' ' ' ALA . 15.6 t -63.27 -33.68 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.348 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.939 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.58 -55.46 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.995 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.3 mmm-85 -50.36 -37.79 38.92 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.215 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -44.44 66.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.828 ' HD2' HD23 ' A' ' 32' ' ' LEU . 9.6 mtmt -57.9 -55.01 40.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.929 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.8 mt -51.27 -57.28 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.906 0.384 . . . . 0.0 111.228 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.52 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -58.36 -51.18 70.9 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.424 0.631 . . . . 0.0 110.656 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.5 -39.38 64.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.81 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' B' ' 17' ' ' ALA . 3.3 mt -54.28 -48.31 67.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.233 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.27 -38.22 95.58 Favored Glycine 0 CA--C 1.498 -1.022 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.495 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.895 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.76 -61.8 1.96 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.743 -0.729 . . . . 0.0 110.504 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.737 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -60.32 -27.59 67.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.32 -48.64 66.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.038 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 0.7 OUTLIER -63.78 -43.74 95.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.895 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -62.09 -34.65 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.472 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.752 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -75.37 -44.11 46.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.639 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.557 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 18.8 p -60.84 -25.8 66.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.474 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 23' ' ' LEU . 26.8 m -90.07 -46.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.991 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.95 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.12 -33.34 75.26 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.18 0.514 . . . . 0.0 110.444 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.95 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.121 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.5 ' HB2' HD21 ' A' ' 4' ' ' LEU . 1.4 m-20 -96.98 -169.95 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -119.24 84.49 2.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.93 164.82 12.21 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.51 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.494 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.58 162.08 13.47 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.46 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.68 -51.71 20.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.789 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.51 -27.68 69.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.035 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.494 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.94 -51.41 22.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.614 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.2 pt -73.06 -28.9 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.706 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.62 -27.31 10.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.3 mt-10 -75.28 -28.56 59.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.269 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.28 -58.44 3.21 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.207 0.527 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.881 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.9 pttt -54.77 -22.93 15.73 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.203 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.538 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.28 -27.74 56.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.091 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.63 -39.77 61.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.074 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.881 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.04 -51.83 68.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.816 0.817 . . . . 0.0 109.463 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -25.04 59.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.073 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.899 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.02 -25.75 34.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.148 0.499 . . . . 0.0 110.451 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.795 ' HB3' HD11 ' A' ' 27' ' ' ILE . 5.6 t80 -87.75 -15.08 37.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.448 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR . 32.0 t70 -90.28 146.24 24.37 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.977 0.894 . . . . 0.0 111.23 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.508 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -63.33 -53.41 53.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -81.83 -6.8 59.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.846 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.56 45.27 59.68 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.402 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -90.42 17.75 6.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.822 0.344 . . . . 0.0 110.759 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.47 89.36 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 46.4 p -150.18 150.52 31.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.795 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.77 140.58 20.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.968 0.413 . . . . 0.0 111.952 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.6 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.34 176.34 8.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.974 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.815 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -70.42 -38.0 74.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.03 0.443 . . . . 0.0 110.251 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.543 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.75 -40.99 89.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.22 178.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.08 -53.47 20.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.234 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.802 HD11 ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -58.43 -54.85 42.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.718 0.77 . . . . 0.0 109.463 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.59 -45.85 92.74 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.508 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.2 m -62.2 -31.39 71.91 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.818 0.342 . . . . 0.0 110.581 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 31' ' ' GLU . 69.6 t -68.08 -57.25 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.441 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.91 -35.36 69.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.436 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -42.13 79.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.945 0.402 . . . . 0.0 110.645 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -79.02 -7.61 58.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.648 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.547 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -91.03 -54.43 3.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.042 0.448 . . . . 0.0 110.754 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.67 34.81 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.888 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.13 -178.97 5.44 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.368 0.604 . . . . 0.0 111.134 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -159.58 56.49 0.89 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.902 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.4 -176.76 3.36 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.502 2.134 . . . . 0.0 112.076 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.608 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -113.53 152.48 30.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.962 0.41 . . . . 0.0 110.199 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -57.51 -49.33 76.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.404 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.69 72.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.75 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -66.06 -54.33 27.18 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.559 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.815 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.92 -34.74 78.82 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.369 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.674 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.46 -42.6 95.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.873 0.368 . . . . 0.0 110.172 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -61.76 -45.38 94.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.245 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -30.77 61.83 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.419 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.556 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -53.75 -38.32 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.511 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -44.98 -28.6 0.69 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.387 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.04 -38.85 51.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.914 0.388 . . . . 0.0 110.758 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.816 HG11 HG21 ' B' ' 6' ' ' ILE . 5.1 m -81.38 -11.89 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.227 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.54 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.8 t0 -103.57 155.35 18.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.748 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.466 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.61 -28.8 26.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.124 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -116.42 -9.68 11.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.452 0.644 . . . . 0.0 110.5 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.35 63.48 5.2 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.488 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -112.06 18.1 19.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.81 0.338 . . . . 0.0 110.225 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.41 19.86 55.91 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.483 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -147.09 176.32 10.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.802 ' CD1' HD11 ' A' ' 32' ' ' LEU . 2.1 mp -115.54 136.55 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 120.6 0.238 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.0 m-20 -86.11 -178.6 6.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.272 0.558 . . . . 0.0 111.885 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -67.65 -56.32 12.35 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.557 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.0 Cg_endo -65.93 -35.4 35.23 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.3 2.0 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -61.85 -52.45 64.1 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.192 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.09 -56.42 21.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.758 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.16 -45.47 83.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.733 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 64.0 m -60.58 -31.57 70.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.069 0.462 . . . . 0.0 110.049 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.919 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.5 tpp -63.49 -61.76 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.01 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.432 ' HG2' HG22 ' B' ' 10' ' ' ILE . 6.9 mtm . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.716 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.799 0.333 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -50.45 -30.59 12.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.232 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.719 ' O ' HG11 ' B' ' 19' ' ' VAL . 2.0 mt-10 -68.88 -30.54 69.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.481 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.691 HG22 ' HE1' ' A' ' 138' ' ' TYR . 8.1 mt -79.49 -51.1 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -74.65 -51.54 14.12 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.618 ' O ' HG23 ' A' ' 91' ' ' VAL . 26.6 tt0 -53.52 -25.32 16.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.929 0.395 . . . . 0.0 110.755 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.749 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.67 -36.43 43.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.248 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 28.1 t80 -67.94 -51.33 48.84 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.053 0.454 . . . . 0.0 110.142 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -32.62 58.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.773 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 87' ' ' GLU . 47.1 t -88.7 -22.73 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.616 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -52.93 -34.22 54.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.231 -179.388 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -99.36 147.87 24.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.487 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -67.48 -38.27 84.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.374 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.25 -9.74 13.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.796 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.03 28.07 32.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.327 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -67.5 -13.98 62.52 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.165 0.482 . . . . 0.0 110.757 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.85 -10.73 55.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.146 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.8 m-85 -127.12 145.28 50.8 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.014 0.435 . . . . 0.0 111.458 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.036 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.17 110.03 26.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.699 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -82.97 176.89 8.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.602 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.11 -30.06 71.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.077 0.465 . . . . 0.0 110.487 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -57.76 11.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.286 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.791 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.5 -45.81 29.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.093 -179.217 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.036 HD13 HD13 ' A' ' 100' ' ' ILE . 38.0 tp -53.0 -31.15 39.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.844 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.6 ttt-85 -73.36 -49.09 29.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.952 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -59.06 -42.04 89.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.207 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.0 t -72.99 -40.01 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.598 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.456 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 27.7 mmt -73.97 -54.2 8.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.521 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.717 HG23 ' HA ' ' A' ' 115' ' ' LYS . 7.5 m -56.92 -47.75 79.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.241 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.698 ' C ' HD12 ' A' ' 112' ' ' LEU . 99.8 m-20 -59.67 -28.42 67.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.899 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.5 mp -123.28 37.09 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.99 -113.18 0.29 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.722 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.44 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.6 OUTLIER -134.58 167.22 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 0.0 110.849 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.717 ' HA ' HG23 ' A' ' 110' ' ' THR . 3.8 tppp? -72.55 99.88 2.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.237 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.971 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.05 114.42 26.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.435 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.923 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.85 175.39 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.381 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.407 ' H ' HG22 ' A' ' 117' ' ' THR . 1.8 m-20 -48.03 -36.0 12.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.782 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -77.34 -35.01 55.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.761 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -72.82 -33.26 66.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.993 0.425 . . . . 0.0 110.178 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.971 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.88 -47.92 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.898 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.54 -52.81 63.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.788 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -57.44 -28.72 63.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.829 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.805 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.5 tpt -76.25 -38.06 56.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.137 0.494 . . . . 0.0 110.108 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.489 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.53 -43.33 80.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.476 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -64.98 -39.18 93.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.786 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.42 -36.28 29.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.945 0.402 . . . . 0.0 110.449 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.452 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -67.88 -37.55 81.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.544 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.732 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.2 t0 -100.35 146.35 27.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.04 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.556 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.72 -40.6 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.077 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.556 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.98 -10.99 60.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.701 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.81 32.93 1.01 Allowed Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -176.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.28 -12.63 24.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.311 -0.944 . . . . 0.0 112.46 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.87 20.12 10.24 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.86 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.67 146.91 30.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 129' ' ' ASP . 38.3 t -130.66 107.28 13.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.348 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.1 t-20 -79.36 174.84 11.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.323 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.691 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.88 -67.36 0.29 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.518 0.675 . . . . 0.0 111.461 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -61.17 -30.38 70.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.884 -178.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.565 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.82 -44.43 77.88 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -31.79 46.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.208 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 138' ' ' TYR . 55.3 t -53.68 -47.79 61.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.487 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -57.82 -42.26 83.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.717 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.24 -37.93 66.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.967 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 6.4 ttp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.978 -179.856 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.948 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.821 0.343 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.31 -51.15 60.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.723 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.59 -53.31 31.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.668 0.271 . . . . 0.0 111.295 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -57.07 -37.57 72.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.46 . . . . 0.0 110.332 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.948 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.7 t -63.38 -34.2 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.364 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.816 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.01 -54.7 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.988 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -51.08 -37.2 44.24 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.159 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -48.37 63.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.492 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.798 ' HD2' HD23 ' A' ' 32' ' ' LEU . 16.0 mtmt -55.51 -54.4 44.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.203 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.919 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.21 -57.46 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.545 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.506 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.93 -51.17 70.82 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.177 0.513 . . . . 0.0 110.96 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.3 -40.55 64.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.747 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.774 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.8 mt -54.64 -49.32 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.484 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.421 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.4 -36.99 94.12 Favored Glycine 0 CA--C 1.498 -1.011 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.934 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.895 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.47 -61.68 2.07 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.381 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.641 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -62.36 -27.54 69.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.668 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.9 -50.37 64.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.204 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.724 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -64.25 -43.63 94.29 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.895 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.0 m -64.25 -33.12 60.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.479 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.674 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.5 OUTLIER -74.55 -45.75 43.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.839 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.537 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.9 p -59.55 -26.11 65.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.483 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.426 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.2 m -90.47 -46.64 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.148 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.921 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.9 pp -63.18 -32.98 74.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.189 0.519 . . . . 0.0 110.511 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.921 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.051 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.594 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.853 0.359 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.456 ' HB2' HD21 ' A' ' 4' ' ' LEU . 1.6 m-20 -86.44 -169.78 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.811 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -120.96 84.36 2.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.96 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.641 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -97.63 164.74 12.29 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.485 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.514 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.14 162.71 13.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.481 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -47.46 -51.3 20.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.856 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -64.43 -27.65 69.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.04 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.514 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.52 -51.43 20.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.734 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.7 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.6 pt -73.2 -28.73 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.854 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.39 -27.38 9.86 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.541 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 2.7 mm-40 -75.18 -28.51 60.08 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.253 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.43 -58.5 3.17 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 121.253 0.549 . . . . 0.0 111.015 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -54.64 -22.84 14.81 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.205 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.3 -28.1 56.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.23 -39.87 62.8 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.11 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.94 -51.81 68.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.861 0.838 . . . . 0.0 109.487 178.751 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.426 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 4.4 p -74.51 -24.43 58.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.122 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.852 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.15 -23.35 35.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.202 0.525 . . . . 0.0 110.347 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.821 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.7 t80 -95.74 -1.02 50.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.608 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.2 t70 -103.12 144.27 31.52 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 122.036 0.922 . . . . 0.0 111.09 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.524 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 12.6 mmtt -60.55 -53.42 57.69 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.571 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.01 -4.65 59.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.876 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.46 45.55 45.93 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.391 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -90.43 17.57 7.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.836 0.35 . . . . 0.0 110.722 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.46 6.2 87.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.508 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.45 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 61.6 p -150.29 149.05 29.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.47 140.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.747 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.683 HG23 ' HG3' ' A' ' 30' ' ' LYS . 1.3 t -87.49 -179.74 6.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.122 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.803 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.9 p -70.42 -44.14 68.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 0.0 110.897 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.683 ' HG3' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -55.5 -40.23 71.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.327 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.915 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -69.63 -53.83 16.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.424 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.86 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.04 -55.15 38.59 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.781 0.801 . . . . 0.0 109.42 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.62 -45.99 92.62 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.594 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.3 m -62.1 -31.22 71.65 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.939 0.37 . . . . 0.0 110.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.5 t -68.02 -57.2 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.842 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.454 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 1.3 tpt -71.97 -35.87 69.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.428 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -42.44 80.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.76 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.0 t -78.93 -8.36 58.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.7 tt -90.54 -54.72 3.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.761 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.467 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.15 35.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.889 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp-100 -137.3 -178.91 5.42 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.362 0.601 . . . . 0.0 111.207 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -159.64 56.59 0.9 Allowed Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.891 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.9 Cg_endo -80.37 -177.11 3.56 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.501 2.134 . . . . 0.0 112.059 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -113.66 152.54 30.28 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 110.263 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.14 -49.52 75.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.442 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.1 -33.12 74.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.764 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 44' ' ' THR . 0.1 OUTLIER -64.94 -54.28 33.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.692 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.803 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.6 -35.82 81.94 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.429 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.745 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -63.49 -42.69 98.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.875 0.369 . . . . 0.0 110.238 179.303 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -61.83 -45.61 93.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.338 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -30.72 61.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.492 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.57 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.524 -179.101 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -45.0 -28.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.328 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.46 -38.78 48.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.92 0.391 . . . . 0.0 110.838 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.919 HG11 HG21 ' B' ' 6' ' ' ILE . 4.8 m -81.14 -11.48 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.157 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.547 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.9 t0 -103.61 155.51 18.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.727 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.59 -29.09 26.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.079 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -116.4 -9.74 11.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.392 0.615 . . . . 0.0 110.485 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.8 63.93 4.76 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.008 -0.997 . . . . 0.0 113.491 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 -112.66 18.31 18.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.88 0.371 . . . . 0.0 110.217 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.408 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 86.09 19.81 56.63 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.474 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 28' ' ' THR . 5.3 p -146.65 176.37 9.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 32' ' ' LEU . 35.5 mt -115.8 136.5 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.595 0.236 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.6 m-20 -86.94 -178.3 6.26 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.329 0.585 . . . . 0.0 111.935 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.96 -55.96 12.38 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.672 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.6 Cg_endo -65.62 -34.71 40.72 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.245 1.963 . . . . 0.0 111.197 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -52.45 62.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.97 -56.88 15.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.83 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.7 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.04 -46.56 82.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 68.9 m -60.67 -31.84 71.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.107 0.479 . . . . 0.0 110.041 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.936 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.3 tpp -62.34 -61.75 2.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.97 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.7 mtp . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.826 179.929 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.771 0.32 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -57.89 -52.2 66.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.986 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.73 -29.21 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.432 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.727 HG22 ' HE1' ' A' ' 138' ' ' TYR . 18.7 mt -65.89 -51.35 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.822 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -75.68 -50.43 15.42 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.774 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.679 ' O ' HG23 ' A' ' 91' ' ' VAL . 21.3 mt-10 -53.79 -31.92 50.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.644 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.555 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -69.84 -38.74 76.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.774 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.554 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.1 t80 -66.82 -55.85 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.967 0.413 . . . . 0.0 110.549 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -53.73 -30.54 44.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.876 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 87' ' ' GLU . 65.9 t -88.46 -22.85 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.214 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.36 -31.85 62.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.047 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -102.44 148.66 25.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.439 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -69.59 -37.67 77.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.385 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -112.28 -9.79 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.53 30.69 32.39 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.08 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.44 -13.46 62.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.992 0.396 . . . . 0.0 110.856 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.2 -13.66 55.32 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.853 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 24.2 m-85 -127.21 145.87 50.61 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.971 0.415 . . . . 0.0 111.268 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.962 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.06 109.97 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.853 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.1 m -83.53 177.28 8.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.393 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.551 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.16 -28.64 69.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.044 0.449 . . . . 0.0 110.427 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.1 -57.67 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.422 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.618 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.42 -42.38 44.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -179.069 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.962 HD13 HD13 ' A' ' 100' ' ' ILE . 52.9 tp -56.93 -31.24 64.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.788 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.0 ttt180 -72.57 -49.3 33.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -60.81 -36.15 78.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.012 0.434 . . . . 0.0 110.437 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 104' ' ' GLU . 60.3 t -72.94 -44.83 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.178 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 24.4 mmt -74.12 -54.06 8.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.556 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.663 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.6 m -55.57 -45.86 77.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.73 0.3 . . . . 0.0 111.267 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.541 ' C ' HD12 ' A' ' 112' ' ' LEU . 11.7 t-20 -60.04 -30.06 68.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.805 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.852 ' O ' HD11 ' A' ' 18' ' ' LEU . 7.0 mp -123.63 38.92 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.578 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.38 -116.1 0.38 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.798 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -133.13 169.53 16.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.889 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.663 ' HA ' HG23 ' A' ' 110' ' ' THR . 4.8 tppt? -74.22 100.07 3.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.95 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.5 114.91 26.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.322 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.929 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.67 175.08 5.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.417 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.413 ' H ' HG22 ' A' ' 117' ' ' THR . 0.7 OUTLIER -48.02 -36.01 12.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.809 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -77.32 -34.76 55.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.774 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -72.86 -34.18 66.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.056 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.95 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.2 -48.59 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.968 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -59.2 -52.83 63.99 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.874 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.56 -28.96 64.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.843 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.858 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.6 tpt -76.32 -37.72 57.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.129 0.49 . . . . 0.0 110.177 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.485 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.64 -42.86 83.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.455 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -65.1 -39.54 93.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.858 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -81.85 -35.44 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.56 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.453 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.3 -37.68 80.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.5 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.771 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.8 t0 -100.44 147.44 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.99 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.558 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.6 pt -84.84 -40.75 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.039 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.558 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.91 -10.95 59.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.709 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.07 32.67 1.09 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.438 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.4 p-10 -96.25 -12.87 23.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.264 -0.968 . . . . 0.0 112.462 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.19 10.17 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.822 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.98 146.37 30.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.962 0.41 . . . . 0.0 109.998 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.771 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.4 t -130.68 107.38 14.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.185 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -80.36 174.83 11.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.338 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.727 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.95 -67.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.494 0.664 . . . . 0.0 111.393 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -34.03 72.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.789 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.539 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.09 -40.53 73.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.827 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.79 -33.15 46.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.046 178.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 64.8 t -55.11 -46.92 77.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.661 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.8 -45.65 85.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.13 -32.87 65.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.406 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 16.6 ttp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.954 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.873 0.368 . . . . 0.0 111.01 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.735 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.33 -51.28 59.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.727 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.63 -53.26 32.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.678 0.275 . . . . 0.0 111.257 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -57.22 -37.46 72.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.0 0.429 . . . . 0.0 110.346 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.954 HG23 ' O ' ' B' ' 1' ' ' ALA . 16.3 t -63.31 -33.72 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.403 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.919 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.7 -55.36 13.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.046 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.6 mmm-85 -50.34 -38.11 40.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.239 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.71 -44.7 66.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.409 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.86 ' HD2' HD23 ' A' ' 32' ' ' LEU . 8.5 mtmt -57.24 -55.19 38.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.98 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.936 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.12 -57.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.309 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -58.23 -51.16 70.91 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.379 0.609 . . . . 0.0 110.65 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.588 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.52 -39.56 64.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.822 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.607 ' O ' ' HB2' ' B' ' 17' ' ' ALA . 3.5 mt -54.31 -48.23 67.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.221 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.412 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.27 -38.37 95.79 Favored Glycine 0 CA--C 1.498 -1.002 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.517 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.901 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.81 -61.66 2.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.683 -0.759 . . . . 0.0 110.506 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.738 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.08 -27.76 67.26 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.14 -48.89 66.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.005 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.1 ppt_? -63.45 -43.6 96.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.13 0.49 . . . . 0.0 109.77 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.901 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.6 m -62.42 -34.83 66.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.476 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.76 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -74.98 -43.86 51.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.7 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.545 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 17.3 p -60.46 -25.68 66.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.511 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.421 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.7 m -90.83 -46.71 14.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.055 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.947 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.54 -33.01 74.07 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.171 0.51 . . . . 0.0 110.362 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.947 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.114 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.705 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.449 ' HB2' HD21 ' A' ' 4' ' ' LEU . 2.0 m-20 -72.98 -170.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -121.2 86.78 2.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.631 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -98.73 164.75 12.1 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.662 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.49 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.8 p -97.96 162.71 13.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.506 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -47.43 -51.47 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.878 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -64.27 -27.73 69.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.147 0.499 . . . . 0.0 109.985 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.4 mm-40 -72.51 -51.36 20.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.736 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.711 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.4 pt -73.22 -28.78 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.898 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.36 -27.32 9.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 13.2 mm-40 -75.17 -28.46 60.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.264 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.51 -58.48 3.18 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-O 121.275 0.56 . . . . 0.0 111.014 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.876 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.52 -22.96 14.49 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.209 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.531 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.27 -27.78 56.8 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.164 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.75 -39.68 61.68 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.051 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.876 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.09 -51.73 68.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 109.43 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.402 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 8.2 p -74.45 -24.91 59.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.083 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.911 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.0 -25.1 35.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.129 0.49 . . . . 0.0 110.438 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.805 ' HB3' HD11 ' A' ' 27' ' ' ILE . 5.1 t80 -89.38 -14.53 35.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.498 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.1 t70 -90.61 145.84 24.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.963 0.887 . . . . 0.0 111.24 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.8 mmtt -63.76 -53.43 51.17 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.575 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.44 -7.07 59.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.772 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.52 45.91 58.94 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.394 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -90.9 18.13 6.99 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.894 0.378 . . . . 0.0 110.732 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.37 5.01 89.14 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.542 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.9 p -150.21 151.92 33.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.805 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -102.67 140.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.977 0.418 . . . . 0.0 111.772 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.546 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.11 176.42 8.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.006 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.819 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -70.4 -38.32 74.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.126 0.489 . . . . 0.0 110.198 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.61 -41.05 89.52 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.176 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.98 -53.71 19.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.264 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.839 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.28 -55.37 35.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.725 0.774 . . . . 0.0 109.393 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.1 -45.96 91.98 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.536 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.21 -31.11 71.6 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.883 0.342 . . . . 0.0 110.589 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 31' ' ' GLU . 69.1 t -68.25 -57.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.864 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.451 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -71.95 -35.51 69.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.474 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -42.98 80.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.625 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 t -79.03 -7.14 57.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.761 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -91.14 -54.51 3.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.27 34.49 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.839 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.36 -178.4 5.2 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.329 0.585 . . . . 0.0 111.106 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -159.59 56.62 0.9 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.901 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.9 Cg_endo -80.41 -176.27 3.11 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.516 2.144 . . . . 0.0 112.118 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.603 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.68 152.49 31.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.942 0.401 . . . . 0.0 110.27 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.21 -49.65 75.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.41 75.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.761 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.56 -54.33 33.84 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.626 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.819 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -66.03 -34.57 78.39 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.378 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.683 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.46 -43.12 95.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.894 0.378 . . . . 0.0 110.193 179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.58 -45.37 94.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.265 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.52 -30.67 61.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.37 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.588 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -53.65 -39.2 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.604 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.421 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.3 m-80 -45.12 -28.58 0.76 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.373 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.89 -38.74 53.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.952 0.406 . . . . 0.0 110.698 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.912 HG11 HG21 ' B' ' 6' ' ' ILE . 4.8 m -80.39 -12.75 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 43.5 t0 -103.53 155.07 18.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.763 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.14 26.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.182 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -116.42 -9.8 11.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.419 0.628 . . . . 0.0 110.402 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.81 61.49 7.31 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.261 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -109.43 18.38 20.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.758 0.313 . . . . 0.0 110.472 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.76 19.79 59.15 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.402 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.5 p -147.95 176.28 10.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.0 mt -113.28 136.61 49.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.64 0.257 . . . . 0.0 110.846 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -85.87 -179.38 6.8 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.178 0.513 . . . . 0.0 111.77 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.3 m-85 -68.26 -55.94 11.65 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.455 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.3 Cg_endo -65.94 -35.27 35.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.181 1.921 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.25 -52.37 64.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.211 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.02 -56.6 19.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.779 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.711 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -54.83 -47.71 73.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.705 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 73.2 m -59.34 -32.18 69.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.146 0.498 . . . . 0.0 109.713 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.902 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.9 tpp -67.73 -61.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.93 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.443 ' HG3' HG22 ' B' ' 10' ' ' ILE . 31.8 mtp . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.599 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -50.46 -30.53 12.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.316 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.658 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -77.17 -29.57 54.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.809 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.719 HG22 ' HE1' ' A' ' 138' ' ' TYR . 6.8 mt -79.3 -51.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.37 -51.97 11.87 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.5 tt0 -53.74 -25.92 20.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 110.71 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.709 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.07 -36.59 48.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.257 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.601 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 25.6 t80 -67.82 -52.02 41.82 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.043 0.449 . . . . 0.0 110.181 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.425 ' NH2' HD11 ' A' ' 39' ' ' LEU . 1.8 ptt180 -54.55 -32.26 58.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.847 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 87' ' ' GLU . 60.4 t -88.72 -22.72 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.577 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.478 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -53.45 -33.45 54.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.207 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -100.19 147.83 25.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.44 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -67.47 -38.35 84.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.403 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.26 -9.75 13.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.835 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.5 28.67 32.12 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.407 -0.901 . . . . 0.0 113.238 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -67.45 -13.9 62.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 117.161 0.481 . . . . 0.0 110.774 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.09 -11.57 55.58 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.085 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.457 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.4 m-85 -127.09 145.34 50.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.993 0.425 . . . . 0.0 111.434 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.046 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.16 109.93 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.686 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -83.29 177.29 8.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.541 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.546 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.32 -28.62 69.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.059 0.457 . . . . 0.0 110.509 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.31 -57.69 9.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.337 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.39 -43.6 39.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.181 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.046 HD13 HD13 ' A' ' 100' ' ' ILE . 35.5 tp -54.95 -31.18 60.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.081 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.814 ' HA ' HD11 ' A' ' 116' ' ' LEU . 3.3 ttt-85 -73.7 -49.3 26.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -61.28 -36.42 80.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.036 0.446 . . . . 0.0 110.369 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 104' ' ' GLU . 41.4 t -72.95 -44.79 56.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.229 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.6 mmt -74.05 -54.33 8.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.45 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.682 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.1 m -55.63 -46.2 77.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.32 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.582 ' C ' HD12 ' A' ' 112' ' ' LEU . 55.7 t30 -59.51 -30.48 68.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.911 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.8 mp -123.47 38.87 4.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.32 -115.69 0.36 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.817 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -133.21 168.87 17.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.93 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.682 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.7 ttmm -74.06 100.62 3.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.313 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.964 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.79 115.43 27.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.279 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.926 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.83 175.05 6.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.404 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.03 -35.91 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 110.821 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -77.36 -35.07 54.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -72.49 -33.92 67.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.994 0.426 . . . . 0.0 110.08 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.964 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.54 -48.46 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.935 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -59.33 -52.75 64.31 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.847 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.47 -28.81 63.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.819 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.813 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.7 tpt -76.33 -37.88 56.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.127 0.489 . . . . 0.0 110.182 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.75 -43.6 79.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.56 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -64.94 -39.2 93.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.837 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.22 -36.14 30.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.518 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.436 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.15 -38.22 81.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.666 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.719 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.7 t0 -99.76 147.6 25.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.09 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.562 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.8 -40.69 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.102 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.562 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.93 -10.98 60.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.698 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.68 1.09 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.2 p-10 -95.99 -12.83 24.39 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.302 -0.949 . . . . 0.0 112.455 -176.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.94 20.15 10.15 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.817 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 1.1 pt20 -146.48 146.8 30.68 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.953 0.406 . . . . 0.0 109.983 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.719 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.4 t -130.73 107.35 13.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.278 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.1 t-20 -79.27 174.6 11.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.285 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.719 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.87 -67.07 0.32 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.527 0.68 . . . . 0.0 111.441 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.403 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -60.5 -34.1 73.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.865 -178.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.506 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.17 -41.89 76.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.306 0.574 . . . . 0.0 109.53 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.772 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.75 -31.81 46.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.132 178.658 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 138' ' ' TYR . 62.2 t -55.95 -47.11 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -56.62 -44.33 81.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.07 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.13 -32.31 64.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.5 ttp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.945 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.865 0.364 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.24 -50.96 61.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.723 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.66 -53.26 32.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.701 0.286 . . . . 0.0 111.289 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.14 -37.63 72.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.028 0.442 . . . . 0.0 110.252 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.945 HG23 ' O ' ' B' ' 1' ' ' ALA . 13.4 t -63.51 -33.69 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.384 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.912 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.43 -55.4 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.966 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.8 mmm-85 -50.61 -37.24 39.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.117 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -47.57 62.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.523 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.839 ' HD2' HD23 ' A' ' 32' ' ' LEU . 15.2 mtmt -55.93 -55.34 33.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.989 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.902 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.8 mt -51.36 -57.48 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.23 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -56.89 -51.2 70.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.93 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.52 -41.53 66.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.655 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.3 mt -54.39 -49.58 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.47 -37.18 94.4 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.017 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.91 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.96 -61.62 2.05 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.723 -0.738 . . . . 0.0 110.354 -179.003 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.66 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.81 -27.73 68.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.615 177.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -64.95 -51.58 61.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.273 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.734 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.89 -43.72 95.14 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.91 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -64.56 -32.92 59.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.694 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.6 OUTLIER -74.02 -45.93 46.64 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.783 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.538 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.7 -26.11 65.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.534 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.414 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.0 m -90.24 -45.9 14.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.171 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.935 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.63 -32.67 74.21 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.127 0.489 . . . . 0.0 110.483 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.935 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.093 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.695 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.835 0.35 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.18 -169.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.68 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -114.6 93.58 4.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.622 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -96.42 164.63 12.55 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.471 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.513 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 6.3 p -98.93 162.58 13.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.464 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -47.73 -51.33 22.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.761 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.74 -27.7 69.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.029 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.513 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.03 -51.54 21.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.62 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.683 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -72.67 -28.98 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.592 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.41 11.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.7 mt-10 -75.1 -28.63 60.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.126 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.608 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.22 -58.42 3.23 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.332 0.587 . . . . 0.0 110.927 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.878 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 11.0 ptmt -54.44 -23.31 15.47 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.231 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.538 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.11 -27.92 57.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.226 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.41 -39.59 62.53 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.052 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.878 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.78 -51.76 68.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.789 0.804 . . . . 0.0 109.452 178.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.51 -24.8 59.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.99 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.838 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.3 tt -82.05 -24.16 35.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.501 . . . . 0.0 110.269 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.802 ' HB3' HD11 ' A' ' 27' ' ' ILE . 4.2 t80 -92.77 -2.72 55.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.567 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.5 t70 -102.41 144.02 31.41 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.988 0.899 . . . . 0.0 111.032 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.2 mmtt -60.93 -53.44 57.29 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.512 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.31 -4.64 59.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.823 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.9 47.33 39.82 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.292 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 p30 -91.81 18.54 7.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.824 0.345 . . . . 0.0 110.685 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.52 4.85 88.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.57 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.1 p -150.17 149.97 30.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.66 0.266 . . . . 0.0 110.349 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.802 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.72 140.4 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.955 0.407 . . . . 0.0 111.822 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.52 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.96 176.99 7.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.131 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.671 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -69.84 -38.28 76.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.108 0.48 . . . . 0.0 110.315 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.81 -41.36 91.09 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.251 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.926 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.46 -52.16 29.34 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.41 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.8 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -60.24 -55.1 37.89 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.836 0.827 . . . . 0.0 109.364 178.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.81 -45.15 91.69 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.431 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.5 m -62.52 -31.24 71.98 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.469 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.6 t -67.59 -57.31 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.833 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.57 ' CE ' HD22 ' A' ' 39' ' ' LEU . 3.4 tpt -71.92 -36.17 69.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.539 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -42.01 81.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.647 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.4 t -78.97 -8.44 58.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.675 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.57 HD22 ' CE ' ' A' ' 36' ' ' MET . 6.8 tt -89.64 -53.93 4.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.103 0.477 . . . . 0.0 110.694 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.97 35.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.803 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.8 tp-100 -137.47 179.99 6.08 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.374 0.607 . . . . 0.0 111.212 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -159.76 56.46 0.87 Allowed Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.831 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.1 Cg_endo -80.38 -175.13 2.54 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.469 2.113 . . . . 0.0 112.195 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.594 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -112.98 152.63 29.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.886 0.374 . . . . 0.0 110.272 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.3 -49.18 76.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.03 74.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.821 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.578 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.96 -54.58 28.33 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.639 -179.396 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.671 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.12 -44.65 96.18 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.93 179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.645 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -58.2 -49.15 78.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.351 . . . . 0.0 110.751 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -53.25 -47.52 68.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.399 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.406 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.2 mmt -74.77 -30.55 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.767 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -53.62 -35.11 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.868 0.366 . . . . 0.0 111.522 -179.021 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -44.99 -28.63 0.7 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.267 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -78.05 -38.86 43.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.914 0.387 . . . . 0.0 110.764 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.869 HG11 HG21 ' B' ' 6' ' ' ILE . 4.5 m -80.49 -11.17 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.549 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.6 t0 -103.69 155.79 18.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.735 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.496 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.63 -29.17 25.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -116.5 -9.65 11.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.444 0.64 . . . . 0.0 110.468 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.61 63.51 5.15 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.484 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -112.11 17.9 19.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.857 0.36 . . . . 0.0 110.268 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.07 19.91 54.47 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.554 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.2 p -147.64 176.42 10.1 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.742 HD12 HD11 ' A' ' 32' ' ' LEU . 12.1 mt -115.49 136.57 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.569 0.223 . . . . 0.0 111.068 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.4 m-20 -88.05 -178.05 5.89 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.219 0.533 . . . . 0.0 111.964 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.86 -55.97 12.61 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.77 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.9 Cg_endo -65.63 -34.91 39.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.237 1.958 . . . . 0.0 111.186 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -52.28 63.64 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.206 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.713 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.97 -56.72 18.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.887 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.683 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.94 -46.25 82.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.653 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.695 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 80.0 m -60.05 -31.91 70.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.092 0.473 . . . . 0.0 110.037 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.921 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.3 tpp -62.24 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.105 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.8 mtm . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.011 -179.897 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.854 0.359 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -50.35 -30.43 12.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.581 ' O ' HG11 ' B' ' 19' ' ' VAL . 6.4 mt-10 -77.68 -29.47 51.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.713 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.667 HG22 ' HE1' ' A' ' 138' ' ' TYR . 16.2 mt -79.15 -51.13 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -72.55 -48.85 36.86 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.663 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.8 tt0 -53.61 -25.49 17.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.807 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.754 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.99 -36.83 48.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.284 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 25.2 t80 -68.29 -51.68 42.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 110.146 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -54.96 -32.2 61.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.772 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 87' ' ' GLU . 47.4 t -88.77 -22.72 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.488 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.55 -33.6 55.26 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.073 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -101.8 147.21 26.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.407 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -69.59 -36.59 76.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.448 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.18 -9.69 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.824 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.64 29.82 34.56 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.251 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -67.51 -13.85 62.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.109 0.455 . . . . 0.0 110.732 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.448 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.18 -12.7 55.47 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.906 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.483 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 20.5 m-85 -127.3 146.91 50.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.86 0.362 . . . . 0.0 111.25 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.847 ' CD1' HD12 ' A' ' 105' ' ' LEU . 1.1 pt -121.11 110.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.854 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m -82.31 178.42 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.644 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.537 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.72 -29.69 70.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 110.638 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.56 -57.2 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.147 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.761 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.43 -45.26 32.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.251 -179.155 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.847 HD12 ' CD1' ' A' ' 100' ' ' ILE . 5.3 tt -53.03 -32.7 48.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.936 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.843 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.5 ttt180 -73.4 -49.36 27.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -59.7 -42.67 93.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.877 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.766 ' O ' HD12 ' A' ' 112' ' ' LEU . 3.4 t -73.0 -40.14 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.73 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.498 ' HE1' ' CD2' ' B' ' 20' ' ' PHE . 30.1 mmt -73.95 -54.19 8.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.529 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.736 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.3 m -57.01 -48.94 77.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.256 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -57.87 -28.4 64.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.838 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.1 mt -123.6 36.6 4.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.44 -116.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.734 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.404 ' O ' HD23 ' A' ' 116' ' ' LEU . 6.9 pt-20 -130.49 168.75 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.85 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.736 ' HA ' HG23 ' A' ' 110' ' ' THR . 63.2 tttt -74.1 100.52 3.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.233 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.971 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.78 114.53 26.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.455 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.928 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -71.83 175.39 5.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.358 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.474 ' H ' HG22 ' A' ' 117' ' ' THR . 1.5 t70 -48.11 -35.93 12.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.746 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -77.37 -35.74 54.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.701 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -71.81 -33.51 68.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.966 0.412 . . . . 0.0 110.063 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.971 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -73.92 -48.61 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.745 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -58.41 -52.82 64.03 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.544 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -60.24 -28.67 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.577 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.619 ' HG2' HD21 ' A' ' 105' ' ' LEU . 5.5 tpt -72.42 -37.74 68.56 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.253 0.549 . . . . 0.0 110.085 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.487 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -70.63 -41.25 77.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.501 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -64.78 -40.16 94.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.6 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -81.84 -34.67 30.03 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.002 0.429 . . . . 0.0 110.374 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -34.75 76.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.517 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.72 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.3 t0 -105.19 146.67 28.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.992 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.56 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -83.69 -40.83 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.08 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.56 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.96 -11.0 60.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.678 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.96 32.6 1.02 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.4 p-10 -96.0 -12.78 24.47 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.332 -0.934 . . . . 0.0 112.432 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.22 10.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.828 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.483 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -146.68 147.4 30.97 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 129' ' ' ASP . 25.6 t -130.76 107.3 13.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.354 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.4 t-20 -81.01 174.51 11.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.239 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.667 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.96 -67.23 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.583 0.706 . . . . 0.0 111.471 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.1 mt-10 -60.81 -29.14 69.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.989 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.546 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.83 -44.26 77.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.069 0.461 . . . . 0.0 109.814 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.7 -32.01 46.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.175 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 138' ' ' TYR . 68.5 t -53.84 -48.14 62.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -58.15 -44.16 87.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.21 -32.63 64.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.789 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 15.3 ttp . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.972 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.786 0.327 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.73 ' O ' HG13 ' B' ' 6' ' ' ILE . 2.1 mmm180 -52.15 -51.54 57.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.746 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.76 -53.43 31.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.612 0.244 . . . . 0.0 111.417 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.05 -37.0 71.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.139 0.495 . . . . 0.0 110.174 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.972 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.6 t -63.7 -34.4 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.417 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.869 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -71.47 -53.87 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.979 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -50.81 -39.77 53.8 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.238 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -48.32 65.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.867 ' O ' HD12 ' B' ' 13' ' ' ILE . 13.9 mtmt -55.01 -54.25 45.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.273 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.921 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.7 mt -51.04 -55.04 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.297 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.533 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 5.9 tpt180 -61.44 -46.46 89.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.224 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.528 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.13 -40.58 64.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.076 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.867 HD12 ' O ' ' B' ' 9' ' ' LYS . 1.8 mt -54.55 -51.71 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.512 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.41 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.46 -36.72 93.54 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.386 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.911 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.15 -61.58 2.16 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.954 -0.623 . . . . 0.0 110.474 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.655 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -63.38 -27.77 69.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.658 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -66.62 -50.91 61.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.203 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.559 ' NE ' HG12 ' B' ' 19' ' ' VAL . 3.9 ppt_? -63.38 -43.5 97.42 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.911 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.5 m -66.94 -31.85 55.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 0.0 110.609 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.659 ' HE2' HG12 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -72.65 -51.15 20.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.814 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.442 ' HA ' ' NE ' ' B' ' 24' ' ' ARG . 50.6 p -57.27 -35.34 69.64 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.116 0.484 . . . . 0.0 110.781 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.493 HG13 ' O ' ' B' ' 18' ' ' ARG . 27.2 m -73.43 -45.81 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.976 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.592 HD21 ' CD1' ' B' ' 20' ' ' PHE . 3.6 pp -65.15 -24.9 67.53 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.916 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 11.2 ptt85 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.901 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.453 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.866 0.365 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.525 ' HB2' HD21 ' A' ' 4' ' ' LEU . 3.0 m-20 -98.48 -169.9 1.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.76 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -116.96 83.98 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.633 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -97.51 164.77 12.3 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.019 0.438 . . . . 0.0 110.475 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.497 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.7 161.97 13.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.438 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -47.68 -51.67 20.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.752 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -64.56 -27.69 69.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.033 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.497 ' HB2' ' H ' ' A' ' 5' ' ' THR . 1.7 mm-40 -71.88 -51.41 22.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.644 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.1 pt -73.01 -28.95 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.72 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.31 10.81 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.546 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 4.0 mt-10 -75.25 -28.55 59.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.281 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.38 -58.52 3.17 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.299 0.571 . . . . 0.0 110.946 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.877 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.5 pttt -54.52 -23.48 16.61 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.183 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -75.65 -28.03 58.59 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.174 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.17 -39.77 63.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.094 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.877 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.04 -51.84 68.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.803 0.811 . . . . 0.0 109.544 178.789 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.49 -24.7 59.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.124 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.842 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.13 -23.13 35.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.165 0.507 . . . . 0.0 110.405 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.82 ' CE2' HG21 ' A' ' 35' ' ' VAL . 3.6 t80 -94.46 -2.82 51.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.639 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 26' ' ' THR . 23.9 t70 -100.83 142.81 31.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.946 0.879 . . . . 0.0 111.096 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -59.84 -53.45 57.78 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.501 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.17 -6.27 59.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.714 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.5 47.37 51.66 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.36 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -92.01 18.8 7.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.882 0.372 . . . . 0.0 110.688 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.42 5.03 89.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.619 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.8 p -150.28 150.27 31.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.688 0.28 . . . . 0.0 110.26 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.78 140.54 20.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.79 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.576 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -84.89 176.35 8.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.024 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.798 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -70.49 -37.97 74.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.128 0.49 . . . . 0.0 110.271 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.87 -41.06 90.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.162 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.1 -53.82 18.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.264 -179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.822 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -58.37 -55.13 39.05 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.695 0.76 . . . . 0.0 109.365 178.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.12 -45.88 92.1 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.514 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.2 m -62.34 -32.3 73.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.874 0.337 . . . . 0.0 110.488 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.9 t -66.45 -57.18 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.448 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.91 -34.61 69.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.376 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -68.97 -42.62 76.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.666 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.5 t -78.91 -7.75 58.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.751 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -91.21 -54.91 3.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.806 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.461 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.11 34.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.9 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 tp-100 -137.59 -178.73 5.37 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.295 0.569 . . . . 0.0 111.223 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -159.56 56.57 0.9 Allowed Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.933 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.0 Cg_endo -80.33 -177.38 3.75 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.538 2.159 . . . . 0.0 112.065 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -112.86 152.36 29.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.955 0.407 . . . . 0.0 110.306 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.51 -49.24 76.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.39 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.65 -31.82 72.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.783 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 44' ' ' THR . 1.0 OUTLIER -66.0 -54.31 27.68 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.611 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.798 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.97 -34.53 78.31 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.34 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.682 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.49 -42.68 95.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.909 0.385 . . . . 0.0 110.172 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.74 -45.45 93.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.186 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.6 mmt -74.52 -30.77 61.91 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.46 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.74 -38.29 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.606 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -45.03 -28.53 0.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.369 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.72 -38.33 47.39 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.849 HG11 HG21 ' B' ' 6' ' ' ILE . 4.7 m -81.58 -11.36 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.239 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.554 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.9 t0 -103.52 155.6 18.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.761 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.479 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.61 -28.8 26.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -116.46 -9.75 11.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.399 0.618 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.53 63.23 5.42 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.402 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -112.23 18.42 18.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.863 0.363 . . . . 0.0 110.188 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.32 19.9 56.0 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.49 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.576 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.0 p -146.85 176.49 9.85 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 32' ' ' LEU . 50.0 mt -116.27 136.53 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.528 0.204 . . . . 0.0 110.92 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.479 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.1 m-20 -87.33 -178.36 6.17 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.328 0.585 . . . . 0.0 112.002 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.511 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.78 -56.37 11.94 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.534 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.4 Cg_endo -65.81 -34.61 39.4 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.285 1.99 . . . . 0.0 111.114 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -52.4 63.67 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.226 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.726 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.47 -56.64 19.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.842 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.73 -46.26 84.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 58.3 m -60.69 -31.01 70.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.075 0.464 . . . . 0.0 110.046 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.928 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.5 tpp -62.43 -61.84 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.163 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 66.9 mtp . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.92 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.797 0.332 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -75.35 -44.4 45.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.723 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.76 -29.3 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.455 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.715 HG22 ' HE1' ' A' ' 138' ' ' TYR . 23.2 mt -65.97 -51.33 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.828 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -75.68 -51.11 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.828 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.659 ' O ' HG23 ' A' ' 91' ' ' VAL . 15.9 tt0 -53.91 -30.78 47.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.666 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.541 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -69.92 -38.78 76.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 22.6 t80 -67.38 -55.17 14.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.969 0.414 . . . . 0.0 110.431 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -54.47 -30.33 52.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.866 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 87' ' ' GLU . 98.4 t -88.38 -22.83 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.148 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.507 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -55.53 -30.55 60.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.036 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -107.69 142.82 37.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.621 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.749 ' NZ ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -65.28 -38.01 88.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.631 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -110.58 -9.58 14.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.43 31.74 36.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.367 -0.921 . . . . 0.0 113.076 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -67.38 -13.61 62.17 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.962 0.381 . . . . 0.0 110.747 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.454 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.19 -13.73 55.32 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.847 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.8 m-85 -127.28 147.42 50.23 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.899 0.381 . . . . 0.0 111.292 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.942 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -120.17 110.02 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.949 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.9 p -83.93 176.09 9.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.462 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.561 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -62.7 -29.98 71.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.08 0.467 . . . . 0.0 110.471 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.03 -57.01 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.287 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.735 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -76.43 -46.49 26.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.323 -179.091 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.942 HD13 HD13 ' A' ' 100' ' ' ILE . 41.0 tp -53.13 -31.08 40.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.818 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.0 ttt180 -73.82 -49.2 26.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.11 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -57.44 -43.7 84.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.292 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.749 HG22 ' NZ ' ' A' ' 94' ' ' LYS . 1.8 t -72.99 -43.0 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.574 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.477 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 31.3 mmt -70.21 -54.22 13.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.569 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.651 HG23 ' HA ' ' A' ' 115' ' ' LYS . 6.4 m -55.56 -45.25 77.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.15 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -61.64 -29.61 70.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.842 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.8 mp -122.35 37.59 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.62 -112.95 0.28 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.723 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.427 ' O ' HD23 ' A' ' 116' ' ' LEU . 2.3 pt-20 -136.61 170.27 16.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.771 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.651 ' HA ' HG23 ' A' ' 110' ' ' THR . 5.0 tppp? -73.59 98.35 2.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.963 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -88.86 113.42 24.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.925 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.74 175.26 5.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.376 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 117' ' ' THR . 73.7 m-20 -48.09 -36.05 12.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -77.34 -34.13 55.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.795 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -73.91 -33.3 63.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.971 0.415 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.963 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.92 -48.4 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.808 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.09 -52.8 64.18 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.736 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.52 -28.71 63.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.798 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.792 ' HG3' HD21 ' A' ' 105' ' ' LEU . 10.2 tpt -76.18 -37.9 57.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.142 0.496 . . . . 0.0 110.244 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -67.17 -42.68 88.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.4 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -62.87 -41.54 99.42 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 124' ' ' MET . 6.7 pt-20 -82.1 -32.79 30.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 110.48 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.54 78.45 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.451 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.754 ' HB2' HG22 ' A' ' 136' ' ' VAL . 18.5 t0 -105.46 149.38 26.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.934 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.579 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.5 pt -84.79 -40.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.26 0.552 . . . . 0.0 109.986 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.579 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.88 -10.93 59.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.67 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.12 32.77 1.13 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.5 p-10 -96.55 -12.9 23.41 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.296 -0.952 . . . . 0.0 112.391 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.09 10.28 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.753 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.491 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.81 146.43 30.24 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.925 0.393 . . . . 0.0 110.094 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 129' ' ' ASP . 41.1 t -130.76 107.38 13.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.224 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.0 t-20 -80.16 174.24 11.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.41 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.715 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.91 -67.07 0.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.5 0.667 . . . . 0.0 111.539 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.78 -33.51 71.79 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.981 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.529 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.1 -41.36 75.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.054 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.872 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.2 OUTLIER -78.77 -32.03 46.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.226 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.58 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 61.8 t -55.78 -51.13 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.722 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -58.25 -47.41 83.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.3 tpp -68.44 -31.66 71.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.79 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.425 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 26.5 ttp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.786 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.95 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.847 0.356 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.3 mmm180 -52.26 -51.17 59.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.728 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.67 -53.21 32.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.681 0.277 . . . . 0.0 111.302 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -57.06 -37.6 72.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.373 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.95 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.9 t -63.38 -33.69 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.37 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.849 HG21 HG11 ' A' ' 55' ' ' VAL . 2.4 mt -71.76 -55.09 14.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.993 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 27.5 mmm-85 -50.2 -37.9 37.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.2 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.19 -46.57 64.33 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.492 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.822 ' HD2' HD23 ' A' ' 32' ' ' LEU . 11.9 mtmt -56.14 -53.57 55.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.127 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.928 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.21 -57.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.662 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.1 tpt180 -61.67 -51.38 68.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.328 0.585 . . . . 0.0 111.028 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.575 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.37 -38.94 63.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.719 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.724 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.41 -49.24 66.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.275 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.408 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.95 -37.76 95.09 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.55 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.92 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.9 -61.62 2.05 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.707 -0.747 . . . . 0.0 110.507 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.736 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -60.51 -27.73 67.83 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.51 -48.99 65.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.04 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.1 ppt_? -63.29 -43.95 96.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.92 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.8 m -61.85 -35.4 67.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.715 0.769 . . . . 0.0 110.234 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.696 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 0.3 OUTLIER -72.49 -46.66 53.75 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.408 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.495 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 59.1 p -59.73 -37.2 78.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.756 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.456 HG13 ' O ' ' B' ' 18' ' ' ARG . 27.2 m -72.28 -45.2 62.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.872 HD23 ' CE1' ' A' ' 141' ' ' PHE . 3.3 pp -64.17 -28.18 69.58 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.893 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.696 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 6.8 ptt85 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.931 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.815 0.34 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.503 ' HB2' HD21 ' A' ' 4' ' ' LEU . 2.5 m-20 -97.59 -169.7 1.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.796 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.52 83.06 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.637 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -96.1 164.68 12.59 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.407 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.529 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.95 162.77 12.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.491 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -47.48 -51.22 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -64.56 -27.64 69.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.057 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.529 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.5 -51.46 19.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.681 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.1 pt -73.1 -28.89 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.666 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.57 -27.31 10.66 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.555 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 7.3 mt-10 -75.24 -28.6 59.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.289 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.0 m-85 -79.53 -58.6 3.12 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.24 0.543 . . . . 0.0 110.981 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.871 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.8 15.13 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.198 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.25 -27.99 56.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.065 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.31 -39.71 62.7 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.053 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.871 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.88 -51.8 68.46 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.82 0.819 . . . . 0.0 109.387 178.734 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.401 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 1.8 p -74.42 -23.95 59.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.064 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.87 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -81.99 -26.15 34.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.285 0.564 . . . . 0.0 110.04 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.843 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.5 t80 -92.91 0.63 57.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.349 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 26' ' ' THR . 27.7 t70 -105.52 144.07 32.8 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.99 0.9 . . . . 0.0 111.025 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 2.3 mmtt -59.6 -53.41 58.43 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.601 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.63 -3.61 59.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.785 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.08 46.83 33.38 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.322 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.2 p30 -91.1 17.96 7.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.845 0.355 . . . . 0.0 110.759 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 84.2 4.9 87.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.668 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.431 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.7 p -150.29 147.82 28.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.639 0.257 . . . . 0.0 110.337 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -99.61 140.39 19.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.825 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.569 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.19 179.07 7.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.346 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.667 HG21 ' CG ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -70.19 -41.94 73.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.181 0.515 . . . . 0.0 110.277 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -57.44 -41.12 79.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.467 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.77 -53.79 16.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.405 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.592 HD13 ' CD1' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -56.24 -55.69 30.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.882 0.849 . . . . 0.0 109.581 178.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.425 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -58.74 -48.0 87.36 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.485 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.413 ' CB ' ' O ' ' A' ' 30' ' ' LYS . 54.9 m -64.38 -31.11 72.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.858 0.329 . . . . 0.0 110.458 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.843 HG21 ' CE2' ' A' ' 19' ' ' PHE . 18.9 t -63.2 -58.03 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.925 0.393 . . . . 0.0 110.486 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.656 ' HB2' ' HD2' ' B' ' 9' ' ' LYS . 0.0 OUTLIER -72.65 -40.66 66.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.238 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.61 -39.62 88.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.554 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -78.83 -12.2 60.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.597 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.545 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.3 tt -87.02 -53.75 4.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.108 0.48 . . . . 0.0 110.553 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.474 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -178.53 36.33 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.654 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 2.0 tp-100 -133.7 178.73 6.71 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.403 0.62 . . . . 0.0 111.267 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -159.87 56.29 0.84 Allowed Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.696 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.4 Cg_endo -80.54 -168.24 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.527 2.151 . . . . 0.0 112.37 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 47' ' ' GLU . 1.2 m -117.37 152.96 33.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.891 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -60.37 -48.53 81.34 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.75 76.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.705 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -62.81 -53.95 46.42 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.484 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -57.65 -51.27 70.19 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.947 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.667 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -53.62 -49.42 67.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.744 0.307 . . . . 0.0 111.289 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -53.11 -48.7 67.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.73 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mmt -74.71 -30.48 61.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.986 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.592 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -53.64 -36.44 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.843 -178.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.406 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 3.7 m-80 -45.66 -28.58 1.03 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.271 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -78.04 -38.34 44.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.932 0.396 . . . . 0.0 110.7 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.022 HG11 HG21 ' B' ' 6' ' ' ILE . 4.1 m -81.21 -12.32 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.063 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 42.5 t0 -103.59 155.24 18.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.744 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.71 -28.27 26.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.156 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -116.39 -9.72 11.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.443 0.64 . . . . 0.0 110.423 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.89 61.2 7.64 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.278 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -109.37 18.42 20.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.759 0.314 . . . . 0.0 110.447 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' CA ' ' HG2' ' A' ' 49' ' ' GLN . . . 84.9 19.78 58.92 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.493 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -147.81 176.35 10.2 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.404 HD12 HD11 ' A' ' 32' ' ' LEU . 31.7 mt -114.11 136.69 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.582 0.229 . . . . 0.0 110.955 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -87.54 -179.61 6.37 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.218 0.532 . . . . 0.0 111.958 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.3 m-85 -67.7 -55.77 13.48 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.54 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.73 -35.35 37.2 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.204 1.936 . . . . 0.0 111.166 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.12 -52.48 63.68 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.319 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.705 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.64 -56.31 23.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.773 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.699 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -58.66 -46.66 86.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.75 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 51.8 m -60.68 -30.66 70.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.147 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.888 ' HG2' HD13 ' B' ' 10' ' ' ILE . 4.6 tpp -59.94 -61.75 2.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.166 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mtm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.918 -179.933 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.862 0.363 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -59.46 -50.75 72.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.718 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.7 -29.27 25.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.518 -179.545 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.725 HG22 ' HE1' ' A' ' 138' ' ' TYR . 19.3 mt -66.61 -51.33 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.829 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.443 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -75.62 -50.67 14.79 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 91' ' ' VAL . 32.4 mt-10 -53.81 -32.11 51.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.648 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -68.68 -39.35 80.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.683 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.556 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 22.9 t80 -66.73 -56.38 10.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.555 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -53.87 -29.93 43.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.905 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 87' ' ' GLU . 97.1 t -88.41 -23.03 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.19 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.453 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.7 -31.94 62.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.061 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -102.69 148.41 25.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.389 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -69.62 -37.51 76.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -112.34 -9.73 13.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.877 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.24 30.83 32.92 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.136 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.41 -13.32 61.91 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.971 0.386 . . . . 0.0 110.813 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.27 -13.86 55.04 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.826 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 24.8 m-85 -127.14 145.69 50.66 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.976 0.417 . . . . 0.0 111.258 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.97 HD13 HD13 ' A' ' 105' ' ' LEU . 1.1 pt -121.15 109.94 26.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.814 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 56.0 m -83.73 177.41 8.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.405 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.13 -28.87 70.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.071 0.463 . . . . 0.0 110.494 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.94 -57.67 9.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.436 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.623 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.36 -42.37 44.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.257 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.97 HD13 HD13 ' A' ' 100' ' ' ILE . 54.5 tp -57.3 -31.12 65.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.082 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.789 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.9 ttt180 -72.37 -49.28 35.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -60.6 -36.54 78.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 110.533 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 104' ' ' GLU . 56.6 t -72.93 -44.56 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.243 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 23.4 mmt -74.05 -53.95 8.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.7 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.0 m -55.42 -45.58 76.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 111.262 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.404 ' HB3' HD12 ' A' ' 112' ' ' LEU . 17.0 t-20 -62.44 -25.7 68.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.838 0.351 . . . . 0.0 110.728 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.87 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.4 mp -125.37 37.41 4.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.755 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -172.3 -113.77 0.31 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.775 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -134.72 169.88 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.36 . . . . 0.0 110.877 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.655 ' HA ' HG23 ' A' ' 110' ' ' THR . 19.0 tttt -74.09 100.07 3.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.252 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.95 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.39 114.76 26.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.285 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.928 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.74 175.1 5.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.412 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.45 ' H ' HG22 ' A' ' 117' ' ' THR . 3.1 t0 -48.11 -36.02 12.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.939 0.4 . . . . 0.0 110.775 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -77.35 -34.4 55.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.777 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -73.29 -34.05 65.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.002 0.43 . . . . 0.0 110.093 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.95 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.4 -48.82 34.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.943 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -58.99 -52.89 63.82 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.908 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.31 -29.02 63.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.839 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.834 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.4 tpt -76.32 -38.07 56.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.091 0.472 . . . . 0.0 110.223 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.14 -42.46 84.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.553 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -65.78 -39.2 90.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.923 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.03 -35.54 28.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.468 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.24 -38.58 81.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.517 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.772 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.6 t0 -98.96 147.48 24.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.078 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.561 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.6 pt -84.79 -40.68 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.307 0.575 . . . . 0.0 110.053 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.561 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.92 -11.02 60.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.713 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.72 1.1 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.3 p-10 -96.28 -12.92 23.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.296 -0.952 . . . . 0.0 112.42 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.96 20.08 10.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.804 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.97 146.31 30.04 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.962 0.41 . . . . 0.0 110.029 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.5 t -130.67 107.44 14.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.229 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -80.25 174.7 11.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.339 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.725 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.99 -66.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.513 0.673 . . . . 0.0 111.479 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -34.01 72.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.909 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.545 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.05 -40.54 73.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.825 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.75 -33.62 46.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.082 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.586 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.4 t -54.68 -46.83 73.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.666 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.98 -45.49 86.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.11 -33.21 65.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.427 ' HE1' HG12 ' A' ' 85' ' ' ILE . 14.7 ttp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.941 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.846 0.355 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.737 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.2 mmm180 -52.24 -50.78 61.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.735 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.63 -53.36 31.4 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.628 0.252 . . . . 0.0 111.323 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.96 -37.1 71.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.129 0.49 . . . . 0.0 109.998 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.941 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.9 t -63.42 -34.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.341 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 1.022 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.99 -55.59 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.253 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 27.6 mmm-85 -49.79 -40.56 41.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.414 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -43.72 70.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.224 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.74 ' O ' HD12 ' B' ' 13' ' ' ILE . 0.0 OUTLIER -54.84 -55.49 29.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.189 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.888 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.5 mt -51.6 -57.49 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.835 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.2 tpt180 -60.56 -51.29 70.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.321 0.582 . . . . 0.0 110.912 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.566 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.4 -40.0 64.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.652 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.74 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.0 mt -54.51 -47.57 71.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.236 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.08 -38.33 95.84 Favored Glycine 0 CA--C 1.497 -1.056 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.546 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.892 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.97 -61.69 2.01 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.637 -0.782 . . . . 0.0 110.495 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.746 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.03 -27.75 67.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.504 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.68 -48.73 65.77 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.935 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.632 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.5 ppt_? -62.27 -43.45 98.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.133 0.492 . . . . 0.0 109.692 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.892 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.6 m -63.89 -34.9 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.866 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -74.8 -45.74 41.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.929 -179.345 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.558 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 12.6 p -59.81 -24.98 64.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.567 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 23' ' ' LEU . 29.5 m -90.73 -46.72 14.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.972 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.945 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.31 -32.76 73.55 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.147 0.498 . . . . 0.0 110.335 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.945 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.131 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.62 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.792 0.33 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.96 -169.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -116.97 90.56 3.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.001 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.64 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.2 mt -98.64 164.75 12.11 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.542 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.485 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.4 p -96.77 161.78 13.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.493 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -47.7 -51.78 20.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.781 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -64.35 -27.72 69.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.031 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.87 -51.52 21.93 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.592 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.697 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -72.98 -28.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.742 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.51 -27.36 10.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 37.3 mt-10 -75.28 -28.47 59.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.203 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.28 -58.51 3.18 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.281 0.562 . . . . 0.0 110.983 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.49 -23.05 14.65 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.285 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.33 -27.87 56.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.116 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.49 -39.8 62.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.074 177.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.74 -51.68 68.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.899 0.857 . . . . 0.0 109.445 178.731 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.404 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 7.3 p -74.37 -24.89 59.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.049 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.894 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.06 -24.64 35.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.172 0.51 . . . . 0.0 110.278 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.808 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.9 t80 -92.66 -2.33 56.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.599 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.9 t70 -102.36 143.37 32.2 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.97 0.891 . . . . 0.0 111.154 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -59.94 -53.42 58.11 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.58 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -84.81 -6.11 59.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.811 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.54 46.27 53.31 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.188 -0.529 . . . . 0.0 113.375 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -90.99 18.15 7.06 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.798 0.333 . . . . 0.0 110.727 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.5 5.7 88.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 48.3 p -150.28 149.9 30.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.808 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.88 140.5 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.944 0.402 . . . . 0.0 111.834 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.586 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.35 176.56 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.02 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.826 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.2 p -70.49 -37.76 74.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.133 0.492 . . . . 0.0 110.268 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.03 -41.11 91.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.155 178.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.921 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.23 -53.43 19.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.282 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.838 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.4 -54.93 41.46 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.771 0.796 . . . . 0.0 109.402 178.594 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.46 -45.89 92.52 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.516 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -62.21 -31.34 71.86 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.851 0.326 . . . . 0.0 110.574 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.7 t -68.0 -57.24 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.853 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.457 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 1.1 tpt -71.91 -35.5 69.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.427 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -68.05 -42.15 80.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.595 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 t -78.97 -7.79 58.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.731 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.73 -54.31 4.03 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.109 0.48 . . . . 0.0 110.776 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.45 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.22 35.19 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.836 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.588 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.0 -178.98 5.44 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 111.16 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -159.65 56.43 0.87 Allowed Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.909 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.0 Cg_endo -80.42 -175.72 2.84 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.519 2.146 . . . . 0.0 112.076 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.605 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.89 152.47 32.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.941 0.401 . . . . 0.0 110.23 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.18 -49.64 75.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.43 75.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.765 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.66 -54.26 34.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.657 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.826 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.87 -34.57 78.44 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.322 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.689 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.54 -43.07 95.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.926 0.393 . . . . 0.0 110.185 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.33 -45.52 94.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.189 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.4 mmt -74.57 -30.73 61.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.403 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.74 -38.02 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.55 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -45.05 -28.55 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.372 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG2' ' HZ1' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.59 -38.75 47.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.915 0.388 . . . . 0.0 110.84 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.886 HG11 HG21 ' B' ' 6' ' ' ILE . 5.0 m -81.17 -11.43 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.157 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.543 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.7 t0 -103.63 155.63 18.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.62 -29.09 26.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -116.45 -9.64 11.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.416 0.626 . . . . 0.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.47 63.56 5.12 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.488 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -112.28 18.16 18.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 0.0 110.241 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.93 55.13 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.475 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.4 p -147.09 176.4 9.97 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 32' ' ' LEU . 57.6 mt -115.77 136.48 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.546 0.212 . . . . 0.0 110.86 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.0 m-20 -87.46 -178.18 6.09 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.318 0.58 . . . . 0.0 111.916 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.1 -55.9 12.13 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.648 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.4 Cg_endo -65.68 -34.39 41.31 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.251 1.967 . . . . 0.0 111.193 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -52.46 61.97 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.209 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.721 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.02 -57.04 14.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.867 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.697 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.1 -47.14 81.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.62 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 54.0 m -60.23 -30.92 69.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 110.077 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.92 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.7 tpp -62.08 -61.84 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.144 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 8.4 mtt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.992 -179.869 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.859 0.361 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -50.44 -30.48 12.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.553 ' O ' HG11 ' B' ' 19' ' ' VAL . 4.6 mt-10 -77.31 -29.55 53.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.73 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.692 HG22 ' HE1' ' A' ' 138' ' ' TYR . 11.3 mt -79.24 -51.13 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -48.48 38.34 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.897 0.379 . . . . 0.0 111.863 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.691 ' OE2' ' HB1' ' B' ' 12' ' ' ALA . 21.5 tt0 -53.5 -26.42 20.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.357 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.744 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.56 -33.99 58.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.964 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.61 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 13.1 t80 -68.96 -50.42 49.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.002 0.43 . . . . 0.0 110.149 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -54.42 -33.21 59.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.767 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.99 -22.7 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.557 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.544 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -52.81 -36.82 59.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.342 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -100.09 147.13 25.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.753 0.311 . . . . 0.0 110.525 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -67.94 -37.71 81.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.434 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -112.2 -9.76 13.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.847 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.41 28.36 33.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.365 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -67.51 -13.96 62.51 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.163 0.481 . . . . 0.0 110.769 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -11.49 55.44 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.084 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.48 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.7 m-85 -127.21 146.94 50.24 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.925 0.393 . . . . 0.0 111.53 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.05 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.14 109.92 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.633 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 m -82.66 176.78 9.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.553 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.14 -29.88 70.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.097 0.475 . . . . 0.0 110.457 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.24 -57.74 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.23 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.833 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.44 -45.46 31.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.157 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.05 HD13 HD13 ' A' ' 100' ' ' ILE . 28.6 tp -53.04 -31.44 41.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.853 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.2 ttt-85 -72.46 -49.13 35.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -59.9 -42.0 92.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.115 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.9 t -73.06 -40.17 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.404 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.46 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.7 mmt -73.92 -54.16 8.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.698 HG23 ' HA ' ' A' ' 115' ' ' LYS . 7.1 m -59.03 -48.9 79.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.202 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -57.26 -28.56 63.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.894 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -124.33 37.0 4.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.731 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.43 -115.88 0.36 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.808 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.422 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -130.7 167.52 18.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 110.883 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.698 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.9 ttmt -73.59 100.07 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.291 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.973 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.55 114.43 26.64 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.393 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.927 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.78 175.26 5.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.385 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -48.01 -35.92 11.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.363 . . . . 0.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.4 -35.44 54.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.698 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -72.29 -33.3 67.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.959 0.409 . . . . 0.0 110.116 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.973 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.65 -48.51 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.846 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -59.41 -52.87 63.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.724 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -57.76 -28.67 64.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.807 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.749 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.6 tpt -76.12 -37.88 57.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.147 0.499 . . . . 0.0 110.248 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.14 -40.65 80.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -66.46 -39.19 88.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.952 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.41 -36.13 29.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.61 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.494 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.09 -37.17 80.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.413 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.646 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.4 t0 -101.36 145.53 28.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.033 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.552 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.0 pt -83.06 -40.8 16.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.165 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.92 -11.02 60.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.747 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.87 32.65 0.99 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.419 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.3 p-10 -95.53 -12.41 25.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.304 -0.948 . . . . 0.0 112.568 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.18 10.19 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.89 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.48 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.99 147.37 31.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 129' ' ' ASP . 18.6 t -130.74 107.25 13.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.39 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -78.81 174.79 11.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.227 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.93 -67.08 0.31 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.635 0.731 . . . . 0.0 111.788 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.4 mt-10 -65.28 -25.3 67.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.42 -1.263 . . . . 0.0 112.554 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.467 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.62 -48.51 74.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.822 0.344 . . . . 0.0 110.271 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.8 p90 -78.91 -30.99 45.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.243 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 138' ' ' TYR . 67.4 t -52.83 -44.5 48.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.121 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -60.34 -37.16 79.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.125 0.488 . . . . 0.0 109.809 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.46 -42.21 62.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.721 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.432 ' CG ' HG21 ' B' ' 22' ' ' VAL . 2.2 ttp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.026 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.946 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.801 0.334 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.736 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.23 -51.08 60.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.722 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.65 -53.27 32.36 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.677 0.275 . . . . 0.0 111.302 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.1 -37.54 72.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.015 0.436 . . . . 0.0 110.339 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.946 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.2 t -63.46 -34.12 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.387 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.886 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -70.84 -54.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.969 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -51.51 -37.24 48.25 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.097 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.63 -48.31 64.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.472 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.838 ' HD2' HD23 ' A' ' 32' ' ' LEU . 17.3 mtmt -55.8 -54.38 45.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.043 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.92 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.5 mt -51.17 -57.45 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.465 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.518 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.8 tpt180 -59.79 -51.23 70.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.237 0.541 . . . . 0.0 111.094 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.691 ' HB1' ' OE2' ' A' ' 87' ' ' GLU . . . -53.19 -40.1 64.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.819 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.783 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.8 mt -54.58 -50.37 59.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.418 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.93 -36.82 93.96 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.056 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.906 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.28 -61.69 2.08 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.539 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.676 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.98 -27.62 69.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.599 177.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -66.04 -50.68 63.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.225 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.754 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -63.64 -43.55 96.46 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.02 0.438 . . . . 0.0 109.847 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.2 m -65.9 -32.69 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.839 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.686 ' HE2' HG12 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -74.66 -48.13 27.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.219 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 13.5 p -58.46 -25.9 62.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.454 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.448 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.5 m -89.93 -47.62 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.161 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.888 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -62.84 -33.02 74.37 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.139 0.495 . . . . 0.0 110.507 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.888 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.107 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.479 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.79 0.328 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.521 ' HB2' HD21 ' A' ' 4' ' ' LEU . 2.7 m-20 -106.17 -170.16 1.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -116.77 83.95 2.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.71 164.71 12.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.539 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.494 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.32 162.73 13.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.48 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -47.39 -51.38 19.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.902 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -64.39 -27.71 69.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.034 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.5 -51.39 20.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.705 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.4 pt -73.18 -28.79 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.809 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.38 -27.32 9.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 35.0 mm-40 -75.25 -28.51 59.88 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.166 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.42 -58.31 3.27 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.228 0.537 . . . . 0.0 111.042 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.876 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 11.2 ptmt -54.56 -22.99 14.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.235 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.27 -28.02 56.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.12 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.33 -39.83 62.58 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.07 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.876 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.01 -51.66 69.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.774 0.797 . . . . 0.0 109.5 178.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.406 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 6.9 p -74.42 -24.78 59.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.072 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.903 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.04 -24.29 35.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.177 0.513 . . . . 0.0 110.285 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.799 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.6 t80 -93.4 -1.71 55.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.563 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.7 t70 -102.7 143.56 32.19 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 122.005 0.907 . . . . 0.0 111.125 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.2 mmtt -59.65 -53.47 57.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.56 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.51 -5.72 59.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.744 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.3 46.31 51.98 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.356 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -90.97 18.15 7.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.799 0.333 . . . . 0.0 110.73 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.72 5.57 88.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.564 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 47.5 p -150.34 149.58 30.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.65 140.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.879 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.591 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.21 176.37 8.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.002 179.334 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.822 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -70.49 -37.77 74.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.126 0.488 . . . . 0.0 110.257 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.09 -41.13 91.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.143 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.918 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -69.09 -53.79 18.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.221 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.841 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.16 -55.62 32.61 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.73 0.776 . . . . 0.0 109.362 178.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.76 -46.18 90.1 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.62 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.7 m -62.5 -32.13 72.99 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.951 0.376 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.8 t -67.03 -57.22 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.922 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.453 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -71.9 -36.37 69.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.471 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -67.07 -41.9 85.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.4 . . . . 0.0 110.552 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.7 t -79.04 -7.94 58.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.698 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.2 tt -91.42 -55.41 3.52 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -174.97 33.1 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.946 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.596 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -134.18 -179.66 5.7 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.337 0.589 . . . . 0.0 111.125 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -159.66 56.33 0.86 Allowed Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.819 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.8 Cg_endo -80.62 -172.78 1.61 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.577 2.185 . . . . 0.0 112.086 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.37 152.42 35.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.884 0.373 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.7 -50.15 73.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 -33.33 75.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.709 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.85 -54.39 31.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.687 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.822 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.83 -34.63 78.61 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.399 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.684 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.48 -42.75 95.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 110.226 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.65 -45.5 93.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.25 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -30.76 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.424 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.73 -38.01 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.529 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -44.93 -28.59 0.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.417 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.45 -38.96 48.34 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 120.89 0.376 . . . . 0.0 110.819 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.858 HG11 HG21 ' B' ' 6' ' ' ILE . 5.0 m -81.23 -11.47 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.182 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.546 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.7 t0 -103.61 155.65 18.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.788 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.66 -29.01 26.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.095 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -116.49 -9.67 11.39 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.407 0.623 . . . . 0.0 110.481 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.31 63.77 4.94 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.481 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -112.39 18.11 18.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.831 0.348 . . . . 0.0 110.216 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.84 19.85 55.11 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.469 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.6 p -147.1 176.42 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.772 HD12 HD11 ' A' ' 32' ' ' LEU . 14.6 mt -115.77 136.52 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.836 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.9 m-20 -87.28 -178.27 6.16 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.218 0.533 . . . . 0.0 111.859 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.08 -55.83 12.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.727 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -65.67 -34.77 40.03 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.272 1.981 . . . . 0.0 111.12 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -52.45 62.95 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.232 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.93 -56.83 16.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.815 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.699 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.75 -45.75 81.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.679 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 55.8 m -60.07 -31.33 69.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.085 0.469 . . . . 0.0 109.954 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.904 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.9 tpp -64.68 -61.8 1.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.949 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.403 ' HG3' HG22 ' B' ' 10' ' ' ILE . 43.0 mtm . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.81 0.338 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.48 -30.64 13.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.397 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.608 ' O ' HG11 ' B' ' 19' ' ' VAL . 2.1 mt-10 -65.94 -29.78 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 110.342 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.681 HG22 ' HE1' ' A' ' 138' ' ' TYR . 11.4 mt -79.45 -50.64 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.308 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.444 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.2 OUTLIER -74.99 -51.24 14.13 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 91' ' ' VAL . 17.0 tt0 -53.5 -25.19 15.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.742 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.705 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.43 -36.61 45.32 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 24.0 t80 -68.12 -52.26 36.92 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.012 0.434 . . . . 0.0 110.091 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.439 ' NH2' HD11 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -54.72 -32.05 59.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.807 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 87' ' ' GLU . 48.4 t -88.74 -22.74 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.522 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.484 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -53.85 -31.64 50.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.144 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -103.25 147.44 27.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.431 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -69.24 -37.03 77.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.432 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.15 -9.75 13.92 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.75 29.89 33.95 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.232 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.37 -13.95 62.48 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.078 0.439 . . . . 0.0 110.779 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.14 -12.12 55.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.969 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.6 m-85 -127.26 146.85 50.28 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.953 0.406 . . . . 0.0 111.247 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.58 HD12 HD22 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.03 110.01 26.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.875 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -84.09 176.9 8.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.522 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.51 -29.55 70.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.08 0.467 . . . . 0.0 110.484 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.73 -57.18 12.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.209 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.749 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.32 -46.11 29.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.309 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.835 HD21 ' HG3' ' A' ' 124' ' ' MET . 20.0 tp -53.14 -31.11 40.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.996 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.836 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.8 ttt-85 -73.35 -49.13 28.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -58.87 -42.87 90.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.142 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.2 t -72.91 -40.37 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.529 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.511 ' HE1' ' CD2' ' B' ' 20' ' ' PHE . 30.0 mmt -73.87 -54.21 8.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.353 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.737 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.3 m -56.96 -48.84 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 0.0 111.147 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.684 ' C ' HD12 ' A' ' 112' ' ' LEU . 60.1 t-20 -58.8 -29.33 66.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.903 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -122.88 37.62 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.802 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 109' ' ' MET . . . -171.2 -113.86 0.31 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.783 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.445 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -134.07 166.85 21.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 110.886 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.737 ' HA ' HG23 ' A' ' 110' ' ' THR . 33.0 tttm -72.39 99.68 2.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.244 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.81 114.51 26.25 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.421 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.923 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.77 175.24 5.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.37 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -48.02 -36.0 12.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 110.77 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.37 -34.88 54.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.723 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -73.0 -33.23 65.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.973 0.416 . . . . 0.0 110.079 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.95 -48.51 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.839 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -59.01 -52.81 64.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.746 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.7 -28.65 64.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.765 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.835 ' HG3' HD21 ' A' ' 105' ' ' LEU . 12.8 tpt -76.15 -37.5 57.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.172 0.51 . . . . 0.0 110.163 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.508 HG12 HD23 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -69.21 -39.16 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.342 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -64.77 -41.94 95.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.418 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -82.08 -32.45 30.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.937 0.398 . . . . 0.0 110.431 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.77 -34.71 76.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.54 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.755 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.0 t0 -107.95 148.07 30.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.014 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.559 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.7 pt -84.91 -40.71 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.013 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.559 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.95 -10.98 60.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.693 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.06 32.8 1.1 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.435 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.35 -12.69 24.02 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.332 -0.934 . . . . 0.0 112.493 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.79 20.14 10.28 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.832 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.485 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.77 146.44 30.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.959 0.409 . . . . 0.0 110.0 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 129' ' ' ASP . 38.4 t -130.79 107.41 13.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.213 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.4 t-20 -79.86 174.22 11.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.259 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.681 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.82 -67.07 0.32 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.554 0.692 . . . . 0.0 111.448 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.404 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.4 mt-10 -60.11 -33.41 72.09 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.903 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.511 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.03 -42.09 75.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.36 0.6 . . . . 0.0 109.496 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.853 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.69 -31.87 46.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.114 178.648 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.573 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 55.5 t -55.38 -48.75 76.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.655 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -55.15 -49.67 71.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -70.57 -30.38 67.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.783 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.415 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.943 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.848 0.356 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.737 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.1 mmm180 -52.38 -51.0 61.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.076 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.722 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.68 -53.24 32.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.679 0.276 . . . . 0.0 111.29 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -57.06 -37.64 72.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.997 0.427 . . . . 0.0 110.34 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.943 HG23 ' O ' ' B' ' 1' ' ' ALA . 13.9 t -63.37 -34.15 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.361 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.858 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.07 -55.28 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.967 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.4 mmm-85 -50.73 -36.84 38.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.098 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -48.28 63.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.466 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.841 ' HD2' HD23 ' A' ' 32' ' ' LEU . 16.2 mtmt -55.56 -54.96 37.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.222 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.904 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.0 mt -51.13 -57.43 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.431 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.525 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -58.92 -51.05 71.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.27 0.557 . . . . 0.0 111.051 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.27 -40.58 64.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.831 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.716 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.9 mt -54.61 -49.7 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.493 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.43 -36.95 94.06 Favored Glycine 0 CA--C 1.499 -0.961 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.068 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.932 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.14 -61.73 2.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.789 -0.705 . . . . 0.0 110.357 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.66 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.75 -28.08 69.72 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.659 177.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.5 -51.48 59.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.227 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.758 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.31 -43.44 97.82 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.037 0.446 . . . . 0.0 109.831 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.932 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.1 m -66.45 -32.55 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.639 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.66 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -71.82 -50.15 32.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.986 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.46 ' HA ' ' NE ' ' B' ' 24' ' ' ARG . 52.7 p -58.27 -35.56 71.96 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.023 0.439 . . . . 0.0 110.836 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.49 HG22 ' C ' ' B' ' 19' ' ' VAL . 26.9 m -73.04 -45.22 55.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.09 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.853 HD23 ' CE1' ' A' ' 141' ' ' PHE . 2.7 pp -64.62 -27.98 69.31 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.933 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 10.9 ptt85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.904 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.628 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.773 0.321 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.407 ' HB2' HD21 ' A' ' 4' ' ' LEU . 3.7 m-20 -66.09 -169.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.824 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -117.49 89.09 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.002 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.63 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.78 164.81 12.24 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.459 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.491 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.28 162.4 13.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.488 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -47.25 -51.35 19.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.845 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.29 -27.72 69.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.115 0.484 . . . . 0.0 110.034 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.0 OUTLIER -72.64 -51.38 19.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.694 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 35.5 pt -73.27 -28.83 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.931 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.44 -27.37 10.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 49.6 mt-10 -75.43 -28.49 59.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.272 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.33 -58.57 3.15 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.242 0.544 . . . . 0.0 111.163 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.878 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -54.75 -23.3 17.22 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.175 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -75.64 -28.26 58.73 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.96 -40.02 63.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.072 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.878 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.11 -51.9 68.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.796 0.808 . . . . 0.0 109.608 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -24.79 59.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.042 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.912 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.15 -26.9 33.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.117 0.484 . . . . 0.0 110.401 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.798 ' HB3' HD11 ' A' ' 27' ' ' ILE . 4.6 t80 -87.2 -14.3 41.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.579 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.8 t70 -90.79 145.27 24.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.931 0.872 . . . . 0.0 111.175 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.493 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.8 mmtt -63.36 -53.39 53.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.578 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -83.09 -7.07 59.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.735 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.3 46.94 56.99 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.398 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -91.73 18.59 7.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.854 0.359 . . . . 0.0 110.659 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.21 5.11 89.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.539 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.7 p -150.28 152.07 33.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.798 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -103.04 140.53 21.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.924 0.392 . . . . 0.0 111.712 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.556 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -84.72 176.14 8.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.008 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.817 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -70.39 -38.45 74.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.085 0.469 . . . . 0.0 110.159 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.48 -40.92 88.51 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.144 178.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.919 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.07 -53.68 19.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.272 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.831 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.41 -54.91 41.64 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.761 0.791 . . . . 0.0 109.47 178.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.46 -46.01 92.39 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.581 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.12 -31.16 71.59 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.806 0.336 . . . . 0.0 110.587 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.7 t -68.18 -57.23 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.447 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -71.89 -35.53 69.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.412 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -42.46 80.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.641 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.7 t -78.95 -7.46 58.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.749 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.549 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -91.11 -54.43 3.95 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.056 0.455 . . . . 0.0 110.796 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.45 34.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.871 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.588 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.02 -178.78 5.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.291 0.567 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -159.59 56.49 0.89 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.884 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.0 Cg_endo -80.37 -176.09 3.02 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.552 2.168 . . . . 0.0 112.065 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.606 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.61 152.45 31.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.94 0.4 . . . . 0.0 110.236 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.13 -49.68 75.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.386 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.24 75.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.72 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 1.3 mm-40 -64.7 -54.32 33.4 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.682 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.817 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.89 -34.69 78.7 Favored 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.405 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.677 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.52 -42.92 95.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.886 0.374 . . . . 0.0 110.162 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.52 -45.44 94.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.233 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -30.71 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.41 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.75 -38.31 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.527 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -45.03 -28.55 0.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.377 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.439 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.76 -38.56 46.58 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.886 0.374 . . . . 0.0 110.841 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.919 HG11 HG21 ' B' ' 6' ' ' ILE . 4.8 m -81.2 -11.27 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.167 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.55 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.4 t0 -103.66 155.62 18.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.759 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.65 -28.93 26.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.034 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -116.45 -9.73 11.41 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.408 0.623 . . . . 0.0 110.501 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.45 63.58 5.1 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.476 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -112.32 18.12 18.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.854 0.359 . . . . 0.0 110.19 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.75 19.9 55.18 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.491 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.8 p -147.32 176.46 9.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.794 HD12 HD11 ' A' ' 32' ' ' LEU . 13.2 mt -115.85 136.51 52.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.557 0.218 . . . . 0.0 110.91 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.7 m-20 -87.11 -178.08 6.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.298 0.571 . . . . 0.0 111.959 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.99 -56.12 11.98 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.674 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.8 -34.44 40.06 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.254 1.969 . . . . 0.0 111.175 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.07 -52.38 62.96 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.166 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.03 -56.92 15.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.893 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.6 -47.13 80.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.628 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 54.7 m -60.21 -30.76 69.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.07 0.462 . . . . 0.0 110.078 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.905 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.1 tpp -64.43 -61.83 1.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.124 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 mtt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.976 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.806 0.336 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -50.45 -30.55 12.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.183 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.708 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -77.24 -29.3 53.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.789 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.638 HG22 ' HE1' ' A' ' 138' ' ' TYR . 16.2 mt -79.08 -51.04 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -73.7 -51.11 17.71 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.839 0.352 . . . . 0.0 111.901 -178.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 91' ' ' VAL . 60.5 tt0 -53.56 -24.61 14.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.722 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -78.67 -35.73 44.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.058 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.8 t80 -69.03 -52.43 28.79 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.108 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -55.7 -31.9 62.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.895 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 87' ' ' GLU . 62.0 t -88.94 -22.73 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.571 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.495 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -54.53 -32.24 57.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.081 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -102.75 147.42 26.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.434 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -69.64 -36.83 76.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -112.18 -9.66 13.91 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.55 30.08 34.1 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.204 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -67.37 -13.82 62.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.004 0.402 . . . . 0.0 110.797 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.446 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.18 -11.71 55.28 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.011 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.47 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.0 m-85 -127.3 145.83 50.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 120.959 0.409 . . . . 0.0 111.354 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.93 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -120.68 110.03 27.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.828 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -83.41 176.4 9.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.525 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.558 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.32 -29.84 71.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.065 0.459 . . . . 0.0 110.432 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.13 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.222 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.37 -46.1 28.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.35 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 100' ' ' ILE . 44.8 tp -53.1 -31.06 40.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.09 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.81 ' HA ' HD11 ' A' ' 116' ' ' LEU . 3.5 ttt-85 -74.21 -49.26 24.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.182 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -58.32 -42.39 86.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.057 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.775 ' O ' HD12 ' A' ' 112' ' ' LEU . 2.5 t -72.87 -40.68 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.563 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.49 ' HE1' ' CD2' ' B' ' 20' ' ' PHE . 30.0 mmt -73.91 -54.34 8.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.351 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.75 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.9 m -57.32 -48.92 77.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.21 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -58.38 -28.61 65.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.912 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.1 mt -123.89 36.63 4.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.802 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.35 -113.47 0.29 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.844 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.426 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.9 pt-20 -133.31 166.24 22.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 110.931 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.75 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.2 tttm -73.12 99.91 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.332 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.972 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.43 114.52 26.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.292 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.917 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.62 174.97 6.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.439 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -48.08 -36.01 12.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 0.0 110.767 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -77.39 -34.27 54.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.734 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -73.5 -33.43 64.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.972 0.415 . . . . 0.0 110.029 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.972 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -75.14 -49.32 28.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.871 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.19 -52.83 63.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.708 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -57.34 -28.65 63.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.679 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.495 ' O ' ' HE3' ' A' ' 124' ' ' MET . 5.9 tpt -75.42 -38.41 59.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.294 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.511 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.98 -41.91 81.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.559 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -65.9 -39.61 90.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.647 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.09 -36.41 27.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.55 83.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.487 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.741 ' HB2' HG22 ' A' ' 136' ' ' VAL . 23.7 t0 -100.35 147.26 26.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.004 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.562 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.79 -40.69 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.086 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.562 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.97 -10.94 60.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.647 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.6 1.08 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.2 p-10 -96.16 -12.87 24.06 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.269 -0.965 . . . . 0.0 112.363 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.93 20.2 10.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.816 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -147.05 146.66 30.08 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.954 0.407 . . . . 0.0 109.969 179.228 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.741 HG22 ' HB2' ' A' ' 129' ' ' ASP . 37.7 t -130.73 107.42 14.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.266 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.4 t-20 -80.18 174.58 11.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.235 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.638 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.96 -66.96 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.448 0.642 . . . . 0.0 111.332 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.83 -33.85 72.31 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.775 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.523 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.15 -40.11 73.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.877 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.74 -34.69 45.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.047 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.574 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 78.8 t -54.3 -46.02 68.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.786 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -57.43 -46.82 83.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.13 -31.54 64.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.948 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.74 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.29 -51.05 60.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.725 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.7 -53.22 33.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.654 0.264 . . . . 0.0 111.284 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -57.16 -37.74 72.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.003 0.43 . . . . 0.0 110.31 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.948 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.5 t -63.14 -34.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.356 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.919 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -70.75 -55.05 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.919 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 mmm-85 -50.55 -37.24 38.38 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.127 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -68.98 -48.32 63.42 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.61 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.831 ' HD2' HD23 ' A' ' 32' ' ' LEU . 16.9 mtmt -55.78 -55.1 36.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.262 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.905 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.24 -57.49 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.56 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.489 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.72 -50.41 73.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.211 0.529 . . . . 0.0 111.028 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.23 -41.06 65.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.809 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.784 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.0 mt -54.57 -47.68 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.485 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.426 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.53 -37.1 93.98 Favored Glycine 0 CA--C 1.498 -1.006 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.671 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.906 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.94 -61.52 2.11 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.728 -0.736 . . . . 0.0 110.275 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.734 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.26 -28.17 68.98 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.616 177.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -64.8 -52.14 58.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.241 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.744 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.56 -43.34 97.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.026 0.441 . . . . 0.0 109.922 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.2 m -65.79 -35.09 74.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.668 0.747 . . . . 0.0 110.424 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.734 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.3 OUTLIER -71.37 -45.75 62.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.363 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.509 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 57.2 p -60.13 -36.66 77.99 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.723 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 19' ' ' VAL . 27.1 m -72.92 -44.35 57.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.171 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.877 HD23 ' CE1' ' A' ' 141' ' ' PHE . 3.4 pp -64.1 -29.53 70.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.779 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.856 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.732 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.75 -170.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -120.87 89.74 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.642 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.4 mt -99.52 164.81 11.93 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.622 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 6.9 p -96.87 161.99 13.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.511 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -47.5 -51.75 19.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.806 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -64.36 -27.65 69.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.973 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.11 -51.55 20.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.643 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.701 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.1 pt -72.8 -28.76 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.882 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.27 -27.33 9.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.0 mt-10 -75.27 -28.42 59.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.314 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.48 -58.51 3.16 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.221 0.534 . . . . 0.0 111.078 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.877 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.54 14.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.218 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.56 -28.01 56.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.036 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.45 -39.87 62.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.059 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.877 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.63 -51.77 68.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.851 0.834 . . . . 0.0 109.416 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -74.46 -24.45 59.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.087 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.2 tt -82.04 -24.88 35.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.233 0.539 . . . . 0.0 110.249 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.815 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.2 t80 -93.05 -1.74 56.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.561 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.2 t70 -103.14 143.64 32.35 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.966 0.888 . . . . 0.0 111.114 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -60.2 -53.47 57.31 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.54 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -84.9 -5.95 59.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.801 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.34 46.64 51.95 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.367 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 p30 -91.35 18.44 7.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.83 0.348 . . . . 0.0 110.706 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.33 88.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.611 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.0 p -150.24 150.07 31.04 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -102.0 140.49 20.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.959 0.409 . . . . 0.0 111.939 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.57 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.25 176.48 8.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.009 179.322 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.83 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.2 p -70.43 -37.88 74.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.058 0.456 . . . . 0.0 110.312 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.0 -41.26 91.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.134 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.926 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -68.91 -53.79 19.1 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.27 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.837 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.96 -55.83 29.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.711 0.767 . . . . 0.0 109.357 178.556 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.45 -45.77 88.75 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.562 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.4 m -62.74 -32.09 73.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.78 0.324 . . . . 0.0 110.585 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.0 t -66.68 -57.24 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.473 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -71.88 -36.94 70.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.436 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -66.13 -41.3 90.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 110.537 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -79.06 -8.72 59.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.65 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.549 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -90.63 -54.28 4.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.084 0.468 . . . . 0.0 110.746 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.447 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.73 34.45 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.891 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.592 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.63 179.99 5.88 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.301 0.572 . . . . 0.0 111.12 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -159.69 56.22 0.84 Allowed Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.812 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.3 Cg_endo -80.67 -172.23 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.538 2.159 . . . . 0.0 112.116 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -119.08 152.41 36.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.926 0.393 . . . . 0.0 110.142 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.91 -50.08 73.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.41 75.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.462 0.649 . . . . 0.0 110.681 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.58 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.77 -54.29 33.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.702 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.83 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -66.05 -34.54 78.3 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.366 179.71 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.688 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -64.64 -42.59 95.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.911 0.386 . . . . 0.0 110.149 179.281 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -61.87 -45.46 93.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.218 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.1 mmt -74.54 -30.7 61.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.47 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.28 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.587 -179.237 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -45.01 -28.6 0.7 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.378 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.43 -39.35 47.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.972 0.415 . . . . 0.0 110.792 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.893 HG11 HG21 ' B' ' 6' ' ' ILE . 4.7 m -80.59 -11.68 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.143 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 38.8 t0 -103.61 155.56 18.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.738 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.491 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.66 -29.08 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.061 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -116.52 -9.66 11.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.429 0.633 . . . . 0.0 110.42 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.2 64.04 4.69 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.445 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -112.45 17.7 19.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.872 0.368 . . . . 0.0 110.214 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.29 19.9 53.85 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.512 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -147.62 176.36 10.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.48 HD12 HD11 ' A' ' 32' ' ' LEU . 54.1 mt -115.03 136.49 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 120.609 0.242 . . . . 0.0 110.853 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.4 m-20 -86.91 -178.42 6.3 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.256 0.551 . . . . 0.0 111.836 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.521 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.87 -55.74 13.06 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.769 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.7 Cg_endo -65.56 -35.14 39.58 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.291 1.994 . . . . 0.0 111.244 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.37 -52.34 62.1 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.242 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.723 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.9 -56.92 15.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.907 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.701 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -54.73 -48.18 72.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.732 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 76.5 m -58.74 -32.3 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.203 0.525 . . . . 0.0 109.716 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.91 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.7 tpp -67.86 -61.6 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.938 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.639 ' HG2' HG22 ' B' ' 10' ' ' ILE . 3.0 mtt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.742 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.795 0.331 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -50.42 -30.48 12.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.241 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.557 ' O ' HG11 ' B' ' 19' ' ' VAL . 4.6 mt-10 -73.77 -29.45 62.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.718 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.654 HG22 ' HE1' ' A' ' 138' ' ' TYR . 14.4 mt -79.04 -51.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -71.95 -50.46 28.76 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 91' ' ' VAL . 83.1 mt-10 -53.51 -25.22 15.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 110.779 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.743 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.72 -36.77 50.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.271 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.9 t80 -68.46 -51.4 43.94 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.014 0.435 . . . . 0.0 110.097 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -55.03 -32.17 61.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.799 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 87' ' ' GLU . 52.0 t -88.78 -22.73 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.617 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.38 -30.11 38.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.049 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -109.13 139.47 43.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.449 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.02 -38.54 91.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.591 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -107.85 -9.64 15.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.18 31.03 39.72 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.144 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -67.53 -13.82 62.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.041 0.421 . . . . 0.0 110.756 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.452 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 100.91 -12.15 59.11 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.976 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 20.3 m-85 -127.35 146.15 50.56 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.914 0.387 . . . . 0.0 111.338 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.834 ' CD1' HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.15 110.01 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.807 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t -83.07 178.24 8.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.43 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.543 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.83 -28.12 69.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.093 0.473 . . . . 0.0 110.557 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.96 -56.8 12.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.291 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.3 mm-40 -76.35 -42.49 44.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.232 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.834 HD13 ' CD1' ' A' ' 100' ' ' ILE . 22.6 tp -56.55 -33.61 66.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.847 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.3 ttt-85 -71.79 -49.47 38.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.945 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -61.87 -38.43 88.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 110.376 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.837 ' O ' HD12 ' A' ' 112' ' ' LEU . 39.9 t -73.06 -43.97 57.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.403 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.451 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 25.4 mmt -73.99 -54.02 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.465 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.619 HG23 ' HA ' ' A' ' 115' ' ' LYS . 8.0 m -55.38 -46.87 76.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.478 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.88 -29.77 68.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.88 ' O ' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -123.0 38.21 4.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.678 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.42 -113.96 0.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.773 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' O ' HD23 ' A' ' 116' ' ' LEU . 4.7 pt-20 -135.21 169.21 17.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.619 ' HA ' HG23 ' A' ' 110' ' ' THR . 6.7 ttpt -73.83 99.75 3.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.0 115.25 27.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.373 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.935 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.81 175.21 5.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.41 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -48.0 -35.89 11.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.397 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -77.4 -35.91 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.71 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -71.66 -33.31 68.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.951 0.405 . . . . 0.0 110.065 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.86 -49.12 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.56 . . . . 0.0 109.849 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -59.46 -52.76 64.22 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.758 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -57.33 -28.7 63.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.82 ' HG3' HD21 ' A' ' 105' ' ' LEU . 10.2 tpt -76.19 -39.43 54.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.121 0.486 . . . . 0.0 110.241 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.495 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -66.58 -41.11 87.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.369 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -64.21 -41.59 96.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.444 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 124' ' ' MET . 7.6 pt-20 -82.73 -33.13 27.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.476 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.39 -35.25 77.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.454 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.707 ' HB2' HG22 ' A' ' 136' ' ' VAL . 20.9 t0 -106.09 146.1 30.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.029 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.562 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.0 pt -82.73 -40.95 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.147 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.562 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.95 -11.05 60.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.675 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.74 33.11 1.0 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.443 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.2 p-10 -96.58 -12.62 23.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.307 -0.946 . . . . 0.0 112.466 -176.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.21 10.18 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.777 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.5 147.21 30.94 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.134 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.707 HG22 ' HB2' ' A' ' 129' ' ' ASP . 26.5 t -130.73 107.25 13.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.364 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.3 t-20 -80.57 174.57 11.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.222 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.654 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.95 -67.15 0.31 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.54 0.686 . . . . 0.0 111.488 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.412 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.3 mt-10 -60.75 -29.54 69.45 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.563 -1.198 . . . . 0.0 111.913 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.565 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.91 -44.05 77.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.08 0.467 . . . . 0.0 109.762 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -31.91 46.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.134 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 138' ' ' TYR . 67.5 t -54.03 -48.29 64.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.132 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.625 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -57.99 -44.99 87.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.7 tpp -73.14 -32.92 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.7 ttp . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.919 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.941 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.3 -50.89 61.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.056 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.726 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.72 -53.26 32.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.678 0.275 . . . . 0.0 111.241 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -57.07 -37.68 72.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.051 0.453 . . . . 0.0 110.365 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.941 HG23 ' O ' ' B' ' 1' ' ' ALA . 12.4 t -63.45 -33.64 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.415 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.893 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.52 -55.43 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.026 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.2 mmm-85 -50.58 -37.61 40.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.214 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -69.76 -47.17 63.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.543 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.837 ' HD2' HD23 ' A' ' 32' ' ' LEU . 14.6 mtmt -56.0 -55.41 33.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.91 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.52 -57.34 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.049 0.452 . . . . 0.0 111.059 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -56.16 -51.19 68.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.954 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.552 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.39 -40.24 64.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.094 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.571 ' O ' ' HB2' ' B' ' 17' ' ' ALA . 3.1 mt -54.44 -51.52 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.506 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.3 -36.27 93.19 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.08 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.916 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.73 -61.44 2.18 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.812 -0.694 . . . . 0.0 110.413 -178.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.668 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -62.97 -27.84 69.68 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.647 177.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -66.05 -51.31 59.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.226 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.564 ' NE ' HG12 ' B' ' 19' ' ' VAL . 3.7 ppt_? -63.49 -43.48 97.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.977 0.418 . . . . 0.0 109.918 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.916 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.4 m -66.61 -32.29 57.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.679 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.668 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -71.65 -50.94 25.95 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.955 -179.191 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.448 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 54.7 p -57.85 -36.24 72.05 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.482 HG22 ' C ' ' B' ' 19' ' ' VAL . 26.8 m -72.55 -45.25 59.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.102 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.537 HD21 ' CD1' ' B' ' 20' ' ' PHE . 3.1 pp -65.71 -26.42 67.75 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.084 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 12.7 ptt180 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.926 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.63 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.765 0.317 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.4 ' HB2' HD21 ' A' ' 4' ' ' LEU . 4.8 m-20 -64.87 -169.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -117.28 89.42 3.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.02 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.632 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.93 164.72 12.25 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.482 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.49 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.0 p -97.84 162.47 13.24 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.527 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -47.51 -51.42 20.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.831 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.39 -27.62 69.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.022 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.49 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.4 -51.43 20.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.72 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.9 pt -73.24 -28.9 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.862 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.47 -27.39 10.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 17.9 mt-10 -75.21 -28.57 60.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.256 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.35 -58.5 3.18 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.873 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 10.9 ptmt -54.52 -23.01 14.64 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.206 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.37 -27.93 56.58 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.143 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.39 -39.9 62.41 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.106 177.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.873 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.8 -51.94 67.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.79 0.805 . . . . 0.0 109.398 178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.43 -24.14 59.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.089 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.903 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.14 -26.29 33.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.22 0.533 . . . . 0.0 110.147 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.878 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.9 t80 -91.24 -1.4 57.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.356 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.9 t70 -103.09 144.11 31.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.004 0.907 . . . . 0.0 111.072 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -60.37 -53.4 58.02 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 113.859 -1.519 . . . . 0.0 111.68 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.29 -6.51 59.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.75 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.06 46.16 56.23 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.169 -0.538 . . . . 0.0 113.371 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.3 p30 -90.88 17.95 7.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.831 0.348 . . . . 0.0 110.732 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.55 88.65 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 49.6 p -150.29 148.98 29.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -100.54 140.52 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.016 0.436 . . . . 0.0 111.907 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.594 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.52 178.07 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.131 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.812 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -70.46 -40.45 73.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.107 0.479 . . . . 0.0 110.382 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -58.48 -40.87 83.94 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.402 178.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.824 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.61 -53.86 16.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.378 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.758 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -57.33 -54.17 49.85 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.785 0.802 . . . . 0.0 109.583 178.57 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.69 -46.78 92.87 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.27 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.9 m -66.25 -30.14 70.52 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.757 0.313 . . . . 0.0 110.493 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.878 HG21 ' CE2' ' A' ' 19' ' ' PHE . 16.7 t -64.03 -57.89 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.06 0.457 . . . . 0.0 110.635 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -72.48 -40.38 66.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.255 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -61.09 -38.87 87.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 110.378 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -78.8 -12.23 60.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.526 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.548 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -87.46 -53.48 4.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.0 110.544 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' N ' HD23 ' A' ' 39' ' ' LEU . . . 180.0 35.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.568 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.609 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -131.31 -179.96 5.66 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.287 0.565 . . . . 0.0 111.245 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -159.71 56.17 0.84 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.783 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.3 Cg_endo -80.72 -173.52 1.88 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.588 2.192 . . . . 0.0 112.202 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -119.7 152.39 37.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 110.075 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.71 -50.14 73.07 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.85 76.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.711 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.577 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.91 -54.37 31.91 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.76 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.812 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.65 -38.18 90.12 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.313 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.711 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -61.79 -42.57 99.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.884 0.373 . . . . 0.0 110.428 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -61.73 -46.09 91.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.5 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -30.6 61.73 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.606 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -53.66 -40.19 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.761 -178.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.423 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.4 m-80 -45.11 -28.68 0.77 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.383 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.84 -38.0 47.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.977 0.418 . . . . 0.0 110.734 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.057 HG11 HG21 ' B' ' 6' ' ' ILE . 3.8 m -80.8 -12.63 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 43.2 t0 -103.46 155.25 18.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.699 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.09 26.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.179 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -116.44 -9.72 11.42 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.402 0.62 . . . . 0.0 110.415 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.72 61.52 7.29 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.295 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -109.74 18.49 20.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.758 0.313 . . . . 0.0 110.411 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.32 19.96 59.65 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.303 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.4 p -147.48 176.23 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.758 HD12 HD11 ' A' ' 32' ' ' LEU . 14.2 mt -113.47 136.66 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.644 0.259 . . . . 0.0 110.717 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -86.24 -179.96 6.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.208 0.528 . . . . 0.0 111.876 -179.384 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.89 -55.88 12.71 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.471 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.7 Cg_endo -65.76 -35.04 38.28 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.186 1.924 . . . . 0.0 111.18 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -52.51 63.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.724 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.35 -56.66 19.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.816 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.73 -47.92 78.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.813 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.63 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 53.3 m -59.39 -30.66 68.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.473 . . . . 0.0 110.102 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.89 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.1 tpp -63.61 -61.79 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.112 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.403 ' CG ' HG22 ' B' ' 10' ' ' ILE . 40.3 mtm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.145 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.791 0.329 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -50.72 -30.67 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.681 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -78.16 -29.44 48.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.678 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.685 HG22 ' HE1' ' A' ' 138' ' ' TYR . 8.4 mt -79.21 -51.13 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.32 -52.04 11.77 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 91' ' ' VAL . 10.1 tt0 -53.85 -25.63 20.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.703 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.46 -35.75 46.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.265 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.601 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 27.6 t80 -68.58 -51.38 43.2 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 110.026 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -54.76 -32.61 60.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.796 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 87' ' ' GLU . 46.6 t -88.75 -22.67 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.631 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.487 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -53.05 -33.33 51.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.271 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -100.64 148.85 24.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.519 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.27 -37.69 78.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.22 -9.77 13.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.782 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.59 28.47 32.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.313 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -67.51 -13.97 62.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.183 0.491 . . . . 0.0 110.752 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.27 -10.27 56.53 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.187 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.469 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.5 m-85 -127.08 145.42 50.74 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.988 0.423 . . . . 0.0 111.5 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.829 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.18 109.9 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.843 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -83.84 175.18 9.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.329 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.549 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -62.63 -29.05 70.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.001 0.429 . . . . 0.0 110.37 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -56.81 14.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.252 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.769 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.37 -46.54 26.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.279 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.829 HD13 HD13 ' A' ' 100' ' ' ILE . 15.5 tp -52.99 -36.07 59.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.798 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.2 ttt180 -68.05 -49.1 63.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.877 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -58.17 -44.52 88.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.232 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.826 ' O ' HD12 ' A' ' 112' ' ' LEU . 1.8 t -73.01 -42.28 59.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.552 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.477 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 26.6 mmt -70.16 -54.06 14.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.514 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 115' ' ' LYS . 7.3 m -58.39 -48.36 80.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.3 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -58.48 -29.29 66.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.84 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.903 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -122.98 37.52 4.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.75 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -168.85 -116.17 0.36 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.708 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 110' ' ' THR . 6.3 pt-20 -131.51 172.23 12.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.72 0.295 . . . . 0.0 110.777 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.625 ' HA ' HG23 ' A' ' 110' ' ' THR . 12.3 ttpt -75.78 98.77 4.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.288 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.967 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.4 OUTLIER -91.47 112.72 24.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.551 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.917 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.8 174.9 6.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.328 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.11 -36.13 12.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 0.0 110.757 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -77.38 -33.91 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.757 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -73.64 -34.72 65.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.023 0.439 . . . . 0.0 110.023 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.967 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -72.73 -47.99 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.872 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -58.81 -52.87 63.89 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.837 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -56.64 -28.91 61.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.928 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.82 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.8 tpt -76.31 -38.73 55.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.182 0.515 . . . . 0.0 110.111 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.51 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -67.51 -48.51 76.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.521 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -60.26 -40.32 89.9 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.85 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 124' ' ' MET . 14.1 pt-20 -80.55 -37.13 32.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 110.604 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.436 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.83 -36.47 82.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.555 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.722 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.4 t0 -101.57 147.87 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.062 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.56 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.7 pt -84.88 -40.74 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.048 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.56 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.98 -10.9 59.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.692 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.09 32.68 1.1 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.433 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.1 -12.79 24.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.303 -0.949 . . . . 0.0 112.482 -176.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.89 20.12 10.22 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.813 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.51 146.83 30.66 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.928 0.395 . . . . 0.0 110.029 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 129' ' ' ASP . 35.4 t -130.74 107.39 14.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.307 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.1 t-20 -79.18 174.69 11.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.337 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.685 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.84 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.548 0.69 . . . . 0.0 111.421 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -60.3 -34.77 74.26 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.839 -178.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.505 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.06 -41.55 75.24 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.059 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.823 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.77 -31.85 46.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.022 178.646 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 138' ' ' TYR . 53.6 t -55.54 -47.23 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.596 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -56.07 -45.15 79.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.966 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.16 -32.11 64.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.5 ' HE2' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.939 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.714 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.47 -52.17 55.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.214 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.704 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.78 -53.32 32.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 111.394 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.94 -36.89 70.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 0.0 110.295 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.939 HG23 ' O ' ' B' ' 1' ' ' ALA . 39.6 t -62.05 -39.19 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.1 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 1.057 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -65.92 -55.48 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.166 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -50.91 -37.31 43.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.022 0.439 . . . . 0.0 110.202 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -73.32 -45.86 52.86 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.718 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.876 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.4 OUTLIER -55.02 -55.47 30.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.999 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.89 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.5 mt -51.49 -57.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.421 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -57.8 -51.33 70.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.218 0.532 . . . . 0.0 111.021 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.525 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.46 -42.47 67.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.779 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.785 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.3 mt -54.57 -48.07 71.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.577 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.26 -38.26 96.18 Favored Glycine 0 CA--C 1.499 -0.954 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.077 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.897 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.14 -61.75 2.06 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.831 -0.685 . . . . 0.0 110.445 -178.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.651 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -61.8 -27.84 69.04 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.65 177.799 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.19 -50.89 64.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.258 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.713 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.89 -43.65 95.37 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.897 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -64.34 -33.68 64.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.532 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.711 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.4 OUTLIER -74.3 -45.04 50.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.737 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.528 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.8 p -59.85 -25.96 65.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.457 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.407 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.5 -46.15 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.134 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.935 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.83 -34.23 76.88 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.164 0.507 . . . . 0.0 110.323 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.935 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.064 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.827 0.346 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.69 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.762 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -123.78 89.36 3.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.107 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.629 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.03 164.71 12.41 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.354 179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.504 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.2 p -97.89 162.31 13.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.482 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -47.53 -51.4 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.819 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -64.48 -27.66 69.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.018 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.504 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.22 -51.52 20.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.683 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.703 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.0 pt -73.31 -28.89 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.806 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.31 10.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.537 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 13.8 mt-10 -75.38 -28.62 59.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.369 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.1 m-85 -79.25 -58.69 3.09 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.174 0.511 . . . . 0.0 111.189 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.872 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -55.37 -21.89 17.33 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.249 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -77.23 -28.03 53.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.18 -40.1 62.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.082 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.872 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.46 -51.95 67.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.853 0.835 . . . . 0.0 109.448 178.707 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 5.1 p -74.35 -24.27 59.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.161 -1.382 . . . . 0.0 112.149 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.905 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.14 -25.85 34.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.31 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.878 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.7 t80 -92.16 -1.99 56.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.632 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.9 t70 -101.77 143.5 31.62 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.963 0.887 . . . . 0.0 111.152 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -60.16 -53.38 58.44 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.552 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.15 -5.6 59.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.791 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.22 46.45 51.42 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.349 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -91.11 18.17 7.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.82 0.343 . . . . 0.0 110.704 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.52 5.1 88.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.605 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 47.0 p -150.29 149.25 29.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.748 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.8 140.51 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.895 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.631 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.29 177.01 7.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.124 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.8 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -70.35 -39.05 74.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.102 0.477 . . . . 0.0 110.301 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.35 -40.78 87.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.285 178.81 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.817 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.57 -53.83 17.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.329 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.771 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -57.7 -54.38 47.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.786 0.803 . . . . 0.0 109.531 178.581 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.33 -46.63 92.69 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.296 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.1 m -66.76 -30.06 70.18 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.749 0.309 . . . . 0.0 110.479 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.878 HG21 ' CE2' ' A' ' 19' ' ' PHE . 13.0 t -63.51 -57.95 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 0.0 110.534 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.534 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -72.44 -40.94 66.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.196 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -39.26 86.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.982 0.42 . . . . 0.0 110.494 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -78.81 -12.14 60.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.537 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.3 tt -87.73 -54.07 4.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 0.0 110.596 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.467 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -179.02 36.87 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.752 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 tp-100 -134.9 -179.46 5.62 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.332 0.587 . . . . 0.0 111.22 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -159.68 56.35 0.86 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.892 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.49 -176.71 3.32 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.583 2.189 . . . . 0.0 112.153 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.604 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -115.89 152.5 33.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 110.203 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.11 -49.64 75.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -34.19 77.57 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.98 -54.35 31.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.657 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.8 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.7 -38.17 90.08 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 120.246 -0.581 . . . . 0.0 110.329 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.715 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.36 -42.15 99.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.891 0.377 . . . . 0.0 110.405 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.09 -47.34 86.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.431 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.41 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 23.9 mmt -74.51 -30.32 61.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.732 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.42 -38.64 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.584 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -45.52 -28.53 0.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.298 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.74 -38.03 47.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.935 0.398 . . . . 0.0 110.833 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.082 HG11 HG21 ' B' ' 6' ' ' ILE . 4.2 m -81.92 -11.78 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.218 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.552 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.9 t0 -103.46 155.48 18.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.729 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.477 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.58 -28.73 26.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.084 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -116.38 -9.72 11.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.387 0.613 . . . . 0.0 110.458 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.38 63.08 5.56 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.467 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -112.19 18.45 18.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.835 0.35 . . . . 0.0 110.194 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 85.9 19.95 56.71 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.445 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.631 HG22 ' HA ' ' A' ' 28' ' ' THR . 5.0 p -146.5 176.44 9.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.771 HD12 HD11 ' A' ' 32' ' ' LEU . 15.1 mt -116.44 136.48 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.522 0.201 . . . . 0.0 110.883 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 8.7 m-20 -86.67 -178.95 6.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.273 0.558 . . . . 0.0 111.908 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.84 -55.94 12.72 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.607 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -65.6 -35.05 39.63 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.22 1.947 . . . . 0.0 111.223 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.64 -52.38 63.57 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.199 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.06 -56.86 16.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.844 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.703 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.11 -47.5 80.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.729 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.413 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 58.3 m -59.06 -30.76 68.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.055 0.455 . . . . 0.0 110.061 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.904 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.1 tpp -65.54 -61.75 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.229 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.485 ' CG ' HG22 ' B' ' 10' ' ' ILE . 12.1 mtm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.104 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.77 0.319 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -77.22 -42.07 38.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.274 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.708 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.71 -29.32 26.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.541 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.726 HG22 ' HE1' ' A' ' 138' ' ' TYR . 23.0 mt -66.07 -51.42 60.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.794 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -75.81 -50.65 14.58 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.774 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.7 mt-10 -53.87 -30.69 46.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.661 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.557 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -71.16 -38.62 72.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.792 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.6 t80 -67.08 -55.92 12.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 0.0 110.541 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.85 -30.51 45.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.832 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 87' ' ' GLU . 75.6 t -88.36 -22.86 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.309 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.25 -32.54 62.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.982 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -102.08 148.64 25.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -69.62 -37.53 76.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.375 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -112.26 -9.76 13.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.5 30.65 32.61 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.119 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -67.42 -13.52 62.1 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.928 0.364 . . . . 0.0 110.823 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.46 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.16 -13.61 55.44 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.846 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.5 m-85 -127.22 145.9 50.61 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.961 0.41 . . . . 0.0 111.3 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.713 HD12 HD12 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.09 109.99 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.85 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -82.19 177.71 8.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.48 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.3 -28.17 69.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.009 0.433 . . . . 0.0 110.559 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.35 -57.72 9.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.314 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.8 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.47 -38.74 54.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.006 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.918 HD11 ' HG3' ' A' ' 124' ' ' MET . 5.5 tt -56.5 -33.15 65.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.821 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.7 ttt180 -74.77 -49.4 21.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.172 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -60.76 -36.72 79.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.064 0.459 . . . . 0.0 110.321 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 104' ' ' GLU . 45.6 t -72.9 -45.69 54.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.242 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.454 ' HE3' HD11 ' B' ' 23' ' ' LEU . 22.3 mmt -73.93 -54.14 8.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.818 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.577 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.2 m -55.46 -43.11 75.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 111.362 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.463 ' C ' HD12 ' A' ' 112' ' ' LEU . 38.4 t-20 -61.21 -31.81 71.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.788 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.905 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -123.17 38.76 4.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.31 -116.96 0.39 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.782 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.404 ' O ' HD23 ' A' ' 116' ' ' LEU . 14.6 pt-20 -133.61 171.88 13.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.821 0.343 . . . . 0.0 110.944 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.577 ' HA ' HG23 ' A' ' 110' ' ' THR . 24.7 ttpt -75.38 100.08 4.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.294 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.951 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.41 115.48 26.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.29 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.933 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.76 174.99 6.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.404 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 117' ' ' THR . 0.6 OUTLIER -48.0 -35.76 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.92 0.391 . . . . 0.0 110.734 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.29 -36.15 54.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.699 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -71.13 -34.56 71.14 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.056 0.455 . . . . 0.0 110.084 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.951 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -73.62 -50.02 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.351 0.596 . . . . 0.0 109.776 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -59.76 -52.85 63.7 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.859 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.84 -28.83 62.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.938 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.918 ' HG3' HD11 ' A' ' 105' ' ' LEU . 7.4 tpt -76.35 -38.75 55.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.151 0.5 . . . . 0.0 110.13 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.619 HG12 HD13 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -66.15 -49.07 78.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.521 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -60.13 -40.12 88.66 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.967 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 124' ' ' MET . 12.2 pt-20 -81.01 -37.31 29.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 110.647 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.466 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.33 -36.96 84.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.518 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.747 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.1 t0 -100.39 148.1 25.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.025 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.563 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.8 -40.8 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.297 0.57 . . . . 0.0 110.073 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.563 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.83 -11.03 60.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.682 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.14 32.59 1.1 Allowed Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.04 -12.94 24.16 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.309 -0.946 . . . . 0.0 112.434 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.88 20.18 10.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.81 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.74 146.69 30.38 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.905 0.383 . . . . 0.0 110.061 179.193 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.747 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.7 t -130.67 107.47 14.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.24 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -80.01 174.65 11.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.426 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.726 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.97 -67.06 0.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.479 0.657 . . . . 0.0 111.531 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -34.15 72.9 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.913 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.532 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.12 -40.34 73.61 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.827 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.79 -33.67 46.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.114 178.562 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.582 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.6 t -54.86 -47.43 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.688 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -58.13 -45.2 87.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.12 -32.5 64.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.408 ' HE1' HG12 ' A' ' 85' ' ' ILE . 14.1 ttp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.937 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.717 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.44 -52.37 54.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.209 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.714 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.83 -53.2 34.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.291 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -56.84 -37.02 70.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.009 0.433 . . . . 0.0 110.256 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.937 HG23 ' O ' ' B' ' 1' ' ' ALA . 40.7 t -61.94 -39.16 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.081 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 1.082 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -66.03 -55.53 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.15 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -50.96 -37.16 42.88 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.2 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.22 -45.55 55.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.622 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.872 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.3 OUTLIER -55.33 -55.32 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.129 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.904 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.5 mt -51.29 -57.5 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.802 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.506 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.8 tpt180 -60.3 -51.32 70.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.273 0.559 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.35 -40.13 64.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.679 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.737 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.46 -47.75 70.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.27 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.41 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.92 -38.25 95.81 Favored Glycine 0 CA--C 1.497 -1.06 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.493 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.898 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.93 -61.61 2.06 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.646 -0.777 . . . . 0.0 110.507 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.76 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.19 -27.49 67.19 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.546 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.81 -48.57 65.89 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.017 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.7 ppt_? -63.28 -43.57 97.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.127 0.489 . . . . 0.0 109.798 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.898 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -61.78 -34.82 64.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.348 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.752 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -74.95 -43.94 51.27 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.633 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.548 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 18.7 p -60.74 -25.77 66.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.495 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.418 HG23 ' N ' ' B' ' 23' ' ' LEU . 29.3 m -90.25 -46.5 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.09 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.954 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.37 -34.47 76.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.184 0.516 . . . . 0.0 110.348 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.954 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.092 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.627 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.821 0.343 . . . . 0.0 111.069 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.65 -169.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -117.5 90.65 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.975 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.2 mt -98.72 164.88 12.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.557 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.484 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.3 p -96.94 161.82 13.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.494 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.52 -51.91 19.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.798 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -64.28 -27.73 69.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.015 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.94 -51.52 21.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.662 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.701 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.6 pt -72.84 -28.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.816 -179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.36 -27.29 9.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 7.9 mt-10 -74.88 -28.5 60.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.171 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.6 -58.34 3.24 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.198 0.523 . . . . 0.0 110.994 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.871 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -54.45 -23.01 14.3 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.188 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.24 -27.94 56.96 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.138 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.48 -39.8 62.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.079 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.871 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.93 -51.82 68.39 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.85 0.834 . . . . 0.0 109.416 178.71 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.43 -24.26 59.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.096 -1.411 . . . . 0.0 112.134 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.857 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.2 tt -82.08 -24.24 35.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.248 0.547 . . . . 0.0 110.191 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.815 ' HB3' HD11 ' A' ' 27' ' ' ILE . 2.6 t80 -95.61 0.82 53.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.434 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.9 t70 -105.58 145.13 31.37 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.013 0.911 . . . . 0.0 111.123 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.0 mmtt -60.54 -53.39 58.07 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.587 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.43 -6.09 59.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.06 47.23 55.12 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.194 -0.526 . . . . 0.0 113.515 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -92.66 17.8 9.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.871 0.367 . . . . 0.0 110.469 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.16 9.25 86.34 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.258 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.462 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 72.8 p -150.16 147.23 27.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.6 mt -101.96 140.39 20.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.904 0.383 . . . . 0.0 111.927 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.683 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.4 t -87.27 -179.29 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.123 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.791 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.4 p -70.49 -45.51 65.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 110.899 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.648 ' HG3' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -54.54 -40.54 68.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.449 178.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.911 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -69.52 -53.83 17.14 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.467 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.858 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.92 -56.07 26.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.78 0.8 . . . . 0.0 109.379 178.569 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -56.86 -46.2 90.73 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.64 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.2 m -62.05 -35.01 77.31 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.047 0.423 . . . . 0.0 110.542 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.0 t -64.0 -57.19 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.46 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -71.82 -36.05 70.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.404 -179.404 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 2.8 ttt-85 -67.25 -41.22 85.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.999 0.428 . . . . 0.0 110.48 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 t -79.0 -8.32 58.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.627 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.541 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.82 -54.33 4.02 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.762 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.447 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.91 34.57 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.837 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.596 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.76 -179.37 5.49 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.317 0.58 . . . . 0.0 111.141 -179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -159.67 56.39 0.87 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.815 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.8 Cg_endo -80.56 -174.85 2.41 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.568 2.179 . . . . 0.0 112.117 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -116.87 152.45 34.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.945 0.402 . . . . 0.0 110.159 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.69 -50.03 73.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.14 74.94 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.75 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.98 -54.3 32.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.733 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.791 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.71 -35.57 81.12 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.419 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.752 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -63.4 -42.95 98.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.868 0.366 . . . . 0.0 110.224 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.85 -45.36 94.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.373 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.56 -30.68 61.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.449 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -53.72 -39.51 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.637 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.415 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 5.9 m-80 -44.99 -28.64 0.7 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.387 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.65 -38.52 54.47 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.954 0.407 . . . . 0.0 110.73 179.79 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.816 HG11 HG21 ' B' ' 6' ' ' ILE . 5.5 m -80.99 -12.77 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.049 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 42.9 t0 -103.5 154.88 18.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.815 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.68 -28.03 26.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.227 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -116.42 -9.72 11.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.386 0.612 . . . . 0.0 110.423 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.91 61.66 7.11 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.315 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -109.52 18.4 20.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 110.475 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.75 18.93 60.66 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.407 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 28' ' ' THR . 6.2 p -146.54 176.12 10.06 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 26' ' ' THR . 61.0 mt -112.91 136.49 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.585 0.231 . . . . 0.0 110.675 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -85.12 179.56 7.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.243 0.544 . . . . 0.0 111.824 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.518 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 6.3 m-85 -67.45 -56.52 12.32 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.285 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.82 -36.11 33.03 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.326 2.017 . . . . 0.0 111.071 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.61 -52.32 65.67 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.135 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.94 -56.29 23.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.657 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.701 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.34 -46.67 83.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.706 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.627 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 65.1 m -61.2 -31.79 71.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.013 0.435 . . . . 0.0 110.11 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.925 ' HG2' HD13 ' B' ' 10' ' ' ILE . 4.5 tpp -60.86 -61.77 2.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.125 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.8 mtp . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.991 -179.871 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -50.47 -30.51 12.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.564 ' O ' HG11 ' B' ' 19' ' ' VAL . 4.7 mt-10 -76.49 -29.59 56.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.685 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.691 HG22 ' HE1' ' A' ' 138' ' ' TYR . 11.2 mt -79.26 -51.13 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -48.41 39.04 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.893 0.378 . . . . 0.0 111.87 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.41 ' OE2' ' HB1' ' B' ' 12' ' ' ALA . 6.5 tt0 -53.6 -26.31 21.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.344 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.742 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.4 -34.31 58.83 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.052 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 12.8 t80 -68.79 -50.05 53.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.12 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -54.5 -33.17 59.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.778 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.8 t -88.95 -22.79 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.542 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.28 -33.63 53.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.206 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -106.18 139.24 41.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.521 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -64.74 -34.77 79.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -112.15 -9.7 13.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.97 29.26 38.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.36 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.68 -13.92 62.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.134 0.467 . . . . 0.0 110.745 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 100.48 -11.6 59.75 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.004 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.483 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.3 m-85 -127.19 147.3 50.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.038 0.447 . . . . 0.0 111.438 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.085 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.19 109.96 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.721 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 t -82.62 176.52 9.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.46 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.09 -29.71 70.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.075 0.464 . . . . 0.0 110.477 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.26 -57.8 10.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.236 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.816 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.45 -45.38 31.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.126 -179.214 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.085 HD13 HD13 ' A' ' 100' ' ' ILE . 31.9 tp -52.95 -31.24 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.191 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.832 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.9 ttt-85 -73.47 -49.17 28.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -58.67 -42.48 88.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.074 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.9 t -72.99 -40.04 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.546 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.7 mmt -73.99 -54.18 8.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.528 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.636 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.4 m -55.5 -46.96 76.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.376 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -59.9 -30.7 69.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.857 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -121.54 37.52 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.49 -113.97 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.688 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.1 pt-20 -135.87 170.61 15.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.824 0.345 . . . . 0.0 110.805 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.636 ' HA ' HG23 ' A' ' 110' ' ' THR . 9.6 tttm -73.73 98.22 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.152 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.14 113.52 24.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.385 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.919 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.79 175.45 5.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.368 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -48.13 -35.93 12.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.896 0.379 . . . . 0.0 110.766 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.4 -34.51 54.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -73.44 -33.5 64.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.009 0.433 . . . . 0.0 110.096 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.47 -48.16 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.819 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.62 -52.85 63.77 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.735 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -57.48 -28.72 63.65 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.779 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.786 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.9 tpt -76.2 -38.02 57.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.121 0.486 . . . . 0.0 110.137 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.491 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.28 -41.84 81.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.494 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -66.08 -38.92 89.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.933 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.54 -35.94 29.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.512 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.471 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.54 -37.47 79.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.416 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.737 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.2 t0 -100.5 145.61 28.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.979 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.553 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.7 pt -83.17 -40.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.248 0.547 . . . . 0.0 110.101 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.553 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.9 -11.06 60.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.781 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.79 32.88 0.99 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -176.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.04 -12.48 24.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.341 -0.93 . . . . 0.0 112.53 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.2 10.18 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.84 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.483 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.31 146.76 30.82 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.2 t -130.75 107.22 13.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.354 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -78.25 175.2 10.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.206 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.735 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.91 -67.12 0.31 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.612 0.72 . . . . 0.0 111.635 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.3 mt-10 -64.96 -25.85 68.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.553 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.574 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -55.57 -48.47 74.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 110.35 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.0 p90 -78.81 -31.03 45.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.24 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 138' ' ' TYR . 65.7 t -52.8 -44.49 48.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.094 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -59.26 -38.74 80.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 109.828 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.49 -40.71 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.704 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.421 ' CG ' HG21 ' B' ' 22' ' ' VAL . 3.8 ttp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.009 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.947 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.815 0.34 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.731 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.26 -51.22 59.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.061 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.711 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.68 -53.28 32.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.261 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.95 -37.54 71.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.999 0.428 . . . . 0.0 110.31 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.947 HG23 ' O ' ' B' ' 1' ' ' ALA . 15.3 t -63.35 -34.44 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.436 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.816 HG21 HG11 ' A' ' 55' ' ' VAL . 2.2 mt -71.32 -54.89 15.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.039 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -50.94 -37.63 45.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.154 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.85 -48.32 63.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.404 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.858 ' HD2' HD23 ' A' ' 32' ' ' LEU . 13.2 mtmt -54.25 -54.08 44.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.067 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.925 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.9 mt -51.13 -57.5 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.4 tpt180 -60.06 -51.41 69.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.28 0.562 . . . . 0.0 111.089 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.39 -40.38 65.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.763 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.755 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.57 -50.8 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.462 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.52 -37.06 94.08 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.235 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.909 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.02 -61.82 2.03 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.861 -0.669 . . . . 0.0 110.529 -178.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.69 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -63.17 -27.59 69.47 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.673 177.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.89 -50.48 64.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.28 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.747 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -64.63 -43.63 93.08 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.909 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.3 m -64.98 -33.02 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.543 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.69 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -74.68 -45.92 41.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.944 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.546 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.46 -26.34 65.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.505 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.438 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.3 -47.41 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.229 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.887 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -62.79 -33.54 75.4 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.254 0.549 . . . . 0.0 110.511 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.887 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.071 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.819 0.343 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.83 -169.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.785 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -118.65 89.26 3.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.994 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.623 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.29 164.7 12.37 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.9 p -98.29 162.67 13.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.48 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -47.56 -51.31 21.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.845 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.48 -27.66 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.994 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.6 OUTLIER -72.4 -51.46 20.32 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.696 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.692 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.2 pt -73.19 -28.89 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.822 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.43 -27.45 10.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.53 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 15.2 mm-40 -75.34 -28.55 59.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.327 178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.36 -58.64 3.11 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.228 0.537 . . . . 0.0 111.083 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.56 -23.26 15.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.243 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -75.86 -28.08 58.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.123 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.07 -39.83 63.18 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.149 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.81 -51.81 68.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.762 0.791 . . . . 0.0 109.515 178.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.38 -24.41 59.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.044 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.1 -25.34 34.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.217 0.532 . . . . 0.0 110.279 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.871 ' CE2' HG21 ' A' ' 35' ' ' VAL . 3.1 t80 -92.23 -2.37 56.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.0 t70 -102.42 143.45 32.14 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.959 0.885 . . . . 0.0 111.026 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 3.7 mmtt -60.01 -53.36 58.77 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.626 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.46 -5.19 59.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.777 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.55 47.0 45.96 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.331 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.6 p30 -91.47 18.22 7.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.905 0.383 . . . . 0.0 110.711 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.54 5.27 88.6 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.589 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.9 p -150.38 148.61 29.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.782 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.32 140.55 19.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.975 0.416 . . . . 0.0 111.763 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.575 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.21 178.21 7.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.374 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.758 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -69.62 -41.2 75.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 110.353 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -58.11 -41.24 83.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.439 179.127 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.811 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.79 -53.75 16.79 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.407 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -58.07 -54.15 50.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.81 0.814 . . . . 0.0 109.555 178.648 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -58.8 -47.08 92.29 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.384 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.4 m -65.33 -30.79 71.67 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.448 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.871 HG21 ' CE2' ' A' ' 19' ' ' PHE . 16.7 t -63.88 -57.91 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.536 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -72.57 -40.25 66.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.31 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 20.5 ttt180 -61.21 -38.56 87.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 110.447 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.3 t -78.84 -12.08 60.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.539 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -87.46 -53.12 4.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.178 0.514 . . . . 0.0 110.52 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.444 ' N ' HD23 ' A' ' 39' ' ' LEU . . . 178.74 36.16 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.606 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.601 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -131.07 179.39 6.03 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.342 0.591 . . . . 0.0 111.257 -179.213 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -159.78 56.11 0.82 Allowed Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.773 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.7 Cg_endo -80.67 -173.74 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.615 2.21 . . . . 0.0 112.226 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.618 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.91 152.42 36.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.87 0.367 . . . . 0.0 110.093 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.41 -50.14 72.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.0 -32.01 72.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.602 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -66.49 -54.45 23.77 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.648 -179.442 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.758 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.26 -47.05 86.06 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.108 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.663 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -55.85 -44.94 78.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 110.806 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.4 -47.51 81.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -74.68 -30.61 61.64 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.968 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -54.15 -36.26 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.667 -178.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.401 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 22.0 t-20 -45.02 -28.64 0.72 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.282 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -79.39 -39.03 33.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.898 0.38 . . . . 0.0 110.731 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.031 HG11 HG21 ' B' ' 6' ' ' ILE . 3.6 m -80.01 -11.16 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.089 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 37.2 t0 -103.58 155.93 18.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.74 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.6 -29.38 25.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.1 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -116.51 -9.61 11.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.428 0.632 . . . . 0.0 110.442 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.4 63.86 4.85 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.519 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -112.49 17.84 18.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.807 0.337 . . . . 0.0 110.186 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.3 19.94 53.69 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.1 p -147.56 176.35 10.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.677 HD12 HD11 ' A' ' 32' ' ' LEU . 19.0 mt -115.03 136.48 51.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.554 0.216 . . . . 0.0 110.95 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.7 m-20 -88.18 -178.14 5.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.29 0.567 . . . . 0.0 112.001 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.75 -55.86 13.15 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.713 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.8 Cg_endo -65.66 -34.32 41.78 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.226 1.95 . . . . 0.0 111.267 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.72 -52.47 60.37 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.219 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.724 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.11 -57.15 13.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.88 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.692 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.23 -47.92 80.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.689 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 52.6 m -58.83 -30.54 67.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.066 0.46 . . . . 0.0 110.05 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.881 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.0 tpp -63.76 -61.71 2.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.234 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.439 ' CG ' HG22 ' B' ' 10' ' ' ILE . 7.5 mtm . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.243 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.811 0.338 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -51.5 -30.53 20.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.666 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -78.0 -29.41 49.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.704 HG22 ' HE1' ' A' ' 138' ' ' TYR . 7.2 mt -79.14 -51.26 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.438 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.3 -51.91 12.11 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 91' ' ' VAL . 12.3 tm-20 -53.76 -25.47 19.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.786 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.706 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.62 -36.21 44.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.214 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.5 t80 -68.2 -52.13 37.84 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.0 0.429 . . . . 0.0 110.1 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -54.73 -31.98 59.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.821 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 87' ' ' GLU . 47.7 t -88.69 -22.74 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.514 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.48 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.36 -34.32 57.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.26 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -99.19 147.93 24.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.467 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -67.54 -38.22 83.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.375 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.29 -9.84 13.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.804 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.93 28.29 31.9 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.246 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -67.48 -13.9 62.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.211 0.505 . . . . 0.0 110.764 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.452 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -11.0 55.35 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.146 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.463 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.9 m-85 -127.09 145.0 50.89 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.011 0.434 . . . . 0.0 111.414 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.032 HD13 HD13 ' A' ' 105' ' ' LEU . 1.1 pt -121.15 109.97 26.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.726 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -83.7 177.15 8.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.582 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.549 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.2 -29.92 71.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.084 0.469 . . . . 0.0 110.449 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.3 -57.68 11.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.28 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.778 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.48 -45.66 30.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.135 -179.205 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.032 HD13 HD13 ' A' ' 100' ' ' ILE . 37.4 tp -53.06 -31.15 40.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.848 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.1 ttt-85 -72.94 -49.06 31.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.976 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -58.9 -42.58 89.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.806 ' O ' HD12 ' A' ' 112' ' ' LEU . 1.8 t -72.85 -40.96 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.456 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.462 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 27.0 mmt -72.54 -54.08 10.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.431 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.729 HG23 ' HA ' ' A' ' 115' ' ' LYS . 6.9 m -58.95 -47.81 83.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.203 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -58.76 -30.18 67.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.805 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.915 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -123.04 38.48 4.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.651 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.6 -114.75 0.33 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.852 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.439 ' O ' HD23 ' A' ' 116' ' ' LEU . 17.8 pt-20 -133.17 166.89 21.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.334 . . . . 0.0 110.908 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.729 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.7 tttt -72.68 99.85 2.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.359 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.968 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.24 114.33 26.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.371 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.926 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.75 175.28 5.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.429 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -48.14 -35.94 12.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.763 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -77.34 -34.82 55.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.774 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -73.06 -33.49 65.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.988 0.423 . . . . 0.0 110.099 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.968 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.73 -48.03 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.854 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.62 -52.87 63.66 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.758 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -57.51 -28.8 63.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.842 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.784 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.5 tpt -76.26 -37.73 57.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.139 0.495 . . . . 0.0 110.134 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.91 -43.58 79.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.552 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -64.99 -39.09 92.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.812 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -81.17 -36.43 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.984 0.421 . . . . 0.0 110.545 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -67.95 -38.25 82.57 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.635 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.729 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.8 t0 -99.39 147.67 25.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.029 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.563 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.85 -40.73 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.06 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.563 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.91 -11.01 60.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.706 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.1 32.72 1.11 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -176.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.4 p-10 -96.11 -12.75 24.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.318 -0.941 . . . . 0.0 112.471 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.88 20.21 10.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.824 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.463 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -146.59 146.64 30.51 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.2 t -130.78 107.4 13.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.266 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.2 t-20 -79.12 174.66 11.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.302 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.704 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.83 -67.12 0.31 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.489 0.661 . . . . 0.0 111.444 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.406 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.5 OUTLIER -60.57 -34.22 73.85 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.892 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.51 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.06 -41.73 75.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 109.504 179.092 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.805 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.72 -31.92 46.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.086 178.684 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 138' ' ' TYR . 61.3 t -56.06 -46.73 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.657 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -56.53 -43.92 80.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.084 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.15 -35.31 66.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.0 ttp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.947 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.839 0.352 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.713 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.5 mmm180 -52.38 -52.15 55.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.715 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.9 -53.31 33.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.365 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.03 -36.87 70.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.033 0.444 . . . . 0.0 110.287 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.947 HG23 ' O ' ' B' ' 1' ' ' ALA . 39.1 t -62.09 -39.57 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.047 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 1.031 HG21 HG11 ' A' ' 55' ' ' VAL . 2.9 mt -65.47 -55.49 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.1 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -50.72 -37.66 42.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.171 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.55 -45.97 56.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.66 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.851 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.3 OUTLIER -55.42 -55.57 30.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.015 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.881 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.4 mt -51.53 -57.42 3.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.343 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -57.44 -51.15 70.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.37 -42.51 66.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.795 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.2 mt -54.48 -48.24 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.583 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.19 -38.24 96.19 Favored Glycine 0 CA--C 1.498 -0.987 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.079 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.902 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.17 -61.79 2.03 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.847 -0.676 . . . . 0.0 110.445 -178.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.655 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.79 -27.75 68.97 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.594 177.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -64.98 -51.36 62.17 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.258 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.716 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.88 -43.55 95.7 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.902 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -64.51 -33.39 62.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.503 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.69 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.5 OUTLIER -74.15 -45.48 48.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.788 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.534 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.0 p -59.68 -26.17 65.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.477 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.413 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.1 m -90.32 -46.16 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.172 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.935 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.38 -32.85 74.39 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.15 0.5 . . . . 0.0 110.468 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.935 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.063 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.794 0.331 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.27 -169.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.8 90.34 3.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.18 164.73 12.37 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.968 0.413 . . . . 0.0 110.375 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.493 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.0 p -98.07 162.55 13.16 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.508 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -47.47 -51.4 20.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.831 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.46 -27.7 69.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.015 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.493 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.31 -51.45 20.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.741 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.696 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.0 pt -73.21 -28.99 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.753 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.44 -27.39 10.16 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.545 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.2 mt-10 -75.24 -28.57 59.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.235 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.1 m-85 -79.35 -58.55 3.15 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.351 0.596 . . . . 0.0 110.995 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.878 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.86 -22.9 16.13 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.219 -179.732 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.545 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -76.08 -27.6 57.25 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.119 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -75.08 -39.66 60.61 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.071 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.878 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.12 -51.9 68.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.875 0.845 . . . . 0.0 109.386 178.672 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.38 -24.82 59.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.104 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.785 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.02 -26.6 33.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.127 0.489 . . . . 0.0 110.409 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.785 ' HB3' HD11 ' A' ' 27' ' ' ILE . 5.3 t80 -86.07 -21.63 27.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.226 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 31.8 t70 -83.33 146.54 28.45 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.896 0.855 . . . . 0.0 111.129 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.5 mmtt -65.39 -53.37 44.18 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.969 -1.468 . . . . 0.0 111.6 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.19 -8.0 59.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.786 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.27 46.6 63.19 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.537 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -91.8 18.19 8.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.832 0.349 . . . . 0.0 110.583 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.18 5.7 89.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.425 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 54.3 p -150.19 151.06 32.49 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.785 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -102.36 140.42 20.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.915 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.646 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.44 176.53 8.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.97 179.163 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.82 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -70.42 -39.05 74.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.149 0.499 . . . . 0.0 110.209 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.63 -40.49 87.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.133 178.693 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 35' ' ' VAL . 1.6 mm-40 -68.15 -53.88 21.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.04 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.846 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.54 -56.27 24.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.747 0.784 . . . . 0.0 109.462 178.672 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.05 -45.49 87.03 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.553 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.9 m -62.85 -32.35 73.55 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.906 0.353 . . . . 0.0 110.562 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 31' ' ' GLU . 72.6 t -66.47 -57.26 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.462 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -71.96 -37.05 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.495 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -41.4 88.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.914 0.387 . . . . 0.0 110.603 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.8 t -78.95 -8.58 59.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.682 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.85 -54.86 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.682 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.457 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.28 33.64 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.87 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.593 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.78 -179.98 5.87 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.314 0.578 . . . . 0.0 111.159 -179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -159.71 56.27 0.85 Allowed Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.831 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.8 Cg_endo -80.58 -173.9 2.03 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.535 2.157 . . . . 0.0 112.113 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.612 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -117.06 152.38 34.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.954 0.407 . . . . 0.0 110.19 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.94 -49.94 74.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.99 -31.9 72.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.734 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 44' ' ' THR . 1.6 mt-10 -66.16 -54.33 26.7 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.667 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.82 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -66.06 -34.5 78.22 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.447 179.642 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.685 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -65.02 -42.16 94.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.92 0.391 . . . . 0.0 110.138 179.169 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.65 -45.78 92.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.154 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.5 mmt -74.53 -30.88 61.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.477 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.72 -36.4 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.382 -179.323 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.408 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 7.7 t-20 -44.87 -28.7 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.34 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG2' ' NZ ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.73 -39.44 44.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.923 0.392 . . . . 0.0 110.744 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.8 HG11 HG21 ' B' ' 6' ' ' ILE . 4.3 m -81.61 -11.56 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.115 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.56 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 44.1 t0 -103.45 155.31 18.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.475 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.797 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.64 -28.77 26.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.036 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -116.51 -9.82 11.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.435 0.636 . . . . 0.0 110.473 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 59.45 61.0 7.77 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.467 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -111.18 18.16 19.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.869 0.366 . . . . 0.0 110.309 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.53 19.8 53.45 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.763 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 28' ' ' THR . 5.6 p -146.09 176.35 9.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.499 0.19 . . . . 0.0 110.501 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 32' ' ' LEU . 25.4 mt -117.59 136.58 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.57 0.224 . . . . 0.0 110.777 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.797 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 1.8 m-20 -87.77 -178.14 5.99 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.338 0.589 . . . . 0.0 112.13 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.52 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.7 m-85 -67.11 -56.2 13.94 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.638 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -65.68 -35.64 36.34 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.355 2.037 . . . . 0.0 111.307 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.28 -52.49 63.5 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.246 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.732 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.1 -56.87 16.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.776 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.696 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.07 -47.22 81.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.756 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 53.0 m -59.16 -30.65 68.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.461 . . . . 0.0 110.124 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.898 ' HG2' HD13 ' B' ' 10' ' ' ILE . 4.4 tpp -60.3 -61.74 2.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.234 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.7 mtt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.103 -179.86 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -50.43 -30.45 12.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 4.6 mt-10 -76.04 -29.62 58.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.775 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.696 HG22 ' HE1' ' A' ' 138' ' ' TYR . 10.0 mt -79.22 -50.99 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.78 -48.43 38.34 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.904 0.383 . . . . 0.0 111.85 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -53.47 -26.52 20.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.396 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.742 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.61 -34.0 58.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.037 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 12.8 t80 -68.92 -50.55 48.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.04 0.448 . . . . 0.0 110.14 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -54.39 -33.18 58.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.727 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.8 t -88.94 -22.78 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -52.74 -36.83 58.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.364 -179.242 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -100.09 147.21 25.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 0.0 110.5 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -68.3 -37.49 80.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.33 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -112.23 -9.78 13.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.815 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.43 28.28 33.5 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.354 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -67.54 -14.0 62.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.206 0.503 . . . . 0.0 110.721 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.477 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.93 -11.35 55.96 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.126 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.5 m-85 -127.2 146.93 50.23 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 120.989 0.423 . . . . 0.0 111.482 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.07 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.14 109.97 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.652 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.92 177.04 8.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.539 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.22 -30.14 71.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.111 0.482 . . . . 0.0 110.484 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.88 -57.81 11.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.239 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.812 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.48 -45.45 31.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.155 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.07 HD13 HD13 ' A' ' 100' ' ' ILE . 30.5 tp -52.95 -31.2 39.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.185 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.84 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.7 ttt-85 -73.01 -49.1 30.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.469 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 13.7 m170 -58.78 -42.66 89.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.6 t -73.07 -39.74 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 29.0 mmt -74.0 -54.14 8.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.538 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 115' ' ' LYS . 6.1 m -55.62 -48.9 74.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.35 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 51.1 m-20 -58.87 -29.68 67.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.785 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.5 mp -121.85 36.6 4.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.29 -113.2 0.28 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.716 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.444 ' O ' HD23 ' A' ' 116' ' ' LEU . 3.1 pt-20 -136.24 170.35 16.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.792 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.625 ' HA ' HG23 ' A' ' 110' ' ' THR . 5.5 ttpp -73.39 98.07 2.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.141 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.38 113.56 24.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.409 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.924 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.77 175.42 5.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.363 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.07 -35.87 12.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 0.0 110.742 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.41 -34.99 54.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.403 ' HB2' ' CA ' ' A' ' 116' ' ' LEU . 9.7 mm-40 -72.89 -33.32 65.96 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.026 0.441 . . . . 0.0 110.145 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.53 -48.62 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.342 0.591 . . . . 0.0 109.786 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.46 -52.91 63.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.775 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.25 -28.68 63.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.808 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.762 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.0 tpt -76.13 -38.1 57.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.131 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.497 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.22 -43.77 84.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.506 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -62.32 -40.82 97.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.971 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 124' ' ' MET . 8.0 pt-20 -80.64 -36.37 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.834 0.35 . . . . 0.0 110.652 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.485 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -67.53 -35.04 78.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.421 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.648 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.4 t0 -104.37 145.54 30.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.983 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.554 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.9 pt -83.03 -40.83 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.165 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.554 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.85 -11.1 60.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.78 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.81 32.74 0.98 Allowed Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -176.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.42 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -95.7 -12.38 25.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.351 -0.924 . . . . 0.0 112.548 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.78 20.27 10.16 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.903 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -146.09 147.35 31.48 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.168 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 129' ' ' ASP . 18.9 t -130.7 107.21 13.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.395 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -78.71 174.87 10.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.256 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.735 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.91 -67.15 0.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.636 0.731 . . . . 0.0 111.695 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 3.5 mt-10 -65.19 -25.49 67.73 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.583 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.481 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.52 -48.56 74.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.829 0.347 . . . . 0.0 110.333 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.9 p90 -78.88 -31.06 45.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.219 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 138' ' ' TYR . 67.6 t -52.87 -44.34 48.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.136 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -59.73 -38.51 81.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.147 0.498 . . . . 0.0 109.879 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.47 -41.04 63.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.714 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.42 ' CG ' HG21 ' B' ' 22' ' ' VAL . 8.5 ttp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.974 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.938 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.733 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.26 -51.21 59.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.021 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.724 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.62 -53.3 31.85 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.232 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.43 -37.58 70.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.069 0.462 . . . . 0.0 110.292 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.938 HG23 ' O ' ' B' ' 1' ' ' ALA . 12.1 t -64.07 -33.67 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.408 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.8 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.71 -52.73 23.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.114 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.424 ' HA ' HD12 ' B' ' 10' ' ' ILE . 31.5 mmm-85 -53.16 -37.36 61.8 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.081 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.03 -48.35 63.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.363 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.846 ' HD2' HD23 ' A' ' 32' ' ' LEU . 17.3 mtmt -55.11 -52.92 61.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.762 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.898 HD13 ' HG2' ' A' ' 71' ' ' MET . 6.1 mt -51.08 -57.44 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.053 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -58.85 -51.46 69.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.287 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.26 -40.1 64.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.825 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.4 mt -54.48 -52.38 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.537 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.63 -36.47 93.3 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.284 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.913 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.59 -61.75 2.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.526 -178.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.701 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -63.2 -27.55 69.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.658 177.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.58 -50.91 63.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.294 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.751 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -64.58 -43.73 92.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.529 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.913 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.3 m -64.95 -32.83 59.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.56 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.701 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.69 -46.13 39.81 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.897 -179.314 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.551 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.33 -26.32 64.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.446 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.439 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.22 -47.4 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.227 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.884 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -63.1 -33.25 75.04 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.2 0.524 . . . . 0.0 110.453 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.884 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.092 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.644 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.787 0.327 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.405 ' HB2' HD21 ' A' ' 4' ' ' LEU . 1.5 m-20 -83.63 -169.74 2.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -121.34 85.88 2.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.4 mt -98.29 164.79 12.16 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.479 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.478 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.1 p -96.85 161.87 13.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.519 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -47.65 -51.74 20.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.739 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -64.43 -27.69 69.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.96 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.94 -51.55 21.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.63 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -72.95 -28.85 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.775 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.43 -27.35 9.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 29.7 mt-10 -75.32 -28.57 59.72 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.251 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.34 -58.53 3.17 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.197 0.522 . . . . 0.0 111.121 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.875 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -54.68 -22.75 14.71 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.246 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.38 -28.03 56.59 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.046 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.44 -39.52 62.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.127 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.91 -51.61 69.32 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.825 0.821 . . . . 0.0 109.367 178.718 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 p -74.32 -24.65 59.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.143 -1.389 . . . . 0.0 112.029 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.78 HD11 ' O ' ' A' ' 112' ' ' LEU . 1.9 tt -81.93 -25.36 34.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.273 0.559 . . . . 0.0 110.194 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.796 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.6 t80 -92.63 -0.74 57.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.456 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.2 t70 -104.26 144.08 32.09 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.038 0.923 . . . . 0.0 111.108 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.49 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 11.5 mmtt -59.99 -53.4 58.28 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.519 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.59 -4.0 59.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.849 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.51 47.06 36.96 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.354 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -91.52 18.4 7.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.857 0.36 . . . . 0.0 110.693 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.32 88.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.615 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.4 p -150.26 148.78 29.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.647 0.261 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.796 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.41 140.46 20.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.99 0.424 . . . . 0.0 111.82 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.523 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.13 177.56 7.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.172 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.693 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -70.33 -38.75 74.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.16 0.505 . . . . 0.0 110.32 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.548 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.39 -41.34 89.17 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 178.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.93 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.4 -53.59 18.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.349 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.835 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.87 -55.62 32.75 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.79 0.805 . . . . 0.0 109.342 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.38 -45.73 88.45 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.519 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.9 m -62.72 -31.83 72.83 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.556 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.93 HG23 ' O ' ' A' ' 31' ' ' GLU . 73.7 t -66.56 -57.38 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.438 . . . . 0.0 110.838 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.494 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 2.3 tpt -72.0 -37.22 69.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.506 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -66.23 -40.94 90.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 110.613 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -79.01 -9.14 59.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.639 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.54 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -89.8 -54.02 4.24 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.634 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.442 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.92 34.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.788 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -132.89 178.78 6.61 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.344 0.593 . . . . 0.0 111.219 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -159.83 56.06 0.81 Allowed Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.709 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.3 Cg_endo -80.65 -170.25 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.552 2.168 . . . . 0.0 112.297 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.603 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.58 152.6 35.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.099 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -56.63 -50.05 73.18 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.81 -32.62 74.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.783 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.33 -54.6 26.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.727 -179.43 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.693 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.1 -44.66 96.17 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.893 179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.636 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -58.06 -49.03 78.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.715 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -53.27 -47.6 69.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.402 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 0.5 OUTLIER -74.7 -30.57 61.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.85 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.549 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -53.76 -35.0 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.524 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -45.05 -28.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.24 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -78.1 -39.12 42.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.922 0.391 . . . . 0.0 110.79 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.881 HG11 HG21 ' B' ' 6' ' ' ILE . 4.6 m -80.22 -11.02 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.182 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 37.6 t0 -103.65 155.73 18.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.787 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.501 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.6 -29.34 25.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.072 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -116.54 -9.57 11.38 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.41 0.624 . . . . 0.0 110.428 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.61 63.74 4.94 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.495 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -112.32 17.77 19.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.799 0.333 . . . . 0.0 110.195 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.25 19.99 53.71 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.553 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.3 p -147.88 176.45 10.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.743 HD12 HD11 ' A' ' 32' ' ' LEU . 12.0 mt -115.03 136.52 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.594 0.235 . . . . 0.0 111.064 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 11.0 m-20 -88.41 -177.85 5.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.281 0.562 . . . . 0.0 111.901 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.91 -55.9 12.63 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.809 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.4 Cg_endo -65.48 -34.39 43.1 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.243 1.962 . . . . 0.0 111.266 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.87 -52.43 60.03 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.308 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.714 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.04 -56.97 14.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.879 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.699 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.83 -46.54 81.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.644 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 69.6 m -61.26 -31.66 71.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.071 0.462 . . . . 0.0 110.09 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.918 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.9 tpp -60.47 -61.78 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.101 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.8 mtt . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.88 179.876 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.834 0.35 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -50.36 -30.66 12.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.317 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.662 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -71.1 -29.45 65.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.934 0.397 . . . . 0.0 110.494 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.689 HG22 ' HE1' ' A' ' 138' ' ' TYR . 17.6 mt -79.05 -49.06 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.197 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -45.45 54.3 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.945 0.402 . . . . 0.0 111.645 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.3 tp10 -53.68 -26.07 21.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.283 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.757 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.0 -33.41 51.31 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.046 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 13.4 t80 -69.33 -51.98 31.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.958 0.408 . . . . 0.0 110.283 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -54.32 -32.3 56.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.723 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 87' ' ' GLU . 42.7 t -88.82 -22.91 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.624 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.29 -36.02 60.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.028 -179.613 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -101.34 148.48 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.445 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -69.18 -37.65 78.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.377 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.16 -9.76 13.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.57 29.4 32.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.258 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.45 -13.88 62.43 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.089 0.444 . . . . 0.0 110.754 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -12.79 55.66 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.94 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 24.6 m-85 -127.13 145.84 50.6 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.956 0.408 . . . . 0.0 111.448 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.926 HD12 HD12 ' A' ' 105' ' ' LEU . 1.1 pt -121.16 109.89 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.763 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.5 m -81.06 178.34 8.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.409 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.53 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.8 -29.63 70.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.002 0.429 . . . . 0.0 110.447 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.24 -57.82 10.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.244 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.51 -39.65 52.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.03 -179.275 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.926 HD12 HD12 ' A' ' 100' ' ' ILE . 8.9 tt -55.42 -41.25 72.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.024 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.89 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.9 ttt180 -65.3 -49.49 69.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -60.46 -39.31 87.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.088 0.471 . . . . 0.0 110.184 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 104' ' ' GLU . 37.1 t -73.21 -42.14 58.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.32 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 30.6 mmt -74.1 -54.31 8.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.688 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.7 m -55.42 -43.92 75.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.445 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.498 ' C ' HD12 ' A' ' 112' ' ' LEU . 3.4 m120 -60.54 -31.43 70.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.347 . . . . 0.0 110.825 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.78 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.7 mp -122.91 37.23 4.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.736 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -167.1 -117.37 0.4 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.819 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.415 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.9 pt-20 -133.8 177.92 7.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.436 ' HA ' HG23 ' A' ' 110' ' ' THR . 22.8 tptt -78.27 97.7 5.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.299 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.976 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.86 114.84 26.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.327 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.924 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.72 174.97 6.1 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.956 -0.297 . . . . 0.0 110.363 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -48.03 -35.78 11.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.366 . . . . 0.0 110.749 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -77.32 -36.21 54.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.759 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -71.06 -33.89 70.68 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.994 0.426 . . . . 0.0 109.985 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.976 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -73.86 -50.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.402 0.62 . . . . 0.0 109.681 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.91 -52.85 63.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.717 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -28.49 64.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.777 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.683 ' HG3' HD11 ' A' ' 105' ' ' LEU . 6.7 tpt -76.2 -37.57 57.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.152 0.501 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.569 HG12 HD13 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -69.94 -39.94 78.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.287 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -70.61 -34.57 72.27 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.411 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 124' ' ' MET . 20.7 pt-20 -82.92 -39.79 21.02 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.429 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.492 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.6 -41.79 87.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.474 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.731 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.2 t0 -91.48 147.18 23.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.07 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.552 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.03 -40.68 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.015 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.92 -10.98 60.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.756 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.88 33.03 1.05 Allowed Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.31 -12.57 24.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.357 -0.922 . . . . 0.0 112.48 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.11 10.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.863 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -146.47 146.76 30.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.1 t -130.71 107.24 13.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.281 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -78.31 175.4 10.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.368 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.729 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.95 -67.1 0.31 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.674 0.75 . . . . 0.0 111.709 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.511 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.3 mt-10 -65.32 -25.28 67.54 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.568 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.576 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.56 -48.61 74.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.813 0.34 . . . . 0.0 110.369 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.6 p90 -78.89 -31.31 45.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.347 178.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 138' ' ' TYR . 73.8 t -53.07 -44.3 50.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.098 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -61.03 -35.5 77.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.095 0.474 . . . . 0.0 109.779 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.414 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 9.5 mmt -73.58 -42.3 61.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.091 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.46 ' CG ' HG21 ' B' ' 22' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.946 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.973 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.777 0.322 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.731 ' O ' HG13 ' B' ' 6' ' ' ILE . 2.1 mmm180 -52.18 -51.52 57.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.039 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.748 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.71 -53.36 31.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.591 0.234 . . . . 0.0 111.458 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -57.2 -36.98 71.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.086 0.47 . . . . 0.0 110.115 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.973 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.4 t -63.77 -34.45 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.393 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.881 HG21 HG11 ' A' ' 55' ' ' VAL . 2.7 mt -71.3 -53.65 20.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.054 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -50.97 -39.92 56.42 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.236 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.84 -48.12 67.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.418 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.849 ' O ' HD12 ' B' ' 13' ' ' ILE . 13.3 mtmt -55.01 -54.53 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.196 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.918 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.7 mt -51.11 -56.91 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.298 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.6 OUTLIER -59.54 -47.95 83.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.199 0.523 . . . . 0.0 111.155 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.11 -39.87 63.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.025 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.849 HD12 ' O ' ' B' ' 9' ' ' LYS . 1.7 mt -54.5 -52.03 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.502 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.422 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.51 -36.38 93.09 Favored Glycine 0 CA--C 1.499 -0.931 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.301 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.919 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -63.8 -61.73 2.11 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.863 -0.668 . . . . 0.0 110.468 -178.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.653 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -64.32 -27.43 69.02 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.789 177.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.12 -49.66 64.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.144 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.761 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -64.69 -43.93 91.94 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.549 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.919 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.6 m -65.07 -32.28 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.579 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.653 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.8 OUTLIER -74.57 -48.41 26.9 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.074 -179.2 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.558 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.7 p -58.43 -26.26 63.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.475 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.46 HG21 ' CG ' ' A' ' 145' ' ' MET . 27.7 m -90.24 -48.05 14.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.258 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.881 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.1 pp -62.54 -32.9 73.93 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.202 0.525 . . . . 0.0 110.442 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.881 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.111 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.63 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.797 0.332 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.1 -169.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -117.68 90.72 3.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.2 mt -98.63 164.86 12.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.485 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.4 p -96.82 161.67 13.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.479 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -47.61 -51.81 20.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.744 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -64.46 -27.63 69.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.973 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.92 -51.49 21.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.58 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.706 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -73.03 -28.9 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.801 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.49 -27.37 10.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.0 mt-10 -75.27 -28.45 59.81 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.314 178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.608 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.29 -58.5 3.19 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.301 0.572 . . . . 0.0 111.04 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.6 pttt -54.58 -22.94 14.74 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.285 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.39 -27.94 56.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.103 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.24 -39.95 62.72 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.027 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.82 -52.1 67.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.829 0.823 . . . . 0.0 109.483 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -24.21 58.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.145 -1.388 . . . . 0.0 112.117 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.883 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.3 tt -82.05 -24.68 35.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.282 0.563 . . . . 0.0 110.202 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.821 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.8 t80 -93.66 -0.83 55.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.522 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.4 t70 -102.87 143.64 32.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.997 0.904 . . . . 0.0 111.026 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.1 mmtt -60.17 -53.38 58.43 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.594 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.66 -5.9 59.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.773 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.59 45.91 53.83 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.425 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -90.83 18.05 7.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.832 0.349 . . . . 0.0 110.705 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.07 5.95 88.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.503 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.451 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 52.7 p -150.1 149.54 30.42 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -102.04 140.51 20.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.934 0.397 . . . . 0.0 112.018 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.598 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.6 176.84 7.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.929 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.811 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -70.49 -38.16 74.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.142 0.496 . . . . 0.0 110.36 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.67 -40.96 89.53 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.22 178.799 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.43 -53.73 17.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.324 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.825 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.96 -54.83 42.52 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.755 0.788 . . . . 0.0 109.422 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.57 -45.97 92.58 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 114.552 -1.203 . . . . 0.0 112.484 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.57 -31.1 71.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.86 0.33 . . . . 0.0 110.572 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 31' ' ' GLU . 72.1 t -67.86 -57.22 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.449 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.98 -35.98 69.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.46 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -42.62 80.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.953 0.406 . . . . 0.0 110.776 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 t -78.96 -8.59 59.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.753 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.7 tt -90.57 -55.09 3.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.766 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.477 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -174.5 34.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.955 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.578 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.6 tp-100 -137.66 -178.86 5.43 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.3 0.571 . . . . 0.0 111.219 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -159.65 56.59 0.89 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.913 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.41 -177.49 3.81 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.457 2.104 . . . . 0.0 112.076 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -112.44 152.45 28.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.952 0.406 . . . . 0.0 110.224 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.7 -49.09 77.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.401 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.64 -31.93 72.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.774 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 1.5 mt-10 -65.83 -54.3 28.59 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.586 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.811 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.98 -34.52 78.28 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.373 179.606 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.694 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.52 -42.6 95.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.882 0.372 . . . . 0.0 110.148 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -61.83 -45.5 93.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.219 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 mmt -74.5 -30.75 61.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.428 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.42 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.624 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -44.99 -28.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.373 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.439 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -77.57 -38.6 48.09 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.905 0.383 . . . . 0.0 110.816 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.884 HG11 HG21 ' B' ' 6' ' ' ILE . 4.5 m -81.43 -11.64 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.244 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.55 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 41.0 t0 -103.63 155.62 18.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.692 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.478 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.59 -28.89 26.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.05 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -116.45 -9.67 11.41 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.435 0.636 . . . . 0.0 110.459 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.14 63.37 5.31 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.446 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -112.37 18.26 18.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.808 0.337 . . . . 0.0 110.183 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.66 20.02 55.04 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.515 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.4 p -146.88 176.36 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.511 HD12 HD11 ' A' ' 32' ' ' LEU . 54.6 mt -116.12 136.54 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.581 0.229 . . . . 0.0 110.803 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.2 m-20 -86.97 -178.49 6.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.268 0.556 . . . . 0.0 111.948 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -67.82 -56.17 12.28 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.589 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.75 -34.81 39.18 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.248 1.965 . . . . 0.0 111.198 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.65 -52.38 63.57 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.204 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.714 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.22 -56.86 16.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.85 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.706 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.83 -46.96 81.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.63 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 59.7 m -60.26 -30.99 69.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 0.0 110.064 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.936 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.3 tpp -63.68 -61.89 2.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.104 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mtm . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.039 -179.848 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -53.47 -53.72 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.29 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.71 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.71 -29.56 27.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.486 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.773 HG22 ' HE1' ' A' ' 138' ' ' TYR . 13.8 mt -65.46 -51.29 65.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.859 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.38 -49.62 18.44 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 110.405 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.7 mt-10 -54.1 -30.22 47.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.243 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -69.88 -37.91 76.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.625 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 11.3 t80 -67.3 -53.93 25.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.519 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -54.08 -31.01 50.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.784 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 87' ' ' GLU . 87.0 t -88.63 -22.85 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.291 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.525 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -55.2 -37.21 66.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.096 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -101.48 147.23 26.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.506 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -69.64 -36.75 76.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.362 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.2 -9.74 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.4 30.14 34.48 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.245 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -67.43 -13.79 62.34 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.01 0.405 . . . . 0.0 110.782 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.19 -13.42 55.38 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.951 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 25.5 m-85 -127.19 145.49 50.74 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.01 0.433 . . . . 0.0 111.353 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.804 ' CD1' HD12 ' A' ' 105' ' ' LEU . 1.1 pp -121.1 109.89 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.705 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.68 178.9 8.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.508 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.467 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.67 -29.94 70.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.055 0.455 . . . . 0.0 110.511 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.44 -57.77 11.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.168 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.799 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.46 -41.47 47.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.951 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.804 HD12 ' CD1' ' A' ' 100' ' ' ILE . 7.7 tt -54.19 -37.46 64.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.936 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HA ' HD11 ' A' ' 116' ' ' LEU . 3.2 ttt-85 -70.06 -49.4 51.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.925 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.51 -37.56 86.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.058 0.456 . . . . 0.0 110.139 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.1 t -73.03 -45.33 54.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.232 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.455 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 21.5 mmt -74.03 -54.27 8.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.701 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 m -55.57 -44.6 77.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.264 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -58.4 -28.44 65.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.789 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.883 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.1 mp -126.06 35.88 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -164.04 -120.46 0.52 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.764 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -127.78 -176.84 3.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 0.0 110.907 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -83.84 97.07 8.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.958 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.28 114.0 25.95 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.426 179.548 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.927 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.78 175.36 5.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.32 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.441 ' H ' HG22 ' A' ' 117' ' ' THR . 3.9 m-20 -48.06 -35.9 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.947 0.403 . . . . 0.0 110.733 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -77.41 -35.44 54.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.841 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -72.12 -33.22 67.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.998 0.427 . . . . 0.0 110.094 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.958 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.7 t -75.08 -50.61 24.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.395 0.617 . . . . 0.0 109.679 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -59.08 -52.83 64.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.717 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -28.73 58.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.767 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.784 ' HG3' HD11 ' A' ' 105' ' ' LEU . 6.4 tpt -76.16 -39.26 55.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.207 0.527 . . . . 0.0 110.044 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.531 HG12 HD13 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -65.89 -46.83 87.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.392 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -62.7 -38.28 89.78 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.911 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 124' ' ' MET . 18.5 pt-20 -81.12 -39.81 25.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.724 0.297 . . . . 0.0 110.814 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.507 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -65.42 -39.35 92.03 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.547 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.725 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.6 t0 -94.94 146.4 24.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.552 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.4 -40.63 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.06 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.91 -10.98 60.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.769 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.68 33.03 0.95 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.431 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.2 p-10 -96.27 -12.49 24.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.369 -0.916 . . . . 0.0 112.56 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.8 20.2 10.23 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.808 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.63 147.29 30.89 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 129' ' ' ASP . 38.9 t -130.68 107.27 13.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.258 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -77.83 175.23 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.445 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.773 ' HE1' HG22 ' A' ' 85' ' ' ILE . 1.1 t80 -46.05 -67.04 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.654 0.74 . . . . 0.0 111.811 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.3 mm-40 -65.57 -25.13 67.28 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.63 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.575 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.56 -48.9 74.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.382 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 9.3 p90 -79.21 -31.32 43.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.364 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 138' ' ' TYR . 72.0 t -52.9 -43.3 46.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.341 -0.39 . . . . 0.0 109.963 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -62.71 -34.79 77.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.81 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.421 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 9.5 mmt -73.48 -44.29 58.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.424 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.44 ' CG ' HG21 ' B' ' 22' ' ' VAL . 7.1 ttp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.159 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.951 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.31 -51.1 60.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.73 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.65 -53.23 32.63 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.655 0.264 . . . . 0.0 111.299 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.17 -37.57 72.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.019 0.438 . . . . 0.0 110.317 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.951 HG23 ' O ' ' B' ' 1' ' ' ALA . 15.0 t -63.36 -33.73 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.388 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.884 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.64 -55.08 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.011 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 26.2 mmm-85 -50.42 -37.88 40.16 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.178 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -46.1 65.15 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.503 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.825 ' HD2' HD23 ' A' ' 32' ' ' LEU . 11.8 mtmt -56.6 -54.12 49.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.936 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.2 -57.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.548 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.544 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.0 OUTLIER -60.92 -51.41 69.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.361 0.601 . . . . 0.0 110.938 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.42 -38.81 63.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.859 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.671 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.31 -50.66 55.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.351 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.42 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.44 -37.28 94.56 Favored Glycine 0 CA--C 1.498 -0.977 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.544 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.86 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -65.0 -61.77 1.95 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.716 -0.742 . . . . 0.0 110.552 -179.11 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.751 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.69 -27.51 67.92 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.47 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -68.36 -46.41 70.17 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.794 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 1.1 ppt_? -63.58 -44.1 95.06 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.86 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.8 m -62.78 -35.42 70.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.934 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.628 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -75.18 -47.2 29.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.064 -179.348 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.573 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 12.1 p -59.4 -25.15 64.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.598 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.484 HG22 ' O ' ' B' ' 18' ' ' ARG . 30.3 m -90.29 -48.52 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.196 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.89 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -61.91 -33.78 74.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.228 0.537 . . . . 0.0 110.44 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.89 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.083 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.801 0.334 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.82 -169.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.782 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -120.59 90.68 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.66 164.75 12.28 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.004 0.43 . . . . 0.0 110.424 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.5 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.44 161.93 13.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.467 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -47.69 -51.68 20.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.766 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -64.5 -27.7 69.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.045 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.5 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.85 -51.5 22.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.619 179.729 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.703 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.9 pt -73.0 -28.97 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.64 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.54 -27.33 10.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 4.6 mm-40 -75.34 -28.55 59.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.281 178.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.34 -58.61 3.13 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.214 0.531 . . . . 0.0 111.033 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.872 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.76 15.04 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.249 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.52 -27.95 56.2 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.08 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.23 -39.92 62.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.043 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.872 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.55 -51.95 67.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.802 0.811 . . . . 0.0 109.363 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.401 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 p -74.51 -24.05 58.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.074 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.878 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.07 -24.74 35.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.261 0.553 . . . . 0.0 110.166 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.9 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.5 t80 -94.64 0.21 54.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.571 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.4 t70 -104.27 142.35 34.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.942 0.877 . . . . 0.0 110.997 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.478 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.7 mmtt -58.4 -53.35 59.33 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.572 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -86.62 -4.88 59.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.765 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.15 47.23 42.13 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.356 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -91.64 18.53 7.36 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.805 0.336 . . . . 0.0 110.673 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.85 5.12 88.25 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.592 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.9 p -150.33 148.65 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.668 0.27 . . . . 0.0 110.344 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.728 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.72 140.46 19.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.801 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.591 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.41 178.66 7.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.294 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.715 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -69.96 -41.8 74.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.056 0.455 . . . . 0.0 110.411 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.537 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -57.28 -40.88 78.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.365 179.07 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.807 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -70.15 -53.82 15.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.47 -179.494 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.729 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -57.5 -54.14 50.26 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.838 0.828 . . . . 0.0 109.572 178.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.33 91.32 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.462 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 30' ' ' LYS . 53.3 m -65.48 -30.74 71.55 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 120.813 0.339 . . . . 0.0 110.432 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.9 HG21 ' CE2' ' A' ' 19' ' ' PHE . 13.9 t -63.62 -57.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.037 0.446 . . . . 0.0 110.568 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.607 ' CE ' HD22 ' A' ' 39' ' ' LEU . 1.7 tpt -72.35 -40.53 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.273 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -61.13 -39.66 90.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.945 0.402 . . . . 0.0 110.489 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.5 t -78.86 -11.48 59.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.578 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.607 HD22 ' CE ' ' A' ' 36' ' ' MET . 6.4 tt -88.0 -53.43 4.74 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.075 0.464 . . . . 0.0 110.552 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.457 ' N ' HD23 ' A' ' 39' ' ' LEU . . . 179.72 37.21 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.624 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.587 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 tp-100 -134.83 -179.8 5.83 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.338 0.589 . . . . 0.0 111.279 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -159.75 56.41 0.86 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.792 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.7 Cg_endo -80.57 -174.29 2.19 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.546 2.164 . . . . 0.0 112.291 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.602 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -117.32 152.64 34.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.873 0.368 . . . . 0.0 110.124 179.23 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.49 -49.99 73.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.26 -32.59 74.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.638 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.577 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -66.31 -54.52 23.75 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.596 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.715 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -61.22 -48.36 81.87 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.929 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.706 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -54.6 -49.97 69.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 110.952 179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.27 -47.23 69.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.682 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -74.68 -30.61 61.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.831 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.567 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -54.68 -36.03 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.588 -178.968 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -45.23 -28.64 0.82 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.213 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -79.6 -38.21 34.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.929 0.395 . . . . 0.0 110.778 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.076 HG11 HG21 ' B' ' 6' ' ' ILE . 3.7 m -81.07 -10.98 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.14 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.558 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.6 t0 -103.59 155.87 18.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.72 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.58 -29.17 26.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.065 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -116.46 -9.72 11.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.397 0.617 . . . . 0.0 110.452 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.68 63.48 5.17 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.498 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -112.47 18.41 18.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.842 0.353 . . . . 0.0 110.201 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.39 19.98 55.68 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.424 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.3 p -146.71 176.49 9.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.729 HD12 HD11 ' A' ' 32' ' ' LEU . 12.4 mt -116.3 136.46 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.544 0.212 . . . . 0.0 110.959 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.5 m-20 -88.24 -178.02 5.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.25 0.548 . . . . 0.0 111.938 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.82 -55.91 12.83 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.659 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -65.67 -34.54 40.94 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.25 1.967 . . . . 0.0 111.241 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.44 -52.47 61.31 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.26 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.718 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.19 -56.99 14.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.789 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.703 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.89 -47.09 83.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.795 -179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.465 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 53.5 m -59.69 -30.46 68.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.074 0.464 . . . . 0.0 110.129 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.912 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.2 tpp -62.71 -61.84 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.083 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.2 mtt . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.001 -179.934 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.804 0.335 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -56.82 -51.44 68.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.221 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.691 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.68 -29.24 25.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.477 -179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.782 HG22 ' HE1' ' A' ' 138' ' ' TYR . 19.8 mt -66.7 -51.45 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.919 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -50.08 16.64 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.075 0.464 . . . . 0.0 110.55 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 91' ' ' VAL . 19.9 tt0 -53.91 -29.19 40.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.252 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -70.83 -38.25 73.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 10.8 t80 -67.35 -54.15 23.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.966 0.412 . . . . 0.0 110.545 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -54.08 -30.67 49.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.791 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 87' ' ' GLU . 98.9 t -88.7 -22.88 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.216 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.526 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -55.3 -38.38 68.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.176 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -100.64 146.87 26.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.503 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -69.72 -36.39 75.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.373 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.27 -9.79 13.87 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.43 30.02 34.75 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.23 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -67.43 -13.62 62.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 117.102 0.451 . . . . 0.0 110.787 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.472 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.22 -13.39 55.29 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.914 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.479 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 25.1 m-85 -127.16 145.95 50.57 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.988 0.423 . . . . 0.0 111.425 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.747 HD12 HD22 ' A' ' 105' ' ' LEU . 1.1 pp -121.13 109.94 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.729 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.1 p -83.55 176.97 8.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.53 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.564 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.7 -30.91 71.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 110.396 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.25 -57.66 11.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.322 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.43 -45.73 30.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.228 -179.156 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.747 HD22 HD12 ' A' ' 100' ' ' ILE . 17.6 tp -53.13 -33.24 51.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.818 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.1 ttt-85 -68.79 -49.15 60.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -59.14 -43.51 92.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.194 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.6 t -72.96 -39.02 57.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.51 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.51 ' HG2' HD12 ' A' ' 105' ' ' LEU . 28.6 mmt -73.97 -54.27 8.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.511 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.663 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.4 m -56.99 -46.9 81.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.088 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -60.0 -26.67 66.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.841 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.878 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.8 mp -124.21 36.19 4.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.36 -116.46 0.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.688 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' HD23 ' A' ' 116' ' ' LEU . 23.1 pt-20 -131.31 172.51 12.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.805 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.663 ' HA ' HG23 ' A' ' 110' ' ' THR . 12.7 tptm -75.05 98.58 3.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.163 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.96 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.88 113.13 24.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.461 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.935 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -71.83 175.28 5.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.32 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 117' ' ' THR . 50.5 m-20 -48.06 -36.04 12.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 110.759 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -77.41 -34.35 54.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -73.64 -33.04 64.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.024 0.44 . . . . 0.0 110.074 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.96 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.96 -48.56 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.829 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.25 -52.87 63.83 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.844 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.08 -28.72 62.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.82 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.739 ' HG3' HD21 ' A' ' 105' ' ' LEU . 5.8 tpt -76.23 -38.47 56.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 110.113 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.511 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -67.15 -44.95 87.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.559 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -61.75 -40.55 95.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.97 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 124' ' ' MET . 8.6 pt-20 -81.0 -37.39 29.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.787 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.482 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.29 -35.84 81.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.338 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.727 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.3 t0 -102.06 146.34 28.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.937 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.554 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.5 -40.61 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.093 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.554 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.98 -11.07 60.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.713 -179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.85 32.77 1.0 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.3 p-10 -95.99 -12.53 24.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.351 -0.924 . . . . 0.0 112.52 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.16 10.23 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.817 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.479 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.54 147.19 30.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 129' ' ' ASP . 33.1 t -130.71 107.32 13.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.232 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.05 175.0 10.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.339 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.782 ' HE1' HG22 ' A' ' 85' ' ' ILE . 1.1 t80 -45.95 -67.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.653 0.74 . . . . 0.0 111.84 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.7 mt-10 -66.02 -24.54 66.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.644 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.547 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.73 -48.86 74.47 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.393 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 10.7 p90 -79.32 -31.21 43.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.399 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 138' ' ' TYR . 75.7 t -52.91 -44.85 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.44 -35.45 79.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.137 0.494 . . . . 0.0 109.826 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.47 -43.35 60.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.81 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.406 ' CG ' HG21 ' B' ' 22' ' ' VAL . 24.5 ttp . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.012 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.916 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.847 0.356 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.732 ' O ' HG13 ' B' ' 6' ' ' ILE . 11.6 mmm180 -52.5 -50.73 62.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.232 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.759 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.79 -53.43 32.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.281 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.69 -36.11 71.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.149 0.5 . . . . 0.0 110.007 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.916 HG23 ' O ' ' B' ' 1' ' ' ALA . 45.1 t -62.84 -41.43 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.997 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 1.076 HG21 HG11 ' A' ' 55' ' ' VAL . 3.2 mt -63.16 -55.42 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.098 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' B' ' 3' ' ' LYS . 24.1 mmm-85 -50.16 -40.43 46.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.031 0.444 . . . . 0.0 110.247 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.88 -44.95 68.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.667 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.829 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.6 OUTLIER -56.34 -55.07 37.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.05 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.912 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.7 mt -51.21 -57.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.751 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.511 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.7 tpt180 -61.32 -51.34 69.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.252 0.548 . . . . 0.0 111.028 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.559 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.33 -39.23 63.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.701 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.733 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.47 -48.94 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.225 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.409 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.77 -37.64 95.0 Favored Glycine 0 CA--C 1.497 -1.041 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.521 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.895 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -65.06 -61.68 2.0 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.741 -0.73 . . . . 0.0 110.555 -179.246 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.75 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.6 -27.46 67.76 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.484 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -68.25 -47.53 67.5 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.978 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.5 ppt_? -63.8 -43.61 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.105 0.479 . . . . 0.0 109.754 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.895 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.8 m -61.86 -35.48 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.529 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.676 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -75.97 -43.1 46.17 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.785 -179.599 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.577 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 21.8 p -61.01 -26.63 67.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.495 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.463 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.4 m -90.42 -48.43 14.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.163 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.894 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.2 pp -63.09 -32.6 74.02 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.199 0.524 . . . . 0.0 110.535 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.894 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.176 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.788 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.817 0.341 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.404 ' HB2' HD21 ' A' ' 4' ' ' LEU . 2.2 m-20 -72.86 -170.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -121.15 87.73 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -98.48 164.79 12.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.544 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.492 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.6 p -97.98 162.84 13.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.494 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -47.35 -51.42 19.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.875 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -64.27 -27.72 69.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.991 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.9 mm-40 -72.68 -51.36 19.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.707 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.725 HG22 HD21 ' A' ' 69' ' ' LEU . 36.7 pt -73.07 -28.74 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.895 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.34 -27.26 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 5.6 mm-40 -74.99 -28.39 60.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.227 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.63 -58.33 3.24 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.293 0.568 . . . . 0.0 111.002 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.875 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 13.1 ptmt -54.41 -23.0 14.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.216 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.21 -28.28 57.15 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.102 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.99 -39.81 63.4 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.07 177.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.26 -52.04 67.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.806 0.812 . . . . 0.0 109.501 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -23.9 58.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.183 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.897 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.1 -25.09 34.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.273 0.558 . . . . 0.0 110.215 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.816 ' HB3' HD11 ' A' ' 27' ' ' ILE . 2.4 t80 -94.42 -0.27 54.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.47 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.7 t70 -103.87 144.88 30.92 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.959 0.885 . . . . 0.0 111.051 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.513 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.5 mmtt -61.13 -53.43 57.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.644 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -83.91 -5.94 59.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.814 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.13 45.31 57.24 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.451 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.9 p30 -90.47 17.23 7.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.832 0.348 . . . . 0.0 110.68 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.37 7.46 87.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.386 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 69.0 p -150.38 148.23 28.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.816 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.7 mt -101.57 140.68 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.808 0.337 . . . . 0.0 111.829 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.703 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.5 t -85.52 179.37 7.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.117 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.781 HG21 ' CG ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -70.43 -45.78 65.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.935 -179.201 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.629 ' HG3' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -54.36 -38.93 66.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.335 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.871 ' O ' HG23 ' A' ' 35' ' ' VAL . 3.4 mm-40 -71.64 -53.75 12.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.395 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.65 HD23 ' CD ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -56.11 -52.52 64.02 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.733 0.778 . . . . 0.0 109.51 178.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.82 -45.5 96.08 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.371 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 m -62.87 -35.88 81.46 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.917 0.389 . . . . 0.0 110.156 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 31' ' ' GLU . 60.1 t -61.76 -56.87 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.652 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.439 ' SD ' HG13 ' B' ' 5' ' ' VAL . 0.2 OUTLIER -71.6 -40.78 69.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.306 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -41.2 99.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 0.0 110.656 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 t -78.88 -10.08 59.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.629 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.6 tt -88.76 -53.88 4.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.585 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.452 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.04 34.59 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.819 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -135.86 -179.94 5.96 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.362 0.601 . . . . 0.0 111.306 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -159.75 56.5 0.87 Allowed Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.754 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 96.0 Cg_endo -80.44 -173.58 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.527 2.151 . . . . 0.0 112.273 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.615 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.39 152.54 31.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.846 0.355 . . . . 0.0 110.166 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -57.68 -49.21 77.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.12 -31.17 71.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.742 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.569 ' H ' HG22 ' A' ' 44' ' ' THR . 1.3 mt-10 -67.16 -54.39 21.7 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.575 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.615 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -63.45 -37.84 88.84 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.209 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.781 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.42 -49.9 73.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.842 0.353 . . . . 0.0 110.588 179.583 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.25 -46.25 76.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.496 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.412 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.4 mmt -74.74 -30.54 61.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.704 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.559 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -53.5 -38.0 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.498 -179.079 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -44.98 -28.59 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.373 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.461 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.83 -39.58 50.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.944 0.402 . . . . 0.0 110.767 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.93 HG11 HG21 ' B' ' 6' ' ' ILE . 5.0 m -80.57 -11.96 12.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.099 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.4 t0 -103.69 155.15 18.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.74 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.502 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.63 -28.86 26.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.152 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -116.46 -9.68 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.44 0.638 . . . . 0.0 110.468 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.5 63.89 4.82 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.519 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -112.71 18.38 18.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.855 0.359 . . . . 0.0 110.133 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.88 19.93 56.79 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.467 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.703 HG22 ' HA ' ' A' ' 28' ' ' THR . 6.1 p -146.1 176.12 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.487 HG12 HG23 ' A' ' 55' ' ' VAL . 95.9 mt -115.21 136.38 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.551 0.215 . . . . 0.0 110.725 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.4 m-20 -87.05 -178.17 6.2 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.16 0.505 . . . . 0.0 111.828 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.521 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.97 -55.46 13.41 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.831 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.2 Cg_endo -65.72 -35.37 37.17 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.234 1.956 . . . . 0.0 111.348 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -63.84 -52.31 60.69 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.305 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.729 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.9 -56.78 17.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.834 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.725 HD21 HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -53.56 -49.51 67.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.83 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.788 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 80.6 m -58.57 -32.42 68.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.226 0.536 . . . . 0.0 109.685 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . 1.004 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.7 tpp -67.19 -61.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.899 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.4 mtm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 179.896 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.847 0.356 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -52.24 -30.55 28.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.311 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.603 ' O ' HG11 ' B' ' 19' ' ' VAL . 1.1 mt-10 -70.54 -29.58 66.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.745 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.715 HG22 ' HE1' ' A' ' 138' ' ' TYR . 7.8 mt -79.45 -51.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.27 -51.82 12.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.659 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.9 tt0 -53.72 -25.53 18.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.884 0.373 . . . . 0.0 110.733 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.694 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.67 -37.13 50.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.204 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.592 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.2 t80 -68.04 -52.12 39.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.034 0.445 . . . . 0.0 110.087 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -54.77 -32.05 59.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.803 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 87' ' ' GLU . 54.3 t -88.63 -22.8 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.55 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.468 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.93 -32.96 55.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.114 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -102.34 148.05 25.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.496 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -69.58 -37.21 76.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.351 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.16 -9.72 13.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.83 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.15 29.64 33.32 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.228 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -67.4 -13.93 62.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.079 0.439 . . . . 0.0 110.75 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.2 -12.23 55.3 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.992 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.1 m-85 -127.25 146.99 50.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.906 0.384 . . . . 0.0 111.378 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.864 HD13 HD13 ' A' ' 105' ' ' LEU . 1.1 pt -121.11 109.98 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.816 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.2 m -83.99 177.07 8.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.466 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.25 -30.09 71.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.097 0.475 . . . . 0.0 110.528 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.35 -57.11 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.205 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.754 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.32 -46.83 25.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.377 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.864 HD13 HD13 ' A' ' 100' ' ' ILE . 30.2 tp -53.19 -31.23 41.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.938 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.845 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.6 ttt-85 -72.54 -49.15 34.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -59.22 -42.8 91.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.144 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.2 t -72.95 -41.03 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.565 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.454 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 30.3 mmt -72.61 -54.17 9.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.536 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.743 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.4 m -57.12 -48.9 77.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.225 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -58.04 -29.9 65.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.796 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.897 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -121.58 37.13 4.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.822 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.35 -116.43 0.39 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.744 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.418 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.8 pt-20 -131.02 168.72 16.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 110.835 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.743 ' HA ' HG23 ' A' ' 110' ' ' THR . 15.6 ttmt -73.71 100.11 3.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.971 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.36 114.13 26.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.929 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -71.86 175.25 5.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.364 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 117' ' ' THR . 1.1 m-20 -48.04 -35.98 12.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 110.779 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.36 -34.98 55.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -72.87 -33.03 65.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.973 0.415 . . . . 0.0 110.091 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.971 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -75.06 -48.76 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.817 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -58.81 -52.77 64.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.788 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -28.74 63.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.791 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.822 ' HG3' HD21 ' A' ' 105' ' ' LEU . 11.7 tpt -76.13 -37.77 57.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.135 0.493 . . . . 0.0 110.282 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.509 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.23 -39.55 81.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.407 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -65.2 -41.41 94.56 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.489 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 124' ' ' MET . 6.2 pt-20 -82.62 -32.84 28.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 110.483 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.87 78.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.484 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.718 ' HB2' HG22 ' A' ' 136' ' ' VAL . 20.1 t0 -105.83 148.6 27.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.974 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.569 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.84 -40.8 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.024 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.569 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.94 -10.93 59.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.691 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.0 32.83 1.08 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.445 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.4 p-10 -96.36 -12.79 23.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.291 -0.954 . . . . 0.0 112.451 -176.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.21 10.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.808 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.6 146.95 30.62 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.043 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' A' ' 129' ' ' ASP . 33.0 t -130.75 107.5 14.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.202 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.1 t-20 -80.35 174.16 11.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.327 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.715 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.88 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.471 0.653 . . . . 0.0 111.433 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.2 mt-10 -59.95 -32.58 70.94 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.045 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.509 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.13 -43.44 78.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.258 0.551 . . . . 0.0 109.65 179.206 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.806 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.0 OUTLIER -78.69 -31.76 46.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.213 178.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 138' ' ' TYR . 62.1 t -54.95 -51.83 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.683 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -56.87 -46.88 81.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.2 tpp -68.72 -31.09 69.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.8 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.427 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 11.3 ttp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.956 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.825 0.345 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.736 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.2 mmm180 -52.24 -51.41 58.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.724 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.73 -53.45 31.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.632 0.253 . . . . 0.0 111.391 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.81 -36.61 70.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.136 0.493 . . . . 0.0 110.09 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.956 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.7 t -64.27 -34.3 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.32 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.93 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -71.56 -49.79 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.235 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' B' ' 3' ' ' LYS . 21.9 mmm-85 -58.01 -33.14 68.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.119 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.07 -49.19 47.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.187 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.789 ' O ' HD12 ' B' ' 13' ' ' ILE . 1.6 ptpt -61.38 -50.52 72.52 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.657 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 1.004 HD13 ' HG2' ' A' ' 71' ' ' MET . 10.6 mt -51.29 -57.37 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.091 0.472 . . . . 0.0 110.766 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.98 -50.79 72.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.93 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 12' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.11 -39.97 63.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.892 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.789 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.6 mt -54.51 -52.11 43.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.612 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.74 -36.27 93.08 Favored Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.21 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.931 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.96 -61.67 2.02 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.847 -0.676 . . . . 0.0 110.389 -178.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 16' ' ' MET . . . . . 0.664 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -62.43 -27.92 69.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.652 177.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.27 -51.55 60.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.209 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.761 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.45 -43.56 97.02 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.571 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.931 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.9 m -66.3 -32.36 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.599 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.667 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 0.6 OUTLIER -71.73 -50.08 33.44 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.006 -179.115 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.448 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 54.7 p -58.49 -36.22 73.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.058 0.456 . . . . 0.0 110.765 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.486 HG22 ' C ' ' B' ' 19' ' ' VAL . 28.4 m -72.54 -45.01 60.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.071 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.806 HD23 ' CE1' ' A' ' 141' ' ' PHE . 3.0 pp -65.29 -27.53 68.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.022 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 13.0 ptt180 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.921 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.474 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.833 0.349 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.543 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 2.1 m-20 -100.95 -170.21 1.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -117.23 83.93 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.633 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.6 164.73 12.3 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.58 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.517 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.6 p -98.6 162.8 12.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.465 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -47.43 -51.33 20.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.879 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -64.42 -27.66 69.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.157 0.503 . . . . 0.0 110.065 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.517 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.2 OUTLIER -72.51 -51.43 20.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.706 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.701 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.9 pt -73.08 -28.85 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.849 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.37 -27.45 9.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.535 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 11.0 mt-10 -75.23 -28.53 59.95 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.207 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.36 -58.41 3.22 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.218 0.532 . . . . 0.0 111.004 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.875 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.5 pttt -54.45 -23.03 14.34 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.273 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.45 -27.85 56.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.134 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.27 -39.78 62.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.072 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.64 -51.89 67.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.845 0.831 . . . . 0.0 109.458 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 p -74.46 -24.45 59.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.101 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.845 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.06 -23.5 35.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.261 0.553 . . . . 0.0 110.28 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.822 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.9 t80 -95.4 -0.76 52.17 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.554 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.7 t70 -103.48 142.64 33.91 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.971 0.891 . . . . 0.0 111.039 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 3.7 mmtt -59.11 -53.38 59.04 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.604 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.93 -5.42 59.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.77 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.51 47.69 44.03 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.303 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -92.06 18.86 7.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.867 0.365 . . . . 0.0 110.685 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.36 5.11 89.06 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.577 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.8 p -150.34 148.86 29.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.755 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.18 140.51 19.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.847 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.575 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.17 176.46 8.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.004 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.819 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -70.52 -37.5 74.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.145 0.497 . . . . 0.0 110.332 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.536 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.23 -41.12 92.46 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.15 178.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.914 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -69.4 -53.41 19.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.26 -179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.828 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -58.24 -54.69 44.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.724 0.773 . . . . 0.0 109.326 178.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.49 -45.83 92.63 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.456 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.7 m -62.39 -30.9 71.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.845 0.322 . . . . 0.0 110.495 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 31' ' ' GLU . 72.5 t -68.2 -57.26 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.87 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.457 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.95 -35.63 69.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.389 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -68.13 -42.74 79.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.848 0.356 . . . . 0.0 110.667 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 t -78.94 -8.14 58.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.806 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.8 tt -90.97 -54.82 3.8 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.468 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -175.88 34.94 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.937 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp-100 -137.56 -178.95 5.46 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.381 0.61 . . . . 0.0 111.163 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -159.64 56.46 0.88 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.927 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.4 Cg_endo -80.37 -175.7 2.83 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.56 2.173 . . . . 0.0 112.101 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.612 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.94 152.5 32.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.956 0.408 . . . . 0.0 110.18 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.22 -49.58 75.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.58 75.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.713 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.52 -54.33 33.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.673 -179.495 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.819 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.85 -34.77 78.9 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.379 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.69 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.39 -42.7 95.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.909 0.385 . . . . 0.0 110.228 179.247 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.76 -45.52 93.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.23 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -30.69 61.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.412 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.555 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.69 -38.29 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.524 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -44.91 -28.68 0.69 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.351 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.6 -38.78 47.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.891 0.376 . . . . 0.0 110.803 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.939 HG11 HG21 ' B' ' 6' ' ' ILE . 4.6 m -81.07 -11.39 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.18 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.549 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.9 t0 -103.73 155.68 18.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.754 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.485 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.57 -29.1 26.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -116.43 -9.66 11.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.416 0.627 . . . . 0.0 110.471 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.44 63.53 5.14 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.517 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -112.26 18.13 18.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.846 0.355 . . . . 0.0 110.193 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.67 19.91 55.31 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.453 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.1 p -147.16 176.41 9.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.768 HD12 HD11 ' A' ' 32' ' ' LEU . 13.8 mt -115.7 136.52 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.562 0.22 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.485 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.9 m-20 -87.28 -178.06 6.11 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.28 0.562 . . . . 0.0 111.931 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.514 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.03 -56.06 11.99 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.622 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.7 Cg_endo -65.65 -34.8 40.07 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.21 1.94 . . . . 0.0 111.166 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.91 -52.35 63.41 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.268 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.718 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.0 -56.63 19.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.867 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.701 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.51 -46.12 84.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.696 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 56.5 m -60.06 -31.15 69.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.041 0.448 . . . . 0.0 109.966 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.929 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.8 tpp -64.54 -61.8 1.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.908 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.7 mtt -66.04 -29.19 69.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.803 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.543 ' HB1' ' CG ' ' A' ' 2' ' ' ASP . . . -57.77 -21.54 42.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.308 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -51.0 95.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 111.103 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -62.61 -18.82 62.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.231 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -29.61 66.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.963 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -88.94 79.33 7.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.68 -167.3 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 63.32 -167.41 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 79' ' ' THR . 19.4 m-20 63.87 30.51 14.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.923 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.1 p -77.53 -30.17 52.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.63 -29.11 36.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.85 -54.48 37.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.713 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.76 -29.43 27.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.375 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.723 HG22 ' HE1' ' A' ' 138' ' ' TYR . 17.9 mt -64.76 -51.23 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.772 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -75.58 -50.57 15.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.043 0.449 . . . . 0.0 110.685 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 91' ' ' VAL . 7.1 mt-10 -53.79 -30.84 46.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.682 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -71.08 -38.55 72.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.781 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 24.2 t80 -67.03 -56.02 11.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.579 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.62 -30.65 43.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.866 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 87' ' ' GLU . 66.7 t -88.4 -22.92 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.211 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.462 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.18 -32.05 61.87 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.046 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -102.16 148.84 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.438 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -69.61 -37.71 76.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.332 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -112.27 -9.78 13.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.66 30.55 32.37 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.119 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.41 -13.73 62.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.96 0.38 . . . . 0.0 110.757 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.24 -13.46 55.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.857 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.7 m-85 -127.14 145.41 50.76 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.967 0.413 . . . . 0.0 111.284 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.949 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.1 109.97 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.885 179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 p -83.39 177.38 8.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.311 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.548 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.18 -28.97 70.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.083 0.468 . . . . 0.0 110.405 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.46 -57.67 9.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.426 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.41 -42.96 42.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.273 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.949 HD13 HD13 ' A' ' 100' ' ' ILE . 56.0 tp -56.9 -31.14 64.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.08 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.794 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.4 ttt180 -72.54 -49.27 33.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.937 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -60.85 -36.5 79.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 110.539 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 104' ' ' GLU . 54.5 t -72.82 -44.14 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.301 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 24.8 mmt -73.99 -54.05 8.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.727 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.648 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.3 m -55.59 -45.55 77.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.367 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.473 ' C ' HD12 ' A' ' 112' ' ' LEU . 7.8 m-20 -60.27 -29.85 69.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.792 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.845 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.9 mp -123.49 38.66 4.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.647 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.95 -116.81 0.4 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.781 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.409 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.8 pt-20 -132.2 170.77 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 110.864 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.648 ' HA ' HG23 ' A' ' 110' ' ' THR . 9.5 ttmm -74.97 99.7 3.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.257 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.953 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.7 114.39 26.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.384 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.934 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.7 175.34 5.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.429 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.411 ' H ' HG22 ' A' ' 117' ' ' THR . 79.3 m-20 -48.09 -35.93 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.755 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -77.4 -35.09 54.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -72.62 -33.67 66.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.977 0.417 . . . . 0.0 110.106 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.953 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.69 -48.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.899 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.21 -52.87 63.82 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.843 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -56.97 -28.85 62.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.857 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.841 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.6 tpt -76.35 -38.64 55.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.146 0.498 . . . . 0.0 110.169 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.491 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -66.87 -48.42 79.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.563 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -60.25 -40.27 89.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.946 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 124' ' ' MET . 12.7 pt-20 -80.86 -37.1 30.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 0.0 110.598 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.451 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.93 -36.18 81.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.764 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.3 t0 -101.37 147.58 26.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.013 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.56 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.6 pt -84.84 -40.67 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.047 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.56 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.95 -10.98 60.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.65 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.68 1.09 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.9 p-10 -96.33 -12.84 23.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.317 -0.941 . . . . 0.0 112.379 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.93 20.1 10.21 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.754 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.9 146.54 30.19 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.899 0.38 . . . . 0.0 110.06 179.211 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.764 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.1 t -130.64 107.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.246 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -80.21 174.84 11.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.304 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.723 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.96 -67.01 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.523 0.677 . . . . 0.0 111.464 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.88 -34.15 72.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.839 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.531 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.01 -40.63 73.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.83 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.2 OUTLIER -78.83 -32.88 46.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.064 178.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 64.0 t -55.35 -46.93 78.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.626 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -57.81 -45.32 86.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.1 -33.12 65.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.4 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 18.0 ttp -59.41 -41.93 90.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 t -78.71 -31.25 46.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.67 151.32 25.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.953 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.736 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.3 mmm180 -52.3 -51.25 59.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.729 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.66 -53.17 33.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.638 0.256 . . . . 0.0 111.289 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -57.24 -37.52 72.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.007 0.432 . . . . 0.0 110.347 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.953 HG23 ' O ' ' B' ' 1' ' ' ALA . 15.6 t -63.27 -33.68 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.348 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.939 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.58 -55.46 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.995 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.3 mmm-85 -50.36 -37.79 38.92 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.215 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -44.44 66.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.828 ' HD2' HD23 ' A' ' 32' ' ' LEU . 9.6 mtmt -57.9 -55.01 40.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.929 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.8 mt -51.27 -57.28 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.906 0.384 . . . . 0.0 111.228 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.52 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -58.36 -51.18 70.9 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.424 0.631 . . . . 0.0 110.656 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.5 -39.38 64.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.81 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' B' ' 17' ' ' ALA . 3.3 mt -54.28 -48.31 67.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.233 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.27 -38.22 95.58 Favored Glycine 0 CA--C 1.498 -1.022 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.495 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.895 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.76 -61.8 1.96 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.743 -0.729 . . . . 0.0 110.504 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.737 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -60.32 -27.59 67.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.32 -48.64 66.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.038 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 0.7 OUTLIER -63.78 -43.74 95.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.895 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -62.09 -34.65 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.472 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.752 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -75.37 -44.11 46.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.639 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.557 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 18.8 p -60.84 -25.8 66.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.474 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 23' ' ' LEU . 26.8 m -90.07 -46.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.991 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.95 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.12 -33.34 75.26 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.18 0.514 . . . . 0.0 110.444 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.95 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.121 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.527 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 1.4 m-20 -96.98 -169.95 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -119.24 84.49 2.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.93 164.82 12.21 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.51 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.494 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.58 162.08 13.47 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.46 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.68 -51.71 20.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.789 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.51 -27.68 69.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.035 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.494 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.94 -51.41 22.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.614 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.2 pt -73.06 -28.9 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.706 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.62 -27.31 10.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.3 mt-10 -75.28 -28.56 59.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.269 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.28 -58.44 3.21 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.207 0.527 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.881 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.9 pttt -54.77 -22.93 15.73 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.203 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.538 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.28 -27.74 56.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.091 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.63 -39.77 61.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.074 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.881 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.04 -51.83 68.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.816 0.817 . . . . 0.0 109.463 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -25.04 59.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.073 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.899 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.02 -25.75 34.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.148 0.499 . . . . 0.0 110.451 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.795 ' HB3' HD11 ' A' ' 27' ' ' ILE . 5.6 t80 -87.75 -15.08 37.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.448 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR . 32.0 t70 -90.28 146.24 24.37 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.977 0.894 . . . . 0.0 111.23 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.508 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -63.33 -53.41 53.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -81.83 -6.8 59.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.846 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.56 45.27 59.68 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.402 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -90.42 17.75 6.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.822 0.344 . . . . 0.0 110.759 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.47 89.36 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 46.4 p -150.18 150.52 31.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.795 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.77 140.58 20.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.968 0.413 . . . . 0.0 111.952 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.6 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.34 176.34 8.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.974 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.815 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -70.42 -38.0 74.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.03 0.443 . . . . 0.0 110.251 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.543 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.75 -40.99 89.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.22 178.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.08 -53.47 20.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.234 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.802 HD11 ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -58.43 -54.85 42.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.718 0.77 . . . . 0.0 109.463 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.59 -45.85 92.74 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.508 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.2 m -62.2 -31.39 71.91 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.818 0.342 . . . . 0.0 110.581 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 31' ' ' GLU . 69.6 t -68.08 -57.25 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.441 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.91 -35.36 69.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.436 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -42.13 79.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.945 0.402 . . . . 0.0 110.645 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -79.02 -7.61 58.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.648 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.547 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -91.03 -54.43 3.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.042 0.448 . . . . 0.0 110.754 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.67 34.81 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.888 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.13 -178.97 5.44 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.368 0.604 . . . . 0.0 111.134 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -159.58 56.49 0.89 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.902 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.4 -176.76 3.36 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.502 2.134 . . . . 0.0 112.076 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.608 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -113.53 152.48 30.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.962 0.41 . . . . 0.0 110.199 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -57.51 -49.33 76.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.404 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.69 72.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.75 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -66.06 -54.33 27.18 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.559 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.815 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.92 -34.74 78.82 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.369 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.674 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.46 -42.6 95.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.873 0.368 . . . . 0.0 110.172 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -61.76 -45.38 94.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.245 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -30.77 61.83 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.419 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.556 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -53.75 -38.32 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.511 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -44.98 -28.6 0.69 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.387 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.04 -38.85 51.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.914 0.388 . . . . 0.0 110.758 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.816 HG11 HG21 ' B' ' 6' ' ' ILE . 5.1 m -81.38 -11.89 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.227 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.54 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.8 t0 -103.57 155.35 18.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.748 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.466 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.61 -28.8 26.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.124 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -116.42 -9.68 11.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.452 0.644 . . . . 0.0 110.5 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.35 63.48 5.2 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.488 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -112.06 18.1 19.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.81 0.338 . . . . 0.0 110.225 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.41 19.86 55.91 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.483 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -147.09 176.32 10.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.802 ' CD1' HD11 ' A' ' 32' ' ' LEU . 2.1 mp -115.54 136.55 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 120.6 0.238 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.0 m-20 -86.11 -178.6 6.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.272 0.558 . . . . 0.0 111.885 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -67.65 -56.32 12.35 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.557 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.0 Cg_endo -65.93 -35.4 35.23 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.3 2.0 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -61.85 -52.45 64.1 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.192 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.09 -56.42 21.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.758 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.16 -45.47 83.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.733 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.41 HG22 ' NH1' ' A' ' 74' ' ' ARG . 64.0 m -60.58 -31.57 70.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.069 0.462 . . . . 0.0 110.049 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.919 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.5 tpp -63.49 -61.76 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.01 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.432 ' HG2' HG22 ' B' ' 10' ' ' ILE . 6.9 mtm -66.63 -27.56 67.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.716 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB1' ' OD1' ' A' ' 2' ' ' ASP . . . -58.9 -20.59 52.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.355 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' NH1' HG22 ' A' ' 70' ' ' THR . 5.9 mpt_? -47.88 96.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.361 . . . . 0.0 111.141 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -20.12 60.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.157 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.6 ttm -65.28 -28.93 69.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.005 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -87.8 54.85 3.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.926 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.14 -167.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 63.58 -165.8 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 79' ' ' THR . 0.4 OUTLIER 66.3 35.73 5.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.907 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.3 m -77.48 -42.96 33.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.6 -29.14 36.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.827 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -50.45 -30.59 12.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.232 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.719 ' O ' HG11 ' B' ' 19' ' ' VAL . 2.0 mt-10 -68.88 -30.54 69.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.481 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.691 HG22 ' HE1' ' A' ' 138' ' ' TYR . 8.1 mt -79.49 -51.1 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -74.65 -51.54 14.12 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.618 ' O ' HG23 ' A' ' 91' ' ' VAL . 26.6 tt0 -53.52 -25.32 16.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.929 0.395 . . . . 0.0 110.755 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.749 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.67 -36.43 43.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.248 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 28.1 t80 -67.94 -51.33 48.84 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.053 0.454 . . . . 0.0 110.142 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -32.62 58.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.773 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 87' ' ' GLU . 47.1 t -88.7 -22.73 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.616 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -52.93 -34.22 54.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.231 -179.388 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -99.36 147.87 24.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.487 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -67.48 -38.27 84.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.374 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.25 -9.74 13.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.796 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.03 28.07 32.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.327 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -67.5 -13.98 62.52 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.165 0.482 . . . . 0.0 110.757 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.85 -10.73 55.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.146 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.8 m-85 -127.12 145.28 50.8 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.014 0.435 . . . . 0.0 111.458 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.036 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.17 110.03 26.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.699 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -82.97 176.89 8.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.602 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.11 -30.06 71.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.077 0.465 . . . . 0.0 110.487 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -57.76 11.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.286 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.791 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.5 -45.81 29.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.093 -179.217 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.036 HD13 HD13 ' A' ' 100' ' ' ILE . 38.0 tp -53.0 -31.15 39.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.844 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.6 ttt-85 -73.36 -49.09 29.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.952 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -59.06 -42.04 89.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.207 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.0 t -72.99 -40.01 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.598 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.456 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 27.7 mmt -73.97 -54.2 8.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.521 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.717 HG23 ' HA ' ' A' ' 115' ' ' LYS . 7.5 m -56.92 -47.75 79.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.241 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.698 ' C ' HD12 ' A' ' 112' ' ' LEU . 99.8 m-20 -59.67 -28.42 67.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.899 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.5 mp -123.28 37.09 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.99 -113.18 0.29 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.722 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.44 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.6 OUTLIER -134.58 167.22 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 0.0 110.849 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.717 ' HA ' HG23 ' A' ' 110' ' ' THR . 3.8 tppp? -72.55 99.88 2.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.237 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.971 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.05 114.42 26.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.435 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.923 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.85 175.39 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.381 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.407 ' H ' HG22 ' A' ' 117' ' ' THR . 1.8 m-20 -48.03 -36.0 12.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.782 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -77.34 -35.01 55.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.761 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -72.82 -33.26 66.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.993 0.425 . . . . 0.0 110.178 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.971 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.88 -47.92 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.898 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.54 -52.81 63.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.788 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -57.44 -28.72 63.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.829 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.805 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.5 tpt -76.25 -38.06 56.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.137 0.494 . . . . 0.0 110.108 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.489 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.53 -43.33 80.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.476 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -64.98 -39.18 93.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.786 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.42 -36.28 29.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.945 0.402 . . . . 0.0 110.449 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.452 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -67.88 -37.55 81.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.544 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.732 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.2 t0 -100.35 146.35 27.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.04 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.556 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.72 -40.6 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.077 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.556 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.98 -10.99 60.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.701 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.81 32.93 1.01 Allowed Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -176.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.28 -12.63 24.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.311 -0.944 . . . . 0.0 112.46 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.87 20.12 10.24 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.86 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.67 146.91 30.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 129' ' ' ASP . 38.3 t -130.66 107.28 13.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.348 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.1 t-20 -79.36 174.84 11.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.323 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.691 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.88 -67.36 0.29 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.518 0.675 . . . . 0.0 111.461 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -61.17 -30.38 70.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.884 -178.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.565 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.82 -44.43 77.88 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -31.79 46.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.208 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 138' ' ' TYR . 55.3 t -53.68 -47.79 61.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.487 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -57.82 -42.26 83.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.717 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.24 -37.93 66.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.967 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 6.4 ttp -57.11 -41.32 78.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.978 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.9 t -80.18 -31.32 38.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.74 146.63 40.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.948 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.821 0.343 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.31 -51.15 60.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.723 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.59 -53.31 31.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.668 0.271 . . . . 0.0 111.295 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -57.07 -37.57 72.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.46 . . . . 0.0 110.332 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.948 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.7 t -63.38 -34.2 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.364 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.816 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.01 -54.7 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.988 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -51.08 -37.2 44.24 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.159 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -48.37 63.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.492 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.798 ' HD2' HD23 ' A' ' 32' ' ' LEU . 16.0 mtmt -55.51 -54.4 44.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.203 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.919 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.21 -57.46 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.545 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.506 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.93 -51.17 70.82 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.177 0.513 . . . . 0.0 110.96 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.3 -40.55 64.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.747 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.774 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.8 mt -54.64 -49.32 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.484 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.421 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.4 -36.99 94.12 Favored Glycine 0 CA--C 1.498 -1.011 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.934 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.895 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.47 -61.68 2.07 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.381 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.641 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -62.36 -27.54 69.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.668 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.9 -50.37 64.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.204 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.724 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -64.25 -43.63 94.29 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.895 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.0 m -64.25 -33.12 60.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.479 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.674 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.5 OUTLIER -74.55 -45.75 43.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.839 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.537 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.9 p -59.55 -26.11 65.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.483 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.426 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.2 m -90.47 -46.64 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.148 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.921 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.9 pp -63.18 -32.98 74.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.189 0.519 . . . . 0.0 110.511 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.921 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.051 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.594 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.853 0.359 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.654 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 1.6 m-20 -86.44 -169.78 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.811 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -120.96 84.36 2.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.96 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.641 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -97.63 164.74 12.29 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.485 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.514 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.14 162.71 13.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.481 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -47.46 -51.3 20.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.856 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -64.43 -27.65 69.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.04 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.514 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.52 -51.43 20.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.734 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.7 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.6 pt -73.2 -28.73 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.854 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.39 -27.38 9.86 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.541 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 2.7 mm-40 -75.18 -28.51 60.08 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.253 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.43 -58.5 3.17 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 121.253 0.549 . . . . 0.0 111.015 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -54.64 -22.84 14.81 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.205 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.3 -28.1 56.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.23 -39.87 62.8 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.11 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.94 -51.81 68.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.861 0.838 . . . . 0.0 109.487 178.751 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.426 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 4.4 p -74.51 -24.43 58.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.122 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.852 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.15 -23.35 35.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.202 0.525 . . . . 0.0 110.347 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.821 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.7 t80 -95.74 -1.02 50.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.608 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.2 t70 -103.12 144.27 31.52 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 122.036 0.922 . . . . 0.0 111.09 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.524 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 12.6 mmtt -60.55 -53.42 57.69 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.571 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.01 -4.65 59.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.876 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.46 45.55 45.93 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.391 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -90.43 17.57 7.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.836 0.35 . . . . 0.0 110.722 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.46 6.2 87.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.508 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.45 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 61.6 p -150.29 149.05 29.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.47 140.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.747 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.683 HG23 ' HG3' ' A' ' 30' ' ' LYS . 1.3 t -87.49 -179.74 6.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.122 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.803 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.9 p -70.42 -44.14 68.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 0.0 110.897 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.683 ' HG3' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -55.5 -40.23 71.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.327 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.915 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -69.63 -53.83 16.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.424 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.86 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.04 -55.15 38.59 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.781 0.801 . . . . 0.0 109.42 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.62 -45.99 92.62 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.594 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.3 m -62.1 -31.22 71.65 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.939 0.37 . . . . 0.0 110.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.5 t -68.02 -57.2 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.842 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.454 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 1.3 tpt -71.97 -35.87 69.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.428 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -42.44 80.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.76 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.0 t -78.93 -8.36 58.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.7 tt -90.54 -54.72 3.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.761 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.467 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.15 35.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.889 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp-100 -137.3 -178.91 5.42 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.362 0.601 . . . . 0.0 111.207 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -159.64 56.59 0.9 Allowed Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.891 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.9 Cg_endo -80.37 -177.11 3.56 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.501 2.134 . . . . 0.0 112.059 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -113.66 152.54 30.28 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 110.263 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.14 -49.52 75.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.442 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.1 -33.12 74.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.764 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 44' ' ' THR . 0.1 OUTLIER -64.94 -54.28 33.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.692 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.803 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.6 -35.82 81.94 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.429 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.745 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -63.49 -42.69 98.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.875 0.369 . . . . 0.0 110.238 179.303 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -61.83 -45.61 93.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.338 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -30.72 61.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.492 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.57 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.524 -179.101 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -45.0 -28.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.328 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.46 -38.78 48.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.92 0.391 . . . . 0.0 110.838 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.919 HG11 HG21 ' B' ' 6' ' ' ILE . 4.8 m -81.14 -11.48 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.157 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.547 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.9 t0 -103.61 155.51 18.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.727 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.59 -29.09 26.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.079 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -116.4 -9.74 11.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.392 0.615 . . . . 0.0 110.485 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.8 63.93 4.76 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.008 -0.997 . . . . 0.0 113.491 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 -112.66 18.31 18.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.88 0.371 . . . . 0.0 110.217 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 86.09 19.81 56.63 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.474 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 28' ' ' THR . 5.3 p -146.65 176.37 9.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 32' ' ' LEU . 35.5 mt -115.8 136.5 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.595 0.236 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.6 m-20 -86.94 -178.3 6.26 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.329 0.585 . . . . 0.0 111.935 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.96 -55.96 12.38 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.672 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.6 Cg_endo -65.62 -34.71 40.72 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.245 1.963 . . . . 0.0 111.197 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -52.45 62.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.97 -56.88 15.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.83 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.7 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.04 -46.56 82.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 68.9 m -60.67 -31.84 71.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.107 0.479 . . . . 0.0 110.041 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.936 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.3 tpp -62.34 -61.75 2.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.97 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.7 mtp -67.62 -28.1 67.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.826 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB1' ' CG ' ' A' ' 2' ' ' ASP . . . -60.21 -20.7 59.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.374 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.56 125.36 20.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.363 . . . . 0.0 111.045 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -87.64 -21.44 25.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.095 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 35.0 tpp -60.76 -29.9 69.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -94.06 135.62 35.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -176.39 -166.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.72 63.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.61 30.84 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.0 t -77.52 -30.44 52.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.958 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -80.22 -31.93 38.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -57.89 -52.2 66.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.986 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.73 -29.21 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.432 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.727 HG22 ' HE1' ' A' ' 138' ' ' TYR . 18.7 mt -65.89 -51.35 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.822 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -75.68 -50.43 15.42 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.774 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.679 ' O ' HG23 ' A' ' 91' ' ' VAL . 21.3 mt-10 -53.79 -31.92 50.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.644 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.555 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -69.84 -38.74 76.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.774 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.554 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.1 t80 -66.82 -55.85 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.967 0.413 . . . . 0.0 110.549 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -53.73 -30.54 44.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.876 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 87' ' ' GLU . 65.9 t -88.46 -22.85 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.214 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.36 -31.85 62.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.047 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -102.44 148.66 25.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.439 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -69.59 -37.67 77.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.385 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -112.28 -9.79 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.53 30.69 32.39 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.08 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.44 -13.46 62.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.992 0.396 . . . . 0.0 110.856 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.2 -13.66 55.32 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.853 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 24.2 m-85 -127.21 145.87 50.61 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.971 0.415 . . . . 0.0 111.268 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.962 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.06 109.97 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.853 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.1 m -83.53 177.28 8.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.393 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.551 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.16 -28.64 69.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.044 0.449 . . . . 0.0 110.427 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.1 -57.67 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.422 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.618 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.42 -42.38 44.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -179.069 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.962 HD13 HD13 ' A' ' 100' ' ' ILE . 52.9 tp -56.93 -31.24 64.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.788 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.0 ttt180 -72.57 -49.3 33.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -60.81 -36.15 78.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.012 0.434 . . . . 0.0 110.437 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 104' ' ' GLU . 60.3 t -72.94 -44.83 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.178 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 24.4 mmt -74.12 -54.06 8.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.556 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.663 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.6 m -55.57 -45.86 77.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.73 0.3 . . . . 0.0 111.267 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.541 ' C ' HD12 ' A' ' 112' ' ' LEU . 11.7 t-20 -60.04 -30.06 68.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.805 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.852 ' O ' HD11 ' A' ' 18' ' ' LEU . 7.0 mp -123.63 38.92 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.578 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.38 -116.1 0.38 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.798 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -133.13 169.53 16.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.889 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.663 ' HA ' HG23 ' A' ' 110' ' ' THR . 4.8 tppt? -74.22 100.07 3.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.95 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.5 114.91 26.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.322 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.929 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.67 175.08 5.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.417 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.413 ' H ' HG22 ' A' ' 117' ' ' THR . 0.7 OUTLIER -48.02 -36.01 12.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.809 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -77.32 -34.76 55.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.774 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -72.86 -34.18 66.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.056 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.95 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.2 -48.59 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.968 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -59.2 -52.83 63.99 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.874 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.56 -28.96 64.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.843 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.858 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.6 tpt -76.32 -37.72 57.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.129 0.49 . . . . 0.0 110.177 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.485 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.64 -42.86 83.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.455 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -65.1 -39.54 93.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.858 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -81.85 -35.44 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.56 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.453 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.3 -37.68 80.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.5 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.771 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.8 t0 -100.44 147.44 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.99 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.558 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.6 pt -84.84 -40.75 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.039 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.558 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.91 -10.95 59.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.709 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.07 32.67 1.09 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.438 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.4 p-10 -96.25 -12.87 23.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.264 -0.968 . . . . 0.0 112.462 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.19 10.17 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.822 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.98 146.37 30.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.962 0.41 . . . . 0.0 109.998 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.771 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.4 t -130.68 107.38 14.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.185 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -80.36 174.83 11.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.338 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.727 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.95 -67.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.494 0.664 . . . . 0.0 111.393 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -34.03 72.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.789 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.539 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.09 -40.53 73.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.827 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.79 -33.15 46.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.046 178.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 64.8 t -55.11 -46.92 77.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.661 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.8 -45.65 85.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.13 -32.87 65.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.406 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 16.6 ttp -59.42 -42.03 90.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 t -78.71 -31.19 46.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.12 7.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.954 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.873 0.368 . . . . 0.0 111.01 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.735 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.33 -51.28 59.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.727 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.63 -53.26 32.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.678 0.275 . . . . 0.0 111.257 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -57.22 -37.46 72.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.0 0.429 . . . . 0.0 110.346 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.954 HG23 ' O ' ' B' ' 1' ' ' ALA . 16.3 t -63.31 -33.72 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.403 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.919 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.7 -55.36 13.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.046 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.6 mmm-85 -50.34 -38.11 40.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.239 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.71 -44.7 66.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.409 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.86 ' HD2' HD23 ' A' ' 32' ' ' LEU . 8.5 mtmt -57.24 -55.19 38.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.98 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.936 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.12 -57.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.309 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -58.23 -51.16 70.91 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.379 0.609 . . . . 0.0 110.65 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.588 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.52 -39.56 64.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.822 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.607 ' O ' ' HB2' ' B' ' 17' ' ' ALA . 3.5 mt -54.31 -48.23 67.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.221 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.412 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.27 -38.37 95.79 Favored Glycine 0 CA--C 1.498 -1.002 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.517 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.901 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.81 -61.66 2.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.683 -0.759 . . . . 0.0 110.506 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.738 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.08 -27.76 67.26 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.14 -48.89 66.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.005 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.1 ppt_? -63.45 -43.6 96.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.13 0.49 . . . . 0.0 109.77 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.901 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.6 m -62.42 -34.83 66.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.476 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.76 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -74.98 -43.86 51.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.7 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.545 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 17.3 p -60.46 -25.68 66.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.511 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.421 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.7 m -90.83 -46.71 14.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.055 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.947 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.54 -33.01 74.07 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.171 0.51 . . . . 0.0 110.362 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.947 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.114 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.705 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.582 ' OD2' ' HB1' ' A' ' 73' ' ' ALA . 2.0 m-20 -72.98 -170.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -121.2 86.78 2.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.631 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -98.73 164.75 12.1 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.662 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.49 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.8 p -97.96 162.71 13.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.506 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -47.43 -51.47 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.878 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -64.27 -27.73 69.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.147 0.499 . . . . 0.0 109.985 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.4 mm-40 -72.51 -51.36 20.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.736 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.711 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.4 pt -73.22 -28.78 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.898 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.36 -27.32 9.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 13.2 mm-40 -75.17 -28.46 60.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.264 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.51 -58.48 3.18 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-O 121.275 0.56 . . . . 0.0 111.014 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.876 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.52 -22.96 14.49 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.209 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.531 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.27 -27.78 56.8 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.164 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.75 -39.68 61.68 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.051 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.876 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.09 -51.73 68.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 109.43 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.402 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 8.2 p -74.45 -24.91 59.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.083 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.911 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.0 -25.1 35.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.129 0.49 . . . . 0.0 110.438 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.805 ' HB3' HD11 ' A' ' 27' ' ' ILE . 5.1 t80 -89.38 -14.53 35.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.498 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.1 t70 -90.61 145.84 24.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.963 0.887 . . . . 0.0 111.24 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.8 mmtt -63.76 -53.43 51.17 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.575 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.44 -7.07 59.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.772 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.52 45.91 58.94 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.394 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -90.9 18.13 6.99 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.894 0.378 . . . . 0.0 110.732 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.37 5.01 89.14 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.542 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.9 p -150.21 151.92 33.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.805 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -102.67 140.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.977 0.418 . . . . 0.0 111.772 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.546 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.11 176.42 8.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.006 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.819 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -70.4 -38.32 74.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.126 0.489 . . . . 0.0 110.198 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.61 -41.05 89.52 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.176 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.98 -53.71 19.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.264 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.839 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.28 -55.37 35.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.725 0.774 . . . . 0.0 109.393 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.1 -45.96 91.98 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.536 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.21 -31.11 71.6 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.883 0.342 . . . . 0.0 110.589 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 31' ' ' GLU . 69.1 t -68.25 -57.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.864 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.451 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -71.95 -35.51 69.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.474 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -42.98 80.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.625 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 t -79.03 -7.14 57.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.761 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -91.14 -54.51 3.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.27 34.49 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.839 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.36 -178.4 5.2 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.329 0.585 . . . . 0.0 111.106 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -159.59 56.62 0.9 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.901 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.9 Cg_endo -80.41 -176.27 3.11 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.516 2.144 . . . . 0.0 112.118 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.603 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.68 152.49 31.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.942 0.401 . . . . 0.0 110.27 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.21 -49.65 75.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.41 75.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.761 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.56 -54.33 33.84 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.626 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.819 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -66.03 -34.57 78.39 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.378 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.683 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.46 -43.12 95.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.894 0.378 . . . . 0.0 110.193 179.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.58 -45.37 94.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.265 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.52 -30.67 61.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.37 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.588 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -53.65 -39.2 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.604 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.421 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.3 m-80 -45.12 -28.58 0.76 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.373 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.89 -38.74 53.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.952 0.406 . . . . 0.0 110.698 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.912 HG11 HG21 ' B' ' 6' ' ' ILE . 4.8 m -80.39 -12.75 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 43.5 t0 -103.53 155.07 18.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.763 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.14 26.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.182 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -116.42 -9.8 11.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.419 0.628 . . . . 0.0 110.402 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.81 61.49 7.31 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.261 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -109.43 18.38 20.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.758 0.313 . . . . 0.0 110.472 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.76 19.79 59.15 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.402 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.5 p -147.95 176.28 10.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.0 mt -113.28 136.61 49.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.64 0.257 . . . . 0.0 110.846 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -85.87 -179.38 6.8 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.178 0.513 . . . . 0.0 111.77 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.3 m-85 -68.26 -55.94 11.65 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.455 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.3 Cg_endo -65.94 -35.27 35.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.181 1.921 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.25 -52.37 64.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.211 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.02 -56.6 19.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.779 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.711 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -54.83 -47.71 73.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.705 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 73.2 m -59.34 -32.18 69.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.146 0.498 . . . . 0.0 109.713 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.902 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.9 tpp -67.73 -61.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.93 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.443 ' HG3' HG22 ' B' ' 10' ' ' ILE . 31.8 mtp -64.71 -29.01 69.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.599 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.582 ' HB1' ' OD2' ' A' ' 2' ' ' ASP . . . -53.63 -24.86 15.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.927 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -60.84 -29.64 69.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.721 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.4 ' CD ' ' O ' ' A' ' 75' ' ' LYS . 1.6 tptp -60.29 -21.29 61.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.023 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -23.16 27.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.232 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -56.68 -77.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 178.3 -177.94 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.946 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 61.83 -173.28 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.458 ' H ' HG22 ' A' ' 79' ' ' THR . 0.8 OUTLIER 62.72 27.76 16.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.136 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -77.57 -49.43 14.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.66 -29.06 36.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.993 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -50.46 -30.53 12.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.316 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.658 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -77.17 -29.57 54.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.809 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.719 HG22 ' HE1' ' A' ' 138' ' ' TYR . 6.8 mt -79.3 -51.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.37 -51.97 11.87 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.5 tt0 -53.74 -25.92 20.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 110.71 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.709 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.07 -36.59 48.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.257 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.601 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 25.6 t80 -67.82 -52.02 41.82 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.043 0.449 . . . . 0.0 110.181 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.425 ' NH2' HD11 ' A' ' 39' ' ' LEU . 1.8 ptt180 -54.55 -32.26 58.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.847 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 87' ' ' GLU . 60.4 t -88.72 -22.72 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.577 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.478 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -53.45 -33.45 54.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.207 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -100.19 147.83 25.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.44 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -67.47 -38.35 84.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.403 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.26 -9.75 13.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.835 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.5 28.67 32.12 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.407 -0.901 . . . . 0.0 113.238 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -67.45 -13.9 62.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 117.161 0.481 . . . . 0.0 110.774 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.09 -11.57 55.58 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.085 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.457 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.4 m-85 -127.09 145.34 50.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.993 0.425 . . . . 0.0 111.434 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.046 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.16 109.93 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.686 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -83.29 177.29 8.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.541 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.546 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.32 -28.62 69.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.059 0.457 . . . . 0.0 110.509 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.31 -57.69 9.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.337 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.39 -43.6 39.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.181 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.046 HD13 HD13 ' A' ' 100' ' ' ILE . 35.5 tp -54.95 -31.18 60.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.081 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.814 ' HA ' HD11 ' A' ' 116' ' ' LEU . 3.3 ttt-85 -73.7 -49.3 26.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -61.28 -36.42 80.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.036 0.446 . . . . 0.0 110.369 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 104' ' ' GLU . 41.4 t -72.95 -44.79 56.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.229 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.6 mmt -74.05 -54.33 8.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.45 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.682 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.1 m -55.63 -46.2 77.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.32 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.582 ' C ' HD12 ' A' ' 112' ' ' LEU . 55.7 t30 -59.51 -30.48 68.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.911 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.8 mp -123.47 38.87 4.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.32 -115.69 0.36 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.817 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -133.21 168.87 17.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.93 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.682 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.7 ttmm -74.06 100.62 3.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.313 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.964 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.79 115.43 27.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.279 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.926 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.83 175.05 6.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.404 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.03 -35.91 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 110.821 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -77.36 -35.07 54.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -72.49 -33.92 67.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.994 0.426 . . . . 0.0 110.08 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.964 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.54 -48.46 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.935 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -59.33 -52.75 64.31 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.847 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.47 -28.81 63.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.819 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.813 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.7 tpt -76.33 -37.88 56.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.127 0.489 . . . . 0.0 110.182 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.75 -43.6 79.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.56 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -64.94 -39.2 93.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.837 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.22 -36.14 30.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.518 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.436 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.15 -38.22 81.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.666 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.719 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.7 t0 -99.76 147.6 25.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.09 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.562 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.8 -40.69 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.102 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.562 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.93 -10.98 60.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.698 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.68 1.09 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.2 p-10 -95.99 -12.83 24.39 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.302 -0.949 . . . . 0.0 112.455 -176.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.94 20.15 10.15 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.817 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 1.1 pt20 -146.48 146.8 30.68 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.953 0.406 . . . . 0.0 109.983 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.719 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.4 t -130.73 107.35 13.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.278 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.1 t-20 -79.27 174.6 11.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.285 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.719 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.87 -67.07 0.32 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.527 0.68 . . . . 0.0 111.441 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.403 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -60.5 -34.1 73.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.865 -178.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.506 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.17 -41.89 76.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.306 0.574 . . . . 0.0 109.53 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.772 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.75 -31.81 46.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.132 178.658 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 138' ' ' TYR . 62.2 t -55.95 -47.11 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -56.62 -44.33 81.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.07 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.13 -32.31 64.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.5 ttp -60.1 -43.12 95.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 t -77.25 -31.24 54.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.96 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 160.71 7.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.874 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.945 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.865 0.364 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.24 -50.96 61.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.723 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.66 -53.26 32.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.701 0.286 . . . . 0.0 111.289 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.14 -37.63 72.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.028 0.442 . . . . 0.0 110.252 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.945 HG23 ' O ' ' B' ' 1' ' ' ALA . 13.4 t -63.51 -33.69 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.384 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.912 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.43 -55.4 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.966 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.8 mmm-85 -50.61 -37.24 39.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.117 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -47.57 62.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.523 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.839 ' HD2' HD23 ' A' ' 32' ' ' LEU . 15.2 mtmt -55.93 -55.34 33.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.989 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.902 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.8 mt -51.36 -57.48 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.23 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -56.89 -51.2 70.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.93 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.52 -41.53 66.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.655 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.3 mt -54.39 -49.58 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.47 -37.18 94.4 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.017 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.91 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.96 -61.62 2.05 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.723 -0.738 . . . . 0.0 110.354 -179.003 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.66 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.81 -27.73 68.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.615 177.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -64.95 -51.58 61.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.273 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.734 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.89 -43.72 95.14 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.91 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -64.56 -32.92 59.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.694 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.6 OUTLIER -74.02 -45.93 46.64 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.783 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.538 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.7 -26.11 65.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.534 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.414 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.0 m -90.24 -45.9 14.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.171 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.935 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.63 -32.67 74.21 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.127 0.489 . . . . 0.0 110.483 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.935 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.093 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.695 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.835 0.35 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.428 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 5.4 m-20 -61.18 -169.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -114.6 93.58 4.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.622 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -96.42 164.63 12.55 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.471 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.513 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 6.3 p -98.93 162.58 13.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.464 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -47.73 -51.33 22.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.761 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.74 -27.7 69.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.029 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.513 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.03 -51.54 21.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.62 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.683 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -72.67 -28.98 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.592 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.41 11.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.7 mt-10 -75.1 -28.63 60.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.126 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.608 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.22 -58.42 3.23 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.332 0.587 . . . . 0.0 110.927 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.878 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 11.0 ptmt -54.44 -23.31 15.47 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.231 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.538 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.11 -27.92 57.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.226 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.41 -39.59 62.53 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.052 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.878 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.78 -51.76 68.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.789 0.804 . . . . 0.0 109.452 178.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.51 -24.8 59.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.99 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.838 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.3 tt -82.05 -24.16 35.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.501 . . . . 0.0 110.269 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.802 ' HB3' HD11 ' A' ' 27' ' ' ILE . 4.2 t80 -92.77 -2.72 55.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.567 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.5 t70 -102.41 144.02 31.41 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.988 0.899 . . . . 0.0 111.032 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.2 mmtt -60.93 -53.44 57.29 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.512 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.31 -4.64 59.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.823 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.9 47.33 39.82 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.292 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 p30 -91.81 18.54 7.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.824 0.345 . . . . 0.0 110.685 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.52 4.85 88.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.57 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.1 p -150.17 149.97 30.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.66 0.266 . . . . 0.0 110.349 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.802 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.72 140.4 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.955 0.407 . . . . 0.0 111.822 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.52 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.96 176.99 7.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.131 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.671 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -69.84 -38.28 76.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.108 0.48 . . . . 0.0 110.315 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.81 -41.36 91.09 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.251 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.926 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.46 -52.16 29.34 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.41 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.8 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -60.24 -55.1 37.89 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.836 0.827 . . . . 0.0 109.364 178.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.81 -45.15 91.69 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.431 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.5 m -62.52 -31.24 71.98 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.469 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.6 t -67.59 -57.31 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.833 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.57 ' CE ' HD22 ' A' ' 39' ' ' LEU . 3.4 tpt -71.92 -36.17 69.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.539 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -42.01 81.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.647 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.4 t -78.97 -8.44 58.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.675 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.57 HD22 ' CE ' ' A' ' 36' ' ' MET . 6.8 tt -89.64 -53.93 4.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.103 0.477 . . . . 0.0 110.694 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.97 35.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.803 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.8 tp-100 -137.47 179.99 6.08 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.374 0.607 . . . . 0.0 111.212 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -159.76 56.46 0.87 Allowed Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.831 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.1 Cg_endo -80.38 -175.13 2.54 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.469 2.113 . . . . 0.0 112.195 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.594 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -112.98 152.63 29.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.886 0.374 . . . . 0.0 110.272 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.3 -49.18 76.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.03 74.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.821 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.578 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.96 -54.58 28.33 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.639 -179.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.671 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.12 -44.65 96.18 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.93 179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.645 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -58.2 -49.15 78.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.351 . . . . 0.0 110.751 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -53.25 -47.52 68.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.399 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.406 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.2 mmt -74.77 -30.55 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.767 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -53.62 -35.11 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.868 0.366 . . . . 0.0 111.522 -179.021 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -44.99 -28.63 0.7 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.267 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -78.05 -38.86 43.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.914 0.387 . . . . 0.0 110.764 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.869 HG11 HG21 ' B' ' 6' ' ' ILE . 4.5 m -80.49 -11.17 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.549 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.6 t0 -103.69 155.79 18.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.735 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.496 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.63 -29.17 25.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -116.5 -9.65 11.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.444 0.64 . . . . 0.0 110.468 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.61 63.51 5.15 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.484 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -112.11 17.9 19.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.857 0.36 . . . . 0.0 110.268 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.07 19.91 54.47 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.554 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.2 p -147.64 176.42 10.1 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.742 HD12 HD11 ' A' ' 32' ' ' LEU . 12.1 mt -115.49 136.57 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.569 0.223 . . . . 0.0 111.068 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.4 m-20 -88.05 -178.05 5.89 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.219 0.533 . . . . 0.0 111.964 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.86 -55.97 12.61 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.77 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.9 Cg_endo -65.63 -34.91 39.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.237 1.958 . . . . 0.0 111.186 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -52.28 63.64 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.206 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.713 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.97 -56.72 18.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.887 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.683 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.94 -46.25 82.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.653 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.695 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 80.0 m -60.05 -31.91 70.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.092 0.473 . . . . 0.0 110.037 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.921 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.3 tpp -62.24 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.105 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.8 mtm -71.26 -30.9 66.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.011 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.428 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.79 0.09 40.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.584 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 tpt85 -56.98 150.14 17.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.808 0.337 . . . . 0.0 111.009 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -72.55 -12.72 61.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.304 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.5 mmt -93.55 -30.83 14.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 110.965 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 100.44 6.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -156.24 -176.35 5.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 61.59 -167.51 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.401 ' H ' HG22 ' A' ' 79' ' ' THR . 11.3 m-20 64.25 65.01 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -77.54 -58.09 3.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.41 -31.01 72.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -50.35 -30.43 12.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.581 ' O ' HG11 ' B' ' 19' ' ' VAL . 6.4 mt-10 -77.68 -29.47 51.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.713 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.667 HG22 ' HE1' ' A' ' 138' ' ' TYR . 16.2 mt -79.15 -51.13 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -72.55 -48.85 36.86 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.663 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.8 tt0 -53.61 -25.49 17.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.807 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.754 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.99 -36.83 48.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.284 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 25.2 t80 -68.29 -51.68 42.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 110.146 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -54.96 -32.2 61.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.772 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 87' ' ' GLU . 47.4 t -88.77 -22.72 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.488 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.55 -33.6 55.26 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.073 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -101.8 147.21 26.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.407 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -69.59 -36.59 76.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.448 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.18 -9.69 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.824 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.64 29.82 34.56 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.251 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -67.51 -13.85 62.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.109 0.455 . . . . 0.0 110.732 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.448 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.18 -12.7 55.47 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.906 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.483 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 20.5 m-85 -127.3 146.91 50.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.86 0.362 . . . . 0.0 111.25 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.847 ' CD1' HD12 ' A' ' 105' ' ' LEU . 1.1 pt -121.11 110.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.854 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m -82.31 178.42 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.644 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.537 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.72 -29.69 70.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 110.638 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.56 -57.2 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.147 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.761 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.43 -45.26 32.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.251 -179.155 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.847 HD12 ' CD1' ' A' ' 100' ' ' ILE . 5.3 tt -53.03 -32.7 48.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.936 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.843 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.5 ttt180 -73.4 -49.36 27.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -59.7 -42.67 93.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.877 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.766 ' O ' HD12 ' A' ' 112' ' ' LEU . 3.4 t -73.0 -40.14 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.73 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.498 ' HE1' ' CD2' ' B' ' 20' ' ' PHE . 30.1 mmt -73.95 -54.19 8.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.529 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.736 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.3 m -57.01 -48.94 77.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.256 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -57.87 -28.4 64.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.838 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.1 mt -123.6 36.6 4.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.44 -116.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.734 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.404 ' O ' HD23 ' A' ' 116' ' ' LEU . 6.9 pt-20 -130.49 168.75 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.85 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.736 ' HA ' HG23 ' A' ' 110' ' ' THR . 63.2 tttt -74.1 100.52 3.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.233 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.971 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.78 114.53 26.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.455 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.928 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -71.83 175.39 5.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.358 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.474 ' H ' HG22 ' A' ' 117' ' ' THR . 1.5 t70 -48.11 -35.93 12.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.746 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -77.37 -35.74 54.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.701 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -71.81 -33.51 68.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.966 0.412 . . . . 0.0 110.063 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.971 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -73.92 -48.61 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.745 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -58.41 -52.82 64.03 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.544 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -60.24 -28.67 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.577 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.619 ' HG2' HD21 ' A' ' 105' ' ' LEU . 5.5 tpt -72.42 -37.74 68.56 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.253 0.549 . . . . 0.0 110.085 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.487 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -70.63 -41.25 77.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.501 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -64.78 -40.16 94.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.6 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -81.84 -34.67 30.03 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.002 0.429 . . . . 0.0 110.374 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -34.75 76.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.517 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.72 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.3 t0 -105.19 146.67 28.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.992 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.56 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -83.69 -40.83 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.08 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.56 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.96 -11.0 60.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.678 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.96 32.6 1.02 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.4 p-10 -96.0 -12.78 24.47 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.332 -0.934 . . . . 0.0 112.432 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.22 10.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.828 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.483 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -146.68 147.4 30.97 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 129' ' ' ASP . 25.6 t -130.76 107.3 13.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.354 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.4 t-20 -81.01 174.51 11.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.239 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.667 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.96 -67.23 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.583 0.706 . . . . 0.0 111.471 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.1 mt-10 -60.81 -29.14 69.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.989 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.546 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.83 -44.26 77.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.069 0.461 . . . . 0.0 109.814 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.7 -32.01 46.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.175 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 138' ' ' TYR . 68.5 t -53.84 -48.14 62.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -58.15 -44.16 87.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.21 -32.63 64.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.789 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 15.3 ttp -60.01 -45.56 92.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 t -74.69 -30.96 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.61 148.87 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.876 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.972 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.786 0.327 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.73 ' O ' HG13 ' B' ' 6' ' ' ILE . 2.1 mmm180 -52.15 -51.54 57.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.746 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.76 -53.43 31.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.612 0.244 . . . . 0.0 111.417 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.05 -37.0 71.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.139 0.495 . . . . 0.0 110.174 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.972 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.6 t -63.7 -34.4 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.417 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.869 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -71.47 -53.87 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.979 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -50.81 -39.77 53.8 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.238 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -48.32 65.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.867 ' O ' HD12 ' B' ' 13' ' ' ILE . 13.9 mtmt -55.01 -54.25 45.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.273 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.921 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.7 mt -51.04 -55.04 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.297 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.533 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 5.9 tpt180 -61.44 -46.46 89.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.224 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.528 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.13 -40.58 64.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.076 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.867 HD12 ' O ' ' B' ' 9' ' ' LYS . 1.8 mt -54.55 -51.71 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.512 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.41 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.46 -36.72 93.54 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.386 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.911 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.15 -61.58 2.16 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.954 -0.623 . . . . 0.0 110.474 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.655 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -63.38 -27.77 69.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.658 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -66.62 -50.91 61.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.203 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.559 ' NE ' HG12 ' B' ' 19' ' ' VAL . 3.9 ppt_? -63.38 -43.5 97.42 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.911 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.5 m -66.94 -31.85 55.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 0.0 110.609 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.659 ' HE2' HG12 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -72.65 -51.15 20.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.814 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.442 ' HA ' ' NE ' ' B' ' 24' ' ' ARG . 50.6 p -57.27 -35.34 69.64 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.116 0.484 . . . . 0.0 110.781 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.493 HG13 ' O ' ' B' ' 18' ' ' ARG . 27.2 m -73.43 -45.81 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.976 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.592 HD21 ' CD1' ' B' ' 20' ' ' PHE . 3.6 pp -65.15 -24.9 67.53 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.916 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 11.2 ptt85 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.901 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . . . . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.866 0.365 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.603 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 3.0 m-20 -98.48 -169.9 1.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.76 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -116.96 83.98 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.633 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -97.51 164.77 12.3 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.019 0.438 . . . . 0.0 110.475 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.497 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.7 161.97 13.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.438 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -47.68 -51.67 20.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.752 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -64.56 -27.69 69.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.033 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.497 ' HB2' ' H ' ' A' ' 5' ' ' THR . 1.7 mm-40 -71.88 -51.41 22.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.644 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.1 pt -73.01 -28.95 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.72 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.31 10.81 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.546 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 4.0 mt-10 -75.25 -28.55 59.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.281 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.38 -58.52 3.17 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.299 0.571 . . . . 0.0 110.946 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.877 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.5 pttt -54.52 -23.48 16.61 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.183 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -75.65 -28.03 58.59 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.174 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.17 -39.77 63.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.094 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.877 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.04 -51.84 68.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.803 0.811 . . . . 0.0 109.544 178.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.49 -24.7 59.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.124 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.842 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.13 -23.13 35.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.165 0.507 . . . . 0.0 110.405 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.82 ' CE2' HG21 ' A' ' 35' ' ' VAL . 3.6 t80 -94.46 -2.82 51.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.639 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 26' ' ' THR . 23.9 t70 -100.83 142.81 31.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.946 0.879 . . . . 0.0 111.096 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -59.84 -53.45 57.78 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.501 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.17 -6.27 59.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.714 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.5 47.37 51.66 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.36 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -92.01 18.8 7.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.882 0.372 . . . . 0.0 110.688 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.42 5.03 89.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.619 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.8 p -150.28 150.27 31.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.688 0.28 . . . . 0.0 110.26 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.78 140.54 20.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.79 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.576 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -84.89 176.35 8.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.024 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.798 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -70.49 -37.97 74.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.128 0.49 . . . . 0.0 110.271 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.87 -41.06 90.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.162 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.1 -53.82 18.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.264 -179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.822 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -58.37 -55.13 39.05 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.695 0.76 . . . . 0.0 109.365 178.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.12 -45.88 92.1 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.514 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.2 m -62.34 -32.3 73.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.874 0.337 . . . . 0.0 110.488 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.9 t -66.45 -57.18 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.448 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.91 -34.61 69.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.376 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -68.97 -42.62 76.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.666 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.5 t -78.91 -7.75 58.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.751 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -91.21 -54.91 3.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.806 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.461 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.11 34.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.9 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 tp-100 -137.59 -178.73 5.37 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.295 0.569 . . . . 0.0 111.223 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -159.56 56.57 0.9 Allowed Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.933 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.0 Cg_endo -80.33 -177.38 3.75 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.538 2.159 . . . . 0.0 112.065 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -112.86 152.36 29.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.955 0.407 . . . . 0.0 110.306 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.51 -49.24 76.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.39 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.65 -31.82 72.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.783 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 44' ' ' THR . 1.0 OUTLIER -66.0 -54.31 27.68 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.611 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.798 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.97 -34.53 78.31 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.34 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.682 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.49 -42.68 95.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.909 0.385 . . . . 0.0 110.172 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.74 -45.45 93.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.186 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.6 mmt -74.52 -30.77 61.91 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.46 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.74 -38.29 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.606 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -45.03 -28.53 0.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.369 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.72 -38.33 47.39 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.849 HG11 HG21 ' B' ' 6' ' ' ILE . 4.7 m -81.58 -11.36 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.239 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.554 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.9 t0 -103.52 155.6 18.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.761 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.479 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.61 -28.8 26.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -116.46 -9.75 11.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.399 0.618 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.53 63.23 5.42 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.402 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -112.23 18.42 18.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.863 0.363 . . . . 0.0 110.188 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.32 19.9 56.0 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.49 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.576 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.0 p -146.85 176.49 9.85 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 32' ' ' LEU . 50.0 mt -116.27 136.53 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.528 0.204 . . . . 0.0 110.92 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.479 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.1 m-20 -87.33 -178.36 6.17 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.328 0.585 . . . . 0.0 112.002 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.511 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.78 -56.37 11.94 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.534 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.4 Cg_endo -65.81 -34.61 39.4 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.285 1.99 . . . . 0.0 111.114 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -52.4 63.67 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.226 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.726 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.47 -56.64 19.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.842 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.73 -46.26 84.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 58.3 m -60.69 -31.01 70.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.075 0.464 . . . . 0.0 110.046 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.928 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.5 tpp -62.43 -61.84 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.163 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 66.9 mtp -62.18 -33.43 74.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.603 ' HB1' ' CG ' ' A' ' 2' ' ' ASP . . . -61.1 -19.29 61.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.399 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -53.56 141.55 25.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.841 0.353 . . . . 0.0 111.134 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 2.1 tptp -87.53 -21.79 25.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.1 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 37.4 ttm -60.01 -23.2 63.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.104 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -57.53 153.66 12.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -105.09 27.38 8.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.05 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.403 HG22 ' HB2' ' A' ' 81' ' ' SER . 9.5 m 68.3 -67.52 0.2 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.037 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.53 36.66 8.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.886 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.403 ' HB2' HG22 ' A' ' 79' ' ' THR . 23.1 t -77.49 -28.88 52.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.034 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -80.61 -29.18 36.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -75.35 -44.4 45.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.723 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.76 -29.3 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.455 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.715 HG22 ' HE1' ' A' ' 138' ' ' TYR . 23.2 mt -65.97 -51.33 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.828 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -75.68 -51.11 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.828 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.659 ' O ' HG23 ' A' ' 91' ' ' VAL . 15.9 tt0 -53.91 -30.78 47.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.666 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.541 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -69.92 -38.78 76.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 22.6 t80 -67.38 -55.17 14.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.969 0.414 . . . . 0.0 110.431 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -54.47 -30.33 52.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.866 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 87' ' ' GLU . 98.4 t -88.38 -22.83 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.148 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.507 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -55.53 -30.55 60.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.036 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -107.69 142.82 37.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.621 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.749 ' NZ ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -65.28 -38.01 88.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.631 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -110.58 -9.58 14.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.43 31.74 36.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.367 -0.921 . . . . 0.0 113.076 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -67.38 -13.61 62.17 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.962 0.381 . . . . 0.0 110.747 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.454 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.19 -13.73 55.32 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.847 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.8 m-85 -127.28 147.42 50.23 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.899 0.381 . . . . 0.0 111.292 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.942 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -120.17 110.02 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.949 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.9 p -83.93 176.09 9.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.462 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.561 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -62.7 -29.98 71.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.08 0.467 . . . . 0.0 110.471 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.03 -57.01 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.287 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.735 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -76.43 -46.49 26.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.323 -179.091 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.942 HD13 HD13 ' A' ' 100' ' ' ILE . 41.0 tp -53.13 -31.08 40.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.818 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.0 ttt180 -73.82 -49.2 26.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.11 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -57.44 -43.7 84.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.292 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.749 HG22 ' NZ ' ' A' ' 94' ' ' LYS . 1.8 t -72.99 -43.0 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.574 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.477 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 31.3 mmt -70.21 -54.22 13.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.569 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.651 HG23 ' HA ' ' A' ' 115' ' ' LYS . 6.4 m -55.56 -45.25 77.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.15 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -61.64 -29.61 70.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.842 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.8 mp -122.35 37.59 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.62 -112.95 0.28 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.723 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.427 ' O ' HD23 ' A' ' 116' ' ' LEU . 2.3 pt-20 -136.61 170.27 16.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.771 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.651 ' HA ' HG23 ' A' ' 110' ' ' THR . 5.0 tppp? -73.59 98.35 2.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.963 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -88.86 113.42 24.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.925 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.74 175.26 5.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.376 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 117' ' ' THR . 73.7 m-20 -48.09 -36.05 12.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -77.34 -34.13 55.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.795 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -73.91 -33.3 63.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.971 0.415 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.963 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.92 -48.4 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.808 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.09 -52.8 64.18 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.736 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.52 -28.71 63.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.798 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.792 ' HG3' HD21 ' A' ' 105' ' ' LEU . 10.2 tpt -76.18 -37.9 57.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.142 0.496 . . . . 0.0 110.244 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -67.17 -42.68 88.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.4 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -62.87 -41.54 99.42 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 124' ' ' MET . 6.7 pt-20 -82.1 -32.79 30.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 110.48 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.54 78.45 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.451 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.754 ' HB2' HG22 ' A' ' 136' ' ' VAL . 18.5 t0 -105.46 149.38 26.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.934 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.579 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.5 pt -84.79 -40.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.26 0.552 . . . . 0.0 109.986 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.579 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.88 -10.93 59.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.67 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.12 32.77 1.13 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.5 p-10 -96.55 -12.9 23.41 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.296 -0.952 . . . . 0.0 112.391 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.09 10.28 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.753 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.491 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.81 146.43 30.24 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.925 0.393 . . . . 0.0 110.094 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 129' ' ' ASP . 41.1 t -130.76 107.38 13.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.224 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.0 t-20 -80.16 174.24 11.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.41 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.715 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.91 -67.07 0.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.5 0.667 . . . . 0.0 111.539 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.78 -33.51 71.79 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.981 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.529 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.1 -41.36 75.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.054 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.872 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.2 OUTLIER -78.77 -32.03 46.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.226 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.58 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 61.8 t -55.78 -51.13 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.722 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -58.25 -47.41 83.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.3 tpp -68.44 -31.66 71.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.79 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.425 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 26.5 ttp -61.11 -46.48 90.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.786 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.3 t -76.96 -30.84 56.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.907 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.64 153.6 19.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.079 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.95 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.847 0.356 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.3 mmm180 -52.26 -51.17 59.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.728 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.67 -53.21 32.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.681 0.277 . . . . 0.0 111.302 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -57.06 -37.6 72.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.373 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.95 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.9 t -63.38 -33.69 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.37 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.849 HG21 HG11 ' A' ' 55' ' ' VAL . 2.4 mt -71.76 -55.09 14.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.993 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 27.5 mmm-85 -50.2 -37.9 37.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.2 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.19 -46.57 64.33 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.492 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.822 ' HD2' HD23 ' A' ' 32' ' ' LEU . 11.9 mtmt -56.14 -53.57 55.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.127 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.928 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.21 -57.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.662 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.1 tpt180 -61.67 -51.38 68.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.328 0.585 . . . . 0.0 111.028 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.575 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.37 -38.94 63.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.719 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.724 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.41 -49.24 66.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.275 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.408 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.95 -37.76 95.09 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.55 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.92 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.9 -61.62 2.05 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.707 -0.747 . . . . 0.0 110.507 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.736 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -60.51 -27.73 67.83 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.51 -48.99 65.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.04 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.1 ppt_? -63.29 -43.95 96.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.92 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.8 m -61.85 -35.4 67.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.715 0.769 . . . . 0.0 110.234 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.696 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 0.3 OUTLIER -72.49 -46.66 53.75 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.408 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.495 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 59.1 p -59.73 -37.2 78.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.756 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.456 HG13 ' O ' ' B' ' 18' ' ' ARG . 27.2 m -72.28 -45.2 62.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.872 HD23 ' CE1' ' A' ' 141' ' ' PHE . 3.3 pp -64.17 -28.18 69.58 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.893 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.696 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 6.8 ptt85 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.931 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.815 0.34 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.578 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 2.5 m-20 -97.59 -169.7 1.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.796 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.52 83.06 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.637 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -96.1 164.68 12.59 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.407 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.529 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.95 162.77 12.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.491 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -47.48 -51.22 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -64.56 -27.64 69.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.057 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.529 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.5 -51.46 19.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.681 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.1 pt -73.1 -28.89 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.666 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.57 -27.31 10.66 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.555 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 7.3 mt-10 -75.24 -28.6 59.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.289 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.0 m-85 -79.53 -58.6 3.12 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.24 0.543 . . . . 0.0 110.981 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.871 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.8 15.13 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.198 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.25 -27.99 56.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.065 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.31 -39.71 62.7 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.053 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.871 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.88 -51.8 68.46 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.82 0.819 . . . . 0.0 109.387 178.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.401 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 1.8 p -74.42 -23.95 59.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.064 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.87 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -81.99 -26.15 34.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.285 0.564 . . . . 0.0 110.04 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.843 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.5 t80 -92.91 0.63 57.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.349 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 26' ' ' THR . 27.7 t70 -105.52 144.07 32.8 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.99 0.9 . . . . 0.0 111.025 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 2.3 mmtt -59.6 -53.41 58.43 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.601 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.63 -3.61 59.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.785 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.08 46.83 33.38 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.322 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.2 p30 -91.1 17.96 7.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.845 0.355 . . . . 0.0 110.759 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 84.2 4.9 87.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.668 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.431 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.7 p -150.29 147.82 28.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.639 0.257 . . . . 0.0 110.337 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -99.61 140.39 19.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.825 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.569 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.19 179.07 7.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.346 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.667 HG21 ' CG ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -70.19 -41.94 73.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.181 0.515 . . . . 0.0 110.277 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -57.44 -41.12 79.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.467 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.77 -53.79 16.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.405 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.592 HD13 ' CD1' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -56.24 -55.69 30.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.882 0.849 . . . . 0.0 109.581 178.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.425 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -58.74 -48.0 87.36 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.485 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.413 ' CB ' ' O ' ' A' ' 30' ' ' LYS . 54.9 m -64.38 -31.11 72.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.858 0.329 . . . . 0.0 110.458 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.843 HG21 ' CE2' ' A' ' 19' ' ' PHE . 18.9 t -63.2 -58.03 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.925 0.393 . . . . 0.0 110.486 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.656 ' HB2' ' HD2' ' B' ' 9' ' ' LYS . 0.0 OUTLIER -72.65 -40.66 66.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.238 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.61 -39.62 88.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.554 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -78.83 -12.2 60.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.597 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.545 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.3 tt -87.02 -53.75 4.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.108 0.48 . . . . 0.0 110.553 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.474 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -178.53 36.33 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.654 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 2.0 tp-100 -133.7 178.73 6.71 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.403 0.62 . . . . 0.0 111.267 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -159.87 56.29 0.84 Allowed Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.696 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.4 Cg_endo -80.54 -168.24 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.527 2.151 . . . . 0.0 112.37 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 47' ' ' GLU . 1.2 m -117.37 152.96 33.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.891 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -60.37 -48.53 81.34 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.75 76.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.705 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -62.81 -53.95 46.42 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.484 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -57.65 -51.27 70.19 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.947 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.667 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -53.62 -49.42 67.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.744 0.307 . . . . 0.0 111.289 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -53.11 -48.7 67.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.73 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mmt -74.71 -30.48 61.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.986 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.592 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -53.64 -36.44 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.843 -178.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.406 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 3.7 m-80 -45.66 -28.58 1.03 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.271 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -78.04 -38.34 44.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.932 0.396 . . . . 0.0 110.7 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.022 HG11 HG21 ' B' ' 6' ' ' ILE . 4.1 m -81.21 -12.32 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.063 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 42.5 t0 -103.59 155.24 18.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.744 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.71 -28.27 26.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.156 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -116.39 -9.72 11.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.443 0.64 . . . . 0.0 110.423 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.89 61.2 7.64 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.278 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -109.37 18.42 20.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.759 0.314 . . . . 0.0 110.447 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' CA ' ' HG2' ' A' ' 49' ' ' GLN . . . 84.9 19.78 58.92 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.493 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -147.81 176.35 10.2 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.404 HD12 HD11 ' A' ' 32' ' ' LEU . 31.7 mt -114.11 136.69 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.582 0.229 . . . . 0.0 110.955 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -87.54 -179.61 6.37 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.218 0.532 . . . . 0.0 111.958 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.3 m-85 -67.7 -55.77 13.48 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.54 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.73 -35.35 37.2 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.204 1.936 . . . . 0.0 111.166 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.12 -52.48 63.68 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.319 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.705 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.64 -56.31 23.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.773 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.699 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -58.66 -46.66 86.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.75 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 51.8 m -60.68 -30.66 70.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.147 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.888 ' HG2' HD13 ' B' ' 10' ' ' ILE . 4.6 tpp -59.94 -61.75 2.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.166 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mtm -62.89 -36.2 82.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.578 ' HB1' ' OD1' ' A' ' 2' ' ' ASP . . . -59.01 -21.46 59.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.352 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -54.94 151.2 9.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.858 0.361 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -87.62 -14.85 38.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.221 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.0 ttm -82.86 -30.78 28.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.939 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.51 105.45 17.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.898 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -176.43 -173.23 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m 64.25 81.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.78 37.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.58 -31.57 53.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -80.67 -36.82 31.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.996 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -59.46 -50.75 72.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.718 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.7 -29.27 25.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.518 -179.545 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.725 HG22 ' HE1' ' A' ' 138' ' ' TYR . 19.3 mt -66.61 -51.33 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.829 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.443 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -75.62 -50.67 14.79 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 91' ' ' VAL . 32.4 mt-10 -53.81 -32.11 51.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.648 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -68.68 -39.35 80.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.683 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.556 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 22.9 t80 -66.73 -56.38 10.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.555 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -53.87 -29.93 43.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.905 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 87' ' ' GLU . 97.1 t -88.41 -23.03 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.19 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.453 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.7 -31.94 62.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.061 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -102.69 148.41 25.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.389 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -69.62 -37.51 76.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -112.34 -9.73 13.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.877 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.24 30.83 32.92 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.136 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.41 -13.32 61.91 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.971 0.386 . . . . 0.0 110.813 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.27 -13.86 55.04 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.826 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 24.8 m-85 -127.14 145.69 50.66 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.976 0.417 . . . . 0.0 111.258 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.97 HD13 HD13 ' A' ' 105' ' ' LEU . 1.1 pt -121.15 109.94 26.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.814 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 56.0 m -83.73 177.41 8.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.405 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.13 -28.87 70.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.071 0.463 . . . . 0.0 110.494 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.94 -57.67 9.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.436 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.623 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.36 -42.37 44.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.257 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.97 HD13 HD13 ' A' ' 100' ' ' ILE . 54.5 tp -57.3 -31.12 65.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.082 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.789 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.9 ttt180 -72.37 -49.28 35.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -60.6 -36.54 78.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 110.533 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 104' ' ' GLU . 56.6 t -72.93 -44.56 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.243 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 23.4 mmt -74.05 -53.95 8.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.7 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.0 m -55.42 -45.58 76.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 111.262 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.404 ' HB3' HD12 ' A' ' 112' ' ' LEU . 17.0 t-20 -62.44 -25.7 68.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.838 0.351 . . . . 0.0 110.728 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.87 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.4 mp -125.37 37.41 4.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.755 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -172.3 -113.77 0.31 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.775 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -134.72 169.88 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.36 . . . . 0.0 110.877 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.655 ' HA ' HG23 ' A' ' 110' ' ' THR . 19.0 tttt -74.09 100.07 3.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.252 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.95 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.39 114.76 26.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.285 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.928 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.74 175.1 5.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.412 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.45 ' H ' HG22 ' A' ' 117' ' ' THR . 3.1 t0 -48.11 -36.02 12.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.939 0.4 . . . . 0.0 110.775 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -77.35 -34.4 55.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.777 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -73.29 -34.05 65.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.002 0.43 . . . . 0.0 110.093 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.95 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.4 -48.82 34.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.943 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -58.99 -52.89 63.82 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.908 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.31 -29.02 63.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.839 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.834 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.4 tpt -76.32 -38.07 56.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.091 0.472 . . . . 0.0 110.223 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.14 -42.46 84.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.553 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -65.78 -39.2 90.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.923 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.03 -35.54 28.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.468 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.24 -38.58 81.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.517 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.772 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.6 t0 -98.96 147.48 24.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.078 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.561 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.6 pt -84.79 -40.68 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.307 0.575 . . . . 0.0 110.053 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.561 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.92 -11.02 60.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.713 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.72 1.1 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.3 p-10 -96.28 -12.92 23.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.296 -0.952 . . . . 0.0 112.42 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.96 20.08 10.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.804 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.97 146.31 30.04 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.962 0.41 . . . . 0.0 110.029 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.5 t -130.67 107.44 14.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.229 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -80.25 174.7 11.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.339 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.725 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.99 -66.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.513 0.673 . . . . 0.0 111.479 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -34.01 72.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.909 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.545 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.05 -40.54 73.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.825 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.75 -33.62 46.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.082 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.586 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.4 t -54.68 -46.83 73.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.666 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.98 -45.49 86.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.11 -33.21 65.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.427 ' HE1' HG12 ' A' ' 85' ' ' ILE . 14.7 ttp -59.25 -41.76 89.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.4 t -79.23 -30.88 43.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.63 161.87 5.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.119 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.941 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.846 0.355 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.737 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.2 mmm180 -52.24 -50.78 61.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.735 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.63 -53.36 31.4 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.628 0.252 . . . . 0.0 111.323 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.96 -37.1 71.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.129 0.49 . . . . 0.0 109.998 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.941 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.9 t -63.42 -34.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.341 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 1.022 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.99 -55.59 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.253 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 27.6 mmm-85 -49.79 -40.56 41.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.414 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -43.72 70.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.224 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.74 ' O ' HD12 ' B' ' 13' ' ' ILE . 0.0 OUTLIER -54.84 -55.49 29.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.189 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.888 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.5 mt -51.6 -57.49 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.835 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.2 tpt180 -60.56 -51.29 70.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.321 0.582 . . . . 0.0 110.912 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.566 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.4 -40.0 64.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.652 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.74 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.0 mt -54.51 -47.57 71.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.236 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.08 -38.33 95.84 Favored Glycine 0 CA--C 1.497 -1.056 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.546 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.892 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.97 -61.69 2.01 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.637 -0.782 . . . . 0.0 110.495 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.746 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.03 -27.75 67.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.504 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.68 -48.73 65.77 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.935 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.632 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.5 ppt_? -62.27 -43.45 98.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.133 0.492 . . . . 0.0 109.692 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.892 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.6 m -63.89 -34.9 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.866 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -74.8 -45.74 41.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.929 -179.345 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.558 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 12.6 p -59.81 -24.98 64.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.567 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 23' ' ' LEU . 29.5 m -90.73 -46.72 14.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.972 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.945 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.31 -32.76 73.55 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.147 0.498 . . . . 0.0 110.335 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.945 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.131 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.62 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.792 0.33 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.574 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.8 m-20 -64.96 -169.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -116.97 90.56 3.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.001 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.64 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.2 mt -98.64 164.75 12.11 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.542 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.485 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.4 p -96.77 161.78 13.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.493 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -47.7 -51.78 20.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.781 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -64.35 -27.72 69.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.031 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.87 -51.52 21.93 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.592 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.697 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -72.98 -28.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.742 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.51 -27.36 10.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 37.3 mt-10 -75.28 -28.47 59.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.203 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.28 -58.51 3.18 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.281 0.562 . . . . 0.0 110.983 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.49 -23.05 14.65 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.285 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.33 -27.87 56.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.116 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.49 -39.8 62.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.074 177.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.74 -51.68 68.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.899 0.857 . . . . 0.0 109.445 178.731 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.404 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 7.3 p -74.37 -24.89 59.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.049 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.894 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.06 -24.64 35.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.172 0.51 . . . . 0.0 110.278 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.808 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.9 t80 -92.66 -2.33 56.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.599 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.9 t70 -102.36 143.37 32.2 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.97 0.891 . . . . 0.0 111.154 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -59.94 -53.42 58.11 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.58 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -84.81 -6.11 59.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.811 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.54 46.27 53.31 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.188 -0.529 . . . . 0.0 113.375 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -90.99 18.15 7.06 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.798 0.333 . . . . 0.0 110.727 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.5 5.7 88.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 48.3 p -150.28 149.9 30.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.808 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.88 140.5 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.944 0.402 . . . . 0.0 111.834 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.586 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.35 176.56 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.02 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.826 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.2 p -70.49 -37.76 74.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.133 0.492 . . . . 0.0 110.268 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.03 -41.11 91.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.155 178.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.921 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.23 -53.43 19.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.282 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.838 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.4 -54.93 41.46 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.771 0.796 . . . . 0.0 109.402 178.594 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.46 -45.89 92.52 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.516 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -62.21 -31.34 71.86 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.851 0.326 . . . . 0.0 110.574 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.7 t -68.0 -57.24 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.853 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.457 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 1.1 tpt -71.91 -35.5 69.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.427 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -68.05 -42.15 80.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.595 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 t -78.97 -7.79 58.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.731 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.73 -54.31 4.03 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.109 0.48 . . . . 0.0 110.776 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.45 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.22 35.19 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.836 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.588 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.0 -178.98 5.44 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 111.16 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -159.65 56.43 0.87 Allowed Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.909 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.0 Cg_endo -80.42 -175.72 2.84 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.519 2.146 . . . . 0.0 112.076 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.605 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.89 152.47 32.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.941 0.401 . . . . 0.0 110.23 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.18 -49.64 75.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.43 75.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.765 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.66 -54.26 34.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.657 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.826 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.87 -34.57 78.44 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.322 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.689 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.54 -43.07 95.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.926 0.393 . . . . 0.0 110.185 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.33 -45.52 94.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.189 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.4 mmt -74.57 -30.73 61.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.403 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.74 -38.02 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.55 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -45.05 -28.55 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.372 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG2' ' HZ1' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.59 -38.75 47.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.915 0.388 . . . . 0.0 110.84 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.886 HG11 HG21 ' B' ' 6' ' ' ILE . 5.0 m -81.17 -11.43 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.157 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.543 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.7 t0 -103.63 155.63 18.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.62 -29.09 26.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -116.45 -9.64 11.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.416 0.626 . . . . 0.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.47 63.56 5.12 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.488 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -112.28 18.16 18.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 0.0 110.241 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.93 55.13 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.475 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.4 p -147.09 176.4 9.97 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 32' ' ' LEU . 57.6 mt -115.77 136.48 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.546 0.212 . . . . 0.0 110.86 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.0 m-20 -87.46 -178.18 6.09 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.318 0.58 . . . . 0.0 111.916 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.1 -55.9 12.13 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.648 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.4 Cg_endo -65.68 -34.39 41.31 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.251 1.967 . . . . 0.0 111.193 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -52.46 61.97 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.209 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.721 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.02 -57.04 14.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.867 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.697 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.1 -47.14 81.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.62 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 54.0 m -60.23 -30.92 69.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 110.077 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.92 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.7 tpp -62.08 -61.84 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.144 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 8.4 mtt -72.77 -31.64 65.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.76 0.04 40.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.602 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -55.68 153.46 8.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.809 0.338 . . . . 0.0 111.062 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tptm -69.64 -12.64 61.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.299 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.2 tpp -93.18 -30.52 15.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.34 . . . . 0.0 110.989 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.74 115.86 20.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -176.53 179.5 1.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 60.46 -167.27 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.864 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.418 ' H ' HG22 ' A' ' 79' ' ' THR . 15.0 m-20 63.45 65.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 110.864 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.45 -46.09 23.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -68.87 -36.6 78.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -50.44 -30.48 12.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.553 ' O ' HG11 ' B' ' 19' ' ' VAL . 4.6 mt-10 -77.31 -29.55 53.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.73 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.692 HG22 ' HE1' ' A' ' 138' ' ' TYR . 11.3 mt -79.24 -51.13 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -48.48 38.34 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.897 0.379 . . . . 0.0 111.863 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.691 ' OE2' ' HB1' ' B' ' 12' ' ' ALA . 21.5 tt0 -53.5 -26.42 20.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.357 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.744 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.56 -33.99 58.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.964 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.61 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 13.1 t80 -68.96 -50.42 49.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.002 0.43 . . . . 0.0 110.149 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -54.42 -33.21 59.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.767 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.99 -22.7 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.557 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.544 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -52.81 -36.82 59.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.342 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -100.09 147.13 25.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.753 0.311 . . . . 0.0 110.525 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -67.94 -37.71 81.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.434 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -112.2 -9.76 13.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.847 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.41 28.36 33.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.365 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -67.51 -13.96 62.51 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.163 0.481 . . . . 0.0 110.769 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -11.49 55.44 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.084 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.48 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.7 m-85 -127.21 146.94 50.24 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.925 0.393 . . . . 0.0 111.53 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.05 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.14 109.92 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.633 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 m -82.66 176.78 9.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.553 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.14 -29.88 70.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.097 0.475 . . . . 0.0 110.457 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.24 -57.74 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.23 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.833 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.44 -45.46 31.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.157 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.05 HD13 HD13 ' A' ' 100' ' ' ILE . 28.6 tp -53.04 -31.44 41.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.853 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.2 ttt-85 -72.46 -49.13 35.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -59.9 -42.0 92.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.115 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.9 t -73.06 -40.17 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.404 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.46 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.7 mmt -73.92 -54.16 8.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.698 HG23 ' HA ' ' A' ' 115' ' ' LYS . 7.1 m -59.03 -48.9 79.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.202 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -57.26 -28.56 63.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.894 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -124.33 37.0 4.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.731 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.43 -115.88 0.36 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.808 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.422 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -130.7 167.52 18.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 110.883 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.698 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.9 ttmt -73.59 100.07 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.291 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.973 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.55 114.43 26.64 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.393 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.927 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.78 175.26 5.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.385 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -48.01 -35.92 11.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.363 . . . . 0.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.4 -35.44 54.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.698 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -72.29 -33.3 67.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.959 0.409 . . . . 0.0 110.116 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.973 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.65 -48.51 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.846 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -59.41 -52.87 63.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.724 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -57.76 -28.67 64.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.807 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.749 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.6 tpt -76.12 -37.88 57.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.147 0.499 . . . . 0.0 110.248 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.14 -40.65 80.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -66.46 -39.19 88.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.952 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.41 -36.13 29.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.61 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.494 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.09 -37.17 80.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.413 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.646 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.4 t0 -101.36 145.53 28.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.033 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.552 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.0 pt -83.06 -40.8 16.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.165 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.92 -11.02 60.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.747 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.87 32.65 0.99 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.419 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.3 p-10 -95.53 -12.41 25.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.304 -0.948 . . . . 0.0 112.568 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.18 10.19 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.89 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.48 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.99 147.37 31.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 129' ' ' ASP . 18.6 t -130.74 107.25 13.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.39 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -78.81 174.79 11.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.227 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.93 -67.08 0.31 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.635 0.731 . . . . 0.0 111.788 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.4 mt-10 -65.28 -25.3 67.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.42 -1.263 . . . . 0.0 112.554 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.467 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.62 -48.51 74.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.822 0.344 . . . . 0.0 110.271 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.8 p90 -78.91 -30.99 45.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.243 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 138' ' ' TYR . 67.4 t -52.83 -44.5 48.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.121 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -60.34 -37.16 79.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.125 0.488 . . . . 0.0 109.809 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.46 -42.21 62.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.721 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.432 ' CG ' HG21 ' B' ' 22' ' ' VAL . 2.2 ttp -52.74 -44.21 66.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.026 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.2 t -78.33 -31.25 48.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 146.84 40.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.946 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.801 0.334 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.736 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.23 -51.08 60.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.722 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.65 -53.27 32.36 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.677 0.275 . . . . 0.0 111.302 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.1 -37.54 72.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.015 0.436 . . . . 0.0 110.339 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.946 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.2 t -63.46 -34.12 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.387 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.886 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -70.84 -54.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.969 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -51.51 -37.24 48.25 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.097 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.63 -48.31 64.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.472 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.838 ' HD2' HD23 ' A' ' 32' ' ' LEU . 17.3 mtmt -55.8 -54.38 45.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.043 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.92 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.5 mt -51.17 -57.45 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.465 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.518 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.8 tpt180 -59.79 -51.23 70.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.237 0.541 . . . . 0.0 111.094 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.691 ' HB1' ' OE2' ' A' ' 87' ' ' GLU . . . -53.19 -40.1 64.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.819 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.783 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.8 mt -54.58 -50.37 59.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.418 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.93 -36.82 93.96 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.056 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.906 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.28 -61.69 2.08 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.539 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.676 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.98 -27.62 69.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.599 177.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -66.04 -50.68 63.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.225 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.754 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -63.64 -43.55 96.46 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.02 0.438 . . . . 0.0 109.847 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.2 m -65.9 -32.69 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.839 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.686 ' HE2' HG12 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -74.66 -48.13 27.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.219 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 13.5 p -58.46 -25.9 62.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.454 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.448 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.5 m -89.93 -47.62 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.161 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.888 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -62.84 -33.02 74.37 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.139 0.495 . . . . 0.0 110.507 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.888 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.107 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.79 0.328 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.525 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 2.7 m-20 -106.17 -170.16 1.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -116.77 83.95 2.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.71 164.71 12.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.539 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.494 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.32 162.73 13.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.48 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -47.39 -51.38 19.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.902 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -64.39 -27.71 69.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.034 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.5 -51.39 20.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.705 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.4 pt -73.18 -28.79 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.809 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.38 -27.32 9.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 35.0 mm-40 -75.25 -28.51 59.88 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.166 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.42 -58.31 3.27 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.228 0.537 . . . . 0.0 111.042 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.876 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 11.2 ptmt -54.56 -22.99 14.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.235 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.27 -28.02 56.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.12 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.33 -39.83 62.58 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.07 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.876 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.01 -51.66 69.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.774 0.797 . . . . 0.0 109.5 178.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.406 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 6.9 p -74.42 -24.78 59.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.072 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.903 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.04 -24.29 35.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.177 0.513 . . . . 0.0 110.285 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.799 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.6 t80 -93.4 -1.71 55.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.563 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.7 t70 -102.7 143.56 32.19 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 122.005 0.907 . . . . 0.0 111.125 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.2 mmtt -59.65 -53.47 57.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.56 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.51 -5.72 59.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.744 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.3 46.31 51.98 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.356 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -90.97 18.15 7.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.799 0.333 . . . . 0.0 110.73 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.72 5.57 88.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.564 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 47.5 p -150.34 149.58 30.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.65 140.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.879 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.591 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.21 176.37 8.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.002 179.334 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.822 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -70.49 -37.77 74.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.126 0.488 . . . . 0.0 110.257 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.09 -41.13 91.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.143 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.918 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -69.09 -53.79 18.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.221 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.841 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.16 -55.62 32.61 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.73 0.776 . . . . 0.0 109.362 178.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.76 -46.18 90.1 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.62 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.7 m -62.5 -32.13 72.99 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.951 0.376 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.8 t -67.03 -57.22 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.922 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.453 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -71.9 -36.37 69.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.471 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -67.07 -41.9 85.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.4 . . . . 0.0 110.552 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.7 t -79.04 -7.94 58.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.698 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.2 tt -91.42 -55.41 3.52 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -174.97 33.1 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.946 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.596 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -134.18 -179.66 5.7 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.337 0.589 . . . . 0.0 111.125 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -159.66 56.33 0.86 Allowed Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.819 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.8 Cg_endo -80.62 -172.78 1.61 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.577 2.185 . . . . 0.0 112.086 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.37 152.42 35.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.884 0.373 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.7 -50.15 73.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 -33.33 75.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.709 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.85 -54.39 31.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.687 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.822 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.83 -34.63 78.61 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.399 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.684 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.48 -42.75 95.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 110.226 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.65 -45.5 93.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.25 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -30.76 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.424 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.73 -38.01 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.529 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -44.93 -28.59 0.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.417 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.45 -38.96 48.34 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 120.89 0.376 . . . . 0.0 110.819 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.858 HG11 HG21 ' B' ' 6' ' ' ILE . 5.0 m -81.23 -11.47 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.182 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.546 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.7 t0 -103.61 155.65 18.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.788 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.66 -29.01 26.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.095 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -116.49 -9.67 11.39 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.407 0.623 . . . . 0.0 110.481 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.31 63.77 4.94 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.481 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -112.39 18.11 18.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.831 0.348 . . . . 0.0 110.216 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.84 19.85 55.11 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.469 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.6 p -147.1 176.42 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.772 HD12 HD11 ' A' ' 32' ' ' LEU . 14.6 mt -115.77 136.52 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.836 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.9 m-20 -87.28 -178.27 6.16 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.218 0.533 . . . . 0.0 111.859 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.08 -55.83 12.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.727 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -65.67 -34.77 40.03 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.272 1.981 . . . . 0.0 111.12 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -52.45 62.95 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.232 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.93 -56.83 16.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.815 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.699 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.75 -45.75 81.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.679 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 55.8 m -60.07 -31.33 69.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.085 0.469 . . . . 0.0 109.954 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.904 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.9 tpp -64.68 -61.8 1.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.949 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.403 ' HG3' HG22 ' B' ' 10' ' ' ILE . 43.0 mtm -68.86 -29.16 67.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.787 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.525 ' HB1' ' CG ' ' A' ' 2' ' ' ASP . . . -57.26 -25.66 59.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.231 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.01 89.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -83.03 -19.83 36.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.104 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 6.8 ttm -68.25 -28.45 67.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.951 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -132.82 42.23 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -90.42 -76.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.72 -164.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.976 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 63.28 63.01 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.071 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.0 p -77.54 -45.83 24.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -80.73 -29.04 36.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.006 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.48 -30.64 13.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.397 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.608 ' O ' HG11 ' B' ' 19' ' ' VAL . 2.1 mt-10 -65.94 -29.78 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 110.342 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.681 HG22 ' HE1' ' A' ' 138' ' ' TYR . 11.4 mt -79.45 -50.64 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.308 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.444 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.2 OUTLIER -74.99 -51.24 14.13 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 91' ' ' VAL . 17.0 tt0 -53.5 -25.19 15.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.742 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.705 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.43 -36.61 45.32 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 24.0 t80 -68.12 -52.26 36.92 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.012 0.434 . . . . 0.0 110.091 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.439 ' NH2' HD11 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -54.72 -32.05 59.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.807 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 87' ' ' GLU . 48.4 t -88.74 -22.74 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.522 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.484 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -53.85 -31.64 50.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.144 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -103.25 147.44 27.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.431 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -69.24 -37.03 77.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.432 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.15 -9.75 13.92 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.75 29.89 33.95 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.232 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.37 -13.95 62.48 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.078 0.439 . . . . 0.0 110.779 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.14 -12.12 55.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.969 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.6 m-85 -127.26 146.85 50.28 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.953 0.406 . . . . 0.0 111.247 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.58 HD12 HD22 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.03 110.01 26.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.875 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -84.09 176.9 8.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.522 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.51 -29.55 70.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.08 0.467 . . . . 0.0 110.484 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.73 -57.18 12.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.209 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.749 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.32 -46.11 29.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.309 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.835 HD21 ' HG3' ' A' ' 124' ' ' MET . 20.0 tp -53.14 -31.11 40.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.996 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.836 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.8 ttt-85 -73.35 -49.13 28.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -58.87 -42.87 90.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.142 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.2 t -72.91 -40.37 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.529 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.511 ' HE1' ' CD2' ' B' ' 20' ' ' PHE . 30.0 mmt -73.87 -54.21 8.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.353 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.737 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.3 m -56.96 -48.84 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 0.0 111.147 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.684 ' C ' HD12 ' A' ' 112' ' ' LEU . 60.1 t-20 -58.8 -29.33 66.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.903 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -122.88 37.62 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.802 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 109' ' ' MET . . . -171.2 -113.86 0.31 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.783 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.445 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -134.07 166.85 21.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 110.886 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.737 ' HA ' HG23 ' A' ' 110' ' ' THR . 33.0 tttm -72.39 99.68 2.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.244 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.81 114.51 26.25 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.421 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.923 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.77 175.24 5.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.37 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -48.02 -36.0 12.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 110.77 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.37 -34.88 54.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.723 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -73.0 -33.23 65.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.973 0.416 . . . . 0.0 110.079 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.95 -48.51 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.839 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -59.01 -52.81 64.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.746 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.7 -28.65 64.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.765 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.835 ' HG3' HD21 ' A' ' 105' ' ' LEU . 12.8 tpt -76.15 -37.5 57.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.172 0.51 . . . . 0.0 110.163 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.508 HG12 HD23 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -69.21 -39.16 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.342 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -64.77 -41.94 95.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.418 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -82.08 -32.45 30.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.937 0.398 . . . . 0.0 110.431 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.77 -34.71 76.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.54 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.755 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.0 t0 -107.95 148.07 30.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.014 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.559 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.7 pt -84.91 -40.71 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.013 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.559 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.95 -10.98 60.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.693 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.06 32.8 1.1 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.435 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.35 -12.69 24.02 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.332 -0.934 . . . . 0.0 112.493 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.79 20.14 10.28 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.832 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.485 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.77 146.44 30.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.959 0.409 . . . . 0.0 110.0 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 129' ' ' ASP . 38.4 t -130.79 107.41 13.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.213 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.4 t-20 -79.86 174.22 11.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.259 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.681 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.82 -67.07 0.32 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.554 0.692 . . . . 0.0 111.448 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.404 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.4 mt-10 -60.11 -33.41 72.09 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.903 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.511 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.03 -42.09 75.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.36 0.6 . . . . 0.0 109.496 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.853 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.69 -31.87 46.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.114 178.648 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.573 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 55.5 t -55.38 -48.75 76.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.655 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -55.15 -49.67 71.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -70.57 -30.38 67.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.783 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.415 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -60.6 -46.06 91.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 t -73.48 -31.32 63.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.83 163.39 4.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.897 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.943 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.848 0.356 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.737 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.1 mmm180 -52.38 -51.0 61.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.076 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.722 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.68 -53.24 32.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.679 0.276 . . . . 0.0 111.29 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -57.06 -37.64 72.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.997 0.427 . . . . 0.0 110.34 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.943 HG23 ' O ' ' B' ' 1' ' ' ALA . 13.9 t -63.37 -34.15 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.361 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.858 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.07 -55.28 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.967 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.4 mmm-85 -50.73 -36.84 38.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.098 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -48.28 63.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.466 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.841 ' HD2' HD23 ' A' ' 32' ' ' LEU . 16.2 mtmt -55.56 -54.96 37.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.222 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.904 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.0 mt -51.13 -57.43 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.431 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.525 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -58.92 -51.05 71.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.27 0.557 . . . . 0.0 111.051 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.27 -40.58 64.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.831 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.716 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.9 mt -54.61 -49.7 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.493 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.43 -36.95 94.06 Favored Glycine 0 CA--C 1.499 -0.961 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.068 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.932 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.14 -61.73 2.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.789 -0.705 . . . . 0.0 110.357 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.66 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.75 -28.08 69.72 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.659 177.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.5 -51.48 59.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.227 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.758 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.31 -43.44 97.82 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.037 0.446 . . . . 0.0 109.831 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.932 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.1 m -66.45 -32.55 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.639 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.66 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -71.82 -50.15 32.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.986 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.46 ' HA ' ' NE ' ' B' ' 24' ' ' ARG . 52.7 p -58.27 -35.56 71.96 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.023 0.439 . . . . 0.0 110.836 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.49 HG22 ' C ' ' B' ' 19' ' ' VAL . 26.9 m -73.04 -45.22 55.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.09 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.853 HD23 ' CE1' ' A' ' 141' ' ' PHE . 2.7 pp -64.62 -27.98 69.31 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.933 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 10.9 ptt85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.904 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.628 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.773 0.321 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.579 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 3.7 m-20 -66.09 -169.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.824 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -117.49 89.09 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.002 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.63 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.78 164.81 12.24 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.459 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.491 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.28 162.4 13.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.488 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -47.25 -51.35 19.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.845 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.29 -27.72 69.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.115 0.484 . . . . 0.0 110.034 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.0 OUTLIER -72.64 -51.38 19.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.694 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 35.5 pt -73.27 -28.83 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.931 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.44 -27.37 10.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 49.6 mt-10 -75.43 -28.49 59.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.272 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.33 -58.57 3.15 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.242 0.544 . . . . 0.0 111.163 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.878 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -54.75 -23.3 17.22 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.175 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -75.64 -28.26 58.73 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.96 -40.02 63.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.072 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.878 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.11 -51.9 68.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.796 0.808 . . . . 0.0 109.608 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -24.79 59.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.042 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.912 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.15 -26.9 33.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.117 0.484 . . . . 0.0 110.401 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.798 ' HB3' HD11 ' A' ' 27' ' ' ILE . 4.6 t80 -87.2 -14.3 41.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.579 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.8 t70 -90.79 145.27 24.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.931 0.872 . . . . 0.0 111.175 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.493 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.8 mmtt -63.36 -53.39 53.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.578 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -83.09 -7.07 59.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.735 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.3 46.94 56.99 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.398 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -91.73 18.59 7.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.854 0.359 . . . . 0.0 110.659 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.21 5.11 89.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.539 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.7 p -150.28 152.07 33.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.798 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -103.04 140.53 21.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.924 0.392 . . . . 0.0 111.712 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.556 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -84.72 176.14 8.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.008 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.817 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -70.39 -38.45 74.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.085 0.469 . . . . 0.0 110.159 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.48 -40.92 88.51 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.144 178.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.919 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.07 -53.68 19.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.272 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.831 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.41 -54.91 41.64 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.761 0.791 . . . . 0.0 109.47 178.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.46 -46.01 92.39 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.581 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.12 -31.16 71.59 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.806 0.336 . . . . 0.0 110.587 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.7 t -68.18 -57.23 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.447 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -71.89 -35.53 69.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.412 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -42.46 80.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.641 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.7 t -78.95 -7.46 58.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.749 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.549 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -91.11 -54.43 3.95 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.056 0.455 . . . . 0.0 110.796 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.45 34.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.871 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.588 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.02 -178.78 5.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.291 0.567 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -159.59 56.49 0.89 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.884 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.0 Cg_endo -80.37 -176.09 3.02 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.552 2.168 . . . . 0.0 112.065 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.606 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.61 152.45 31.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.94 0.4 . . . . 0.0 110.236 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.13 -49.68 75.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.386 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.24 75.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.72 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 1.3 mm-40 -64.7 -54.32 33.4 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.682 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.817 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.89 -34.69 78.7 Favored 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.405 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.677 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.52 -42.92 95.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.886 0.374 . . . . 0.0 110.162 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.52 -45.44 94.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.233 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -30.71 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.41 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.75 -38.31 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.527 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -45.03 -28.55 0.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.377 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.439 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.76 -38.56 46.58 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.886 0.374 . . . . 0.0 110.841 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.919 HG11 HG21 ' B' ' 6' ' ' ILE . 4.8 m -81.2 -11.27 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.167 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.55 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.4 t0 -103.66 155.62 18.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.759 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.65 -28.93 26.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.034 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -116.45 -9.73 11.41 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.408 0.623 . . . . 0.0 110.501 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.45 63.58 5.1 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.476 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -112.32 18.12 18.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.854 0.359 . . . . 0.0 110.19 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.75 19.9 55.18 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.491 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.8 p -147.32 176.46 9.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.794 HD12 HD11 ' A' ' 32' ' ' LEU . 13.2 mt -115.85 136.51 52.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.557 0.218 . . . . 0.0 110.91 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.7 m-20 -87.11 -178.08 6.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.298 0.571 . . . . 0.0 111.959 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.99 -56.12 11.98 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.674 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.8 -34.44 40.06 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.254 1.969 . . . . 0.0 111.175 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.07 -52.38 62.96 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.166 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.03 -56.92 15.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.893 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.6 -47.13 80.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.628 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 54.7 m -60.21 -30.76 69.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.07 0.462 . . . . 0.0 110.078 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.905 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.1 tpp -64.43 -61.83 1.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.124 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 mtt -68.78 -31.15 69.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.976 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.98 0.13 41.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.631 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -55.08 141.25 35.21 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.858 0.361 . . . . 0.0 111.075 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.62 -16.37 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.246 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 8.5 tpp -76.43 -30.76 57.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.943 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.49 144.71 31.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.86 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -174.75 -166.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.4 m 63.29 88.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -166.01 53.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -77.54 -56.63 4.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.54 -29.64 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -50.45 -30.55 12.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.183 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.708 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -77.24 -29.3 53.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.789 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.638 HG22 ' HE1' ' A' ' 138' ' ' TYR . 16.2 mt -79.08 -51.04 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -73.7 -51.11 17.71 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.839 0.352 . . . . 0.0 111.901 -178.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 91' ' ' VAL . 60.5 tt0 -53.56 -24.61 14.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.722 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -78.67 -35.73 44.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.058 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.8 t80 -69.03 -52.43 28.79 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.108 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -55.7 -31.9 62.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.895 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 87' ' ' GLU . 62.0 t -88.94 -22.73 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.571 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.495 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -54.53 -32.24 57.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.081 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -102.75 147.42 26.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.434 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -69.64 -36.83 76.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -112.18 -9.66 13.91 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.55 30.08 34.1 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.204 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -67.37 -13.82 62.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.004 0.402 . . . . 0.0 110.797 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.446 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.18 -11.71 55.28 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.011 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.47 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.0 m-85 -127.3 145.83 50.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 120.959 0.409 . . . . 0.0 111.354 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.93 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -120.68 110.03 27.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.828 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -83.41 176.4 9.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.525 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.558 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.32 -29.84 71.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.065 0.459 . . . . 0.0 110.432 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.13 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.222 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.37 -46.1 28.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.35 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 100' ' ' ILE . 44.8 tp -53.1 -31.06 40.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.09 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.81 ' HA ' HD11 ' A' ' 116' ' ' LEU . 3.5 ttt-85 -74.21 -49.26 24.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.182 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -58.32 -42.39 86.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.057 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.775 ' O ' HD12 ' A' ' 112' ' ' LEU . 2.5 t -72.87 -40.68 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.563 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.49 ' HE1' ' CD2' ' B' ' 20' ' ' PHE . 30.0 mmt -73.91 -54.34 8.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.351 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.75 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.9 m -57.32 -48.92 77.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.21 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -58.38 -28.61 65.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.912 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.1 mt -123.89 36.63 4.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.802 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.35 -113.47 0.29 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.844 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.426 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.9 pt-20 -133.31 166.24 22.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 110.931 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.75 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.2 tttm -73.12 99.91 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.332 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.972 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.43 114.52 26.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.292 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.917 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.62 174.97 6.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.439 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -48.08 -36.01 12.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 0.0 110.767 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -77.39 -34.27 54.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.734 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -73.5 -33.43 64.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.972 0.415 . . . . 0.0 110.029 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.972 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -75.14 -49.32 28.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.871 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.19 -52.83 63.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.708 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -57.34 -28.65 63.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.679 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.495 ' O ' ' HE3' ' A' ' 124' ' ' MET . 5.9 tpt -75.42 -38.41 59.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.294 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.511 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.98 -41.91 81.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.559 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -65.9 -39.61 90.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.647 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.09 -36.41 27.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.55 83.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.487 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.741 ' HB2' HG22 ' A' ' 136' ' ' VAL . 23.7 t0 -100.35 147.26 26.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.004 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.562 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.79 -40.69 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.086 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.562 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.97 -10.94 60.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.647 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.6 1.08 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.2 p-10 -96.16 -12.87 24.06 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.269 -0.965 . . . . 0.0 112.363 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.93 20.2 10.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.816 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -147.05 146.66 30.08 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.954 0.407 . . . . 0.0 109.969 179.228 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.741 HG22 ' HB2' ' A' ' 129' ' ' ASP . 37.7 t -130.73 107.42 14.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.266 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.4 t-20 -80.18 174.58 11.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.235 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.638 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.96 -66.96 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.448 0.642 . . . . 0.0 111.332 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.83 -33.85 72.31 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.775 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.523 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.15 -40.11 73.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.877 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.74 -34.69 45.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.047 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.574 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 78.8 t -54.3 -46.02 68.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.786 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -57.43 -46.82 83.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.13 -31.54 64.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -60.3 -42.33 95.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.3 t -78.07 -30.88 49.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.62 148.97 31.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.932 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.948 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.74 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.29 -51.05 60.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.725 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.7 -53.22 33.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.654 0.264 . . . . 0.0 111.284 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -57.16 -37.74 72.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.003 0.43 . . . . 0.0 110.31 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.948 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.5 t -63.14 -34.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.356 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.919 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -70.75 -55.05 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.919 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 mmm-85 -50.55 -37.24 38.38 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.127 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -68.98 -48.32 63.42 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.61 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.831 ' HD2' HD23 ' A' ' 32' ' ' LEU . 16.9 mtmt -55.78 -55.1 36.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.262 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.905 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.24 -57.49 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.56 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.489 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.72 -50.41 73.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.211 0.529 . . . . 0.0 111.028 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.23 -41.06 65.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.809 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.784 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.0 mt -54.57 -47.68 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.485 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.426 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.53 -37.1 93.98 Favored Glycine 0 CA--C 1.498 -1.006 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.671 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.906 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.94 -61.52 2.11 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.728 -0.736 . . . . 0.0 110.275 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.734 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.26 -28.17 68.98 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.616 177.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -64.8 -52.14 58.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.241 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.744 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.56 -43.34 97.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.026 0.441 . . . . 0.0 109.922 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.2 m -65.79 -35.09 74.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.668 0.747 . . . . 0.0 110.424 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.734 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.3 OUTLIER -71.37 -45.75 62.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.363 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.509 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 57.2 p -60.13 -36.66 77.99 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.723 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 19' ' ' VAL . 27.1 m -72.92 -44.35 57.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.171 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.877 HD23 ' CE1' ' A' ' 141' ' ' PHE . 3.4 pp -64.1 -29.53 70.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.779 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.856 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.732 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.644 ' OD2' ' HB1' ' A' ' 73' ' ' ALA . 2.2 m-20 -72.75 -170.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -120.87 89.74 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.642 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.4 mt -99.52 164.81 11.93 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.622 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 6.9 p -96.87 161.99 13.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.511 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -47.5 -51.75 19.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.806 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -64.36 -27.65 69.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.973 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.11 -51.55 20.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.643 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.701 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.1 pt -72.8 -28.76 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.882 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.27 -27.33 9.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.0 mt-10 -75.27 -28.42 59.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.314 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.48 -58.51 3.16 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.221 0.534 . . . . 0.0 111.078 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.877 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.54 14.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.218 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.56 -28.01 56.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.036 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.45 -39.87 62.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.059 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.877 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.63 -51.77 68.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.851 0.834 . . . . 0.0 109.416 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -74.46 -24.45 59.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.087 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.2 tt -82.04 -24.88 35.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.233 0.539 . . . . 0.0 110.249 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.815 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.2 t80 -93.05 -1.74 56.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.561 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.2 t70 -103.14 143.64 32.35 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.966 0.888 . . . . 0.0 111.114 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -60.2 -53.47 57.31 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.54 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -84.9 -5.95 59.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.801 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.34 46.64 51.95 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.367 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 p30 -91.35 18.44 7.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.83 0.348 . . . . 0.0 110.706 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.33 88.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.611 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.0 p -150.24 150.07 31.04 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -102.0 140.49 20.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.959 0.409 . . . . 0.0 111.939 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.57 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.25 176.48 8.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.009 179.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.83 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.2 p -70.43 -37.88 74.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.058 0.456 . . . . 0.0 110.312 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.0 -41.26 91.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.134 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.926 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -68.91 -53.79 19.1 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.27 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.837 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.96 -55.83 29.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.711 0.767 . . . . 0.0 109.357 178.556 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.45 -45.77 88.75 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.562 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.4 m -62.74 -32.09 73.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.78 0.324 . . . . 0.0 110.585 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.0 t -66.68 -57.24 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.473 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -71.88 -36.94 70.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.436 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -66.13 -41.3 90.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 110.537 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -79.06 -8.72 59.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.65 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.549 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -90.63 -54.28 4.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.084 0.468 . . . . 0.0 110.746 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.447 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.73 34.45 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.891 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.592 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.63 179.99 5.88 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.301 0.572 . . . . 0.0 111.12 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -159.69 56.22 0.84 Allowed Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.812 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.3 Cg_endo -80.67 -172.23 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.538 2.159 . . . . 0.0 112.116 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -119.08 152.41 36.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.926 0.393 . . . . 0.0 110.142 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.91 -50.08 73.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.41 75.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.462 0.649 . . . . 0.0 110.681 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.58 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.77 -54.29 33.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.702 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.83 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -66.05 -34.54 78.3 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.366 179.71 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.688 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -64.64 -42.59 95.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.911 0.386 . . . . 0.0 110.149 179.281 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -61.87 -45.46 93.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.218 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.1 mmt -74.54 -30.7 61.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.47 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.28 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.587 -179.237 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -45.01 -28.6 0.7 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.378 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.43 -39.35 47.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.972 0.415 . . . . 0.0 110.792 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.893 HG11 HG21 ' B' ' 6' ' ' ILE . 4.7 m -80.59 -11.68 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.143 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 38.8 t0 -103.61 155.56 18.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.738 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.491 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.66 -29.08 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.061 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -116.52 -9.66 11.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.429 0.633 . . . . 0.0 110.42 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.2 64.04 4.69 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.445 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -112.45 17.7 19.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.872 0.368 . . . . 0.0 110.214 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.29 19.9 53.85 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.512 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -147.62 176.36 10.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.48 HD12 HD11 ' A' ' 32' ' ' LEU . 54.1 mt -115.03 136.49 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 120.609 0.242 . . . . 0.0 110.853 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.4 m-20 -86.91 -178.42 6.3 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.256 0.551 . . . . 0.0 111.836 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.521 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.87 -55.74 13.06 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.769 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.7 Cg_endo -65.56 -35.14 39.58 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.291 1.994 . . . . 0.0 111.244 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.37 -52.34 62.1 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.242 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.723 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.9 -56.92 15.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.907 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.701 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -54.73 -48.18 72.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.732 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 76.5 m -58.74 -32.3 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.203 0.525 . . . . 0.0 109.716 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.91 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.7 tpp -67.86 -61.6 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.938 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.639 ' HG2' HG22 ' B' ' 10' ' ' ILE . 3.0 mtt -63.53 -29.89 71.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.742 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.644 ' HB1' ' OD2' ' A' ' 2' ' ' ASP . . . -53.31 -24.61 12.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.964 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.99 -29.37 67.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' CD ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -58.58 -22.24 55.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.077 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 28.7 mmt -56.81 -23.03 40.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.205 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -55.93 -81.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.985 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 177.72 -178.71 0.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.351 . . . . 0.0 110.956 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 60.99 -179.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.041 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.478 ' H ' HG22 ' A' ' 79' ' ' THR . 3.4 m-20 63.25 31.7 15.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.006 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 77.3 p -77.51 -51.93 9.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.847 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -80.72 -29.22 36.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.983 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -50.42 -30.48 12.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.241 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.557 ' O ' HG11 ' B' ' 19' ' ' VAL . 4.6 mt-10 -73.77 -29.45 62.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.718 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.654 HG22 ' HE1' ' A' ' 138' ' ' TYR . 14.4 mt -79.04 -51.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -71.95 -50.46 28.76 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 91' ' ' VAL . 83.1 mt-10 -53.51 -25.22 15.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 110.779 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.743 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.72 -36.77 50.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.271 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.9 t80 -68.46 -51.4 43.94 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.014 0.435 . . . . 0.0 110.097 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -55.03 -32.17 61.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.799 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 87' ' ' GLU . 52.0 t -88.78 -22.73 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.617 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.38 -30.11 38.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.049 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -109.13 139.47 43.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.449 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.02 -38.54 91.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.591 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -107.85 -9.64 15.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.18 31.03 39.72 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.144 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -67.53 -13.82 62.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.041 0.421 . . . . 0.0 110.756 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.452 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 100.91 -12.15 59.11 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.976 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 20.3 m-85 -127.35 146.15 50.56 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.914 0.387 . . . . 0.0 111.338 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.834 ' CD1' HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.15 110.01 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.807 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t -83.07 178.24 8.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.43 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.543 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.83 -28.12 69.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.093 0.473 . . . . 0.0 110.557 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.96 -56.8 12.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.291 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.3 mm-40 -76.35 -42.49 44.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.232 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.834 HD13 ' CD1' ' A' ' 100' ' ' ILE . 22.6 tp -56.55 -33.61 66.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.847 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.3 ttt-85 -71.79 -49.47 38.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.945 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -61.87 -38.43 88.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 110.376 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.837 ' O ' HD12 ' A' ' 112' ' ' LEU . 39.9 t -73.06 -43.97 57.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.403 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.451 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 25.4 mmt -73.99 -54.02 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.465 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.619 HG23 ' HA ' ' A' ' 115' ' ' LYS . 8.0 m -55.38 -46.87 76.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.478 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.88 -29.77 68.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.88 ' O ' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -123.0 38.21 4.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.678 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.42 -113.96 0.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.773 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' O ' HD23 ' A' ' 116' ' ' LEU . 4.7 pt-20 -135.21 169.21 17.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.619 ' HA ' HG23 ' A' ' 110' ' ' THR . 6.7 ttpt -73.83 99.75 3.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.0 115.25 27.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.373 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.935 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.81 175.21 5.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.41 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -48.0 -35.89 11.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.397 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -77.4 -35.91 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.71 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -71.66 -33.31 68.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.951 0.405 . . . . 0.0 110.065 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.86 -49.12 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.56 . . . . 0.0 109.849 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -59.46 -52.76 64.22 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.758 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -57.33 -28.7 63.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.82 ' HG3' HD21 ' A' ' 105' ' ' LEU . 10.2 tpt -76.19 -39.43 54.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.121 0.486 . . . . 0.0 110.241 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.495 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -66.58 -41.11 87.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.369 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -64.21 -41.59 96.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.444 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 124' ' ' MET . 7.6 pt-20 -82.73 -33.13 27.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.476 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.39 -35.25 77.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.454 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.707 ' HB2' HG22 ' A' ' 136' ' ' VAL . 20.9 t0 -106.09 146.1 30.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.029 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.562 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.0 pt -82.73 -40.95 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.147 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.562 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.95 -11.05 60.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.675 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.74 33.11 1.0 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.443 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.2 p-10 -96.58 -12.62 23.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.307 -0.946 . . . . 0.0 112.466 -176.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.21 10.18 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.777 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.5 147.21 30.94 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.134 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.707 HG22 ' HB2' ' A' ' 129' ' ' ASP . 26.5 t -130.73 107.25 13.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.364 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.3 t-20 -80.57 174.57 11.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.222 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.654 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.95 -67.15 0.31 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.54 0.686 . . . . 0.0 111.488 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.412 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.3 mt-10 -60.75 -29.54 69.45 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.563 -1.198 . . . . 0.0 111.913 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.565 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.91 -44.05 77.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.08 0.467 . . . . 0.0 109.762 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -31.91 46.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.134 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 138' ' ' TYR . 67.5 t -54.03 -48.29 64.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.132 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.625 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -57.99 -44.99 87.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.7 tpp -73.14 -32.92 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.7 ttp -59.89 -43.05 95.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.2 t -77.59 -30.9 52.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.59 149.3 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.89 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.941 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.3 -50.89 61.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.056 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.726 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.72 -53.26 32.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.678 0.275 . . . . 0.0 111.241 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -57.07 -37.68 72.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.051 0.453 . . . . 0.0 110.365 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.941 HG23 ' O ' ' B' ' 1' ' ' ALA . 12.4 t -63.45 -33.64 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.415 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.893 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.52 -55.43 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.026 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.2 mmm-85 -50.58 -37.61 40.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.214 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -69.76 -47.17 63.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.543 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.837 ' HD2' HD23 ' A' ' 32' ' ' LEU . 14.6 mtmt -56.0 -55.41 33.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.91 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.52 -57.34 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.049 0.452 . . . . 0.0 111.059 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -56.16 -51.19 68.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.954 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.552 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.39 -40.24 64.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.094 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.571 ' O ' ' HB2' ' B' ' 17' ' ' ALA . 3.1 mt -54.44 -51.52 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.506 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.3 -36.27 93.19 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.08 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.916 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.73 -61.44 2.18 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.812 -0.694 . . . . 0.0 110.413 -178.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.668 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -62.97 -27.84 69.68 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.647 177.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -66.05 -51.31 59.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.226 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.564 ' NE ' HG12 ' B' ' 19' ' ' VAL . 3.7 ppt_? -63.49 -43.48 97.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.977 0.418 . . . . 0.0 109.918 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.916 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.4 m -66.61 -32.29 57.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.679 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.668 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -71.65 -50.94 25.95 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.955 -179.191 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.448 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 54.7 p -57.85 -36.24 72.05 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.482 HG22 ' C ' ' B' ' 19' ' ' VAL . 26.8 m -72.55 -45.25 59.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.102 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.537 HD21 ' CD1' ' B' ' 20' ' ' PHE . 3.1 pp -65.71 -26.42 67.75 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.084 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 12.7 ptt180 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.926 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.63 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.765 0.317 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.537 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.8 m-20 -64.87 -169.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -117.28 89.42 3.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.02 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.632 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.93 164.72 12.25 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.482 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.49 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.0 p -97.84 162.47 13.24 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.527 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -47.51 -51.42 20.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.831 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.39 -27.62 69.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.022 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.49 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.4 -51.43 20.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.72 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.9 pt -73.24 -28.9 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.862 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.47 -27.39 10.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 17.9 mt-10 -75.21 -28.57 60.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.256 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.35 -58.5 3.18 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.873 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 10.9 ptmt -54.52 -23.01 14.64 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.206 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.37 -27.93 56.58 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.143 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.39 -39.9 62.41 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.106 177.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.873 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.8 -51.94 67.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.79 0.805 . . . . 0.0 109.398 178.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.43 -24.14 59.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.089 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.903 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.14 -26.29 33.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.22 0.533 . . . . 0.0 110.147 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.878 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.9 t80 -91.24 -1.4 57.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.356 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.9 t70 -103.09 144.11 31.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.004 0.907 . . . . 0.0 111.072 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -60.37 -53.4 58.02 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 113.859 -1.519 . . . . 0.0 111.68 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.29 -6.51 59.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.75 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.06 46.16 56.23 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.169 -0.538 . . . . 0.0 113.371 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.3 p30 -90.88 17.95 7.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.831 0.348 . . . . 0.0 110.732 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.55 88.65 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 49.6 p -150.29 148.98 29.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -100.54 140.52 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.016 0.436 . . . . 0.0 111.907 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.594 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.52 178.07 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.131 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.812 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -70.46 -40.45 73.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.107 0.479 . . . . 0.0 110.382 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -58.48 -40.87 83.94 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.402 178.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.824 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.61 -53.86 16.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.378 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.758 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -57.33 -54.17 49.85 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.785 0.802 . . . . 0.0 109.583 178.57 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.69 -46.78 92.87 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.27 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.9 m -66.25 -30.14 70.52 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.757 0.313 . . . . 0.0 110.493 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.878 HG21 ' CE2' ' A' ' 19' ' ' PHE . 16.7 t -64.03 -57.89 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.06 0.457 . . . . 0.0 110.635 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -72.48 -40.38 66.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.255 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -61.09 -38.87 87.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 110.378 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -78.8 -12.23 60.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.526 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.548 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -87.46 -53.48 4.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.0 110.544 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' N ' HD23 ' A' ' 39' ' ' LEU . . . 180.0 35.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.568 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.609 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -131.31 -179.96 5.66 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.287 0.565 . . . . 0.0 111.245 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -159.71 56.17 0.84 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.783 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.3 Cg_endo -80.72 -173.52 1.88 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.588 2.192 . . . . 0.0 112.202 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -119.7 152.39 37.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 110.075 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.71 -50.14 73.07 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.85 76.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.711 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.577 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.91 -54.37 31.91 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.76 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.812 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.65 -38.18 90.12 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.313 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.711 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -61.79 -42.57 99.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.884 0.373 . . . . 0.0 110.428 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -61.73 -46.09 91.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.5 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -30.6 61.73 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.606 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -53.66 -40.19 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.761 -178.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.423 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.4 m-80 -45.11 -28.68 0.77 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.383 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.84 -38.0 47.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.977 0.418 . . . . 0.0 110.734 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.057 HG11 HG21 ' B' ' 6' ' ' ILE . 3.8 m -80.8 -12.63 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 43.2 t0 -103.46 155.25 18.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.699 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.09 26.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.179 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -116.44 -9.72 11.42 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.402 0.62 . . . . 0.0 110.415 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.72 61.52 7.29 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.295 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -109.74 18.49 20.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.758 0.313 . . . . 0.0 110.411 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.32 19.96 59.65 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.303 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.4 p -147.48 176.23 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.758 HD12 HD11 ' A' ' 32' ' ' LEU . 14.2 mt -113.47 136.66 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.644 0.259 . . . . 0.0 110.717 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -86.24 -179.96 6.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.208 0.528 . . . . 0.0 111.876 -179.384 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.89 -55.88 12.71 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.471 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.7 Cg_endo -65.76 -35.04 38.28 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.186 1.924 . . . . 0.0 111.18 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -52.51 63.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.724 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.35 -56.66 19.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.816 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.73 -47.92 78.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.813 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.63 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 53.3 m -59.39 -30.66 68.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.473 . . . . 0.0 110.102 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.89 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.1 tpp -63.61 -61.79 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.112 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.403 ' CG ' HG22 ' B' ' 10' ' ' ILE . 40.3 mtm -72.12 -29.65 64.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.145 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.09 0.07 37.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.687 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -53.2 121.14 6.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.835 0.35 . . . . 0.0 111.067 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -16.6 63.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.217 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 32.9 mtt -76.88 -29.61 55.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.964 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -100.16 144.56 29.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -177.05 -169.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 62.17 -167.27 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.414 ' H ' HG22 ' A' ' 79' ' ' THR . 13.7 m-20 63.96 60.6 1.01 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.46 -33.39 54.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -76.86 -29.22 55.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.933 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -50.72 -30.67 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.681 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -78.16 -29.44 48.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.678 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.685 HG22 ' HE1' ' A' ' 138' ' ' TYR . 8.4 mt -79.21 -51.13 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.32 -52.04 11.77 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 91' ' ' VAL . 10.1 tt0 -53.85 -25.63 20.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.703 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.46 -35.75 46.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.265 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.601 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 27.6 t80 -68.58 -51.38 43.2 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 110.026 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -54.76 -32.61 60.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.796 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 87' ' ' GLU . 46.6 t -88.75 -22.67 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.631 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.487 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -53.05 -33.33 51.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.271 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -100.64 148.85 24.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.519 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.27 -37.69 78.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.22 -9.77 13.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.782 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.59 28.47 32.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.313 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -67.51 -13.97 62.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.183 0.491 . . . . 0.0 110.752 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.27 -10.27 56.53 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.187 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.469 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.5 m-85 -127.08 145.42 50.74 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.988 0.423 . . . . 0.0 111.5 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.829 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.18 109.9 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.843 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -83.84 175.18 9.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.329 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.549 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -62.63 -29.05 70.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.001 0.429 . . . . 0.0 110.37 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -56.81 14.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.252 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.769 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.37 -46.54 26.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.279 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.829 HD13 HD13 ' A' ' 100' ' ' ILE . 15.5 tp -52.99 -36.07 59.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.798 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.2 ttt180 -68.05 -49.1 63.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.877 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -58.17 -44.52 88.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.232 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.826 ' O ' HD12 ' A' ' 112' ' ' LEU . 1.8 t -73.01 -42.28 59.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.552 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.477 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 26.6 mmt -70.16 -54.06 14.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.514 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 115' ' ' LYS . 7.3 m -58.39 -48.36 80.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.3 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -58.48 -29.29 66.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.84 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.903 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -122.98 37.52 4.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.75 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -168.85 -116.17 0.36 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.708 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 110' ' ' THR . 6.3 pt-20 -131.51 172.23 12.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.72 0.295 . . . . 0.0 110.777 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.625 ' HA ' HG23 ' A' ' 110' ' ' THR . 12.3 ttpt -75.78 98.77 4.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.288 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.967 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.4 OUTLIER -91.47 112.72 24.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.551 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.917 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.8 174.9 6.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.328 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.11 -36.13 12.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 0.0 110.757 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -77.38 -33.91 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.757 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -73.64 -34.72 65.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.023 0.439 . . . . 0.0 110.023 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.967 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -72.73 -47.99 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.872 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -58.81 -52.87 63.89 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.837 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -56.64 -28.91 61.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.928 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.82 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.8 tpt -76.31 -38.73 55.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.182 0.515 . . . . 0.0 110.111 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.51 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -67.51 -48.51 76.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.521 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -60.26 -40.32 89.9 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.85 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 124' ' ' MET . 14.1 pt-20 -80.55 -37.13 32.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 110.604 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.436 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.83 -36.47 82.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.555 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.722 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.4 t0 -101.57 147.87 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.062 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.56 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.7 pt -84.88 -40.74 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.048 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.56 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.98 -10.9 59.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.692 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.09 32.68 1.1 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.433 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.1 -12.79 24.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.303 -0.949 . . . . 0.0 112.482 -176.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.89 20.12 10.22 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.813 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.51 146.83 30.66 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.928 0.395 . . . . 0.0 110.029 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 129' ' ' ASP . 35.4 t -130.74 107.39 14.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.307 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.1 t-20 -79.18 174.69 11.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.337 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.685 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.84 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.548 0.69 . . . . 0.0 111.421 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -60.3 -34.77 74.26 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.839 -178.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.505 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.06 -41.55 75.24 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.059 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.823 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.77 -31.85 46.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.022 178.646 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 138' ' ' TYR . 53.6 t -55.54 -47.23 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.596 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -56.07 -45.15 79.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.966 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.16 -32.11 64.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.5 ' HE2' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -59.95 -42.92 95.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 t -76.97 -31.3 56.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.76 152.24 23.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.939 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.714 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.47 -52.17 55.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.214 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.704 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.78 -53.32 32.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 111.394 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.94 -36.89 70.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 0.0 110.295 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.939 HG23 ' O ' ' B' ' 1' ' ' ALA . 39.6 t -62.05 -39.19 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.1 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 1.057 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -65.92 -55.48 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.166 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -50.91 -37.31 43.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.022 0.439 . . . . 0.0 110.202 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -73.32 -45.86 52.86 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.718 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.876 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.4 OUTLIER -55.02 -55.47 30.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.999 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.89 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.5 mt -51.49 -57.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.421 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -57.8 -51.33 70.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.218 0.532 . . . . 0.0 111.021 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.525 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.46 -42.47 67.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.779 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.785 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.3 mt -54.57 -48.07 71.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.577 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.26 -38.26 96.18 Favored Glycine 0 CA--C 1.499 -0.954 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.077 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.897 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.14 -61.75 2.06 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.831 -0.685 . . . . 0.0 110.445 -178.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.651 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -61.8 -27.84 69.04 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.65 177.799 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.19 -50.89 64.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.258 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.713 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.89 -43.65 95.37 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.897 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -64.34 -33.68 64.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.532 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.711 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.4 OUTLIER -74.3 -45.04 50.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.737 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.528 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.8 p -59.85 -25.96 65.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.457 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.407 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.5 -46.15 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.134 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.935 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.83 -34.23 76.88 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.164 0.507 . . . . 0.0 110.323 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.935 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.064 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.827 0.346 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.69 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.762 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -123.78 89.36 3.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.107 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.629 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.03 164.71 12.41 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.354 179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.504 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.2 p -97.89 162.31 13.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.482 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -47.53 -51.4 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.819 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -64.48 -27.66 69.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.018 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.504 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.22 -51.52 20.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.683 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.703 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.0 pt -73.31 -28.89 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.806 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.31 10.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.537 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 13.8 mt-10 -75.38 -28.62 59.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.369 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.1 m-85 -79.25 -58.69 3.09 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.174 0.511 . . . . 0.0 111.189 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.872 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -55.37 -21.89 17.33 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.249 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -77.23 -28.03 53.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.18 -40.1 62.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.082 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.872 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.46 -51.95 67.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.853 0.835 . . . . 0.0 109.448 178.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 5.1 p -74.35 -24.27 59.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.161 -1.382 . . . . 0.0 112.149 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.905 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.14 -25.85 34.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.31 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.878 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.7 t80 -92.16 -1.99 56.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.632 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.9 t70 -101.77 143.5 31.62 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.963 0.887 . . . . 0.0 111.152 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -60.16 -53.38 58.44 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.552 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.15 -5.6 59.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.791 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.22 46.45 51.42 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.349 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -91.11 18.17 7.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.82 0.343 . . . . 0.0 110.704 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.52 5.1 88.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.605 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 47.0 p -150.29 149.25 29.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.748 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.8 140.51 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.895 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.631 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.29 177.01 7.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.124 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.8 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -70.35 -39.05 74.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.102 0.477 . . . . 0.0 110.301 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.35 -40.78 87.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.285 178.81 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.817 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.57 -53.83 17.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.329 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.771 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -57.7 -54.38 47.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.786 0.803 . . . . 0.0 109.531 178.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.33 -46.63 92.69 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.296 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.1 m -66.76 -30.06 70.18 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.749 0.309 . . . . 0.0 110.479 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.878 HG21 ' CE2' ' A' ' 19' ' ' PHE . 13.0 t -63.51 -57.95 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 0.0 110.534 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.534 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -72.44 -40.94 66.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.196 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -39.26 86.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.982 0.42 . . . . 0.0 110.494 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -78.81 -12.14 60.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.537 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.3 tt -87.73 -54.07 4.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 0.0 110.596 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.467 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -179.02 36.87 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.752 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 tp-100 -134.9 -179.46 5.62 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.332 0.587 . . . . 0.0 111.22 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -159.68 56.35 0.86 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.892 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.49 -176.71 3.32 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.583 2.189 . . . . 0.0 112.153 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.604 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -115.89 152.5 33.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 110.203 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.11 -49.64 75.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -34.19 77.57 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.98 -54.35 31.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.657 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.8 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.7 -38.17 90.08 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 120.246 -0.581 . . . . 0.0 110.329 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.715 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.36 -42.15 99.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.891 0.377 . . . . 0.0 110.405 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.09 -47.34 86.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.431 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.41 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 23.9 mmt -74.51 -30.32 61.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.732 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.42 -38.64 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.584 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -45.52 -28.53 0.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.298 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.74 -38.03 47.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.935 0.398 . . . . 0.0 110.833 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.082 HG11 HG21 ' B' ' 6' ' ' ILE . 4.2 m -81.92 -11.78 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.218 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.552 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.9 t0 -103.46 155.48 18.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.729 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.477 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.58 -28.73 26.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.084 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -116.38 -9.72 11.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.387 0.613 . . . . 0.0 110.458 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.38 63.08 5.56 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.467 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -112.19 18.45 18.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.835 0.35 . . . . 0.0 110.194 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 85.9 19.95 56.71 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.445 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.631 HG22 ' HA ' ' A' ' 28' ' ' THR . 5.0 p -146.5 176.44 9.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.771 HD12 HD11 ' A' ' 32' ' ' LEU . 15.1 mt -116.44 136.48 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.522 0.201 . . . . 0.0 110.883 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 8.7 m-20 -86.67 -178.95 6.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.273 0.558 . . . . 0.0 111.908 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.84 -55.94 12.72 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.607 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -65.6 -35.05 39.63 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.22 1.947 . . . . 0.0 111.223 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.64 -52.38 63.57 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.199 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.06 -56.86 16.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.844 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.703 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.11 -47.5 80.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.729 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.413 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 58.3 m -59.06 -30.76 68.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.055 0.455 . . . . 0.0 110.061 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.904 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.1 tpp -65.54 -61.75 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.229 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.485 ' CG ' HG22 ' B' ' 10' ' ' ILE . 12.1 mtm -69.35 -37.32 77.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.104 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -21.08 43.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.432 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.33 105.9 0.13 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.88 0.372 . . . . 0.0 111.083 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -19.14 62.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 tpp -68.63 -29.34 67.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.985 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.02 117.82 21.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.956 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -136.75 -177.46 4.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 m 59.88 102.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 178.04 -33.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -53.21 -31.15 41.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.233 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -80.74 -31.78 35.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.021 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -77.22 -42.07 38.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.274 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.708 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.71 -29.32 26.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.541 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.726 HG22 ' HE1' ' A' ' 138' ' ' TYR . 23.0 mt -66.07 -51.42 60.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.794 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -75.81 -50.65 14.58 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.774 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.7 mt-10 -53.87 -30.69 46.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.661 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.557 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -71.16 -38.62 72.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.792 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.6 t80 -67.08 -55.92 12.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 0.0 110.541 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.85 -30.51 45.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.832 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 87' ' ' GLU . 75.6 t -88.36 -22.86 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.309 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.25 -32.54 62.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.982 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -102.08 148.64 25.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -69.62 -37.53 76.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.375 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -112.26 -9.76 13.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.5 30.65 32.61 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.119 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -67.42 -13.52 62.1 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.928 0.364 . . . . 0.0 110.823 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.46 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.16 -13.61 55.44 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.846 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.5 m-85 -127.22 145.9 50.61 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.961 0.41 . . . . 0.0 111.3 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.713 HD12 HD12 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.09 109.99 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.85 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -82.19 177.71 8.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.48 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.3 -28.17 69.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.009 0.433 . . . . 0.0 110.559 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.35 -57.72 9.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.314 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.8 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.47 -38.74 54.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.006 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.918 HD11 ' HG3' ' A' ' 124' ' ' MET . 5.5 tt -56.5 -33.15 65.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.821 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.7 ttt180 -74.77 -49.4 21.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.172 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -60.76 -36.72 79.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.064 0.459 . . . . 0.0 110.321 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 104' ' ' GLU . 45.6 t -72.9 -45.69 54.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.242 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.454 ' HE3' HD11 ' B' ' 23' ' ' LEU . 22.3 mmt -73.93 -54.14 8.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.818 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.577 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.2 m -55.46 -43.11 75.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 111.362 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.463 ' C ' HD12 ' A' ' 112' ' ' LEU . 38.4 t-20 -61.21 -31.81 71.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.788 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.905 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -123.17 38.76 4.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.31 -116.96 0.39 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.782 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.404 ' O ' HD23 ' A' ' 116' ' ' LEU . 14.6 pt-20 -133.61 171.88 13.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.821 0.343 . . . . 0.0 110.944 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.577 ' HA ' HG23 ' A' ' 110' ' ' THR . 24.7 ttpt -75.38 100.08 4.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.294 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.951 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.41 115.48 26.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.29 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.933 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.76 174.99 6.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.404 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 117' ' ' THR . 0.6 OUTLIER -48.0 -35.76 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.92 0.391 . . . . 0.0 110.734 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.29 -36.15 54.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.699 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -71.13 -34.56 71.14 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.056 0.455 . . . . 0.0 110.084 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.951 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -73.62 -50.02 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.351 0.596 . . . . 0.0 109.776 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -59.76 -52.85 63.7 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.859 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.84 -28.83 62.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.938 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.918 ' HG3' HD11 ' A' ' 105' ' ' LEU . 7.4 tpt -76.35 -38.75 55.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.151 0.5 . . . . 0.0 110.13 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.619 HG12 HD13 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -66.15 -49.07 78.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.521 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -60.13 -40.12 88.66 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.967 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 124' ' ' MET . 12.2 pt-20 -81.01 -37.31 29.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 110.647 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.466 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.33 -36.96 84.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.518 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.747 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.1 t0 -100.39 148.1 25.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.025 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.563 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.8 -40.8 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.297 0.57 . . . . 0.0 110.073 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.563 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.83 -11.03 60.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.682 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.14 32.59 1.1 Allowed Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.04 -12.94 24.16 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.309 -0.946 . . . . 0.0 112.434 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.88 20.18 10.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.81 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.74 146.69 30.38 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.905 0.383 . . . . 0.0 110.061 179.193 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.747 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.7 t -130.67 107.47 14.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.24 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -80.01 174.65 11.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.426 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.726 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.97 -67.06 0.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.479 0.657 . . . . 0.0 111.531 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -34.15 72.9 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.913 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.532 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.12 -40.34 73.61 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.827 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.79 -33.67 46.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.114 178.562 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.582 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.6 t -54.86 -47.43 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.688 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -58.13 -45.2 87.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.12 -32.5 64.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.408 ' HE1' HG12 ' A' ' 85' ' ' ILE . 14.1 ttp -59.81 -43.63 94.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 t -76.81 -31.19 56.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.923 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.71 160.79 6.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.91 179.973 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.937 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.717 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.44 -52.37 54.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.209 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.714 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.83 -53.2 34.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.291 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -56.84 -37.02 70.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.009 0.433 . . . . 0.0 110.256 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.937 HG23 ' O ' ' B' ' 1' ' ' ALA . 40.7 t -61.94 -39.16 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.081 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 1.082 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -66.03 -55.53 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.15 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -50.96 -37.16 42.88 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.2 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.22 -45.55 55.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.622 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.872 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.3 OUTLIER -55.33 -55.32 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.129 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.904 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.5 mt -51.29 -57.5 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.802 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.506 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.8 tpt180 -60.3 -51.32 70.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.273 0.559 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.35 -40.13 64.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.679 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.737 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.46 -47.75 70.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.27 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.41 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.92 -38.25 95.81 Favored Glycine 0 CA--C 1.497 -1.06 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.493 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.898 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.93 -61.61 2.06 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.646 -0.777 . . . . 0.0 110.507 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.76 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.19 -27.49 67.19 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.546 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.81 -48.57 65.89 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.017 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.7 ppt_? -63.28 -43.57 97.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.127 0.489 . . . . 0.0 109.798 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.898 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -61.78 -34.82 64.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.348 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.752 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -74.95 -43.94 51.27 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.633 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.548 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 18.7 p -60.74 -25.77 66.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.495 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.418 HG23 ' N ' ' B' ' 23' ' ' LEU . 29.3 m -90.25 -46.5 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.09 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.954 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.37 -34.47 76.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.184 0.516 . . . . 0.0 110.348 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.954 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.092 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.627 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.821 0.343 . . . . 0.0 111.069 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.568 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 m-20 -66.65 -169.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -117.5 90.65 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.975 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.2 mt -98.72 164.88 12.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.557 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.484 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.3 p -96.94 161.82 13.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.494 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.52 -51.91 19.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.798 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -64.28 -27.73 69.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.015 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.94 -51.52 21.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.662 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.701 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.6 pt -72.84 -28.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.816 -179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.36 -27.29 9.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 7.9 mt-10 -74.88 -28.5 60.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.171 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.6 -58.34 3.24 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.198 0.523 . . . . 0.0 110.994 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.871 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -54.45 -23.01 14.3 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.188 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.24 -27.94 56.96 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.138 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.48 -39.8 62.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.079 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.871 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.93 -51.82 68.39 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.85 0.834 . . . . 0.0 109.416 178.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.43 -24.26 59.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.096 -1.411 . . . . 0.0 112.134 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.857 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.2 tt -82.08 -24.24 35.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.248 0.547 . . . . 0.0 110.191 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.815 ' HB3' HD11 ' A' ' 27' ' ' ILE . 2.6 t80 -95.61 0.82 53.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.434 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.9 t70 -105.58 145.13 31.37 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.013 0.911 . . . . 0.0 111.123 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.0 mmtt -60.54 -53.39 58.07 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.587 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.43 -6.09 59.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.06 47.23 55.12 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.194 -0.526 . . . . 0.0 113.515 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -92.66 17.8 9.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.871 0.367 . . . . 0.0 110.469 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.16 9.25 86.34 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.258 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.462 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 72.8 p -150.16 147.23 27.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.6 mt -101.96 140.39 20.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.904 0.383 . . . . 0.0 111.927 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.683 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.4 t -87.27 -179.29 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.123 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.791 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.4 p -70.49 -45.51 65.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 110.899 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.648 ' HG3' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -54.54 -40.54 68.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.449 178.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.911 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -69.52 -53.83 17.14 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.467 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.858 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.92 -56.07 26.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.78 0.8 . . . . 0.0 109.379 178.569 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -56.86 -46.2 90.73 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.64 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.2 m -62.05 -35.01 77.31 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.047 0.423 . . . . 0.0 110.542 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.0 t -64.0 -57.19 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.46 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -71.82 -36.05 70.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.404 -179.404 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 2.8 ttt-85 -67.25 -41.22 85.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.999 0.428 . . . . 0.0 110.48 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 t -79.0 -8.32 58.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.627 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.541 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.82 -54.33 4.02 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.762 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.447 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.91 34.57 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.837 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.596 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.76 -179.37 5.49 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.317 0.58 . . . . 0.0 111.141 -179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -159.67 56.39 0.87 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.815 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.8 Cg_endo -80.56 -174.85 2.41 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.568 2.179 . . . . 0.0 112.117 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -116.87 152.45 34.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.945 0.402 . . . . 0.0 110.159 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.69 -50.03 73.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.14 74.94 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.75 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.98 -54.3 32.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.733 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.791 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.71 -35.57 81.12 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.419 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.752 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -63.4 -42.95 98.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.868 0.366 . . . . 0.0 110.224 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.85 -45.36 94.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.373 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.56 -30.68 61.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.449 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -53.72 -39.51 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.637 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.415 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 5.9 m-80 -44.99 -28.64 0.7 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.387 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.65 -38.52 54.47 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.954 0.407 . . . . 0.0 110.73 179.79 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.816 HG11 HG21 ' B' ' 6' ' ' ILE . 5.5 m -80.99 -12.77 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.049 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 42.9 t0 -103.5 154.88 18.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.815 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.68 -28.03 26.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.227 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -116.42 -9.72 11.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.386 0.612 . . . . 0.0 110.423 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.91 61.66 7.11 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.315 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -109.52 18.4 20.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 110.475 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.75 18.93 60.66 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.407 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 28' ' ' THR . 6.2 p -146.54 176.12 10.06 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 26' ' ' THR . 61.0 mt -112.91 136.49 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.585 0.231 . . . . 0.0 110.675 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -85.12 179.56 7.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.243 0.544 . . . . 0.0 111.824 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.518 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 6.3 m-85 -67.45 -56.52 12.32 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.285 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.82 -36.11 33.03 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.326 2.017 . . . . 0.0 111.071 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.61 -52.32 65.67 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.135 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.94 -56.29 23.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.657 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.701 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.34 -46.67 83.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.706 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.627 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 65.1 m -61.2 -31.79 71.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.013 0.435 . . . . 0.0 110.11 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.925 ' HG2' HD13 ' B' ' 10' ' ' ILE . 4.5 tpp -60.86 -61.77 2.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.125 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.8 mtp -72.2 -31.59 66.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.991 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.568 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.76 0.04 40.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.638 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -56.02 152.62 10.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.875 0.369 . . . . 0.0 110.982 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -69.6 -12.68 61.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.295 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.5 mtt -93.49 -30.65 14.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.821 0.343 . . . . 0.0 110.962 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.01 116.56 21.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -176.6 -178.47 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 60.75 -166.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.792 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.415 ' H ' HG22 ' A' ' 79' ' ' THR . 5.6 m-20 63.94 65.87 0.68 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.57 -52.31 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.858 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -66.13 -35.52 80.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -50.47 -30.51 12.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.564 ' O ' HG11 ' B' ' 19' ' ' VAL . 4.7 mt-10 -76.49 -29.59 56.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.685 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.691 HG22 ' HE1' ' A' ' 138' ' ' TYR . 11.2 mt -79.26 -51.13 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -48.41 39.04 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.893 0.378 . . . . 0.0 111.87 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.41 ' OE2' ' HB1' ' B' ' 12' ' ' ALA . 6.5 tt0 -53.6 -26.31 21.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.344 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.742 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.4 -34.31 58.83 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.052 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 12.8 t80 -68.79 -50.05 53.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.12 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -54.5 -33.17 59.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.778 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.8 t -88.95 -22.79 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.542 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.28 -33.63 53.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.206 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -106.18 139.24 41.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.521 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -64.74 -34.77 79.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -112.15 -9.7 13.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.97 29.26 38.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.36 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.68 -13.92 62.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.134 0.467 . . . . 0.0 110.745 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 100.48 -11.6 59.75 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.004 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.483 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.3 m-85 -127.19 147.3 50.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.038 0.447 . . . . 0.0 111.438 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.085 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.19 109.96 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.721 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 t -82.62 176.52 9.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.46 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.09 -29.71 70.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.075 0.464 . . . . 0.0 110.477 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.26 -57.8 10.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.236 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.816 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.45 -45.38 31.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.126 -179.214 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.085 HD13 HD13 ' A' ' 100' ' ' ILE . 31.9 tp -52.95 -31.24 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.191 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.832 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.9 ttt-85 -73.47 -49.17 28.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -58.67 -42.48 88.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.074 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.9 t -72.99 -40.04 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.546 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.7 mmt -73.99 -54.18 8.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.528 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.636 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.4 m -55.5 -46.96 76.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.376 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -59.9 -30.7 69.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.857 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -121.54 37.52 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.49 -113.97 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.688 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.1 pt-20 -135.87 170.61 15.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.824 0.345 . . . . 0.0 110.805 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.636 ' HA ' HG23 ' A' ' 110' ' ' THR . 9.6 tttm -73.73 98.22 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.152 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.14 113.52 24.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.385 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.919 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.79 175.45 5.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.368 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -48.13 -35.93 12.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.896 0.379 . . . . 0.0 110.766 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.4 -34.51 54.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -73.44 -33.5 64.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.009 0.433 . . . . 0.0 110.096 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.47 -48.16 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.819 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.62 -52.85 63.77 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.735 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -57.48 -28.72 63.65 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.779 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.786 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.9 tpt -76.2 -38.02 57.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.121 0.486 . . . . 0.0 110.137 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.491 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.28 -41.84 81.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.494 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -66.08 -38.92 89.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.933 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.54 -35.94 29.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.512 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.471 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.54 -37.47 79.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.416 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.737 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.2 t0 -100.5 145.61 28.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.979 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.553 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.7 pt -83.17 -40.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.248 0.547 . . . . 0.0 110.101 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.553 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.9 -11.06 60.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.781 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.79 32.88 0.99 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -176.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.04 -12.48 24.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.341 -0.93 . . . . 0.0 112.53 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.2 10.18 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.84 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.483 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.31 146.76 30.82 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.2 t -130.75 107.22 13.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.354 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -78.25 175.2 10.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.206 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.735 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.91 -67.12 0.31 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.612 0.72 . . . . 0.0 111.635 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.3 mt-10 -64.96 -25.85 68.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.553 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.574 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -55.57 -48.47 74.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 110.35 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.0 p90 -78.81 -31.03 45.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.24 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 138' ' ' TYR . 65.7 t -52.8 -44.49 48.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.094 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -59.26 -38.74 80.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 109.828 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.49 -40.71 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.704 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.421 ' CG ' HG21 ' B' ' 22' ' ' VAL . 3.8 ttp -53.41 -43.58 68.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.009 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 t -78.89 -31.31 45.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 146.87 40.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.076 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.947 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.815 0.34 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.731 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.26 -51.22 59.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.061 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.711 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.68 -53.28 32.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.261 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.95 -37.54 71.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.999 0.428 . . . . 0.0 110.31 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.947 HG23 ' O ' ' B' ' 1' ' ' ALA . 15.3 t -63.35 -34.44 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.436 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.816 HG21 HG11 ' A' ' 55' ' ' VAL . 2.2 mt -71.32 -54.89 15.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.039 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -50.94 -37.63 45.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.154 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.85 -48.32 63.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.404 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.858 ' HD2' HD23 ' A' ' 32' ' ' LEU . 13.2 mtmt -54.25 -54.08 44.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.067 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.925 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.9 mt -51.13 -57.5 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.4 tpt180 -60.06 -51.41 69.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.28 0.562 . . . . 0.0 111.089 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.39 -40.38 65.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.763 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.755 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.57 -50.8 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.462 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.52 -37.06 94.08 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.235 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.909 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.02 -61.82 2.03 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.861 -0.669 . . . . 0.0 110.529 -178.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.69 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -63.17 -27.59 69.47 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.673 177.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.89 -50.48 64.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.28 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.747 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -64.63 -43.63 93.08 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.909 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.3 m -64.98 -33.02 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.543 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.69 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -74.68 -45.92 41.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.944 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.546 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.46 -26.34 65.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.505 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.438 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.3 -47.41 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.229 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.887 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -62.79 -33.54 75.4 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.254 0.549 . . . . 0.0 110.511 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.887 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.071 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.819 0.343 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.536 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.2 m-20 -65.83 -169.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.785 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -118.65 89.26 3.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.994 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.623 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.29 164.7 12.37 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.9 p -98.29 162.67 13.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.48 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -47.56 -51.31 21.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.845 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.48 -27.66 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.994 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.6 OUTLIER -72.4 -51.46 20.32 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.696 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.692 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.2 pt -73.19 -28.89 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.822 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.43 -27.45 10.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.53 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 15.2 mm-40 -75.34 -28.55 59.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.327 178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.36 -58.64 3.11 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.228 0.537 . . . . 0.0 111.083 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.56 -23.26 15.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.243 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -75.86 -28.08 58.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.123 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.07 -39.83 63.18 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.149 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.81 -51.81 68.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.762 0.791 . . . . 0.0 109.515 178.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.38 -24.41 59.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.044 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.1 -25.34 34.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.217 0.532 . . . . 0.0 110.279 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.871 ' CE2' HG21 ' A' ' 35' ' ' VAL . 3.1 t80 -92.23 -2.37 56.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.0 t70 -102.42 143.45 32.14 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.959 0.885 . . . . 0.0 111.026 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 3.7 mmtt -60.01 -53.36 58.77 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.626 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.46 -5.19 59.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.777 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.55 47.0 45.96 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.331 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.6 p30 -91.47 18.22 7.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.905 0.383 . . . . 0.0 110.711 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.54 5.27 88.6 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.589 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.9 p -150.38 148.61 29.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.782 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.32 140.55 19.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.975 0.416 . . . . 0.0 111.763 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.575 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.21 178.21 7.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.374 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.758 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -69.62 -41.2 75.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 110.353 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -58.11 -41.24 83.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.439 179.127 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.811 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.79 -53.75 16.79 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.407 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -58.07 -54.15 50.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.81 0.814 . . . . 0.0 109.555 178.648 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -58.8 -47.08 92.29 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.384 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.4 m -65.33 -30.79 71.67 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.448 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.871 HG21 ' CE2' ' A' ' 19' ' ' PHE . 16.7 t -63.88 -57.91 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.536 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -72.57 -40.25 66.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.31 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 20.5 ttt180 -61.21 -38.56 87.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 110.447 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.3 t -78.84 -12.08 60.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.539 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -87.46 -53.12 4.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.178 0.514 . . . . 0.0 110.52 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.444 ' N ' HD23 ' A' ' 39' ' ' LEU . . . 178.74 36.16 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.606 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.601 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -131.07 179.39 6.03 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.342 0.591 . . . . 0.0 111.257 -179.213 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -159.78 56.11 0.82 Allowed Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.773 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.7 Cg_endo -80.67 -173.74 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.615 2.21 . . . . 0.0 112.226 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.618 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.91 152.42 36.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.87 0.367 . . . . 0.0 110.093 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.41 -50.14 72.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.0 -32.01 72.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.602 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -66.49 -54.45 23.77 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.648 -179.442 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.758 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.26 -47.05 86.06 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.108 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.663 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -55.85 -44.94 78.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 110.806 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.4 -47.51 81.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -74.68 -30.61 61.64 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.968 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -54.15 -36.26 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.667 -178.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.401 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 22.0 t-20 -45.02 -28.64 0.72 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.282 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -79.39 -39.03 33.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.898 0.38 . . . . 0.0 110.731 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.031 HG11 HG21 ' B' ' 6' ' ' ILE . 3.6 m -80.01 -11.16 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.089 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 37.2 t0 -103.58 155.93 18.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.74 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.6 -29.38 25.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.1 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -116.51 -9.61 11.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.428 0.632 . . . . 0.0 110.442 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.4 63.86 4.85 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.519 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -112.49 17.84 18.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.807 0.337 . . . . 0.0 110.186 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.3 19.94 53.69 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.1 p -147.56 176.35 10.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.677 HD12 HD11 ' A' ' 32' ' ' LEU . 19.0 mt -115.03 136.48 51.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.554 0.216 . . . . 0.0 110.95 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.7 m-20 -88.18 -178.14 5.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.29 0.567 . . . . 0.0 112.001 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.75 -55.86 13.15 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.713 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.8 Cg_endo -65.66 -34.32 41.78 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.226 1.95 . . . . 0.0 111.267 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.72 -52.47 60.37 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.219 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.724 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.11 -57.15 13.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.88 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.692 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.23 -47.92 80.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.689 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 52.6 m -58.83 -30.54 67.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.066 0.46 . . . . 0.0 110.05 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.881 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.0 tpp -63.76 -61.71 2.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.234 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.439 ' CG ' HG22 ' B' ' 10' ' ' ILE . 7.5 mtm -72.84 -28.53 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.243 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.18 0.14 37.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.706 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -54.83 122.88 11.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.823 0.344 . . . . 0.0 110.989 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -65.0 -16.68 63.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.229 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 74.8 mtp -76.5 -29.47 56.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.807 0.337 . . . . 0.0 111.03 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -99.33 143.38 29.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.74 -173.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 63.84 -165.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' H ' HG22 ' A' ' 79' ' ' THR . 2.3 m-20 65.5 59.97 0.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 t -77.5 -33.52 54.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -76.03 -29.84 58.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -51.5 -30.53 20.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.666 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -78.0 -29.41 49.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.704 HG22 ' HE1' ' A' ' 138' ' ' TYR . 7.2 mt -79.14 -51.26 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.438 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.3 -51.91 12.11 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 91' ' ' VAL . 12.3 tm-20 -53.76 -25.47 19.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.786 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.706 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.62 -36.21 44.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.214 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.5 t80 -68.2 -52.13 37.84 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.0 0.429 . . . . 0.0 110.1 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -54.73 -31.98 59.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.821 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 87' ' ' GLU . 47.7 t -88.69 -22.74 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.514 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.48 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.36 -34.32 57.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.26 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -99.19 147.93 24.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.467 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -67.54 -38.22 83.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.375 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.29 -9.84 13.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.804 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.93 28.29 31.9 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.246 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -67.48 -13.9 62.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.211 0.505 . . . . 0.0 110.764 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.452 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -11.0 55.35 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.146 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.463 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.9 m-85 -127.09 145.0 50.89 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.011 0.434 . . . . 0.0 111.414 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.032 HD13 HD13 ' A' ' 105' ' ' LEU . 1.1 pt -121.15 109.97 26.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.726 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -83.7 177.15 8.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.582 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.549 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.2 -29.92 71.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.084 0.469 . . . . 0.0 110.449 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.3 -57.68 11.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.28 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.778 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.48 -45.66 30.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.135 -179.205 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.032 HD13 HD13 ' A' ' 100' ' ' ILE . 37.4 tp -53.06 -31.15 40.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.848 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.1 ttt-85 -72.94 -49.06 31.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.976 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -58.9 -42.58 89.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.806 ' O ' HD12 ' A' ' 112' ' ' LEU . 1.8 t -72.85 -40.96 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.456 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.462 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 27.0 mmt -72.54 -54.08 10.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.431 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.729 HG23 ' HA ' ' A' ' 115' ' ' LYS . 6.9 m -58.95 -47.81 83.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.203 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -58.76 -30.18 67.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.805 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.915 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -123.04 38.48 4.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.651 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.6 -114.75 0.33 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.852 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.439 ' O ' HD23 ' A' ' 116' ' ' LEU . 17.8 pt-20 -133.17 166.89 21.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.334 . . . . 0.0 110.908 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.729 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.7 tttt -72.68 99.85 2.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.359 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.968 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.24 114.33 26.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.371 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.926 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.75 175.28 5.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.429 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -48.14 -35.94 12.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.763 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -77.34 -34.82 55.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.774 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -73.06 -33.49 65.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.988 0.423 . . . . 0.0 110.099 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.968 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.73 -48.03 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.854 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.62 -52.87 63.66 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.758 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -57.51 -28.8 63.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.842 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.784 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.5 tpt -76.26 -37.73 57.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.139 0.495 . . . . 0.0 110.134 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.91 -43.58 79.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.552 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -64.99 -39.09 92.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.812 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -81.17 -36.43 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.984 0.421 . . . . 0.0 110.545 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -67.95 -38.25 82.57 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.635 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.729 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.8 t0 -99.39 147.67 25.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.029 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.563 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.85 -40.73 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.06 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.563 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.91 -11.01 60.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.706 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.1 32.72 1.11 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -176.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.4 p-10 -96.11 -12.75 24.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.318 -0.941 . . . . 0.0 112.471 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.88 20.21 10.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.824 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.463 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -146.59 146.64 30.51 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.2 t -130.78 107.4 13.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.266 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.2 t-20 -79.12 174.66 11.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.302 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.704 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.83 -67.12 0.31 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.489 0.661 . . . . 0.0 111.444 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.406 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.5 OUTLIER -60.57 -34.22 73.85 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.892 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.51 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.06 -41.73 75.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 109.504 179.092 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.805 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.72 -31.92 46.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.086 178.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 138' ' ' TYR . 61.3 t -56.06 -46.73 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.657 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -56.53 -43.92 80.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.084 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.15 -35.31 66.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.0 ttp -59.87 -41.5 91.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.3 t -79.02 -31.0 44.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.6 155.09 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.947 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.839 0.352 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.713 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.5 mmm180 -52.38 -52.15 55.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.715 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.9 -53.31 33.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.365 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.03 -36.87 70.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.033 0.444 . . . . 0.0 110.287 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.947 HG23 ' O ' ' B' ' 1' ' ' ALA . 39.1 t -62.09 -39.57 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.047 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 1.031 HG21 HG11 ' A' ' 55' ' ' VAL . 2.9 mt -65.47 -55.49 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.1 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -50.72 -37.66 42.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.171 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.55 -45.97 56.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.66 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.851 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.3 OUTLIER -55.42 -55.57 30.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.015 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.881 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.4 mt -51.53 -57.42 3.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.343 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -57.44 -51.15 70.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.37 -42.51 66.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.795 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.2 mt -54.48 -48.24 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.583 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.19 -38.24 96.19 Favored Glycine 0 CA--C 1.498 -0.987 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.079 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.902 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.17 -61.79 2.03 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.847 -0.676 . . . . 0.0 110.445 -178.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.655 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.79 -27.75 68.97 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.594 177.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -64.98 -51.36 62.17 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.258 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.716 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.88 -43.55 95.7 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.902 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -64.51 -33.39 62.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.503 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.69 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.5 OUTLIER -74.15 -45.48 48.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.788 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.534 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.0 p -59.68 -26.17 65.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.477 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.413 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.1 m -90.32 -46.16 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.172 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.935 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.38 -32.85 74.39 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.15 0.5 . . . . 0.0 110.468 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.935 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.063 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.794 0.331 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.524 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.4 m-20 -62.27 -169.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.8 90.34 3.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.18 164.73 12.37 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.968 0.413 . . . . 0.0 110.375 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.493 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.0 p -98.07 162.55 13.16 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.508 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -47.47 -51.4 20.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.831 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.46 -27.7 69.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.015 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.493 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.31 -51.45 20.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.741 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.696 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.0 pt -73.21 -28.99 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.753 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.44 -27.39 10.16 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.545 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.2 mt-10 -75.24 -28.57 59.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.235 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.1 m-85 -79.35 -58.55 3.15 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.351 0.596 . . . . 0.0 110.995 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.878 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.86 -22.9 16.13 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.219 -179.732 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.545 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -76.08 -27.6 57.25 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.119 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -75.08 -39.66 60.61 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.071 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.878 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.12 -51.9 68.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.875 0.845 . . . . 0.0 109.386 178.672 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.38 -24.82 59.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.104 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.785 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.02 -26.6 33.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.127 0.489 . . . . 0.0 110.409 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.785 ' HB3' HD11 ' A' ' 27' ' ' ILE . 5.3 t80 -86.07 -21.63 27.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.226 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 31.8 t70 -83.33 146.54 28.45 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.896 0.855 . . . . 0.0 111.129 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.5 mmtt -65.39 -53.37 44.18 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.969 -1.468 . . . . 0.0 111.6 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.19 -8.0 59.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.786 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.27 46.6 63.19 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.537 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -91.8 18.19 8.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.832 0.349 . . . . 0.0 110.583 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.18 5.7 89.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.425 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 54.3 p -150.19 151.06 32.49 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.785 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -102.36 140.42 20.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.915 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.646 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.44 176.53 8.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.97 179.163 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.82 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -70.42 -39.05 74.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.149 0.499 . . . . 0.0 110.209 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.63 -40.49 87.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.133 178.693 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 35' ' ' VAL . 1.6 mm-40 -68.15 -53.88 21.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.04 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.846 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.54 -56.27 24.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.747 0.784 . . . . 0.0 109.462 178.672 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.05 -45.49 87.03 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.553 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.9 m -62.85 -32.35 73.55 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.906 0.353 . . . . 0.0 110.562 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 31' ' ' GLU . 72.6 t -66.47 -57.26 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.462 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -71.96 -37.05 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.495 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -41.4 88.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.914 0.387 . . . . 0.0 110.603 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.8 t -78.95 -8.58 59.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.682 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.85 -54.86 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.682 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.457 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.28 33.64 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.87 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.593 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.78 -179.98 5.87 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.314 0.578 . . . . 0.0 111.159 -179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -159.71 56.27 0.85 Allowed Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.831 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.8 Cg_endo -80.58 -173.9 2.03 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.535 2.157 . . . . 0.0 112.113 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.612 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -117.06 152.38 34.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.954 0.407 . . . . 0.0 110.19 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.94 -49.94 74.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.99 -31.9 72.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.734 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 44' ' ' THR . 1.6 mt-10 -66.16 -54.33 26.7 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.667 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.82 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -66.06 -34.5 78.22 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.447 179.642 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.685 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -65.02 -42.16 94.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.92 0.391 . . . . 0.0 110.138 179.169 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.65 -45.78 92.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.154 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.5 mmt -74.53 -30.88 61.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.477 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.72 -36.4 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.382 -179.323 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.408 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 7.7 t-20 -44.87 -28.7 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.34 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG2' ' NZ ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.73 -39.44 44.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.923 0.392 . . . . 0.0 110.744 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.8 HG11 HG21 ' B' ' 6' ' ' ILE . 4.3 m -81.61 -11.56 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.115 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.56 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 44.1 t0 -103.45 155.31 18.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.475 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.797 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.64 -28.77 26.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.036 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -116.51 -9.82 11.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.435 0.636 . . . . 0.0 110.473 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 59.45 61.0 7.77 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.467 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -111.18 18.16 19.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.869 0.366 . . . . 0.0 110.309 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.53 19.8 53.45 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.763 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 28' ' ' THR . 5.6 p -146.09 176.35 9.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.499 0.19 . . . . 0.0 110.501 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 32' ' ' LEU . 25.4 mt -117.59 136.58 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.57 0.224 . . . . 0.0 110.777 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.797 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 1.8 m-20 -87.77 -178.14 5.99 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.338 0.589 . . . . 0.0 112.13 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.52 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.7 m-85 -67.11 -56.2 13.94 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.638 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -65.68 -35.64 36.34 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.355 2.037 . . . . 0.0 111.307 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.28 -52.49 63.5 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.246 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.732 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.1 -56.87 16.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.776 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.696 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.07 -47.22 81.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.756 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 53.0 m -59.16 -30.65 68.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.461 . . . . 0.0 110.124 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.898 ' HG2' HD13 ' B' ' 10' ' ' ILE . 4.4 tpp -60.3 -61.74 2.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.234 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.7 mtt -75.34 -36.98 60.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.103 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.524 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -67.82 -13.33 62.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.568 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.23 149.46 1.5 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.867 0.365 . . . . 0.0 111.088 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -68.0 -13.39 62.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.398 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -94.81 -27.58 15.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.782 0.325 . . . . 0.0 111.001 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.21 82.19 3.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.978 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -143.15 -178.43 5.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 62.45 -167.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.401 ' H ' HG22 ' A' ' 79' ' ' THR . 3.0 m-20 65.41 61.6 0.7 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.4 m -77.61 -58.18 3.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -63.6 -34.59 78.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -50.43 -30.45 12.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 4.6 mt-10 -76.04 -29.62 58.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.775 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.696 HG22 ' HE1' ' A' ' 138' ' ' TYR . 10.0 mt -79.22 -50.99 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.78 -48.43 38.34 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.904 0.383 . . . . 0.0 111.85 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -53.47 -26.52 20.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.396 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.742 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.61 -34.0 58.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.037 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 12.8 t80 -68.92 -50.55 48.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.04 0.448 . . . . 0.0 110.14 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -54.39 -33.18 58.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.727 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.8 t -88.94 -22.78 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -52.74 -36.83 58.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.364 -179.242 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -100.09 147.21 25.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 0.0 110.5 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -68.3 -37.49 80.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.33 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -112.23 -9.78 13.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.815 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.43 28.28 33.5 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.354 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -67.54 -14.0 62.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.206 0.503 . . . . 0.0 110.721 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.477 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.93 -11.35 55.96 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.126 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.5 m-85 -127.2 146.93 50.23 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 120.989 0.423 . . . . 0.0 111.482 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.07 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.14 109.97 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.652 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.92 177.04 8.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.539 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.22 -30.14 71.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.111 0.482 . . . . 0.0 110.484 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.88 -57.81 11.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.239 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.812 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.48 -45.45 31.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.155 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.07 HD13 HD13 ' A' ' 100' ' ' ILE . 30.5 tp -52.95 -31.2 39.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.185 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.84 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.7 ttt-85 -73.01 -49.1 30.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.469 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 13.7 m170 -58.78 -42.66 89.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.118 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.6 t -73.07 -39.74 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 29.0 mmt -74.0 -54.14 8.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.538 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 115' ' ' LYS . 6.1 m -55.62 -48.9 74.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.35 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 107' ' ' HIS . 51.1 m-20 -58.87 -29.68 67.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.934 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.785 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.5 mp -121.85 36.6 4.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.29 -113.2 0.28 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.716 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.444 ' O ' HD23 ' A' ' 116' ' ' LEU . 3.1 pt-20 -136.24 170.35 16.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.792 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.625 ' HA ' HG23 ' A' ' 110' ' ' THR . 5.5 ttpp -73.39 98.07 2.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.141 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.38 113.56 24.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.409 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.924 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.77 175.42 5.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.363 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.07 -35.87 12.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 0.0 110.742 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.41 -34.99 54.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.403 ' HB2' ' CA ' ' A' ' 116' ' ' LEU . 9.7 mm-40 -72.89 -33.32 65.96 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.026 0.441 . . . . 0.0 110.145 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.53 -48.62 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.342 0.591 . . . . 0.0 109.786 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.46 -52.91 63.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.775 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.25 -28.68 63.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.808 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.762 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.0 tpt -76.13 -38.1 57.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.131 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.497 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.22 -43.77 84.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.506 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -62.32 -40.82 97.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.971 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 124' ' ' MET . 8.0 pt-20 -80.64 -36.37 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.834 0.35 . . . . 0.0 110.652 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.485 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -67.53 -35.04 78.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.421 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.648 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.4 t0 -104.37 145.54 30.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.983 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.554 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.9 pt -83.03 -40.83 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.165 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.554 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.85 -11.1 60.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.78 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.81 32.74 0.98 Allowed Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -176.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.42 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -95.7 -12.38 25.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.351 -0.924 . . . . 0.0 112.548 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.78 20.27 10.16 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.903 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -146.09 147.35 31.48 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.168 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 129' ' ' ASP . 18.9 t -130.7 107.21 13.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.395 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -78.71 174.87 10.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.256 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.735 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.91 -67.15 0.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.636 0.731 . . . . 0.0 111.695 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 3.5 mt-10 -65.19 -25.49 67.73 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.583 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.481 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.52 -48.56 74.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.829 0.347 . . . . 0.0 110.333 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.9 p90 -78.88 -31.06 45.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.219 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 138' ' ' TYR . 67.6 t -52.87 -44.34 48.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.136 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -59.73 -38.51 81.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.147 0.498 . . . . 0.0 109.879 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.47 -41.04 63.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.714 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.42 ' CG ' HG21 ' B' ' 22' ' ' VAL . 8.5 ttp -53.38 -43.62 67.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.974 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 t -78.82 -31.36 45.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.72 159.03 9.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.938 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.733 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.26 -51.21 59.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.021 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.724 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.62 -53.3 31.85 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.232 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.43 -37.58 70.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.069 0.462 . . . . 0.0 110.292 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.938 HG23 ' O ' ' B' ' 1' ' ' ALA . 12.1 t -64.07 -33.67 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.408 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.8 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.71 -52.73 23.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.114 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.424 ' HA ' HD12 ' B' ' 10' ' ' ILE . 31.5 mmm-85 -53.16 -37.36 61.8 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.081 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.03 -48.35 63.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.363 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.846 ' HD2' HD23 ' A' ' 32' ' ' LEU . 17.3 mtmt -55.11 -52.92 61.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.762 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.898 HD13 ' HG2' ' A' ' 71' ' ' MET . 6.1 mt -51.08 -57.44 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.053 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -58.85 -51.46 69.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.287 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.26 -40.1 64.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.825 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.4 mt -54.48 -52.38 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.537 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.63 -36.47 93.3 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.284 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.913 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.59 -61.75 2.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.526 -178.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.701 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -63.2 -27.55 69.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.658 177.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.58 -50.91 63.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.294 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.751 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -64.58 -43.73 92.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.529 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.913 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.3 m -64.95 -32.83 59.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.56 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.701 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.69 -46.13 39.81 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.897 -179.314 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.551 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.33 -26.32 64.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.446 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.439 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.22 -47.4 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.227 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.884 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -63.1 -33.25 75.04 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.2 0.524 . . . . 0.0 110.453 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.884 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.092 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.644 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.787 0.327 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.638 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 1.5 m-20 -83.63 -169.74 2.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -121.34 85.88 2.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.4 mt -98.29 164.79 12.16 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.479 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.478 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.1 p -96.85 161.87 13.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.519 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -47.65 -51.74 20.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.739 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -64.43 -27.69 69.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.96 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.94 -51.55 21.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.63 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -72.95 -28.85 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.775 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.43 -27.35 9.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 29.7 mt-10 -75.32 -28.57 59.72 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.251 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.34 -58.53 3.17 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.197 0.522 . . . . 0.0 111.121 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.875 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -54.68 -22.75 14.71 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.246 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.38 -28.03 56.59 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.046 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.44 -39.52 62.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.127 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.91 -51.61 69.32 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.825 0.821 . . . . 0.0 109.367 178.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 p -74.32 -24.65 59.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.143 -1.389 . . . . 0.0 112.029 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.78 HD11 ' O ' ' A' ' 112' ' ' LEU . 1.9 tt -81.93 -25.36 34.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.273 0.559 . . . . 0.0 110.194 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.796 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.6 t80 -92.63 -0.74 57.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.456 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.2 t70 -104.26 144.08 32.09 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.038 0.923 . . . . 0.0 111.108 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.49 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 11.5 mmtt -59.99 -53.4 58.28 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.519 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.59 -4.0 59.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.849 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.51 47.06 36.96 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.354 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -91.52 18.4 7.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.857 0.36 . . . . 0.0 110.693 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.32 88.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.615 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.4 p -150.26 148.78 29.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.647 0.261 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.796 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.41 140.46 20.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.99 0.424 . . . . 0.0 111.82 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.523 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.13 177.56 7.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.172 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.693 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -70.33 -38.75 74.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.16 0.505 . . . . 0.0 110.32 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.548 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.39 -41.34 89.17 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 178.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.93 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.4 -53.59 18.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.349 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.835 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.87 -55.62 32.75 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.79 0.805 . . . . 0.0 109.342 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.38 -45.73 88.45 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.519 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.9 m -62.72 -31.83 72.83 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.556 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.93 HG23 ' O ' ' A' ' 31' ' ' GLU . 73.7 t -66.56 -57.38 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.438 . . . . 0.0 110.838 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.494 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 2.3 tpt -72.0 -37.22 69.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.506 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -66.23 -40.94 90.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 110.613 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -79.01 -9.14 59.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.639 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.54 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -89.8 -54.02 4.24 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.634 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.92 34.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.788 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -132.89 178.78 6.61 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.344 0.593 . . . . 0.0 111.219 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -159.83 56.06 0.81 Allowed Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.709 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.3 Cg_endo -80.65 -170.25 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.552 2.168 . . . . 0.0 112.297 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.603 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.58 152.6 35.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.099 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -56.63 -50.05 73.18 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.81 -32.62 74.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.783 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.33 -54.6 26.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.727 -179.43 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.693 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.1 -44.66 96.17 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.893 179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.636 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -58.06 -49.03 78.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.715 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -53.27 -47.6 69.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.402 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 0.5 OUTLIER -74.7 -30.57 61.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.85 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.549 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -53.76 -35.0 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.524 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -45.05 -28.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.24 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -78.1 -39.12 42.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.922 0.391 . . . . 0.0 110.79 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.881 HG11 HG21 ' B' ' 6' ' ' ILE . 4.6 m -80.22 -11.02 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.182 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 37.6 t0 -103.65 155.73 18.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.787 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.501 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.6 -29.34 25.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.072 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -116.54 -9.57 11.38 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.41 0.624 . . . . 0.0 110.428 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.61 63.74 4.94 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.495 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -112.32 17.77 19.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.799 0.333 . . . . 0.0 110.195 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.25 19.99 53.71 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.553 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.3 p -147.88 176.45 10.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.743 HD12 HD11 ' A' ' 32' ' ' LEU . 12.0 mt -115.03 136.52 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.594 0.235 . . . . 0.0 111.064 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 11.0 m-20 -88.41 -177.85 5.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.281 0.562 . . . . 0.0 111.901 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.91 -55.9 12.63 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.809 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.4 Cg_endo -65.48 -34.39 43.1 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.243 1.962 . . . . 0.0 111.266 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.87 -52.43 60.03 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.308 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.714 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.04 -56.97 14.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.879 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.699 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.83 -46.54 81.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.644 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 69.6 m -61.26 -31.66 71.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.071 0.462 . . . . 0.0 110.09 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.918 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.9 tpp -60.47 -61.78 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.101 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.8 mtt -67.44 -27.95 67.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.638 ' HB1' ' CG ' ' A' ' 2' ' ' ASP . . . -60.23 -20.13 57.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.408 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -53.95 113.49 1.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.832 0.349 . . . . 0.0 111.067 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -21.61 60.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.048 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -28.89 69.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -82.73 59.23 4.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.847 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.99 -174.59 4.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 64.24 -167.82 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.418 ' H ' HG22 ' A' ' 79' ' ' THR . 24.8 m-20 64.82 41.39 5.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.9 m -69.09 -51.31 40.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.809 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -80.6 -28.98 36.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -50.36 -30.66 12.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.317 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.662 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -71.1 -29.45 65.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.934 0.397 . . . . 0.0 110.494 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.689 HG22 ' HE1' ' A' ' 138' ' ' TYR . 17.6 mt -79.05 -49.06 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.197 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -45.45 54.3 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.945 0.402 . . . . 0.0 111.645 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.3 tp10 -53.68 -26.07 21.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.283 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.757 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.0 -33.41 51.31 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.046 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 13.4 t80 -69.33 -51.98 31.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.958 0.408 . . . . 0.0 110.283 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -54.32 -32.3 56.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.723 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 87' ' ' GLU . 42.7 t -88.82 -22.91 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.624 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.29 -36.02 60.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.028 -179.613 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -101.34 148.48 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.445 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -69.18 -37.65 78.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.377 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.16 -9.76 13.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.57 29.4 32.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.258 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.45 -13.88 62.43 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.089 0.444 . . . . 0.0 110.754 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -12.79 55.66 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.94 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 24.6 m-85 -127.13 145.84 50.6 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.956 0.408 . . . . 0.0 111.448 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.926 HD12 HD12 ' A' ' 105' ' ' LEU . 1.1 pt -121.16 109.89 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.763 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.5 m -81.06 178.34 8.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.409 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.53 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.8 -29.63 70.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.002 0.429 . . . . 0.0 110.447 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.24 -57.82 10.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.244 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.51 -39.65 52.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.03 -179.275 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.926 HD12 HD12 ' A' ' 100' ' ' ILE . 8.9 tt -55.42 -41.25 72.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.024 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.89 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.9 ttt180 -65.3 -49.49 69.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -60.46 -39.31 87.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.088 0.471 . . . . 0.0 110.184 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 104' ' ' GLU . 37.1 t -73.21 -42.14 58.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.32 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 30.6 mmt -74.1 -54.31 8.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.688 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.7 m -55.42 -43.92 75.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.445 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.498 ' C ' HD12 ' A' ' 112' ' ' LEU . 3.4 m120 -60.54 -31.43 70.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.347 . . . . 0.0 110.825 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.78 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.7 mp -122.91 37.23 4.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.736 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -167.1 -117.37 0.4 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.819 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.415 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.9 pt-20 -133.8 177.92 7.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.436 ' HA ' HG23 ' A' ' 110' ' ' THR . 22.8 tptt -78.27 97.7 5.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.299 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.976 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.86 114.84 26.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.327 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.924 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.72 174.97 6.1 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.956 -0.297 . . . . 0.0 110.363 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -48.03 -35.78 11.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.366 . . . . 0.0 110.749 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -77.32 -36.21 54.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.759 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -71.06 -33.89 70.68 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.994 0.426 . . . . 0.0 109.985 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.976 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -73.86 -50.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.402 0.62 . . . . 0.0 109.681 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.91 -52.85 63.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.717 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -28.49 64.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.777 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.683 ' HG3' HD11 ' A' ' 105' ' ' LEU . 6.7 tpt -76.2 -37.57 57.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.152 0.501 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.569 HG12 HD13 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -69.94 -39.94 78.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.287 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -70.61 -34.57 72.27 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.411 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 124' ' ' MET . 20.7 pt-20 -82.92 -39.79 21.02 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.429 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.492 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.6 -41.79 87.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.474 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.731 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.2 t0 -91.48 147.18 23.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.07 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.552 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.03 -40.68 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.015 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.92 -10.98 60.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.756 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.88 33.03 1.05 Allowed Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.31 -12.57 24.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.357 -0.922 . . . . 0.0 112.48 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.11 10.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.863 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -146.47 146.76 30.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.1 t -130.71 107.24 13.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.281 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -78.31 175.4 10.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.368 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.729 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.95 -67.1 0.31 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.674 0.75 . . . . 0.0 111.709 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.511 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.3 mt-10 -65.32 -25.28 67.54 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.568 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.576 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.56 -48.61 74.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.813 0.34 . . . . 0.0 110.369 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.6 p90 -78.89 -31.31 45.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.347 178.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 138' ' ' TYR . 73.8 t -53.07 -44.3 50.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.098 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -61.03 -35.5 77.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.095 0.474 . . . . 0.0 109.779 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.414 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 9.5 mmt -73.58 -42.3 61.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.091 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.46 ' CG ' HG21 ' B' ' 22' ' ' VAL . 0.2 OUTLIER -51.29 -48.64 62.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.946 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 t -74.36 -31.22 62.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.73 146.72 40.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.973 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.777 0.322 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.731 ' O ' HG13 ' B' ' 6' ' ' ILE . 2.1 mmm180 -52.18 -51.52 57.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.039 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.748 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.71 -53.36 31.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.591 0.234 . . . . 0.0 111.458 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -57.2 -36.98 71.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.086 0.47 . . . . 0.0 110.115 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.973 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.4 t -63.77 -34.45 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.393 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.881 HG21 HG11 ' A' ' 55' ' ' VAL . 2.7 mt -71.3 -53.65 20.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.054 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -50.97 -39.92 56.42 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.236 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.84 -48.12 67.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.418 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.849 ' O ' HD12 ' B' ' 13' ' ' ILE . 13.3 mtmt -55.01 -54.53 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.196 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.918 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.7 mt -51.11 -56.91 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.298 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.6 OUTLIER -59.54 -47.95 83.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.199 0.523 . . . . 0.0 111.155 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.11 -39.87 63.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.025 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.849 HD12 ' O ' ' B' ' 9' ' ' LYS . 1.7 mt -54.5 -52.03 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.502 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.422 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.51 -36.38 93.09 Favored Glycine 0 CA--C 1.499 -0.931 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.301 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.919 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -63.8 -61.73 2.11 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.863 -0.668 . . . . 0.0 110.468 -178.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.653 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -64.32 -27.43 69.02 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.789 177.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.12 -49.66 64.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.144 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.761 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -64.69 -43.93 91.94 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.549 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.919 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.6 m -65.07 -32.28 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.579 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.653 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.8 OUTLIER -74.57 -48.41 26.9 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.074 -179.2 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.558 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.7 p -58.43 -26.26 63.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.475 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.46 HG21 ' CG ' ' A' ' 145' ' ' MET . 27.7 m -90.24 -48.05 14.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.258 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.881 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.1 pp -62.54 -32.9 73.93 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.202 0.525 . . . . 0.0 110.442 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.881 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.111 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.63 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.797 0.332 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.541 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.1 m-20 -66.1 -169.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -117.68 90.72 3.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.2 mt -98.63 164.86 12.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.485 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.4 p -96.82 161.67 13.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.479 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -47.61 -51.81 20.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.744 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -64.46 -27.63 69.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.973 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.92 -51.49 21.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.58 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.706 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -73.03 -28.9 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.801 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.49 -27.37 10.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.0 mt-10 -75.27 -28.45 59.81 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.314 178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.608 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.29 -58.5 3.19 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.301 0.572 . . . . 0.0 111.04 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.6 pttt -54.58 -22.94 14.74 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.285 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.39 -27.94 56.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.103 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.24 -39.95 62.72 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.027 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.82 -52.1 67.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.829 0.823 . . . . 0.0 109.483 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -24.21 58.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.145 -1.388 . . . . 0.0 112.117 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.883 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.3 tt -82.05 -24.68 35.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.282 0.563 . . . . 0.0 110.202 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.821 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.8 t80 -93.66 -0.83 55.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.522 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.4 t70 -102.87 143.64 32.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.997 0.904 . . . . 0.0 111.026 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.1 mmtt -60.17 -53.38 58.43 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.594 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.66 -5.9 59.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.773 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.59 45.91 53.83 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.425 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -90.83 18.05 7.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.832 0.349 . . . . 0.0 110.705 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.07 5.95 88.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.503 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.451 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 52.7 p -150.1 149.54 30.42 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -102.04 140.51 20.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.934 0.397 . . . . 0.0 112.018 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.598 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.6 176.84 7.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.929 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.811 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -70.49 -38.16 74.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.142 0.496 . . . . 0.0 110.36 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.67 -40.96 89.53 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.22 178.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.43 -53.73 17.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.324 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.825 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.96 -54.83 42.52 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.755 0.788 . . . . 0.0 109.422 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.57 -45.97 92.58 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 114.552 -1.203 . . . . 0.0 112.484 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.57 -31.1 71.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.86 0.33 . . . . 0.0 110.572 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 31' ' ' GLU . 72.1 t -67.86 -57.22 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.449 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.98 -35.98 69.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.46 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -42.62 80.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.953 0.406 . . . . 0.0 110.776 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 t -78.96 -8.59 59.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.753 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.7 tt -90.57 -55.09 3.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.766 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.477 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -174.5 34.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.955 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.578 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.6 tp-100 -137.66 -178.86 5.43 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.3 0.571 . . . . 0.0 111.219 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -159.65 56.59 0.89 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.913 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.41 -177.49 3.81 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.457 2.104 . . . . 0.0 112.076 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -112.44 152.45 28.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.952 0.406 . . . . 0.0 110.224 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.7 -49.09 77.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.401 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.64 -31.93 72.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.774 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 1.5 mt-10 -65.83 -54.3 28.59 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.586 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.811 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.98 -34.52 78.28 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.373 179.606 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.694 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.52 -42.6 95.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.882 0.372 . . . . 0.0 110.148 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -61.83 -45.5 93.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.219 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 mmt -74.5 -30.75 61.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.428 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.42 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.624 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -44.99 -28.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.373 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.439 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -77.57 -38.6 48.09 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.905 0.383 . . . . 0.0 110.816 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.884 HG11 HG21 ' B' ' 6' ' ' ILE . 4.5 m -81.43 -11.64 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.244 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.55 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 41.0 t0 -103.63 155.62 18.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.692 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.478 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.59 -28.89 26.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.05 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -116.45 -9.67 11.41 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.435 0.636 . . . . 0.0 110.459 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.14 63.37 5.31 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.446 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -112.37 18.26 18.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.808 0.337 . . . . 0.0 110.183 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.66 20.02 55.04 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.515 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.4 p -146.88 176.36 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.511 HD12 HD11 ' A' ' 32' ' ' LEU . 54.6 mt -116.12 136.54 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.581 0.229 . . . . 0.0 110.803 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.2 m-20 -86.97 -178.49 6.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.268 0.556 . . . . 0.0 111.948 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -67.82 -56.17 12.28 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.589 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.75 -34.81 39.18 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.248 1.965 . . . . 0.0 111.198 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.65 -52.38 63.57 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.204 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.714 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.22 -56.86 16.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.85 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.706 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.83 -46.96 81.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.63 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 59.7 m -60.26 -30.99 69.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 0.0 110.064 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.936 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.3 tpp -63.68 -61.89 2.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.104 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mtm -70.49 -30.2 66.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.039 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.47 0.08 39.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.674 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -56.41 158.01 4.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.837 0.351 . . . . 0.0 111.008 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -86.5 -12.69 48.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.304 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.1 ttt -95.02 -30.79 13.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.786 0.327 . . . . 0.0 110.973 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -77.3 124.31 27.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -168.64 -170.87 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 62.39 -166.02 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' H ' HG22 ' A' ' 79' ' ' THR . 1.9 m-20 66.6 36.29 4.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 p -77.55 -45.23 26.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -80.74 -29.15 36.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -53.47 -53.72 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.29 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.71 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.71 -29.56 27.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.486 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.773 HG22 ' HE1' ' A' ' 138' ' ' TYR . 13.8 mt -65.46 -51.29 65.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.859 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.38 -49.62 18.44 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 110.405 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.7 mt-10 -54.1 -30.22 47.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.243 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -69.88 -37.91 76.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.625 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 11.3 t80 -67.3 -53.93 25.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.519 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -54.08 -31.01 50.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.784 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 87' ' ' GLU . 87.0 t -88.63 -22.85 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.291 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.525 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -55.2 -37.21 66.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.096 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -101.48 147.23 26.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.506 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -69.64 -36.75 76.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.362 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.2 -9.74 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.4 30.14 34.48 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.245 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -67.43 -13.79 62.34 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.01 0.405 . . . . 0.0 110.782 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.19 -13.42 55.38 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.951 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 25.5 m-85 -127.19 145.49 50.74 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.01 0.433 . . . . 0.0 111.353 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.804 ' CD1' HD12 ' A' ' 105' ' ' LEU . 1.1 pp -121.1 109.89 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.705 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.68 178.9 8.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.508 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.467 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.67 -29.94 70.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.055 0.455 . . . . 0.0 110.511 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.44 -57.77 11.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.168 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.799 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.46 -41.47 47.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.951 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.804 HD12 ' CD1' ' A' ' 100' ' ' ILE . 7.7 tt -54.19 -37.46 64.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.936 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HA ' HD11 ' A' ' 116' ' ' LEU . 3.2 ttt-85 -70.06 -49.4 51.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.925 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.51 -37.56 86.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.058 0.456 . . . . 0.0 110.139 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.1 t -73.03 -45.33 54.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.232 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.455 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 21.5 mmt -74.03 -54.27 8.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.701 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 m -55.57 -44.6 77.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.264 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -58.4 -28.44 65.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.789 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.883 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.1 mp -126.06 35.88 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -164.04 -120.46 0.52 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.764 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -127.78 -176.84 3.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 0.0 110.907 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -83.84 97.07 8.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.958 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.28 114.0 25.95 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.426 179.548 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.927 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.78 175.36 5.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.32 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.441 ' H ' HG22 ' A' ' 117' ' ' THR . 3.9 m-20 -48.06 -35.9 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.947 0.403 . . . . 0.0 110.733 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -77.41 -35.44 54.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.841 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -72.12 -33.22 67.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.998 0.427 . . . . 0.0 110.094 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.958 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.7 t -75.08 -50.61 24.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.395 0.617 . . . . 0.0 109.679 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -59.08 -52.83 64.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.717 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -28.73 58.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.767 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.784 ' HG3' HD11 ' A' ' 105' ' ' LEU . 6.4 tpt -76.16 -39.26 55.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.207 0.527 . . . . 0.0 110.044 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.531 HG12 HD13 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -65.89 -46.83 87.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.392 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -62.7 -38.28 89.78 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.911 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 124' ' ' MET . 18.5 pt-20 -81.12 -39.81 25.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.724 0.297 . . . . 0.0 110.814 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.507 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -65.42 -39.35 92.03 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.547 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.725 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.6 t0 -94.94 146.4 24.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.552 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.4 -40.63 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.06 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.91 -10.98 60.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.769 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.68 33.03 0.95 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.431 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.2 p-10 -96.27 -12.49 24.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.369 -0.916 . . . . 0.0 112.56 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.8 20.2 10.23 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.808 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.63 147.29 30.89 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 129' ' ' ASP . 38.9 t -130.68 107.27 13.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.258 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -77.83 175.23 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.445 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.773 ' HE1' HG22 ' A' ' 85' ' ' ILE . 1.1 t80 -46.05 -67.04 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.654 0.74 . . . . 0.0 111.811 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.3 mm-40 -65.57 -25.13 67.28 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.63 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.575 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.56 -48.9 74.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.382 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 9.3 p90 -79.21 -31.32 43.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.364 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 138' ' ' TYR . 72.0 t -52.9 -43.3 46.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.341 -0.39 . . . . 0.0 109.963 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -62.71 -34.79 77.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.81 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.421 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 9.5 mmt -73.48 -44.29 58.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.424 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.44 ' CG ' HG21 ' B' ' 22' ' ' VAL . 7.1 ttp -51.12 -46.97 62.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.159 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.1 t -75.89 -31.24 59.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.71 162.37 5.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.911 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.951 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.31 -51.1 60.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.73 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.65 -53.23 32.63 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.655 0.264 . . . . 0.0 111.299 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.17 -37.57 72.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.019 0.438 . . . . 0.0 110.317 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.951 HG23 ' O ' ' B' ' 1' ' ' ALA . 15.0 t -63.36 -33.73 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.388 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.884 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.64 -55.08 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.011 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 26.2 mmm-85 -50.42 -37.88 40.16 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.178 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -46.1 65.15 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.503 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.825 ' HD2' HD23 ' A' ' 32' ' ' LEU . 11.8 mtmt -56.6 -54.12 49.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.936 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.2 -57.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.548 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.544 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.0 OUTLIER -60.92 -51.41 69.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.361 0.601 . . . . 0.0 110.938 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.42 -38.81 63.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.859 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.671 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.31 -50.66 55.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.351 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.42 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.44 -37.28 94.56 Favored Glycine 0 CA--C 1.498 -0.977 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.544 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.86 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -65.0 -61.77 1.95 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.716 -0.742 . . . . 0.0 110.552 -179.11 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.751 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.69 -27.51 67.92 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.47 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -68.36 -46.41 70.17 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.794 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 1.1 ppt_? -63.58 -44.1 95.06 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.86 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.8 m -62.78 -35.42 70.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.934 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.628 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -75.18 -47.2 29.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.064 -179.348 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.573 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 12.1 p -59.4 -25.15 64.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.598 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.484 HG22 ' O ' ' B' ' 18' ' ' ARG . 30.3 m -90.29 -48.52 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.196 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.89 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -61.91 -33.78 74.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.228 0.537 . . . . 0.0 110.44 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.89 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.083 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.801 0.334 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.542 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.2 m-20 -64.82 -169.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.782 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -120.59 90.68 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.66 164.75 12.28 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.004 0.43 . . . . 0.0 110.424 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.5 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.44 161.93 13.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.467 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -47.69 -51.68 20.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.766 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -64.5 -27.7 69.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.045 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.5 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.85 -51.5 22.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.619 179.729 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.703 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.9 pt -73.0 -28.97 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.64 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.54 -27.33 10.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 4.6 mm-40 -75.34 -28.55 59.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.281 178.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.34 -58.61 3.13 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.214 0.531 . . . . 0.0 111.033 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.872 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.76 15.04 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.249 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.52 -27.95 56.2 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.08 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.23 -39.92 62.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.043 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.872 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.55 -51.95 67.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.802 0.811 . . . . 0.0 109.363 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.401 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 p -74.51 -24.05 58.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.074 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.878 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.07 -24.74 35.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.261 0.553 . . . . 0.0 110.166 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.9 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.5 t80 -94.64 0.21 54.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.571 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.4 t70 -104.27 142.35 34.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.942 0.877 . . . . 0.0 110.997 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.478 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.7 mmtt -58.4 -53.35 59.33 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.572 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -86.62 -4.88 59.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.765 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.15 47.23 42.13 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.356 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -91.64 18.53 7.36 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.805 0.336 . . . . 0.0 110.673 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.85 5.12 88.25 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.592 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.9 p -150.33 148.65 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.668 0.27 . . . . 0.0 110.344 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.728 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.72 140.46 19.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.801 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.591 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.41 178.66 7.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.294 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.715 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -69.96 -41.8 74.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.056 0.455 . . . . 0.0 110.411 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.537 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -57.28 -40.88 78.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.365 179.07 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.807 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -70.15 -53.82 15.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.47 -179.494 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.729 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -57.5 -54.14 50.26 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.838 0.828 . . . . 0.0 109.572 178.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.33 91.32 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.462 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 30' ' ' LYS . 53.3 m -65.48 -30.74 71.55 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 120.813 0.339 . . . . 0.0 110.432 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.9 HG21 ' CE2' ' A' ' 19' ' ' PHE . 13.9 t -63.62 -57.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.037 0.446 . . . . 0.0 110.568 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.607 ' CE ' HD22 ' A' ' 39' ' ' LEU . 1.7 tpt -72.35 -40.53 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.273 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -61.13 -39.66 90.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.945 0.402 . . . . 0.0 110.489 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.5 t -78.86 -11.48 59.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.578 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.607 HD22 ' CE ' ' A' ' 36' ' ' MET . 6.4 tt -88.0 -53.43 4.74 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.075 0.464 . . . . 0.0 110.552 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.457 ' N ' HD23 ' A' ' 39' ' ' LEU . . . 179.72 37.21 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.624 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.587 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 tp-100 -134.83 -179.8 5.83 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.338 0.589 . . . . 0.0 111.279 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -159.75 56.41 0.86 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.792 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.7 Cg_endo -80.57 -174.29 2.19 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.546 2.164 . . . . 0.0 112.291 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.602 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -117.32 152.64 34.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.873 0.368 . . . . 0.0 110.124 179.23 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.49 -49.99 73.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.26 -32.59 74.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.638 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.577 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -66.31 -54.52 23.75 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.596 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.715 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -61.22 -48.36 81.87 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.929 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.706 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -54.6 -49.97 69.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 110.952 179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.27 -47.23 69.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.682 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -74.68 -30.61 61.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.831 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.567 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -54.68 -36.03 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.588 -178.968 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -45.23 -28.64 0.82 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.213 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -79.6 -38.21 34.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.929 0.395 . . . . 0.0 110.778 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.076 HG11 HG21 ' B' ' 6' ' ' ILE . 3.7 m -81.07 -10.98 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.14 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.558 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.6 t0 -103.59 155.87 18.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.72 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.58 -29.17 26.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.065 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -116.46 -9.72 11.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.397 0.617 . . . . 0.0 110.452 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.68 63.48 5.17 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.498 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -112.47 18.41 18.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.842 0.353 . . . . 0.0 110.201 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.39 19.98 55.68 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.424 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.3 p -146.71 176.49 9.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.729 HD12 HD11 ' A' ' 32' ' ' LEU . 12.4 mt -116.3 136.46 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.544 0.212 . . . . 0.0 110.959 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.5 m-20 -88.24 -178.02 5.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.25 0.548 . . . . 0.0 111.938 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.82 -55.91 12.83 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.659 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -65.67 -34.54 40.94 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.25 1.967 . . . . 0.0 111.241 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.44 -52.47 61.31 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.26 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.718 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.19 -56.99 14.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.789 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.703 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.89 -47.09 83.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.795 -179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.465 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 53.5 m -59.69 -30.46 68.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.074 0.464 . . . . 0.0 110.129 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.912 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.2 tpp -62.71 -61.84 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.083 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.2 mtt -70.1 -41.39 74.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.001 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.542 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -63.63 -18.51 64.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.367 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.43 147.62 13.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.806 0.336 . . . . 0.0 111.096 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.18 -14.33 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.22 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.7 mtp -84.71 -30.6 24.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.762 0.315 . . . . 0.0 110.971 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -85.26 122.48 29.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.04 -169.13 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 62.06 -167.15 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.414 ' H ' HG22 ' A' ' 79' ' ' THR . 0.5 OUTLIER 64.37 37.68 8.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.53 -38.23 49.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -80.77 -30.65 36.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.0 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -56.82 -51.44 68.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.221 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.691 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.68 -29.24 25.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.477 -179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.782 HG22 ' HE1' ' A' ' 138' ' ' TYR . 19.8 mt -66.7 -51.45 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.919 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -50.08 16.64 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.075 0.464 . . . . 0.0 110.55 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 91' ' ' VAL . 19.9 tt0 -53.91 -29.19 40.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.252 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -70.83 -38.25 73.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 10.8 t80 -67.35 -54.15 23.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.966 0.412 . . . . 0.0 110.545 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -54.08 -30.67 49.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.791 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 87' ' ' GLU . 98.9 t -88.7 -22.88 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.216 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.526 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -55.3 -38.38 68.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.176 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -100.64 146.87 26.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.503 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -69.72 -36.39 75.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.373 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.27 -9.79 13.87 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.43 30.02 34.75 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.23 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -67.43 -13.62 62.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 117.102 0.451 . . . . 0.0 110.787 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.472 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.22 -13.39 55.29 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.914 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.479 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 25.1 m-85 -127.16 145.95 50.57 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.988 0.423 . . . . 0.0 111.425 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.747 HD12 HD22 ' A' ' 105' ' ' LEU . 1.1 pp -121.13 109.94 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.729 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.1 p -83.55 176.97 8.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.53 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.564 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.7 -30.91 71.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 110.396 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.25 -57.66 11.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.322 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.43 -45.73 30.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.228 -179.156 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.747 HD22 HD12 ' A' ' 100' ' ' ILE . 17.6 tp -53.13 -33.24 51.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.818 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.1 ttt-85 -68.79 -49.15 60.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -59.14 -43.51 92.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.194 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.6 t -72.96 -39.02 57.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.51 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.51 ' HG2' HD12 ' A' ' 105' ' ' LEU . 28.6 mmt -73.97 -54.27 8.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.511 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.663 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.4 m -56.99 -46.9 81.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.088 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -60.0 -26.67 66.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.841 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.878 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.8 mp -124.21 36.19 4.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.36 -116.46 0.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.688 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' HD23 ' A' ' 116' ' ' LEU . 23.1 pt-20 -131.31 172.51 12.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.805 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.663 ' HA ' HG23 ' A' ' 110' ' ' THR . 12.7 tptm -75.05 98.58 3.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.163 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.96 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.88 113.13 24.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.461 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.935 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -71.83 175.28 5.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.32 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 117' ' ' THR . 50.5 m-20 -48.06 -36.04 12.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 110.759 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -77.41 -34.35 54.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -73.64 -33.04 64.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.024 0.44 . . . . 0.0 110.074 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.96 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.96 -48.56 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.829 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.25 -52.87 63.83 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.844 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.08 -28.72 62.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.82 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.739 ' HG3' HD21 ' A' ' 105' ' ' LEU . 5.8 tpt -76.23 -38.47 56.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 110.113 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.511 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -67.15 -44.95 87.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.559 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -61.75 -40.55 95.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.97 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 124' ' ' MET . 8.6 pt-20 -81.0 -37.39 29.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.787 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.482 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.29 -35.84 81.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.338 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.727 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.3 t0 -102.06 146.34 28.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.937 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.554 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.5 -40.61 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.093 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.554 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.98 -11.07 60.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.713 -179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.85 32.77 1.0 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.3 p-10 -95.99 -12.53 24.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.351 -0.924 . . . . 0.0 112.52 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.16 10.23 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.817 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.479 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.54 147.19 30.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 129' ' ' ASP . 33.1 t -130.71 107.32 13.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.232 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.05 175.0 10.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.339 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.782 ' HE1' HG22 ' A' ' 85' ' ' ILE . 1.1 t80 -45.95 -67.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.653 0.74 . . . . 0.0 111.84 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.7 mt-10 -66.02 -24.54 66.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.644 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.547 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.73 -48.86 74.47 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.393 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 10.7 p90 -79.32 -31.21 43.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.399 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 138' ' ' TYR . 75.7 t -52.91 -44.85 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.44 -35.45 79.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.137 0.494 . . . . 0.0 109.826 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.47 -43.35 60.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.81 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.406 ' CG ' HG21 ' B' ' 22' ' ' VAL . 24.5 ttp -52.77 -45.15 66.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.012 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 t -77.79 -31.17 51.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.962 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.81 147.3 38.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.096 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.916 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.847 0.356 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.732 ' O ' HG13 ' B' ' 6' ' ' ILE . 11.6 mmm180 -52.5 -50.73 62.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.232 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.759 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.79 -53.43 32.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.281 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.69 -36.11 71.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.149 0.5 . . . . 0.0 110.007 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.916 HG23 ' O ' ' B' ' 1' ' ' ALA . 45.1 t -62.84 -41.43 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.997 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 1.076 HG21 HG11 ' A' ' 55' ' ' VAL . 3.2 mt -63.16 -55.42 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.098 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' B' ' 3' ' ' LYS . 24.1 mmm-85 -50.16 -40.43 46.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.031 0.444 . . . . 0.0 110.247 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.88 -44.95 68.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.667 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.829 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.6 OUTLIER -56.34 -55.07 37.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.05 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.912 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.7 mt -51.21 -57.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.751 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.511 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.7 tpt180 -61.32 -51.34 69.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.252 0.548 . . . . 0.0 111.028 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.559 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.33 -39.23 63.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.701 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.733 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.47 -48.94 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.225 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.409 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.77 -37.64 95.0 Favored Glycine 0 CA--C 1.497 -1.041 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.521 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.895 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -65.06 -61.68 2.0 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.741 -0.73 . . . . 0.0 110.555 -179.246 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.75 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.6 -27.46 67.76 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.484 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -68.25 -47.53 67.5 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.978 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.5 ppt_? -63.8 -43.61 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.105 0.479 . . . . 0.0 109.754 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.895 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.8 m -61.86 -35.48 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.529 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.676 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -75.97 -43.1 46.17 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.785 -179.599 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.577 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 21.8 p -61.01 -26.63 67.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.495 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.463 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.4 m -90.42 -48.43 14.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.163 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.894 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.2 pp -63.09 -32.6 74.02 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.199 0.524 . . . . 0.0 110.535 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.894 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.176 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.788 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.817 0.341 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.71 ' OD2' ' HB1' ' A' ' 73' ' ' ALA . 2.2 m-20 -72.86 -170.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -121.15 87.73 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -98.48 164.79 12.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.544 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.492 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.6 p -97.98 162.84 13.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.494 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -47.35 -51.42 19.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.875 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -64.27 -27.72 69.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.991 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.9 mm-40 -72.68 -51.36 19.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.707 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.725 HG22 HD21 ' A' ' 69' ' ' LEU . 36.7 pt -73.07 -28.74 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.895 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.34 -27.26 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 5.6 mm-40 -74.99 -28.39 60.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.227 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.63 -58.33 3.24 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.293 0.568 . . . . 0.0 111.002 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.875 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 13.1 ptmt -54.41 -23.0 14.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.216 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.21 -28.28 57.15 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.102 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.99 -39.81 63.4 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.07 177.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.26 -52.04 67.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.806 0.812 . . . . 0.0 109.501 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -23.9 58.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.183 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.897 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.1 -25.09 34.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.273 0.558 . . . . 0.0 110.215 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.816 ' HB3' HD11 ' A' ' 27' ' ' ILE . 2.4 t80 -94.42 -0.27 54.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.47 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.7 t70 -103.87 144.88 30.92 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.959 0.885 . . . . 0.0 111.051 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.513 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.5 mmtt -61.13 -53.43 57.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.644 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -83.91 -5.94 59.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.814 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.13 45.31 57.24 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.451 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.9 p30 -90.47 17.23 7.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.832 0.348 . . . . 0.0 110.68 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.37 7.46 87.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.386 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 69.0 p -150.38 148.23 28.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.816 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.7 mt -101.57 140.68 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.808 0.337 . . . . 0.0 111.829 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.703 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.5 t -85.52 179.37 7.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.117 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.781 HG21 ' CG ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -70.43 -45.78 65.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.935 -179.201 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.629 ' HG3' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -54.36 -38.93 66.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.335 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.871 ' O ' HG23 ' A' ' 35' ' ' VAL . 3.4 mm-40 -71.64 -53.75 12.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.395 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.65 HD23 ' CD ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -56.11 -52.52 64.02 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.733 0.778 . . . . 0.0 109.51 178.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.82 -45.5 96.08 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.371 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 m -62.87 -35.88 81.46 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.917 0.389 . . . . 0.0 110.156 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 31' ' ' GLU . 60.1 t -61.76 -56.87 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.652 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.439 ' SD ' HG13 ' B' ' 5' ' ' VAL . 0.2 OUTLIER -71.6 -40.78 69.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.306 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -41.2 99.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 0.0 110.656 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 t -78.88 -10.08 59.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.629 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.6 tt -88.76 -53.88 4.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.585 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.452 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.04 34.59 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.819 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -135.86 -179.94 5.96 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.362 0.601 . . . . 0.0 111.306 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -159.75 56.5 0.87 Allowed Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.754 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 96.0 Cg_endo -80.44 -173.58 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.527 2.151 . . . . 0.0 112.273 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.615 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.39 152.54 31.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.846 0.355 . . . . 0.0 110.166 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -57.68 -49.21 77.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.12 -31.17 71.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.742 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.569 ' H ' HG22 ' A' ' 44' ' ' THR . 1.3 mt-10 -67.16 -54.39 21.7 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.575 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.615 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -63.45 -37.84 88.84 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.209 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.781 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.42 -49.9 73.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.842 0.353 . . . . 0.0 110.588 179.583 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.25 -46.25 76.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.496 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.412 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.4 mmt -74.74 -30.54 61.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.704 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.559 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -53.5 -38.0 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.498 -179.079 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -44.98 -28.59 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.373 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.461 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.83 -39.58 50.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.944 0.402 . . . . 0.0 110.767 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.93 HG11 HG21 ' B' ' 6' ' ' ILE . 5.0 m -80.57 -11.96 12.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.099 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.4 t0 -103.69 155.15 18.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.74 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.502 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.63 -28.86 26.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.152 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -116.46 -9.68 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.44 0.638 . . . . 0.0 110.468 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.5 63.89 4.82 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.519 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -112.71 18.38 18.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.855 0.359 . . . . 0.0 110.133 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.88 19.93 56.79 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.467 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.703 HG22 ' HA ' ' A' ' 28' ' ' THR . 6.1 p -146.1 176.12 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.487 HG12 HG23 ' A' ' 55' ' ' VAL . 95.9 mt -115.21 136.38 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.551 0.215 . . . . 0.0 110.725 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.4 m-20 -87.05 -178.17 6.2 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.16 0.505 . . . . 0.0 111.828 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.521 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.97 -55.46 13.41 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.831 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.2 Cg_endo -65.72 -35.37 37.17 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.234 1.956 . . . . 0.0 111.348 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -63.84 -52.31 60.69 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.305 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.729 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.9 -56.78 17.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.834 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.725 HD21 HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -53.56 -49.51 67.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.83 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.788 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 80.6 m -58.57 -32.42 68.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.226 0.536 . . . . 0.0 109.685 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 1.004 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.7 tpp -67.19 -61.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.899 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.4 mtm -64.2 -29.12 70.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.71 ' HB1' ' OD2' ' A' ' 2' ' ' ASP . . . -54.01 -24.11 15.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -28.08 52.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.008 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -58.99 -21.86 59.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.033 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.69 -23.06 26.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.325 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 45.14 1.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 111.193 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 t0 53.58 -165.55 0.08 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.22 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 69.15 155.67 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.022 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.18 30.71 13.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.096 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -77.55 -51.81 10.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.817 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -80.79 -29.15 36.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.006 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -52.24 -30.55 28.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.311 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.603 ' O ' HG11 ' B' ' 19' ' ' VAL . 1.1 mt-10 -70.54 -29.58 66.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.745 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.715 HG22 ' HE1' ' A' ' 138' ' ' TYR . 7.8 mt -79.45 -51.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.27 -51.82 12.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.659 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.9 tt0 -53.72 -25.53 18.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.884 0.373 . . . . 0.0 110.733 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.694 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.67 -37.13 50.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.204 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.592 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.2 t80 -68.04 -52.12 39.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.034 0.445 . . . . 0.0 110.087 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -54.77 -32.05 59.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.803 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 87' ' ' GLU . 54.3 t -88.63 -22.8 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.55 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.468 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.93 -32.96 55.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.114 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -102.34 148.05 25.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.496 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -69.58 -37.21 76.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.351 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.16 -9.72 13.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.83 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.15 29.64 33.32 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.228 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -67.4 -13.93 62.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.079 0.439 . . . . 0.0 110.75 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.2 -12.23 55.3 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.992 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.1 m-85 -127.25 146.99 50.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.906 0.384 . . . . 0.0 111.378 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.864 HD13 HD13 ' A' ' 105' ' ' LEU . 1.1 pt -121.11 109.98 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.816 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.2 m -83.99 177.07 8.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.466 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.25 -30.09 71.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.097 0.475 . . . . 0.0 110.528 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.35 -57.11 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.205 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.754 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.32 -46.83 25.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.377 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.864 HD13 HD13 ' A' ' 100' ' ' ILE . 30.2 tp -53.19 -31.23 41.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.938 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.845 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.6 ttt-85 -72.54 -49.15 34.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -59.22 -42.8 91.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.144 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.2 t -72.95 -41.03 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.565 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.454 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 30.3 mmt -72.61 -54.17 9.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.536 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.743 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.4 m -57.12 -48.9 77.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.225 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -58.04 -29.9 65.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.796 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.897 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -121.58 37.13 4.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.822 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.35 -116.43 0.39 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.744 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.418 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.8 pt-20 -131.02 168.72 16.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 110.835 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.743 ' HA ' HG23 ' A' ' 110' ' ' THR . 15.6 ttmt -73.71 100.11 3.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.971 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.36 114.13 26.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.929 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -71.86 175.25 5.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.364 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 117' ' ' THR . 1.1 m-20 -48.04 -35.98 12.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 110.779 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.36 -34.98 55.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -72.87 -33.03 65.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.973 0.415 . . . . 0.0 110.091 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.971 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -75.06 -48.76 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.817 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -58.81 -52.77 64.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.788 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -28.74 63.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.791 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.822 ' HG3' HD21 ' A' ' 105' ' ' LEU . 11.7 tpt -76.13 -37.77 57.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.135 0.493 . . . . 0.0 110.282 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.509 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.23 -39.55 81.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.407 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -65.2 -41.41 94.56 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.489 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 124' ' ' MET . 6.2 pt-20 -82.62 -32.84 28.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 110.483 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.87 78.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.484 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.718 ' HB2' HG22 ' A' ' 136' ' ' VAL . 20.1 t0 -105.83 148.6 27.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.974 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.569 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.84 -40.8 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.024 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.569 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.94 -10.93 59.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.691 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.0 32.83 1.08 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.445 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.4 p-10 -96.36 -12.79 23.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.291 -0.954 . . . . 0.0 112.451 -176.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.21 10.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.808 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.6 146.95 30.62 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.043 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' A' ' 129' ' ' ASP . 33.0 t -130.75 107.5 14.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.202 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 7.1 t-20 -80.35 174.16 11.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.327 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.715 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.88 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.471 0.653 . . . . 0.0 111.433 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.2 mt-10 -59.95 -32.58 70.94 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.045 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.509 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.13 -43.44 78.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.258 0.551 . . . . 0.0 109.65 179.206 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.806 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.0 OUTLIER -78.69 -31.76 46.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.213 178.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 138' ' ' TYR . 62.1 t -54.95 -51.83 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.683 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -56.87 -46.88 81.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.2 tpp -68.72 -31.09 69.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.8 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.427 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 11.3 ttp -61.61 -46.19 90.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.2 t -77.06 -30.96 55.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.59 154.24 18.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.956 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.825 0.345 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.736 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.2 mmm180 -52.24 -51.41 58.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.724 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.73 -53.45 31.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.632 0.253 . . . . 0.0 111.391 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.81 -36.61 70.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.136 0.493 . . . . 0.0 110.09 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.956 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.7 t -64.27 -34.3 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.32 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.93 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -71.56 -49.79 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.235 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' B' ' 3' ' ' LYS . 21.9 mmm-85 -58.01 -33.14 68.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.119 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.07 -49.19 47.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.187 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.789 ' O ' HD12 ' B' ' 13' ' ' ILE . 1.6 ptpt -61.38 -50.52 72.52 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.657 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 1.004 HD13 ' HG2' ' A' ' 71' ' ' MET . 10.6 mt -51.29 -57.37 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.091 0.472 . . . . 0.0 110.766 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.98 -50.79 72.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.93 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.11 -39.97 63.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.892 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.789 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.6 mt -54.51 -52.11 43.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.612 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.74 -36.27 93.08 Favored Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.21 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.931 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.96 -61.67 2.02 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.847 -0.676 . . . . 0.0 110.389 -178.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 16' ' ' MET . . . . . 0.664 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -62.43 -27.92 69.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.652 177.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.27 -51.55 60.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.209 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.761 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.45 -43.56 97.02 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.571 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.931 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.9 m -66.3 -32.36 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.599 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.667 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 0.6 OUTLIER -71.73 -50.08 33.44 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.006 -179.115 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.448 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 54.7 p -58.49 -36.22 73.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.058 0.456 . . . . 0.0 110.765 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.486 HG22 ' C ' ' B' ' 19' ' ' VAL . 28.4 m -72.54 -45.01 60.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.071 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.806 HD23 ' CE1' ' A' ' 141' ' ' PHE . 3.0 pp -65.29 -27.53 68.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.022 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 13.0 ptt180 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.921 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.474 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.833 0.349 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.534 ' HB2' HD21 ' A' ' 4' ' ' LEU . 2.1 m-20 -100.95 -170.21 1.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -117.23 83.93 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.633 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.6 164.73 12.3 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.58 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.517 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.6 p -98.6 162.8 12.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.465 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -47.43 -51.33 20.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.879 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -64.42 -27.66 69.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.157 0.503 . . . . 0.0 110.065 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.517 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.2 OUTLIER -72.51 -51.43 20.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.706 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.701 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.9 pt -73.08 -28.85 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.849 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.37 -27.45 9.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.535 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 11.0 mt-10 -75.23 -28.53 59.95 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.207 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.36 -58.41 3.22 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.218 0.532 . . . . 0.0 111.004 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.875 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.5 pttt -54.45 -23.03 14.34 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.273 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.45 -27.85 56.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.27 -39.78 62.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.072 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.64 -51.89 67.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.845 0.831 . . . . 0.0 109.458 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 p -74.46 -24.45 59.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.101 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.845 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.06 -23.5 35.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.261 0.553 . . . . 0.0 110.28 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.822 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.9 t80 -95.4 -0.76 52.17 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.554 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.7 t70 -103.48 142.64 33.91 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.971 0.891 . . . . 0.0 111.039 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 3.7 mmtt -59.11 -53.38 59.04 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.604 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.93 -5.42 59.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.77 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.51 47.69 44.03 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.303 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -92.06 18.86 7.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.867 0.365 . . . . 0.0 110.685 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.36 5.11 89.06 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.577 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.8 p -150.34 148.86 29.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.755 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.18 140.51 19.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.847 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.575 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.17 176.46 8.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.004 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.819 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -70.52 -37.5 74.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.145 0.497 . . . . 0.0 110.332 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.536 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.23 -41.12 92.46 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.15 178.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.914 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -69.4 -53.41 19.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.26 -179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.828 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -58.24 -54.69 44.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.724 0.773 . . . . 0.0 109.326 178.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.49 -45.83 92.63 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.456 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.7 m -62.39 -30.9 71.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.845 0.322 . . . . 0.0 110.495 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 31' ' ' GLU . 72.5 t -68.2 -57.26 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.87 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.457 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.95 -35.63 69.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.389 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -68.13 -42.74 79.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.848 0.356 . . . . 0.0 110.667 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 t -78.94 -8.14 58.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.806 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.8 tt -90.97 -54.82 3.8 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.468 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -175.88 34.94 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.937 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp-100 -137.56 -178.95 5.46 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.381 0.61 . . . . 0.0 111.163 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -159.64 56.46 0.88 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.927 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.4 Cg_endo -80.37 -175.7 2.83 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.56 2.173 . . . . 0.0 112.101 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.612 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.94 152.5 32.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.956 0.408 . . . . 0.0 110.18 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.22 -49.58 75.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.58 75.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.713 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.52 -54.33 33.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.673 -179.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.819 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.85 -34.77 78.9 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.379 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.69 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.39 -42.7 95.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.909 0.385 . . . . 0.0 110.228 179.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.76 -45.52 93.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.23 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -30.69 61.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.412 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.555 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.69 -38.29 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.524 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -44.91 -28.68 0.69 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.351 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.6 -38.78 47.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.891 0.376 . . . . 0.0 110.803 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.939 HG11 HG21 ' B' ' 6' ' ' ILE . 4.6 m -81.07 -11.39 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.18 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.549 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.9 t0 -103.73 155.68 18.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.754 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.485 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.57 -29.1 26.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -116.43 -9.66 11.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.416 0.627 . . . . 0.0 110.471 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.44 63.53 5.14 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.517 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -112.26 18.13 18.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.846 0.355 . . . . 0.0 110.193 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.67 19.91 55.31 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.453 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.1 p -147.16 176.41 9.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.768 HD12 HD11 ' A' ' 32' ' ' LEU . 13.8 mt -115.7 136.52 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.562 0.22 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.485 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.9 m-20 -87.28 -178.06 6.11 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.28 0.562 . . . . 0.0 111.931 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.514 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.03 -56.06 11.99 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.622 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.7 Cg_endo -65.65 -34.8 40.07 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.21 1.94 . . . . 0.0 111.166 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.91 -52.35 63.41 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.268 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.718 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.0 -56.63 19.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.867 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.701 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.51 -46.12 84.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.696 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 56.5 m -60.06 -31.15 69.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.041 0.448 . . . . 0.0 109.966 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.929 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.8 tpp -64.54 -61.8 1.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.908 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.7 mtt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.803 179.957 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.735 0.303 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.85 -54.48 37.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.713 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.76 -29.43 27.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.375 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.723 HG22 ' HE1' ' A' ' 138' ' ' TYR . 17.9 mt -64.76 -51.23 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.772 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -75.58 -50.57 15.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.043 0.449 . . . . 0.0 110.685 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 91' ' ' VAL . 7.1 mt-10 -53.79 -30.84 46.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.682 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -71.08 -38.55 72.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.781 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 24.2 t80 -67.03 -56.02 11.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.579 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.62 -30.65 43.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.866 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 87' ' ' GLU . 66.7 t -88.4 -22.92 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.211 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.462 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.18 -32.05 61.87 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.046 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -102.16 148.84 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.438 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -69.61 -37.71 76.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.332 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -112.27 -9.78 13.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.66 30.55 32.37 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.119 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.41 -13.73 62.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.96 0.38 . . . . 0.0 110.757 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.24 -13.46 55.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.857 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.7 m-85 -127.14 145.41 50.76 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.967 0.413 . . . . 0.0 111.284 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.949 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.1 109.97 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.885 179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 p -83.39 177.38 8.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.311 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.548 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.18 -28.97 70.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.083 0.468 . . . . 0.0 110.405 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.46 -57.67 9.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.426 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.41 -42.96 42.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.273 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.949 HD13 HD13 ' A' ' 100' ' ' ILE . 56.0 tp -56.9 -31.14 64.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.08 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.794 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.4 ttt180 -72.54 -49.27 33.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.937 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -60.85 -36.5 79.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 110.539 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 104' ' ' GLU . 54.5 t -72.82 -44.14 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.301 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 24.8 mmt -73.99 -54.05 8.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.727 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.648 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.3 m -55.59 -45.55 77.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.367 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.473 ' C ' HD12 ' A' ' 112' ' ' LEU . 7.8 m-20 -60.27 -29.85 69.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.792 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.845 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.9 mp -123.49 38.66 4.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.647 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.95 -116.81 0.4 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.781 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.409 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.8 pt-20 -132.2 170.77 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 110.864 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.648 ' HA ' HG23 ' A' ' 110' ' ' THR . 9.5 ttmm -74.97 99.7 3.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.257 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.953 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.7 114.39 26.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.384 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.934 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.7 175.34 5.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.429 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.411 ' H ' HG22 ' A' ' 117' ' ' THR . 79.3 m-20 -48.09 -35.93 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.755 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -77.4 -35.09 54.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -72.62 -33.67 66.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.977 0.417 . . . . 0.0 110.106 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.953 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.69 -48.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.899 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.21 -52.87 63.82 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.843 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -56.97 -28.85 62.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.857 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.841 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.6 tpt -76.35 -38.64 55.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.146 0.498 . . . . 0.0 110.169 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.491 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -66.87 -48.42 79.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.563 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -60.25 -40.27 89.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.946 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 124' ' ' MET . 12.7 pt-20 -80.86 -37.1 30.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 0.0 110.598 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.451 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.93 -36.18 81.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.764 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.3 t0 -101.37 147.58 26.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.013 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.56 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.6 pt -84.84 -40.67 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.047 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.56 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.95 -10.98 60.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.65 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.68 1.09 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.9 p-10 -96.33 -12.84 23.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.317 -0.941 . . . . 0.0 112.379 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.93 20.1 10.21 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.754 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.9 146.54 30.19 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.899 0.38 . . . . 0.0 110.06 179.211 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.764 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.1 t -130.64 107.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.246 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.552 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.21 174.84 11.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.304 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.723 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.96 -67.01 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.523 0.677 . . . . 0.0 111.464 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.88 -34.15 72.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.839 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.531 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.01 -40.63 73.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.83 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.2 OUTLIER -78.83 -32.88 46.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.064 178.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 64.0 t -55.35 -46.93 78.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.626 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -57.81 -45.32 86.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.1 -33.12 65.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.4 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 18.0 ttp . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.953 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.736 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.3 mmm180 -52.3 -51.25 59.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.729 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.66 -53.17 33.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.638 0.256 . . . . 0.0 111.289 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -57.24 -37.52 72.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.007 0.432 . . . . 0.0 110.347 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.953 HG23 ' O ' ' B' ' 1' ' ' ALA . 15.6 t -63.27 -33.68 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.348 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.939 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.58 -55.46 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.995 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.3 mmm-85 -50.36 -37.79 38.92 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.215 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -44.44 66.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.828 ' HD2' HD23 ' A' ' 32' ' ' LEU . 9.6 mtmt -57.9 -55.01 40.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.929 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.8 mt -51.27 -57.28 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.906 0.384 . . . . 0.0 111.228 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.52 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -58.36 -51.18 70.9 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.424 0.631 . . . . 0.0 110.656 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.5 -39.38 64.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.81 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' B' ' 17' ' ' ALA . 3.3 mt -54.28 -48.31 67.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.233 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.27 -38.22 95.58 Favored Glycine 0 CA--C 1.498 -1.022 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.495 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.895 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.76 -61.8 1.96 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.743 -0.729 . . . . 0.0 110.504 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.737 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -60.32 -27.59 67.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.32 -48.64 66.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.038 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 0.7 OUTLIER -63.78 -43.74 95.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.895 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -62.09 -34.65 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.472 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.752 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -75.37 -44.11 46.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.639 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.557 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 18.8 p -60.84 -25.8 66.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.474 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 23' ' ' LEU . 26.8 m -90.07 -46.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.991 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.95 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.12 -33.34 75.26 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.18 0.514 . . . . 0.0 110.444 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.95 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.121 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.5 ' HB2' HD21 ' A' ' 4' ' ' LEU . 1.4 m-20 -96.98 -169.95 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -119.24 84.49 2.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.93 164.82 12.21 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.51 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.494 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.58 162.08 13.47 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.46 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.68 -51.71 20.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.789 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.51 -27.68 69.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.035 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.494 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.94 -51.41 22.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.614 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.2 pt -73.06 -28.9 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.706 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.62 -27.31 10.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.3 mt-10 -75.28 -28.56 59.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.269 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.28 -58.44 3.21 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.207 0.527 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.881 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.9 pttt -54.77 -22.93 15.73 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.203 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.538 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.28 -27.74 56.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.63 -39.77 61.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.074 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.881 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.04 -51.83 68.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.816 0.817 . . . . 0.0 109.463 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -25.04 59.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.073 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.899 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.02 -25.75 34.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.148 0.499 . . . . 0.0 110.451 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.795 ' HB3' HD11 ' A' ' 27' ' ' ILE . 5.6 t80 -87.75 -15.08 37.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.448 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR . 32.0 t70 -90.28 146.24 24.37 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.977 0.894 . . . . 0.0 111.23 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.508 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -63.33 -53.41 53.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -81.83 -6.8 59.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.846 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.56 45.27 59.68 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.402 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -90.42 17.75 6.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.822 0.344 . . . . 0.0 110.759 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.47 89.36 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 46.4 p -150.18 150.52 31.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.795 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.77 140.58 20.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.968 0.413 . . . . 0.0 111.952 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.6 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.34 176.34 8.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.974 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.815 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -70.42 -38.0 74.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.03 0.443 . . . . 0.0 110.251 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.543 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.75 -40.99 89.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.22 178.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.08 -53.47 20.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.234 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.802 HD11 ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -58.43 -54.85 42.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.718 0.77 . . . . 0.0 109.463 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.59 -45.85 92.74 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.508 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.2 m -62.2 -31.39 71.91 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.818 0.342 . . . . 0.0 110.581 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 31' ' ' GLU . 69.6 t -68.08 -57.25 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.441 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.91 -35.36 69.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.436 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -42.13 79.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.945 0.402 . . . . 0.0 110.645 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -79.02 -7.61 58.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.648 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.547 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -91.03 -54.43 3.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.042 0.448 . . . . 0.0 110.754 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.67 34.81 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.888 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.13 -178.97 5.44 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.368 0.604 . . . . 0.0 111.134 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -159.58 56.49 0.89 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.902 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.4 -176.76 3.36 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.502 2.134 . . . . 0.0 112.076 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.608 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -113.53 152.48 30.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.962 0.41 . . . . 0.0 110.199 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -57.51 -49.33 76.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.404 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.69 72.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.75 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -66.06 -54.33 27.18 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.559 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.815 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.92 -34.74 78.82 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.369 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.674 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.46 -42.6 95.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.873 0.368 . . . . 0.0 110.172 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -61.76 -45.38 94.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.245 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -30.77 61.83 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.419 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.556 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -53.75 -38.32 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.511 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -44.98 -28.6 0.69 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.387 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.04 -38.85 51.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.914 0.388 . . . . 0.0 110.758 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.816 HG11 HG21 ' B' ' 6' ' ' ILE . 5.1 m -81.38 -11.89 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.227 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.54 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.8 t0 -103.57 155.35 18.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.748 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.466 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.61 -28.8 26.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.124 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -116.42 -9.68 11.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.452 0.644 . . . . 0.0 110.5 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.35 63.48 5.2 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.488 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -112.06 18.1 19.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.81 0.338 . . . . 0.0 110.225 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.41 19.86 55.91 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.483 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -147.09 176.32 10.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.802 ' CD1' HD11 ' A' ' 32' ' ' LEU . 2.1 mp -115.54 136.55 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 120.6 0.238 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.0 m-20 -86.11 -178.6 6.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.272 0.558 . . . . 0.0 111.885 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -67.65 -56.32 12.35 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.557 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.0 Cg_endo -65.93 -35.4 35.23 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.3 2.0 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -61.85 -52.45 64.1 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.192 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.09 -56.42 21.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.758 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.16 -45.47 83.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.733 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 64.0 m -60.58 -31.57 70.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.069 0.462 . . . . 0.0 110.049 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.919 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.5 tpp -63.49 -61.76 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.01 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.432 ' HG2' HG22 ' B' ' 10' ' ' ILE . 6.9 mtm . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.716 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.799 0.333 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -50.45 -30.59 12.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.232 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.719 ' O ' HG11 ' B' ' 19' ' ' VAL . 2.0 mt-10 -68.88 -30.54 69.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.481 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.691 HG22 ' HE1' ' A' ' 138' ' ' TYR . 8.1 mt -79.49 -51.1 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -74.65 -51.54 14.12 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.618 ' O ' HG23 ' A' ' 91' ' ' VAL . 26.6 tt0 -53.52 -25.32 16.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.929 0.395 . . . . 0.0 110.755 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.749 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.67 -36.43 43.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.248 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 28.1 t80 -67.94 -51.33 48.84 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.053 0.454 . . . . 0.0 110.142 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -32.62 58.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.773 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 87' ' ' GLU . 47.1 t -88.7 -22.73 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.616 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -52.93 -34.22 54.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.231 -179.388 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -99.36 147.87 24.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.487 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -67.48 -38.27 84.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.374 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.25 -9.74 13.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.796 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.03 28.07 32.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.327 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -67.5 -13.98 62.52 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.165 0.482 . . . . 0.0 110.757 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.85 -10.73 55.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.146 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.8 m-85 -127.12 145.28 50.8 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.014 0.435 . . . . 0.0 111.458 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.036 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.17 110.03 26.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.699 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -82.97 176.89 8.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.602 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.11 -30.06 71.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.077 0.465 . . . . 0.0 110.487 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -57.76 11.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.286 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.791 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.5 -45.81 29.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.093 -179.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.036 HD13 HD13 ' A' ' 100' ' ' ILE . 38.0 tp -53.0 -31.15 39.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.844 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.6 ttt-85 -73.36 -49.09 29.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.952 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -59.06 -42.04 89.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.207 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.0 t -72.99 -40.01 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.598 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.456 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 27.7 mmt -73.97 -54.2 8.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.521 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.717 HG23 ' HA ' ' A' ' 115' ' ' LYS . 7.5 m -56.92 -47.75 79.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.241 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.698 ' C ' HD12 ' A' ' 112' ' ' LEU . 99.8 m-20 -59.67 -28.42 67.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.899 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.5 mp -123.28 37.09 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.99 -113.18 0.29 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.722 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.44 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.6 OUTLIER -134.58 167.22 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 0.0 110.849 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.717 ' HA ' HG23 ' A' ' 110' ' ' THR . 3.8 tppp? -72.55 99.88 2.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.237 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.971 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.05 114.42 26.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.435 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.923 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.85 175.39 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.381 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.407 ' H ' HG22 ' A' ' 117' ' ' THR . 1.8 m-20 -48.03 -36.0 12.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.782 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -77.34 -35.01 55.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.761 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -72.82 -33.26 66.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.993 0.425 . . . . 0.0 110.178 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.971 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.88 -47.92 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.898 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.54 -52.81 63.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.788 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -57.44 -28.72 63.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.829 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.805 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.5 tpt -76.25 -38.06 56.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.137 0.494 . . . . 0.0 110.108 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.489 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.53 -43.33 80.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.476 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -64.98 -39.18 93.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.786 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.42 -36.28 29.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.945 0.402 . . . . 0.0 110.449 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.452 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -67.88 -37.55 81.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.544 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.732 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.2 t0 -100.35 146.35 27.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.04 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.556 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.72 -40.6 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.077 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.556 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.98 -10.99 60.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.701 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.81 32.93 1.01 Allowed Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -176.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.28 -12.63 24.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.311 -0.944 . . . . 0.0 112.46 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.87 20.12 10.24 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.86 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.67 146.91 30.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 129' ' ' ASP . 38.3 t -130.66 107.28 13.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.348 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.549 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -79.36 174.84 11.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.323 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.691 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.88 -67.36 0.29 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.518 0.675 . . . . 0.0 111.461 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -61.17 -30.38 70.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.884 -178.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.565 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.82 -44.43 77.88 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -31.79 46.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.208 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 138' ' ' TYR . 55.3 t -53.68 -47.79 61.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.487 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -57.82 -42.26 83.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.717 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.24 -37.93 66.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.967 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 6.4 ttp . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.978 -179.856 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.948 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.821 0.343 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.31 -51.15 60.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.723 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.59 -53.31 31.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.668 0.271 . . . . 0.0 111.295 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -57.07 -37.57 72.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.46 . . . . 0.0 110.332 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.948 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.7 t -63.38 -34.2 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.364 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.816 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.01 -54.7 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.988 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -51.08 -37.2 44.24 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.159 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -48.37 63.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.492 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.798 ' HD2' HD23 ' A' ' 32' ' ' LEU . 16.0 mtmt -55.51 -54.4 44.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.203 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.919 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.21 -57.46 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.545 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.506 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.93 -51.17 70.82 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.177 0.513 . . . . 0.0 110.96 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.3 -40.55 64.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.747 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.774 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.8 mt -54.64 -49.32 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.484 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.421 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.4 -36.99 94.12 Favored Glycine 0 CA--C 1.498 -1.011 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.934 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.895 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.47 -61.68 2.07 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.381 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.641 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -62.36 -27.54 69.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.668 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.9 -50.37 64.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.204 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.724 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -64.25 -43.63 94.29 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.895 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.0 m -64.25 -33.12 60.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.479 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.674 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.5 OUTLIER -74.55 -45.75 43.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.839 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.537 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.9 p -59.55 -26.11 65.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.483 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.426 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.2 m -90.47 -46.64 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.148 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.921 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.9 pp -63.18 -32.98 74.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.189 0.519 . . . . 0.0 110.511 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.921 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.051 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.594 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.853 0.359 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.456 ' HB2' HD21 ' A' ' 4' ' ' LEU . 1.6 m-20 -86.44 -169.78 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.811 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -120.96 84.36 2.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.96 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.641 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -97.63 164.74 12.29 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.485 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.514 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.14 162.71 13.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.481 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -47.46 -51.3 20.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.856 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -64.43 -27.65 69.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.04 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.514 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.52 -51.43 20.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.734 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.7 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.6 pt -73.2 -28.73 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.854 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.39 -27.38 9.86 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.541 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 2.7 mm-40 -75.18 -28.51 60.08 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.253 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.43 -58.5 3.17 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 121.253 0.549 . . . . 0.0 111.015 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -54.64 -22.84 14.81 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.205 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.3 -28.1 56.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.23 -39.87 62.8 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.11 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.94 -51.81 68.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.861 0.838 . . . . 0.0 109.487 178.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.426 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 4.4 p -74.51 -24.43 58.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.122 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.852 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.15 -23.35 35.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.202 0.525 . . . . 0.0 110.347 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.821 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.7 t80 -95.74 -1.02 50.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.608 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.2 t70 -103.12 144.27 31.52 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 122.036 0.922 . . . . 0.0 111.09 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.524 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 12.6 mmtt -60.55 -53.42 57.69 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.571 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.01 -4.65 59.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.876 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.46 45.55 45.93 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.391 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -90.43 17.57 7.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.836 0.35 . . . . 0.0 110.722 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.46 6.2 87.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.508 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.45 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 61.6 p -150.29 149.05 29.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.47 140.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.747 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.683 HG23 ' HG3' ' A' ' 30' ' ' LYS . 1.3 t -87.49 -179.74 6.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.122 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.803 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.9 p -70.42 -44.14 68.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 0.0 110.897 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.683 ' HG3' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -55.5 -40.23 71.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.327 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.915 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -69.63 -53.83 16.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.424 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.86 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.04 -55.15 38.59 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.781 0.801 . . . . 0.0 109.42 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.62 -45.99 92.62 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.594 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.3 m -62.1 -31.22 71.65 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.939 0.37 . . . . 0.0 110.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.5 t -68.02 -57.2 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.842 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.454 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 1.3 tpt -71.97 -35.87 69.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.428 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -42.44 80.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.76 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.0 t -78.93 -8.36 58.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.7 tt -90.54 -54.72 3.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.761 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.467 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.15 35.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.889 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp-100 -137.3 -178.91 5.42 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.362 0.601 . . . . 0.0 111.207 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -159.64 56.59 0.9 Allowed Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.891 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.9 Cg_endo -80.37 -177.11 3.56 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.501 2.134 . . . . 0.0 112.059 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -113.66 152.54 30.28 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 110.263 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.14 -49.52 75.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.442 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.1 -33.12 74.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.764 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 44' ' ' THR . 0.1 OUTLIER -64.94 -54.28 33.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.692 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.803 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.6 -35.82 81.94 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.429 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.745 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -63.49 -42.69 98.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.875 0.369 . . . . 0.0 110.238 179.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -61.83 -45.61 93.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.338 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -30.72 61.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.492 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.57 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.524 -179.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -45.0 -28.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.328 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.46 -38.78 48.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.92 0.391 . . . . 0.0 110.838 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.919 HG11 HG21 ' B' ' 6' ' ' ILE . 4.8 m -81.14 -11.48 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.157 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.547 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.9 t0 -103.61 155.51 18.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.727 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.59 -29.09 26.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.079 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -116.4 -9.74 11.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.392 0.615 . . . . 0.0 110.485 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.8 63.93 4.76 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.008 -0.997 . . . . 0.0 113.491 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 -112.66 18.31 18.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.88 0.371 . . . . 0.0 110.217 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.408 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 86.09 19.81 56.63 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.474 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 28' ' ' THR . 5.3 p -146.65 176.37 9.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 32' ' ' LEU . 35.5 mt -115.8 136.5 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.595 0.236 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.6 m-20 -86.94 -178.3 6.26 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.329 0.585 . . . . 0.0 111.935 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.96 -55.96 12.38 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.672 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.6 Cg_endo -65.62 -34.71 40.72 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.245 1.963 . . . . 0.0 111.197 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -52.45 62.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.97 -56.88 15.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.83 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.7 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.04 -46.56 82.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 68.9 m -60.67 -31.84 71.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.107 0.479 . . . . 0.0 110.041 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.936 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.3 tpp -62.34 -61.75 2.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.97 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.7 mtp . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.826 179.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.771 0.32 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -57.89 -52.2 66.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.986 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.73 -29.21 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.432 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.727 HG22 ' HE1' ' A' ' 138' ' ' TYR . 18.7 mt -65.89 -51.35 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.822 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -75.68 -50.43 15.42 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.774 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.679 ' O ' HG23 ' A' ' 91' ' ' VAL . 21.3 mt-10 -53.79 -31.92 50.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.644 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.555 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -69.84 -38.74 76.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.774 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.554 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.1 t80 -66.82 -55.85 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.967 0.413 . . . . 0.0 110.549 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -53.73 -30.54 44.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.876 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 87' ' ' GLU . 65.9 t -88.46 -22.85 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.214 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.36 -31.85 62.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.047 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -102.44 148.66 25.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.439 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -69.59 -37.67 77.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.385 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -112.28 -9.79 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.53 30.69 32.39 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.08 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.44 -13.46 62.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.992 0.396 . . . . 0.0 110.856 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.2 -13.66 55.32 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.853 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 24.2 m-85 -127.21 145.87 50.61 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.971 0.415 . . . . 0.0 111.268 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.962 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.06 109.97 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.853 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.1 m -83.53 177.28 8.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.393 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.551 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.16 -28.64 69.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.044 0.449 . . . . 0.0 110.427 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.1 -57.67 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.422 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.618 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.42 -42.38 44.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -179.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.962 HD13 HD13 ' A' ' 100' ' ' ILE . 52.9 tp -56.93 -31.24 64.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.788 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.0 ttt180 -72.57 -49.3 33.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -60.81 -36.15 78.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.012 0.434 . . . . 0.0 110.437 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 104' ' ' GLU . 60.3 t -72.94 -44.83 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.178 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 24.4 mmt -74.12 -54.06 8.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.556 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.663 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.6 m -55.57 -45.86 77.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.73 0.3 . . . . 0.0 111.267 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.541 ' C ' HD12 ' A' ' 112' ' ' LEU . 11.7 t-20 -60.04 -30.06 68.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.805 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.852 ' O ' HD11 ' A' ' 18' ' ' LEU . 7.0 mp -123.63 38.92 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.578 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.38 -116.1 0.38 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.798 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -133.13 169.53 16.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.889 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.663 ' HA ' HG23 ' A' ' 110' ' ' THR . 4.8 tppt? -74.22 100.07 3.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.95 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.5 114.91 26.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.322 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.929 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.67 175.08 5.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.417 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.413 ' H ' HG22 ' A' ' 117' ' ' THR . 0.7 OUTLIER -48.02 -36.01 12.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.809 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -77.32 -34.76 55.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.774 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -72.86 -34.18 66.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.056 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.95 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.2 -48.59 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.968 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -59.2 -52.83 63.99 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.874 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.56 -28.96 64.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.843 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.858 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.6 tpt -76.32 -37.72 57.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.129 0.49 . . . . 0.0 110.177 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.485 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.64 -42.86 83.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.455 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -65.1 -39.54 93.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.858 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -81.85 -35.44 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.56 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.453 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.3 -37.68 80.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.5 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.771 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.8 t0 -100.44 147.44 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.99 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.558 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.6 pt -84.84 -40.75 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.039 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.558 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.91 -10.95 59.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.709 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.07 32.67 1.09 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.438 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.4 p-10 -96.25 -12.87 23.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.264 -0.968 . . . . 0.0 112.462 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.19 10.17 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.822 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.98 146.37 30.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.962 0.41 . . . . 0.0 109.998 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.771 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.4 t -130.68 107.38 14.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.185 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.552 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.36 174.83 11.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.338 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.727 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.95 -67.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.494 0.664 . . . . 0.0 111.393 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -34.03 72.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.789 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.539 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.09 -40.53 73.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.827 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.79 -33.15 46.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.046 178.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 64.8 t -55.11 -46.92 77.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.661 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.8 -45.65 85.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.13 -32.87 65.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.406 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 16.6 ttp . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.954 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.873 0.368 . . . . 0.0 111.01 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.735 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.33 -51.28 59.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.727 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.63 -53.26 32.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.678 0.275 . . . . 0.0 111.257 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -57.22 -37.46 72.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.0 0.429 . . . . 0.0 110.346 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.954 HG23 ' O ' ' B' ' 1' ' ' ALA . 16.3 t -63.31 -33.72 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.403 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.919 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.7 -55.36 13.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.046 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.6 mmm-85 -50.34 -38.11 40.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.239 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.71 -44.7 66.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.409 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.86 ' HD2' HD23 ' A' ' 32' ' ' LEU . 8.5 mtmt -57.24 -55.19 38.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.98 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.936 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.12 -57.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.309 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -58.23 -51.16 70.91 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.379 0.609 . . . . 0.0 110.65 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.588 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.52 -39.56 64.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.822 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.607 ' O ' ' HB2' ' B' ' 17' ' ' ALA . 3.5 mt -54.31 -48.23 67.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.221 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.412 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.27 -38.37 95.79 Favored Glycine 0 CA--C 1.498 -1.002 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.517 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.901 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.81 -61.66 2.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.683 -0.759 . . . . 0.0 110.506 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.738 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.08 -27.76 67.26 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.14 -48.89 66.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.005 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.1 ppt_? -63.45 -43.6 96.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.13 0.49 . . . . 0.0 109.77 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.901 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.6 m -62.42 -34.83 66.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.476 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.76 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -74.98 -43.86 51.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.7 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.545 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 17.3 p -60.46 -25.68 66.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.511 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.421 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.7 m -90.83 -46.71 14.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.055 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.947 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.54 -33.01 74.07 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.171 0.51 . . . . 0.0 110.362 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.947 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.114 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.705 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.449 ' HB2' HD21 ' A' ' 4' ' ' LEU . 2.0 m-20 -72.98 -170.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -121.2 86.78 2.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.631 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -98.73 164.75 12.1 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.662 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.49 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.8 p -97.96 162.71 13.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.506 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -47.43 -51.47 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.878 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -64.27 -27.73 69.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.147 0.499 . . . . 0.0 109.985 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.4 mm-40 -72.51 -51.36 20.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.736 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.711 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.4 pt -73.22 -28.78 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.898 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.36 -27.32 9.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 13.2 mm-40 -75.17 -28.46 60.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.264 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.51 -58.48 3.18 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-O 121.275 0.56 . . . . 0.0 111.014 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.876 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.52 -22.96 14.49 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.209 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.531 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.27 -27.78 56.8 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.75 -39.68 61.68 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.051 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.876 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.09 -51.73 68.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 109.43 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.402 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 8.2 p -74.45 -24.91 59.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.083 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.911 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.0 -25.1 35.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.129 0.49 . . . . 0.0 110.438 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.805 ' HB3' HD11 ' A' ' 27' ' ' ILE . 5.1 t80 -89.38 -14.53 35.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.498 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.1 t70 -90.61 145.84 24.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.963 0.887 . . . . 0.0 111.24 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.8 mmtt -63.76 -53.43 51.17 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.575 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.44 -7.07 59.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.772 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.52 45.91 58.94 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.394 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -90.9 18.13 6.99 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.894 0.378 . . . . 0.0 110.732 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.37 5.01 89.14 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.542 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.9 p -150.21 151.92 33.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.805 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -102.67 140.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.977 0.418 . . . . 0.0 111.772 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.546 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.11 176.42 8.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.006 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.819 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -70.4 -38.32 74.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.126 0.489 . . . . 0.0 110.198 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.61 -41.05 89.52 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.176 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.98 -53.71 19.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.264 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.839 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.28 -55.37 35.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.725 0.774 . . . . 0.0 109.393 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.1 -45.96 91.98 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.536 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.21 -31.11 71.6 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.883 0.342 . . . . 0.0 110.589 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 31' ' ' GLU . 69.1 t -68.25 -57.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.864 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.451 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -71.95 -35.51 69.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.474 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -42.98 80.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.625 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 t -79.03 -7.14 57.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.761 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -91.14 -54.51 3.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.27 34.49 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.839 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.36 -178.4 5.2 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.329 0.585 . . . . 0.0 111.106 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -159.59 56.62 0.9 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.901 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.9 Cg_endo -80.41 -176.27 3.11 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.516 2.144 . . . . 0.0 112.118 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.603 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.68 152.49 31.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.942 0.401 . . . . 0.0 110.27 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.21 -49.65 75.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.41 75.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.761 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.56 -54.33 33.84 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.626 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.819 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -66.03 -34.57 78.39 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.378 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.683 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.46 -43.12 95.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.894 0.378 . . . . 0.0 110.193 179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.58 -45.37 94.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.265 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.52 -30.67 61.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.37 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.588 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -53.65 -39.2 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.604 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.421 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.3 m-80 -45.12 -28.58 0.76 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.373 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.89 -38.74 53.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.952 0.406 . . . . 0.0 110.698 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.912 HG11 HG21 ' B' ' 6' ' ' ILE . 4.8 m -80.39 -12.75 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 43.5 t0 -103.53 155.07 18.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.763 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.14 26.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.182 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -116.42 -9.8 11.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.419 0.628 . . . . 0.0 110.402 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.81 61.49 7.31 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.261 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -109.43 18.38 20.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.758 0.313 . . . . 0.0 110.472 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.76 19.79 59.15 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.402 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.5 p -147.95 176.28 10.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.0 mt -113.28 136.61 49.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.64 0.257 . . . . 0.0 110.846 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -85.87 -179.38 6.8 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.178 0.513 . . . . 0.0 111.77 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.3 m-85 -68.26 -55.94 11.65 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.455 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.3 Cg_endo -65.94 -35.27 35.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.181 1.921 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.25 -52.37 64.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.211 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.02 -56.6 19.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.779 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.711 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -54.83 -47.71 73.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.705 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 73.2 m -59.34 -32.18 69.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.146 0.498 . . . . 0.0 109.713 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.902 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.9 tpp -67.73 -61.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.93 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.443 ' HG3' HG22 ' B' ' 10' ' ' ILE . 31.8 mtp . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.599 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -50.46 -30.53 12.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.316 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.658 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -77.17 -29.57 54.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.809 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.719 HG22 ' HE1' ' A' ' 138' ' ' TYR . 6.8 mt -79.3 -51.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.37 -51.97 11.87 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.5 tt0 -53.74 -25.92 20.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 110.71 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.709 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.07 -36.59 48.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.257 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.601 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 25.6 t80 -67.82 -52.02 41.82 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.043 0.449 . . . . 0.0 110.181 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.425 ' NH2' HD11 ' A' ' 39' ' ' LEU . 1.8 ptt180 -54.55 -32.26 58.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.847 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 87' ' ' GLU . 60.4 t -88.72 -22.72 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.577 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.478 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -53.45 -33.45 54.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.207 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -100.19 147.83 25.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.44 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -67.47 -38.35 84.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.403 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.26 -9.75 13.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.835 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.5 28.67 32.12 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.407 -0.901 . . . . 0.0 113.238 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -67.45 -13.9 62.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 117.161 0.481 . . . . 0.0 110.774 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.09 -11.57 55.58 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.085 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.457 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.4 m-85 -127.09 145.34 50.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.993 0.425 . . . . 0.0 111.434 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.046 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.16 109.93 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.686 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -83.29 177.29 8.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.541 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.546 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.32 -28.62 69.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.059 0.457 . . . . 0.0 110.509 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.31 -57.69 9.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.337 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.39 -43.6 39.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.181 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.046 HD13 HD13 ' A' ' 100' ' ' ILE . 35.5 tp -54.95 -31.18 60.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.081 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.814 ' HA ' HD11 ' A' ' 116' ' ' LEU . 3.3 ttt-85 -73.7 -49.3 26.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -61.28 -36.42 80.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.036 0.446 . . . . 0.0 110.369 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 104' ' ' GLU . 41.4 t -72.95 -44.79 56.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.229 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.6 mmt -74.05 -54.33 8.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.45 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.682 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.1 m -55.63 -46.2 77.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.32 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.582 ' C ' HD12 ' A' ' 112' ' ' LEU . 55.7 t30 -59.51 -30.48 68.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.911 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.8 mp -123.47 38.87 4.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.32 -115.69 0.36 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.817 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -133.21 168.87 17.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.93 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.682 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.7 ttmm -74.06 100.62 3.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.313 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.964 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.79 115.43 27.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.279 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.926 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.83 175.05 6.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.404 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.03 -35.91 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 110.821 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -77.36 -35.07 54.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -72.49 -33.92 67.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.994 0.426 . . . . 0.0 110.08 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.964 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.54 -48.46 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.935 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -59.33 -52.75 64.31 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.847 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.47 -28.81 63.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.819 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.813 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.7 tpt -76.33 -37.88 56.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.127 0.489 . . . . 0.0 110.182 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.75 -43.6 79.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.56 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -64.94 -39.2 93.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.837 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.22 -36.14 30.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.518 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.436 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.15 -38.22 81.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.666 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.719 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.7 t0 -99.76 147.6 25.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.09 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.562 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.8 -40.69 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.102 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.562 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.93 -10.98 60.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.698 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.68 1.09 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.2 p-10 -95.99 -12.83 24.39 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.302 -0.949 . . . . 0.0 112.455 -176.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.94 20.15 10.15 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.817 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 1.1 pt20 -146.48 146.8 30.68 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.953 0.406 . . . . 0.0 109.983 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.719 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.4 t -130.73 107.35 13.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.278 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.542 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -79.27 174.6 11.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.285 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.719 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.87 -67.07 0.32 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.527 0.68 . . . . 0.0 111.441 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.403 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -60.5 -34.1 73.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.865 -178.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.506 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.17 -41.89 76.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.306 0.574 . . . . 0.0 109.53 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.772 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.75 -31.81 46.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.132 178.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 138' ' ' TYR . 62.2 t -55.95 -47.11 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -56.62 -44.33 81.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.07 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.13 -32.31 64.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.5 ttp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.945 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.865 0.364 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.24 -50.96 61.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.723 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.66 -53.26 32.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.701 0.286 . . . . 0.0 111.289 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.14 -37.63 72.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.028 0.442 . . . . 0.0 110.252 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.945 HG23 ' O ' ' B' ' 1' ' ' ALA . 13.4 t -63.51 -33.69 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.384 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.912 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.43 -55.4 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.966 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.8 mmm-85 -50.61 -37.24 39.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.117 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -47.57 62.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.523 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.839 ' HD2' HD23 ' A' ' 32' ' ' LEU . 15.2 mtmt -55.93 -55.34 33.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.989 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.902 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.8 mt -51.36 -57.48 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.23 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -56.89 -51.2 70.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.93 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.52 -41.53 66.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.655 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.3 mt -54.39 -49.58 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.47 -37.18 94.4 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.017 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.91 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.96 -61.62 2.05 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.723 -0.738 . . . . 0.0 110.354 -179.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.66 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.81 -27.73 68.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.615 177.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -64.95 -51.58 61.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.273 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.734 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.89 -43.72 95.14 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.91 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -64.56 -32.92 59.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.694 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.6 OUTLIER -74.02 -45.93 46.64 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.783 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.538 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.7 -26.11 65.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.534 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.414 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.0 m -90.24 -45.9 14.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.171 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.935 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.63 -32.67 74.21 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.127 0.489 . . . . 0.0 110.483 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.935 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.093 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.695 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.835 0.35 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.18 -169.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.68 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -114.6 93.58 4.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.622 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -96.42 164.63 12.55 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.471 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.513 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 6.3 p -98.93 162.58 13.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.464 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -47.73 -51.33 22.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.761 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.74 -27.7 69.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.029 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.513 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.03 -51.54 21.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.62 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.683 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -72.67 -28.98 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.592 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.41 11.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.7 mt-10 -75.1 -28.63 60.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.126 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.608 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.22 -58.42 3.23 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.332 0.587 . . . . 0.0 110.927 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.878 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 11.0 ptmt -54.44 -23.31 15.47 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.231 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.538 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.11 -27.92 57.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.41 -39.59 62.53 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.052 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.878 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.78 -51.76 68.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.789 0.804 . . . . 0.0 109.452 178.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.51 -24.8 59.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.99 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.838 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.3 tt -82.05 -24.16 35.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.501 . . . . 0.0 110.269 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.802 ' HB3' HD11 ' A' ' 27' ' ' ILE . 4.2 t80 -92.77 -2.72 55.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.567 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.5 t70 -102.41 144.02 31.41 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.988 0.899 . . . . 0.0 111.032 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.2 mmtt -60.93 -53.44 57.29 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.512 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.31 -4.64 59.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.823 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.9 47.33 39.82 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.292 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 p30 -91.81 18.54 7.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.824 0.345 . . . . 0.0 110.685 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.52 4.85 88.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.57 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.1 p -150.17 149.97 30.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.66 0.266 . . . . 0.0 110.349 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.802 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.72 140.4 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.955 0.407 . . . . 0.0 111.822 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.52 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.96 176.99 7.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.131 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.671 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -69.84 -38.28 76.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.108 0.48 . . . . 0.0 110.315 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.81 -41.36 91.09 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.251 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.926 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.46 -52.16 29.34 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.41 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.8 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -60.24 -55.1 37.89 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.836 0.827 . . . . 0.0 109.364 178.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.81 -45.15 91.69 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.431 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.5 m -62.52 -31.24 71.98 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.469 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.6 t -67.59 -57.31 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.833 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.57 ' CE ' HD22 ' A' ' 39' ' ' LEU . 3.4 tpt -71.92 -36.17 69.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.539 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -42.01 81.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.647 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.4 t -78.97 -8.44 58.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.675 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.57 HD22 ' CE ' ' A' ' 36' ' ' MET . 6.8 tt -89.64 -53.93 4.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.103 0.477 . . . . 0.0 110.694 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.97 35.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.803 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.8 tp-100 -137.47 179.99 6.08 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.374 0.607 . . . . 0.0 111.212 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -159.76 56.46 0.87 Allowed Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.831 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.1 Cg_endo -80.38 -175.13 2.54 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.469 2.113 . . . . 0.0 112.195 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.594 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -112.98 152.63 29.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.886 0.374 . . . . 0.0 110.272 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.3 -49.18 76.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.03 74.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.821 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.578 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.96 -54.58 28.33 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.639 -179.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.671 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.12 -44.65 96.18 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.93 179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.645 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -58.2 -49.15 78.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.351 . . . . 0.0 110.751 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -53.25 -47.52 68.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.399 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.406 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.2 mmt -74.77 -30.55 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.767 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -53.62 -35.11 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.868 0.366 . . . . 0.0 111.522 -179.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -44.99 -28.63 0.7 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.267 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -78.05 -38.86 43.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.914 0.387 . . . . 0.0 110.764 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.869 HG11 HG21 ' B' ' 6' ' ' ILE . 4.5 m -80.49 -11.17 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.549 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.6 t0 -103.69 155.79 18.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.735 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.496 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.63 -29.17 25.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -116.5 -9.65 11.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.444 0.64 . . . . 0.0 110.468 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.61 63.51 5.15 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.484 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -112.11 17.9 19.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.857 0.36 . . . . 0.0 110.268 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.07 19.91 54.47 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.554 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.2 p -147.64 176.42 10.1 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.742 HD12 HD11 ' A' ' 32' ' ' LEU . 12.1 mt -115.49 136.57 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.569 0.223 . . . . 0.0 111.068 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.4 m-20 -88.05 -178.05 5.89 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.219 0.533 . . . . 0.0 111.964 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.86 -55.97 12.61 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.77 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.9 Cg_endo -65.63 -34.91 39.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.237 1.958 . . . . 0.0 111.186 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -52.28 63.64 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.206 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.713 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.97 -56.72 18.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.887 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.683 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.94 -46.25 82.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.653 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.695 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 80.0 m -60.05 -31.91 70.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.092 0.473 . . . . 0.0 110.037 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.921 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.3 tpp -62.24 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.105 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.8 mtm . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.011 -179.897 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.854 0.359 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -50.35 -30.43 12.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.581 ' O ' HG11 ' B' ' 19' ' ' VAL . 6.4 mt-10 -77.68 -29.47 51.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.713 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.667 HG22 ' HE1' ' A' ' 138' ' ' TYR . 16.2 mt -79.15 -51.13 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -72.55 -48.85 36.86 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.663 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.8 tt0 -53.61 -25.49 17.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.807 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.754 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.99 -36.83 48.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.284 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 25.2 t80 -68.29 -51.68 42.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 110.146 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -54.96 -32.2 61.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.772 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 87' ' ' GLU . 47.4 t -88.77 -22.72 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.488 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.55 -33.6 55.26 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.073 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -101.8 147.21 26.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.407 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -69.59 -36.59 76.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.448 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.18 -9.69 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.824 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.64 29.82 34.56 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.251 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -67.51 -13.85 62.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.109 0.455 . . . . 0.0 110.732 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.448 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.18 -12.7 55.47 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.906 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.483 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 20.5 m-85 -127.3 146.91 50.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.86 0.362 . . . . 0.0 111.25 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.847 ' CD1' HD12 ' A' ' 105' ' ' LEU . 1.1 pt -121.11 110.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.854 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m -82.31 178.42 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.644 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.537 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.72 -29.69 70.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 110.638 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.56 -57.2 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.147 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.761 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.43 -45.26 32.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.251 -179.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.847 HD12 ' CD1' ' A' ' 100' ' ' ILE . 5.3 tt -53.03 -32.7 48.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.936 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.843 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.5 ttt180 -73.4 -49.36 27.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -59.7 -42.67 93.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.877 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.766 ' O ' HD12 ' A' ' 112' ' ' LEU . 3.4 t -73.0 -40.14 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.73 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.498 ' HE1' ' CD2' ' B' ' 20' ' ' PHE . 30.1 mmt -73.95 -54.19 8.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.529 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.736 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.3 m -57.01 -48.94 77.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.256 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -57.87 -28.4 64.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.838 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.1 mt -123.6 36.6 4.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.44 -116.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.734 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.404 ' O ' HD23 ' A' ' 116' ' ' LEU . 6.9 pt-20 -130.49 168.75 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.85 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.736 ' HA ' HG23 ' A' ' 110' ' ' THR . 63.2 tttt -74.1 100.52 3.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.233 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.971 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.78 114.53 26.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.455 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.928 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -71.83 175.39 5.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.358 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.474 ' H ' HG22 ' A' ' 117' ' ' THR . 1.5 t70 -48.11 -35.93 12.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.746 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -77.37 -35.74 54.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.701 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -71.81 -33.51 68.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.966 0.412 . . . . 0.0 110.063 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.971 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -73.92 -48.61 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.745 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -58.41 -52.82 64.03 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.544 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -60.24 -28.67 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.577 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.619 ' HG2' HD21 ' A' ' 105' ' ' LEU . 5.5 tpt -72.42 -37.74 68.56 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.253 0.549 . . . . 0.0 110.085 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.487 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -70.63 -41.25 77.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.501 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -64.78 -40.16 94.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.6 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -81.84 -34.67 30.03 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.002 0.429 . . . . 0.0 110.374 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -34.75 76.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.517 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.72 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.3 t0 -105.19 146.67 28.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.992 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.56 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -83.69 -40.83 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.08 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.56 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.96 -11.0 60.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.678 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.96 32.6 1.02 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.4 p-10 -96.0 -12.78 24.47 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.332 -0.934 . . . . 0.0 112.432 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.22 10.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.828 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.483 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -146.68 147.4 30.97 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 129' ' ' ASP . 25.6 t -130.76 107.3 13.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.354 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.553 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -81.01 174.51 11.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.239 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.667 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.96 -67.23 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.583 0.706 . . . . 0.0 111.471 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.1 mt-10 -60.81 -29.14 69.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.989 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.546 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.83 -44.26 77.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.069 0.461 . . . . 0.0 109.814 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.7 -32.01 46.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.175 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 138' ' ' TYR . 68.5 t -53.84 -48.14 62.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -58.15 -44.16 87.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.21 -32.63 64.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.789 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 15.3 ttp . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.972 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.786 0.327 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.73 ' O ' HG13 ' B' ' 6' ' ' ILE . 2.1 mmm180 -52.15 -51.54 57.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.746 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.76 -53.43 31.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.612 0.244 . . . . 0.0 111.417 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.05 -37.0 71.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.139 0.495 . . . . 0.0 110.174 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.972 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.6 t -63.7 -34.4 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.417 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.869 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -71.47 -53.87 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.979 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -50.81 -39.77 53.8 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.238 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -48.32 65.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.867 ' O ' HD12 ' B' ' 13' ' ' ILE . 13.9 mtmt -55.01 -54.25 45.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.273 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.921 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.7 mt -51.04 -55.04 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.297 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.533 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 5.9 tpt180 -61.44 -46.46 89.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.224 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.528 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.13 -40.58 64.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.076 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.867 HD12 ' O ' ' B' ' 9' ' ' LYS . 1.8 mt -54.55 -51.71 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.512 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.41 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.46 -36.72 93.54 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.386 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.911 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.15 -61.58 2.16 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.954 -0.623 . . . . 0.0 110.474 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.655 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -63.38 -27.77 69.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.658 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -66.62 -50.91 61.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.203 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.559 ' NE ' HG12 ' B' ' 19' ' ' VAL . 3.9 ppt_? -63.38 -43.5 97.42 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.911 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.5 m -66.94 -31.85 55.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 0.0 110.609 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.659 ' HE2' HG12 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -72.65 -51.15 20.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.814 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.442 ' HA ' ' NE ' ' B' ' 24' ' ' ARG . 50.6 p -57.27 -35.34 69.64 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.116 0.484 . . . . 0.0 110.781 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.493 HG13 ' O ' ' B' ' 18' ' ' ARG . 27.2 m -73.43 -45.81 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.976 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.592 HD21 ' CD1' ' B' ' 20' ' ' PHE . 3.6 pp -65.15 -24.9 67.53 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.916 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 11.2 ptt85 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.901 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.453 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.866 0.365 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.525 ' HB2' HD21 ' A' ' 4' ' ' LEU . 3.0 m-20 -98.48 -169.9 1.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.76 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -116.96 83.98 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.633 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -97.51 164.77 12.3 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.019 0.438 . . . . 0.0 110.475 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.497 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.7 161.97 13.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.438 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -47.68 -51.67 20.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.752 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -64.56 -27.69 69.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.033 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.497 ' HB2' ' H ' ' A' ' 5' ' ' THR . 1.7 mm-40 -71.88 -51.41 22.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.644 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.1 pt -73.01 -28.95 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.72 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.31 10.81 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.546 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 4.0 mt-10 -75.25 -28.55 59.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.281 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.38 -58.52 3.17 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.299 0.571 . . . . 0.0 110.946 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.877 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.5 pttt -54.52 -23.48 16.61 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.183 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -75.65 -28.03 58.59 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.174 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.17 -39.77 63.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.094 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.877 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.04 -51.84 68.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.803 0.811 . . . . 0.0 109.544 178.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.49 -24.7 59.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.124 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.842 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.13 -23.13 35.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.165 0.507 . . . . 0.0 110.405 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.82 ' CE2' HG21 ' A' ' 35' ' ' VAL . 3.6 t80 -94.46 -2.82 51.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.639 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 26' ' ' THR . 23.9 t70 -100.83 142.81 31.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.946 0.879 . . . . 0.0 111.096 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -59.84 -53.45 57.78 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.501 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.17 -6.27 59.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.714 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.5 47.37 51.66 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.36 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -92.01 18.8 7.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.882 0.372 . . . . 0.0 110.688 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.42 5.03 89.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.619 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.8 p -150.28 150.27 31.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.688 0.28 . . . . 0.0 110.26 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.78 140.54 20.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.79 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.576 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -84.89 176.35 8.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.024 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.798 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -70.49 -37.97 74.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.128 0.49 . . . . 0.0 110.271 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.87 -41.06 90.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.162 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.1 -53.82 18.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.264 -179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.822 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -58.37 -55.13 39.05 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.695 0.76 . . . . 0.0 109.365 178.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.12 -45.88 92.1 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.514 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.2 m -62.34 -32.3 73.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.874 0.337 . . . . 0.0 110.488 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.9 t -66.45 -57.18 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.448 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.91 -34.61 69.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.376 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -68.97 -42.62 76.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.666 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.5 t -78.91 -7.75 58.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.751 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -91.21 -54.91 3.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.806 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.461 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.11 34.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.9 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 tp-100 -137.59 -178.73 5.37 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.295 0.569 . . . . 0.0 111.223 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -159.56 56.57 0.9 Allowed Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.933 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.0 Cg_endo -80.33 -177.38 3.75 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.538 2.159 . . . . 0.0 112.065 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -112.86 152.36 29.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.955 0.407 . . . . 0.0 110.306 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.51 -49.24 76.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.39 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.65 -31.82 72.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.783 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 44' ' ' THR . 1.0 OUTLIER -66.0 -54.31 27.68 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.611 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.798 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.97 -34.53 78.31 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.34 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.682 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.49 -42.68 95.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.909 0.385 . . . . 0.0 110.172 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.74 -45.45 93.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.186 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.6 mmt -74.52 -30.77 61.91 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.46 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.74 -38.29 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.606 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -45.03 -28.53 0.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.369 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.72 -38.33 47.39 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.849 HG11 HG21 ' B' ' 6' ' ' ILE . 4.7 m -81.58 -11.36 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.239 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.554 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.9 t0 -103.52 155.6 18.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.761 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.479 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.61 -28.8 26.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -116.46 -9.75 11.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.399 0.618 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.53 63.23 5.42 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.402 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -112.23 18.42 18.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.863 0.363 . . . . 0.0 110.188 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.32 19.9 56.0 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.49 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.576 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.0 p -146.85 176.49 9.85 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 32' ' ' LEU . 50.0 mt -116.27 136.53 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.528 0.204 . . . . 0.0 110.92 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.479 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.1 m-20 -87.33 -178.36 6.17 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.328 0.585 . . . . 0.0 112.002 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.511 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.78 -56.37 11.94 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.534 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.4 Cg_endo -65.81 -34.61 39.4 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.285 1.99 . . . . 0.0 111.114 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -52.4 63.67 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.226 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.726 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.47 -56.64 19.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.842 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.73 -46.26 84.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 58.3 m -60.69 -31.01 70.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.075 0.464 . . . . 0.0 110.046 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.928 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.5 tpp -62.43 -61.84 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.163 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 66.9 mtp . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.92 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.797 0.332 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -75.35 -44.4 45.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.723 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.76 -29.3 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.455 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.715 HG22 ' HE1' ' A' ' 138' ' ' TYR . 23.2 mt -65.97 -51.33 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.828 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -75.68 -51.11 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.828 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.659 ' O ' HG23 ' A' ' 91' ' ' VAL . 15.9 tt0 -53.91 -30.78 47.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.666 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.541 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -69.92 -38.78 76.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 22.6 t80 -67.38 -55.17 14.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.969 0.414 . . . . 0.0 110.431 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -54.47 -30.33 52.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.866 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 87' ' ' GLU . 98.4 t -88.38 -22.83 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.148 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.507 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -55.53 -30.55 60.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.036 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -107.69 142.82 37.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.621 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.749 ' NZ ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -65.28 -38.01 88.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.631 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -110.58 -9.58 14.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.43 31.74 36.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.367 -0.921 . . . . 0.0 113.076 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -67.38 -13.61 62.17 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.962 0.381 . . . . 0.0 110.747 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.454 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.19 -13.73 55.32 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.847 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.8 m-85 -127.28 147.42 50.23 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.899 0.381 . . . . 0.0 111.292 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.942 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -120.17 110.02 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.949 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.9 p -83.93 176.09 9.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.462 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.561 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -62.7 -29.98 71.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.08 0.467 . . . . 0.0 110.471 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.03 -57.01 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.287 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.735 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -76.43 -46.49 26.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.323 -179.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.942 HD13 HD13 ' A' ' 100' ' ' ILE . 41.0 tp -53.13 -31.08 40.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.818 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.0 ttt180 -73.82 -49.2 26.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.11 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -57.44 -43.7 84.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.292 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.749 HG22 ' NZ ' ' A' ' 94' ' ' LYS . 1.8 t -72.99 -43.0 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.574 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.477 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 31.3 mmt -70.21 -54.22 13.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.569 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.651 HG23 ' HA ' ' A' ' 115' ' ' LYS . 6.4 m -55.56 -45.25 77.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.15 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -61.64 -29.61 70.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.842 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.8 mp -122.35 37.59 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.62 -112.95 0.28 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.723 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.427 ' O ' HD23 ' A' ' 116' ' ' LEU . 2.3 pt-20 -136.61 170.27 16.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.771 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.651 ' HA ' HG23 ' A' ' 110' ' ' THR . 5.0 tppp? -73.59 98.35 2.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.963 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -88.86 113.42 24.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.925 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.74 175.26 5.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.376 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 117' ' ' THR . 73.7 m-20 -48.09 -36.05 12.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -77.34 -34.13 55.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.795 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -73.91 -33.3 63.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.971 0.415 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.963 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.92 -48.4 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.808 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.09 -52.8 64.18 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.736 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.52 -28.71 63.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.798 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.792 ' HG3' HD21 ' A' ' 105' ' ' LEU . 10.2 tpt -76.18 -37.9 57.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.142 0.496 . . . . 0.0 110.244 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -67.17 -42.68 88.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.4 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -62.87 -41.54 99.42 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 124' ' ' MET . 6.7 pt-20 -82.1 -32.79 30.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 110.48 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.54 78.45 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.451 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.754 ' HB2' HG22 ' A' ' 136' ' ' VAL . 18.5 t0 -105.46 149.38 26.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.934 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.579 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.5 pt -84.79 -40.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.26 0.552 . . . . 0.0 109.986 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.579 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.88 -10.93 59.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.67 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.12 32.77 1.13 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.5 p-10 -96.55 -12.9 23.41 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.296 -0.952 . . . . 0.0 112.391 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.09 10.28 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.753 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.491 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.81 146.43 30.24 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.925 0.393 . . . . 0.0 110.094 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 129' ' ' ASP . 41.1 t -130.76 107.38 13.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.224 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.546 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.16 174.24 11.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.41 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.715 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.91 -67.07 0.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.5 0.667 . . . . 0.0 111.539 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.78 -33.51 71.79 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.981 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.529 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.1 -41.36 75.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.872 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.2 OUTLIER -78.77 -32.03 46.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.226 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.58 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 61.8 t -55.78 -51.13 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.722 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -58.25 -47.41 83.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.3 tpp -68.44 -31.66 71.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.79 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.425 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 26.5 ttp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.786 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.95 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.847 0.356 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.3 mmm180 -52.26 -51.17 59.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.728 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.67 -53.21 32.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.681 0.277 . . . . 0.0 111.302 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -57.06 -37.6 72.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.373 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.95 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.9 t -63.38 -33.69 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.37 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.849 HG21 HG11 ' A' ' 55' ' ' VAL . 2.4 mt -71.76 -55.09 14.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.993 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 27.5 mmm-85 -50.2 -37.9 37.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.2 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.19 -46.57 64.33 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.492 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.822 ' HD2' HD23 ' A' ' 32' ' ' LEU . 11.9 mtmt -56.14 -53.57 55.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.127 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.928 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.21 -57.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.662 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.1 tpt180 -61.67 -51.38 68.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.328 0.585 . . . . 0.0 111.028 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.575 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.37 -38.94 63.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.719 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.724 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.41 -49.24 66.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.275 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.408 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.95 -37.76 95.09 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.55 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.92 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.9 -61.62 2.05 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.707 -0.747 . . . . 0.0 110.507 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.736 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -60.51 -27.73 67.83 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.51 -48.99 65.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.04 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.1 ppt_? -63.29 -43.95 96.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.92 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.8 m -61.85 -35.4 67.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.715 0.769 . . . . 0.0 110.234 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.696 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 0.3 OUTLIER -72.49 -46.66 53.75 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.408 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.495 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 59.1 p -59.73 -37.2 78.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.756 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.456 HG13 ' O ' ' B' ' 18' ' ' ARG . 27.2 m -72.28 -45.2 62.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.872 HD23 ' CE1' ' A' ' 141' ' ' PHE . 3.3 pp -64.17 -28.18 69.58 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.893 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.696 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 6.8 ptt85 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.931 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.815 0.34 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.503 ' HB2' HD21 ' A' ' 4' ' ' LEU . 2.5 m-20 -97.59 -169.7 1.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.796 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.52 83.06 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.637 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -96.1 164.68 12.59 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.407 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.529 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.95 162.77 12.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.491 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -47.48 -51.22 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -64.56 -27.64 69.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.057 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.529 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.5 -51.46 19.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.681 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.1 pt -73.1 -28.89 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.666 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.57 -27.31 10.66 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.555 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 7.3 mt-10 -75.24 -28.6 59.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.289 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.0 m-85 -79.53 -58.6 3.12 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.24 0.543 . . . . 0.0 110.981 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.871 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.8 15.13 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.198 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.25 -27.99 56.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.31 -39.71 62.7 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.053 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.871 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.88 -51.8 68.46 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.82 0.819 . . . . 0.0 109.387 178.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.401 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 1.8 p -74.42 -23.95 59.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.064 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.87 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -81.99 -26.15 34.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.285 0.564 . . . . 0.0 110.04 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.843 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.5 t80 -92.91 0.63 57.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.349 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 26' ' ' THR . 27.7 t70 -105.52 144.07 32.8 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.99 0.9 . . . . 0.0 111.025 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 2.3 mmtt -59.6 -53.41 58.43 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.601 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.63 -3.61 59.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.785 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.08 46.83 33.38 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.322 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.2 p30 -91.1 17.96 7.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.845 0.355 . . . . 0.0 110.759 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 84.2 4.9 87.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.668 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.431 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.7 p -150.29 147.82 28.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.639 0.257 . . . . 0.0 110.337 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -99.61 140.39 19.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.825 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.569 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.19 179.07 7.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.346 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.667 HG21 ' CG ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -70.19 -41.94 73.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.181 0.515 . . . . 0.0 110.277 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -57.44 -41.12 79.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.467 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.77 -53.79 16.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.405 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.592 HD13 ' CD1' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -56.24 -55.69 30.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.882 0.849 . . . . 0.0 109.581 178.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.425 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -58.74 -48.0 87.36 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.485 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.413 ' CB ' ' O ' ' A' ' 30' ' ' LYS . 54.9 m -64.38 -31.11 72.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.858 0.329 . . . . 0.0 110.458 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.843 HG21 ' CE2' ' A' ' 19' ' ' PHE . 18.9 t -63.2 -58.03 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.925 0.393 . . . . 0.0 110.486 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.656 ' HB2' ' HD2' ' B' ' 9' ' ' LYS . 0.0 OUTLIER -72.65 -40.66 66.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.238 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.61 -39.62 88.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.554 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -78.83 -12.2 60.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.597 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.545 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.3 tt -87.02 -53.75 4.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.108 0.48 . . . . 0.0 110.553 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.474 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -178.53 36.33 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.654 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 2.0 tp-100 -133.7 178.73 6.71 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.403 0.62 . . . . 0.0 111.267 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -159.87 56.29 0.84 Allowed Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.696 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.4 Cg_endo -80.54 -168.24 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.527 2.151 . . . . 0.0 112.37 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 47' ' ' GLU . 1.2 m -117.37 152.96 33.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.891 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -60.37 -48.53 81.34 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.75 76.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.705 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -62.81 -53.95 46.42 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.484 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -57.65 -51.27 70.19 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.947 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.667 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -53.62 -49.42 67.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.744 0.307 . . . . 0.0 111.289 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -53.11 -48.7 67.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.73 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mmt -74.71 -30.48 61.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.986 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.592 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -53.64 -36.44 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.843 -178.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.406 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 3.7 m-80 -45.66 -28.58 1.03 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.271 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -78.04 -38.34 44.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.932 0.396 . . . . 0.0 110.7 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.022 HG11 HG21 ' B' ' 6' ' ' ILE . 4.1 m -81.21 -12.32 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.063 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 42.5 t0 -103.59 155.24 18.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.744 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.71 -28.27 26.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.156 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -116.39 -9.72 11.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.443 0.64 . . . . 0.0 110.423 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.89 61.2 7.64 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.278 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -109.37 18.42 20.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.759 0.314 . . . . 0.0 110.447 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' CA ' ' HG2' ' A' ' 49' ' ' GLN . . . 84.9 19.78 58.92 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.493 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -147.81 176.35 10.2 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.404 HD12 HD11 ' A' ' 32' ' ' LEU . 31.7 mt -114.11 136.69 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.582 0.229 . . . . 0.0 110.955 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -87.54 -179.61 6.37 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.218 0.532 . . . . 0.0 111.958 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.3 m-85 -67.7 -55.77 13.48 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.54 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.73 -35.35 37.2 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.204 1.936 . . . . 0.0 111.166 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.12 -52.48 63.68 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.319 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.705 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.64 -56.31 23.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.773 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.699 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -58.66 -46.66 86.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.75 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 51.8 m -60.68 -30.66 70.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.147 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.888 ' HG2' HD13 ' B' ' 10' ' ' ILE . 4.6 tpp -59.94 -61.75 2.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.166 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mtm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.918 -179.933 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.862 0.363 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -59.46 -50.75 72.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.718 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.7 -29.27 25.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.518 -179.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.725 HG22 ' HE1' ' A' ' 138' ' ' TYR . 19.3 mt -66.61 -51.33 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.829 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.443 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -75.62 -50.67 14.79 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 91' ' ' VAL . 32.4 mt-10 -53.81 -32.11 51.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.648 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -68.68 -39.35 80.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.683 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.556 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 22.9 t80 -66.73 -56.38 10.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.555 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -53.87 -29.93 43.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.905 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 87' ' ' GLU . 97.1 t -88.41 -23.03 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.19 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.453 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.7 -31.94 62.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.061 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -102.69 148.41 25.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.389 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -69.62 -37.51 76.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -112.34 -9.73 13.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.877 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.24 30.83 32.92 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.136 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.41 -13.32 61.91 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.971 0.386 . . . . 0.0 110.813 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.27 -13.86 55.04 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.826 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 24.8 m-85 -127.14 145.69 50.66 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.976 0.417 . . . . 0.0 111.258 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.97 HD13 HD13 ' A' ' 105' ' ' LEU . 1.1 pt -121.15 109.94 26.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.814 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 56.0 m -83.73 177.41 8.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.405 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.13 -28.87 70.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.071 0.463 . . . . 0.0 110.494 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.94 -57.67 9.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.436 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.623 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.36 -42.37 44.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.257 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.97 HD13 HD13 ' A' ' 100' ' ' ILE . 54.5 tp -57.3 -31.12 65.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.082 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.789 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.9 ttt180 -72.37 -49.28 35.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -60.6 -36.54 78.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 110.533 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 104' ' ' GLU . 56.6 t -72.93 -44.56 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.243 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 23.4 mmt -74.05 -53.95 8.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.7 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.0 m -55.42 -45.58 76.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 111.262 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.404 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.0 OUTLIER -62.44 -25.7 68.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.838 0.351 . . . . 0.0 110.728 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.87 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.4 mp -125.37 37.41 4.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.755 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -172.3 -113.77 0.31 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.775 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -134.72 169.88 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.36 . . . . 0.0 110.877 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.655 ' HA ' HG23 ' A' ' 110' ' ' THR . 19.0 tttt -74.09 100.07 3.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.252 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.95 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.39 114.76 26.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.285 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.928 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.74 175.1 5.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.412 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.45 ' H ' HG22 ' A' ' 117' ' ' THR . 3.1 t0 -48.11 -36.02 12.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.939 0.4 . . . . 0.0 110.775 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -77.35 -34.4 55.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.777 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -73.29 -34.05 65.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.002 0.43 . . . . 0.0 110.093 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.95 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.4 -48.82 34.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.943 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -58.99 -52.89 63.82 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.908 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.31 -29.02 63.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.839 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.834 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.4 tpt -76.32 -38.07 56.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.091 0.472 . . . . 0.0 110.223 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.14 -42.46 84.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.553 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -65.78 -39.2 90.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.923 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.03 -35.54 28.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.468 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.24 -38.58 81.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.517 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.772 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.6 t0 -98.96 147.48 24.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.078 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.561 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.6 pt -84.79 -40.68 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.307 0.575 . . . . 0.0 110.053 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.561 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.92 -11.02 60.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.713 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.72 1.1 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.3 p-10 -96.28 -12.92 23.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.296 -0.952 . . . . 0.0 112.42 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.96 20.08 10.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.804 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.97 146.31 30.04 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.962 0.41 . . . . 0.0 110.029 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.5 t -130.67 107.44 14.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.229 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.551 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.25 174.7 11.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.339 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.725 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.99 -66.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.513 0.673 . . . . 0.0 111.479 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -34.01 72.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.909 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.545 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.05 -40.54 73.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.825 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.75 -33.62 46.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.082 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.586 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.4 t -54.68 -46.83 73.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.666 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.98 -45.49 86.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.11 -33.21 65.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.427 ' HE1' HG12 ' A' ' 85' ' ' ILE . 14.7 ttp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.941 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.846 0.355 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.737 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.2 mmm180 -52.24 -50.78 61.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.735 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.63 -53.36 31.4 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.628 0.252 . . . . 0.0 111.323 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.96 -37.1 71.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.129 0.49 . . . . 0.0 109.998 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.941 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.9 t -63.42 -34.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.341 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 1.022 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.99 -55.59 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.253 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 27.6 mmm-85 -49.79 -40.56 41.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.414 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -43.72 70.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.224 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.74 ' O ' HD12 ' B' ' 13' ' ' ILE . 0.0 OUTLIER -54.84 -55.49 29.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.189 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.888 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.5 mt -51.6 -57.49 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.835 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.2 tpt180 -60.56 -51.29 70.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.321 0.582 . . . . 0.0 110.912 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.566 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.4 -40.0 64.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.652 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.74 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.0 mt -54.51 -47.57 71.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.236 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.08 -38.33 95.84 Favored Glycine 0 CA--C 1.497 -1.056 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.546 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.892 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.97 -61.69 2.01 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.637 -0.782 . . . . 0.0 110.495 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.746 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.03 -27.75 67.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.68 -48.73 65.77 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.935 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.632 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.5 ppt_? -62.27 -43.45 98.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.133 0.492 . . . . 0.0 109.692 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.892 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.6 m -63.89 -34.9 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.866 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -74.8 -45.74 41.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.929 -179.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.558 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 12.6 p -59.81 -24.98 64.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.567 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 23' ' ' LEU . 29.5 m -90.73 -46.72 14.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.972 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.945 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.31 -32.76 73.55 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.147 0.498 . . . . 0.0 110.335 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.945 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.131 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.62 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.792 0.33 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.96 -169.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -116.97 90.56 3.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.001 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.64 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.2 mt -98.64 164.75 12.11 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.542 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.485 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.4 p -96.77 161.78 13.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.493 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -47.7 -51.78 20.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.781 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -64.35 -27.72 69.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.031 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.87 -51.52 21.93 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.592 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.697 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -72.98 -28.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.742 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.51 -27.36 10.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 37.3 mt-10 -75.28 -28.47 59.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.203 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.28 -58.51 3.18 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.281 0.562 . . . . 0.0 110.983 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.49 -23.05 14.65 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.285 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.33 -27.87 56.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.49 -39.8 62.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.074 177.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.74 -51.68 68.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.899 0.857 . . . . 0.0 109.445 178.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.404 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 7.3 p -74.37 -24.89 59.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.049 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.894 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.06 -24.64 35.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.172 0.51 . . . . 0.0 110.278 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.808 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.9 t80 -92.66 -2.33 56.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.599 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.9 t70 -102.36 143.37 32.2 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.97 0.891 . . . . 0.0 111.154 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -59.94 -53.42 58.11 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.58 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -84.81 -6.11 59.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.811 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.54 46.27 53.31 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.188 -0.529 . . . . 0.0 113.375 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -90.99 18.15 7.06 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.798 0.333 . . . . 0.0 110.727 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.5 5.7 88.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 48.3 p -150.28 149.9 30.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.808 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.88 140.5 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.944 0.402 . . . . 0.0 111.834 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.586 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.35 176.56 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.02 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.826 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.2 p -70.49 -37.76 74.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.133 0.492 . . . . 0.0 110.268 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.03 -41.11 91.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.155 178.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.921 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.23 -53.43 19.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.282 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.838 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.4 -54.93 41.46 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.771 0.796 . . . . 0.0 109.402 178.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.46 -45.89 92.52 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.516 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -62.21 -31.34 71.86 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.851 0.326 . . . . 0.0 110.574 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.7 t -68.0 -57.24 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.853 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.457 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 1.1 tpt -71.91 -35.5 69.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.427 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -68.05 -42.15 80.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.595 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 t -78.97 -7.79 58.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.731 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.73 -54.31 4.03 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.109 0.48 . . . . 0.0 110.776 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.45 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.22 35.19 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.836 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.588 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.0 -178.98 5.44 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 111.16 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -159.65 56.43 0.87 Allowed Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.909 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.0 Cg_endo -80.42 -175.72 2.84 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.519 2.146 . . . . 0.0 112.076 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.605 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.89 152.47 32.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.941 0.401 . . . . 0.0 110.23 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.18 -49.64 75.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.43 75.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.765 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.66 -54.26 34.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.657 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.826 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.87 -34.57 78.44 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.322 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.689 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.54 -43.07 95.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.926 0.393 . . . . 0.0 110.185 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.33 -45.52 94.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.189 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.4 mmt -74.57 -30.73 61.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.403 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.74 -38.02 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.55 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -45.05 -28.55 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.372 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG2' ' HZ1' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.59 -38.75 47.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.915 0.388 . . . . 0.0 110.84 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.886 HG11 HG21 ' B' ' 6' ' ' ILE . 5.0 m -81.17 -11.43 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.157 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.543 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.7 t0 -103.63 155.63 18.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.62 -29.09 26.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -116.45 -9.64 11.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.416 0.626 . . . . 0.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.47 63.56 5.12 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.488 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -112.28 18.16 18.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 0.0 110.241 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.93 55.13 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.475 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.4 p -147.09 176.4 9.97 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 32' ' ' LEU . 57.6 mt -115.77 136.48 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.546 0.212 . . . . 0.0 110.86 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.0 m-20 -87.46 -178.18 6.09 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.318 0.58 . . . . 0.0 111.916 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.1 -55.9 12.13 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.648 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.4 Cg_endo -65.68 -34.39 41.31 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.251 1.967 . . . . 0.0 111.193 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -52.46 61.97 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.209 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.721 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.02 -57.04 14.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.867 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.697 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.1 -47.14 81.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.62 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 54.0 m -60.23 -30.92 69.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 110.077 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.92 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.7 tpp -62.08 -61.84 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.144 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 8.4 mtt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.992 -179.869 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.859 0.361 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -50.44 -30.48 12.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.553 ' O ' HG11 ' B' ' 19' ' ' VAL . 4.6 mt-10 -77.31 -29.55 53.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.73 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.692 HG22 ' HE1' ' A' ' 138' ' ' TYR . 11.3 mt -79.24 -51.13 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -48.48 38.34 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.897 0.379 . . . . 0.0 111.863 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.691 ' OE2' ' HB1' ' B' ' 12' ' ' ALA . 21.5 tt0 -53.5 -26.42 20.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.357 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.744 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.56 -33.99 58.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.964 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.61 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 13.1 t80 -68.96 -50.42 49.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.002 0.43 . . . . 0.0 110.149 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -54.42 -33.21 59.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.767 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.99 -22.7 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.557 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.544 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -52.81 -36.82 59.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.342 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -100.09 147.13 25.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.753 0.311 . . . . 0.0 110.525 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -67.94 -37.71 81.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.434 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -112.2 -9.76 13.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.847 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.41 28.36 33.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.365 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -67.51 -13.96 62.51 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.163 0.481 . . . . 0.0 110.769 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -11.49 55.44 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.084 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.48 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.7 m-85 -127.21 146.94 50.24 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.925 0.393 . . . . 0.0 111.53 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.05 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.14 109.92 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.633 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 m -82.66 176.78 9.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.553 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.14 -29.88 70.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.097 0.475 . . . . 0.0 110.457 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.24 -57.74 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.23 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.833 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.44 -45.46 31.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.157 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.05 HD13 HD13 ' A' ' 100' ' ' ILE . 28.6 tp -53.04 -31.44 41.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.853 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.2 ttt-85 -72.46 -49.13 35.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -59.9 -42.0 92.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.115 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.9 t -73.06 -40.17 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.404 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.46 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.7 mmt -73.92 -54.16 8.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.698 HG23 ' HA ' ' A' ' 115' ' ' LYS . 7.1 m -59.03 -48.9 79.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.202 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -57.26 -28.56 63.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.894 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -124.33 37.0 4.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.731 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.43 -115.88 0.36 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.808 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.422 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -130.7 167.52 18.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 110.883 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.698 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.9 ttmt -73.59 100.07 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.291 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.973 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.55 114.43 26.64 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.393 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.927 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.78 175.26 5.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.385 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -48.01 -35.92 11.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.363 . . . . 0.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.4 -35.44 54.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.698 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -72.29 -33.3 67.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.959 0.409 . . . . 0.0 110.116 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.973 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.65 -48.51 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.846 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -59.41 -52.87 63.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.724 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -57.76 -28.67 64.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.807 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.749 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.6 tpt -76.12 -37.88 57.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.147 0.499 . . . . 0.0 110.248 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.14 -40.65 80.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -66.46 -39.19 88.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.952 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.41 -36.13 29.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.61 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.494 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.09 -37.17 80.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.413 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.646 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.4 t0 -101.36 145.53 28.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.033 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.552 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.0 pt -83.06 -40.8 16.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.165 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.92 -11.02 60.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.747 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.87 32.65 0.99 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.419 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.3 p-10 -95.53 -12.41 25.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.304 -0.948 . . . . 0.0 112.568 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.18 10.19 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.89 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.48 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.99 147.37 31.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 129' ' ' ASP . 18.6 t -130.74 107.25 13.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.39 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -78.81 174.79 11.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.227 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.93 -67.08 0.31 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.635 0.731 . . . . 0.0 111.788 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.4 mt-10 -65.28 -25.3 67.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.42 -1.263 . . . . 0.0 112.554 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.467 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.62 -48.51 74.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.822 0.344 . . . . 0.0 110.271 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.8 p90 -78.91 -30.99 45.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.243 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 138' ' ' TYR . 67.4 t -52.83 -44.5 48.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.121 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -60.34 -37.16 79.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.125 0.488 . . . . 0.0 109.809 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.46 -42.21 62.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.721 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.432 ' CG ' HG21 ' B' ' 22' ' ' VAL . 2.2 ttp . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.026 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.946 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.801 0.334 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.736 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.23 -51.08 60.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.722 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.65 -53.27 32.36 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.677 0.275 . . . . 0.0 111.302 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.1 -37.54 72.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.015 0.436 . . . . 0.0 110.339 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.946 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.2 t -63.46 -34.12 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.387 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.886 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -70.84 -54.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.969 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -51.51 -37.24 48.25 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.097 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.63 -48.31 64.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.472 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.838 ' HD2' HD23 ' A' ' 32' ' ' LEU . 17.3 mtmt -55.8 -54.38 45.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.043 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.92 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.5 mt -51.17 -57.45 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.465 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.518 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.8 tpt180 -59.79 -51.23 70.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.237 0.541 . . . . 0.0 111.094 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.691 ' HB1' ' OE2' ' A' ' 87' ' ' GLU . . . -53.19 -40.1 64.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.819 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.783 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.8 mt -54.58 -50.37 59.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.418 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.93 -36.82 93.96 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.056 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.906 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.28 -61.69 2.08 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.539 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.676 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.98 -27.62 69.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.599 177.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -66.04 -50.68 63.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.225 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.754 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -63.64 -43.55 96.46 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.02 0.438 . . . . 0.0 109.847 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.2 m -65.9 -32.69 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.839 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.686 ' HE2' HG12 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -74.66 -48.13 27.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.219 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 13.5 p -58.46 -25.9 62.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.454 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.448 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.5 m -89.93 -47.62 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.161 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.888 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -62.84 -33.02 74.37 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.139 0.495 . . . . 0.0 110.507 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.888 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.107 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.479 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.79 0.328 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.521 ' HB2' HD21 ' A' ' 4' ' ' LEU . 2.7 m-20 -106.17 -170.16 1.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -116.77 83.95 2.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.71 164.71 12.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.539 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.494 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.32 162.73 13.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.48 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -47.39 -51.38 19.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.902 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -64.39 -27.71 69.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.034 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.5 -51.39 20.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.705 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.4 pt -73.18 -28.79 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.809 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.38 -27.32 9.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 35.0 mm-40 -75.25 -28.51 59.88 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.166 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.42 -58.31 3.27 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.228 0.537 . . . . 0.0 111.042 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.876 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 11.2 ptmt -54.56 -22.99 14.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.235 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.27 -28.02 56.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.33 -39.83 62.58 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.07 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.876 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.01 -51.66 69.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.774 0.797 . . . . 0.0 109.5 178.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.406 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 6.9 p -74.42 -24.78 59.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.072 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.903 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.04 -24.29 35.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.177 0.513 . . . . 0.0 110.285 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.799 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.6 t80 -93.4 -1.71 55.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.563 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.7 t70 -102.7 143.56 32.19 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 122.005 0.907 . . . . 0.0 111.125 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.2 mmtt -59.65 -53.47 57.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.56 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.51 -5.72 59.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.744 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.3 46.31 51.98 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.356 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -90.97 18.15 7.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.799 0.333 . . . . 0.0 110.73 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.72 5.57 88.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.564 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 47.5 p -150.34 149.58 30.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.65 140.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.879 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.591 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.21 176.37 8.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.002 179.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.822 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -70.49 -37.77 74.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.126 0.488 . . . . 0.0 110.257 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.09 -41.13 91.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.143 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.918 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -69.09 -53.79 18.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.221 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.841 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.16 -55.62 32.61 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.73 0.776 . . . . 0.0 109.362 178.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.76 -46.18 90.1 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.62 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.7 m -62.5 -32.13 72.99 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.951 0.376 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.8 t -67.03 -57.22 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.922 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.453 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -71.9 -36.37 69.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.471 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -67.07 -41.9 85.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.4 . . . . 0.0 110.552 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.7 t -79.04 -7.94 58.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.698 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.2 tt -91.42 -55.41 3.52 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -174.97 33.1 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.946 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.596 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -134.18 -179.66 5.7 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.337 0.589 . . . . 0.0 111.125 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -159.66 56.33 0.86 Allowed Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.819 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.8 Cg_endo -80.62 -172.78 1.61 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.577 2.185 . . . . 0.0 112.086 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.37 152.42 35.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.884 0.373 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.7 -50.15 73.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 -33.33 75.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.709 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.85 -54.39 31.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.687 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.822 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.83 -34.63 78.61 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.399 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.684 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.48 -42.75 95.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 110.226 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.65 -45.5 93.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.25 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -30.76 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.424 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.73 -38.01 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.529 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -44.93 -28.59 0.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.417 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.45 -38.96 48.34 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 120.89 0.376 . . . . 0.0 110.819 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.858 HG11 HG21 ' B' ' 6' ' ' ILE . 5.0 m -81.23 -11.47 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.182 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.546 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.7 t0 -103.61 155.65 18.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.788 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.66 -29.01 26.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.095 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -116.49 -9.67 11.39 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.407 0.623 . . . . 0.0 110.481 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.31 63.77 4.94 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.481 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -112.39 18.11 18.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.831 0.348 . . . . 0.0 110.216 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.84 19.85 55.11 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.469 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.6 p -147.1 176.42 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.772 HD12 HD11 ' A' ' 32' ' ' LEU . 14.6 mt -115.77 136.52 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.836 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.9 m-20 -87.28 -178.27 6.16 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.218 0.533 . . . . 0.0 111.859 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.08 -55.83 12.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.727 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -65.67 -34.77 40.03 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.272 1.981 . . . . 0.0 111.12 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -52.45 62.95 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.232 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.93 -56.83 16.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.815 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.699 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.75 -45.75 81.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.679 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 55.8 m -60.07 -31.33 69.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.085 0.469 . . . . 0.0 109.954 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.904 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.9 tpp -64.68 -61.8 1.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.949 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.403 ' HG3' HG22 ' B' ' 10' ' ' ILE . 43.0 mtm . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.81 0.338 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.48 -30.64 13.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.397 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.608 ' O ' HG11 ' B' ' 19' ' ' VAL . 2.1 mt-10 -65.94 -29.78 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 110.342 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.681 HG22 ' HE1' ' A' ' 138' ' ' TYR . 11.4 mt -79.45 -50.64 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.308 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.444 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.2 OUTLIER -74.99 -51.24 14.13 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 91' ' ' VAL . 17.0 tt0 -53.5 -25.19 15.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.742 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.705 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.43 -36.61 45.32 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 24.0 t80 -68.12 -52.26 36.92 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.012 0.434 . . . . 0.0 110.091 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.439 ' NH2' HD11 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -54.72 -32.05 59.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.807 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 87' ' ' GLU . 48.4 t -88.74 -22.74 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.522 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.484 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -53.85 -31.64 50.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.144 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -103.25 147.44 27.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.431 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -69.24 -37.03 77.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.432 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.15 -9.75 13.92 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.75 29.89 33.95 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.232 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.37 -13.95 62.48 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.078 0.439 . . . . 0.0 110.779 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.14 -12.12 55.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.969 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.6 m-85 -127.26 146.85 50.28 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.953 0.406 . . . . 0.0 111.247 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.58 HD12 HD22 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.03 110.01 26.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.875 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -84.09 176.9 8.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.522 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.51 -29.55 70.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.08 0.467 . . . . 0.0 110.484 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.73 -57.18 12.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.209 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.749 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.32 -46.11 29.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.309 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.835 HD21 ' HG3' ' A' ' 124' ' ' MET . 20.0 tp -53.14 -31.11 40.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.996 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.836 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.8 ttt-85 -73.35 -49.13 28.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -58.87 -42.87 90.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.142 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.2 t -72.91 -40.37 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.529 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.511 ' HE1' ' CD2' ' B' ' 20' ' ' PHE . 30.0 mmt -73.87 -54.21 8.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.353 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.737 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.3 m -56.96 -48.84 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 0.0 111.147 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.684 ' C ' HD12 ' A' ' 112' ' ' LEU . 60.1 t-20 -58.8 -29.33 66.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.903 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -122.88 37.62 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.802 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 109' ' ' MET . . . -171.2 -113.86 0.31 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.783 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.445 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -134.07 166.85 21.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 110.886 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.737 ' HA ' HG23 ' A' ' 110' ' ' THR . 33.0 tttm -72.39 99.68 2.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.244 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.81 114.51 26.25 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.421 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.923 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.77 175.24 5.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.37 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -48.02 -36.0 12.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 110.77 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.37 -34.88 54.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.723 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -73.0 -33.23 65.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.973 0.416 . . . . 0.0 110.079 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.95 -48.51 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.839 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -59.01 -52.81 64.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.746 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.7 -28.65 64.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.765 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.835 ' HG3' HD21 ' A' ' 105' ' ' LEU . 12.8 tpt -76.15 -37.5 57.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.172 0.51 . . . . 0.0 110.163 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.508 HG12 HD23 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -69.21 -39.16 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.342 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -64.77 -41.94 95.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.418 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -82.08 -32.45 30.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.937 0.398 . . . . 0.0 110.431 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.77 -34.71 76.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.54 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.755 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.0 t0 -107.95 148.07 30.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.014 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.559 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.7 pt -84.91 -40.71 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.013 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.559 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.95 -10.98 60.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.693 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.06 32.8 1.1 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.435 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.35 -12.69 24.02 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.332 -0.934 . . . . 0.0 112.493 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.79 20.14 10.28 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.832 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.485 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.77 146.44 30.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.959 0.409 . . . . 0.0 110.0 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 129' ' ' ASP . 38.4 t -130.79 107.41 13.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.213 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.539 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -79.86 174.22 11.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.259 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.681 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.82 -67.07 0.32 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.554 0.692 . . . . 0.0 111.448 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.404 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.4 mt-10 -60.11 -33.41 72.09 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.903 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.511 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.03 -42.09 75.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.36 0.6 . . . . 0.0 109.496 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.853 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.69 -31.87 46.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.114 178.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.573 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 55.5 t -55.38 -48.75 76.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.655 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -55.15 -49.67 71.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -70.57 -30.38 67.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.783 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.415 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.943 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.848 0.356 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.737 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.1 mmm180 -52.38 -51.0 61.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.076 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.722 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.68 -53.24 32.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.679 0.276 . . . . 0.0 111.29 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -57.06 -37.64 72.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.997 0.427 . . . . 0.0 110.34 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.943 HG23 ' O ' ' B' ' 1' ' ' ALA . 13.9 t -63.37 -34.15 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.361 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.858 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.07 -55.28 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.967 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.4 mmm-85 -50.73 -36.84 38.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.098 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -48.28 63.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.466 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.841 ' HD2' HD23 ' A' ' 32' ' ' LEU . 16.2 mtmt -55.56 -54.96 37.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.222 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.904 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.0 mt -51.13 -57.43 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.431 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.525 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -58.92 -51.05 71.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.27 0.557 . . . . 0.0 111.051 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.27 -40.58 64.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.831 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.716 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.9 mt -54.61 -49.7 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.493 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.43 -36.95 94.06 Favored Glycine 0 CA--C 1.499 -0.961 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.068 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.932 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.14 -61.73 2.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.789 -0.705 . . . . 0.0 110.357 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.66 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.75 -28.08 69.72 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.659 177.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.5 -51.48 59.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.227 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.758 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.31 -43.44 97.82 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.037 0.446 . . . . 0.0 109.831 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.932 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.1 m -66.45 -32.55 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.639 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.66 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -71.82 -50.15 32.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.986 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.46 ' HA ' ' NE ' ' B' ' 24' ' ' ARG . 52.7 p -58.27 -35.56 71.96 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.023 0.439 . . . . 0.0 110.836 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.49 HG22 ' C ' ' B' ' 19' ' ' VAL . 26.9 m -73.04 -45.22 55.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.09 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.853 HD23 ' CE1' ' A' ' 141' ' ' PHE . 2.7 pp -64.62 -27.98 69.31 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.933 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 10.9 ptt85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.904 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.628 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.773 0.321 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.407 ' HB2' HD21 ' A' ' 4' ' ' LEU . 3.7 m-20 -66.09 -169.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.824 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -117.49 89.09 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.002 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.63 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.78 164.81 12.24 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.459 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.491 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.28 162.4 13.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.488 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -47.25 -51.35 19.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.845 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.29 -27.72 69.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.115 0.484 . . . . 0.0 110.034 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.0 OUTLIER -72.64 -51.38 19.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.694 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 35.5 pt -73.27 -28.83 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.931 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.44 -27.37 10.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 49.6 mt-10 -75.43 -28.49 59.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.272 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.33 -58.57 3.15 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.242 0.544 . . . . 0.0 111.163 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.878 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -54.75 -23.3 17.22 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.175 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -75.64 -28.26 58.73 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.96 -40.02 63.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.072 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.878 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.11 -51.9 68.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.796 0.808 . . . . 0.0 109.608 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -24.79 59.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.042 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.912 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.15 -26.9 33.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.117 0.484 . . . . 0.0 110.401 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.798 ' HB3' HD11 ' A' ' 27' ' ' ILE . 4.6 t80 -87.2 -14.3 41.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.579 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.8 t70 -90.79 145.27 24.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.931 0.872 . . . . 0.0 111.175 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.493 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.8 mmtt -63.36 -53.39 53.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.578 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -83.09 -7.07 59.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.735 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.3 46.94 56.99 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.398 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -91.73 18.59 7.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.854 0.359 . . . . 0.0 110.659 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.21 5.11 89.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.539 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.7 p -150.28 152.07 33.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.798 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -103.04 140.53 21.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.924 0.392 . . . . 0.0 111.712 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.556 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -84.72 176.14 8.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.008 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.817 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -70.39 -38.45 74.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.085 0.469 . . . . 0.0 110.159 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.48 -40.92 88.51 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.144 178.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.919 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.07 -53.68 19.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.272 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.831 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.41 -54.91 41.64 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.761 0.791 . . . . 0.0 109.47 178.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.46 -46.01 92.39 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.581 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.12 -31.16 71.59 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.806 0.336 . . . . 0.0 110.587 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.7 t -68.18 -57.23 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.447 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -71.89 -35.53 69.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.412 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -42.46 80.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.641 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.7 t -78.95 -7.46 58.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.749 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.549 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -91.11 -54.43 3.95 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.056 0.455 . . . . 0.0 110.796 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.45 34.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.871 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.588 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.02 -178.78 5.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.291 0.567 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -159.59 56.49 0.89 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.884 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.0 Cg_endo -80.37 -176.09 3.02 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.552 2.168 . . . . 0.0 112.065 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.606 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.61 152.45 31.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.94 0.4 . . . . 0.0 110.236 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.13 -49.68 75.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.386 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.24 75.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.72 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 1.3 mm-40 -64.7 -54.32 33.4 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.682 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.817 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.89 -34.69 78.7 Favored 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.405 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.677 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.52 -42.92 95.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.886 0.374 . . . . 0.0 110.162 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.52 -45.44 94.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.233 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -30.71 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.41 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.75 -38.31 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.527 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -45.03 -28.55 0.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.377 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.439 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.76 -38.56 46.58 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.886 0.374 . . . . 0.0 110.841 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.919 HG11 HG21 ' B' ' 6' ' ' ILE . 4.8 m -81.2 -11.27 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.167 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.55 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.4 t0 -103.66 155.62 18.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.759 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.65 -28.93 26.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.034 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -116.45 -9.73 11.41 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.408 0.623 . . . . 0.0 110.501 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.45 63.58 5.1 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.476 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -112.32 18.12 18.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.854 0.359 . . . . 0.0 110.19 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.75 19.9 55.18 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.491 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.8 p -147.32 176.46 9.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.794 HD12 HD11 ' A' ' 32' ' ' LEU . 13.2 mt -115.85 136.51 52.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.557 0.218 . . . . 0.0 110.91 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.7 m-20 -87.11 -178.08 6.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.298 0.571 . . . . 0.0 111.959 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.517 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.99 -56.12 11.98 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.674 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.8 -34.44 40.06 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.254 1.969 . . . . 0.0 111.175 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.07 -52.38 62.96 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.166 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.03 -56.92 15.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.893 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.6 -47.13 80.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.628 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 54.7 m -60.21 -30.76 69.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.07 0.462 . . . . 0.0 110.078 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.905 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.1 tpp -64.43 -61.83 1.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.124 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 mtt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.976 -179.94 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.806 0.336 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -50.45 -30.55 12.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.183 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.708 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -77.24 -29.3 53.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.789 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.638 HG22 ' HE1' ' A' ' 138' ' ' TYR . 16.2 mt -79.08 -51.04 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -73.7 -51.11 17.71 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.839 0.352 . . . . 0.0 111.901 -178.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 91' ' ' VAL . 60.5 tt0 -53.56 -24.61 14.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.722 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -78.67 -35.73 44.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.058 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.8 t80 -69.03 -52.43 28.79 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.108 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -55.7 -31.9 62.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.895 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 87' ' ' GLU . 62.0 t -88.94 -22.73 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.571 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.495 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -54.53 -32.24 57.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.081 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -102.75 147.42 26.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.434 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -69.64 -36.83 76.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -112.18 -9.66 13.91 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.55 30.08 34.1 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.204 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -67.37 -13.82 62.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.004 0.402 . . . . 0.0 110.797 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.446 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.18 -11.71 55.28 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.011 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.47 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.0 m-85 -127.3 145.83 50.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 120.959 0.409 . . . . 0.0 111.354 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.93 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -120.68 110.03 27.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.828 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -83.41 176.4 9.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.525 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.558 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.32 -29.84 71.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.065 0.459 . . . . 0.0 110.432 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.13 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.222 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.37 -46.1 28.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.35 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 100' ' ' ILE . 44.8 tp -53.1 -31.06 40.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.09 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.81 ' HA ' HD11 ' A' ' 116' ' ' LEU . 3.5 ttt-85 -74.21 -49.26 24.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.182 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -58.32 -42.39 86.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.057 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.775 ' O ' HD12 ' A' ' 112' ' ' LEU . 2.5 t -72.87 -40.68 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.563 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.49 ' HE1' ' CD2' ' B' ' 20' ' ' PHE . 30.0 mmt -73.91 -54.34 8.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.351 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.75 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.9 m -57.32 -48.92 77.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.21 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -58.38 -28.61 65.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.912 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.1 mt -123.89 36.63 4.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.802 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.35 -113.47 0.29 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.844 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.426 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.9 pt-20 -133.31 166.24 22.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 110.931 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.75 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.2 tttm -73.12 99.91 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.332 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.972 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.43 114.52 26.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.292 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.917 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.62 174.97 6.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.439 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -48.08 -36.01 12.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 0.0 110.767 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -77.39 -34.27 54.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.734 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -73.5 -33.43 64.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.972 0.415 . . . . 0.0 110.029 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.972 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -75.14 -49.32 28.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.871 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.19 -52.83 63.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.708 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -57.34 -28.65 63.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.679 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.495 ' O ' ' HE3' ' A' ' 124' ' ' MET . 5.9 tpt -75.42 -38.41 59.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.294 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.511 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.98 -41.91 81.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.559 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -65.9 -39.61 90.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.647 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.09 -36.41 27.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.55 83.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.487 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.741 ' HB2' HG22 ' A' ' 136' ' ' VAL . 23.7 t0 -100.35 147.26 26.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.004 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.562 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.79 -40.69 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.086 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.562 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.97 -10.94 60.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.647 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.6 1.08 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.2 p-10 -96.16 -12.87 24.06 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.269 -0.965 . . . . 0.0 112.363 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.93 20.2 10.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.816 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -147.05 146.66 30.08 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.954 0.407 . . . . 0.0 109.969 179.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.741 HG22 ' HB2' ' A' ' 129' ' ' ASP . 37.7 t -130.73 107.42 14.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.266 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.547 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.18 174.58 11.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.235 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.638 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.96 -66.96 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.448 0.642 . . . . 0.0 111.332 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.83 -33.85 72.31 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.775 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.523 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.15 -40.11 73.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.877 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.74 -34.69 45.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.047 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.574 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 78.8 t -54.3 -46.02 68.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.786 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -57.43 -46.82 83.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.13 -31.54 64.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.948 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.74 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.29 -51.05 60.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.725 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.7 -53.22 33.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.654 0.264 . . . . 0.0 111.284 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -57.16 -37.74 72.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.003 0.43 . . . . 0.0 110.31 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.948 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.5 t -63.14 -34.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.356 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.919 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -70.75 -55.05 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.919 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 mmm-85 -50.55 -37.24 38.38 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.127 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -68.98 -48.32 63.42 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.61 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.831 ' HD2' HD23 ' A' ' 32' ' ' LEU . 16.9 mtmt -55.78 -55.1 36.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.262 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.905 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.24 -57.49 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.56 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.489 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.72 -50.41 73.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.211 0.529 . . . . 0.0 111.028 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.23 -41.06 65.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.809 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.784 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.0 mt -54.57 -47.68 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.485 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.426 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.53 -37.1 93.98 Favored Glycine 0 CA--C 1.498 -1.006 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.671 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.906 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.94 -61.52 2.11 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.728 -0.736 . . . . 0.0 110.275 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.734 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.26 -28.17 68.98 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.616 177.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -64.8 -52.14 58.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.241 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.744 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.56 -43.34 97.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.026 0.441 . . . . 0.0 109.922 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.2 m -65.79 -35.09 74.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.668 0.747 . . . . 0.0 110.424 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.734 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.3 OUTLIER -71.37 -45.75 62.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.363 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.509 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 57.2 p -60.13 -36.66 77.99 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.723 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 19' ' ' VAL . 27.1 m -72.92 -44.35 57.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.171 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.877 HD23 ' CE1' ' A' ' 141' ' ' PHE . 3.4 pp -64.1 -29.53 70.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.779 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.856 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.732 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -72.75 -170.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -120.87 89.74 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.642 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.4 mt -99.52 164.81 11.93 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.622 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 6.9 p -96.87 161.99 13.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.511 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -47.5 -51.75 19.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.806 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -64.36 -27.65 69.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.973 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.11 -51.55 20.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.643 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.701 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.1 pt -72.8 -28.76 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.882 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.27 -27.33 9.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.0 mt-10 -75.27 -28.42 59.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.314 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.48 -58.51 3.16 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.221 0.534 . . . . 0.0 111.078 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.877 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.54 14.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.218 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.56 -28.01 56.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.45 -39.87 62.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.059 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.877 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.63 -51.77 68.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.851 0.834 . . . . 0.0 109.416 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -74.46 -24.45 59.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.087 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.2 tt -82.04 -24.88 35.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.233 0.539 . . . . 0.0 110.249 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.815 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.2 t80 -93.05 -1.74 56.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.561 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.2 t70 -103.14 143.64 32.35 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.966 0.888 . . . . 0.0 111.114 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -60.2 -53.47 57.31 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.54 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -84.9 -5.95 59.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.801 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.34 46.64 51.95 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.367 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 p30 -91.35 18.44 7.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.83 0.348 . . . . 0.0 110.706 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.33 88.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.611 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.0 p -150.24 150.07 31.04 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -102.0 140.49 20.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.959 0.409 . . . . 0.0 111.939 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.57 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.25 176.48 8.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.009 179.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.83 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.2 p -70.43 -37.88 74.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.058 0.456 . . . . 0.0 110.312 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.0 -41.26 91.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.134 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.926 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -68.91 -53.79 19.1 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.27 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.837 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.96 -55.83 29.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.711 0.767 . . . . 0.0 109.357 178.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.45 -45.77 88.75 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.562 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.4 m -62.74 -32.09 73.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.78 0.324 . . . . 0.0 110.585 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.0 t -66.68 -57.24 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.473 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -71.88 -36.94 70.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.436 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -66.13 -41.3 90.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 110.537 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -79.06 -8.72 59.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.65 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.549 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -90.63 -54.28 4.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.084 0.468 . . . . 0.0 110.746 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.447 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.73 34.45 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.891 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.592 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.63 179.99 5.88 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.301 0.572 . . . . 0.0 111.12 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -159.69 56.22 0.84 Allowed Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.812 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.3 Cg_endo -80.67 -172.23 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.538 2.159 . . . . 0.0 112.116 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -119.08 152.41 36.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.926 0.393 . . . . 0.0 110.142 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.91 -50.08 73.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.41 75.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.462 0.649 . . . . 0.0 110.681 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.58 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.77 -54.29 33.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.702 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.83 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -66.05 -34.54 78.3 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.366 179.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.688 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -64.64 -42.59 95.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.911 0.386 . . . . 0.0 110.149 179.281 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -61.87 -45.46 93.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.218 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.1 mmt -74.54 -30.7 61.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.47 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.28 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.587 -179.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -45.01 -28.6 0.7 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.378 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.43 -39.35 47.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.972 0.415 . . . . 0.0 110.792 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.893 HG11 HG21 ' B' ' 6' ' ' ILE . 4.7 m -80.59 -11.68 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.143 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 38.8 t0 -103.61 155.56 18.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.738 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.491 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.66 -29.08 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.061 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -116.52 -9.66 11.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.429 0.633 . . . . 0.0 110.42 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.2 64.04 4.69 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.445 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -112.45 17.7 19.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.872 0.368 . . . . 0.0 110.214 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.29 19.9 53.85 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.512 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -147.62 176.36 10.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.48 HD12 HD11 ' A' ' 32' ' ' LEU . 54.1 mt -115.03 136.49 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 120.609 0.242 . . . . 0.0 110.853 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.4 m-20 -86.91 -178.42 6.3 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.256 0.551 . . . . 0.0 111.836 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.521 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.87 -55.74 13.06 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.769 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.7 Cg_endo -65.56 -35.14 39.58 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.291 1.994 . . . . 0.0 111.244 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.37 -52.34 62.1 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.242 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.723 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.9 -56.92 15.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.907 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.701 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -54.73 -48.18 72.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.732 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 76.5 m -58.74 -32.3 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.203 0.525 . . . . 0.0 109.716 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.91 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.7 tpp -67.86 -61.6 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.938 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.639 ' HG2' HG22 ' B' ' 10' ' ' ILE . 3.0 mtt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.742 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.795 0.331 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -50.42 -30.48 12.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.241 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.557 ' O ' HG11 ' B' ' 19' ' ' VAL . 4.6 mt-10 -73.77 -29.45 62.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.718 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.654 HG22 ' HE1' ' A' ' 138' ' ' TYR . 14.4 mt -79.04 -51.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -71.95 -50.46 28.76 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 91' ' ' VAL . 83.1 mt-10 -53.51 -25.22 15.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 110.779 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.743 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.72 -36.77 50.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.271 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.9 t80 -68.46 -51.4 43.94 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.014 0.435 . . . . 0.0 110.097 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -55.03 -32.17 61.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.799 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 87' ' ' GLU . 52.0 t -88.78 -22.73 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.617 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.38 -30.11 38.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.049 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -109.13 139.47 43.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.449 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.02 -38.54 91.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.591 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -107.85 -9.64 15.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.18 31.03 39.72 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.144 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -67.53 -13.82 62.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.041 0.421 . . . . 0.0 110.756 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.452 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 100.91 -12.15 59.11 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.976 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 20.3 m-85 -127.35 146.15 50.56 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.914 0.387 . . . . 0.0 111.338 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.834 ' CD1' HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.15 110.01 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.807 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t -83.07 178.24 8.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.43 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.543 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.83 -28.12 69.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.093 0.473 . . . . 0.0 110.557 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.96 -56.8 12.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.291 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.3 mm-40 -76.35 -42.49 44.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.232 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.834 HD13 ' CD1' ' A' ' 100' ' ' ILE . 22.6 tp -56.55 -33.61 66.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.847 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.3 ttt-85 -71.79 -49.47 38.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.945 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -61.87 -38.43 88.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 110.376 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.837 ' O ' HD12 ' A' ' 112' ' ' LEU . 39.9 t -73.06 -43.97 57.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.403 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.451 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 25.4 mmt -73.99 -54.02 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.465 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.619 HG23 ' HA ' ' A' ' 115' ' ' LYS . 8.0 m -55.38 -46.87 76.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.478 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.88 -29.77 68.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.88 ' O ' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -123.0 38.21 4.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.678 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.42 -113.96 0.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.773 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' O ' HD23 ' A' ' 116' ' ' LEU . 4.7 pt-20 -135.21 169.21 17.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.619 ' HA ' HG23 ' A' ' 110' ' ' THR . 6.7 ttpt -73.83 99.75 3.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.0 115.25 27.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.373 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.935 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.81 175.21 5.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.41 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -48.0 -35.89 11.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.397 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -77.4 -35.91 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.71 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -71.66 -33.31 68.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.951 0.405 . . . . 0.0 110.065 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.86 -49.12 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.56 . . . . 0.0 109.849 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -59.46 -52.76 64.22 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.758 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -57.33 -28.7 63.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.82 ' HG3' HD21 ' A' ' 105' ' ' LEU . 10.2 tpt -76.19 -39.43 54.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.121 0.486 . . . . 0.0 110.241 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.495 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -66.58 -41.11 87.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.369 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -64.21 -41.59 96.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.444 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 124' ' ' MET . 7.6 pt-20 -82.73 -33.13 27.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.476 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.39 -35.25 77.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.454 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.707 ' HB2' HG22 ' A' ' 136' ' ' VAL . 20.9 t0 -106.09 146.1 30.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.029 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.562 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.0 pt -82.73 -40.95 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.147 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.562 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.95 -11.05 60.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.675 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.74 33.11 1.0 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.443 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.2 p-10 -96.58 -12.62 23.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.307 -0.946 . . . . 0.0 112.466 -176.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.21 10.18 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.777 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.5 147.21 30.94 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.134 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.707 HG22 ' HB2' ' A' ' 129' ' ' ASP . 26.5 t -130.73 107.25 13.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.364 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.549 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.57 174.57 11.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.222 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.654 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.95 -67.15 0.31 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.54 0.686 . . . . 0.0 111.488 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.412 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.3 mt-10 -60.75 -29.54 69.45 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.563 -1.198 . . . . 0.0 111.913 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.565 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.91 -44.05 77.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.08 0.467 . . . . 0.0 109.762 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -31.91 46.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.134 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 138' ' ' TYR . 67.5 t -54.03 -48.29 64.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.132 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.625 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -57.99 -44.99 87.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.7 tpp -73.14 -32.92 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.7 ttp . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.919 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.941 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.3 -50.89 61.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.056 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.726 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.72 -53.26 32.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.678 0.275 . . . . 0.0 111.241 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -57.07 -37.68 72.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.051 0.453 . . . . 0.0 110.365 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.941 HG23 ' O ' ' B' ' 1' ' ' ALA . 12.4 t -63.45 -33.64 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.415 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.893 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.52 -55.43 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.026 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.2 mmm-85 -50.58 -37.61 40.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.214 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -69.76 -47.17 63.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.543 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.837 ' HD2' HD23 ' A' ' 32' ' ' LEU . 14.6 mtmt -56.0 -55.41 33.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.91 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.52 -57.34 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.049 0.452 . . . . 0.0 111.059 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -56.16 -51.19 68.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.954 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.552 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.39 -40.24 64.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.094 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.571 ' O ' ' HB2' ' B' ' 17' ' ' ALA . 3.1 mt -54.44 -51.52 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.506 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.3 -36.27 93.19 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.08 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.916 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.73 -61.44 2.18 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.812 -0.694 . . . . 0.0 110.413 -178.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.668 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -62.97 -27.84 69.68 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.647 177.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -66.05 -51.31 59.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.226 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.564 ' NE ' HG12 ' B' ' 19' ' ' VAL . 3.7 ppt_? -63.49 -43.48 97.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.977 0.418 . . . . 0.0 109.918 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.916 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.4 m -66.61 -32.29 57.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.679 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.668 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -71.65 -50.94 25.95 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.955 -179.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.448 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 54.7 p -57.85 -36.24 72.05 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.482 HG22 ' C ' ' B' ' 19' ' ' VAL . 26.8 m -72.55 -45.25 59.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.102 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.537 HD21 ' CD1' ' B' ' 20' ' ' PHE . 3.1 pp -65.71 -26.42 67.75 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.084 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 12.7 ptt180 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.926 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.63 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.765 0.317 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.4 ' HB2' HD21 ' A' ' 4' ' ' LEU . 4.8 m-20 -64.87 -169.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -117.28 89.42 3.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.02 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.632 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.93 164.72 12.25 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.482 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.49 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.0 p -97.84 162.47 13.24 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.527 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -47.51 -51.42 20.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.831 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.39 -27.62 69.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.022 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.49 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.4 -51.43 20.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.72 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.9 pt -73.24 -28.9 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.862 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.47 -27.39 10.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 17.9 mt-10 -75.21 -28.57 60.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.256 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.35 -58.5 3.18 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.873 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 10.9 ptmt -54.52 -23.01 14.64 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.206 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.37 -27.93 56.58 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.39 -39.9 62.41 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.106 177.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.873 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.8 -51.94 67.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.79 0.805 . . . . 0.0 109.398 178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.43 -24.14 59.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.089 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.903 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.14 -26.29 33.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.22 0.533 . . . . 0.0 110.147 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.878 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.9 t80 -91.24 -1.4 57.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.356 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.9 t70 -103.09 144.11 31.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.004 0.907 . . . . 0.0 111.072 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -60.37 -53.4 58.02 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 113.859 -1.519 . . . . 0.0 111.68 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.29 -6.51 59.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.75 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.06 46.16 56.23 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.169 -0.538 . . . . 0.0 113.371 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.3 p30 -90.88 17.95 7.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.831 0.348 . . . . 0.0 110.732 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.55 88.65 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 49.6 p -150.29 148.98 29.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -100.54 140.52 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.016 0.436 . . . . 0.0 111.907 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.594 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.52 178.07 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.131 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.812 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -70.46 -40.45 73.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.107 0.479 . . . . 0.0 110.382 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -58.48 -40.87 83.94 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.402 178.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.824 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.61 -53.86 16.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.378 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.758 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -57.33 -54.17 49.85 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.785 0.802 . . . . 0.0 109.583 178.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.69 -46.78 92.87 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.27 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.9 m -66.25 -30.14 70.52 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.757 0.313 . . . . 0.0 110.493 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.878 HG21 ' CE2' ' A' ' 19' ' ' PHE . 16.7 t -64.03 -57.89 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.06 0.457 . . . . 0.0 110.635 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -72.48 -40.38 66.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.255 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -61.09 -38.87 87.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 110.378 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -78.8 -12.23 60.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.526 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.548 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -87.46 -53.48 4.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.0 110.544 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.453 ' N ' HD23 ' A' ' 39' ' ' LEU . . . 180.0 35.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.568 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.609 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -131.31 -179.96 5.66 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.287 0.565 . . . . 0.0 111.245 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -159.71 56.17 0.84 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.783 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.3 Cg_endo -80.72 -173.52 1.88 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.588 2.192 . . . . 0.0 112.202 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -119.7 152.39 37.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 110.075 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.71 -50.14 73.07 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.85 76.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.711 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.577 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.91 -54.37 31.91 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.76 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.812 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.65 -38.18 90.12 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.313 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.711 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -61.79 -42.57 99.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.884 0.373 . . . . 0.0 110.428 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -61.73 -46.09 91.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.5 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -30.6 61.73 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.606 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -53.66 -40.19 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.761 -178.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.423 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.4 m-80 -45.11 -28.68 0.77 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.383 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.84 -38.0 47.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.977 0.418 . . . . 0.0 110.734 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.057 HG11 HG21 ' B' ' 6' ' ' ILE . 3.8 m -80.8 -12.63 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 43.2 t0 -103.46 155.25 18.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.699 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.09 26.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.179 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -116.44 -9.72 11.42 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.402 0.62 . . . . 0.0 110.415 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.72 61.52 7.29 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.295 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -109.74 18.49 20.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.758 0.313 . . . . 0.0 110.411 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.32 19.96 59.65 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.303 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.4 p -147.48 176.23 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.758 HD12 HD11 ' A' ' 32' ' ' LEU . 14.2 mt -113.47 136.66 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.644 0.259 . . . . 0.0 110.717 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -86.24 -179.96 6.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.208 0.528 . . . . 0.0 111.876 -179.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.89 -55.88 12.71 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.471 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.7 Cg_endo -65.76 -35.04 38.28 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.186 1.924 . . . . 0.0 111.18 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -52.51 63.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.724 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.35 -56.66 19.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.816 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.73 -47.92 78.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.813 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.63 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 53.3 m -59.39 -30.66 68.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.473 . . . . 0.0 110.102 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.89 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.1 tpp -63.61 -61.79 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.112 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.403 ' CG ' HG22 ' B' ' 10' ' ' ILE . 40.3 mtm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.145 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.791 0.329 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -50.72 -30.67 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.681 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -78.16 -29.44 48.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.678 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.685 HG22 ' HE1' ' A' ' 138' ' ' TYR . 8.4 mt -79.21 -51.13 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.32 -52.04 11.77 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 91' ' ' VAL . 10.1 tt0 -53.85 -25.63 20.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.703 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.46 -35.75 46.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.265 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.601 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 27.6 t80 -68.58 -51.38 43.2 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 110.026 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -54.76 -32.61 60.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.796 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 87' ' ' GLU . 46.6 t -88.75 -22.67 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.631 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.487 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -53.05 -33.33 51.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.271 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -100.64 148.85 24.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.519 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.27 -37.69 78.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.22 -9.77 13.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.782 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.59 28.47 32.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.313 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -67.51 -13.97 62.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.183 0.491 . . . . 0.0 110.752 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.27 -10.27 56.53 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.187 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.469 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.5 m-85 -127.08 145.42 50.74 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.988 0.423 . . . . 0.0 111.5 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.829 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.18 109.9 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.843 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -83.84 175.18 9.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.329 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.549 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -62.63 -29.05 70.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.001 0.429 . . . . 0.0 110.37 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -56.81 14.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.252 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.769 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.37 -46.54 26.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.279 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.829 HD13 HD13 ' A' ' 100' ' ' ILE . 15.5 tp -52.99 -36.07 59.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.798 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.2 ttt180 -68.05 -49.1 63.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.877 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -58.17 -44.52 88.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.232 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.826 ' O ' HD12 ' A' ' 112' ' ' LEU . 1.8 t -73.01 -42.28 59.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.552 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.477 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 26.6 mmt -70.16 -54.06 14.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.514 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 115' ' ' LYS . 7.3 m -58.39 -48.36 80.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.3 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -58.48 -29.29 66.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.84 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.903 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -122.98 37.52 4.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.75 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -168.85 -116.17 0.36 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.708 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 110' ' ' THR . 6.3 pt-20 -131.51 172.23 12.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.72 0.295 . . . . 0.0 110.777 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.625 ' HA ' HG23 ' A' ' 110' ' ' THR . 12.3 ttpt -75.78 98.77 4.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.288 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.967 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.4 OUTLIER -91.47 112.72 24.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.551 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.917 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.8 174.9 6.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.328 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.11 -36.13 12.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 0.0 110.757 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -77.38 -33.91 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.757 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -73.64 -34.72 65.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.023 0.439 . . . . 0.0 110.023 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.967 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -72.73 -47.99 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.872 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -58.81 -52.87 63.89 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.837 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -56.64 -28.91 61.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.928 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.82 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.8 tpt -76.31 -38.73 55.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.182 0.515 . . . . 0.0 110.111 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.51 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -67.51 -48.51 76.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.521 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -60.26 -40.32 89.9 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.85 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 124' ' ' MET . 14.1 pt-20 -80.55 -37.13 32.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 110.604 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.436 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.83 -36.47 82.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.555 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.722 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.4 t0 -101.57 147.87 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.062 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.56 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.7 pt -84.88 -40.74 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.048 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.56 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.98 -10.9 59.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.692 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.09 32.68 1.1 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.433 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.1 -12.79 24.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.303 -0.949 . . . . 0.0 112.482 -176.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.89 20.12 10.22 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.813 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.51 146.83 30.66 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.928 0.395 . . . . 0.0 110.029 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 129' ' ' ASP . 35.4 t -130.74 107.39 14.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.307 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.546 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -79.18 174.69 11.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.337 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.685 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.84 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.548 0.69 . . . . 0.0 111.421 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -60.3 -34.77 74.26 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.839 -178.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.505 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.06 -41.55 75.24 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.823 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.77 -31.85 46.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.022 178.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 138' ' ' TYR . 53.6 t -55.54 -47.23 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.596 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -56.07 -45.15 79.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.966 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.16 -32.11 64.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.5 ' HE2' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.939 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.714 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.47 -52.17 55.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.214 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.704 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.78 -53.32 32.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 111.394 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.94 -36.89 70.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 0.0 110.295 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.939 HG23 ' O ' ' B' ' 1' ' ' ALA . 39.6 t -62.05 -39.19 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.1 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 1.057 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -65.92 -55.48 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.166 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -50.91 -37.31 43.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.022 0.439 . . . . 0.0 110.202 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -73.32 -45.86 52.86 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.718 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.876 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.4 OUTLIER -55.02 -55.47 30.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.999 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.89 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.5 mt -51.49 -57.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.421 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -57.8 -51.33 70.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.218 0.532 . . . . 0.0 111.021 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.525 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.46 -42.47 67.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.779 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.785 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.3 mt -54.57 -48.07 71.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.577 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.26 -38.26 96.18 Favored Glycine 0 CA--C 1.499 -0.954 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.077 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.897 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.14 -61.75 2.06 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.831 -0.685 . . . . 0.0 110.445 -178.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.651 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.7 OUTLIER -61.8 -27.84 69.04 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.65 177.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.19 -50.89 64.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.258 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.713 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.89 -43.65 95.37 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.897 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -64.34 -33.68 64.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.532 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.711 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.4 OUTLIER -74.3 -45.04 50.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.737 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.528 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.8 p -59.85 -25.96 65.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.457 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.407 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.5 -46.15 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.134 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.935 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.83 -34.23 76.88 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.164 0.507 . . . . 0.0 110.323 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.935 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.064 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.827 0.346 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.69 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.762 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -123.78 89.36 3.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.107 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.629 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.03 164.71 12.41 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.354 179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.504 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.2 p -97.89 162.31 13.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.482 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -47.53 -51.4 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.819 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -64.48 -27.66 69.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.018 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.504 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.22 -51.52 20.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.683 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.703 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.0 pt -73.31 -28.89 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.806 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.31 10.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.537 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 13.8 mt-10 -75.38 -28.62 59.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.369 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.1 m-85 -79.25 -58.69 3.09 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.174 0.511 . . . . 0.0 111.189 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.872 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -55.37 -21.89 17.33 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.249 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -77.23 -28.03 53.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.18 -40.1 62.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.082 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.872 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.46 -51.95 67.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.853 0.835 . . . . 0.0 109.448 178.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 5.1 p -74.35 -24.27 59.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.161 -1.382 . . . . 0.0 112.149 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.905 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.14 -25.85 34.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.31 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.878 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.7 t80 -92.16 -1.99 56.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.632 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.9 t70 -101.77 143.5 31.62 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.963 0.887 . . . . 0.0 111.152 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -60.16 -53.38 58.44 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.552 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.15 -5.6 59.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.791 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.22 46.45 51.42 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.349 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -91.11 18.17 7.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.82 0.343 . . . . 0.0 110.704 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.52 5.1 88.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.605 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 47.0 p -150.29 149.25 29.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.748 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.8 140.51 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.895 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.631 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.29 177.01 7.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.124 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.8 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -70.35 -39.05 74.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.102 0.477 . . . . 0.0 110.301 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.534 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.35 -40.78 87.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.285 178.81 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.817 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.57 -53.83 17.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.329 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.771 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -57.7 -54.38 47.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.786 0.803 . . . . 0.0 109.531 178.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.33 -46.63 92.69 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.296 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.1 m -66.76 -30.06 70.18 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.749 0.309 . . . . 0.0 110.479 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.878 HG21 ' CE2' ' A' ' 19' ' ' PHE . 13.0 t -63.51 -57.95 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 0.0 110.534 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.534 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -72.44 -40.94 66.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.196 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -39.26 86.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.982 0.42 . . . . 0.0 110.494 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -78.81 -12.14 60.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.537 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.3 tt -87.73 -54.07 4.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 0.0 110.596 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.467 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -179.02 36.87 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.752 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 tp-100 -134.9 -179.46 5.62 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.332 0.587 . . . . 0.0 111.22 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -159.68 56.35 0.86 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.892 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.49 -176.71 3.32 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.583 2.189 . . . . 0.0 112.153 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.604 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -115.89 152.5 33.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 110.203 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.11 -49.64 75.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -34.19 77.57 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.98 -54.35 31.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.657 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.8 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.7 -38.17 90.08 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 120.246 -0.581 . . . . 0.0 110.329 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.715 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.36 -42.15 99.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.891 0.377 . . . . 0.0 110.405 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.09 -47.34 86.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.431 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.41 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 23.9 mmt -74.51 -30.32 61.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.732 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.42 -38.64 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.584 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -45.52 -28.53 0.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.298 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.74 -38.03 47.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.935 0.398 . . . . 0.0 110.833 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.082 HG11 HG21 ' B' ' 6' ' ' ILE . 4.2 m -81.92 -11.78 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.218 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.552 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.9 t0 -103.46 155.48 18.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.729 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.477 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.58 -28.73 26.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.084 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -116.38 -9.72 11.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.387 0.613 . . . . 0.0 110.458 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.38 63.08 5.56 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.467 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -112.19 18.45 18.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.835 0.35 . . . . 0.0 110.194 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 85.9 19.95 56.71 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.445 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.631 HG22 ' HA ' ' A' ' 28' ' ' THR . 5.0 p -146.5 176.44 9.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.771 HD12 HD11 ' A' ' 32' ' ' LEU . 15.1 mt -116.44 136.48 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.522 0.201 . . . . 0.0 110.883 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 8.7 m-20 -86.67 -178.95 6.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.273 0.558 . . . . 0.0 111.908 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.84 -55.94 12.72 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.607 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -65.6 -35.05 39.63 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.22 1.947 . . . . 0.0 111.223 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.64 -52.38 63.57 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.199 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.06 -56.86 16.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.844 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.703 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.11 -47.5 80.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.729 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.413 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 58.3 m -59.06 -30.76 68.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.055 0.455 . . . . 0.0 110.061 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.904 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.1 tpp -65.54 -61.75 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.229 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.485 ' CG ' HG22 ' B' ' 10' ' ' ILE . 12.1 mtm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.104 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.77 0.319 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -77.22 -42.07 38.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.274 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.708 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.71 -29.32 26.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.541 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.726 HG22 ' HE1' ' A' ' 138' ' ' TYR . 23.0 mt -66.07 -51.42 60.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.794 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -75.81 -50.65 14.58 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.774 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.7 mt-10 -53.87 -30.69 46.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.661 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.557 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -71.16 -38.62 72.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.792 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.6 t80 -67.08 -55.92 12.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 0.0 110.541 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.85 -30.51 45.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.832 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 87' ' ' GLU . 75.6 t -88.36 -22.86 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.309 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.25 -32.54 62.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.982 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -102.08 148.64 25.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -69.62 -37.53 76.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.375 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -112.26 -9.76 13.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.5 30.65 32.61 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.119 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -67.42 -13.52 62.1 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.928 0.364 . . . . 0.0 110.823 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.46 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.16 -13.61 55.44 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.846 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.5 m-85 -127.22 145.9 50.61 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.961 0.41 . . . . 0.0 111.3 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.713 HD12 HD12 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.09 109.99 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.85 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -82.19 177.71 8.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.48 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.3 -28.17 69.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.009 0.433 . . . . 0.0 110.559 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.35 -57.72 9.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.314 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.8 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.47 -38.74 54.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.006 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.918 HD11 ' HG3' ' A' ' 124' ' ' MET . 5.5 tt -56.5 -33.15 65.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.821 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.7 ttt180 -74.77 -49.4 21.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.172 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -36.72 79.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.064 0.459 . . . . 0.0 110.321 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 104' ' ' GLU . 45.6 t -72.9 -45.69 54.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.242 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.454 ' HE3' HD11 ' B' ' 23' ' ' LEU . 22.3 mmt -73.93 -54.14 8.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.818 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.577 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.2 m -55.46 -43.11 75.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 111.362 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.463 ' C ' HD12 ' A' ' 112' ' ' LEU . 38.4 t-20 -61.21 -31.81 71.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.788 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.905 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -123.17 38.76 4.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.31 -116.96 0.39 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.782 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.404 ' O ' HD23 ' A' ' 116' ' ' LEU . 14.6 pt-20 -133.61 171.88 13.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.821 0.343 . . . . 0.0 110.944 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.577 ' HA ' HG23 ' A' ' 110' ' ' THR . 24.7 ttpt -75.38 100.08 4.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.294 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.951 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.41 115.48 26.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.29 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.933 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.76 174.99 6.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.404 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 117' ' ' THR . 0.6 OUTLIER -48.0 -35.76 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.92 0.391 . . . . 0.0 110.734 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.29 -36.15 54.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.699 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -71.13 -34.56 71.14 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.056 0.455 . . . . 0.0 110.084 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.951 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -73.62 -50.02 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.351 0.596 . . . . 0.0 109.776 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -59.76 -52.85 63.7 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.859 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.84 -28.83 62.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.938 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.918 ' HG3' HD11 ' A' ' 105' ' ' LEU . 7.4 tpt -76.35 -38.75 55.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.151 0.5 . . . . 0.0 110.13 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.619 HG12 HD13 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -66.15 -49.07 78.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.521 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -60.13 -40.12 88.66 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.967 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 124' ' ' MET . 12.2 pt-20 -81.01 -37.31 29.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 110.647 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.466 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.33 -36.96 84.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.518 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.747 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.1 t0 -100.39 148.1 25.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.025 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.563 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.8 -40.8 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.297 0.57 . . . . 0.0 110.073 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.563 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.83 -11.03 60.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.682 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.14 32.59 1.1 Allowed Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.04 -12.94 24.16 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.309 -0.946 . . . . 0.0 112.434 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.88 20.18 10.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.81 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -146.74 146.69 30.38 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.905 0.383 . . . . 0.0 110.061 179.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.747 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.7 t -130.67 107.47 14.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.24 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.546 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.01 174.65 11.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.426 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.726 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.97 -67.06 0.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.479 0.657 . . . . 0.0 111.531 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -34.15 72.9 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.913 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.532 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.12 -40.34 73.61 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.827 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.79 -33.67 46.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.114 178.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.582 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.6 t -54.86 -47.43 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.688 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -58.13 -45.2 87.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.12 -32.5 64.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.408 ' HE1' HG12 ' A' ' 85' ' ' ILE . 14.1 ttp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.937 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.717 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.44 -52.37 54.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.209 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.714 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.83 -53.2 34.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.291 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -56.84 -37.02 70.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.009 0.433 . . . . 0.0 110.256 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.937 HG23 ' O ' ' B' ' 1' ' ' ALA . 40.7 t -61.94 -39.16 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.081 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 1.082 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -66.03 -55.53 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.15 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -50.96 -37.16 42.88 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.2 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.22 -45.55 55.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.622 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.872 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.3 OUTLIER -55.33 -55.32 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.129 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.904 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.5 mt -51.29 -57.5 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.802 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.506 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.8 tpt180 -60.3 -51.32 70.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.273 0.559 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.35 -40.13 64.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.679 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.737 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.46 -47.75 70.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.27 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.41 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.92 -38.25 95.81 Favored Glycine 0 CA--C 1.497 -1.06 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.493 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.898 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.93 -61.61 2.06 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.646 -0.777 . . . . 0.0 110.507 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.76 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.19 -27.49 67.19 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.81 -48.57 65.89 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.017 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.7 ppt_? -63.28 -43.57 97.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.127 0.489 . . . . 0.0 109.798 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.898 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -61.78 -34.82 64.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.348 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.752 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -74.95 -43.94 51.27 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.633 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.548 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 18.7 p -60.74 -25.77 66.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.495 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.418 HG23 ' N ' ' B' ' 23' ' ' LEU . 29.3 m -90.25 -46.5 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.09 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.954 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.37 -34.47 76.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.184 0.516 . . . . 0.0 110.348 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.954 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.092 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.627 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.821 0.343 . . . . 0.0 111.069 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.65 -169.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -117.5 90.65 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.975 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.2 mt -98.72 164.88 12.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.557 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.484 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.3 p -96.94 161.82 13.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.494 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.52 -51.91 19.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.798 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -64.28 -27.73 69.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.015 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.94 -51.52 21.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.662 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.701 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.6 pt -72.84 -28.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.816 -179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.36 -27.29 9.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 7.9 mt-10 -74.88 -28.5 60.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.171 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.6 -58.34 3.24 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.198 0.523 . . . . 0.0 110.994 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.871 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -54.45 -23.01 14.3 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.188 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.24 -27.94 56.96 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.48 -39.8 62.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.079 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.871 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.93 -51.82 68.39 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.85 0.834 . . . . 0.0 109.416 178.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.43 -24.26 59.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.096 -1.411 . . . . 0.0 112.134 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.857 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.2 tt -82.08 -24.24 35.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.248 0.547 . . . . 0.0 110.191 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.815 ' HB3' HD11 ' A' ' 27' ' ' ILE . 2.6 t80 -95.61 0.82 53.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.434 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.9 t70 -105.58 145.13 31.37 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.013 0.911 . . . . 0.0 111.123 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.0 mmtt -60.54 -53.39 58.07 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.587 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.43 -6.09 59.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.06 47.23 55.12 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.194 -0.526 . . . . 0.0 113.515 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -92.66 17.8 9.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.871 0.367 . . . . 0.0 110.469 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.16 9.25 86.34 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.258 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.462 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 72.8 p -150.16 147.23 27.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.6 mt -101.96 140.39 20.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.904 0.383 . . . . 0.0 111.927 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.683 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.4 t -87.27 -179.29 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.123 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.791 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.4 p -70.49 -45.51 65.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 110.899 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.648 ' HG3' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -54.54 -40.54 68.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.449 178.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.911 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -69.52 -53.83 17.14 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.467 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.858 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.92 -56.07 26.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.78 0.8 . . . . 0.0 109.379 178.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -56.86 -46.2 90.73 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.64 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.2 m -62.05 -35.01 77.31 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.047 0.423 . . . . 0.0 110.542 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.0 t -64.0 -57.19 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.46 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -71.82 -36.05 70.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.404 -179.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 2.8 ttt-85 -67.25 -41.22 85.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.999 0.428 . . . . 0.0 110.48 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 t -79.0 -8.32 58.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.627 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.541 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.82 -54.33 4.02 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.762 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.447 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.91 34.57 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.837 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.596 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.76 -179.37 5.49 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.317 0.58 . . . . 0.0 111.141 -179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -159.67 56.39 0.87 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.815 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.8 Cg_endo -80.56 -174.85 2.41 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.568 2.179 . . . . 0.0 112.117 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -116.87 152.45 34.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.945 0.402 . . . . 0.0 110.159 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.69 -50.03 73.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.14 74.94 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.75 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.98 -54.3 32.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.733 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.791 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.71 -35.57 81.12 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.419 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.752 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -63.4 -42.95 98.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.868 0.366 . . . . 0.0 110.224 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.85 -45.36 94.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.373 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.56 -30.68 61.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.449 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -53.72 -39.51 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.637 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.415 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 5.9 m-80 -44.99 -28.64 0.7 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.387 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.65 -38.52 54.47 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.954 0.407 . . . . 0.0 110.73 179.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.816 HG11 HG21 ' B' ' 6' ' ' ILE . 5.5 m -80.99 -12.77 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.049 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 42.9 t0 -103.5 154.88 18.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.815 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.68 -28.03 26.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.227 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -116.42 -9.72 11.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.386 0.612 . . . . 0.0 110.423 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.91 61.66 7.11 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.315 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -109.52 18.4 20.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 110.475 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.75 18.93 60.66 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.407 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 28' ' ' THR . 6.2 p -146.54 176.12 10.06 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 26' ' ' THR . 61.0 mt -112.91 136.49 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.585 0.231 . . . . 0.0 110.675 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -85.12 179.56 7.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.243 0.544 . . . . 0.0 111.824 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.518 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 6.3 m-85 -67.45 -56.52 12.32 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.285 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.82 -36.11 33.03 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.326 2.017 . . . . 0.0 111.071 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.61 -52.32 65.67 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.135 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.94 -56.29 23.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.657 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.701 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.34 -46.67 83.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.706 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.627 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 65.1 m -61.2 -31.79 71.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.013 0.435 . . . . 0.0 110.11 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.925 ' HG2' HD13 ' B' ' 10' ' ' ILE . 4.5 tpp -60.86 -61.77 2.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.125 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.8 mtp . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.991 -179.871 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.866 0.365 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -50.47 -30.51 12.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.564 ' O ' HG11 ' B' ' 19' ' ' VAL . 4.7 mt-10 -76.49 -29.59 56.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.685 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.691 HG22 ' HE1' ' A' ' 138' ' ' TYR . 11.2 mt -79.26 -51.13 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -48.41 39.04 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.893 0.378 . . . . 0.0 111.87 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.41 ' OE2' ' HB1' ' B' ' 12' ' ' ALA . 6.5 tt0 -53.6 -26.31 21.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.344 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.742 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.4 -34.31 58.83 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.052 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 12.8 t80 -68.79 -50.05 53.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.12 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -54.5 -33.17 59.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.778 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.8 t -88.95 -22.79 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.542 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.28 -33.63 53.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.206 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -106.18 139.24 41.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.521 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -64.74 -34.77 79.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -112.15 -9.7 13.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.97 29.26 38.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.36 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.68 -13.92 62.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.134 0.467 . . . . 0.0 110.745 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 100.48 -11.6 59.75 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.004 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.483 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.3 m-85 -127.19 147.3 50.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.038 0.447 . . . . 0.0 111.438 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.085 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.19 109.96 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.721 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 t -82.62 176.52 9.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.46 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.09 -29.71 70.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.075 0.464 . . . . 0.0 110.477 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.26 -57.8 10.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.236 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.816 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.45 -45.38 31.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.126 -179.214 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.085 HD13 HD13 ' A' ' 100' ' ' ILE . 31.9 tp -52.95 -31.24 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.191 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.832 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.9 ttt-85 -73.47 -49.17 28.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -58.67 -42.48 88.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.074 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.9 t -72.99 -40.04 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.546 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.7 mmt -73.99 -54.18 8.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.528 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.636 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.4 m -55.5 -46.96 76.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.376 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -59.9 -30.7 69.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.857 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -121.54 37.52 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.49 -113.97 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.688 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.1 pt-20 -135.87 170.61 15.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.824 0.345 . . . . 0.0 110.805 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.636 ' HA ' HG23 ' A' ' 110' ' ' THR . 9.6 tttm -73.73 98.22 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.152 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.14 113.52 24.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.385 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.919 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.79 175.45 5.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.368 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -48.13 -35.93 12.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.896 0.379 . . . . 0.0 110.766 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.4 -34.51 54.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -73.44 -33.5 64.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.009 0.433 . . . . 0.0 110.096 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.47 -48.16 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.819 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.62 -52.85 63.77 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.735 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -57.48 -28.72 63.65 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.779 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.786 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.9 tpt -76.2 -38.02 57.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.121 0.486 . . . . 0.0 110.137 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.491 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.28 -41.84 81.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.494 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -66.08 -38.92 89.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.933 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.54 -35.94 29.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.512 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.471 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.54 -37.47 79.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.416 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.737 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.2 t0 -100.5 145.61 28.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.979 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.553 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.7 pt -83.17 -40.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.248 0.547 . . . . 0.0 110.101 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.553 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.9 -11.06 60.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.781 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.79 32.88 0.99 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -176.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.04 -12.48 24.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.341 -0.93 . . . . 0.0 112.53 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.2 10.18 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.84 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.483 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.31 146.76 30.82 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.2 t -130.75 107.22 13.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.354 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.567 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.3 t30 -78.25 175.2 10.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.206 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.735 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.91 -67.12 0.31 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.612 0.72 . . . . 0.0 111.635 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.3 mt-10 -64.96 -25.85 68.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.553 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.574 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -55.57 -48.47 74.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 110.35 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.0 p90 -78.81 -31.03 45.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.24 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 138' ' ' TYR . 65.7 t -52.8 -44.49 48.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.094 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -59.26 -38.74 80.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 109.828 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.49 -40.71 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.704 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.421 ' CG ' HG21 ' B' ' 22' ' ' VAL . 3.8 ttp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.009 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.947 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.815 0.34 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.731 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.26 -51.22 59.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.061 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.711 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.68 -53.28 32.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.261 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.95 -37.54 71.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.999 0.428 . . . . 0.0 110.31 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.947 HG23 ' O ' ' B' ' 1' ' ' ALA . 15.3 t -63.35 -34.44 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.436 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.816 HG21 HG11 ' A' ' 55' ' ' VAL . 2.2 mt -71.32 -54.89 15.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.039 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -50.94 -37.63 45.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.154 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.85 -48.32 63.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.404 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.858 ' HD2' HD23 ' A' ' 32' ' ' LEU . 13.2 mtmt -54.25 -54.08 44.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.067 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.925 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.9 mt -51.13 -57.5 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.4 tpt180 -60.06 -51.41 69.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.28 0.562 . . . . 0.0 111.089 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.39 -40.38 65.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.763 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.755 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.57 -50.8 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.462 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.52 -37.06 94.08 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.235 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.909 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.02 -61.82 2.03 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.861 -0.669 . . . . 0.0 110.529 -178.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.69 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -63.17 -27.59 69.47 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.673 177.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.89 -50.48 64.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.28 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.747 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -64.63 -43.63 93.08 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.909 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.3 m -64.98 -33.02 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.543 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.69 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -74.68 -45.92 41.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.944 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.546 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.46 -26.34 65.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.505 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.438 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.3 -47.41 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.229 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.887 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -62.79 -33.54 75.4 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.254 0.549 . . . . 0.0 110.511 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.887 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.071 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.819 0.343 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.83 -169.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.785 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -118.65 89.26 3.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.994 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.623 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.29 164.7 12.37 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.9 p -98.29 162.67 13.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.48 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -47.56 -51.31 21.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.845 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.48 -27.66 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.994 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.6 OUTLIER -72.4 -51.46 20.32 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.696 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.692 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.2 pt -73.19 -28.89 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.822 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.43 -27.45 10.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.53 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 15.2 mm-40 -75.34 -28.55 59.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.327 178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.36 -58.64 3.11 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.228 0.537 . . . . 0.0 111.083 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.56 -23.26 15.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.243 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -75.86 -28.08 58.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.123 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.07 -39.83 63.18 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.149 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.81 -51.81 68.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.762 0.791 . . . . 0.0 109.515 178.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.38 -24.41 59.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.044 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.1 -25.34 34.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.217 0.532 . . . . 0.0 110.279 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.871 ' CE2' HG21 ' A' ' 35' ' ' VAL . 3.1 t80 -92.23 -2.37 56.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.0 t70 -102.42 143.45 32.14 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.959 0.885 . . . . 0.0 111.026 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 3.7 mmtt -60.01 -53.36 58.77 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.626 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.46 -5.19 59.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.777 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.55 47.0 45.96 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.331 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.6 p30 -91.47 18.22 7.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.905 0.383 . . . . 0.0 110.711 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.54 5.27 88.6 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.589 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.9 p -150.38 148.61 29.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.782 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.32 140.55 19.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.975 0.416 . . . . 0.0 111.763 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.575 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.21 178.21 7.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.374 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.758 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -69.62 -41.2 75.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 110.353 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -58.11 -41.24 83.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.439 179.127 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.811 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.79 -53.75 16.79 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.407 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -58.07 -54.15 50.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.81 0.814 . . . . 0.0 109.555 178.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -58.8 -47.08 92.29 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.384 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.4 m -65.33 -30.79 71.67 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.448 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.871 HG21 ' CE2' ' A' ' 19' ' ' PHE . 16.7 t -63.88 -57.91 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.536 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -72.57 -40.25 66.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.31 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 20.5 ttt180 -61.21 -38.56 87.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 110.447 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.3 t -78.84 -12.08 60.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.539 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -87.46 -53.12 4.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.178 0.514 . . . . 0.0 110.52 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.444 ' N ' HD23 ' A' ' 39' ' ' LEU . . . 178.74 36.16 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.606 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.601 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -131.07 179.39 6.03 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.342 0.591 . . . . 0.0 111.257 -179.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -159.78 56.11 0.82 Allowed Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.773 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.7 Cg_endo -80.67 -173.74 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.615 2.21 . . . . 0.0 112.226 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.618 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.91 152.42 36.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.87 0.367 . . . . 0.0 110.093 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.41 -50.14 72.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.0 -32.01 72.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.602 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -66.49 -54.45 23.77 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.648 -179.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.758 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.26 -47.05 86.06 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.108 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.663 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -55.85 -44.94 78.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 110.806 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.4 -47.51 81.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -74.68 -30.61 61.64 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.968 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -54.15 -36.26 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.667 -178.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.401 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 22.0 t-20 -45.02 -28.64 0.72 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.282 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -79.39 -39.03 33.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.898 0.38 . . . . 0.0 110.731 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.031 HG11 HG21 ' B' ' 6' ' ' ILE . 3.6 m -80.01 -11.16 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.089 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 37.2 t0 -103.58 155.93 18.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.74 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.6 -29.38 25.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.1 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -116.51 -9.61 11.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.428 0.632 . . . . 0.0 110.442 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.4 63.86 4.85 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.519 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -112.49 17.84 18.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.807 0.337 . . . . 0.0 110.186 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.3 19.94 53.69 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.1 p -147.56 176.35 10.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.677 HD12 HD11 ' A' ' 32' ' ' LEU . 19.0 mt -115.03 136.48 51.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.554 0.216 . . . . 0.0 110.95 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.7 m-20 -88.18 -178.14 5.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.29 0.567 . . . . 0.0 112.001 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.75 -55.86 13.15 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.713 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.8 Cg_endo -65.66 -34.32 41.78 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.226 1.95 . . . . 0.0 111.267 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.72 -52.47 60.37 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.219 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.724 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.11 -57.15 13.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.88 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.692 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.23 -47.92 80.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.689 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 52.6 m -58.83 -30.54 67.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.066 0.46 . . . . 0.0 110.05 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.881 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.0 tpp -63.76 -61.71 2.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.234 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.439 ' CG ' HG22 ' B' ' 10' ' ' ILE . 7.5 mtm . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.243 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.811 0.338 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -51.5 -30.53 20.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.666 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -78.0 -29.41 49.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.704 HG22 ' HE1' ' A' ' 138' ' ' TYR . 7.2 mt -79.14 -51.26 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.438 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.3 -51.91 12.11 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 91' ' ' VAL . 12.3 tm-20 -53.76 -25.47 19.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.786 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.706 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.62 -36.21 44.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.214 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.5 t80 -68.2 -52.13 37.84 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.0 0.429 . . . . 0.0 110.1 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -54.73 -31.98 59.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.821 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 87' ' ' GLU . 47.7 t -88.69 -22.74 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.514 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.48 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.36 -34.32 57.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.26 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -99.19 147.93 24.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.467 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -67.54 -38.22 83.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.375 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.29 -9.84 13.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.804 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.93 28.29 31.9 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.246 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -67.48 -13.9 62.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.211 0.505 . . . . 0.0 110.764 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.452 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -11.0 55.35 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.146 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.463 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.9 m-85 -127.09 145.0 50.89 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.011 0.434 . . . . 0.0 111.414 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.032 HD13 HD13 ' A' ' 105' ' ' LEU . 1.1 pt -121.15 109.97 26.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.726 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -83.7 177.15 8.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.582 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.549 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.2 -29.92 71.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.084 0.469 . . . . 0.0 110.449 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.3 -57.68 11.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.28 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.778 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.48 -45.66 30.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.135 -179.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.032 HD13 HD13 ' A' ' 100' ' ' ILE . 37.4 tp -53.06 -31.15 40.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.848 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.1 ttt-85 -72.94 -49.06 31.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.976 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -58.9 -42.58 89.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.806 ' O ' HD12 ' A' ' 112' ' ' LEU . 1.8 t -72.85 -40.96 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.456 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.462 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 27.0 mmt -72.54 -54.08 10.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.431 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.729 HG23 ' HA ' ' A' ' 115' ' ' LYS . 6.9 m -58.95 -47.81 83.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.203 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -58.76 -30.18 67.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.805 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.915 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -123.04 38.48 4.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.651 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.6 -114.75 0.33 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.852 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.439 ' O ' HD23 ' A' ' 116' ' ' LEU . 17.8 pt-20 -133.17 166.89 21.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.334 . . . . 0.0 110.908 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.729 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.7 tttt -72.68 99.85 2.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.359 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.968 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.24 114.33 26.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.371 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.926 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.75 175.28 5.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.429 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -48.14 -35.94 12.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.763 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -77.34 -34.82 55.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.774 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -73.06 -33.49 65.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.988 0.423 . . . . 0.0 110.099 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.968 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.73 -48.03 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.854 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.62 -52.87 63.66 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.758 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -57.51 -28.8 63.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.842 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.784 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.5 tpt -76.26 -37.73 57.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.139 0.495 . . . . 0.0 110.134 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.91 -43.58 79.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.552 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -64.99 -39.09 92.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.812 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -81.17 -36.43 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.984 0.421 . . . . 0.0 110.545 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -67.95 -38.25 82.57 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.635 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.729 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.8 t0 -99.39 147.67 25.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.029 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.563 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.85 -40.73 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.06 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.563 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.91 -11.01 60.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.706 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.1 32.72 1.11 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -176.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.4 p-10 -96.11 -12.75 24.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.318 -0.941 . . . . 0.0 112.471 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.88 20.21 10.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.824 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.463 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -146.59 146.64 30.51 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.2 t -130.78 107.4 13.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.266 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.542 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -79.12 174.66 11.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.302 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.704 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.83 -67.12 0.31 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.489 0.661 . . . . 0.0 111.444 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.406 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.5 OUTLIER -60.57 -34.22 73.85 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.892 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.51 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.06 -41.73 75.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 109.504 179.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.805 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.72 -31.92 46.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.086 178.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 138' ' ' TYR . 61.3 t -56.06 -46.73 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.657 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -56.53 -43.92 80.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.084 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.15 -35.31 66.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.0 ttp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.947 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.839 0.352 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.713 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.5 mmm180 -52.38 -52.15 55.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.715 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.9 -53.31 33.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.365 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.03 -36.87 70.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.033 0.444 . . . . 0.0 110.287 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.947 HG23 ' O ' ' B' ' 1' ' ' ALA . 39.1 t -62.09 -39.57 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.047 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 1.031 HG21 HG11 ' A' ' 55' ' ' VAL . 2.9 mt -65.47 -55.49 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.1 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -50.72 -37.66 42.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.171 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.55 -45.97 56.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.66 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.851 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.3 OUTLIER -55.42 -55.57 30.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.015 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.881 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.4 mt -51.53 -57.42 3.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.343 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -57.44 -51.15 70.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.37 -42.51 66.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.795 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.2 mt -54.48 -48.24 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.583 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.19 -38.24 96.19 Favored Glycine 0 CA--C 1.498 -0.987 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.079 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.902 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.17 -61.79 2.03 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.847 -0.676 . . . . 0.0 110.445 -178.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.655 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.79 -27.75 68.97 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.594 177.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -64.98 -51.36 62.17 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.258 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.716 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.88 -43.55 95.7 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.902 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -64.51 -33.39 62.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.503 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.69 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.5 OUTLIER -74.15 -45.48 48.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.788 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.534 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.0 p -59.68 -26.17 65.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.477 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.413 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.1 m -90.32 -46.16 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.172 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.935 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.38 -32.85 74.39 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.15 0.5 . . . . 0.0 110.468 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.935 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.063 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.794 0.331 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.27 -169.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.8 90.34 3.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.18 164.73 12.37 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.968 0.413 . . . . 0.0 110.375 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.493 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.0 p -98.07 162.55 13.16 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.508 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -47.47 -51.4 20.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.831 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.46 -27.7 69.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.015 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.493 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.31 -51.45 20.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.741 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.696 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.0 pt -73.21 -28.99 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.753 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.44 -27.39 10.16 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.545 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.2 mt-10 -75.24 -28.57 59.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.235 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.1 m-85 -79.35 -58.55 3.15 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.351 0.596 . . . . 0.0 110.995 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.878 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.86 -22.9 16.13 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.219 -179.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.545 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -76.08 -27.6 57.25 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.119 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -75.08 -39.66 60.61 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.071 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.878 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.12 -51.9 68.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.875 0.845 . . . . 0.0 109.386 178.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.38 -24.82 59.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.104 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.785 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.02 -26.6 33.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.127 0.489 . . . . 0.0 110.409 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.785 ' HB3' HD11 ' A' ' 27' ' ' ILE . 5.3 t80 -86.07 -21.63 27.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.226 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 31.8 t70 -83.33 146.54 28.45 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.896 0.855 . . . . 0.0 111.129 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.5 mmtt -65.39 -53.37 44.18 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.969 -1.468 . . . . 0.0 111.6 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.19 -8.0 59.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.786 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.27 46.6 63.19 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.537 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -91.8 18.19 8.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.832 0.349 . . . . 0.0 110.583 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.18 5.7 89.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.425 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 54.3 p -150.19 151.06 32.49 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.785 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -102.36 140.42 20.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.915 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.646 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.44 176.53 8.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.97 179.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.82 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -70.42 -39.05 74.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.149 0.499 . . . . 0.0 110.209 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.63 -40.49 87.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.133 178.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 35' ' ' VAL . 1.6 mm-40 -68.15 -53.88 21.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.04 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.846 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.54 -56.27 24.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.747 0.784 . . . . 0.0 109.462 178.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.05 -45.49 87.03 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.553 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.9 m -62.85 -32.35 73.55 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.906 0.353 . . . . 0.0 110.562 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 31' ' ' GLU . 72.6 t -66.47 -57.26 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.462 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -71.96 -37.05 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.495 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -41.4 88.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.914 0.387 . . . . 0.0 110.603 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.8 t -78.95 -8.58 59.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.682 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.85 -54.86 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.682 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.457 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.28 33.64 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.87 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.593 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.78 -179.98 5.87 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.314 0.578 . . . . 0.0 111.159 -179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -159.71 56.27 0.85 Allowed Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.831 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.8 Cg_endo -80.58 -173.9 2.03 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.535 2.157 . . . . 0.0 112.113 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.612 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -117.06 152.38 34.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.954 0.407 . . . . 0.0 110.19 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.94 -49.94 74.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.99 -31.9 72.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.734 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 44' ' ' THR . 1.6 mt-10 -66.16 -54.33 26.7 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.667 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.82 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -66.06 -34.5 78.22 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.447 179.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.685 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -65.02 -42.16 94.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.92 0.391 . . . . 0.0 110.138 179.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.65 -45.78 92.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.154 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.5 mmt -74.53 -30.88 61.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.477 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.72 -36.4 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.382 -179.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.408 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 7.7 t-20 -44.87 -28.7 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.34 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG2' ' NZ ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.73 -39.44 44.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.923 0.392 . . . . 0.0 110.744 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.8 HG11 HG21 ' B' ' 6' ' ' ILE . 4.3 m -81.61 -11.56 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.115 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.56 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 44.1 t0 -103.45 155.31 18.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.475 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.797 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.64 -28.77 26.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.036 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -116.51 -9.82 11.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.435 0.636 . . . . 0.0 110.473 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 59.45 61.0 7.77 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.467 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -111.18 18.16 19.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.869 0.366 . . . . 0.0 110.309 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.53 19.8 53.45 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.763 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 28' ' ' THR . 5.6 p -146.09 176.35 9.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.499 0.19 . . . . 0.0 110.501 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 32' ' ' LEU . 25.4 mt -117.59 136.58 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.57 0.224 . . . . 0.0 110.777 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.797 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 1.8 m-20 -87.77 -178.14 5.99 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.338 0.589 . . . . 0.0 112.13 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.52 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.7 m-85 -67.11 -56.2 13.94 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.638 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -65.68 -35.64 36.34 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.355 2.037 . . . . 0.0 111.307 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.28 -52.49 63.5 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.246 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.732 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.1 -56.87 16.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.776 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.696 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.07 -47.22 81.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.756 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 53.0 m -59.16 -30.65 68.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.461 . . . . 0.0 110.124 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.898 ' HG2' HD13 ' B' ' 10' ' ' ILE . 4.4 tpp -60.3 -61.74 2.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.234 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.7 mtt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.103 -179.86 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.862 0.363 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -50.43 -30.45 12.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 4.6 mt-10 -76.04 -29.62 58.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.775 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.696 HG22 ' HE1' ' A' ' 138' ' ' TYR . 10.0 mt -79.22 -50.99 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.78 -48.43 38.34 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.904 0.383 . . . . 0.0 111.85 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -53.47 -26.52 20.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.396 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.742 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.61 -34.0 58.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.037 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 12.8 t80 -68.92 -50.55 48.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.04 0.448 . . . . 0.0 110.14 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -54.39 -33.18 58.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.727 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.8 t -88.94 -22.78 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -52.74 -36.83 58.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.364 -179.242 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -100.09 147.21 25.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 0.0 110.5 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -68.3 -37.49 80.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.33 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -112.23 -9.78 13.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.815 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.43 28.28 33.5 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.354 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -67.54 -14.0 62.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.206 0.503 . . . . 0.0 110.721 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.477 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.93 -11.35 55.96 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.126 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.5 m-85 -127.2 146.93 50.23 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 120.989 0.423 . . . . 0.0 111.482 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.07 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.14 109.97 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.652 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.92 177.04 8.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.539 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.22 -30.14 71.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.111 0.482 . . . . 0.0 110.484 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.88 -57.81 11.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.239 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.812 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.48 -45.45 31.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.155 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.07 HD13 HD13 ' A' ' 100' ' ' ILE . 30.5 tp -52.95 -31.2 39.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.185 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.84 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.7 ttt-85 -73.01 -49.1 30.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -58.78 -42.66 89.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.118 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.6 t -73.07 -39.74 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 29.0 mmt -74.0 -54.14 8.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.538 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 115' ' ' LYS . 6.1 m -55.62 -48.9 74.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.35 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -58.87 -29.68 67.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.934 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.785 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.5 mp -121.85 36.6 4.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.29 -113.2 0.28 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.716 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.444 ' O ' HD23 ' A' ' 116' ' ' LEU . 3.1 pt-20 -136.24 170.35 16.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.792 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.625 ' HA ' HG23 ' A' ' 110' ' ' THR . 5.5 ttpp -73.39 98.07 2.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.141 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.38 113.56 24.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.409 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.924 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.77 175.42 5.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.363 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.07 -35.87 12.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 0.0 110.742 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.41 -34.99 54.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.403 ' HB2' ' CA ' ' A' ' 116' ' ' LEU . 9.7 mm-40 -72.89 -33.32 65.96 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.026 0.441 . . . . 0.0 110.145 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.53 -48.62 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.342 0.591 . . . . 0.0 109.786 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.46 -52.91 63.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.775 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.25 -28.68 63.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.808 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.762 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.0 tpt -76.13 -38.1 57.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.131 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.497 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.22 -43.77 84.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.506 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -62.32 -40.82 97.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.971 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 124' ' ' MET . 8.0 pt-20 -80.64 -36.37 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.834 0.35 . . . . 0.0 110.652 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.485 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -67.53 -35.04 78.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.421 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.648 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.4 t0 -104.37 145.54 30.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.983 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.554 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.9 pt -83.03 -40.83 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.165 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.554 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.85 -11.1 60.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.78 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.81 32.74 0.98 Allowed Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -176.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.42 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -95.7 -12.38 25.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.351 -0.924 . . . . 0.0 112.548 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.78 20.27 10.16 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.903 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -146.09 147.35 31.48 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 129' ' ' ASP . 18.9 t -130.7 107.21 13.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.395 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -78.71 174.87 10.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.256 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.735 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.91 -67.15 0.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.636 0.731 . . . . 0.0 111.695 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 3.5 mt-10 -65.19 -25.49 67.73 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.583 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.481 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.52 -48.56 74.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.829 0.347 . . . . 0.0 110.333 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.9 p90 -78.88 -31.06 45.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.219 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 138' ' ' TYR . 67.6 t -52.87 -44.34 48.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.136 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -59.73 -38.51 81.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.147 0.498 . . . . 0.0 109.879 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.47 -41.04 63.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.714 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.42 ' CG ' HG21 ' B' ' 22' ' ' VAL . 8.5 ttp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.974 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.938 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.733 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.26 -51.21 59.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.021 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.724 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.62 -53.3 31.85 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.232 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.43 -37.58 70.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.069 0.462 . . . . 0.0 110.292 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.938 HG23 ' O ' ' B' ' 1' ' ' ALA . 12.1 t -64.07 -33.67 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.408 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.8 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.71 -52.73 23.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.114 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.424 ' HA ' HD12 ' B' ' 10' ' ' ILE . 31.5 mmm-85 -53.16 -37.36 61.8 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.081 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.03 -48.35 63.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.363 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.846 ' HD2' HD23 ' A' ' 32' ' ' LEU . 17.3 mtmt -55.11 -52.92 61.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.762 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.898 HD13 ' HG2' ' A' ' 71' ' ' MET . 6.1 mt -51.08 -57.44 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.053 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -58.85 -51.46 69.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.287 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.26 -40.1 64.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.825 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.4 mt -54.48 -52.38 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.537 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.63 -36.47 93.3 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.284 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.913 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.59 -61.75 2.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.526 -178.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.701 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -63.2 -27.55 69.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.658 177.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.58 -50.91 63.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.294 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.751 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -64.58 -43.73 92.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.913 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.3 m -64.95 -32.83 59.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.56 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.701 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.69 -46.13 39.81 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.897 -179.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.551 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.33 -26.32 64.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.446 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.439 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.22 -47.4 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.227 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.884 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -63.1 -33.25 75.04 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.2 0.524 . . . . 0.0 110.453 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.884 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.092 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.644 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.787 0.327 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.405 ' HB2' HD21 ' A' ' 4' ' ' LEU . 1.5 m-20 -83.63 -169.74 2.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -121.34 85.88 2.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.4 mt -98.29 164.79 12.16 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.479 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.478 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.1 p -96.85 161.87 13.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.519 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -47.65 -51.74 20.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.739 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -64.43 -27.69 69.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.96 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.94 -51.55 21.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.63 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -72.95 -28.85 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.775 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.43 -27.35 9.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 29.7 mt-10 -75.32 -28.57 59.72 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.251 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.34 -58.53 3.17 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.197 0.522 . . . . 0.0 111.121 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.875 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -54.68 -22.75 14.71 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.246 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.38 -28.03 56.59 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.046 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.44 -39.52 62.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.127 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.91 -51.61 69.32 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.825 0.821 . . . . 0.0 109.367 178.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 p -74.32 -24.65 59.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.143 -1.389 . . . . 0.0 112.029 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.78 HD11 ' O ' ' A' ' 112' ' ' LEU . 1.9 tt -81.93 -25.36 34.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.273 0.559 . . . . 0.0 110.194 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.796 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.6 t80 -92.63 -0.74 57.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.456 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.2 t70 -104.26 144.08 32.09 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.038 0.923 . . . . 0.0 111.108 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.49 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 11.5 mmtt -59.99 -53.4 58.28 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.519 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.59 -4.0 59.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.849 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.51 47.06 36.96 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.354 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -91.52 18.4 7.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.857 0.36 . . . . 0.0 110.693 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.32 88.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.615 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.4 p -150.26 148.78 29.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.647 0.261 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.796 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.41 140.46 20.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.99 0.424 . . . . 0.0 111.82 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.523 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.13 177.56 7.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.172 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.693 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -70.33 -38.75 74.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.16 0.505 . . . . 0.0 110.32 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.548 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.39 -41.34 89.17 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 178.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.93 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.4 -53.59 18.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.349 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.835 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.87 -55.62 32.75 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.79 0.805 . . . . 0.0 109.342 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.38 -45.73 88.45 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.519 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.9 m -62.72 -31.83 72.83 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.556 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.93 HG23 ' O ' ' A' ' 31' ' ' GLU . 73.7 t -66.56 -57.38 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.438 . . . . 0.0 110.838 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.494 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 2.3 tpt -72.0 -37.22 69.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.506 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -66.23 -40.94 90.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 110.613 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -79.01 -9.14 59.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.639 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.54 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -89.8 -54.02 4.24 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.634 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.442 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.92 34.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.788 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -132.89 178.78 6.61 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.344 0.593 . . . . 0.0 111.219 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -159.83 56.06 0.81 Allowed Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.709 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.3 Cg_endo -80.65 -170.25 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.552 2.168 . . . . 0.0 112.297 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.603 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.58 152.6 35.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.099 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -56.63 -50.05 73.18 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.81 -32.62 74.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.783 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.33 -54.6 26.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.727 -179.43 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.693 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.1 -44.66 96.17 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.893 179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.636 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -58.06 -49.03 78.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.715 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -53.27 -47.6 69.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.402 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 0.5 OUTLIER -74.7 -30.57 61.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.85 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.549 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -53.76 -35.0 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.524 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -45.05 -28.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.24 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG2' ' NZ ' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -78.1 -39.12 42.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.922 0.391 . . . . 0.0 110.79 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.881 HG11 HG21 ' B' ' 6' ' ' ILE . 4.6 m -80.22 -11.02 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.182 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 37.6 t0 -103.65 155.73 18.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.787 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.501 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.6 -29.34 25.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.072 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -116.54 -9.57 11.38 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.41 0.624 . . . . 0.0 110.428 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.61 63.74 4.94 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.495 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -112.32 17.77 19.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.799 0.333 . . . . 0.0 110.195 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.25 19.99 53.71 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.553 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.3 p -147.88 176.45 10.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.743 HD12 HD11 ' A' ' 32' ' ' LEU . 12.0 mt -115.03 136.52 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.594 0.235 . . . . 0.0 111.064 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 11.0 m-20 -88.41 -177.85 5.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.281 0.562 . . . . 0.0 111.901 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.91 -55.9 12.63 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.809 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.4 Cg_endo -65.48 -34.39 43.1 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.243 1.962 . . . . 0.0 111.266 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.87 -52.43 60.03 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.308 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.714 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.04 -56.97 14.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.879 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.699 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.83 -46.54 81.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.644 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 69.6 m -61.26 -31.66 71.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.071 0.462 . . . . 0.0 110.09 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.918 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.9 tpp -60.47 -61.78 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.101 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.8 mtt . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.88 179.876 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.834 0.35 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -50.36 -30.66 12.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.317 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.662 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -71.1 -29.45 65.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.934 0.397 . . . . 0.0 110.494 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.689 HG22 ' HE1' ' A' ' 138' ' ' TYR . 17.6 mt -79.05 -49.06 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.197 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -45.45 54.3 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.945 0.402 . . . . 0.0 111.645 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.3 tp10 -53.68 -26.07 21.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.283 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.757 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.0 -33.41 51.31 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.046 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 13.4 t80 -69.33 -51.98 31.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.958 0.408 . . . . 0.0 110.283 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -54.32 -32.3 56.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.723 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 87' ' ' GLU . 42.7 t -88.82 -22.91 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.624 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.29 -36.02 60.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.028 -179.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -101.34 148.48 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.445 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -69.18 -37.65 78.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.377 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.16 -9.76 13.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.57 29.4 32.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.258 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.45 -13.88 62.43 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.089 0.444 . . . . 0.0 110.754 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -12.79 55.66 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.94 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 24.6 m-85 -127.13 145.84 50.6 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.956 0.408 . . . . 0.0 111.448 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.926 HD12 HD12 ' A' ' 105' ' ' LEU . 1.1 pt -121.16 109.89 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.763 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.5 m -81.06 178.34 8.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.409 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.53 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.8 -29.63 70.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.002 0.429 . . . . 0.0 110.447 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.24 -57.82 10.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.244 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.51 -39.65 52.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.03 -179.275 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.926 HD12 HD12 ' A' ' 100' ' ' ILE . 8.9 tt -55.42 -41.25 72.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.024 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.89 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.9 ttt180 -65.3 -49.49 69.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -60.46 -39.31 87.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.088 0.471 . . . . 0.0 110.184 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 104' ' ' GLU . 37.1 t -73.21 -42.14 58.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.32 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 30.6 mmt -74.1 -54.31 8.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.688 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.7 m -55.42 -43.92 75.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.445 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.498 ' C ' HD12 ' A' ' 112' ' ' LEU . 2.0 m-80 -60.54 -31.43 70.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.347 . . . . 0.0 110.825 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.78 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.7 mp -122.91 37.23 4.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.736 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -167.1 -117.37 0.4 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.819 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.415 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.9 pt-20 -133.8 177.92 7.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.436 ' HA ' HG23 ' A' ' 110' ' ' THR . 22.8 tptt -78.27 97.7 5.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.299 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.976 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.86 114.84 26.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.327 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.924 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.72 174.97 6.1 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.956 -0.297 . . . . 0.0 110.363 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -48.03 -35.78 11.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.366 . . . . 0.0 110.749 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -77.32 -36.21 54.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.759 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -71.06 -33.89 70.68 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.994 0.426 . . . . 0.0 109.985 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.976 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -73.86 -50.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.402 0.62 . . . . 0.0 109.681 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.91 -52.85 63.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.717 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -28.49 64.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.777 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.683 ' HG3' HD11 ' A' ' 105' ' ' LEU . 6.7 tpt -76.2 -37.57 57.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.152 0.501 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.569 HG12 HD13 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -69.94 -39.94 78.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.287 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -70.61 -34.57 72.27 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.411 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 124' ' ' MET . 20.7 pt-20 -82.92 -39.79 21.02 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.429 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.492 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.6 -41.79 87.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.474 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.731 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.2 t0 -91.48 147.18 23.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.07 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.552 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.03 -40.68 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.015 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.92 -10.98 60.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.756 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.88 33.03 1.05 Allowed Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.31 -12.57 24.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.357 -0.922 . . . . 0.0 112.48 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.11 10.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.863 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -146.47 146.76 30.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.1 t -130.71 107.24 13.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.281 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.563 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.3 t30 -78.31 175.4 10.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.368 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.729 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.95 -67.1 0.31 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.674 0.75 . . . . 0.0 111.709 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.511 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.3 mt-10 -65.32 -25.28 67.54 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.568 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.576 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.56 -48.61 74.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.813 0.34 . . . . 0.0 110.369 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.6 p90 -78.89 -31.31 45.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.347 178.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 138' ' ' TYR . 73.8 t -53.07 -44.3 50.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.098 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -61.03 -35.5 77.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.095 0.474 . . . . 0.0 109.779 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.414 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 9.5 mmt -73.58 -42.3 61.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.091 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.46 ' CG ' HG21 ' B' ' 22' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.946 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.973 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.777 0.322 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.731 ' O ' HG13 ' B' ' 6' ' ' ILE . 2.1 mmm180 -52.18 -51.52 57.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.039 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.748 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.71 -53.36 31.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.591 0.234 . . . . 0.0 111.458 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -57.2 -36.98 71.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.086 0.47 . . . . 0.0 110.115 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.973 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.4 t -63.77 -34.45 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.393 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.881 HG21 HG11 ' A' ' 55' ' ' VAL . 2.7 mt -71.3 -53.65 20.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.054 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -50.97 -39.92 56.42 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.236 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.84 -48.12 67.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.418 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.849 ' O ' HD12 ' B' ' 13' ' ' ILE . 13.3 mtmt -55.01 -54.53 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.196 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.918 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.7 mt -51.11 -56.91 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.298 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.6 OUTLIER -59.54 -47.95 83.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.199 0.523 . . . . 0.0 111.155 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.11 -39.87 63.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.025 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.849 HD12 ' O ' ' B' ' 9' ' ' LYS . 1.7 mt -54.5 -52.03 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.502 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.422 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.51 -36.38 93.09 Favored Glycine 0 CA--C 1.499 -0.931 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.301 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.919 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -63.8 -61.73 2.11 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.863 -0.668 . . . . 0.0 110.468 -178.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.653 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -64.32 -27.43 69.02 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.789 177.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.12 -49.66 64.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.144 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.761 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -64.69 -43.93 91.94 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.919 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.6 m -65.07 -32.28 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.579 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.653 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.8 OUTLIER -74.57 -48.41 26.9 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.074 -179.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.558 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.7 p -58.43 -26.26 63.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.475 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.46 HG21 ' CG ' ' A' ' 145' ' ' MET . 27.7 m -90.24 -48.05 14.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.258 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.881 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.1 pp -62.54 -32.9 73.93 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.202 0.525 . . . . 0.0 110.442 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.881 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.111 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.63 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.797 0.332 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.1 -169.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -117.68 90.72 3.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.2 mt -98.63 164.86 12.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.485 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.4 p -96.82 161.67 13.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.479 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -47.61 -51.81 20.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.744 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -64.46 -27.63 69.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.973 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.92 -51.49 21.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.58 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.706 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -73.03 -28.9 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.801 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.49 -27.37 10.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.0 mt-10 -75.27 -28.45 59.81 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.314 178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.608 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.29 -58.5 3.19 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.301 0.572 . . . . 0.0 111.04 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.6 pttt -54.58 -22.94 14.74 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.285 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.39 -27.94 56.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.103 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.24 -39.95 62.72 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.027 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.82 -52.1 67.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.829 0.823 . . . . 0.0 109.483 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -24.21 58.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.145 -1.388 . . . . 0.0 112.117 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.883 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.3 tt -82.05 -24.68 35.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.282 0.563 . . . . 0.0 110.202 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.821 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.8 t80 -93.66 -0.83 55.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.522 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.4 t70 -102.87 143.64 32.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.997 0.904 . . . . 0.0 111.026 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.1 mmtt -60.17 -53.38 58.43 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.594 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.66 -5.9 59.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.773 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.59 45.91 53.83 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.425 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -90.83 18.05 7.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.832 0.349 . . . . 0.0 110.705 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.07 5.95 88.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.503 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.451 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 52.7 p -150.1 149.54 30.42 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -102.04 140.51 20.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.934 0.397 . . . . 0.0 112.018 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.598 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.6 176.84 7.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.929 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.811 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -70.49 -38.16 74.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.142 0.496 . . . . 0.0 110.36 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.67 -40.96 89.53 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.22 178.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.43 -53.73 17.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.324 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.825 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.96 -54.83 42.52 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.755 0.788 . . . . 0.0 109.422 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.57 -45.97 92.58 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 114.552 -1.203 . . . . 0.0 112.484 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.57 -31.1 71.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.86 0.33 . . . . 0.0 110.572 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 31' ' ' GLU . 72.1 t -67.86 -57.22 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.449 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.98 -35.98 69.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.46 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -42.62 80.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.953 0.406 . . . . 0.0 110.776 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 t -78.96 -8.59 59.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.753 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.7 tt -90.57 -55.09 3.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.766 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.477 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -174.5 34.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.955 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.578 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.6 tp-100 -137.66 -178.86 5.43 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.3 0.571 . . . . 0.0 111.219 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -159.65 56.59 0.89 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.913 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.41 -177.49 3.81 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.457 2.104 . . . . 0.0 112.076 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -112.44 152.45 28.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.952 0.406 . . . . 0.0 110.224 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.7 -49.09 77.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.401 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.64 -31.93 72.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.774 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 1.5 mt-10 -65.83 -54.3 28.59 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.586 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.811 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.98 -34.52 78.28 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.373 179.606 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.694 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.52 -42.6 95.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.882 0.372 . . . . 0.0 110.148 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -61.83 -45.5 93.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.219 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 mmt -74.5 -30.75 61.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.428 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.42 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.624 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -44.99 -28.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.373 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.439 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -77.57 -38.6 48.09 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.905 0.383 . . . . 0.0 110.816 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.884 HG11 HG21 ' B' ' 6' ' ' ILE . 4.5 m -81.43 -11.64 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.244 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.55 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 41.0 t0 -103.63 155.62 18.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.692 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.478 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.59 -28.89 26.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.05 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -116.45 -9.67 11.41 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.435 0.636 . . . . 0.0 110.459 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.14 63.37 5.31 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.446 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -112.37 18.26 18.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.808 0.337 . . . . 0.0 110.183 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.66 20.02 55.04 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.515 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.4 p -146.88 176.36 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.511 HD12 HD11 ' A' ' 32' ' ' LEU . 54.6 mt -116.12 136.54 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.581 0.229 . . . . 0.0 110.803 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.2 m-20 -86.97 -178.49 6.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.268 0.556 . . . . 0.0 111.948 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -67.82 -56.17 12.28 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.589 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.75 -34.81 39.18 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.248 1.965 . . . . 0.0 111.198 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.65 -52.38 63.57 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.204 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.714 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.22 -56.86 16.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.85 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.706 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.83 -46.96 81.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.63 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 59.7 m -60.26 -30.99 69.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 0.0 110.064 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.936 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.3 tpp -63.68 -61.89 2.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.104 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mtm . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.039 -179.848 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -53.47 -53.72 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.29 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.71 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.71 -29.56 27.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.486 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.773 HG22 ' HE1' ' A' ' 138' ' ' TYR . 13.8 mt -65.46 -51.29 65.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.859 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.38 -49.62 18.44 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 110.405 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.7 mt-10 -54.1 -30.22 47.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.243 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -69.88 -37.91 76.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.625 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 11.3 t80 -67.3 -53.93 25.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.519 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -54.08 -31.01 50.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.784 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 87' ' ' GLU . 87.0 t -88.63 -22.85 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.291 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.525 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -55.2 -37.21 66.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.096 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -101.48 147.23 26.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.506 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -69.64 -36.75 76.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.362 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.2 -9.74 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.4 30.14 34.48 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.245 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -67.43 -13.79 62.34 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.01 0.405 . . . . 0.0 110.782 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.19 -13.42 55.38 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.951 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 25.5 m-85 -127.19 145.49 50.74 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.01 0.433 . . . . 0.0 111.353 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.804 ' CD1' HD12 ' A' ' 105' ' ' LEU . 1.1 pp -121.1 109.89 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.705 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.68 178.9 8.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.508 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.467 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.67 -29.94 70.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.055 0.455 . . . . 0.0 110.511 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.44 -57.77 11.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.168 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.799 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.46 -41.47 47.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.951 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.804 HD12 ' CD1' ' A' ' 100' ' ' ILE . 7.7 tt -54.19 -37.46 64.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.936 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HA ' HD11 ' A' ' 116' ' ' LEU . 3.2 ttt-85 -70.06 -49.4 51.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.925 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.51 -37.56 86.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.058 0.456 . . . . 0.0 110.139 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.1 t -73.03 -45.33 54.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.232 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.455 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 21.5 mmt -74.03 -54.27 8.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.701 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 m -55.57 -44.6 77.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.264 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -58.4 -28.44 65.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.789 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.883 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.1 mp -126.06 35.88 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -164.04 -120.46 0.52 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.764 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -127.78 -176.84 3.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 0.0 110.907 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -83.84 97.07 8.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.958 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.28 114.0 25.95 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.426 179.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.927 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.78 175.36 5.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.32 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.441 ' H ' HG22 ' A' ' 117' ' ' THR . 3.9 m-20 -48.06 -35.9 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.947 0.403 . . . . 0.0 110.733 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -77.41 -35.44 54.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.841 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -72.12 -33.22 67.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.998 0.427 . . . . 0.0 110.094 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.958 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.7 t -75.08 -50.61 24.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.395 0.617 . . . . 0.0 109.679 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -59.08 -52.83 64.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.717 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -28.73 58.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.767 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.784 ' HG3' HD11 ' A' ' 105' ' ' LEU . 6.4 tpt -76.16 -39.26 55.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.207 0.527 . . . . 0.0 110.044 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.531 HG12 HD13 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -65.89 -46.83 87.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.392 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -62.7 -38.28 89.78 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.911 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 124' ' ' MET . 18.5 pt-20 -81.12 -39.81 25.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.724 0.297 . . . . 0.0 110.814 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.507 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -65.42 -39.35 92.03 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.547 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.725 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.6 t0 -94.94 146.4 24.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.552 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.4 -40.63 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.06 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.91 -10.98 60.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.769 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.68 33.03 0.95 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.431 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.2 p-10 -96.27 -12.49 24.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.369 -0.916 . . . . 0.0 112.56 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.8 20.2 10.23 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.808 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.63 147.29 30.89 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 129' ' ' ASP . 38.9 t -130.68 107.27 13.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.258 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.567 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.3 t30 -77.83 175.23 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.445 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.773 ' HE1' HG22 ' A' ' 85' ' ' ILE . 1.1 t80 -46.05 -67.04 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.654 0.74 . . . . 0.0 111.811 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.3 mm-40 -65.57 -25.13 67.28 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.63 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.575 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.56 -48.9 74.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.382 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 9.3 p90 -79.21 -31.32 43.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.364 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 138' ' ' TYR . 72.0 t -52.9 -43.3 46.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.341 -0.39 . . . . 0.0 109.963 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -62.71 -34.79 77.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.81 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.421 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 9.5 mmt -73.48 -44.29 58.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.424 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.44 ' CG ' HG21 ' B' ' 22' ' ' VAL . 7.1 ttp . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.159 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.951 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.31 -51.1 60.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.73 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.65 -53.23 32.63 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.655 0.264 . . . . 0.0 111.299 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.17 -37.57 72.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.019 0.438 . . . . 0.0 110.317 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.951 HG23 ' O ' ' B' ' 1' ' ' ALA . 15.0 t -63.36 -33.73 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.388 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.884 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.64 -55.08 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.011 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 26.2 mmm-85 -50.42 -37.88 40.16 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.178 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -46.1 65.15 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.503 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.825 ' HD2' HD23 ' A' ' 32' ' ' LEU . 11.8 mtmt -56.6 -54.12 49.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.936 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.2 -57.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.548 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.544 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.0 OUTLIER -60.92 -51.41 69.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.361 0.601 . . . . 0.0 110.938 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.42 -38.81 63.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.859 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.671 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.31 -50.66 55.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.351 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.42 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.44 -37.28 94.56 Favored Glycine 0 CA--C 1.498 -0.977 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.544 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.86 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -65.0 -61.77 1.95 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.716 -0.742 . . . . 0.0 110.552 -179.11 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.751 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.69 -27.51 67.92 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -68.36 -46.41 70.17 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.794 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 1.1 ppt_? -63.58 -44.1 95.06 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.86 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.8 m -62.78 -35.42 70.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.934 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.628 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -75.18 -47.2 29.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.064 -179.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.573 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 12.1 p -59.4 -25.15 64.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.598 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.484 HG22 ' O ' ' B' ' 18' ' ' ARG . 30.3 m -90.29 -48.52 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.196 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.89 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -61.91 -33.78 74.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.228 0.537 . . . . 0.0 110.44 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.89 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.083 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.801 0.334 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.82 -169.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.782 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -120.59 90.68 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.66 164.75 12.28 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.004 0.43 . . . . 0.0 110.424 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.5 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.44 161.93 13.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.467 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -47.69 -51.68 20.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.766 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -64.5 -27.7 69.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.045 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.5 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.85 -51.5 22.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.619 179.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.703 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.9 pt -73.0 -28.97 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.64 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.54 -27.33 10.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 4.6 mm-40 -75.34 -28.55 59.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.281 178.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.34 -58.61 3.13 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.214 0.531 . . . . 0.0 111.033 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.872 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.76 15.04 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.249 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.52 -27.95 56.2 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.23 -39.92 62.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.043 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.872 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.55 -51.95 67.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.802 0.811 . . . . 0.0 109.363 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.401 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 p -74.51 -24.05 58.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.074 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.878 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.07 -24.74 35.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.261 0.553 . . . . 0.0 110.166 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.9 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.5 t80 -94.64 0.21 54.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.571 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.4 t70 -104.27 142.35 34.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.942 0.877 . . . . 0.0 110.997 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.478 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.7 mmtt -58.4 -53.35 59.33 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.572 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -86.62 -4.88 59.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.765 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.15 47.23 42.13 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.356 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -91.64 18.53 7.36 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.805 0.336 . . . . 0.0 110.673 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.85 5.12 88.25 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.592 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.9 p -150.33 148.65 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.668 0.27 . . . . 0.0 110.344 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.728 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.72 140.46 19.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.801 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.591 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.41 178.66 7.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.294 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.715 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -69.96 -41.8 74.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.056 0.455 . . . . 0.0 110.411 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.537 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -57.28 -40.88 78.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.365 179.07 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.807 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -70.15 -53.82 15.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.47 -179.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.729 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -57.5 -54.14 50.26 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.838 0.828 . . . . 0.0 109.572 178.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.33 91.32 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.462 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 30' ' ' LYS . 53.3 m -65.48 -30.74 71.55 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 120.813 0.339 . . . . 0.0 110.432 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.9 HG21 ' CE2' ' A' ' 19' ' ' PHE . 13.9 t -63.62 -57.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.037 0.446 . . . . 0.0 110.568 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.607 ' CE ' HD22 ' A' ' 39' ' ' LEU . 1.7 tpt -72.35 -40.53 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.273 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -61.13 -39.66 90.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.945 0.402 . . . . 0.0 110.489 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.5 t -78.86 -11.48 59.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.578 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.607 HD22 ' CE ' ' A' ' 36' ' ' MET . 6.4 tt -88.0 -53.43 4.74 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.075 0.464 . . . . 0.0 110.552 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.457 ' N ' HD23 ' A' ' 39' ' ' LEU . . . 179.72 37.21 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.624 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.587 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 tp-100 -134.83 -179.8 5.83 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.338 0.589 . . . . 0.0 111.279 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -159.75 56.41 0.86 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.792 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.7 Cg_endo -80.57 -174.29 2.19 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.546 2.164 . . . . 0.0 112.291 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.602 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -117.32 152.64 34.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.873 0.368 . . . . 0.0 110.124 179.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.49 -49.99 73.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.26 -32.59 74.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.638 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.577 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -66.31 -54.52 23.75 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.596 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.715 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -61.22 -48.36 81.87 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.929 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.706 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -54.6 -49.97 69.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 110.952 179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.27 -47.23 69.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.682 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -74.68 -30.61 61.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.831 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.567 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -54.68 -36.03 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.588 -178.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -45.23 -28.64 0.82 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.213 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -79.6 -38.21 34.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.929 0.395 . . . . 0.0 110.778 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.076 HG11 HG21 ' B' ' 6' ' ' ILE . 3.7 m -81.07 -10.98 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.14 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.558 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.6 t0 -103.59 155.87 18.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.72 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.58 -29.17 26.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.065 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -116.46 -9.72 11.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.397 0.617 . . . . 0.0 110.452 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.68 63.48 5.17 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.498 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -112.47 18.41 18.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.842 0.353 . . . . 0.0 110.201 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.39 19.98 55.68 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.424 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.3 p -146.71 176.49 9.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.729 HD12 HD11 ' A' ' 32' ' ' LEU . 12.4 mt -116.3 136.46 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.544 0.212 . . . . 0.0 110.959 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.5 m-20 -88.24 -178.02 5.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.25 0.548 . . . . 0.0 111.938 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.82 -55.91 12.83 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.659 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -65.67 -34.54 40.94 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.25 1.967 . . . . 0.0 111.241 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.44 -52.47 61.31 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.26 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.718 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.19 -56.99 14.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.789 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.703 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.89 -47.09 83.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.795 -179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.465 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 53.5 m -59.69 -30.46 68.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.074 0.464 . . . . 0.0 110.129 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.912 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.2 tpp -62.71 -61.84 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.083 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.2 mtt . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.001 -179.934 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.804 0.335 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -56.82 -51.44 68.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.221 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.691 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.68 -29.24 25.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.477 -179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.782 HG22 ' HE1' ' A' ' 138' ' ' TYR . 19.8 mt -66.7 -51.45 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.919 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -50.08 16.64 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.075 0.464 . . . . 0.0 110.55 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 91' ' ' VAL . 19.9 tt0 -53.91 -29.19 40.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.252 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -70.83 -38.25 73.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 10.8 t80 -67.35 -54.15 23.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.966 0.412 . . . . 0.0 110.545 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -54.08 -30.67 49.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.791 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 87' ' ' GLU . 98.9 t -88.7 -22.88 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.216 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.526 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -55.3 -38.38 68.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.176 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -100.64 146.87 26.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.503 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -69.72 -36.39 75.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.373 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.27 -9.79 13.87 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.43 30.02 34.75 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.23 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -67.43 -13.62 62.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 117.102 0.451 . . . . 0.0 110.787 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.472 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.22 -13.39 55.29 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.914 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.479 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 25.1 m-85 -127.16 145.95 50.57 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.988 0.423 . . . . 0.0 111.425 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.747 HD12 HD22 ' A' ' 105' ' ' LEU . 1.1 pp -121.13 109.94 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.729 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.1 p -83.55 176.97 8.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.53 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.564 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.7 -30.91 71.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 110.396 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.25 -57.66 11.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.322 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.43 -45.73 30.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.228 -179.156 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.747 HD22 HD12 ' A' ' 100' ' ' ILE . 17.6 tp -53.13 -33.24 51.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.818 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.1 ttt-85 -68.79 -49.15 60.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -59.14 -43.51 92.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.194 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.6 t -72.96 -39.02 57.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.51 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.51 ' HG2' HD12 ' A' ' 105' ' ' LEU . 28.6 mmt -73.97 -54.27 8.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.511 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.663 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.4 m -56.99 -46.9 81.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.088 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -60.0 -26.67 66.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.841 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.878 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.8 mp -124.21 36.19 4.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.36 -116.46 0.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.688 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' HD23 ' A' ' 116' ' ' LEU . 23.1 pt-20 -131.31 172.51 12.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.805 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.663 ' HA ' HG23 ' A' ' 110' ' ' THR . 12.7 tptm -75.05 98.58 3.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.163 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.96 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.88 113.13 24.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.461 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.935 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -71.83 175.28 5.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.32 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 117' ' ' THR . 50.5 m-20 -48.06 -36.04 12.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 110.759 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -77.41 -34.35 54.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -73.64 -33.04 64.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.024 0.44 . . . . 0.0 110.074 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.96 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.96 -48.56 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.829 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.25 -52.87 63.83 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.844 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.08 -28.72 62.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.82 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.739 ' HG3' HD21 ' A' ' 105' ' ' LEU . 5.8 tpt -76.23 -38.47 56.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 110.113 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.511 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -67.15 -44.95 87.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.559 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -61.75 -40.55 95.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.97 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 124' ' ' MET . 8.6 pt-20 -81.0 -37.39 29.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.787 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.482 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.29 -35.84 81.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.338 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.727 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.3 t0 -102.06 146.34 28.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.937 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.554 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.5 -40.61 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.093 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.554 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.98 -11.07 60.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.713 -179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.85 32.77 1.0 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.3 p-10 -95.99 -12.53 24.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.351 -0.924 . . . . 0.0 112.52 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.16 10.23 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.817 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.479 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.54 147.19 30.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 129' ' ' ASP . 33.1 t -130.71 107.32 13.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.232 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.569 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -78.05 175.0 10.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.339 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.782 ' HE1' HG22 ' A' ' 85' ' ' ILE . 1.1 t80 -45.95 -67.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.653 0.74 . . . . 0.0 111.84 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.7 mt-10 -66.02 -24.54 66.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.644 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.547 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.73 -48.86 74.47 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.393 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 10.7 p90 -79.32 -31.21 43.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.399 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 138' ' ' TYR . 75.7 t -52.91 -44.85 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.44 -35.45 79.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.137 0.494 . . . . 0.0 109.826 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.47 -43.35 60.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.81 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.406 ' CG ' HG21 ' B' ' 22' ' ' VAL . 24.5 ttp . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.012 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.916 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.847 0.356 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.732 ' O ' HG13 ' B' ' 6' ' ' ILE . 11.6 mmm180 -52.5 -50.73 62.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.232 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.759 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.79 -53.43 32.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.281 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.69 -36.11 71.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.149 0.5 . . . . 0.0 110.007 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.916 HG23 ' O ' ' B' ' 1' ' ' ALA . 45.1 t -62.84 -41.43 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.997 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 1.076 HG21 HG11 ' A' ' 55' ' ' VAL . 3.2 mt -63.16 -55.42 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.098 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' B' ' 3' ' ' LYS . 24.1 mmm-85 -50.16 -40.43 46.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.031 0.444 . . . . 0.0 110.247 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.88 -44.95 68.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.667 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.829 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.6 OUTLIER -56.34 -55.07 37.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.05 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.912 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.7 mt -51.21 -57.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.751 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.511 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.7 tpt180 -61.32 -51.34 69.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.252 0.548 . . . . 0.0 111.028 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.559 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.33 -39.23 63.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.701 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.733 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.47 -48.94 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.225 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.409 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.77 -37.64 95.0 Favored Glycine 0 CA--C 1.497 -1.041 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.521 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.895 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -65.06 -61.68 2.0 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.741 -0.73 . . . . 0.0 110.555 -179.246 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.75 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.6 -27.46 67.76 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -68.25 -47.53 67.5 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.978 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.5 ppt_? -63.8 -43.61 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.105 0.479 . . . . 0.0 109.754 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.895 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.8 m -61.86 -35.48 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.529 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.676 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -75.97 -43.1 46.17 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.785 -179.599 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.577 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 21.8 p -61.01 -26.63 67.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.495 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.463 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.4 m -90.42 -48.43 14.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.163 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.894 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.2 pp -63.09 -32.6 74.02 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.199 0.524 . . . . 0.0 110.535 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.894 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.176 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.788 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.817 0.341 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.404 ' HB2' HD21 ' A' ' 4' ' ' LEU . 2.2 m-20 -72.86 -170.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -121.15 87.73 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -98.48 164.79 12.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.544 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.492 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.6 p -97.98 162.84 13.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.494 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -47.35 -51.42 19.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.875 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -64.27 -27.72 69.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.991 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.9 mm-40 -72.68 -51.36 19.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.707 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.725 HG22 HD21 ' A' ' 69' ' ' LEU . 36.7 pt -73.07 -28.74 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.895 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.34 -27.26 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 5.6 mm-40 -74.99 -28.39 60.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.227 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.63 -58.33 3.24 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.293 0.568 . . . . 0.0 111.002 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.875 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 13.1 ptmt -54.41 -23.0 14.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.216 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.21 -28.28 57.15 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.99 -39.81 63.4 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.07 177.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.26 -52.04 67.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.806 0.812 . . . . 0.0 109.501 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -23.9 58.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.183 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.897 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.1 -25.09 34.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.273 0.558 . . . . 0.0 110.215 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.816 ' HB3' HD11 ' A' ' 27' ' ' ILE . 2.4 t80 -94.42 -0.27 54.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.47 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.7 t70 -103.87 144.88 30.92 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.959 0.885 . . . . 0.0 111.051 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.513 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.5 mmtt -61.13 -53.43 57.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.644 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -83.91 -5.94 59.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.814 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.13 45.31 57.24 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.451 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.9 p30 -90.47 17.23 7.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.832 0.348 . . . . 0.0 110.68 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.37 7.46 87.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.386 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 69.0 p -150.38 148.23 28.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.816 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.7 mt -101.57 140.68 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.808 0.337 . . . . 0.0 111.829 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.703 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.5 t -85.52 179.37 7.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.117 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.781 HG21 ' CG ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -70.43 -45.78 65.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.935 -179.201 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.629 ' HG3' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -54.36 -38.93 66.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.335 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.871 ' O ' HG23 ' A' ' 35' ' ' VAL . 3.4 mm-40 -71.64 -53.75 12.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.395 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.65 HD23 ' CD ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -56.11 -52.52 64.02 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.733 0.778 . . . . 0.0 109.51 178.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.82 -45.5 96.08 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.371 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 m -62.87 -35.88 81.46 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.917 0.389 . . . . 0.0 110.156 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 31' ' ' GLU . 60.1 t -61.76 -56.87 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.652 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.439 ' SD ' HG13 ' B' ' 5' ' ' VAL . 0.2 OUTLIER -71.6 -40.78 69.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.306 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -41.2 99.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 0.0 110.656 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 t -78.88 -10.08 59.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.629 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.6 tt -88.76 -53.88 4.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.585 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.452 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.04 34.59 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.819 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -135.86 -179.94 5.96 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.362 0.601 . . . . 0.0 111.306 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -159.75 56.5 0.87 Allowed Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.754 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 96.0 Cg_endo -80.44 -173.58 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.527 2.151 . . . . 0.0 112.273 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.615 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.39 152.54 31.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.846 0.355 . . . . 0.0 110.166 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -57.68 -49.21 77.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.12 -31.17 71.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.742 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.569 ' H ' HG22 ' A' ' 44' ' ' THR . 1.3 mt-10 -67.16 -54.39 21.7 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.575 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.615 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -63.45 -37.84 88.84 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.209 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.781 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.42 -49.9 73.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.842 0.353 . . . . 0.0 110.588 179.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.25 -46.25 76.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.496 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.412 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.4 mmt -74.74 -30.54 61.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.704 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.559 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -53.5 -38.0 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.498 -179.079 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -44.98 -28.59 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.373 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.461 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.83 -39.58 50.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.944 0.402 . . . . 0.0 110.767 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.93 HG11 HG21 ' B' ' 6' ' ' ILE . 5.0 m -80.57 -11.96 12.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.099 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.4 t0 -103.69 155.15 18.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.74 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.502 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.63 -28.86 26.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.152 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -116.46 -9.68 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.44 0.638 . . . . 0.0 110.468 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.5 63.89 4.82 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.519 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -112.71 18.38 18.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.855 0.359 . . . . 0.0 110.133 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.88 19.93 56.79 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.467 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.703 HG22 ' HA ' ' A' ' 28' ' ' THR . 6.1 p -146.1 176.12 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.487 HG12 HG23 ' A' ' 55' ' ' VAL . 95.9 mt -115.21 136.38 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.551 0.215 . . . . 0.0 110.725 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.4 m-20 -87.05 -178.17 6.2 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.16 0.505 . . . . 0.0 111.828 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.521 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.97 -55.46 13.41 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.831 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.2 Cg_endo -65.72 -35.37 37.17 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.234 1.956 . . . . 0.0 111.348 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -63.84 -52.31 60.69 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.305 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.729 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.9 -56.78 17.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.834 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.725 HD21 HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -53.56 -49.51 67.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.83 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.788 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 80.6 m -58.57 -32.42 68.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.226 0.536 . . . . 0.0 109.685 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 1.004 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.7 tpp -67.19 -61.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.899 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.4 mtm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 179.896 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.847 0.356 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -52.24 -30.55 28.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.311 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.603 ' O ' HG11 ' B' ' 19' ' ' VAL . 1.1 mt-10 -70.54 -29.58 66.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.745 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.715 HG22 ' HE1' ' A' ' 138' ' ' TYR . 7.8 mt -79.45 -51.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.27 -51.82 12.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.659 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.9 tt0 -53.72 -25.53 18.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.884 0.373 . . . . 0.0 110.733 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.694 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.67 -37.13 50.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.204 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.592 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.2 t80 -68.04 -52.12 39.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.034 0.445 . . . . 0.0 110.087 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -54.77 -32.05 59.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.803 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 87' ' ' GLU . 54.3 t -88.63 -22.8 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.55 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.468 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.93 -32.96 55.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.114 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -102.34 148.05 25.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.496 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -69.58 -37.21 76.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.351 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.16 -9.72 13.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.83 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.15 29.64 33.32 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.228 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -67.4 -13.93 62.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.079 0.439 . . . . 0.0 110.75 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.2 -12.23 55.3 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.992 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.1 m-85 -127.25 146.99 50.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.906 0.384 . . . . 0.0 111.378 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.864 HD13 HD13 ' A' ' 105' ' ' LEU . 1.1 pt -121.11 109.98 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.816 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.2 m -83.99 177.07 8.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.466 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.25 -30.09 71.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.097 0.475 . . . . 0.0 110.528 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.35 -57.11 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.205 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.754 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.32 -46.83 25.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.377 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.864 HD13 HD13 ' A' ' 100' ' ' ILE . 30.2 tp -53.19 -31.23 41.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.938 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.845 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.6 ttt-85 -72.54 -49.15 34.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -59.22 -42.8 91.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.144 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.2 t -72.95 -41.03 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.565 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.454 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 30.3 mmt -72.61 -54.17 9.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.536 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.743 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.4 m -57.12 -48.9 77.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.225 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -58.04 -29.9 65.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.796 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.897 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -121.58 37.13 4.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.822 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.35 -116.43 0.39 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.744 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.418 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.8 pt-20 -131.02 168.72 16.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 110.835 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.743 ' HA ' HG23 ' A' ' 110' ' ' THR . 15.6 ttmt -73.71 100.11 3.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.971 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.36 114.13 26.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.929 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -71.86 175.25 5.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.364 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 117' ' ' THR . 1.1 m-20 -48.04 -35.98 12.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 110.779 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.36 -34.98 55.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -72.87 -33.03 65.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.973 0.415 . . . . 0.0 110.091 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.971 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -75.06 -48.76 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.817 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -58.81 -52.77 64.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.788 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -28.74 63.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.791 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.822 ' HG3' HD21 ' A' ' 105' ' ' LEU . 11.7 tpt -76.13 -37.77 57.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.135 0.493 . . . . 0.0 110.282 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.509 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.23 -39.55 81.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.407 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -65.2 -41.41 94.56 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.489 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 124' ' ' MET . 6.2 pt-20 -82.62 -32.84 28.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 110.483 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.87 78.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.484 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.718 ' HB2' HG22 ' A' ' 136' ' ' VAL . 20.1 t0 -105.83 148.6 27.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.974 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.569 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.84 -40.8 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.024 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.569 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.94 -10.93 59.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.691 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.0 32.83 1.08 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.445 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.4 p-10 -96.36 -12.79 23.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.291 -0.954 . . . . 0.0 112.451 -176.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.21 10.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.808 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.6 146.95 30.62 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.043 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' A' ' 129' ' ' ASP . 33.0 t -130.75 107.5 14.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.202 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.35 174.16 11.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.327 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.715 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.88 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.471 0.653 . . . . 0.0 111.433 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.2 mt-10 -59.95 -32.58 70.94 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.045 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.509 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.13 -43.44 78.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.258 0.551 . . . . 0.0 109.65 179.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.806 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.0 OUTLIER -78.69 -31.76 46.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.213 178.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 138' ' ' TYR . 62.1 t -54.95 -51.83 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.683 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -56.87 -46.88 81.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.2 tpp -68.72 -31.09 69.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.8 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.427 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 11.3 ttp . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.956 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.825 0.345 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.736 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.2 mmm180 -52.24 -51.41 58.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.724 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.73 -53.45 31.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.632 0.253 . . . . 0.0 111.391 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.81 -36.61 70.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.136 0.493 . . . . 0.0 110.09 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.956 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.7 t -64.27 -34.3 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.32 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.93 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -71.56 -49.79 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.235 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' B' ' 3' ' ' LYS . 21.9 mmm-85 -58.01 -33.14 68.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.119 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.07 -49.19 47.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.187 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.789 ' O ' HD12 ' B' ' 13' ' ' ILE . 1.6 ptpt -61.38 -50.52 72.52 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.657 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 1.004 HD13 ' HG2' ' A' ' 71' ' ' MET . 10.6 mt -51.29 -57.37 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.091 0.472 . . . . 0.0 110.766 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.98 -50.79 72.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.93 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.11 -39.97 63.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.892 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.789 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.6 mt -54.51 -52.11 43.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.612 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.74 -36.27 93.08 Favored Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.21 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.931 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.96 -61.67 2.02 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.847 -0.676 . . . . 0.0 110.389 -178.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' MET . . . . . 0.664 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -62.43 -27.92 69.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.652 177.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.27 -51.55 60.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.209 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.761 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.45 -43.56 97.02 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.931 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.9 m -66.3 -32.36 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.599 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.667 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 0.6 OUTLIER -71.73 -50.08 33.44 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.006 -179.115 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.448 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 54.7 p -58.49 -36.22 73.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.058 0.456 . . . . 0.0 110.765 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.486 HG22 ' C ' ' B' ' 19' ' ' VAL . 28.4 m -72.54 -45.01 60.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.071 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.806 HD23 ' CE1' ' A' ' 141' ' ' PHE . 3.0 pp -65.29 -27.53 68.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.022 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 13.0 ptt180 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.921 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.474 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.833 0.349 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.543 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 2.1 m-20 -100.95 -170.21 1.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.827 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -117.23 83.93 2.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.633 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.6 164.73 12.3 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.58 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.517 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.6 p -98.6 162.8 12.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.465 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -47.43 -51.33 20.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.879 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -64.42 -27.66 69.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.157 0.503 . . . . 0.0 110.065 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.517 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.2 OUTLIER -72.51 -51.43 20.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.706 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.701 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.9 pt -73.08 -28.85 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.849 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.37 -27.45 9.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.535 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 11.0 mt-10 -75.23 -28.53 59.95 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.207 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.36 -58.41 3.22 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.218 0.532 . . . . 0.0 111.004 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.875 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.5 pttt -54.45 -23.03 14.34 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.273 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.45 -27.85 56.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.27 -39.78 62.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.072 177.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.64 -51.89 67.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.845 0.831 . . . . 0.0 109.458 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 p -74.46 -24.45 59.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.101 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.845 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.06 -23.5 35.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.261 0.553 . . . . 0.0 110.28 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.822 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.9 t80 -95.4 -0.76 52.17 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.554 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.7 t70 -103.48 142.64 33.91 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.971 0.891 . . . . 0.0 111.039 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 3.7 mmtt -59.11 -53.38 59.04 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.604 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.93 -5.42 59.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.77 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.51 47.69 44.03 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.303 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -92.06 18.86 7.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.867 0.365 . . . . 0.0 110.685 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.36 5.11 89.06 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.577 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.8 p -150.34 148.86 29.33 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.755 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.18 140.51 19.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.847 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.575 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.17 176.46 8.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.004 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.819 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -70.52 -37.5 74.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.145 0.497 . . . . 0.0 110.332 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.536 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.23 -41.12 92.46 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.15 178.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.914 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -69.4 -53.41 19.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.26 -179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.828 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -58.24 -54.69 44.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.724 0.773 . . . . 0.0 109.326 178.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.49 -45.83 92.63 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.456 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.7 m -62.39 -30.9 71.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.845 0.322 . . . . 0.0 110.495 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 31' ' ' GLU . 72.5 t -68.2 -57.26 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.87 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.457 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.95 -35.63 69.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.389 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -68.13 -42.74 79.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.848 0.356 . . . . 0.0 110.667 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 t -78.94 -8.14 58.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.806 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.8 tt -90.97 -54.82 3.8 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.468 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -175.88 34.94 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.937 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp-100 -137.56 -178.95 5.46 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.381 0.61 . . . . 0.0 111.163 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -159.64 56.46 0.88 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.927 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.4 Cg_endo -80.37 -175.7 2.83 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.56 2.173 . . . . 0.0 112.101 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.612 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.94 152.5 32.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.956 0.408 . . . . 0.0 110.18 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.22 -49.58 75.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.81 -33.58 75.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.713 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.52 -54.33 33.93 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.673 -179.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.819 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.85 -34.77 78.9 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.379 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.69 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.39 -42.7 95.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.909 0.385 . . . . 0.0 110.228 179.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -61.76 -45.52 93.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.23 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -30.69 61.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.412 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.555 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.69 -38.29 34.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.524 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -44.91 -28.68 0.69 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.351 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.6 -38.78 47.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.891 0.376 . . . . 0.0 110.803 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.939 HG11 HG21 ' B' ' 6' ' ' ILE . 4.6 m -81.07 -11.39 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.18 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.549 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.9 t0 -103.73 155.68 18.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.754 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.485 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.57 -29.1 26.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -116.43 -9.66 11.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.416 0.627 . . . . 0.0 110.471 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.44 63.53 5.14 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.517 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -112.26 18.13 18.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.846 0.355 . . . . 0.0 110.193 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.67 19.91 55.31 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.453 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.1 p -147.16 176.41 9.98 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.768 HD12 HD11 ' A' ' 32' ' ' LEU . 13.8 mt -115.7 136.52 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-O 120.562 0.22 . . . . 0.0 110.889 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.485 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.9 m-20 -87.28 -178.06 6.11 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.28 0.562 . . . . 0.0 111.931 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.514 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.03 -56.06 11.99 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.622 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.7 Cg_endo -65.65 -34.8 40.07 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.21 1.94 . . . . 0.0 111.166 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.91 -52.35 63.41 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.268 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.718 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.0 -56.63 19.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.867 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.701 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.51 -46.12 84.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.696 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 56.5 m -60.06 -31.15 69.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.041 0.448 . . . . 0.0 109.966 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.929 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.8 tpp -64.54 -61.8 1.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.908 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.7 mtt -66.04 -29.19 69.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.803 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.543 ' HB1' ' CG ' ' A' ' 2' ' ' ASP . . . -57.77 -21.54 42.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.308 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -51.0 95.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 111.103 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -62.61 -18.82 62.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.231 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -29.61 66.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.963 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -88.94 79.33 7.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.68 -167.3 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 63.32 -167.41 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 79' ' ' THR . 19.4 m-20 63.87 30.51 14.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.923 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.1 p -77.53 -30.17 52.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.63 -29.11 36.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.85 -54.48 37.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.713 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.76 -29.43 27.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.375 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.723 HG22 ' HE1' ' A' ' 138' ' ' TYR . 17.9 mt -64.76 -51.23 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.772 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -75.58 -50.57 15.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.043 0.449 . . . . 0.0 110.685 179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 91' ' ' VAL . 7.1 mt-10 -53.79 -30.84 46.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.682 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -71.08 -38.55 72.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.781 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 24.2 t80 -67.03 -56.02 11.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.579 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.62 -30.65 43.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.866 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 87' ' ' GLU . 66.7 t -88.4 -22.92 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.211 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.462 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.18 -32.05 61.87 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.046 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -102.16 148.84 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.438 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -69.61 -37.71 76.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.332 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -112.27 -9.78 13.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.66 30.55 32.37 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.119 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.41 -13.73 62.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.96 0.38 . . . . 0.0 110.757 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.24 -13.46 55.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.857 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.7 m-85 -127.14 145.41 50.76 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 120.967 0.413 . . . . 0.0 111.284 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.949 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.1 109.97 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.885 179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.1 p -83.39 177.38 8.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.311 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.548 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.18 -28.97 70.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.083 0.468 . . . . 0.0 110.405 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.46 -57.67 9.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.426 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.41 -42.96 42.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.273 -179.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.949 HD13 HD13 ' A' ' 100' ' ' ILE . 56.0 tp -56.9 -31.14 64.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.08 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.794 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.4 ttt180 -72.54 -49.27 33.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.937 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -60.85 -36.5 79.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.991 0.424 . . . . 0.0 110.539 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 104' ' ' GLU . 54.5 t -72.82 -44.14 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.301 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 24.8 mmt -73.99 -54.05 8.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.727 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.648 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.3 m -55.59 -45.55 77.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.367 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.473 ' C ' HD12 ' A' ' 112' ' ' LEU . 7.8 m-20 -60.27 -29.85 69.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.86 0.362 . . . . 0.0 110.792 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.845 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.9 mp -123.49 38.66 4.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.647 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.95 -116.81 0.4 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.781 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.409 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.8 pt-20 -132.2 170.77 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 110.864 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.648 ' HA ' HG23 ' A' ' 110' ' ' THR . 9.5 ttmm -74.97 99.7 3.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.257 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.953 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.7 114.39 26.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.384 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.934 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.7 175.34 5.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.429 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.411 ' H ' HG22 ' A' ' 117' ' ' THR . 79.3 m-20 -48.09 -35.93 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.755 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -77.4 -35.09 54.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -72.62 -33.67 66.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.977 0.417 . . . . 0.0 110.106 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.953 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.69 -48.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.899 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.21 -52.87 63.82 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.843 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -56.97 -28.85 62.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.857 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.841 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.6 tpt -76.35 -38.64 55.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.146 0.498 . . . . 0.0 110.169 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.491 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -66.87 -48.42 79.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.563 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -60.25 -40.27 89.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.946 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 124' ' ' MET . 12.7 pt-20 -80.86 -37.1 30.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.856 0.36 . . . . 0.0 110.598 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.451 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.93 -36.18 81.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.764 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.3 t0 -101.37 147.58 26.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.013 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.56 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.6 pt -84.84 -40.67 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.047 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.56 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.95 -10.98 60.18 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.65 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.68 1.09 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.9 p-10 -96.33 -12.84 23.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.317 -0.941 . . . . 0.0 112.379 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.93 20.1 10.21 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.754 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.9 146.54 30.19 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.899 0.38 . . . . 0.0 110.06 179.211 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.764 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.1 t -130.64 107.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.246 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.552 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.21 174.84 11.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.304 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.723 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.96 -67.01 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.523 0.677 . . . . 0.0 111.464 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.88 -34.15 72.78 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.839 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.531 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.01 -40.63 73.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.83 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.2 OUTLIER -78.83 -32.88 46.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.064 178.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 64.0 t -55.35 -46.93 78.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.626 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -57.81 -45.32 86.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.1 -33.12 65.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.4 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 18.0 ttp -59.41 -41.93 90.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 t -78.71 -31.25 46.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.67 151.32 25.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.953 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.736 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.3 mmm180 -52.3 -51.25 59.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.729 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.66 -53.17 33.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.638 0.256 . . . . 0.0 111.289 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -57.24 -37.52 72.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.007 0.432 . . . . 0.0 110.347 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.953 HG23 ' O ' ' B' ' 1' ' ' ALA . 15.6 t -63.27 -33.68 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.348 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.939 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.58 -55.46 13.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.995 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.3 mmm-85 -50.36 -37.79 38.92 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.215 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -44.44 66.01 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.828 ' HD2' HD23 ' A' ' 32' ' ' LEU . 9.6 mtmt -57.9 -55.01 40.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.95 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.929 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.8 mt -51.27 -57.28 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.906 0.384 . . . . 0.0 111.228 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.52 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -58.36 -51.18 70.9 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 121.424 0.631 . . . . 0.0 110.656 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.5 -39.38 64.53 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.81 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' B' ' 17' ' ' ALA . 3.3 mt -54.28 -48.31 67.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.233 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.27 -38.22 95.58 Favored Glycine 0 CA--C 1.498 -1.022 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.495 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.895 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.76 -61.8 1.96 Allowed 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.743 -0.729 . . . . 0.0 110.504 -179.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.737 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -60.32 -27.59 67.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.32 -48.64 66.98 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.038 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.57 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 0.7 OUTLIER -63.78 -43.74 95.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.429 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.895 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -62.09 -34.65 64.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.472 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.752 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -75.37 -44.11 46.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.639 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.557 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 18.8 p -60.84 -25.8 66.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.474 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 23' ' ' LEU . 26.8 m -90.07 -46.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.991 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.95 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.12 -33.34 75.26 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.18 0.514 . . . . 0.0 110.444 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.95 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.121 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.527 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 1.4 m-20 -96.98 -169.95 1.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -119.24 84.49 2.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.93 164.82 12.21 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.51 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.494 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.58 162.08 13.47 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.46 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.68 -51.71 20.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.789 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -64.51 -27.68 69.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.035 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.494 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.94 -51.41 22.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.614 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.2 pt -73.06 -28.9 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.706 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.62 -27.31 10.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.3 mt-10 -75.28 -28.56 59.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.269 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.28 -58.44 3.21 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 121.207 0.527 . . . . 0.0 110.991 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.881 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.9 pttt -54.77 -22.93 15.73 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.203 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.538 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.28 -27.74 56.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 178.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.63 -39.77 61.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.074 177.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.881 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.04 -51.83 68.38 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.816 0.817 . . . . 0.0 109.463 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -25.04 59.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.171 -1.377 . . . . 0.0 112.073 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.899 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.02 -25.75 34.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.148 0.499 . . . . 0.0 110.451 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.795 ' HB3' HD11 ' A' ' 27' ' ' ILE . 5.6 t80 -87.75 -15.08 37.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.448 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR . 32.0 t70 -90.28 146.24 24.37 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.977 0.894 . . . . 0.0 111.23 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.508 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -63.33 -53.41 53.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.609 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -81.83 -6.8 59.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.846 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.56 45.27 59.68 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.402 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.3 p-10 -90.42 17.75 6.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.822 0.344 . . . . 0.0 110.759 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.81 5.47 89.36 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.449 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 46.4 p -150.18 150.52 31.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.795 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.77 140.58 20.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.968 0.413 . . . . 0.0 111.952 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.6 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.34 176.34 8.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.974 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.815 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -70.42 -38.0 74.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.03 0.443 . . . . 0.0 110.251 -179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.543 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.75 -40.99 89.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.22 178.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.08 -53.47 20.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.234 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.802 HD11 ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -58.43 -54.85 42.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.718 0.77 . . . . 0.0 109.463 178.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.59 -45.85 92.74 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.508 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.2 m -62.2 -31.39 71.91 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.818 0.342 . . . . 0.0 110.581 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 31' ' ' GLU . 69.6 t -68.08 -57.25 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.906 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.441 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.91 -35.36 69.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.436 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -42.13 79.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.945 0.402 . . . . 0.0 110.645 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.8 t -79.02 -7.61 58.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.648 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.547 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -91.03 -54.43 3.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.042 0.448 . . . . 0.0 110.754 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.67 34.81 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.888 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.13 -178.97 5.44 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.368 0.604 . . . . 0.0 111.134 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -159.58 56.49 0.89 Allowed Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.902 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.4 -176.76 3.36 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.502 2.134 . . . . 0.0 112.076 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.608 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -113.53 152.48 30.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.962 0.41 . . . . 0.0 110.199 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -57.51 -49.33 76.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.404 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.49 -31.69 72.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.75 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -66.06 -54.33 27.18 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.559 -179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.815 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.92 -34.74 78.82 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.369 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.674 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.46 -42.6 95.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.873 0.368 . . . . 0.0 110.172 179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -61.76 -45.38 94.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.245 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -30.77 61.83 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.419 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.556 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -53.75 -38.32 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.511 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -44.98 -28.6 0.69 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.387 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.04 -38.85 51.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.914 0.388 . . . . 0.0 110.758 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.816 HG11 HG21 ' B' ' 6' ' ' ILE . 5.1 m -81.38 -11.89 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.227 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.54 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.8 t0 -103.57 155.35 18.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.748 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.466 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.61 -28.8 26.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.124 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -116.42 -9.68 11.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.452 0.644 . . . . 0.0 110.5 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.35 63.48 5.2 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.488 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -112.06 18.1 19.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.81 0.338 . . . . 0.0 110.225 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.41 19.86 55.91 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.483 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -147.09 176.32 10.03 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.802 ' CD1' HD11 ' A' ' 32' ' ' LEU . 2.1 mp -115.54 136.55 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 120.6 0.238 . . . . 0.0 110.817 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.0 m-20 -86.11 -178.6 6.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.272 0.558 . . . . 0.0 111.885 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -67.65 -56.32 12.35 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.557 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.0 Cg_endo -65.93 -35.4 35.23 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.3 2.0 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -61.85 -52.45 64.1 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.192 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.09 -56.42 21.94 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.758 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.16 -45.47 83.59 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.733 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.41 HG22 ' NH1' ' A' ' 74' ' ' ARG . 64.0 m -60.58 -31.57 70.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.069 0.462 . . . . 0.0 110.049 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.919 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.5 tpp -63.49 -61.76 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.01 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.432 ' HG2' HG22 ' B' ' 10' ' ' ILE . 6.9 mtm -66.63 -27.56 67.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.716 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB1' ' OD1' ' A' ' 2' ' ' ASP . . . -58.9 -20.59 52.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.355 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' NH1' HG22 ' A' ' 70' ' ' THR . 5.9 mpt_? -47.88 96.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.859 0.361 . . . . 0.0 111.141 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -20.12 60.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.157 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.6 ttm -65.28 -28.93 69.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.005 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -87.8 54.85 3.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.926 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.14 -167.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 63.58 -165.8 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 79' ' ' THR . 0.4 OUTLIER 66.3 35.73 5.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.907 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.3 m -77.48 -42.96 33.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.6 -29.14 36.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.827 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -50.45 -30.59 12.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.232 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.719 ' O ' HG11 ' B' ' 19' ' ' VAL . 2.0 mt-10 -68.88 -30.54 69.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.481 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.691 HG22 ' HE1' ' A' ' 138' ' ' TYR . 8.1 mt -79.49 -51.1 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -74.65 -51.54 14.12 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.618 ' O ' HG23 ' A' ' 91' ' ' VAL . 26.6 tt0 -53.52 -25.32 16.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.929 0.395 . . . . 0.0 110.755 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.749 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.67 -36.43 43.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.248 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 28.1 t80 -67.94 -51.33 48.84 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.053 0.454 . . . . 0.0 110.142 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -32.62 58.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.773 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 87' ' ' GLU . 47.1 t -88.7 -22.73 6.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.616 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -52.93 -34.22 54.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.231 -179.388 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -99.36 147.87 24.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.487 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -67.48 -38.27 84.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.374 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.25 -9.74 13.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.796 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.03 28.07 32.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.327 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -67.5 -13.98 62.52 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.165 0.482 . . . . 0.0 110.757 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.85 -10.73 55.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.146 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.8 m-85 -127.12 145.28 50.8 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.014 0.435 . . . . 0.0 111.458 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.036 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.17 110.03 26.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.699 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 m -82.97 176.89 8.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.602 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.11 -30.06 71.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.077 0.465 . . . . 0.0 110.487 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.92 -57.76 11.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.286 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.791 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.5 -45.81 29.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.093 -179.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.036 HD13 HD13 ' A' ' 100' ' ' ILE . 38.0 tp -53.0 -31.15 39.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.844 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.6 ttt-85 -73.36 -49.09 29.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.952 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -59.06 -42.04 89.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.207 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.0 t -72.99 -40.01 58.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.598 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.456 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 27.7 mmt -73.97 -54.2 8.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.521 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.717 HG23 ' HA ' ' A' ' 115' ' ' LYS . 7.5 m -56.92 -47.75 79.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.241 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.698 ' C ' HD12 ' A' ' 112' ' ' LEU . 99.8 m-20 -59.67 -28.42 67.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.899 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.5 mp -123.28 37.09 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.99 -113.18 0.29 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.722 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.44 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.6 OUTLIER -134.58 167.22 21.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 0.0 110.849 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.717 ' HA ' HG23 ' A' ' 110' ' ' THR . 3.8 tppp? -72.55 99.88 2.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.237 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.971 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.05 114.42 26.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.435 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.923 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.85 175.39 5.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.381 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.407 ' H ' HG22 ' A' ' 117' ' ' THR . 1.8 m-20 -48.03 -36.0 12.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.782 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -77.34 -35.01 55.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.761 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -72.82 -33.26 66.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.993 0.425 . . . . 0.0 110.178 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.971 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.88 -47.92 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.898 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -59.54 -52.81 63.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.788 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -57.44 -28.72 63.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.829 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.805 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.5 tpt -76.25 -38.06 56.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.137 0.494 . . . . 0.0 110.108 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.489 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.53 -43.33 80.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.476 179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -64.98 -39.18 93.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.786 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.42 -36.28 29.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.945 0.402 . . . . 0.0 110.449 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.452 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -67.88 -37.55 81.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.544 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.732 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.2 t0 -100.35 146.35 27.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.04 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.556 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.72 -40.6 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.077 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.556 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.98 -10.99 60.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.701 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.81 32.93 1.01 Allowed Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -176.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.28 -12.63 24.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.311 -0.944 . . . . 0.0 112.46 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.87 20.12 10.24 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.86 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.67 146.91 30.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 129' ' ' ASP . 38.3 t -130.66 107.28 13.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.348 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.549 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -79.36 174.84 11.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.323 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.691 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.88 -67.36 0.29 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.518 0.675 . . . . 0.0 111.461 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -61.17 -30.38 70.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.884 -178.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.565 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.82 -44.43 77.88 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -31.79 46.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.208 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 138' ' ' TYR . 55.3 t -53.68 -47.79 61.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.487 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -57.82 -42.26 83.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.717 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.24 -37.93 66.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.967 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 6.4 ttp -57.11 -41.32 78.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.978 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.9 t -80.18 -31.32 38.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.74 146.63 40.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.913 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.948 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.821 0.343 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.31 -51.15 60.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.723 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.59 -53.31 31.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.668 0.271 . . . . 0.0 111.295 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -57.07 -37.57 72.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.46 . . . . 0.0 110.332 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.948 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.7 t -63.38 -34.2 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.364 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.816 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.01 -54.7 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.988 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -51.08 -37.2 44.24 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.159 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -48.37 63.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.492 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.798 ' HD2' HD23 ' A' ' 32' ' ' LEU . 16.0 mtmt -55.51 -54.4 44.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.203 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.919 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.21 -57.46 2.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.545 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.506 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.93 -51.17 70.82 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.177 0.513 . . . . 0.0 110.96 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.3 -40.55 64.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.747 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.774 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.8 mt -54.64 -49.32 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.484 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.421 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.4 -36.99 94.12 Favored Glycine 0 CA--C 1.498 -1.011 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.934 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.895 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.47 -61.68 2.07 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.381 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.641 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -62.36 -27.54 69.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.668 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.9 -50.37 64.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.204 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.724 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -64.25 -43.63 94.29 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.895 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.0 m -64.25 -33.12 60.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.479 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.674 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.5 OUTLIER -74.55 -45.75 43.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.839 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.537 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.9 p -59.55 -26.11 65.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.483 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.426 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.2 m -90.47 -46.64 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.148 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.921 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.9 pp -63.18 -32.98 74.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.189 0.519 . . . . 0.0 110.511 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.921 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.051 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.594 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.853 0.359 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.654 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 1.6 m-20 -86.44 -169.78 2.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.811 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -120.96 84.36 2.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.96 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.641 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -97.63 164.74 12.29 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.485 179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.514 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.14 162.71 13.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.481 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -47.46 -51.3 20.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.856 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -64.43 -27.65 69.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.04 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.514 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.52 -51.43 20.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.734 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.7 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.6 pt -73.2 -28.73 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.854 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.39 -27.38 9.86 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.541 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 2.7 mm-40 -75.18 -28.51 60.08 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.253 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.43 -58.5 3.17 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 121.253 0.549 . . . . 0.0 111.015 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -54.64 -22.84 14.81 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.205 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.3 -28.1 56.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.23 -39.87 62.8 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.11 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.94 -51.81 68.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.861 0.838 . . . . 0.0 109.487 178.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.426 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 4.4 p -74.51 -24.43 58.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.149 -1.387 . . . . 0.0 112.122 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.852 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.15 -23.35 35.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.202 0.525 . . . . 0.0 110.347 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.821 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.7 t80 -95.74 -1.02 50.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.608 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.2 t70 -103.12 144.27 31.52 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 122.036 0.922 . . . . 0.0 111.09 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.524 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 12.6 mmtt -60.55 -53.42 57.69 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 113.849 -1.523 . . . . 0.0 111.571 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.01 -4.65 59.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.876 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.46 45.55 45.93 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.391 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -90.43 17.57 7.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.836 0.35 . . . . 0.0 110.722 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.46 6.2 87.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.508 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.45 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 61.6 p -150.29 149.05 29.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.47 140.31 20.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.747 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.683 HG23 ' HG3' ' A' ' 30' ' ' LYS . 1.3 t -87.49 -179.74 6.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.122 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.803 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.9 p -70.42 -44.14 68.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 0.0 110.897 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.683 ' HG3' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -55.5 -40.23 71.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.327 179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.915 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -69.63 -53.83 16.88 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.424 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.86 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.04 -55.15 38.59 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 121.781 0.801 . . . . 0.0 109.42 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.62 -45.99 92.62 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.594 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.3 m -62.1 -31.22 71.65 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.939 0.37 . . . . 0.0 110.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.5 t -68.02 -57.2 10.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.842 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.454 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 1.3 tpt -71.97 -35.87 69.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.428 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -42.44 80.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.76 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.0 t -78.93 -8.36 58.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.76 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.7 tt -90.54 -54.72 3.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.761 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.467 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.15 35.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.889 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 tp-100 -137.3 -178.91 5.42 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.362 0.601 . . . . 0.0 111.207 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -159.64 56.59 0.9 Allowed Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.891 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.9 Cg_endo -80.37 -177.11 3.56 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.501 2.134 . . . . 0.0 112.059 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -113.66 152.54 30.28 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 110.263 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.14 -49.52 75.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.442 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.1 -33.12 74.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.764 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 44' ' ' THR . 0.1 OUTLIER -64.94 -54.28 33.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.692 -179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.803 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.6 -35.82 81.94 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.429 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.745 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -63.49 -42.69 98.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.875 0.369 . . . . 0.0 110.238 179.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -61.83 -45.61 93.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.338 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -30.72 61.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.492 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.57 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.524 -179.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -45.0 -28.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.328 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.46 -38.78 48.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.92 0.391 . . . . 0.0 110.838 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.919 HG11 HG21 ' B' ' 6' ' ' ILE . 4.8 m -81.14 -11.48 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.157 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.547 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.9 t0 -103.61 155.51 18.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.727 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.59 -29.09 26.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.079 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -116.4 -9.74 11.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.392 0.615 . . . . 0.0 110.485 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.8 63.93 4.76 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.008 -0.997 . . . . 0.0 113.491 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.2 p-10 -112.66 18.31 18.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.88 0.371 . . . . 0.0 110.217 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 86.09 19.81 56.63 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.474 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.639 HG22 ' HA ' ' A' ' 28' ' ' THR . 5.3 p -146.65 176.37 9.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 32' ' ' LEU . 35.5 mt -115.8 136.5 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.595 0.236 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.6 m-20 -86.94 -178.3 6.26 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.329 0.585 . . . . 0.0 111.935 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.96 -55.96 12.38 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.672 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.6 Cg_endo -65.62 -34.71 40.72 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.245 1.963 . . . . 0.0 111.197 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -52.45 62.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.97 -56.88 15.97 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.83 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.7 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.04 -46.56 82.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 68.9 m -60.67 -31.84 71.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.107 0.479 . . . . 0.0 110.041 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.936 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.3 tpp -62.34 -61.75 2.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.97 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 65.7 mtp -67.62 -28.1 67.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.826 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB1' ' CG ' ' A' ' 2' ' ' ASP . . . -60.21 -20.7 59.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.374 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.56 125.36 20.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.863 0.363 . . . . 0.0 111.045 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -87.64 -21.44 25.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.095 -179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 35.0 tpp -60.76 -29.9 69.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -94.06 135.62 35.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.897 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -176.39 -166.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.72 63.46 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -163.61 30.84 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.0 t -77.52 -30.44 52.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.958 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -80.22 -31.93 38.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -57.89 -52.2 66.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.986 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.73 -29.21 25.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.432 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.727 HG22 ' HE1' ' A' ' 138' ' ' TYR . 18.7 mt -65.89 -51.35 62.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.822 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -75.68 -50.43 15.42 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.774 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.679 ' O ' HG23 ' A' ' 91' ' ' VAL . 21.3 mt-10 -53.79 -31.92 50.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.644 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.555 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -69.84 -38.74 76.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.774 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.554 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.1 t80 -66.82 -55.85 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.967 0.413 . . . . 0.0 110.549 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -53.73 -30.54 44.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.876 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 87' ' ' GLU . 65.9 t -88.46 -22.85 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.214 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.36 -31.85 62.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.047 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -102.44 148.66 25.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.439 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -69.59 -37.67 77.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.385 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -112.28 -9.79 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.53 30.69 32.39 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.08 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.44 -13.46 62.05 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.992 0.396 . . . . 0.0 110.856 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.2 -13.66 55.32 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.853 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 24.2 m-85 -127.21 145.87 50.61 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 120.971 0.415 . . . . 0.0 111.268 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.962 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.06 109.97 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.853 179.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.1 m -83.53 177.28 8.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.393 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.551 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.16 -28.64 69.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.044 0.449 . . . . 0.0 110.427 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.1 -57.67 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.422 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.618 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.42 -42.38 44.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -179.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.962 HD13 HD13 ' A' ' 100' ' ' ILE . 52.9 tp -56.93 -31.24 64.74 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.788 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.0 ttt180 -72.57 -49.3 33.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -60.81 -36.15 78.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.012 0.434 . . . . 0.0 110.437 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 104' ' ' GLU . 60.3 t -72.94 -44.83 56.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.178 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.452 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 24.4 mmt -74.12 -54.06 8.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.556 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.663 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.6 m -55.57 -45.86 77.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.73 0.3 . . . . 0.0 111.267 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.541 ' C ' HD12 ' A' ' 112' ' ' LEU . 11.7 t-20 -60.04 -30.06 68.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.805 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.852 ' O ' HD11 ' A' ' 18' ' ' LEU . 7.0 mp -123.63 38.92 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.578 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.38 -116.1 0.38 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.798 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -133.13 169.53 16.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.889 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.663 ' HA ' HG23 ' A' ' 110' ' ' THR . 4.8 tppt? -74.22 100.07 3.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.95 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.5 114.91 26.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.322 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.929 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.67 175.08 5.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.417 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.413 ' H ' HG22 ' A' ' 117' ' ' THR . 0.7 OUTLIER -48.02 -36.01 12.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.93 0.395 . . . . 0.0 110.809 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -77.32 -34.76 55.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.774 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -72.86 -34.18 66.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.056 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.95 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.2 -48.59 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.968 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -59.2 -52.83 63.99 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.874 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.56 -28.96 64.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.843 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.858 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.6 tpt -76.32 -37.72 57.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.129 0.49 . . . . 0.0 110.177 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.485 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.64 -42.86 83.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.455 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -65.1 -39.54 93.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.858 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -81.85 -35.44 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 0.0 110.56 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.453 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.3 -37.68 80.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.5 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.771 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.8 t0 -100.44 147.44 25.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.99 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.558 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.6 pt -84.84 -40.75 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.039 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.558 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.91 -10.95 59.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.709 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.07 32.67 1.09 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.438 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.4 p-10 -96.25 -12.87 23.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.264 -0.968 . . . . 0.0 112.462 -176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.19 10.17 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.822 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.98 146.37 30.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.962 0.41 . . . . 0.0 109.998 179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.771 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.4 t -130.68 107.38 14.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.185 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.552 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.36 174.83 11.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.338 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.727 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.95 -67.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.494 0.664 . . . . 0.0 111.393 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -34.03 72.49 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.789 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.539 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.09 -40.53 73.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.827 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.79 -33.15 46.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.046 178.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.581 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 64.8 t -55.11 -46.92 77.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.661 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -57.8 -45.65 85.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.13 -32.87 65.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.406 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 16.6 ttp -59.42 -42.03 90.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 t -78.71 -31.19 46.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.12 7.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.104 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.954 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.873 0.368 . . . . 0.0 111.01 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.735 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.33 -51.28 59.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.727 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.63 -53.26 32.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.678 0.275 . . . . 0.0 111.257 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -57.22 -37.46 72.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.0 0.429 . . . . 0.0 110.346 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.954 HG23 ' O ' ' B' ' 1' ' ' ALA . 16.3 t -63.31 -33.72 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.403 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.919 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.7 -55.36 13.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.046 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.6 mmm-85 -50.34 -38.11 40.28 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.239 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.71 -44.7 66.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.409 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.86 ' HD2' HD23 ' A' ' 32' ' ' LEU . 8.5 mtmt -57.24 -55.19 38.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.98 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.936 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.12 -57.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.309 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -58.23 -51.16 70.91 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.379 0.609 . . . . 0.0 110.65 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.588 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.52 -39.56 64.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.822 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.607 ' O ' ' HB2' ' B' ' 17' ' ' ALA . 3.5 mt -54.31 -48.23 67.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.221 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.412 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.27 -38.37 95.79 Favored Glycine 0 CA--C 1.498 -1.002 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.517 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.901 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.81 -61.66 2.04 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.683 -0.759 . . . . 0.0 110.506 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.738 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.08 -27.76 67.26 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.14 -48.89 66.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.005 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.1 ppt_? -63.45 -43.6 96.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.13 0.49 . . . . 0.0 109.77 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.901 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.6 m -62.42 -34.83 66.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.476 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.76 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -74.98 -43.86 51.56 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.7 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.545 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 17.3 p -60.46 -25.68 66.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.511 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.421 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.7 m -90.83 -46.71 14.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.055 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.947 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.54 -33.01 74.07 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.171 0.51 . . . . 0.0 110.362 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.947 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.114 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.705 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.844 0.354 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.582 ' OD2' ' HB1' ' A' ' 73' ' ' ALA . 2.0 m-20 -72.98 -170.17 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -121.2 86.78 2.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.631 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -98.73 164.75 12.1 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.662 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.49 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.8 p -97.96 162.71 13.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.506 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -47.43 -51.47 19.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.878 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -64.27 -27.73 69.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.147 0.499 . . . . 0.0 109.985 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.4 mm-40 -72.51 -51.36 20.36 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.736 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.711 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.4 pt -73.22 -28.78 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.898 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.36 -27.32 9.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 13.2 mm-40 -75.17 -28.46 60.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.264 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.51 -58.48 3.18 Favored 'General case' 0 CA--C 1.522 -0.114 0 CA-C-O 121.275 0.56 . . . . 0.0 111.014 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.876 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.52 -22.96 14.49 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.209 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.531 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.27 -27.78 56.8 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.164 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.75 -39.68 61.68 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.051 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.876 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.09 -51.73 68.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.838 0.828 . . . . 0.0 109.43 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.402 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 8.2 p -74.45 -24.91 59.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.083 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.911 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.0 -25.1 35.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.129 0.49 . . . . 0.0 110.438 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.805 ' HB3' HD11 ' A' ' 27' ' ' ILE . 5.1 t80 -89.38 -14.53 35.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.498 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.1 t70 -90.61 145.84 24.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.963 0.887 . . . . 0.0 111.24 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.8 mmtt -63.76 -53.43 51.17 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.575 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -82.44 -7.07 59.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.772 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.52 45.91 58.94 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.394 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -90.9 18.13 6.99 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.894 0.378 . . . . 0.0 110.732 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.37 5.01 89.14 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.542 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.9 p -150.21 151.92 33.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.805 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -102.67 140.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.977 0.418 . . . . 0.0 111.772 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.546 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.11 176.42 8.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.006 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.819 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -70.4 -38.32 74.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.126 0.489 . . . . 0.0 110.198 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.61 -41.05 89.52 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.176 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.98 -53.71 19.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.264 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.839 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.28 -55.37 35.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.725 0.774 . . . . 0.0 109.393 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.1 -45.96 91.98 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.536 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.21 -31.11 71.6 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.883 0.342 . . . . 0.0 110.589 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 31' ' ' GLU . 69.1 t -68.25 -57.21 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.864 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.451 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -71.95 -35.51 69.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.474 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -42.98 80.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.625 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 26.7 t -79.03 -7.14 57.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.761 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -91.14 -54.51 3.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.27 34.49 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.839 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.36 -178.4 5.2 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 121.329 0.585 . . . . 0.0 111.106 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -159.59 56.62 0.9 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.901 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.9 Cg_endo -80.41 -176.27 3.11 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.516 2.144 . . . . 0.0 112.118 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.603 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.68 152.49 31.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.942 0.401 . . . . 0.0 110.27 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.21 -49.65 75.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.78 -33.41 75.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.761 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.56 -54.33 33.84 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.626 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.819 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -66.03 -34.57 78.39 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.378 179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.683 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.46 -43.12 95.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.894 0.378 . . . . 0.0 110.193 179.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.58 -45.37 94.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.265 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -74.52 -30.67 61.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.37 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.588 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -53.65 -39.2 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.604 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.421 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.3 m-80 -45.12 -28.58 0.76 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.373 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.89 -38.74 53.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.952 0.406 . . . . 0.0 110.698 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.912 HG11 HG21 ' B' ' 6' ' ' ILE . 4.8 m -80.39 -12.75 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 43.5 t0 -103.53 155.07 18.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.763 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.14 26.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.182 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -116.42 -9.8 11.42 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.419 0.628 . . . . 0.0 110.402 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.81 61.49 7.31 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.261 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -109.43 18.38 20.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.758 0.313 . . . . 0.0 110.472 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.76 19.79 59.15 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.402 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.5 p -147.95 176.28 10.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.0 mt -113.28 136.61 49.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.64 0.257 . . . . 0.0 110.846 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -85.87 -179.38 6.8 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.178 0.513 . . . . 0.0 111.77 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.3 m-85 -68.26 -55.94 11.65 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.455 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.3 Cg_endo -65.94 -35.27 35.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.181 1.921 . . . . 0.0 111.104 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.25 -52.37 64.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.211 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.02 -56.6 19.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.779 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.711 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -54.83 -47.71 73.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.705 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 73.2 m -59.34 -32.18 69.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.146 0.498 . . . . 0.0 109.713 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.902 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.9 tpp -67.73 -61.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.93 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.443 ' HG3' HG22 ' B' ' 10' ' ' ILE . 31.8 mtp -64.71 -29.01 69.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.599 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.582 ' HB1' ' OD2' ' A' ' 2' ' ' ASP . . . -53.63 -24.86 15.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.927 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 -60.84 -29.64 69.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.721 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.4 ' CD ' ' O ' ' A' ' 75' ' ' LYS . 1.6 tptp -60.29 -21.29 61.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.023 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -23.16 27.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.232 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -56.68 -77.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 178.3 -177.94 0.25 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.854 0.359 . . . . 0.0 110.946 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 61.83 -173.28 0.14 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.458 ' H ' HG22 ' A' ' 79' ' ' THR . 0.8 OUTLIER 62.72 27.76 16.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.136 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 m -77.57 -49.43 14.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.66 -29.06 36.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.993 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -50.46 -30.53 12.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.316 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.658 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -77.17 -29.57 54.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.809 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.719 HG22 ' HE1' ' A' ' 138' ' ' TYR . 6.8 mt -79.3 -51.19 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.37 -51.97 11.87 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.5 tt0 -53.74 -25.92 20.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 110.71 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.709 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.07 -36.59 48.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.257 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.601 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 25.6 t80 -67.82 -52.02 41.82 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.043 0.449 . . . . 0.0 110.181 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.425 ' NH2' HD11 ' A' ' 39' ' ' LEU . 1.8 ptt180 -54.55 -32.26 58.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.847 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 87' ' ' GLU . 60.4 t -88.72 -22.72 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.577 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.478 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -53.45 -33.45 54.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.207 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -100.19 147.83 25.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.44 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -67.47 -38.35 84.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.403 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.26 -9.75 13.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.835 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.5 28.67 32.12 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.407 -0.901 . . . . 0.0 113.238 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -67.45 -13.9 62.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 117.161 0.481 . . . . 0.0 110.774 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.09 -11.57 55.58 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.085 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.457 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.4 m-85 -127.09 145.34 50.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.993 0.425 . . . . 0.0 111.434 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.046 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.16 109.93 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.686 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -83.29 177.29 8.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.541 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.546 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.32 -28.62 69.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.059 0.457 . . . . 0.0 110.509 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.31 -57.69 9.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.337 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.718 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.39 -43.6 39.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.181 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.046 HD13 HD13 ' A' ' 100' ' ' ILE . 35.5 tp -54.95 -31.18 60.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.081 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.814 ' HA ' HD11 ' A' ' 116' ' ' LEU . 3.3 ttt-85 -73.7 -49.3 26.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -61.28 -36.42 80.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.036 0.446 . . . . 0.0 110.369 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 104' ' ' GLU . 41.4 t -72.95 -44.79 56.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.229 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.6 mmt -74.05 -54.33 8.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.45 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.682 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.1 m -55.63 -46.2 77.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.32 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.582 ' C ' HD12 ' A' ' 112' ' ' LEU . 55.7 t30 -59.51 -30.48 68.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.911 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.8 mp -123.47 38.87 4.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.625 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.32 -115.69 0.36 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.817 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.419 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -133.21 168.87 17.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 110.93 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.682 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.7 ttmm -74.06 100.62 3.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.313 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.964 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.79 115.43 27.13 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.279 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.926 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.83 175.05 6.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.404 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.03 -35.91 11.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 110.821 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -77.36 -35.07 54.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -72.49 -33.92 67.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.994 0.426 . . . . 0.0 110.08 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.964 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.54 -48.46 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.935 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -59.33 -52.75 64.31 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.847 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.47 -28.81 63.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.819 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.813 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.7 tpt -76.33 -37.88 56.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.127 0.489 . . . . 0.0 110.182 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.75 -43.6 79.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.56 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -64.94 -39.2 93.14 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.837 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.22 -36.14 30.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.518 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.436 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.15 -38.22 81.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.666 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.719 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.7 t0 -99.76 147.6 25.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.09 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.562 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.8 -40.69 15.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.102 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.562 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.93 -10.98 60.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.698 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.68 1.09 Allowed Glycine 0 C--N 1.338 0.642 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -176.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.2 p-10 -95.99 -12.83 24.39 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.302 -0.949 . . . . 0.0 112.455 -176.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.94 20.15 10.15 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.817 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 1.1 pt20 -146.48 146.8 30.68 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.953 0.406 . . . . 0.0 109.983 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.719 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.4 t -130.73 107.35 13.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.278 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.542 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -79.27 174.6 11.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.285 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.719 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.87 -67.07 0.32 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.527 0.68 . . . . 0.0 111.441 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.403 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -60.5 -34.1 73.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.865 -178.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.506 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.17 -41.89 76.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.306 0.574 . . . . 0.0 109.53 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.772 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.75 -31.81 46.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.132 178.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 138' ' ' TYR . 62.2 t -55.95 -47.11 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -56.62 -44.33 81.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.07 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.13 -32.31 64.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 14.5 ttp -60.1 -43.12 95.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 t -77.25 -31.24 54.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.96 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 160.71 7.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.111 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.874 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.945 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.865 0.364 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.24 -50.96 61.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.723 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.66 -53.26 32.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.701 0.286 . . . . 0.0 111.289 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.14 -37.63 72.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.028 0.442 . . . . 0.0 110.252 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.945 HG23 ' O ' ' B' ' 1' ' ' ALA . 13.4 t -63.51 -33.69 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.384 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.912 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.43 -55.4 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.966 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.8 mmm-85 -50.61 -37.24 39.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.117 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.64 -47.57 62.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.523 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.839 ' HD2' HD23 ' A' ' 32' ' ' LEU . 15.2 mtmt -55.93 -55.34 33.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.989 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.902 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.8 mt -51.36 -57.48 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.23 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -56.89 -51.2 70.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.93 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.52 -41.53 66.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.9 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.655 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.3 mt -54.39 -49.58 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.6 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.47 -37.18 94.4 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.017 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.91 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.96 -61.62 2.05 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.723 -0.738 . . . . 0.0 110.354 -179.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.66 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.81 -27.73 68.97 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.615 177.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -64.95 -51.58 61.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.273 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.734 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.89 -43.72 95.14 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.91 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -64.56 -32.92 59.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.694 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.6 OUTLIER -74.02 -45.93 46.64 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.783 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.538 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.7 -26.11 65.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.534 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.414 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.0 m -90.24 -45.9 14.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.171 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.935 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.63 -32.67 74.21 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-O 121.127 0.489 . . . . 0.0 110.483 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.935 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.093 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.695 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.835 0.35 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.428 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 5.4 m-20 -61.18 -169.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -114.6 93.58 4.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.622 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -96.42 164.63 12.55 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.471 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.513 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 6.3 p -98.93 162.58 13.0 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.464 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -47.73 -51.33 22.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.761 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -64.74 -27.7 69.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.029 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.513 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.03 -51.54 21.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.62 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.683 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -72.67 -28.98 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.592 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.41 11.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.7 mt-10 -75.1 -28.63 60.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.126 178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.608 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.22 -58.42 3.23 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.332 0.587 . . . . 0.0 110.927 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.878 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 11.0 ptmt -54.44 -23.31 15.47 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.231 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.538 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.11 -27.92 57.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.41 -39.59 62.53 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.052 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.878 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.78 -51.76 68.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.789 0.804 . . . . 0.0 109.452 178.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.51 -24.8 59.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.99 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.838 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.3 tt -82.05 -24.16 35.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.501 . . . . 0.0 110.269 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.802 ' HB3' HD11 ' A' ' 27' ' ' ILE . 4.2 t80 -92.77 -2.72 55.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.567 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.5 t70 -102.41 144.02 31.41 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.988 0.899 . . . . 0.0 111.032 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.509 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.2 mmtt -60.93 -53.44 57.29 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.512 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.31 -4.64 59.22 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.823 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.9 47.33 39.82 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.292 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 p30 -91.81 18.54 7.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.824 0.345 . . . . 0.0 110.685 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.52 4.85 88.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.57 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.1 p -150.17 149.97 30.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.66 0.266 . . . . 0.0 110.349 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.802 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.72 140.4 20.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.955 0.407 . . . . 0.0 111.822 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.52 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.96 176.99 7.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.131 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.671 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -69.84 -38.28 76.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.108 0.48 . . . . 0.0 110.315 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.81 -41.36 91.09 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.251 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.926 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.46 -52.16 29.34 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.41 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.8 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -60.24 -55.1 37.89 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.836 0.827 . . . . 0.0 109.364 178.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.81 -45.15 91.69 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.431 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.5 m -62.52 -31.24 71.98 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.469 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.6 t -67.59 -57.31 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.833 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.57 ' CE ' HD22 ' A' ' 39' ' ' LEU . 3.4 tpt -71.92 -36.17 69.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.539 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -42.01 81.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.647 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.4 t -78.97 -8.44 58.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.675 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.57 HD22 ' CE ' ' A' ' 36' ' ' MET . 6.8 tt -89.64 -53.93 4.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.103 0.477 . . . . 0.0 110.694 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.97 35.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.803 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.8 tp-100 -137.47 179.99 6.08 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.374 0.607 . . . . 0.0 111.212 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -159.76 56.46 0.87 Allowed Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.831 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.1 Cg_endo -80.38 -175.13 2.54 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.469 2.113 . . . . 0.0 112.195 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.594 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -112.98 152.63 29.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.886 0.374 . . . . 0.0 110.272 179.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.3 -49.18 76.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.03 74.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.821 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.578 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.96 -54.58 28.33 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.639 -179.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.671 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.12 -44.65 96.18 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.93 179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.645 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -58.2 -49.15 78.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.351 . . . . 0.0 110.751 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -53.25 -47.52 68.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.399 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.406 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.2 mmt -74.77 -30.55 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.767 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -53.62 -35.11 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.868 0.366 . . . . 0.0 111.522 -179.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -44.99 -28.63 0.7 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.267 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.426 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -78.05 -38.86 43.51 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.914 0.387 . . . . 0.0 110.764 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.869 HG11 HG21 ' B' ' 6' ' ' ILE . 4.5 m -80.49 -11.17 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.549 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.6 t0 -103.69 155.79 18.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.735 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.496 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.63 -29.17 25.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.063 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -116.5 -9.65 11.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.444 0.64 . . . . 0.0 110.468 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.61 63.51 5.15 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.484 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -112.11 17.9 19.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.857 0.36 . . . . 0.0 110.268 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.07 19.91 54.47 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.554 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.52 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.2 p -147.64 176.42 10.1 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.742 HD12 HD11 ' A' ' 32' ' ' LEU . 12.1 mt -115.49 136.57 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.569 0.223 . . . . 0.0 111.068 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.4 m-20 -88.05 -178.05 5.89 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.219 0.533 . . . . 0.0 111.964 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.86 -55.97 12.61 Favored Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.77 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.9 Cg_endo -65.63 -34.91 39.94 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.237 1.958 . . . . 0.0 111.186 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -52.28 63.64 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.206 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.713 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.97 -56.72 18.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.887 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.683 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.94 -46.25 82.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.653 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.695 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 80.0 m -60.05 -31.91 70.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.092 0.473 . . . . 0.0 110.037 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.921 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.3 tpp -62.24 -61.74 2.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.105 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 36.8 mtm -71.26 -30.9 66.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.011 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.428 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.79 0.09 40.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.584 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 tpt85 -56.98 150.14 17.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.808 0.337 . . . . 0.0 111.009 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -72.55 -12.72 61.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.304 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.5 mmt -93.55 -30.83 14.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 110.965 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 100.44 6.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -156.24 -176.35 5.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 61.59 -167.51 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.401 ' H ' HG22 ' A' ' 79' ' ' THR . 11.3 m-20 64.25 65.01 0.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.0 m -77.54 -58.09 3.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.41 -31.01 72.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -50.35 -30.43 12.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.581 ' O ' HG11 ' B' ' 19' ' ' VAL . 6.4 mt-10 -77.68 -29.47 51.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.713 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.667 HG22 ' HE1' ' A' ' 138' ' ' TYR . 16.2 mt -79.15 -51.13 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -72.55 -48.85 36.86 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.663 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.8 tt0 -53.61 -25.49 17.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.807 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.754 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.99 -36.83 48.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.284 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 25.2 t80 -68.29 -51.68 42.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 110.146 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -54.96 -32.2 61.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.772 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 87' ' ' GLU . 47.4 t -88.77 -22.72 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.488 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.55 -33.6 55.26 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.073 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -101.8 147.21 26.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.407 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -69.59 -36.59 76.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.448 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.18 -9.69 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.824 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.64 29.82 34.56 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.251 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -67.51 -13.85 62.41 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.109 0.455 . . . . 0.0 110.732 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.448 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.18 -12.7 55.47 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.906 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.483 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 20.5 m-85 -127.3 146.91 50.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.86 0.362 . . . . 0.0 111.25 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.847 ' CD1' HD12 ' A' ' 105' ' ' LEU . 1.1 pt -121.11 110.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.854 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.3 m -82.31 178.42 8.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.644 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.537 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.72 -29.69 70.88 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 110.638 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.56 -57.2 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.147 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.761 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.43 -45.26 32.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.251 -179.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.847 HD12 ' CD1' ' A' ' 100' ' ' ILE . 5.3 tt -53.03 -32.7 48.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.936 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.843 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.5 ttt180 -73.4 -49.36 27.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.131 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -59.7 -42.67 93.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.877 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.766 ' O ' HD12 ' A' ' 112' ' ' LEU . 3.4 t -73.0 -40.14 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.73 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.498 ' HE1' ' CD2' ' B' ' 20' ' ' PHE . 30.1 mmt -73.95 -54.19 8.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.529 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.736 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.3 m -57.01 -48.94 77.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.256 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -57.87 -28.4 64.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.838 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.1 mt -123.6 36.6 4.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.44 -116.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.734 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.404 ' O ' HD23 ' A' ' 116' ' ' LEU . 6.9 pt-20 -130.49 168.75 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.85 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.736 ' HA ' HG23 ' A' ' 110' ' ' THR . 63.2 tttt -74.1 100.52 3.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.233 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.971 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.78 114.53 26.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.455 179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.928 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -71.83 175.39 5.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.358 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.474 ' H ' HG22 ' A' ' 117' ' ' THR . 1.5 t70 -48.11 -35.93 12.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.746 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -77.37 -35.74 54.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.701 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -71.81 -33.51 68.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.966 0.412 . . . . 0.0 110.063 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.971 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -73.92 -48.61 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.745 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -58.41 -52.82 64.03 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.544 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -60.24 -28.67 68.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.577 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.619 ' HG2' HD21 ' A' ' 105' ' ' LEU . 5.5 tpt -72.42 -37.74 68.56 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.253 0.549 . . . . 0.0 110.085 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.487 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -70.63 -41.25 77.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.501 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -64.78 -40.16 94.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.6 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -81.84 -34.67 30.03 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.002 0.429 . . . . 0.0 110.374 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.78 -34.75 76.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.517 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.72 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.3 t0 -105.19 146.67 28.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.992 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.56 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -83.69 -40.83 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.08 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.56 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.96 -11.0 60.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.678 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.96 32.6 1.02 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.4 p-10 -96.0 -12.78 24.47 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.332 -0.934 . . . . 0.0 112.432 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.22 10.16 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.828 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.483 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -146.68 147.4 30.97 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 129' ' ' ASP . 25.6 t -130.76 107.3 13.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.354 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.553 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -81.01 174.51 11.55 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.239 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.667 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.96 -67.23 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.583 0.706 . . . . 0.0 111.471 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.1 mt-10 -60.81 -29.14 69.29 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.561 -1.199 . . . . 0.0 111.989 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.546 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.83 -44.26 77.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.069 0.461 . . . . 0.0 109.814 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.7 -32.01 46.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.175 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 138' ' ' TYR . 68.5 t -53.84 -48.14 62.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -58.15 -44.16 87.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.6 tpp -73.21 -32.63 64.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.789 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 15.3 ttp -60.01 -45.56 92.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 t -74.69 -30.96 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.61 148.87 32.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.091 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.876 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.972 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.786 0.327 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.73 ' O ' HG13 ' B' ' 6' ' ' ILE . 2.1 mmm180 -52.15 -51.54 57.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.746 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.76 -53.43 31.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.612 0.244 . . . . 0.0 111.417 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.05 -37.0 71.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.139 0.495 . . . . 0.0 110.174 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.972 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.6 t -63.7 -34.4 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.417 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.869 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -71.47 -53.87 19.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.979 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -50.81 -39.77 53.8 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.238 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -48.32 65.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.459 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.867 ' O ' HD12 ' B' ' 13' ' ' ILE . 13.9 mtmt -55.01 -54.25 45.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.273 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.921 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.7 mt -51.04 -55.04 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.297 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.533 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 5.9 tpt180 -61.44 -46.46 89.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.224 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.528 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.13 -40.58 64.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.076 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.867 HD12 ' O ' ' B' ' 9' ' ' LYS . 1.8 mt -54.55 -51.71 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.512 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.41 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.46 -36.72 93.54 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.386 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.911 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.15 -61.58 2.16 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.954 -0.623 . . . . 0.0 110.474 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.655 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -63.38 -27.77 69.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.658 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -66.62 -50.91 61.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.203 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.559 ' NE ' HG12 ' B' ' 19' ' ' VAL . 3.9 ppt_? -63.38 -43.5 97.42 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.911 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.5 m -66.94 -31.85 55.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 0.0 110.609 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.659 ' HE2' HG12 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -72.65 -51.15 20.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.814 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.442 ' HA ' ' NE ' ' B' ' 24' ' ' ARG . 50.6 p -57.27 -35.34 69.64 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.116 0.484 . . . . 0.0 110.781 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.493 HG13 ' O ' ' B' ' 18' ' ' ARG . 27.2 m -73.43 -45.81 51.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.976 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.592 HD21 ' CD1' ' B' ' 20' ' ' PHE . 3.6 pp -65.15 -24.9 67.53 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.916 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 11.2 ptt85 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.901 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . . . . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.866 0.365 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.603 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 3.0 m-20 -98.48 -169.9 1.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.76 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -116.96 83.98 2.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.633 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -97.51 164.77 12.3 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.019 0.438 . . . . 0.0 110.475 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.497 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.7 161.97 13.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.438 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -47.68 -51.67 20.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.752 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -64.56 -27.69 69.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.033 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.497 ' HB2' ' H ' ' A' ' 5' ' ' THR . 1.7 mm-40 -71.88 -51.41 22.45 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.644 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.1 pt -73.01 -28.95 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.72 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.31 10.81 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.546 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 4.0 mt-10 -75.25 -28.55 59.89 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.281 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.61 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.38 -58.52 3.17 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.299 0.571 . . . . 0.0 110.946 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.877 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.5 pttt -54.52 -23.48 16.61 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.183 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -75.65 -28.03 58.59 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.174 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.17 -39.77 63.0 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.094 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.877 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.04 -51.84 68.31 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.803 0.811 . . . . 0.0 109.544 178.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.49 -24.7 59.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.124 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.842 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.13 -23.13 35.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.165 0.507 . . . . 0.0 110.405 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.82 ' CE2' HG21 ' A' ' 35' ' ' VAL . 3.6 t80 -94.46 -2.82 51.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.639 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 26' ' ' THR . 23.9 t70 -100.83 142.81 31.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.946 0.879 . . . . 0.0 111.096 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -59.84 -53.45 57.78 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.501 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.17 -6.27 59.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.714 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.5 47.37 51.66 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.36 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -92.01 18.8 7.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.882 0.372 . . . . 0.0 110.688 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.42 5.03 89.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.619 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.441 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.8 p -150.28 150.27 31.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.688 0.28 . . . . 0.0 110.26 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.78 140.54 20.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.79 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.576 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -84.89 176.35 8.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.024 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.798 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -70.49 -37.97 74.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.128 0.49 . . . . 0.0 110.271 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.87 -41.06 90.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.162 178.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.922 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.1 -53.82 18.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.264 -179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.822 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.2 OUTLIER -58.37 -55.13 39.05 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.695 0.76 . . . . 0.0 109.365 178.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.12 -45.88 92.1 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 114.53 -1.214 . . . . 0.0 112.514 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.2 m -62.34 -32.3 73.06 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.874 0.337 . . . . 0.0 110.488 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.9 t -66.45 -57.18 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.85 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.448 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.91 -34.61 69.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.376 -179.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -68.97 -42.62 76.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.666 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.5 t -78.91 -7.75 58.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.751 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -91.21 -54.91 3.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.806 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.461 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.11 34.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.9 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 tp-100 -137.59 -178.73 5.37 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.295 0.569 . . . . 0.0 111.223 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -159.56 56.57 0.9 Allowed Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.933 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.0 Cg_endo -80.33 -177.38 3.75 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.538 2.159 . . . . 0.0 112.065 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -112.86 152.36 29.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.955 0.407 . . . . 0.0 110.306 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.51 -49.24 76.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.39 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.65 -31.82 72.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.783 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.584 ' H ' HG22 ' A' ' 44' ' ' THR . 1.0 OUTLIER -66.0 -54.31 27.68 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.611 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.798 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.97 -34.53 78.31 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.34 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.682 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.49 -42.68 95.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.909 0.385 . . . . 0.0 110.172 179.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -61.74 -45.45 93.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.186 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.6 mmt -74.52 -30.77 61.91 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.46 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.74 -38.29 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.606 -179.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -45.03 -28.53 0.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.369 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.72 -38.33 47.39 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.849 HG11 HG21 ' B' ' 6' ' ' ILE . 4.7 m -81.58 -11.36 12.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.239 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.554 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.9 t0 -103.52 155.6 18.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.761 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.479 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.61 -28.8 26.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -116.46 -9.75 11.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.399 0.618 . . . . 0.0 110.433 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.53 63.23 5.42 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.402 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.0 p-10 -112.23 18.42 18.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.863 0.363 . . . . 0.0 110.188 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.32 19.9 56.0 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.49 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.576 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.0 p -146.85 176.49 9.85 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.475 -0.195 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.576 HD12 HD11 ' A' ' 32' ' ' LEU . 50.0 mt -116.27 136.53 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.528 0.204 . . . . 0.0 110.92 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.479 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.1 m-20 -87.33 -178.36 6.17 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.328 0.585 . . . . 0.0 112.002 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.511 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.78 -56.37 11.94 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.534 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.4 Cg_endo -65.81 -34.61 39.4 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.285 1.99 . . . . 0.0 111.114 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -52.4 63.67 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.226 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.726 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.47 -56.64 19.2 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.842 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.73 -46.26 84.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 58.3 m -60.69 -31.01 70.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.075 0.464 . . . . 0.0 110.046 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.928 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.5 tpp -62.43 -61.84 2.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.163 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 66.9 mtp -62.18 -33.43 74.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.603 ' HB1' ' CG ' ' A' ' 2' ' ' ASP . . . -61.1 -19.29 61.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.399 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -53.56 141.55 25.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.841 0.353 . . . . 0.0 111.134 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 2.1 tptp -87.53 -21.79 25.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.1 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 37.4 ttm -60.01 -23.2 63.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.104 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -57.53 153.66 12.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -105.09 27.38 8.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.05 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.403 HG22 ' HB2' ' A' ' 81' ' ' SER . 9.5 m 68.3 -67.52 0.2 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.037 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.53 36.66 8.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.886 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.403 ' HB2' HG22 ' A' ' 79' ' ' THR . 23.1 t -77.49 -28.88 52.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.034 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -80.61 -29.18 36.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.032 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -75.35 -44.4 45.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.723 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.76 -29.3 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.455 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.715 HG22 ' HE1' ' A' ' 138' ' ' TYR . 23.2 mt -65.97 -51.33 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.828 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -75.68 -51.11 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.828 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.659 ' O ' HG23 ' A' ' 91' ' ' VAL . 15.9 tt0 -53.91 -30.78 47.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.666 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.541 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -69.92 -38.78 76.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.708 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 22.6 t80 -67.38 -55.17 14.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.969 0.414 . . . . 0.0 110.431 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -54.47 -30.33 52.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.866 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 87' ' ' GLU . 98.4 t -88.38 -22.83 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.148 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.507 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -55.53 -30.55 60.91 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.036 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -107.69 142.82 37.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.621 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.749 ' NZ ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -65.28 -38.01 88.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.631 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -110.58 -9.58 14.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.43 31.74 36.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.367 -0.921 . . . . 0.0 113.076 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -67.38 -13.61 62.17 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.962 0.381 . . . . 0.0 110.747 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.454 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.19 -13.73 55.32 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.847 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.491 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.8 m-85 -127.28 147.42 50.23 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.899 0.381 . . . . 0.0 111.292 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.942 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -120.17 110.02 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.949 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.9 p -83.93 176.09 9.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.462 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.561 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -62.7 -29.98 71.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.08 0.467 . . . . 0.0 110.471 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.03 -57.01 14.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.287 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.735 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -76.43 -46.49 26.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.323 -179.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.942 HD13 HD13 ' A' ' 100' ' ' ILE . 41.0 tp -53.13 -31.08 40.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.818 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.0 ttt180 -73.82 -49.2 26.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.11 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -57.44 -43.7 84.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.292 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.749 HG22 ' NZ ' ' A' ' 94' ' ' LYS . 1.8 t -72.99 -43.0 59.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.574 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.477 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 31.3 mmt -70.21 -54.22 13.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.569 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.651 HG23 ' HA ' ' A' ' 115' ' ' LYS . 6.4 m -55.56 -45.25 77.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.717 0.294 . . . . 0.0 111.15 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -61.64 -29.61 70.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.842 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.8 mp -122.35 37.59 4.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.62 -112.95 0.28 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.723 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.427 ' O ' HD23 ' A' ' 116' ' ' LEU . 2.3 pt-20 -136.61 170.27 16.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.771 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.651 ' HA ' HG23 ' A' ' 110' ' ' THR . 5.0 tppp? -73.59 98.35 2.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.963 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -88.86 113.42 24.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.346 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.925 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.74 175.26 5.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.376 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 117' ' ' THR . 73.7 m-20 -48.09 -36.05 12.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.748 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -77.34 -34.13 55.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.795 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -73.91 -33.3 63.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.971 0.415 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.963 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.92 -48.4 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.808 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -59.09 -52.8 64.18 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.736 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -57.52 -28.71 63.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.798 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.792 ' HG3' HD21 ' A' ' 105' ' ' LEU . 10.2 tpt -76.18 -37.9 57.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.142 0.496 . . . . 0.0 110.244 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.5 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -67.17 -42.68 88.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.4 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -62.87 -41.54 99.42 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 124' ' ' MET . 6.7 pt-20 -82.1 -32.79 30.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 110.48 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.54 78.45 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.451 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.754 ' HB2' HG22 ' A' ' 136' ' ' VAL . 18.5 t0 -105.46 149.38 26.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.934 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.579 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.5 pt -84.79 -40.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.26 0.552 . . . . 0.0 109.986 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.579 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.88 -10.93 59.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.67 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.12 32.77 1.13 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.5 p-10 -96.55 -12.9 23.41 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.296 -0.952 . . . . 0.0 112.391 -176.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.09 10.28 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.753 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.491 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.81 146.43 30.24 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 120.925 0.393 . . . . 0.0 110.094 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 129' ' ' ASP . 41.1 t -130.76 107.38 13.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.224 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.546 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.16 174.24 11.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.41 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.715 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.91 -67.07 0.31 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.5 0.667 . . . . 0.0 111.539 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.78 -33.51 71.79 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.981 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.529 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.1 -41.36 75.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.872 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.2 OUTLIER -78.77 -32.03 46.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.226 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.58 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 61.8 t -55.78 -51.13 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.722 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -58.25 -47.41 83.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.3 tpp -68.44 -31.66 71.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.79 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.425 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 26.5 ttp -61.11 -46.48 90.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.786 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.3 t -76.96 -30.84 56.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.907 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.64 153.6 19.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.079 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.95 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.847 0.356 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.3 mmm180 -52.26 -51.17 59.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.728 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.67 -53.21 32.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.681 0.277 . . . . 0.0 111.302 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -57.06 -37.6 72.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.002 0.43 . . . . 0.0 110.373 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.95 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.9 t -63.38 -33.69 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.37 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.849 HG21 HG11 ' A' ' 55' ' ' VAL . 2.4 mt -71.76 -55.09 14.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.993 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 27.5 mmm-85 -50.2 -37.9 37.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.2 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.19 -46.57 64.33 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.492 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.822 ' HD2' HD23 ' A' ' 32' ' ' LEU . 11.9 mtmt -56.14 -53.57 55.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.127 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.928 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.21 -57.57 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.662 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.1 tpt180 -61.67 -51.38 68.68 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.328 0.585 . . . . 0.0 111.028 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.575 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.37 -38.94 63.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.719 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.724 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.41 -49.24 66.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.275 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.408 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.95 -37.76 95.09 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.55 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.92 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.9 -61.62 2.05 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.707 -0.747 . . . . 0.0 110.507 -179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.736 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -60.51 -27.73 67.83 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.51 -48.99 65.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.04 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.606 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.1 ppt_? -63.29 -43.95 96.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.92 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.8 m -61.85 -35.4 67.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.715 0.769 . . . . 0.0 110.234 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.696 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 0.3 OUTLIER -72.49 -46.66 53.75 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.408 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.495 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 59.1 p -59.73 -37.2 78.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.756 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.456 HG13 ' O ' ' B' ' 18' ' ' ARG . 27.2 m -72.28 -45.2 62.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.105 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.872 HD23 ' CE1' ' A' ' 141' ' ' PHE . 3.3 pp -64.17 -28.18 69.58 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.893 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.696 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 6.8 ptt85 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.931 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.815 0.34 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.578 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 2.5 m-20 -97.59 -169.7 1.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.796 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -118.52 83.06 1.95 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.637 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -96.1 164.68 12.59 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.407 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.529 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.95 162.77 12.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.491 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -47.48 -51.22 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.873 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -64.56 -27.64 69.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.057 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.529 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.5 -51.46 19.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.681 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.1 pt -73.1 -28.89 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.666 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.57 -27.31 10.66 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.555 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 7.3 mt-10 -75.24 -28.6 59.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.289 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.0 m-85 -79.53 -58.6 3.12 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.24 0.543 . . . . 0.0 110.981 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.871 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.8 15.13 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.198 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.25 -27.99 56.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.31 -39.71 62.7 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.053 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.871 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.88 -51.8 68.46 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.82 0.819 . . . . 0.0 109.387 178.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.401 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 1.8 p -74.42 -23.95 59.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.064 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.87 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -81.99 -26.15 34.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.285 0.564 . . . . 0.0 110.04 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.843 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.5 t80 -92.91 0.63 57.44 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.349 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 26' ' ' THR . 27.7 t70 -105.52 144.07 32.8 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.99 0.9 . . . . 0.0 111.025 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 2.3 mmtt -59.6 -53.41 58.43 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.601 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.63 -3.61 59.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.785 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.08 46.83 33.38 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.322 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.2 p30 -91.1 17.96 7.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.845 0.355 . . . . 0.0 110.759 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 84.2 4.9 87.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.668 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.431 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.7 p -150.29 147.82 28.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.639 0.257 . . . . 0.0 110.337 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.747 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -99.61 140.39 19.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.825 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.569 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.19 179.07 7.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.346 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.667 HG21 ' CG ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -70.19 -41.94 73.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.181 0.515 . . . . 0.0 110.277 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -57.44 -41.12 79.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.467 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.77 -53.79 16.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.405 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.592 HD13 ' CD1' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -56.24 -55.69 30.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.882 0.849 . . . . 0.0 109.581 178.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.425 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -58.74 -48.0 87.36 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.485 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.413 ' CB ' ' O ' ' A' ' 30' ' ' LYS . 54.9 m -64.38 -31.11 72.18 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.858 0.329 . . . . 0.0 110.458 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.843 HG21 ' CE2' ' A' ' 19' ' ' PHE . 18.9 t -63.2 -58.03 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.925 0.393 . . . . 0.0 110.486 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.656 ' HB2' ' HD2' ' B' ' 9' ' ' LYS . 0.0 OUTLIER -72.65 -40.66 66.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.238 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.61 -39.62 88.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 0.0 110.554 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 t -78.83 -12.2 60.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.597 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.545 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.3 tt -87.02 -53.75 4.7 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.108 0.48 . . . . 0.0 110.553 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.474 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -178.53 36.33 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.654 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 2.0 tp-100 -133.7 178.73 6.71 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.403 0.62 . . . . 0.0 111.267 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -159.87 56.29 0.84 Allowed Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.696 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.4 Cg_endo -80.54 -168.24 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.527 2.151 . . . . 0.0 112.37 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.582 HG22 ' H ' ' A' ' 47' ' ' GLU . 1.2 m -117.37 152.96 33.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.891 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -60.37 -48.53 81.34 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.26 -33.75 76.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.705 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -62.81 -53.95 46.42 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.484 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -57.65 -51.27 70.19 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.947 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.667 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -53.62 -49.42 67.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.744 0.307 . . . . 0.0 111.289 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -53.11 -48.7 67.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.73 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.2 mmt -74.71 -30.48 61.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.986 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.592 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -53.64 -36.44 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.843 -178.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.406 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 3.7 m-80 -45.66 -28.58 1.03 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.271 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -78.04 -38.34 44.79 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 120.932 0.396 . . . . 0.0 110.7 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.022 HG11 HG21 ' B' ' 6' ' ' ILE . 4.1 m -81.21 -12.32 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.063 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 42.5 t0 -103.59 155.24 18.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.744 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.71 -28.27 26.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.156 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -116.39 -9.72 11.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.443 0.64 . . . . 0.0 110.423 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.89 61.2 7.64 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.99 -1.004 . . . . 0.0 113.278 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -109.37 18.42 20.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.759 0.314 . . . . 0.0 110.447 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' CA ' ' HG2' ' A' ' 49' ' ' GLN . . . 84.9 19.78 58.92 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.493 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -147.81 176.35 10.2 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.404 HD12 HD11 ' A' ' 32' ' ' LEU . 31.7 mt -114.11 136.69 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 120.582 0.229 . . . . 0.0 110.955 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -87.54 -179.61 6.37 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.218 0.532 . . . . 0.0 111.958 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.516 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.3 m-85 -67.7 -55.77 13.48 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.54 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.73 -35.35 37.2 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.204 1.936 . . . . 0.0 111.166 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.12 -52.48 63.68 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.319 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.705 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.64 -56.31 23.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.773 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.699 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -58.66 -46.66 86.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.75 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 51.8 m -60.68 -30.66 70.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.147 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.888 ' HG2' HD13 ' B' ' 10' ' ' ILE . 4.6 tpp -59.94 -61.75 2.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.166 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.6 mtm -62.89 -36.2 82.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.578 ' HB1' ' OD1' ' A' ' 2' ' ' ASP . . . -59.01 -21.46 59.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.352 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -54.94 151.2 9.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.858 0.361 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -87.62 -14.85 38.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.221 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.0 ttm -82.86 -30.78 28.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.939 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.51 105.45 17.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.898 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -176.43 -173.23 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 m 64.25 81.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.939 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.78 37.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.58 -31.57 53.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -80.67 -36.82 31.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.996 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -59.46 -50.75 72.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.718 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.7 -29.27 25.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.518 -179.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.725 HG22 ' HE1' ' A' ' 138' ' ' TYR . 19.3 mt -66.61 -51.33 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.829 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.443 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -75.62 -50.67 14.79 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 91' ' ' VAL . 32.4 mt-10 -53.81 -32.11 51.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.648 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -68.68 -39.35 80.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.683 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.556 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 22.9 t80 -66.73 -56.38 10.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.555 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -53.87 -29.93 43.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.905 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 87' ' ' GLU . 97.1 t -88.41 -23.03 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.19 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.453 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.7 -31.94 62.88 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.061 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -102.69 148.41 25.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.389 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -69.62 -37.51 76.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -112.34 -9.73 13.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.877 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.24 30.83 32.92 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.425 -0.893 . . . . 0.0 113.136 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -67.41 -13.32 61.91 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.971 0.386 . . . . 0.0 110.813 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.27 -13.86 55.04 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.826 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 24.8 m-85 -127.14 145.69 50.66 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.976 0.417 . . . . 0.0 111.258 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.97 HD13 HD13 ' A' ' 105' ' ' LEU . 1.1 pt -121.15 109.94 26.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.814 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 56.0 m -83.73 177.41 8.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.405 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.13 -28.87 70.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.071 0.463 . . . . 0.0 110.494 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.94 -57.67 9.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.436 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.623 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.36 -42.37 44.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.257 -179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.97 HD13 HD13 ' A' ' 100' ' ' ILE . 54.5 tp -57.3 -31.12 65.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.082 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.789 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.9 ttt180 -72.37 -49.28 35.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -60.6 -36.54 78.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.028 0.442 . . . . 0.0 110.533 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 104' ' ' GLU . 56.6 t -72.93 -44.56 57.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.243 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.45 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 23.4 mmt -74.05 -53.95 8.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.7 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.0 m -55.42 -45.58 76.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 111.262 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.404 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.0 OUTLIER -62.44 -25.7 68.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.838 0.351 . . . . 0.0 110.728 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.87 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.4 mp -125.37 37.41 4.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.755 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -172.3 -113.77 0.31 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.775 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.417 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -134.72 169.88 16.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.855 0.36 . . . . 0.0 110.877 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.655 ' HA ' HG23 ' A' ' 110' ' ' THR . 19.0 tttt -74.09 100.07 3.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.252 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.95 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.39 114.76 26.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.285 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.928 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.74 175.1 5.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.412 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.45 ' H ' HG22 ' A' ' 117' ' ' THR . 3.1 t0 -48.11 -36.02 12.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.939 0.4 . . . . 0.0 110.775 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -77.35 -34.4 55.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.777 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -73.29 -34.05 65.54 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.002 0.43 . . . . 0.0 110.093 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.95 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.4 -48.82 34.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.943 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -58.99 -52.89 63.82 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.908 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.31 -29.02 63.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.839 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.834 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.4 tpt -76.32 -38.07 56.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.091 0.472 . . . . 0.0 110.223 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.14 -42.46 84.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.553 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -65.78 -39.2 90.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.923 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.03 -35.54 28.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.468 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.24 -38.58 81.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.517 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.772 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.6 t0 -98.96 147.48 24.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.078 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.561 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.6 pt -84.79 -40.68 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 121.307 0.575 . . . . 0.0 110.053 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.561 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.92 -11.02 60.21 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.713 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.72 1.1 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.3 p-10 -96.28 -12.92 23.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.296 -0.952 . . . . 0.0 112.42 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.96 20.08 10.2 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.804 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.97 146.31 30.04 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.962 0.41 . . . . 0.0 110.029 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.5 t -130.67 107.44 14.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.229 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.551 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.25 174.7 11.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.339 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.725 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.99 -66.96 0.33 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.513 0.673 . . . . 0.0 111.479 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -34.01 72.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.909 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.545 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.05 -40.54 73.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.825 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.75 -33.62 46.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.082 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.586 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.4 t -54.68 -46.83 73.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.666 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -57.98 -45.49 86.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.11 -33.21 65.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.427 ' HE1' HG12 ' A' ' 85' ' ' ILE . 14.7 ttp -59.25 -41.76 89.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.4 t -79.23 -30.88 43.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.63 161.87 5.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.119 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.941 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.846 0.355 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.737 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.2 mmm180 -52.24 -50.78 61.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.735 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.63 -53.36 31.4 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 120.628 0.252 . . . . 0.0 111.323 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.96 -37.1 71.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.129 0.49 . . . . 0.0 109.998 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.941 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.9 t -63.42 -34.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.341 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 1.022 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.99 -55.59 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.253 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 27.6 mmm-85 -49.79 -40.56 41.95 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.414 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.22 -43.72 70.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.224 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.74 ' O ' HD12 ' B' ' 13' ' ' ILE . 0.0 OUTLIER -54.84 -55.49 29.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.189 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.888 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.5 mt -51.6 -57.49 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.835 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.2 tpt180 -60.56 -51.29 70.05 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.321 0.582 . . . . 0.0 110.912 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.566 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.4 -40.0 64.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.652 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.74 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.0 mt -54.51 -47.57 71.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.236 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.08 -38.33 95.84 Favored Glycine 0 CA--C 1.497 -1.056 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.546 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.892 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.97 -61.69 2.01 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.637 -0.782 . . . . 0.0 110.495 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.746 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.03 -27.75 67.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.68 -48.73 65.77 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.935 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.632 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.5 ppt_? -62.27 -43.45 98.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.133 0.492 . . . . 0.0 109.692 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.892 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.6 m -63.89 -34.9 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.866 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -74.8 -45.74 41.48 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.929 -179.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.558 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 12.6 p -59.81 -24.98 64.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.567 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 23' ' ' LEU . 29.5 m -90.73 -46.72 14.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.972 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.945 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.31 -32.76 73.55 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.147 0.498 . . . . 0.0 110.335 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.945 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.131 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.62 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.792 0.33 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.574 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.8 m-20 -64.96 -169.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -116.97 90.56 3.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.001 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.64 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.2 mt -98.64 164.75 12.11 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.542 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.485 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.4 p -96.77 161.78 13.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.493 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -47.7 -51.78 20.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.781 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -64.35 -27.72 69.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.031 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.87 -51.52 21.93 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.592 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.697 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -72.98 -28.91 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.742 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.51 -27.36 10.43 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 37.3 mt-10 -75.28 -28.47 59.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.203 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.28 -58.51 3.18 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.281 0.562 . . . . 0.0 110.983 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.49 -23.05 14.65 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.285 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.33 -27.87 56.69 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.49 -39.8 62.21 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.074 177.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.74 -51.68 68.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.899 0.857 . . . . 0.0 109.445 178.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.404 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 7.3 p -74.37 -24.89 59.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.088 -1.415 . . . . 0.0 112.049 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.894 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.06 -24.64 35.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.172 0.51 . . . . 0.0 110.278 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.808 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.9 t80 -92.66 -2.33 56.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.599 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.9 t70 -102.36 143.37 32.2 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.97 0.891 . . . . 0.0 111.154 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -59.94 -53.42 58.11 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.58 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -84.81 -6.11 59.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.811 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.54 46.27 53.31 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.188 -0.529 . . . . 0.0 113.375 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -90.99 18.15 7.06 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.798 0.333 . . . . 0.0 110.727 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.5 5.7 88.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 48.3 p -150.28 149.9 30.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.808 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -101.88 140.5 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.944 0.402 . . . . 0.0 111.834 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.586 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.35 176.56 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.02 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.826 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.2 p -70.49 -37.76 74.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.133 0.492 . . . . 0.0 110.268 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.03 -41.11 91.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.155 178.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.921 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.23 -53.43 19.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.282 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.838 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.4 -54.93 41.46 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.771 0.796 . . . . 0.0 109.402 178.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.46 -45.89 92.52 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.52 -1.218 . . . . 0.0 112.516 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -62.21 -31.34 71.86 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.851 0.326 . . . . 0.0 110.574 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.7 t -68.0 -57.24 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.853 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.457 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 1.1 tpt -71.91 -35.5 69.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.427 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.0 ttt180 -68.05 -42.15 80.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.927 0.394 . . . . 0.0 110.595 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.0 t -78.97 -7.79 58.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.731 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.73 -54.31 4.03 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.109 0.48 . . . . 0.0 110.776 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.45 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.22 35.19 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.836 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.588 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.0 -178.98 5.44 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 111.16 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -159.65 56.43 0.87 Allowed Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.909 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.0 Cg_endo -80.42 -175.72 2.84 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.519 2.146 . . . . 0.0 112.076 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.605 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.89 152.47 32.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.941 0.401 . . . . 0.0 110.23 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.18 -49.64 75.34 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.43 75.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.765 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.66 -54.26 34.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.657 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.826 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.87 -34.57 78.44 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.322 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.689 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.54 -43.07 95.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.926 0.393 . . . . 0.0 110.185 179.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -61.33 -45.52 94.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.189 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.4 mmt -74.57 -30.73 61.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.403 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.74 -38.02 33.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.55 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -45.05 -28.55 0.72 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.372 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG2' ' HZ1' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.59 -38.75 47.57 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.915 0.388 . . . . 0.0 110.84 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.886 HG11 HG21 ' B' ' 6' ' ' ILE . 5.0 m -81.17 -11.43 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.157 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.543 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.7 t0 -103.63 155.63 18.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.62 -29.09 26.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -116.45 -9.64 11.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.416 0.626 . . . . 0.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.47 63.56 5.12 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.488 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -112.28 18.16 18.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.85 0.357 . . . . 0.0 110.241 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.93 55.13 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.475 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.4 p -147.09 176.4 9.97 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.484 HD12 HD11 ' A' ' 32' ' ' LEU . 57.6 mt -115.77 136.48 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 120.546 0.212 . . . . 0.0 110.86 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.489 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.0 m-20 -87.46 -178.18 6.09 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.318 0.58 . . . . 0.0 111.916 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.1 -55.9 12.13 Favored Pre-proline 0 C--O 1.235 0.342 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.648 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.4 Cg_endo -65.68 -34.39 41.31 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.251 1.967 . . . . 0.0 111.193 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.26 -52.46 61.97 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.209 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.721 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.02 -57.04 14.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.867 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.697 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.1 -47.14 81.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.854 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.62 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 54.0 m -60.23 -30.92 69.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.059 0.457 . . . . 0.0 110.077 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.92 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.7 tpp -62.08 -61.84 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.144 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 8.4 mtt -72.77 -31.64 65.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.992 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.76 0.04 40.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.602 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -55.68 153.46 8.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.809 0.338 . . . . 0.0 111.062 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.5 tptm -69.64 -12.64 61.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.299 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.2 tpp -93.18 -30.52 15.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.34 . . . . 0.0 110.989 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.74 115.86 20.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -176.53 179.5 1.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 60.46 -167.27 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.864 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.418 ' H ' HG22 ' A' ' 79' ' ' THR . 15.0 m-20 63.45 65.96 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 110.864 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.45 -46.09 23.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -68.87 -36.6 78.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -50.44 -30.48 12.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.553 ' O ' HG11 ' B' ' 19' ' ' VAL . 4.6 mt-10 -77.31 -29.55 53.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.73 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.692 HG22 ' HE1' ' A' ' 138' ' ' TYR . 11.3 mt -79.24 -51.13 17.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -48.48 38.34 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 120.897 0.379 . . . . 0.0 111.863 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.691 ' OE2' ' HB1' ' B' ' 12' ' ' ALA . 21.5 tt0 -53.5 -26.42 20.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.357 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.744 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.56 -33.99 58.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.964 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.61 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 13.1 t80 -68.96 -50.42 49.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.002 0.43 . . . . 0.0 110.149 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -54.42 -33.21 59.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.767 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.99 -22.7 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.557 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.544 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -52.81 -36.82 59.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.342 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -100.09 147.13 25.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.753 0.311 . . . . 0.0 110.525 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -67.94 -37.71 81.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.434 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -112.2 -9.76 13.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.847 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.41 28.36 33.35 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.365 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -67.51 -13.96 62.51 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.163 0.481 . . . . 0.0 110.769 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -11.49 55.44 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.084 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.48 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.7 m-85 -127.21 146.94 50.24 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 120.925 0.393 . . . . 0.0 111.53 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.05 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.14 109.92 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.633 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 m -82.66 176.78 9.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.553 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.14 -29.88 70.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.097 0.475 . . . . 0.0 110.457 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.24 -57.74 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.23 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.833 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.44 -45.46 31.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.157 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.05 HD13 HD13 ' A' ' 100' ' ' ILE . 28.6 tp -53.04 -31.44 41.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.199 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.853 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.2 ttt-85 -72.46 -49.13 35.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -59.9 -42.0 92.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.115 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.9 t -73.06 -40.17 58.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.404 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.46 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.7 mmt -73.92 -54.16 8.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.698 HG23 ' HA ' ' A' ' 115' ' ' LYS . 7.1 m -59.03 -48.9 79.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.202 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -57.26 -28.56 63.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.894 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -124.33 37.0 4.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.731 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.43 -115.88 0.36 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.808 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.422 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -130.7 167.52 18.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 110.883 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.698 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.9 ttmt -73.59 100.07 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.291 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.973 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.55 114.43 26.64 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.393 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.927 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.78 175.26 5.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.385 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -48.01 -35.92 11.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.363 . . . . 0.0 110.809 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -77.4 -35.44 54.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.698 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -72.29 -33.3 67.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.959 0.409 . . . . 0.0 110.116 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.973 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.65 -48.51 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.846 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -59.41 -52.87 63.76 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.724 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -57.76 -28.67 64.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.807 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.749 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.6 tpt -76.12 -37.88 57.54 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.147 0.499 . . . . 0.0 110.248 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.14 -40.65 80.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -66.46 -39.19 88.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.952 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.41 -36.13 29.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.833 0.349 . . . . 0.0 110.61 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.494 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.09 -37.17 80.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.413 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.646 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.4 t0 -101.36 145.53 28.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.033 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.552 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.0 pt -83.06 -40.8 16.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.165 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.92 -11.02 60.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.747 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.87 32.65 0.99 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.419 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.3 p-10 -95.53 -12.41 25.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.304 -0.948 . . . . 0.0 112.568 -176.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.86 20.18 10.19 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.89 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.48 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.99 147.37 31.6 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 129' ' ' ASP . 18.6 t -130.74 107.25 13.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.39 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -78.81 174.79 11.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.227 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.93 -67.08 0.31 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.635 0.731 . . . . 0.0 111.788 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.4 mt-10 -65.28 -25.3 67.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.42 -1.263 . . . . 0.0 112.554 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.467 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.62 -48.51 74.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.822 0.344 . . . . 0.0 110.271 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.8 p90 -78.91 -30.99 45.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.243 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 138' ' ' TYR . 67.4 t -52.83 -44.5 48.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.121 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -60.34 -37.16 79.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.125 0.488 . . . . 0.0 109.809 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.46 -42.21 62.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.721 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.432 ' CG ' HG21 ' B' ' 22' ' ' VAL . 2.2 ttp -52.74 -44.21 66.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.026 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.2 t -78.33 -31.25 48.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 146.84 40.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.946 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.801 0.334 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.736 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.23 -51.08 60.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.722 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.65 -53.27 32.36 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.677 0.275 . . . . 0.0 111.302 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.1 -37.54 72.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.015 0.436 . . . . 0.0 110.339 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.946 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.2 t -63.46 -34.12 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.387 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.886 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -70.84 -54.34 18.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.969 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -51.51 -37.24 48.25 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.097 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.63 -48.31 64.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.472 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.838 ' HD2' HD23 ' A' ' 32' ' ' LEU . 17.3 mtmt -55.8 -54.38 45.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.043 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.92 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.5 mt -51.17 -57.45 2.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.465 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.518 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.8 tpt180 -59.79 -51.23 70.64 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.237 0.541 . . . . 0.0 111.094 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.691 ' HB1' ' OE2' ' A' ' 87' ' ' GLU . . . -53.19 -40.1 64.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.819 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.783 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.8 mt -54.58 -50.37 59.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.418 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.93 -36.82 93.96 Favored Glycine 0 CA--C 1.498 -0.999 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.056 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.906 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.28 -61.69 2.08 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.787 -0.706 . . . . 0.0 110.539 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.676 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.98 -27.62 69.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.599 177.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -66.04 -50.68 63.35 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.225 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.754 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -63.64 -43.55 96.46 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.02 0.438 . . . . 0.0 109.847 179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.2 m -65.9 -32.69 59.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.839 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.686 ' HE2' HG12 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -74.66 -48.13 27.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.219 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 13.5 p -58.46 -25.9 62.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.454 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.448 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.5 m -89.93 -47.62 14.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.161 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.888 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -62.84 -33.02 74.37 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.139 0.495 . . . . 0.0 110.507 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.888 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.107 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.79 0.328 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.525 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 2.7 m-20 -106.17 -170.16 1.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -116.77 83.95 2.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.71 164.71 12.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.539 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.494 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.32 162.73 13.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.48 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -47.39 -51.38 19.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.902 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -64.39 -27.71 69.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.034 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.5 -51.39 20.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.705 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.4 pt -73.18 -28.79 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.809 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.38 -27.32 9.61 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 35.0 mm-40 -75.25 -28.51 59.88 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.166 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.42 -58.31 3.27 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.228 0.537 . . . . 0.0 111.042 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.876 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 11.2 ptmt -54.56 -22.99 14.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.235 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.27 -28.02 56.91 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.33 -39.83 62.58 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.07 177.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.876 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -59.01 -51.66 69.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.774 0.797 . . . . 0.0 109.5 178.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.406 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 6.9 p -74.42 -24.78 59.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.072 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.903 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.04 -24.29 35.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.177 0.513 . . . . 0.0 110.285 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.799 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.6 t80 -93.4 -1.71 55.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.563 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.7 t70 -102.7 143.56 32.19 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 122.005 0.907 . . . . 0.0 111.125 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.2 mmtt -59.65 -53.47 57.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 113.863 -1.517 . . . . 0.0 111.56 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.51 -5.72 59.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.744 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.3 46.31 51.98 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.356 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -90.97 18.15 7.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.799 0.333 . . . . 0.0 110.73 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.72 5.57 88.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.564 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 47.5 p -150.34 149.58 30.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.65 140.51 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.879 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.591 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.21 176.37 8.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.002 179.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.822 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.1 p -70.49 -37.77 74.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.126 0.488 . . . . 0.0 110.257 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.09 -41.13 91.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.143 178.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.918 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -69.09 -53.79 18.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.221 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.841 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.16 -55.62 32.61 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.73 0.776 . . . . 0.0 109.362 178.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.76 -46.18 90.1 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.62 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.7 m -62.5 -32.13 72.99 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.951 0.376 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.8 t -67.03 -57.22 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 110.922 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.453 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -71.9 -36.37 69.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.471 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -67.07 -41.9 85.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.4 . . . . 0.0 110.552 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.7 t -79.04 -7.94 58.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.698 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.2 tt -91.42 -55.41 3.52 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -174.97 33.1 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.946 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.596 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -134.18 -179.66 5.7 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.337 0.589 . . . . 0.0 111.125 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -159.66 56.33 0.86 Allowed Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.819 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.8 Cg_endo -80.62 -172.78 1.61 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.577 2.185 . . . . 0.0 112.086 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.37 152.42 35.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.884 0.373 . . . . 0.0 110.101 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.7 -50.15 73.01 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 -33.33 75.44 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.709 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.85 -54.39 31.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.687 -179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.822 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.83 -34.63 78.61 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.399 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.684 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.48 -42.75 95.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 110.226 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -61.65 -45.5 93.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.25 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -30.76 61.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.424 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.73 -38.01 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.529 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -44.93 -28.59 0.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.417 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.45 -38.96 48.34 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 120.89 0.376 . . . . 0.0 110.819 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.858 HG11 HG21 ' B' ' 6' ' ' ILE . 5.0 m -81.23 -11.47 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.182 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.546 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.7 t0 -103.61 155.65 18.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.788 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.66 -29.01 26.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.095 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -116.49 -9.67 11.39 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.407 0.623 . . . . 0.0 110.481 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.31 63.77 4.94 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.995 -1.002 . . . . 0.0 113.481 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -112.39 18.11 18.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.831 0.348 . . . . 0.0 110.216 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.84 19.85 55.11 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.469 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.6 p -147.1 176.42 9.96 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.772 HD12 HD11 ' A' ' 32' ' ' LEU . 14.6 mt -115.77 136.52 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 120.604 0.24 . . . . 0.0 110.836 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.9 m-20 -87.28 -178.27 6.16 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.218 0.533 . . . . 0.0 111.859 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -68.08 -55.83 12.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.727 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -65.67 -34.77 40.03 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.272 1.981 . . . . 0.0 111.12 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.96 -52.45 62.95 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.232 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.725 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.93 -56.83 16.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.815 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.699 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.75 -45.75 81.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.679 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 55.8 m -60.07 -31.33 69.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.085 0.469 . . . . 0.0 109.954 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.904 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.9 tpp -64.68 -61.8 1.97 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.949 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.403 ' HG3' HG22 ' B' ' 10' ' ' ILE . 43.0 mtm -68.86 -29.16 67.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.787 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.525 ' HB1' ' CG ' ' A' ' 2' ' ' ASP . . . -57.26 -25.66 59.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.231 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -57.01 89.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 tptt -83.03 -19.83 36.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.104 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 6.8 ttm -68.25 -28.45 67.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.951 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -132.82 42.23 3.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.891 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -90.42 -76.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.72 -164.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.976 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 63.28 63.01 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.071 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.0 p -77.54 -45.83 24.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.879 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -80.73 -29.04 36.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.006 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -50.48 -30.64 13.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.397 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.608 ' O ' HG11 ' B' ' 19' ' ' VAL . 2.1 mt-10 -65.94 -29.78 70.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 110.342 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.681 HG22 ' HE1' ' A' ' 138' ' ' TYR . 11.4 mt -79.45 -50.64 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 112.308 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.444 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.2 OUTLIER -74.99 -51.24 14.13 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -178.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.655 ' O ' HG23 ' A' ' 91' ' ' VAL . 17.0 tt0 -53.5 -25.19 15.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.742 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.705 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.43 -36.61 45.32 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 24.0 t80 -68.12 -52.26 36.92 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.012 0.434 . . . . 0.0 110.091 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.439 ' NH2' HD11 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -54.72 -32.05 59.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.807 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 87' ' ' GLU . 48.4 t -88.74 -22.74 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.522 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.484 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -53.85 -31.64 50.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.144 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -103.25 147.44 27.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.431 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -69.24 -37.03 77.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.432 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.15 -9.75 13.92 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.75 29.89 33.95 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.232 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -67.37 -13.95 62.48 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 117.078 0.439 . . . . 0.0 110.779 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.14 -12.12 55.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.969 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.6 m-85 -127.26 146.85 50.28 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.953 0.406 . . . . 0.0 111.247 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.58 HD12 HD22 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.03 110.01 26.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.875 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.1 m -84.09 176.9 8.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.522 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.51 -29.55 70.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.08 0.467 . . . . 0.0 110.484 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.73 -57.18 12.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.209 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.749 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.32 -46.11 29.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.309 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.835 HD21 ' HG3' ' A' ' 124' ' ' MET . 20.0 tp -53.14 -31.11 40.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.996 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.836 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.8 ttt-85 -73.35 -49.13 28.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -58.87 -42.87 90.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.142 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.2 t -72.91 -40.37 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.529 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.511 ' HE1' ' CD2' ' B' ' 20' ' ' PHE . 30.0 mmt -73.87 -54.21 8.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.353 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.737 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.3 m -56.96 -48.84 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 0.0 111.147 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.684 ' C ' HD12 ' A' ' 112' ' ' LEU . 60.1 t-20 -58.8 -29.33 66.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.903 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -122.88 37.62 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.802 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 109' ' ' MET . . . -171.2 -113.86 0.31 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.783 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.445 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -134.07 166.85 21.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 110.886 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.737 ' HA ' HG23 ' A' ' 110' ' ' THR . 33.0 tttm -72.39 99.68 2.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.244 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.81 114.51 26.25 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.421 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.923 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.77 175.24 5.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.37 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -48.02 -36.0 12.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 110.77 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.37 -34.88 54.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.723 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -73.0 -33.23 65.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.973 0.416 . . . . 0.0 110.079 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.95 -48.51 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.839 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -59.01 -52.81 64.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.746 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.7 -28.65 64.02 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.765 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.835 ' HG3' HD21 ' A' ' 105' ' ' LEU . 12.8 tpt -76.15 -37.5 57.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.172 0.51 . . . . 0.0 110.163 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.508 HG12 HD23 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -69.21 -39.16 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.342 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -64.77 -41.94 95.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.418 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -82.08 -32.45 30.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.937 0.398 . . . . 0.0 110.431 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.77 -34.71 76.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.54 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.755 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.0 t0 -107.95 148.07 30.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.014 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.559 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.7 pt -84.91 -40.71 15.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.013 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.559 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.95 -10.98 60.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.693 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.06 32.8 1.1 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.435 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.35 -12.69 24.02 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.332 -0.934 . . . . 0.0 112.493 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.79 20.14 10.28 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.832 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.485 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.77 146.44 30.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.959 0.409 . . . . 0.0 110.0 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 129' ' ' ASP . 38.4 t -130.79 107.41 13.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.213 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.539 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -79.86 174.22 11.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.259 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.681 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.82 -67.07 0.32 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.554 0.692 . . . . 0.0 111.448 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.404 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.4 mt-10 -60.11 -33.41 72.09 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.903 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.511 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.03 -42.09 75.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.36 0.6 . . . . 0.0 109.496 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.853 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.69 -31.87 46.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.114 178.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.573 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 55.5 t -55.38 -48.75 76.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.655 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -55.15 -49.67 71.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -70.57 -30.38 67.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.783 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.415 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -60.6 -46.06 91.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.7 t -73.48 -31.32 63.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.83 163.39 4.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.897 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.943 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.848 0.356 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.737 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.1 mmm180 -52.38 -51.0 61.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.076 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.722 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.68 -53.24 32.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.679 0.276 . . . . 0.0 111.29 179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -57.06 -37.64 72.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.997 0.427 . . . . 0.0 110.34 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.943 HG23 ' O ' ' B' ' 1' ' ' ALA . 13.9 t -63.37 -34.15 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.361 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.858 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.07 -55.28 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.967 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.4 mmm-85 -50.73 -36.84 38.44 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.098 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.05 -48.28 63.21 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.466 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.841 ' HD2' HD23 ' A' ' 32' ' ' LEU . 16.2 mtmt -55.56 -54.96 37.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.222 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.904 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.0 mt -51.13 -57.43 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.431 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.525 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -58.92 -51.05 71.7 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.27 0.557 . . . . 0.0 111.051 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.27 -40.58 64.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.831 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.716 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.9 mt -54.61 -49.7 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.493 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.43 -36.95 94.06 Favored Glycine 0 CA--C 1.499 -0.961 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.068 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.932 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.14 -61.73 2.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.789 -0.705 . . . . 0.0 110.357 -179.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.66 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -62.75 -28.08 69.72 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.659 177.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.5 -51.48 59.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.227 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.758 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.31 -43.44 97.82 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.037 0.446 . . . . 0.0 109.831 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.932 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.1 m -66.45 -32.55 58.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.639 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.66 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -71.82 -50.15 32.24 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.986 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.46 ' HA ' ' NE ' ' B' ' 24' ' ' ARG . 52.7 p -58.27 -35.56 71.96 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.023 0.439 . . . . 0.0 110.836 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.49 HG22 ' C ' ' B' ' 19' ' ' VAL . 26.9 m -73.04 -45.22 55.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.09 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.853 HD23 ' CE1' ' A' ' 141' ' ' PHE . 2.7 pp -64.62 -27.98 69.31 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.933 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 10.9 ptt85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.904 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.628 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.773 0.321 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.579 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 3.7 m-20 -66.09 -169.56 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.824 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -117.49 89.09 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.002 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.63 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.78 164.81 12.24 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.459 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.491 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.7 p -98.28 162.4 13.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.488 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -47.25 -51.35 19.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.845 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.29 -27.72 69.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.115 0.484 . . . . 0.0 110.034 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.0 OUTLIER -72.64 -51.38 19.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.694 179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 35.5 pt -73.27 -28.83 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.931 -178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.44 -27.37 10.11 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 49.6 mt-10 -75.43 -28.49 59.37 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.272 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.33 -58.57 3.15 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.242 0.544 . . . . 0.0 111.163 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.878 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -54.75 -23.3 17.22 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.175 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -75.64 -28.26 58.73 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.96 -40.02 63.31 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.072 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.878 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.11 -51.9 68.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.796 0.808 . . . . 0.0 109.608 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.27 -24.79 59.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.042 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.912 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.15 -26.9 33.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.117 0.484 . . . . 0.0 110.401 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.798 ' HB3' HD11 ' A' ' 27' ' ' ILE . 4.6 t80 -87.2 -14.3 41.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.579 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.8 t70 -90.79 145.27 24.92 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.931 0.872 . . . . 0.0 111.175 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.493 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.8 mmtt -63.36 -53.39 53.35 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.578 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -83.09 -7.07 59.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.735 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.3 46.94 56.99 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.398 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -91.73 18.59 7.4 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.854 0.359 . . . . 0.0 110.659 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.21 5.11 89.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.539 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.7 p -150.28 152.07 33.95 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.798 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -103.04 140.53 21.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.924 0.392 . . . . 0.0 111.712 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.556 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -84.72 176.14 8.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.008 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.817 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -70.39 -38.45 74.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.085 0.469 . . . . 0.0 110.159 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.48 -40.92 88.51 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.144 178.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.919 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.07 -53.68 19.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.272 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.831 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.41 -54.91 41.64 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.761 0.791 . . . . 0.0 109.47 178.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.46 -46.01 92.39 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.581 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.12 -31.16 71.59 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.806 0.336 . . . . 0.0 110.587 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.7 t -68.18 -57.23 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.447 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -71.89 -35.53 69.77 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.412 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -42.46 80.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.641 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 28.7 t -78.95 -7.46 58.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.749 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.549 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -91.11 -54.43 3.95 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.056 0.455 . . . . 0.0 110.796 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.45 34.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.871 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.588 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 tp-100 -137.02 -178.78 5.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.291 0.567 . . . . 0.0 111.169 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -159.59 56.49 0.89 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.884 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.0 Cg_endo -80.37 -176.09 3.02 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.552 2.168 . . . . 0.0 112.065 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.606 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.61 152.45 31.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.94 0.4 . . . . 0.0 110.236 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -57.13 -49.68 75.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.386 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.24 75.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.72 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 1.3 mm-40 -64.7 -54.32 33.4 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.682 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.817 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.89 -34.69 78.7 Favored 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.405 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.677 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.3 OUTLIER -64.52 -42.92 95.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.886 0.374 . . . . 0.0 110.162 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -61.52 -45.44 94.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.233 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -30.71 61.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.41 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.548 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.75 -38.31 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.527 -179.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -45.03 -28.55 0.71 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.377 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.439 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.76 -38.56 46.58 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.886 0.374 . . . . 0.0 110.841 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.919 HG11 HG21 ' B' ' 6' ' ' ILE . 4.8 m -81.2 -11.27 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.167 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.55 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.4 t0 -103.66 155.62 18.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.759 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.488 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.65 -28.93 26.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.034 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -116.45 -9.73 11.41 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.408 0.623 . . . . 0.0 110.501 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.45 63.58 5.1 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 114.968 -1.015 . . . . 0.0 113.476 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -112.32 18.12 18.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.854 0.359 . . . . 0.0 110.19 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.75 19.9 55.18 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.491 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.8 p -147.32 176.46 9.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.794 HD12 HD11 ' A' ' 32' ' ' LEU . 13.2 mt -115.85 136.51 52.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.557 0.218 . . . . 0.0 110.91 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.488 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.7 m-20 -87.11 -178.08 6.16 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.298 0.571 . . . . 0.0 111.959 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.517 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.99 -56.12 11.98 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.674 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.8 -34.44 40.06 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.254 1.969 . . . . 0.0 111.175 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.07 -52.38 62.96 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.166 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.72 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.03 -56.92 15.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.893 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.6 -47.13 80.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.628 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 54.7 m -60.21 -30.76 69.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.07 0.462 . . . . 0.0 110.078 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.905 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.1 tpp -64.43 -61.83 1.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.124 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 27.8 mtt -68.78 -31.15 69.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.976 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.98 0.13 41.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.631 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -55.08 141.25 35.21 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.858 0.361 . . . . 0.0 111.075 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.62 -16.37 34.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.246 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 8.5 tpp -76.43 -30.76 57.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.943 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.49 144.71 31.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.86 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -174.75 -166.95 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.907 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.4 m 63.29 88.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -166.01 53.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -77.54 -56.63 4.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.54 -29.64 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -50.45 -30.55 12.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.183 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.708 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -77.24 -29.3 53.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.789 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.638 HG22 ' HE1' ' A' ' 138' ' ' TYR . 16.2 mt -79.08 -51.04 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -73.7 -51.11 17.71 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.839 0.352 . . . . 0.0 111.901 -178.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 91' ' ' VAL . 60.5 tt0 -53.56 -24.61 14.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.722 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -78.67 -35.73 44.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.058 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.8 t80 -69.03 -52.43 28.79 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.018 0.437 . . . . 0.0 110.108 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -55.7 -31.9 62.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.895 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 87' ' ' GLU . 62.0 t -88.94 -22.73 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.571 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.495 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -54.53 -32.24 57.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.081 -179.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -102.75 147.42 26.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.434 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -69.64 -36.83 76.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.41 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -112.18 -9.66 13.91 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.55 30.08 34.1 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.204 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -67.37 -13.82 62.36 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.004 0.402 . . . . 0.0 110.797 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.446 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.18 -11.71 55.28 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.011 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.47 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.0 m-85 -127.3 145.83 50.66 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 120.959 0.409 . . . . 0.0 111.354 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.93 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -120.68 110.03 27.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.828 179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -83.41 176.4 9.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.525 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.558 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.32 -29.84 71.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.065 0.459 . . . . 0.0 110.432 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.13 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.222 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.37 -46.1 28.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.35 -179.07 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 100' ' ' ILE . 44.8 tp -53.1 -31.06 40.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.09 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.81 ' HA ' HD11 ' A' ' 116' ' ' LEU . 3.5 ttt-85 -74.21 -49.26 24.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.182 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -58.32 -42.39 86.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.057 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.775 ' O ' HD12 ' A' ' 112' ' ' LEU . 2.5 t -72.87 -40.68 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.563 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.49 ' HE1' ' CD2' ' B' ' 20' ' ' PHE . 30.0 mmt -73.91 -54.34 8.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.351 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.75 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.9 m -57.32 -48.92 77.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.21 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -58.38 -28.61 65.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.023 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.912 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.1 mt -123.89 36.63 4.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.802 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.35 -113.47 0.29 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.844 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.426 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.9 pt-20 -133.31 166.24 22.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 110.931 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.75 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.2 tttm -73.12 99.91 2.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.332 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.972 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.43 114.52 26.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.292 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.917 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.62 174.97 6.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.439 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -48.08 -36.01 12.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.882 0.372 . . . . 0.0 110.767 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -77.39 -34.27 54.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.734 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -73.5 -33.43 64.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.972 0.415 . . . . 0.0 110.029 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.972 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -75.14 -49.32 28.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.871 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.19 -52.83 63.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.708 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -57.34 -28.65 63.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.679 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.495 ' O ' ' HE3' ' A' ' 124' ' ' MET . 5.9 tpt -75.42 -38.41 59.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.294 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.511 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.98 -41.91 81.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.559 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -65.9 -39.61 90.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.647 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -82.09 -36.41 27.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.932 0.396 . . . . 0.0 110.541 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.55 83.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.487 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.741 ' HB2' HG22 ' A' ' 136' ' ' VAL . 23.7 t0 -100.35 147.26 26.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.004 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.562 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.79 -40.69 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.086 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.562 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.97 -10.94 60.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.647 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.08 32.6 1.08 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.2 p-10 -96.16 -12.87 24.06 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.269 -0.965 . . . . 0.0 112.363 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.93 20.2 10.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.816 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -147.05 146.66 30.08 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.954 0.407 . . . . 0.0 109.969 179.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.741 HG22 ' HB2' ' A' ' 129' ' ' ASP . 37.7 t -130.73 107.42 14.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.266 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.547 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.18 174.58 11.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.235 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.638 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.96 -66.96 0.33 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.448 0.642 . . . . 0.0 111.332 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.83 -33.85 72.31 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.775 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.523 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.15 -40.11 73.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.877 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.74 -34.69 45.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.047 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.574 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 78.8 t -54.3 -46.02 68.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.786 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -57.43 -46.82 83.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.869 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.13 -31.54 64.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -60.3 -42.33 95.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.3 t -78.07 -30.88 49.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.62 148.97 31.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.932 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.948 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.854 0.359 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.74 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.29 -51.05 60.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.725 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.7 -53.22 33.03 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.654 0.264 . . . . 0.0 111.284 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -57.16 -37.74 72.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.003 0.43 . . . . 0.0 110.31 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.948 HG23 ' O ' ' B' ' 1' ' ' ALA . 14.5 t -63.14 -34.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.356 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.919 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -70.75 -55.05 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.919 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 mmm-85 -50.55 -37.24 38.38 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.127 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -68.98 -48.32 63.42 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.61 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.831 ' HD2' HD23 ' A' ' 32' ' ' LEU . 16.9 mtmt -55.78 -55.1 36.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.262 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.905 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.24 -57.49 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.56 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.489 ' O ' ' HE3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.72 -50.41 73.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.211 0.529 . . . . 0.0 111.028 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.23 -41.06 65.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.809 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.784 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.0 mt -54.57 -47.68 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.485 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.426 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -64.53 -37.1 93.98 Favored Glycine 0 CA--C 1.498 -1.006 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.671 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.906 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.94 -61.52 2.11 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.728 -0.736 . . . . 0.0 110.275 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.734 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.26 -28.17 68.98 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.616 177.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -64.8 -52.14 58.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.241 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.744 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.56 -43.34 97.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.026 0.441 . . . . 0.0 109.922 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.2 m -65.79 -35.09 74.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.668 0.747 . . . . 0.0 110.424 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.734 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.3 OUTLIER -71.37 -45.75 62.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.363 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.509 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 57.2 p -60.13 -36.66 77.99 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.723 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 19' ' ' VAL . 27.1 m -72.92 -44.35 57.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.171 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.877 HD23 ' CE1' ' A' ' 141' ' ' PHE . 3.4 pp -64.1 -29.53 70.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.779 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.856 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.732 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.644 ' OD2' ' HB1' ' A' ' 73' ' ' ALA . 2.2 m-20 -72.75 -170.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -120.87 89.74 3.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.642 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.4 mt -99.52 164.81 11.93 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.622 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 6.9 p -96.87 161.99 13.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.511 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -47.5 -51.75 19.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.806 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -64.36 -27.65 69.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.973 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -72.11 -51.55 20.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.643 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.701 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.1 pt -72.8 -28.76 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.882 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.27 -27.33 9.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.0 mt-10 -75.27 -28.42 59.79 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.314 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.3 m-85 -79.48 -58.51 3.16 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.221 0.534 . . . . 0.0 111.078 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.877 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.54 14.31 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.218 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -76.56 -28.01 56.11 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.45 -39.87 62.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.059 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.877 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.63 -51.77 68.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.851 0.834 . . . . 0.0 109.416 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -74.46 -24.45 59.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.087 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.2 tt -82.04 -24.88 35.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.233 0.539 . . . . 0.0 110.249 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.815 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.2 t80 -93.05 -1.74 56.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.561 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.2 t70 -103.14 143.64 32.35 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.966 0.888 . . . . 0.0 111.114 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -60.2 -53.47 57.31 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.54 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -84.9 -5.95 59.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.801 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.34 46.64 51.95 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.367 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.1 p30 -91.35 18.44 7.13 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.83 0.348 . . . . 0.0 110.706 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.33 88.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.611 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.0 p -150.24 150.07 31.04 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -102.0 140.49 20.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.959 0.409 . . . . 0.0 111.939 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.57 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.25 176.48 8.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.009 179.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.83 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.2 p -70.43 -37.88 74.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.058 0.456 . . . . 0.0 110.312 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.546 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -60.0 -41.26 91.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.134 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.926 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -68.91 -53.79 19.1 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.27 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.837 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.96 -55.83 29.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.711 0.767 . . . . 0.0 109.357 178.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.45 -45.77 88.75 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.562 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.4 m -62.74 -32.09 73.14 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.78 0.324 . . . . 0.0 110.585 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 31' ' ' GLU . 71.0 t -66.68 -57.24 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.473 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -71.88 -36.94 70.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.436 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -66.13 -41.3 90.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.99 0.424 . . . . 0.0 110.537 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -79.06 -8.72 59.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.65 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.549 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -90.63 -54.28 4.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.084 0.468 . . . . 0.0 110.746 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.447 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.73 34.45 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.891 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.592 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.63 179.99 5.88 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.301 0.572 . . . . 0.0 111.12 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -159.69 56.22 0.84 Allowed Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.812 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.592 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.3 Cg_endo -80.67 -172.23 1.46 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.538 2.159 . . . . 0.0 112.116 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -119.08 152.41 36.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.926 0.393 . . . . 0.0 110.142 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.91 -50.08 73.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.5 -33.41 75.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.462 0.649 . . . . 0.0 110.681 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.58 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.77 -54.29 33.72 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.702 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.83 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -66.05 -34.54 78.3 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.366 179.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.688 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -64.64 -42.59 95.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.911 0.386 . . . . 0.0 110.149 179.281 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -61.87 -45.46 93.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.218 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.1 mmt -74.54 -30.7 61.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.47 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.553 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.28 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.587 -179.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -45.01 -28.6 0.7 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.378 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.43 -39.35 47.22 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.972 0.415 . . . . 0.0 110.792 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.893 HG11 HG21 ' B' ' 6' ' ' ILE . 4.7 m -80.59 -11.68 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.143 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 38.8 t0 -103.61 155.56 18.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.738 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.491 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.66 -29.08 25.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.061 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -116.52 -9.66 11.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.429 0.633 . . . . 0.0 110.42 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.2 64.04 4.69 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.445 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -112.45 17.7 19.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.872 0.368 . . . . 0.0 110.214 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.29 19.9 53.85 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.512 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.57 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -147.62 176.36 10.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.48 HD12 HD11 ' A' ' 32' ' ' LEU . 54.1 mt -115.03 136.49 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 120.609 0.242 . . . . 0.0 110.853 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 10.4 m-20 -86.91 -178.42 6.3 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.256 0.551 . . . . 0.0 111.836 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.521 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.87 -55.74 13.06 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.769 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.7 Cg_endo -65.56 -35.14 39.58 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.291 1.994 . . . . 0.0 111.244 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.37 -52.34 62.1 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.242 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.723 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.9 -56.92 15.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.907 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.701 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -54.73 -48.18 72.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.827 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.732 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 76.5 m -58.74 -32.3 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.203 0.525 . . . . 0.0 109.716 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.91 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.7 tpp -67.86 -61.6 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.938 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.639 ' HG2' HG22 ' B' ' 10' ' ' ILE . 3.0 mtt -63.53 -29.89 71.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.742 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.644 ' HB1' ' OD2' ' A' ' 2' ' ' ASP . . . -53.31 -24.61 12.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.964 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.99 -29.37 67.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' CD ' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -58.58 -22.24 55.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.077 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 28.7 mmt -56.81 -23.03 40.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.205 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -55.93 -81.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.985 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 177.72 -178.71 0.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.838 0.351 . . . . 0.0 110.956 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 60.99 -179.44 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.041 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.478 ' H ' HG22 ' A' ' 79' ' ' THR . 3.4 m-20 63.25 31.7 15.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.006 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 77.3 p -77.51 -51.93 9.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.847 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -80.72 -29.22 36.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.983 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -50.42 -30.48 12.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.241 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.557 ' O ' HG11 ' B' ' 19' ' ' VAL . 4.6 mt-10 -73.77 -29.45 62.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.718 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.654 HG22 ' HE1' ' A' ' 138' ' ' TYR . 14.4 mt -79.04 -51.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.412 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -71.95 -50.46 28.76 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.633 ' O ' HG23 ' A' ' 91' ' ' VAL . 83.1 mt-10 -53.51 -25.22 15.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 110.779 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.743 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.72 -36.77 50.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.271 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.9 t80 -68.46 -51.4 43.94 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.014 0.435 . . . . 0.0 110.097 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -55.03 -32.17 61.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.799 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 87' ' ' GLU . 52.0 t -88.78 -22.73 6.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.617 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.38 -30.11 38.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.049 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -109.13 139.47 43.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.449 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -63.02 -38.54 91.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.591 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -107.85 -9.64 15.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.18 31.03 39.72 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.144 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -67.53 -13.82 62.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 117.041 0.421 . . . . 0.0 110.756 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.452 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 100.91 -12.15 59.11 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.976 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 20.3 m-85 -127.35 146.15 50.56 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.914 0.387 . . . . 0.0 111.338 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.834 ' CD1' HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.15 110.01 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.807 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.7 t -83.07 178.24 8.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.43 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.543 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.83 -28.12 69.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.093 0.473 . . . . 0.0 110.557 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.96 -56.8 12.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.291 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.756 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.3 mm-40 -76.35 -42.49 44.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.232 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.834 HD13 ' CD1' ' A' ' 100' ' ' ILE . 22.6 tp -56.55 -33.61 66.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.916 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.847 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.3 ttt-85 -71.79 -49.47 38.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.945 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -61.87 -38.43 88.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.049 0.452 . . . . 0.0 110.376 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.837 ' O ' HD12 ' A' ' 112' ' ' LEU . 39.9 t -73.06 -43.97 57.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.403 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.451 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 25.4 mmt -73.99 -54.02 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.465 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.619 HG23 ' HA ' ' A' ' 115' ' ' LYS . 8.0 m -55.38 -46.87 76.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.478 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.88 -29.77 68.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.88 ' O ' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -123.0 38.21 4.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.678 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.42 -113.96 0.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.773 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' O ' HD23 ' A' ' 116' ' ' LEU . 4.7 pt-20 -135.21 169.21 17.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.619 ' HA ' HG23 ' A' ' 110' ' ' THR . 6.7 ttpt -73.83 99.75 3.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.227 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.0 115.25 27.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.373 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.935 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.81 175.21 5.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.41 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -48.0 -35.89 11.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.397 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -77.4 -35.91 53.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.71 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -71.66 -33.31 68.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.951 0.405 . . . . 0.0 110.065 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.86 -49.12 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.277 0.56 . . . . 0.0 109.849 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -59.46 -52.76 64.22 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.758 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -57.33 -28.7 63.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.82 ' HG3' HD21 ' A' ' 105' ' ' LEU . 10.2 tpt -76.19 -39.43 54.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.121 0.486 . . . . 0.0 110.241 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.495 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -66.58 -41.11 87.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.369 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -64.21 -41.59 96.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.444 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 124' ' ' MET . 7.6 pt-20 -82.73 -33.13 27.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.476 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.39 -35.25 77.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.454 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.707 ' HB2' HG22 ' A' ' 136' ' ' VAL . 20.9 t0 -106.09 146.1 30.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.029 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.562 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.0 pt -82.73 -40.95 17.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.147 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.562 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.95 -11.05 60.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.675 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.74 33.11 1.0 Allowed Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.443 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.2 p-10 -96.58 -12.62 23.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.307 -0.946 . . . . 0.0 112.466 -176.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.21 10.18 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.777 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.5 147.21 30.94 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.134 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.707 HG22 ' HB2' ' A' ' 129' ' ' ASP . 26.5 t -130.73 107.25 13.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.364 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.549 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.57 174.57 11.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.222 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.654 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.95 -67.15 0.31 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.54 0.686 . . . . 0.0 111.488 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.412 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.3 mt-10 -60.75 -29.54 69.45 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.563 -1.198 . . . . 0.0 111.913 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.565 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.91 -44.05 77.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.08 0.467 . . . . 0.0 109.762 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -31.91 46.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.134 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 138' ' ' TYR . 67.5 t -54.03 -48.29 64.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.132 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.625 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -57.99 -44.99 87.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.7 tpp -73.14 -32.92 65.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 34.7 ttp -59.89 -43.05 95.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.2 t -77.59 -30.9 52.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.59 149.3 30.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.89 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.941 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.2 mmm180 -52.3 -50.89 61.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.056 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.726 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.72 -53.26 32.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.678 0.275 . . . . 0.0 111.241 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -57.07 -37.68 72.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.051 0.453 . . . . 0.0 110.365 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.941 HG23 ' O ' ' B' ' 1' ' ' ALA . 12.4 t -63.45 -33.64 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.415 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.893 HG21 HG11 ' A' ' 55' ' ' VAL . 2.6 mt -71.52 -55.43 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.026 179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.2 mmm-85 -50.58 -37.61 40.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.214 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -69.76 -47.17 63.95 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.543 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.837 ' HD2' HD23 ' A' ' 32' ' ' LEU . 14.6 mtmt -56.0 -55.41 33.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.91 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.9 mt -51.52 -57.34 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.049 0.452 . . . . 0.0 111.059 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -56.16 -51.19 68.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.954 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.552 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.39 -40.24 64.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.094 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.571 ' O ' ' HB2' ' B' ' 17' ' ' ALA . 3.1 mt -54.44 -51.52 48.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.506 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.3 -36.27 93.19 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.08 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.916 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.73 -61.44 2.18 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.812 -0.694 . . . . 0.0 110.413 -178.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.668 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -62.97 -27.84 69.68 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.647 177.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -66.05 -51.31 59.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.226 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.564 ' NE ' HG12 ' B' ' 19' ' ' VAL . 3.7 ppt_? -63.49 -43.48 97.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.977 0.418 . . . . 0.0 109.918 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.916 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.4 m -66.61 -32.29 57.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.679 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.668 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -71.65 -50.94 25.95 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.955 -179.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.448 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 54.7 p -57.85 -36.24 72.05 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.482 HG22 ' C ' ' B' ' 19' ' ' VAL . 26.8 m -72.55 -45.25 59.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.102 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.537 HD21 ' CD1' ' B' ' 20' ' ' PHE . 3.1 pp -65.71 -26.42 67.75 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.084 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.654 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 12.7 ptt180 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.926 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.63 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.765 0.317 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.537 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.8 m-20 -64.87 -169.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -117.28 89.42 3.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.02 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.632 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.93 164.72 12.25 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.482 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.49 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.0 p -97.84 162.47 13.24 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.527 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -47.51 -51.42 20.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.831 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.39 -27.62 69.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.022 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.49 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.4 -51.43 20.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.72 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.704 HG22 ' CD2' ' A' ' 69' ' ' LEU . 37.9 pt -73.24 -28.9 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.862 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.47 -27.39 10.29 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 17.9 mt-10 -75.21 -28.57 60.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.256 178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.603 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.35 -58.5 3.18 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.873 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 10.9 ptmt -54.52 -23.01 14.64 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.206 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.37 -27.93 56.58 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.143 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.39 -39.9 62.41 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.106 177.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.873 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.8 -51.94 67.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.79 0.805 . . . . 0.0 109.398 178.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.43 -24.14 59.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.089 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.903 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.14 -26.29 33.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.22 0.533 . . . . 0.0 110.147 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.878 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.9 t80 -91.24 -1.4 57.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.356 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.9 t70 -103.09 144.11 31.72 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.004 0.907 . . . . 0.0 111.072 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.8 mmtt -60.37 -53.4 58.02 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 113.859 -1.519 . . . . 0.0 111.68 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.29 -6.51 59.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.75 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.06 46.16 56.23 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.169 -0.538 . . . . 0.0 113.371 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.3 p30 -90.88 17.95 7.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.831 0.348 . . . . 0.0 110.732 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.34 5.55 88.65 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.532 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.428 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 49.6 p -150.29 148.98 29.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.774 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -100.54 140.52 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.016 0.436 . . . . 0.0 111.907 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.594 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.52 178.07 7.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.131 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.812 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -70.46 -40.45 73.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.107 0.479 . . . . 0.0 110.382 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -58.48 -40.87 83.94 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.402 178.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.824 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.61 -53.86 16.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.378 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.758 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -57.33 -54.17 49.85 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.785 0.802 . . . . 0.0 109.583 178.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.69 -46.78 92.87 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.27 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.9 m -66.25 -30.14 70.52 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.757 0.313 . . . . 0.0 110.493 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.878 HG21 ' CE2' ' A' ' 19' ' ' PHE . 16.7 t -64.03 -57.89 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.06 0.457 . . . . 0.0 110.635 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.524 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -72.48 -40.38 66.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.255 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -61.09 -38.87 87.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 110.378 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.0 t -78.8 -12.23 60.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.526 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.548 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -87.46 -53.48 4.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 121.152 0.501 . . . . 0.0 110.544 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' N ' HD23 ' A' ' 39' ' ' LEU . . . 180.0 35.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.568 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.609 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -131.31 -179.96 5.66 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.287 0.565 . . . . 0.0 111.245 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -159.71 56.17 0.84 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.783 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.609 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.3 Cg_endo -80.72 -173.52 1.88 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.588 2.192 . . . . 0.0 112.202 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -119.7 152.39 37.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.885 0.374 . . . . 0.0 110.075 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.71 -50.14 73.07 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.85 76.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.711 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.577 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.91 -54.37 31.91 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.76 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.812 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.65 -38.18 90.12 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.313 179.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.711 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -61.79 -42.57 99.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.884 0.373 . . . . 0.0 110.428 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -61.73 -46.09 91.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.5 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.61 -30.6 61.73 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.606 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -53.66 -40.19 41.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.761 -178.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.423 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 1.4 m-80 -45.11 -28.68 0.77 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.383 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.84 -38.0 47.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.977 0.418 . . . . 0.0 110.734 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.057 HG11 HG21 ' B' ' 6' ' ' ILE . 3.8 m -80.8 -12.63 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 43.2 t0 -103.46 155.25 18.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.699 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.09 26.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.179 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -116.44 -9.72 11.42 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.402 0.62 . . . . 0.0 110.415 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.72 61.52 7.29 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.295 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.2 p-10 -109.74 18.49 20.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.758 0.313 . . . . 0.0 110.411 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.32 19.96 59.65 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.303 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.4 p -147.48 176.23 10.21 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.758 HD12 HD11 ' A' ' 32' ' ' LEU . 14.2 mt -113.47 136.66 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.644 0.259 . . . . 0.0 110.717 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -86.24 -179.96 6.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.208 0.528 . . . . 0.0 111.876 -179.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.89 -55.88 12.71 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.471 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.7 Cg_endo -65.76 -35.04 38.28 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.186 1.924 . . . . 0.0 111.18 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -52.51 63.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.724 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.35 -56.66 19.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.816 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.704 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.73 -47.92 78.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.813 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.63 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 53.3 m -59.39 -30.66 68.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.094 0.473 . . . . 0.0 110.102 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.89 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.1 tpp -63.61 -61.79 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.112 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.403 ' CG ' HG22 ' B' ' 10' ' ' ILE . 40.3 mtm -72.12 -29.65 64.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.145 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.537 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.09 0.07 37.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.687 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -53.2 121.14 6.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.835 0.35 . . . . 0.0 111.067 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -16.6 63.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.217 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 32.9 mtt -76.88 -29.61 55.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.964 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -100.16 144.56 29.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.872 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -177.05 -169.0 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 62.17 -167.27 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.414 ' H ' HG22 ' A' ' 79' ' ' THR . 13.7 m-20 63.96 60.6 1.01 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.46 -33.39 54.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -76.86 -29.22 55.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.933 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -50.72 -30.67 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.154 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.681 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -78.16 -29.44 48.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.678 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.685 HG22 ' HE1' ' A' ' 138' ' ' TYR . 8.4 mt -79.21 -51.13 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.32 -52.04 11.77 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.647 ' O ' HG23 ' A' ' 91' ' ' VAL . 10.1 tt0 -53.85 -25.63 20.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.754 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.703 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.46 -35.75 46.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.265 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.601 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 27.6 t80 -68.58 -51.38 43.2 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 110.026 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -54.76 -32.61 60.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.796 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 87' ' ' GLU . 46.6 t -88.75 -22.67 6.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.631 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.487 ' CG ' HG21 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -53.05 -33.33 51.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.271 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -100.64 148.85 24.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.519 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.27 -37.69 78.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.294 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -112.22 -9.77 13.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.782 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.59 28.47 32.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.313 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -67.51 -13.97 62.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.183 0.491 . . . . 0.0 110.752 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.27 -10.27 56.53 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.187 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.469 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.5 m-85 -127.08 145.42 50.74 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.988 0.423 . . . . 0.0 111.5 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.829 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.18 109.9 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.843 179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -83.84 175.18 9.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.329 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.549 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -62.63 -29.05 70.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.001 0.429 . . . . 0.0 110.37 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -56.81 14.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.252 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.769 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.37 -46.54 26.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.279 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.829 HD13 HD13 ' A' ' 100' ' ' ILE . 15.5 tp -52.99 -36.07 59.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.798 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.2 ttt180 -68.05 -49.1 63.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.877 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -58.17 -44.52 88.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.232 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.826 ' O ' HD12 ' A' ' 112' ' ' LEU . 1.8 t -73.01 -42.28 59.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.552 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.477 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 26.6 mmt -70.16 -54.06 14.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.514 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 115' ' ' LYS . 7.3 m -58.39 -48.36 80.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.3 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -58.48 -29.29 66.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.84 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.903 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -122.98 37.52 4.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.75 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -168.85 -116.17 0.36 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.708 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 110' ' ' THR . 6.3 pt-20 -131.51 172.23 12.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.72 0.295 . . . . 0.0 110.777 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.625 ' HA ' HG23 ' A' ' 110' ' ' THR . 12.3 ttpt -75.78 98.77 4.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.288 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.967 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.4 OUTLIER -91.47 112.72 24.75 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.551 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.917 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.8 174.9 6.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.328 179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.11 -36.13 12.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 0.0 110.757 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -77.38 -33.91 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.757 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -73.64 -34.72 65.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.023 0.439 . . . . 0.0 110.023 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.967 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -72.73 -47.99 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.872 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -58.81 -52.87 63.89 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.837 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -56.64 -28.91 61.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.928 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.82 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.8 tpt -76.31 -38.73 55.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.182 0.515 . . . . 0.0 110.111 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.51 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -67.51 -48.51 76.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.521 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -60.26 -40.32 89.9 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.85 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 124' ' ' MET . 14.1 pt-20 -80.55 -37.13 32.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.929 0.395 . . . . 0.0 110.604 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.436 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.83 -36.47 82.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.555 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.722 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.4 t0 -101.57 147.87 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.062 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.56 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.7 pt -84.88 -40.74 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.048 178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.56 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.98 -10.9 59.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.692 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.09 32.68 1.1 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.433 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.1 -12.79 24.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.303 -0.949 . . . . 0.0 112.482 -176.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.89 20.12 10.22 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.813 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.51 146.83 30.66 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.928 0.395 . . . . 0.0 110.029 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 129' ' ' ASP . 35.4 t -130.74 107.39 14.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.307 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.546 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -79.18 174.69 11.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.337 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.685 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.84 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.548 0.69 . . . . 0.0 111.421 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -60.3 -34.77 74.26 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.839 -178.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.505 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.06 -41.55 75.24 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.823 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.77 -31.85 46.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.022 178.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 138' ' ' TYR . 53.6 t -55.54 -47.23 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.596 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -56.07 -45.15 79.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.966 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.16 -32.11 64.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.5 ' HE2' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -59.95 -42.92 95.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.911 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 t -76.97 -31.3 56.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.76 152.24 23.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.939 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.714 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.47 -52.17 55.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.214 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.704 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.78 -53.32 32.84 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.722 0.296 . . . . 0.0 111.394 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.94 -36.89 70.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 0.0 110.295 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.939 HG23 ' O ' ' B' ' 1' ' ' ALA . 39.6 t -62.05 -39.19 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.1 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 1.057 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -65.92 -55.48 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.166 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 24.5 mmm-85 -50.91 -37.31 43.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.022 0.439 . . . . 0.0 110.202 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -73.32 -45.86 52.86 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.718 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.876 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.4 OUTLIER -55.02 -55.47 30.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.999 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.89 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.5 mt -51.49 -57.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.421 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -57.8 -51.33 70.0 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.218 0.532 . . . . 0.0 111.021 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.525 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.46 -42.47 67.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.779 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.785 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.3 mt -54.57 -48.07 71.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.577 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.26 -38.26 96.18 Favored Glycine 0 CA--C 1.499 -0.954 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.077 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.897 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.14 -61.75 2.06 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.831 -0.685 . . . . 0.0 110.445 -178.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.651 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.7 OUTLIER -61.8 -27.84 69.04 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.65 177.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.19 -50.89 64.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.258 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.713 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.89 -43.65 95.37 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.897 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -64.34 -33.68 64.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.532 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.711 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.4 OUTLIER -74.3 -45.04 50.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.737 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.528 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.8 p -59.85 -25.96 65.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.457 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.407 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.5 -46.15 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.134 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.935 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.83 -34.23 76.88 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.164 0.507 . . . . 0.0 110.323 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.935 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.064 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.827 0.346 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.69 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.762 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -123.78 89.36 3.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.107 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.629 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.03 164.71 12.41 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.354 179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.504 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.2 p -97.89 162.31 13.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.482 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -47.53 -51.4 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.819 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -64.48 -27.66 69.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.018 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.504 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.22 -51.52 20.7 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.683 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.703 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.0 pt -73.31 -28.89 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.806 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.31 10.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.537 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 13.8 mt-10 -75.38 -28.62 59.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.369 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.1 m-85 -79.25 -58.69 3.09 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.174 0.511 . . . . 0.0 111.189 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.872 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -55.37 -21.89 17.33 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.249 -179.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.537 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -77.23 -28.03 53.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.18 -40.1 62.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.082 177.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.872 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.46 -51.95 67.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.853 0.835 . . . . 0.0 109.448 178.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 5.1 p -74.35 -24.27 59.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.161 -1.382 . . . . 0.0 112.149 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.905 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.14 -25.85 34.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.31 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.878 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.7 t80 -92.16 -1.99 56.83 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.632 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.9 t70 -101.77 143.5 31.62 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.963 0.887 . . . . 0.0 111.152 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.3 mmtt -60.16 -53.38 58.44 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.552 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.15 -5.6 59.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.791 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.22 46.45 51.42 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.349 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -91.11 18.17 7.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.82 0.343 . . . . 0.0 110.704 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.52 5.1 88.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.605 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 47.0 p -150.29 149.25 29.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.748 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.8 140.51 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.895 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.631 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.29 177.01 7.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.124 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.8 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -70.35 -39.05 74.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.102 0.477 . . . . 0.0 110.301 -179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.35 -40.78 87.47 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.285 178.81 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.817 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.57 -53.83 17.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.329 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.771 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -57.7 -54.38 47.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.786 0.803 . . . . 0.0 109.531 178.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.33 -46.63 92.69 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 114.456 -1.247 . . . . 0.0 112.296 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.1 m -66.76 -30.06 70.18 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.749 0.309 . . . . 0.0 110.479 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.878 HG21 ' CE2' ' A' ' 19' ' ' PHE . 13.0 t -63.51 -57.95 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 0.0 110.534 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.534 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -72.44 -40.94 66.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.196 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -39.26 86.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.982 0.42 . . . . 0.0 110.494 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -78.81 -12.14 60.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.537 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.3 tt -87.73 -54.07 4.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 0.0 110.596 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.467 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -179.02 36.87 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.752 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 tp-100 -134.9 -179.46 5.62 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.332 0.587 . . . . 0.0 111.22 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -159.68 56.35 0.86 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.892 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.49 -176.71 3.32 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.583 2.189 . . . . 0.0 112.153 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.604 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -115.89 152.5 33.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 110.203 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.11 -49.64 75.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -34.19 77.57 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.78 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.98 -54.35 31.87 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.657 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.8 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -64.7 -38.17 90.08 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 120.246 -0.581 . . . . 0.0 110.329 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.715 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.36 -42.15 99.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.891 0.377 . . . . 0.0 110.405 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.09 -47.34 86.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.431 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.41 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 23.9 mmt -74.51 -30.32 61.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.732 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.543 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.42 -38.64 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.584 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -45.52 -28.53 0.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.298 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.74 -38.03 47.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.935 0.398 . . . . 0.0 110.833 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.082 HG11 HG21 ' B' ' 6' ' ' ILE . 4.2 m -81.92 -11.78 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.218 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.552 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 40.9 t0 -103.46 155.48 18.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.729 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.477 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.58 -28.73 26.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.084 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -116.38 -9.72 11.46 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.387 0.613 . . . . 0.0 110.458 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.552 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.38 63.08 5.56 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.99 -1.005 . . . . 0.0 113.467 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -112.19 18.45 18.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.835 0.35 . . . . 0.0 110.194 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 85.9 19.95 56.71 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.445 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.631 HG22 ' HA ' ' A' ' 28' ' ' THR . 5.0 p -146.5 176.44 9.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.771 HD12 HD11 ' A' ' 32' ' ' LEU . 15.1 mt -116.44 136.48 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.522 0.201 . . . . 0.0 110.883 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 8.7 m-20 -86.67 -178.95 6.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.273 0.558 . . . . 0.0 111.908 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.84 -55.94 12.72 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.607 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -65.6 -35.05 39.63 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.22 1.947 . . . . 0.0 111.223 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.64 -52.38 63.57 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.199 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.06 -56.86 16.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.844 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.703 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.11 -47.5 80.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.729 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.413 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 58.3 m -59.06 -30.76 68.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.055 0.455 . . . . 0.0 110.061 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.904 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.1 tpp -65.54 -61.75 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.229 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.485 ' CG ' HG22 ' B' ' 10' ' ' ILE . 12.1 mtm -69.35 -37.32 77.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.104 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.03 -21.08 43.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.432 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.33 105.9 0.13 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.88 0.372 . . . . 0.0 111.083 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -19.14 62.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 tpp -68.63 -29.34 67.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.985 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.02 117.82 21.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.956 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -136.75 -177.46 4.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 m 59.88 102.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 178.04 -33.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.115 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -53.21 -31.15 41.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.233 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -80.74 -31.78 35.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.021 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -77.22 -42.07 38.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.274 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.708 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.71 -29.32 26.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.541 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.726 HG22 ' HE1' ' A' ' 138' ' ' TYR . 23.0 mt -66.07 -51.42 60.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.794 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -75.81 -50.65 14.58 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.774 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.673 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.7 mt-10 -53.87 -30.69 46.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.661 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.557 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -71.16 -38.62 72.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.792 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.6 t80 -67.08 -55.92 12.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 0.0 110.541 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.85 -30.51 45.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.832 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 87' ' ' GLU . 75.6 t -88.36 -22.86 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.309 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -55.25 -32.54 62.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.982 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -102.08 148.64 25.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -69.62 -37.53 76.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.375 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -112.26 -9.76 13.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.5 30.65 32.61 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.119 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -67.42 -13.52 62.1 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.928 0.364 . . . . 0.0 110.823 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.46 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.16 -13.61 55.44 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.846 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.469 ' HB3' ' HB3' ' A' ' 135' ' ' GLN . 24.5 m-85 -127.22 145.9 50.61 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 120.961 0.41 . . . . 0.0 111.3 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.713 HD12 HD12 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.09 109.99 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.85 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -82.19 177.71 8.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.383 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.48 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.3 -28.17 69.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.009 0.433 . . . . 0.0 110.559 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.35 -57.72 9.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.314 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.8 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.47 -38.74 54.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.006 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.918 HD11 ' HG3' ' A' ' 124' ' ' MET . 5.5 tt -56.5 -33.15 65.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.888 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.821 ' HA ' HD11 ' A' ' 116' ' ' LEU . 6.7 ttt180 -74.77 -49.4 21.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.172 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.76 -36.72 79.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.064 0.459 . . . . 0.0 110.321 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 104' ' ' GLU . 45.6 t -72.9 -45.69 54.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.242 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.454 ' HE3' HD11 ' B' ' 23' ' ' LEU . 22.3 mmt -73.93 -54.14 8.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.818 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.577 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.2 m -55.46 -43.11 75.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 111.362 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.463 ' C ' HD12 ' A' ' 112' ' ' LEU . 38.4 t-20 -61.21 -31.81 71.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 110.788 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.905 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -123.17 38.76 4.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.562 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.31 -116.96 0.39 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.782 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.404 ' O ' HD23 ' A' ' 116' ' ' LEU . 14.6 pt-20 -133.61 171.88 13.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.821 0.343 . . . . 0.0 110.944 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.577 ' HA ' HG23 ' A' ' 110' ' ' THR . 24.7 ttpt -75.38 100.08 4.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.294 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.951 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.41 115.48 26.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.29 179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.933 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.76 174.99 6.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.404 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 117' ' ' THR . 0.6 OUTLIER -48.0 -35.76 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.92 0.391 . . . . 0.0 110.734 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -77.29 -36.15 54.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.699 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -71.13 -34.56 71.14 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.056 0.455 . . . . 0.0 110.084 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.951 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -73.62 -50.02 32.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.351 0.596 . . . . 0.0 109.776 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -59.76 -52.85 63.7 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.859 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -56.84 -28.83 62.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.938 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.918 ' HG3' HD11 ' A' ' 105' ' ' LEU . 7.4 tpt -76.35 -38.75 55.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.151 0.5 . . . . 0.0 110.13 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.619 HG12 HD13 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -66.15 -49.07 78.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.521 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -60.13 -40.12 88.66 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.967 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 124' ' ' MET . 12.2 pt-20 -81.01 -37.31 29.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.912 0.387 . . . . 0.0 110.647 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.466 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.33 -36.96 84.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.518 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.747 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.1 t0 -100.39 148.1 25.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.025 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.563 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.8 -40.8 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 121.297 0.57 . . . . 0.0 110.073 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.563 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.83 -11.03 60.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.682 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.14 32.59 1.1 Allowed Glycine 0 C--N 1.337 0.618 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.7 p-10 -96.04 -12.94 24.16 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.309 -0.946 . . . . 0.0 112.434 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.88 20.18 10.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.81 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -146.74 146.69 30.38 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.905 0.383 . . . . 0.0 110.061 179.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.747 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.7 t -130.67 107.47 14.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.24 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.546 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -80.01 174.65 11.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.426 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.726 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.97 -67.06 0.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.479 0.657 . . . . 0.0 111.531 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.97 -34.15 72.9 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.913 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.532 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.12 -40.34 73.61 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.827 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -78.79 -33.67 46.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.114 178.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.582 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 67.6 t -54.86 -47.43 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.688 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -58.13 -45.2 87.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.12 -32.5 64.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.408 ' HE1' HG12 ' A' ' 85' ' ' ILE . 14.1 ttp -59.81 -43.63 94.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 t -76.81 -31.19 56.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.923 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.71 160.79 6.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.91 179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.937 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.717 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.44 -52.37 54.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.209 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.714 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.83 -53.2 34.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.291 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -56.84 -37.02 70.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.009 0.433 . . . . 0.0 110.256 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.937 HG23 ' O ' ' B' ' 1' ' ' ALA . 40.7 t -61.94 -39.16 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.081 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 1.082 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -66.03 -55.53 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.15 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -50.96 -37.16 42.88 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.2 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.22 -45.55 55.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.622 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.872 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.3 OUTLIER -55.33 -55.32 32.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.129 -179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.904 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.5 mt -51.29 -57.5 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.802 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.506 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.8 tpt180 -60.3 -51.32 70.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.273 0.559 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.554 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.35 -40.13 64.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.679 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.737 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.46 -47.75 70.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.27 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.41 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.92 -38.25 95.81 Favored Glycine 0 CA--C 1.497 -1.06 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.493 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.898 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -64.93 -61.61 2.06 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.646 -0.777 . . . . 0.0 110.507 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.76 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.19 -27.49 67.19 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.81 -48.57 65.89 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.017 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.621 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.7 ppt_? -63.28 -43.57 97.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.127 0.489 . . . . 0.0 109.798 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.898 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -61.78 -34.82 64.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.348 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.752 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -74.95 -43.94 51.27 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.633 -179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.548 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 18.7 p -60.74 -25.77 66.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.495 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.418 HG23 ' N ' ' B' ' 23' ' ' LEU . 29.3 m -90.25 -46.5 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.09 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.954 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -62.37 -34.47 76.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.184 0.516 . . . . 0.0 110.348 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.954 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.092 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.627 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.821 0.343 . . . . 0.0 111.069 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.568 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 m-20 -66.65 -169.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -117.5 90.65 3.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.975 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.2 mt -98.72 164.88 12.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.557 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.484 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.3 p -96.94 161.82 13.67 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.494 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.52 -51.91 19.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.798 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -64.28 -27.73 69.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.015 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.94 -51.52 21.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.662 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.701 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.6 pt -72.84 -28.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.816 -179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.36 -27.29 9.44 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 7.9 mt-10 -74.88 -28.5 60.67 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.171 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.602 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.6 -58.34 3.24 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.198 0.523 . . . . 0.0 110.994 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.871 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -54.45 -23.01 14.3 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.188 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.24 -27.94 56.96 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.48 -39.8 62.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.079 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.871 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.93 -51.82 68.39 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.85 0.834 . . . . 0.0 109.416 178.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.43 -24.26 59.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.096 -1.411 . . . . 0.0 112.134 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.857 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.2 tt -82.08 -24.24 35.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.248 0.547 . . . . 0.0 110.191 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.815 ' HB3' HD11 ' A' ' 27' ' ' ILE . 2.6 t80 -95.61 0.82 53.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.434 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' A' ' 26' ' ' THR . 26.9 t70 -105.58 145.13 31.37 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.013 0.911 . . . . 0.0 111.123 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.0 mmtt -60.54 -53.39 58.07 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.587 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.43 -6.09 59.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.784 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.06 47.23 55.12 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.194 -0.526 . . . . 0.0 113.515 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -92.66 17.8 9.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.871 0.367 . . . . 0.0 110.469 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.16 9.25 86.34 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.258 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.462 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 72.8 p -150.16 147.23 27.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.6 mt -101.96 140.39 20.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.904 0.383 . . . . 0.0 111.927 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.683 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.4 t -87.27 -179.29 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.123 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.791 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.4 p -70.49 -45.51 65.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.944 0.402 . . . . 0.0 110.899 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.648 ' HG3' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -54.54 -40.54 68.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.449 178.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.911 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -69.52 -53.83 17.14 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.467 -179.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.858 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.92 -56.07 26.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.78 0.8 . . . . 0.0 109.379 178.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -56.86 -46.2 90.73 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.43 -1.259 . . . . 0.0 112.64 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.2 m -62.05 -35.01 77.31 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.047 0.423 . . . . 0.0 110.542 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.911 HG23 ' O ' ' A' ' 31' ' ' GLU . 70.0 t -64.0 -57.19 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.46 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.6 OUTLIER -71.82 -36.05 70.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.404 -179.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 2.8 ttt-85 -67.25 -41.22 85.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.999 0.428 . . . . 0.0 110.48 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.1 t -79.0 -8.32 58.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.627 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.541 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.82 -54.33 4.02 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.762 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.447 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.91 34.57 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.837 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.596 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.76 -179.37 5.49 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.317 0.58 . . . . 0.0 111.141 -179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -159.67 56.39 0.87 Allowed Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.815 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.8 Cg_endo -80.56 -174.85 2.41 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.568 2.179 . . . . 0.0 112.117 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -116.87 152.45 34.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.945 0.402 . . . . 0.0 110.159 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -56.69 -50.03 73.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.93 -33.14 74.94 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.75 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -64.98 -54.3 32.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.733 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.791 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.71 -35.57 81.12 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.419 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.752 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -63.4 -42.95 98.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.868 0.366 . . . . 0.0 110.224 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.85 -45.36 94.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.373 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.56 -30.68 61.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.449 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -53.72 -39.51 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.637 -179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.415 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 5.9 m-80 -44.99 -28.64 0.7 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.387 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.65 -38.52 54.47 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.954 0.407 . . . . 0.0 110.73 179.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.816 HG11 HG21 ' B' ' 6' ' ' ILE . 5.5 m -80.99 -12.77 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.049 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 42.9 t0 -103.5 154.88 18.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.815 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.68 -28.03 26.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.227 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -116.42 -9.72 11.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.386 0.612 . . . . 0.0 110.423 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.91 61.66 7.11 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.315 179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -109.52 18.4 20.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.873 0.368 . . . . 0.0 110.475 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.75 18.93 60.66 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.407 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 28' ' ' THR . 6.2 p -146.54 176.12 10.06 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' HG22 ' A' ' 26' ' ' THR . 61.0 mt -112.91 136.49 49.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.585 0.231 . . . . 0.0 110.675 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -85.12 179.56 7.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.243 0.544 . . . . 0.0 111.824 -179.399 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.518 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 6.3 m-85 -67.45 -56.52 12.32 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.285 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.82 -36.11 33.03 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.326 2.017 . . . . 0.0 111.071 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -60.61 -52.32 65.67 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.135 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.722 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.94 -56.29 23.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.657 179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.701 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.34 -46.67 83.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.706 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.627 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 65.1 m -61.2 -31.79 71.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.013 0.435 . . . . 0.0 110.11 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.925 ' HG2' HD13 ' B' ' 10' ' ' ILE . 4.5 tpp -60.86 -61.77 2.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.125 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 30.8 mtp -72.2 -31.59 66.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.991 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.568 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.76 0.04 40.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.638 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -56.02 152.62 10.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.875 0.369 . . . . 0.0 110.982 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 tptt -69.6 -12.68 61.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.295 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 17.5 mtt -93.49 -30.65 14.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.821 0.343 . . . . 0.0 110.962 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.01 116.56 21.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -176.6 -178.47 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 60.75 -166.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.792 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.415 ' H ' HG22 ' A' ' 79' ' ' THR . 5.6 m-20 63.94 65.87 0.68 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.57 -52.31 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.858 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -66.13 -35.52 80.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -50.47 -30.51 12.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.14 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.564 ' O ' HG11 ' B' ' 19' ' ' VAL . 4.7 mt-10 -76.49 -29.59 56.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.685 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.691 HG22 ' HE1' ' A' ' 138' ' ' TYR . 11.2 mt -79.26 -51.13 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -48.41 39.04 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.893 0.378 . . . . 0.0 111.87 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.41 ' OE2' ' HB1' ' B' ' 12' ' ' ALA . 6.5 tt0 -53.6 -26.31 21.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.344 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.742 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.4 -34.31 58.83 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.052 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.614 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 12.8 t80 -68.79 -50.05 53.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.12 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -54.5 -33.17 59.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.778 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.8 t -88.95 -22.79 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.542 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.28 -33.63 53.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.206 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -106.18 139.24 41.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.521 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -64.74 -34.77 79.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -112.15 -9.7 13.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.97 29.26 38.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.36 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.68 -13.92 62.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.134 0.467 . . . . 0.0 110.745 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 100.48 -11.6 59.75 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.004 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.483 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.3 m-85 -127.19 147.3 50.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.038 0.447 . . . . 0.0 111.438 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.085 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.19 109.96 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.721 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 t -82.62 176.52 9.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.46 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.09 -29.71 70.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.075 0.464 . . . . 0.0 110.477 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.26 -57.8 10.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.236 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.816 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.45 -45.38 31.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.126 -179.214 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.085 HD13 HD13 ' A' ' 100' ' ' ILE . 31.9 tp -52.95 -31.24 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.191 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.832 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.9 ttt-85 -73.47 -49.17 28.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -58.67 -42.48 88.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.074 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.9 t -72.99 -40.04 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.546 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.461 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 28.7 mmt -73.99 -54.18 8.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.528 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.636 HG23 ' HA ' ' A' ' 115' ' ' LYS . 5.4 m -55.5 -46.96 76.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.376 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -59.9 -30.7 69.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.857 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -121.54 37.52 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.49 -113.97 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.688 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.1 pt-20 -135.87 170.61 15.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.824 0.345 . . . . 0.0 110.805 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.636 ' HA ' HG23 ' A' ' 110' ' ' THR . 9.6 tttm -73.73 98.22 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.152 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.14 113.52 24.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.385 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.919 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.79 175.45 5.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.368 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -48.13 -35.93 12.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.896 0.379 . . . . 0.0 110.766 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.4 -34.51 54.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -73.44 -33.5 64.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.009 0.433 . . . . 0.0 110.096 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.5 t -74.47 -48.16 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.819 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -59.62 -52.85 63.77 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.735 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -57.48 -28.72 63.65 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.779 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.786 ' HG3' HD21 ' A' ' 105' ' ' LEU . 6.9 tpt -76.2 -38.02 57.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.121 0.486 . . . . 0.0 110.137 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.491 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.28 -41.84 81.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.494 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -66.08 -38.92 89.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.933 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.54 -35.94 29.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.512 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.471 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -68.54 -37.47 79.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.416 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.737 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.2 t0 -100.5 145.61 28.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.979 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.553 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.7 pt -83.17 -40.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.248 0.547 . . . . 0.0 110.101 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.553 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.9 -11.06 60.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.781 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.79 32.88 0.99 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -176.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.04 -12.48 24.85 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.341 -0.93 . . . . 0.0 112.53 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.2 10.18 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.84 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.483 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.31 146.76 30.82 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.2 t -130.75 107.22 13.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.354 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.567 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.3 t30 -78.25 175.2 10.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.206 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.735 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.91 -67.12 0.31 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.612 0.72 . . . . 0.0 111.635 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.3 mt-10 -64.96 -25.85 68.05 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.396 -1.275 . . . . 0.0 112.553 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.574 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -55.57 -48.47 74.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 110.35 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.0 p90 -78.81 -31.03 45.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.24 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 138' ' ' TYR . 65.7 t -52.8 -44.49 48.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.094 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -59.26 -38.74 80.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 109.828 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.49 -40.71 63.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.704 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.421 ' CG ' HG21 ' B' ' 22' ' ' VAL . 3.8 ttp -53.41 -43.58 68.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.009 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 t -78.89 -31.31 45.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.78 146.87 40.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.076 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.947 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.815 0.34 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.731 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.26 -51.22 59.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.061 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.711 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.68 -53.28 32.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.261 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.95 -37.54 71.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.999 0.428 . . . . 0.0 110.31 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.947 HG23 ' O ' ' B' ' 1' ' ' ALA . 15.3 t -63.35 -34.44 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.436 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.816 HG21 HG11 ' A' ' 55' ' ' VAL . 2.2 mt -71.32 -54.89 15.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.039 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -50.94 -37.63 45.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.154 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.85 -48.32 63.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.404 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.858 ' HD2' HD23 ' A' ' 32' ' ' LEU . 13.2 mtmt -54.25 -54.08 44.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.067 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.925 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.9 mt -51.13 -57.5 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.617 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.4 tpt180 -60.06 -51.41 69.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.28 0.562 . . . . 0.0 111.089 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.39 -40.38 65.0 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.763 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.755 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.57 -50.8 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.462 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.416 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.52 -37.06 94.08 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.235 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.909 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.02 -61.82 2.03 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.861 -0.669 . . . . 0.0 110.529 -178.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.69 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -63.17 -27.59 69.47 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.673 177.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.89 -50.48 64.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.28 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.747 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -64.63 -43.63 93.08 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.909 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.3 m -64.98 -33.02 60.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.543 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.69 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.5 OUTLIER -74.68 -45.92 41.33 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.944 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.546 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.46 -26.34 65.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.505 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.438 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.3 -47.41 14.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.229 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.887 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -62.79 -33.54 75.4 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.254 0.549 . . . . 0.0 110.511 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.887 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.071 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.819 0.343 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.536 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.2 m-20 -65.83 -169.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.785 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -118.65 89.26 3.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.994 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.623 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.29 164.7 12.37 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.9 p -98.29 162.67 13.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.48 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -47.56 -51.31 21.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.845 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -64.48 -27.66 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.994 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.6 OUTLIER -72.4 -51.46 20.32 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.696 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.692 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.2 pt -73.19 -28.89 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.822 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.43 -27.45 10.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.53 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 15.2 mm-40 -75.34 -28.55 59.65 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.327 178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.36 -58.64 3.11 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.228 0.537 . . . . 0.0 111.083 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.56 -23.26 15.94 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.243 -179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.7 OUTLIER -75.86 -28.08 58.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.123 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.07 -39.83 63.18 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.149 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.81 -51.81 68.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.762 0.791 . . . . 0.0 109.515 178.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.38 -24.41 59.13 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.26 -1.336 . . . . 0.0 112.044 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.5 tt -82.1 -25.34 34.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.217 0.532 . . . . 0.0 110.279 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.871 ' CE2' HG21 ' A' ' 35' ' ' VAL . 3.1 t80 -92.23 -2.37 56.53 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.524 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.0 t70 -102.42 143.45 32.14 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.959 0.885 . . . . 0.0 111.026 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 3.7 mmtt -60.01 -53.36 58.77 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.626 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.46 -5.19 59.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.777 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.55 47.0 45.96 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.331 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.6 p30 -91.47 18.22 7.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.905 0.383 . . . . 0.0 110.711 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.54 5.27 88.6 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.589 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.9 p -150.38 148.61 29.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.782 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.32 140.55 19.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.975 0.416 . . . . 0.0 111.763 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.575 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.21 178.21 7.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.374 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.758 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -69.62 -41.2 75.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 110.353 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -58.11 -41.24 83.12 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.439 179.127 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.811 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.79 -53.75 16.79 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.407 -179.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -58.07 -54.15 50.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.81 0.814 . . . . 0.0 109.555 178.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 37' ' ' ARG . . . -58.8 -47.08 92.29 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 114.457 -1.247 . . . . 0.0 112.384 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.4 m -65.33 -30.79 71.67 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.448 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.871 HG21 ' CE2' ' A' ' 19' ' ' PHE . 16.7 t -63.88 -57.91 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.087 0.47 . . . . 0.0 110.577 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.536 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -72.57 -40.25 66.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.31 -179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 33' ' ' GLY . 20.5 ttt180 -61.21 -38.56 87.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 110.447 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.3 t -78.84 -12.08 60.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.539 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -87.46 -53.12 4.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.178 0.514 . . . . 0.0 110.52 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.444 ' N ' HD23 ' A' ' 39' ' ' LEU . . . 178.74 36.16 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.606 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.601 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -131.07 179.39 6.03 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.342 0.591 . . . . 0.0 111.257 -179.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -159.78 56.11 0.82 Allowed Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.773 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.7 Cg_endo -80.67 -173.74 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.615 2.21 . . . . 0.0 112.226 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.618 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.91 152.42 36.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.87 0.367 . . . . 0.0 110.093 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.41 -50.14 72.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.0 -32.01 72.95 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.602 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 44' ' ' THR . 0.9 OUTLIER -66.49 -54.45 23.77 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.648 -179.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.758 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.26 -47.05 86.06 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.108 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.663 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -55.85 -44.94 78.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 110.806 179.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.4 -47.51 81.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.523 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -74.68 -30.61 61.64 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.968 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -54.15 -36.26 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.667 -178.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.401 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 22.0 t-20 -45.02 -28.64 0.72 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.282 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -79.39 -39.03 33.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.898 0.38 . . . . 0.0 110.731 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.031 HG11 HG21 ' B' ' 6' ' ' ILE . 3.6 m -80.01 -11.16 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.089 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 37.2 t0 -103.58 155.93 18.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.74 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.6 -29.38 25.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.1 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -116.51 -9.61 11.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.428 0.632 . . . . 0.0 110.442 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.4 63.86 4.85 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.014 -0.994 . . . . 0.0 113.519 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -112.49 17.84 18.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.807 0.337 . . . . 0.0 110.186 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.3 19.94 53.69 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.51 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.1 p -147.56 176.35 10.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.677 HD12 HD11 ' A' ' 32' ' ' LEU . 19.0 mt -115.03 136.48 51.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.554 0.216 . . . . 0.0 110.95 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.7 m-20 -88.18 -178.14 5.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.29 0.567 . . . . 0.0 112.001 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.75 -55.86 13.15 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.713 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.8 Cg_endo -65.66 -34.32 41.78 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.226 1.95 . . . . 0.0 111.267 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.72 -52.47 60.37 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.219 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.724 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.11 -57.15 13.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.88 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.692 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.23 -47.92 80.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.689 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 52.6 m -58.83 -30.54 67.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.066 0.46 . . . . 0.0 110.05 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.881 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.0 tpp -63.76 -61.71 2.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.234 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.439 ' CG ' HG22 ' B' ' 10' ' ' ILE . 7.5 mtm -72.84 -28.53 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.243 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.18 0.14 37.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.706 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -54.83 122.88 11.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.823 0.344 . . . . 0.0 110.989 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -65.0 -16.68 63.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.229 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 74.8 mtp -76.5 -29.47 56.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.807 0.337 . . . . 0.0 111.03 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -99.33 143.38 29.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.74 -173.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.845 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 63.84 -165.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' H ' HG22 ' A' ' 79' ' ' THR . 2.3 m-20 65.5 59.97 0.76 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 t -77.5 -33.52 54.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -76.03 -29.84 58.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -51.5 -30.53 20.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.666 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -78.0 -29.41 49.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.704 HG22 ' HE1' ' A' ' 138' ' ' TYR . 7.2 mt -79.14 -51.26 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.438 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.3 -51.91 12.11 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -178.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.649 ' O ' HG23 ' A' ' 91' ' ' VAL . 12.3 tm-20 -53.76 -25.47 19.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.786 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.706 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.62 -36.21 44.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.214 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 26.5 t80 -68.2 -52.13 37.84 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.0 0.429 . . . . 0.0 110.1 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -54.73 -31.98 59.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.821 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 87' ' ' GLU . 47.7 t -88.69 -22.74 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.514 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.48 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.36 -34.32 57.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.26 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -99.19 147.93 24.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.467 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -67.54 -38.22 83.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.375 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.29 -9.84 13.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.804 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.93 28.29 31.9 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.246 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -67.48 -13.9 62.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.211 0.505 . . . . 0.0 110.764 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.452 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -11.0 55.35 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.146 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.463 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 23.9 m-85 -127.09 145.0 50.89 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.011 0.434 . . . . 0.0 111.414 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.032 HD13 HD13 ' A' ' 105' ' ' LEU . 1.1 pt -121.15 109.97 26.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.726 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.3 m -83.7 177.15 8.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.582 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.549 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.2 -29.92 71.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.084 0.469 . . . . 0.0 110.449 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.3 -57.68 11.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.28 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.778 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.48 -45.66 30.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.135 -179.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.032 HD13 HD13 ' A' ' 100' ' ' ILE . 37.4 tp -53.06 -31.15 40.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.132 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.848 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.1 ttt-85 -72.94 -49.06 31.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.976 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -58.9 -42.58 89.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.806 ' O ' HD12 ' A' ' 112' ' ' LEU . 1.8 t -72.85 -40.96 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.456 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.462 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 27.0 mmt -72.54 -54.08 10.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.431 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.729 HG23 ' HA ' ' A' ' 115' ' ' LYS . 6.9 m -58.95 -47.81 83.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.203 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -58.76 -30.18 67.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.805 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.915 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -123.04 38.48 4.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.651 179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.6 -114.75 0.33 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.852 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.439 ' O ' HD23 ' A' ' 116' ' ' LEU . 17.8 pt-20 -133.17 166.89 21.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.8 0.334 . . . . 0.0 110.908 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.729 ' HA ' HG23 ' A' ' 110' ' ' THR . 16.7 tttt -72.68 99.85 2.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.359 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.968 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.24 114.33 26.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.371 179.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.926 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.75 175.28 5.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.429 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -48.14 -35.94 12.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.763 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -77.34 -34.82 55.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.774 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -73.06 -33.49 65.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.988 0.423 . . . . 0.0 110.099 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.968 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.73 -48.03 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.854 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.62 -52.87 63.66 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.758 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -57.51 -28.8 63.79 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.842 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.784 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.5 tpt -76.26 -37.73 57.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.139 0.495 . . . . 0.0 110.134 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.494 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -69.91 -43.58 79.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.552 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -64.99 -39.09 92.95 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.812 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -81.17 -36.43 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.984 0.421 . . . . 0.0 110.545 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.438 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -67.95 -38.25 82.57 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.635 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.729 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.8 t0 -99.39 147.67 25.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.029 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.563 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.85 -40.73 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.06 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.563 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.91 -11.01 60.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.706 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.1 32.72 1.11 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -176.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.4 p-10 -96.11 -12.75 24.32 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.318 -0.941 . . . . 0.0 112.471 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.88 20.21 10.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.824 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.463 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -146.59 146.64 30.51 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.729 HG22 ' HB2' ' A' ' 129' ' ' ASP . 40.2 t -130.78 107.4 13.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.266 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.542 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -79.12 174.66 11.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.302 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.704 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -45.83 -67.12 0.31 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.489 0.661 . . . . 0.0 111.444 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.406 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 0.5 OUTLIER -60.57 -34.22 73.85 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.892 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.51 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -56.06 -41.73 75.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.352 0.596 . . . . 0.0 109.504 179.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.805 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.1 OUTLIER -78.72 -31.92 46.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.086 178.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 138' ' ' TYR . 61.3 t -56.06 -46.73 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.657 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -56.53 -43.92 80.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.084 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpp -73.15 -35.31 66.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.0 ttp -59.87 -41.5 91.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.3 t -79.02 -31.0 44.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.6 155.09 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.947 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.839 0.352 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.713 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.5 mmm180 -52.38 -52.15 55.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.715 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.9 -53.31 33.69 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.365 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.03 -36.87 70.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.033 0.444 . . . . 0.0 110.287 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.947 HG23 ' O ' ' B' ' 1' ' ' ALA . 39.1 t -62.09 -39.57 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.047 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 1.031 HG21 HG11 ' A' ' 55' ' ' VAL . 2.9 mt -65.47 -55.49 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.1 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 25.0 mmm-85 -50.72 -37.66 42.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.171 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.55 -45.97 56.71 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.66 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.851 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.3 OUTLIER -55.42 -55.57 30.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.015 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.881 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.4 mt -51.53 -57.42 3.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.343 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -57.44 -51.15 70.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.37 -42.51 66.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.795 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.2 mt -54.48 -48.24 69.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.583 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.415 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.19 -38.24 96.19 Favored Glycine 0 CA--C 1.498 -0.987 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.079 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.902 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.17 -61.79 2.03 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.847 -0.676 . . . . 0.0 110.445 -178.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.655 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.6 OUTLIER -61.79 -27.75 68.97 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.594 177.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -64.98 -51.36 62.17 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.258 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.716 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.88 -43.55 95.7 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.902 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.7 m -64.51 -33.39 62.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.503 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.69 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.5 OUTLIER -74.15 -45.48 48.46 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.788 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.534 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.0 p -59.68 -26.17 65.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.477 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.413 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.1 m -90.32 -46.16 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.172 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.935 HD12 ' N ' ' B' ' 24' ' ' ARG . 3.8 pp -63.38 -32.85 74.39 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.15 0.5 . . . . 0.0 110.468 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.935 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.063 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.794 0.331 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.524 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.4 m-20 -62.27 -169.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.8 90.34 3.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.628 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.18 164.73 12.37 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.968 0.413 . . . . 0.0 110.375 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.493 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 5.0 p -98.07 162.55 13.16 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.508 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -47.47 -51.4 20.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.831 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -64.46 -27.7 69.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.015 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.493 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -72.31 -51.45 20.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.741 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.696 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.0 pt -73.21 -28.99 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.753 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.44 -27.39 10.16 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.545 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 3.2 mt-10 -75.24 -28.57 59.93 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.235 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.1 m-85 -79.35 -58.55 3.15 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.351 0.596 . . . . 0.0 110.995 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.878 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.86 -22.9 16.13 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.219 -179.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.545 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -76.08 -27.6 57.25 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.119 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -75.08 -39.66 60.61 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.071 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.878 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.12 -51.9 68.03 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.875 0.845 . . . . 0.0 109.386 178.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.38 -24.82 59.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.104 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.785 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.02 -26.6 33.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.127 0.489 . . . . 0.0 110.409 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.785 ' HB3' HD11 ' A' ' 27' ' ' ILE . 5.3 t80 -86.07 -21.63 27.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.226 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 26' ' ' THR . 31.8 t70 -83.33 146.54 28.45 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.896 0.855 . . . . 0.0 111.129 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 14.5 mmtt -65.39 -53.37 44.18 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.969 -1.468 . . . . 0.0 111.6 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.19 -8.0 59.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.786 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 53.27 46.6 63.19 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.537 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -91.8 18.19 8.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.832 0.349 . . . . 0.0 110.583 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.18 5.7 89.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.425 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.432 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 54.3 p -150.19 151.06 32.49 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.785 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.4 mt -102.36 140.42 20.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.915 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.646 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.44 176.53 8.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.97 179.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.82 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -70.42 -39.05 74.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.149 0.499 . . . . 0.0 110.209 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.63 -40.49 87.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.133 178.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 35' ' ' VAL . 1.6 mm-40 -68.15 -53.88 21.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.04 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.846 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.54 -56.27 24.28 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.747 0.784 . . . . 0.0 109.462 178.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.05 -45.49 87.03 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 114.494 -1.23 . . . . 0.0 112.553 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.9 m -62.85 -32.35 73.55 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.906 0.353 . . . . 0.0 110.562 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 31' ' ' GLU . 72.6 t -66.47 -57.26 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.462 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -71.96 -37.05 69.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.495 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -41.4 88.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.914 0.387 . . . . 0.0 110.603 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.8 t -78.95 -8.58 59.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.682 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.85 -54.86 3.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.682 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.457 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -176.28 33.64 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.87 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.593 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.8 OUTLIER -133.78 -179.98 5.87 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.314 0.578 . . . . 0.0 111.159 -179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -159.71 56.27 0.85 Allowed Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.831 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 95.8 Cg_endo -80.58 -173.9 2.03 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.535 2.157 . . . . 0.0 112.113 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.612 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -117.06 152.38 34.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.954 0.407 . . . . 0.0 110.19 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.94 -49.94 74.12 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.99 -31.9 72.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.734 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.581 ' H ' HG22 ' A' ' 44' ' ' THR . 1.6 mt-10 -66.16 -54.33 26.7 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.667 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.82 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -66.06 -34.5 78.22 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.447 179.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.685 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -65.02 -42.16 94.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.92 0.391 . . . . 0.0 110.138 179.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.65 -45.78 92.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.154 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.5 mmt -74.53 -30.88 61.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.477 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.72 -36.4 29.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.382 -179.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.408 ' HA ' ' HA2' ' A' ' 59' ' ' GLY . 7.7 t-20 -44.87 -28.7 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.34 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG2' ' NZ ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -77.73 -39.44 44.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 120.923 0.392 . . . . 0.0 110.744 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.8 HG11 HG21 ' B' ' 6' ' ' ILE . 4.3 m -81.61 -11.56 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.115 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.56 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 44.1 t0 -103.45 155.31 18.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.475 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.797 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.64 -28.77 26.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.036 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -116.51 -9.82 11.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.435 0.636 . . . . 0.0 110.473 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 59.45 61.0 7.77 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.942 -1.026 . . . . 0.0 113.467 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -111.18 18.16 19.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.869 0.366 . . . . 0.0 110.309 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.53 19.8 53.45 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.763 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 28' ' ' THR . 5.6 p -146.09 176.35 9.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.499 0.19 . . . . 0.0 110.501 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 32' ' ' LEU . 25.4 mt -117.59 136.58 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.57 0.224 . . . . 0.0 110.777 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.797 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 1.8 m-20 -87.77 -178.14 5.99 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.338 0.589 . . . . 0.0 112.13 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.52 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.7 m-85 -67.11 -56.2 13.94 Favored Pre-proline 0 C--O 1.236 0.369 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.638 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -65.68 -35.64 36.34 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.355 2.037 . . . . 0.0 111.307 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.28 -52.49 63.5 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.246 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.732 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.1 -56.87 16.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.776 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.696 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -57.07 -47.22 81.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.756 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 53.0 m -59.16 -30.65 68.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.067 0.461 . . . . 0.0 110.124 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.898 ' HG2' HD13 ' B' ' 10' ' ' ILE . 4.4 tpp -60.3 -61.74 2.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.234 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.7 mtt -75.34 -36.98 60.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.103 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.524 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -67.82 -13.33 62.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.568 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.23 149.46 1.5 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.867 0.365 . . . . 0.0 111.088 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -68.0 -13.39 62.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.398 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -94.81 -27.58 15.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.782 0.325 . . . . 0.0 111.001 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.21 82.19 3.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.978 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -143.15 -178.43 5.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 62.45 -167.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.401 ' H ' HG22 ' A' ' 79' ' ' THR . 3.0 m-20 65.41 61.6 0.7 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.877 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.4 m -77.61 -58.18 3.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -63.6 -34.59 78.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -50.43 -30.45 12.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 4.6 mt-10 -76.04 -29.62 58.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.775 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.696 HG22 ' HE1' ' A' ' 138' ' ' TYR . 10.0 mt -79.22 -50.99 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.78 -48.43 38.34 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.904 0.383 . . . . 0.0 111.85 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -53.47 -26.52 20.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.396 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.742 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -76.61 -34.0 58.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.037 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 12.8 t80 -68.92 -50.55 48.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.04 0.448 . . . . 0.0 110.14 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -54.39 -33.18 58.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.727 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 84.8 t -88.94 -22.78 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.605 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.541 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -52.74 -36.83 58.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.364 -179.242 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -100.09 147.21 25.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 0.0 110.5 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -68.3 -37.49 80.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.33 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -112.23 -9.78 13.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.815 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.43 28.28 33.5 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.43 -0.89 . . . . 0.0 113.354 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -67.54 -14.0 62.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.206 0.503 . . . . 0.0 110.721 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.477 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 102.93 -11.35 55.96 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.126 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.482 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 22.5 m-85 -127.2 146.93 50.23 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 120.989 0.423 . . . . 0.0 111.482 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.07 HD13 HD13 ' A' ' 105' ' ' LEU . 1.0 OUTLIER -121.14 109.97 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.652 179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.92 177.04 8.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.539 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.55 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.22 -30.14 71.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.111 0.482 . . . . 0.0 110.484 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.88 -57.81 11.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.239 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.812 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -76.48 -45.45 31.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.155 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.07 HD13 HD13 ' A' ' 100' ' ' ILE . 30.5 tp -52.95 -31.2 39.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.185 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.84 ' HA ' HD11 ' A' ' 116' ' ' LEU . 2.7 ttt-85 -73.01 -49.1 30.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -58.78 -42.66 89.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.118 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.6 t -73.07 -39.74 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.411 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.471 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 29.0 mmt -74.0 -54.14 8.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.538 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 115' ' ' LYS . 6.1 m -55.62 -48.9 74.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.35 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -58.87 -29.68 67.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.934 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.785 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.5 mp -121.85 36.6 4.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.29 -113.2 0.28 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.716 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.444 ' O ' HD23 ' A' ' 116' ' ' LEU . 3.1 pt-20 -136.24 170.35 16.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.792 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.625 ' HA ' HG23 ' A' ' 110' ' ' THR . 5.5 ttpp -73.39 98.07 2.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.141 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.969 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.38 113.56 24.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.409 179.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.924 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.77 175.42 5.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.363 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.07 -35.87 12.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 0.0 110.742 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.41 -34.99 54.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.403 ' HB2' ' CA ' ' A' ' 116' ' ' LEU . 9.7 mm-40 -72.89 -33.32 65.96 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.026 0.441 . . . . 0.0 110.145 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.969 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.53 -48.62 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.342 0.591 . . . . 0.0 109.786 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.46 -52.91 63.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.775 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.25 -28.68 63.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.808 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.762 ' HG3' HD21 ' A' ' 105' ' ' LEU . 7.0 tpt -76.13 -38.1 57.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.131 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.497 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.22 -43.77 84.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.506 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -62.32 -40.82 97.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.971 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 124' ' ' MET . 8.0 pt-20 -80.64 -36.37 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.834 0.35 . . . . 0.0 110.652 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.485 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -67.53 -35.04 78.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.421 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.648 ' HB2' HG22 ' A' ' 136' ' ' VAL . 22.4 t0 -104.37 145.54 30.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.983 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.554 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.9 pt -83.03 -40.83 16.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.165 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.554 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.85 -11.1 60.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.78 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.81 32.74 0.98 Allowed Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -176.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.42 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -95.7 -12.38 25.57 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.351 -0.924 . . . . 0.0 112.548 -176.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.78 20.27 10.16 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.903 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -146.09 147.35 31.48 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 129' ' ' ASP . 18.9 t -130.7 107.21 13.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.395 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -78.71 174.87 10.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.256 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.735 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.91 -67.15 0.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.636 0.731 . . . . 0.0 111.695 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 3.5 mt-10 -65.19 -25.49 67.73 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.583 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.481 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.52 -48.56 74.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.829 0.347 . . . . 0.0 110.333 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.9 p90 -78.88 -31.06 45.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.219 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 138' ' ' TYR . 67.6 t -52.87 -44.34 48.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.136 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -59.73 -38.51 81.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.147 0.498 . . . . 0.0 109.879 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.47 -41.04 63.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.714 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.42 ' CG ' HG21 ' B' ' 22' ' ' VAL . 8.5 ttp -53.38 -43.62 67.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.974 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 t -78.82 -31.36 45.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.899 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.72 159.03 9.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.938 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.733 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.0 mmm180 -52.26 -51.21 59.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.021 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.724 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.62 -53.3 31.85 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.022 -0.271 . . . . 0.0 111.232 179.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.43 -37.58 70.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.069 0.462 . . . . 0.0 110.292 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.938 HG23 ' O ' ' B' ' 1' ' ' ALA . 12.1 t -64.07 -33.67 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.408 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.8 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.71 -52.73 23.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.114 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.424 ' HA ' HD12 ' B' ' 10' ' ' ILE . 31.5 mmm-85 -53.16 -37.36 61.8 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.081 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.03 -48.35 63.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.363 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.846 ' HD2' HD23 ' A' ' 32' ' ' LEU . 17.3 mtmt -55.11 -52.92 61.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.762 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.898 HD13 ' HG2' ' A' ' 71' ' ' MET . 6.1 mt -51.08 -57.44 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.053 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.562 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -58.85 -51.46 69.93 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.287 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.562 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.26 -40.1 64.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.98 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.825 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.4 mt -54.48 -52.38 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.537 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.413 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.63 -36.47 93.3 Favored Glycine 0 CA--C 1.499 -0.94 0 C-N-CA 121.087 -0.578 . . . . 0.0 113.284 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.913 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.59 -61.75 2.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.526 -178.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.701 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -63.2 -27.55 69.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.658 177.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.58 -50.91 63.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.294 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.751 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.4 OUTLIER -64.58 -43.73 92.92 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.913 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.3 m -64.95 -32.83 59.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.56 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.701 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.6 OUTLIER -74.69 -46.13 39.81 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.897 -179.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.551 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 15.3 p -59.33 -26.32 64.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.446 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.439 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.3 m -90.22 -47.4 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.227 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.884 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -63.1 -33.25 75.04 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.2 0.524 . . . . 0.0 110.453 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.884 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.092 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.644 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.787 0.327 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.638 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 1.5 m-20 -83.63 -169.74 2.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -121.34 85.88 2.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.635 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.4 mt -98.29 164.79 12.16 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.479 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.478 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.1 p -96.85 161.87 13.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.519 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -47.65 -51.74 20.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.739 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -64.43 -27.69 69.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.96 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -71.94 -51.55 21.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.63 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.699 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -72.95 -28.85 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.775 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.43 -27.35 9.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 29.7 mt-10 -75.32 -28.57 59.72 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.251 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.34 -58.53 3.17 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.197 0.522 . . . . 0.0 111.121 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.875 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -54.68 -22.75 14.71 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.246 -179.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -76.38 -28.03 56.59 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.046 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.44 -39.52 62.51 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.127 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -58.91 -51.61 69.32 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.825 0.821 . . . . 0.0 109.367 178.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 p -74.32 -24.65 59.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.143 -1.389 . . . . 0.0 112.029 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.78 HD11 ' O ' ' A' ' 112' ' ' LEU . 1.9 tt -81.93 -25.36 34.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.273 0.559 . . . . 0.0 110.194 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.796 ' HB3' HD11 ' A' ' 27' ' ' ILE . 3.6 t80 -92.63 -0.74 57.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.456 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.2 t70 -104.26 144.08 32.09 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 122.038 0.923 . . . . 0.0 111.108 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.49 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 11.5 mmtt -59.99 -53.4 58.28 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.519 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.59 -4.0 59.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.849 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.51 47.06 36.96 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.164 -0.541 . . . . 0.0 113.354 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -91.52 18.4 7.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.857 0.36 . . . . 0.0 110.693 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.32 88.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.615 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 44.4 p -150.26 148.78 29.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.647 0.261 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.796 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -101.41 140.46 20.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.99 0.424 . . . . 0.0 111.82 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.523 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.13 177.56 7.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.172 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.693 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -70.33 -38.75 74.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.16 0.505 . . . . 0.0 110.32 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.548 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.39 -41.34 89.17 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.251 178.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.93 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.4 -53.59 18.62 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.349 -179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.835 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -58.87 -55.62 32.75 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.79 0.805 . . . . 0.0 109.342 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.38 -45.73 88.45 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.519 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.9 m -62.72 -31.83 72.83 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.556 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.93 HG23 ' O ' ' A' ' 31' ' ' GLU . 73.7 t -66.56 -57.38 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.438 . . . . 0.0 110.838 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.494 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 2.3 tpt -72.0 -37.22 69.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.506 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -66.23 -40.94 90.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.959 0.409 . . . . 0.0 110.613 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.9 t -79.01 -9.14 59.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.639 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.54 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.9 tt -89.8 -54.02 4.24 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.634 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.92 34.0 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.788 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -132.89 178.78 6.61 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.344 0.593 . . . . 0.0 111.219 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -159.83 56.06 0.81 Allowed Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.709 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.3 Cg_endo -80.65 -170.25 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.552 2.168 . . . . 0.0 112.297 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.603 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -118.58 152.6 35.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.099 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -56.63 -50.05 73.18 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.81 -32.62 74.02 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.783 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.579 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -65.33 -54.6 26.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.727 -179.43 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.693 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.1 -44.66 96.17 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.893 179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.636 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -58.06 -49.03 78.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.816 0.341 . . . . 0.0 110.715 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -53.27 -47.6 69.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.402 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 0.5 OUTLIER -74.7 -30.57 61.59 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.85 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.549 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -53.76 -35.0 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.524 -178.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -45.05 -28.67 0.73 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.24 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HG2' ' NZ ' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -78.1 -39.12 42.4 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.922 0.391 . . . . 0.0 110.79 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.881 HG11 HG21 ' B' ' 6' ' ' ILE . 4.6 m -80.22 -11.02 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.182 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 37.6 t0 -103.65 155.73 18.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.787 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.501 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.6 -29.34 25.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.072 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -116.54 -9.57 11.38 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.41 0.624 . . . . 0.0 110.428 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.61 63.74 4.94 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.495 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.8 p-10 -112.32 17.77 19.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.799 0.333 . . . . 0.0 110.195 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 87.25 19.99 53.71 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.553 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.3 p -147.88 176.45 10.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.743 HD12 HD11 ' A' ' 32' ' ' LEU . 12.0 mt -115.03 136.52 51.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.594 0.235 . . . . 0.0 111.064 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 11.0 m-20 -88.41 -177.85 5.73 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.281 0.562 . . . . 0.0 111.901 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 m-85 -67.91 -55.9 12.63 Favored Pre-proline 0 C--O 1.235 0.309 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.809 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 29.4 Cg_endo -65.48 -34.39 43.1 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.243 1.962 . . . . 0.0 111.266 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -63.87 -52.43 60.03 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.308 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.714 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.04 -56.97 14.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.879 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.699 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.83 -46.54 81.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.644 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 69.6 m -61.26 -31.66 71.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.071 0.462 . . . . 0.0 110.09 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.918 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.9 tpp -60.47 -61.78 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.101 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 41.8 mtt -67.44 -27.95 67.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.638 ' HB1' ' CG ' ' A' ' 2' ' ' ASP . . . -60.23 -20.13 57.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.408 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -53.95 113.49 1.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.832 0.349 . . . . 0.0 111.067 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -21.61 60.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.048 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -28.89 69.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.995 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -82.73 59.23 4.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.847 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -80.99 -174.59 4.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 64.24 -167.82 0.21 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.418 ' H ' HG22 ' A' ' 79' ' ' THR . 24.8 m-20 64.82 41.39 5.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.9 m -69.09 -51.31 40.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.809 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -80.6 -28.98 36.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -50.36 -30.66 12.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.317 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.662 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.1 OUTLIER -71.1 -29.45 65.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.934 0.397 . . . . 0.0 110.494 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.689 HG22 ' HE1' ' A' ' 138' ' ' TYR . 17.6 mt -79.05 -49.06 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.197 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -73.44 -45.45 54.3 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 120.945 0.402 . . . . 0.0 111.645 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.3 tp10 -53.68 -26.07 21.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.283 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.757 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -78.0 -33.41 51.31 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.046 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 13.4 t80 -69.33 -51.98 31.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 120.958 0.408 . . . . 0.0 110.283 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -54.32 -32.3 56.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.723 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 87' ' ' GLU . 42.7 t -88.82 -22.91 6.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.624 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.29 -36.02 60.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.028 -179.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -101.34 148.48 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.445 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -69.18 -37.65 78.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.377 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.16 -9.76 13.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.57 29.4 32.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.258 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.45 -13.88 62.43 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 117.089 0.444 . . . . 0.0 110.754 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.13 -12.79 55.66 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.94 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 24.6 m-85 -127.13 145.84 50.6 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.956 0.408 . . . . 0.0 111.448 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.926 HD12 HD12 ' A' ' 105' ' ' LEU . 1.1 pt -121.16 109.89 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.763 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.5 m -81.06 178.34 8.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.409 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.53 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.8 -29.63 70.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.002 0.429 . . . . 0.0 110.447 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.24 -57.82 10.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.244 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.839 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.51 -39.65 52.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.03 -179.275 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.926 HD12 HD12 ' A' ' 100' ' ' ILE . 8.9 tt -55.42 -41.25 72.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.024 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.89 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.9 ttt180 -65.3 -49.49 69.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -60.46 -39.31 87.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.088 0.471 . . . . 0.0 110.184 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 104' ' ' GLU . 37.1 t -73.21 -42.14 58.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.32 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 30.6 mmt -74.1 -54.31 8.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.688 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.7 m -55.42 -43.92 75.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.445 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.498 ' C ' HD12 ' A' ' 112' ' ' LEU . 2.0 m-80 -60.54 -31.43 70.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.347 . . . . 0.0 110.825 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.78 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.7 mp -122.91 37.23 4.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.736 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -167.1 -117.37 0.4 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.819 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.415 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.9 pt-20 -133.8 177.92 7.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.883 0.373 . . . . 0.0 110.876 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.436 ' HA ' HG23 ' A' ' 110' ' ' THR . 22.8 tptt -78.27 97.7 5.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.299 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.976 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.86 114.84 26.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.327 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.924 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.72 174.97 6.1 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.956 -0.297 . . . . 0.0 110.363 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -48.03 -35.78 11.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.366 . . . . 0.0 110.749 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -77.32 -36.21 54.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.759 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -71.06 -33.89 70.68 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.994 0.426 . . . . 0.0 109.985 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.976 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -73.86 -50.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.402 0.62 . . . . 0.0 109.681 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.91 -52.85 63.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.717 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -28.49 64.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.777 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.683 ' HG3' HD11 ' A' ' 105' ' ' LEU . 6.7 tpt -76.2 -37.57 57.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.152 0.501 . . . . 0.0 110.242 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.569 HG12 HD13 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -69.94 -39.94 78.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.287 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -70.61 -34.57 72.27 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.411 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 124' ' ' MET . 20.7 pt-20 -82.92 -39.79 21.02 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.429 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.492 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.6 -41.79 87.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.474 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.731 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.2 t0 -91.48 147.18 23.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.07 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.552 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.03 -40.68 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.015 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.92 -10.98 60.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.756 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.88 33.03 1.05 Allowed Glycine 0 C--N 1.337 0.604 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -176.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 42.9 p-10 -96.31 -12.57 24.26 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.357 -0.922 . . . . 0.0 112.48 -176.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.85 20.11 10.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.863 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -146.47 146.76 30.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 129' ' ' ASP . 39.1 t -130.71 107.24 13.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.281 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.563 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.3 t30 -78.31 175.4 10.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.368 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.729 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.1 t80 -45.95 -67.1 0.31 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.674 0.75 . . . . 0.0 111.709 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.511 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.3 mt-10 -65.32 -25.28 67.54 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.568 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.576 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.56 -48.61 74.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.813 0.34 . . . . 0.0 110.369 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 7.6 p90 -78.89 -31.31 45.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.347 178.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 138' ' ' TYR . 73.8 t -53.07 -44.3 50.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.098 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -61.03 -35.5 77.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.095 0.474 . . . . 0.0 109.779 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.414 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 9.5 mmt -73.58 -42.3 61.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.091 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.46 ' CG ' HG21 ' B' ' 22' ' ' VAL . 0.2 OUTLIER -51.29 -48.64 62.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.946 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 t -74.36 -31.22 62.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.893 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.73 146.72 40.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.973 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.777 0.322 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.731 ' O ' HG13 ' B' ' 6' ' ' ILE . 2.1 mmm180 -52.18 -51.52 57.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.039 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.748 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.71 -53.36 31.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.591 0.234 . . . . 0.0 111.458 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -57.2 -36.98 71.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.086 0.47 . . . . 0.0 110.115 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.973 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.4 t -63.77 -34.45 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.393 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.881 HG21 HG11 ' A' ' 55' ' ' VAL . 2.7 mt -71.3 -53.65 20.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.054 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -50.97 -39.92 56.42 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.236 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.84 -48.12 67.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.418 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.849 ' O ' HD12 ' B' ' 13' ' ' ILE . 13.3 mtmt -55.01 -54.53 41.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.196 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.918 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.7 mt -51.11 -56.91 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.298 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.517 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.6 OUTLIER -59.54 -47.95 83.53 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.199 0.523 . . . . 0.0 111.155 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.11 -39.87 63.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.025 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.849 HD12 ' O ' ' B' ' 9' ' ' LYS . 1.7 mt -54.5 -52.03 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.502 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.422 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.51 -36.38 93.09 Favored Glycine 0 CA--C 1.499 -0.931 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.301 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.919 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -63.8 -61.73 2.11 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.863 -0.668 . . . . 0.0 110.468 -178.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.653 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -64.32 -27.43 69.02 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.789 177.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -67.12 -49.66 64.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.144 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.761 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -64.69 -43.93 91.94 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.549 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.919 HG13 ' O ' ' B' ' 15' ' ' LYS . 2.6 m -65.07 -32.28 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.579 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.653 ' HB2' ' O ' ' B' ' 16' ' ' MET . 0.8 OUTLIER -74.57 -48.41 26.9 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.074 -179.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.558 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 14.7 p -58.43 -26.26 63.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.475 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.46 HG21 ' CG ' ' A' ' 145' ' ' MET . 27.7 m -90.24 -48.05 14.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.258 -178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.881 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.1 pp -62.54 -32.9 73.93 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.202 0.525 . . . . 0.0 110.442 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.881 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.111 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.63 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.797 0.332 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.541 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.1 m-20 -66.1 -169.57 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -117.68 90.72 3.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.2 mt -98.63 164.86 12.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.501 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.485 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.4 p -96.82 161.67 13.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.479 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -47.61 -51.81 20.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.744 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -64.46 -27.63 69.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.973 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.92 -51.49 21.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.58 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.706 HG22 ' CD2' ' A' ' 69' ' ' LEU . 39.0 pt -73.03 -28.9 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.801 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.49 -27.37 10.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 8.0 mt-10 -75.27 -28.45 59.81 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.314 178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.608 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.29 -58.5 3.19 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.301 0.572 . . . . 0.0 111.04 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.874 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 4.6 pttt -54.58 -22.94 14.74 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.285 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.39 -27.94 56.54 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.103 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.24 -39.95 62.72 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.027 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.874 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.82 -52.1 67.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.829 0.823 . . . . 0.0 109.483 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -24.21 58.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.145 -1.388 . . . . 0.0 112.117 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.883 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.3 tt -82.05 -24.68 35.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.282 0.563 . . . . 0.0 110.202 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.821 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.8 t80 -93.66 -0.83 55.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.522 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' CG ' ' O ' ' A' ' 26' ' ' THR . 25.4 t70 -102.87 143.64 32.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.997 0.904 . . . . 0.0 111.026 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.1 mmtt -60.17 -53.38 58.43 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.594 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -84.66 -5.9 59.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.773 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 51.59 45.91 53.83 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.425 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.2 p30 -90.83 18.05 7.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.832 0.349 . . . . 0.0 110.705 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.07 5.95 88.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.503 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.451 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 52.7 p -150.1 149.54 30.42 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.183 -0.302 . . . . 0.0 110.183 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -102.04 140.51 20.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.934 0.397 . . . . 0.0 112.018 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.598 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -85.6 176.84 7.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.929 179.222 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.811 ' HB ' HD12 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -70.49 -38.16 74.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.142 0.496 . . . . 0.0 110.36 -179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -59.67 -40.96 89.53 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.22 178.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.924 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.43 -53.73 17.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.324 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.825 HD23 ' HD2' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -57.96 -54.83 42.52 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.755 0.788 . . . . 0.0 109.422 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.57 -45.97 92.58 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 114.552 -1.203 . . . . 0.0 112.484 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -62.57 -31.1 71.85 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.86 0.33 . . . . 0.0 110.572 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 31' ' ' GLU . 72.1 t -67.86 -57.22 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.449 ' HG3' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -71.98 -35.98 69.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.46 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -42.62 80.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.953 0.406 . . . . 0.0 110.776 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 t -78.96 -8.59 59.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.753 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.554 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.7 tt -90.57 -55.09 3.72 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.766 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.477 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -174.5 34.01 0.11 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.955 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.578 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.6 tp-100 -137.66 -178.86 5.43 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.3 0.571 . . . . 0.0 111.219 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -159.65 56.59 0.89 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.913 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 94.5 Cg_endo -80.41 -177.49 3.81 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.457 2.104 . . . . 0.0 112.076 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.611 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -112.44 152.45 28.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.952 0.406 . . . . 0.0 110.224 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.7 -49.09 77.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.401 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.64 -31.93 72.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.774 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' H ' HG22 ' A' ' 44' ' ' THR . 1.5 mt-10 -65.83 -54.3 28.59 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.586 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.811 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.98 -34.52 78.28 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.373 179.606 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.694 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -64.52 -42.6 95.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.882 0.372 . . . . 0.0 110.148 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -61.83 -45.5 93.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.219 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 mmt -74.5 -30.75 61.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.428 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -53.67 -38.42 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.624 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -44.99 -28.58 0.7 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.373 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.439 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -77.57 -38.6 48.09 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.905 0.383 . . . . 0.0 110.816 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.884 HG11 HG21 ' B' ' 6' ' ' ILE . 4.5 m -81.43 -11.64 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.244 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.55 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 41.0 t0 -103.63 155.62 18.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.692 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.478 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.59 -28.89 26.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.05 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -116.45 -9.67 11.41 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.435 0.636 . . . . 0.0 110.459 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.55 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.14 63.37 5.31 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.446 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -112.37 18.26 18.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.808 0.337 . . . . 0.0 110.183 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.66 20.02 55.04 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.515 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.4 p -146.88 176.36 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.511 HD12 HD11 ' A' ' 32' ' ' LEU . 54.6 mt -116.12 136.54 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.581 0.229 . . . . 0.0 110.803 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 9.2 m-20 -86.97 -178.49 6.3 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.268 0.556 . . . . 0.0 111.948 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -67.82 -56.17 12.28 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.589 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.5 Cg_endo -65.75 -34.81 39.18 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.248 1.965 . . . . 0.0 111.198 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.65 -52.38 63.57 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.204 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.714 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.22 -56.86 16.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.85 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.706 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -56.83 -46.96 81.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.63 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 59.7 m -60.26 -30.99 69.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 0.0 110.064 179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.936 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.3 tpp -63.68 -61.89 2.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.104 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mtm -70.49 -30.2 66.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.039 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.541 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -81.47 0.08 39.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.674 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -56.41 158.01 4.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.837 0.351 . . . . 0.0 111.008 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -86.5 -12.69 48.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.304 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.1 ttt -95.02 -30.79 13.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.786 0.327 . . . . 0.0 110.973 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -77.3 124.31 27.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -168.64 -170.87 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 62.39 -166.02 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' H ' HG22 ' A' ' 79' ' ' THR . 1.9 m-20 66.6 36.29 4.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.927 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 p -77.55 -45.23 26.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -80.74 -29.15 36.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -53.47 -53.72 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.29 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.71 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.71 -29.56 27.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.486 -179.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.773 HG22 ' HE1' ' A' ' 138' ' ' TYR . 13.8 mt -65.46 -51.29 65.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.859 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.38 -49.62 18.44 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.139 0.495 . . . . 0.0 110.405 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 91' ' ' VAL . 33.7 mt-10 -54.1 -30.22 47.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.243 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -69.88 -37.91 76.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.625 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 11.3 t80 -67.3 -53.93 25.37 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.519 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -54.08 -31.01 50.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.784 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 87' ' ' GLU . 87.0 t -88.63 -22.85 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.291 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.525 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -55.2 -37.21 66.81 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.096 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -101.48 147.23 26.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.506 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -69.64 -36.75 76.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.362 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.2 -9.74 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.4 30.14 34.48 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.245 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -67.43 -13.79 62.34 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.01 0.405 . . . . 0.0 110.782 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.19 -13.42 55.38 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.951 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 25.5 m-85 -127.19 145.49 50.74 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.01 0.433 . . . . 0.0 111.353 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.804 ' CD1' HD12 ' A' ' 105' ' ' LEU . 1.1 pp -121.1 109.89 26.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.705 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.68 178.9 8.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.508 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.467 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -64.67 -29.94 70.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.055 0.455 . . . . 0.0 110.511 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.44 -57.77 11.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.168 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.799 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.4 OUTLIER -76.46 -41.47 47.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.951 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.804 HD12 ' CD1' ' A' ' 100' ' ' ILE . 7.7 tt -54.19 -37.46 64.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.936 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HA ' HD11 ' A' ' 116' ' ' LEU . 3.2 ttt-85 -70.06 -49.4 51.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.925 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.51 -37.56 86.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.058 0.456 . . . . 0.0 110.139 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 104' ' ' GLU . 47.1 t -73.03 -45.33 54.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.232 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.455 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 21.5 mmt -74.03 -54.27 8.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.701 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.0 m -55.57 -44.6 77.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.264 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -58.4 -28.44 65.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 110.789 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.883 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.1 mp -126.06 35.88 4.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.564 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -164.04 -120.46 0.52 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.764 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -127.78 -176.84 3.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 0.0 110.907 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -83.84 97.07 8.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.958 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.28 114.0 25.95 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.426 179.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.927 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -71.78 175.36 5.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.32 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.441 ' H ' HG22 ' A' ' 117' ' ' THR . 3.9 m-20 -48.06 -35.9 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.947 0.403 . . . . 0.0 110.733 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -77.41 -35.44 54.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.841 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -72.12 -33.22 67.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.998 0.427 . . . . 0.0 110.094 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.958 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.7 t -75.08 -50.61 24.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.395 0.617 . . . . 0.0 109.679 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -59.08 -52.83 64.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.717 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -28.73 58.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.767 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.784 ' HG3' HD11 ' A' ' 105' ' ' LEU . 6.4 tpt -76.16 -39.26 55.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.207 0.527 . . . . 0.0 110.044 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.531 HG12 HD13 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -65.89 -46.83 87.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.392 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -62.7 -38.28 89.78 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.911 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 124' ' ' MET . 18.5 pt-20 -81.12 -39.81 25.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.724 0.297 . . . . 0.0 110.814 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.507 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -65.42 -39.35 92.03 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.955 0.407 . . . . 0.0 110.547 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.725 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.6 t0 -94.94 146.4 24.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.165 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.552 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.4 -40.63 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.06 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.91 -10.98 60.07 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.769 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.68 33.03 0.95 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.431 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.2 p-10 -96.27 -12.49 24.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.369 -0.916 . . . . 0.0 112.56 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.8 20.2 10.23 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.808 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.63 147.29 30.89 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 129' ' ' ASP . 38.9 t -130.68 107.27 13.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.258 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.567 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.3 t30 -77.83 175.23 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.445 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.773 ' HE1' HG22 ' A' ' 85' ' ' ILE . 1.1 t80 -46.05 -67.04 0.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.654 0.74 . . . . 0.0 111.811 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 2.3 mm-40 -65.57 -25.13 67.28 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.451 -1.25 . . . . 0.0 112.63 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.575 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.56 -48.9 74.03 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.382 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 9.3 p90 -79.21 -31.32 43.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.364 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 138' ' ' TYR . 72.0 t -52.9 -43.3 46.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.341 -0.39 . . . . 0.0 109.963 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -62.71 -34.79 77.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.81 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.421 ' HG3' ' HA ' ' A' ' 128' ' ' ALA . 9.5 mmt -73.48 -44.29 58.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.424 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.44 ' CG ' HG21 ' B' ' 22' ' ' VAL . 7.1 ttp -51.12 -46.97 62.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.159 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.1 t -75.89 -31.24 59.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.71 162.37 5.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.911 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.951 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 110.984 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.738 ' O ' HG13 ' B' ' 6' ' ' ILE . 8.4 mmm180 -52.31 -51.1 60.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.73 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.65 -53.23 32.63 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.655 0.264 . . . . 0.0 111.299 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.17 -37.57 72.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.019 0.438 . . . . 0.0 110.317 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.951 HG23 ' O ' ' B' ' 1' ' ' ALA . 15.0 t -63.36 -33.73 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.388 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.884 HG21 HG11 ' A' ' 55' ' ' VAL . 2.5 mt -71.64 -55.08 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.011 179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . . . . . . . . . 26.2 mmm-85 -50.42 -37.88 40.16 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.178 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -46.1 65.15 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.503 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.825 ' HD2' HD23 ' A' ' 32' ' ' LEU . 11.8 mtmt -56.6 -54.12 49.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.936 HD13 ' HG2' ' A' ' 71' ' ' MET . 4.3 mt -51.2 -57.55 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.548 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.544 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.0 OUTLIER -60.92 -51.41 69.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.361 0.601 . . . . 0.0 110.938 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.585 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.42 -38.81 63.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.859 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.671 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.31 -50.66 55.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.351 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.42 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.44 -37.28 94.56 Favored Glycine 0 CA--C 1.498 -0.977 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.544 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.86 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -65.0 -61.77 1.95 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.716 -0.742 . . . . 0.0 110.552 -179.11 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.751 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.69 -27.51 67.92 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -68.36 -46.41 70.17 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.794 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 1.1 ppt_? -63.58 -44.1 95.06 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.86 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.8 m -62.78 -35.42 70.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.934 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.628 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -75.18 -47.2 29.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.064 -179.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.573 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 12.1 p -59.4 -25.15 64.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.598 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.484 HG22 ' O ' ' B' ' 18' ' ' ARG . 30.3 m -90.29 -48.52 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.196 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.89 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.0 pp -61.91 -33.78 74.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.228 0.537 . . . . 0.0 110.44 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.89 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.083 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.801 0.334 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.542 ' H ' ' HB1' ' A' ' 73' ' ' ALA . 4.2 m-20 -64.82 -169.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.782 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -120.59 90.68 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -97.66 164.75 12.28 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.004 0.43 . . . . 0.0 110.424 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.5 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 7.2 p -97.44 161.93 13.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.467 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -47.69 -51.68 20.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.766 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -64.5 -27.7 69.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.045 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.5 ' HB2' ' H ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -71.85 -51.5 22.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.619 179.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.703 HG22 ' CD2' ' A' ' 69' ' ' LEU . 38.9 pt -73.0 -28.97 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.64 -179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.54 -27.33 10.54 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.543 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 4.6 mm-40 -75.34 -28.55 59.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.281 178.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.607 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.34 -58.61 3.13 Favored 'General case' 0 CA--C 1.522 -0.116 0 CA-C-O 121.214 0.531 . . . . 0.0 111.033 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.872 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -54.73 -22.76 15.04 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.249 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 1.0 OUTLIER -76.52 -27.95 56.2 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -74.23 -39.92 62.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.043 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.872 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -58.55 -51.95 67.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.802 0.811 . . . . 0.0 109.363 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.401 ' HB3' ' HA2' ' A' ' 25' ' ' GLY . 2.0 p -74.51 -24.05 58.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.074 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.878 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.07 -24.74 35.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.261 0.553 . . . . 0.0 110.166 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.9 ' CE2' HG21 ' A' ' 35' ' ' VAL . 2.5 t80 -94.64 0.21 54.94 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.571 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' ' 26' ' ' THR . 24.4 t70 -104.27 142.35 34.7 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.942 0.877 . . . . 0.0 110.997 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.478 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 10.7 mmtt -58.4 -53.35 59.33 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 113.884 -1.507 . . . . 0.0 111.572 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -86.62 -4.88 59.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.765 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.15 47.23 42.13 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.356 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.5 p30 -91.64 18.53 7.36 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.805 0.336 . . . . 0.0 110.673 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 83.85 5.12 88.25 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.592 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.438 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 45.9 p -150.33 148.65 29.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.668 0.27 . . . . 0.0 110.344 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.728 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.5 mt -100.72 140.46 19.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.801 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.591 ' HA ' HG22 ' A' ' 62' ' ' THR . 0.0 OUTLIER -86.41 178.66 7.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.294 179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.715 ' HB ' HD12 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -69.96 -41.8 74.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.056 0.455 . . . . 0.0 110.411 -179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.537 ' CD ' ' N ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -57.28 -40.88 78.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.365 179.07 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.807 ' O ' HG23 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -70.15 -53.82 15.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.47 -179.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.729 HD11 HD12 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -57.5 -54.14 50.26 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.838 0.828 . . . . 0.0 109.572 178.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -47.33 91.32 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.462 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.408 ' CB ' ' O ' ' A' ' 30' ' ' LYS . 53.3 m -65.48 -30.74 71.55 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 120.813 0.339 . . . . 0.0 110.432 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.9 HG21 ' CE2' ' A' ' 19' ' ' PHE . 13.9 t -63.62 -57.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.037 0.446 . . . . 0.0 110.568 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.607 ' CE ' HD22 ' A' ' 39' ' ' LEU . 1.7 tpt -72.35 -40.53 67.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.273 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -61.13 -39.66 90.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.945 0.402 . . . . 0.0 110.489 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.5 t -78.86 -11.48 59.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.578 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.607 HD22 ' CE ' ' A' ' 36' ' ' MET . 6.4 tt -88.0 -53.43 4.74 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.075 0.464 . . . . 0.0 110.552 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.457 ' N ' HD23 ' A' ' 39' ' ' LEU . . . 179.72 37.21 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.624 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.587 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 tp-100 -134.83 -179.8 5.83 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.338 0.589 . . . . 0.0 111.279 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -159.75 56.41 0.86 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.792 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 92.7 Cg_endo -80.57 -174.29 2.19 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.546 2.164 . . . . 0.0 112.291 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.602 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -117.32 152.64 34.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.873 0.368 . . . . 0.0 110.124 179.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -56.49 -49.99 73.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.26 -32.59 74.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.638 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.577 ' H ' HG22 ' A' ' 44' ' ' THR . 0.0 OUTLIER -66.31 -54.52 23.75 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.596 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.715 HD12 ' HB ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -61.22 -48.36 81.87 Favored 'General case' 0 C--O 1.218 -0.58 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.929 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.706 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -54.6 -49.97 69.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 110.952 179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.27 -47.23 69.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.682 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -74.68 -30.61 61.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.831 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.567 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -54.68 -36.03 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.588 -178.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -45.23 -28.64 0.82 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.213 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' HG2' ' HE2' ' B' ' 3' ' ' LYS . 0.1 OUTLIER -79.6 -38.21 34.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.929 0.395 . . . . 0.0 110.778 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.076 HG11 HG21 ' B' ' 6' ' ' ILE . 3.7 m -81.07 -10.98 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.14 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.558 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.6 t0 -103.59 155.87 18.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.72 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.58 -29.17 26.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.065 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -116.46 -9.72 11.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.397 0.617 . . . . 0.0 110.452 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.68 63.48 5.17 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.498 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -112.47 18.41 18.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.842 0.353 . . . . 0.0 110.201 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.39 19.98 55.68 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.424 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.591 HG22 ' HA ' ' A' ' 28' ' ' THR . 4.3 p -146.71 176.49 9.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.729 HD12 HD11 ' A' ' 32' ' ' LEU . 12.4 mt -116.3 136.46 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.544 0.212 . . . . 0.0 110.959 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 10.5 m-20 -88.24 -178.02 5.82 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.25 0.548 . . . . 0.0 111.938 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.515 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.82 -55.91 12.83 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.659 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -65.67 -34.54 40.94 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.25 1.967 . . . . 0.0 111.241 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.44 -52.47 61.31 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.26 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.718 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -57.19 -56.99 14.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.789 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.703 ' CD2' HG22 ' A' ' 9' ' ' ILE . 0.4 OUTLIER -57.89 -47.09 83.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.795 -179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.465 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 53.5 m -59.69 -30.46 68.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.074 0.464 . . . . 0.0 110.129 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.912 ' HG2' HD13 ' B' ' 10' ' ' ILE . 3.2 tpp -62.71 -61.84 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.083 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.2 mtt -70.1 -41.39 74.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.001 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.542 ' HB1' ' H ' ' A' ' 2' ' ' ASP . . . -63.63 -18.51 64.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.367 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.43 147.62 13.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.806 0.336 . . . . 0.0 111.096 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.18 -14.33 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.22 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.7 mtp -84.71 -30.6 24.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.762 0.315 . . . . 0.0 110.971 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -85.26 122.48 29.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.913 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.04 -169.13 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 62.06 -167.15 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.414 ' H ' HG22 ' A' ' 79' ' ' THR . 0.5 OUTLIER 64.37 37.68 8.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.53 -38.23 49.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -80.77 -30.65 36.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.0 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -56.82 -51.44 68.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.221 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.691 ' HB3' ' HB3' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -52.68 -29.24 25.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.477 -179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.782 HG22 ' HE1' ' A' ' 138' ' ' TYR . 19.8 mt -66.7 -51.45 56.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.919 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.58 -50.08 16.64 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.075 0.464 . . . . 0.0 110.55 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.601 ' O ' HG23 ' A' ' 91' ' ' VAL . 19.9 tt0 -53.91 -29.19 40.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.252 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' B' ' 19' ' ' VAL . . . -70.83 -38.25 73.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.616 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 10.8 t80 -67.35 -54.15 23.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.966 0.412 . . . . 0.0 110.545 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -54.08 -30.67 49.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.791 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 87' ' ' GLU . 98.9 t -88.7 -22.88 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.216 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.526 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -55.3 -38.38 68.58 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.176 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -100.64 146.87 26.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.503 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -69.72 -36.39 75.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.373 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -112.27 -9.79 13.87 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.43 30.02 34.75 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.23 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -67.43 -13.62 62.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 117.102 0.451 . . . . 0.0 110.787 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.472 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.22 -13.39 55.29 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.914 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.479 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 25.1 m-85 -127.16 145.95 50.57 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.988 0.423 . . . . 0.0 111.425 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.747 HD12 HD22 ' A' ' 105' ' ' LEU . 1.1 pp -121.13 109.94 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.729 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.1 p -83.55 176.97 8.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.53 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.564 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.7 -30.91 71.95 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 110.396 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.25 -57.66 11.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.322 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.736 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -76.43 -45.73 30.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.228 -179.156 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.747 HD22 HD12 ' A' ' 100' ' ' ILE . 17.6 tp -53.13 -33.24 51.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.12 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.818 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.1 ttt-85 -68.79 -49.15 60.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -59.14 -43.51 92.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.194 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 104' ' ' GLU . 1.6 t -72.96 -39.02 57.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.51 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.51 ' HG2' HD12 ' A' ' 105' ' ' LEU . 28.6 mmt -73.97 -54.27 8.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.511 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.663 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.4 m -56.99 -46.9 81.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 0.0 111.088 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -60.0 -26.67 66.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.841 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.878 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.8 mp -124.21 36.19 4.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -170.36 -116.46 0.38 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.688 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.414 ' O ' HD23 ' A' ' 116' ' ' LEU . 23.1 pt-20 -131.31 172.51 12.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.805 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.663 ' HA ' HG23 ' A' ' 110' ' ' THR . 12.7 tptm -75.05 98.58 3.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.163 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.96 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -89.88 113.13 24.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.461 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.935 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -71.83 175.28 5.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.32 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 117' ' ' THR . 50.5 m-20 -48.06 -36.04 12.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 110.759 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -77.41 -34.35 54.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -73.64 -33.04 64.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.024 0.44 . . . . 0.0 110.074 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.96 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -74.96 -48.56 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.829 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.25 -52.87 63.83 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.844 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.08 -28.72 62.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.82 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.739 ' HG3' HD21 ' A' ' 105' ' ' LEU . 5.8 tpt -76.23 -38.47 56.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.14 0.495 . . . . 0.0 110.113 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.511 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -67.15 -44.95 87.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.559 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -61.75 -40.55 95.52 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.97 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 124' ' ' MET . 8.6 pt-20 -81.0 -37.39 29.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 110.787 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.482 ' HB2' ' CE ' ' A' ' 124' ' ' MET . . . -66.29 -35.84 81.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.338 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.727 ' HB2' HG22 ' A' ' 136' ' ' VAL . 21.3 t0 -102.06 146.34 28.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.937 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.554 HG13 ' OD1' ' A' ' 131' ' ' ASP . 18.8 pt -83.5 -40.61 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.093 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.554 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -68.98 -11.07 60.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.713 -179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 41.85 32.77 1.0 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 43.3 p-10 -95.99 -12.53 24.86 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.351 -0.924 . . . . 0.0 112.52 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.16 10.23 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.817 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.479 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -146.54 147.19 30.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.727 HG22 ' HB2' ' A' ' 129' ' ' ASP . 33.1 t -130.71 107.32 13.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.232 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.569 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.2 t30 -78.05 175.0 10.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.339 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.782 ' HE1' HG22 ' A' ' 85' ' ' ILE . 1.1 t80 -45.95 -67.03 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.653 0.74 . . . . 0.0 111.84 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.7 mt-10 -66.02 -24.54 66.77 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.644 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.547 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -55.73 -48.86 74.47 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.393 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 89' ' ' PHE . 10.7 p90 -79.32 -31.21 43.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.399 178.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 138' ' ' TYR . 75.7 t -52.91 -44.85 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.44 -35.45 79.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.137 0.494 . . . . 0.0 109.826 178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.47 -43.35 60.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.81 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.406 ' CG ' HG21 ' B' ' 22' ' ' VAL . 24.5 ttp -52.77 -45.15 66.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.012 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.5 t -77.79 -31.17 51.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.962 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.81 147.3 38.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.096 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.916 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.847 0.356 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.732 ' O ' HG13 ' B' ' 6' ' ' ILE . 11.6 mmm180 -52.5 -50.73 62.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.232 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.759 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.8 OUTLIER -50.79 -53.43 32.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.281 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.69 -36.11 71.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.149 0.5 . . . . 0.0 110.007 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.916 HG23 ' O ' ' B' ' 1' ' ' ALA . 45.1 t -62.84 -41.43 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.997 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 1.076 HG21 HG11 ' A' ' 55' ' ' VAL . 3.2 mt -63.16 -55.42 23.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.098 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' B' ' 3' ' ' LYS . 24.1 mmm-85 -50.16 -40.43 46.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.031 0.444 . . . . 0.0 110.247 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.88 -44.95 68.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.667 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.829 ' HD3' HG12 ' B' ' 5' ' ' VAL . 0.6 OUTLIER -56.34 -55.07 37.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.05 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.912 HD13 ' HG2' ' A' ' 71' ' ' MET . 3.7 mt -51.21 -57.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.751 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.511 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 1.7 tpt180 -61.32 -51.34 69.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.252 0.548 . . . . 0.0 111.028 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.559 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.33 -39.23 63.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.701 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.733 HD12 ' O ' ' B' ' 9' ' ' LYS . 3.1 mt -54.47 -48.94 68.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.225 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.409 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -63.77 -37.64 95.0 Favored Glycine 0 CA--C 1.497 -1.041 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.521 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.895 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -65.06 -61.68 2.0 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.741 -0.73 . . . . 0.0 110.555 -179.246 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.75 ' O ' HG22 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -60.6 -27.46 67.76 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -68.25 -47.53 67.5 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.978 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' B' ' 15' ' ' LYS . 2.5 ppt_? -63.8 -43.61 95.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.105 0.479 . . . . 0.0 109.754 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.895 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.8 m -61.86 -35.48 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.529 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.676 ' CD1' HD21 ' B' ' 23' ' ' LEU . 0.3 OUTLIER -75.97 -43.1 46.17 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.785 -179.599 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.577 ' HA ' ' HG2' ' B' ' 24' ' ' ARG . 21.8 p -61.01 -26.63 67.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.495 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.463 HG23 ' N ' ' B' ' 23' ' ' LEU . 27.4 m -90.42 -48.43 14.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.163 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.894 HD12 ' N ' ' B' ' 24' ' ' ARG . 4.2 pp -63.09 -32.6 74.02 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.199 0.524 . . . . 0.0 110.535 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.894 ' N ' HD12 ' B' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.176 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.788 ' HB2' ' OG1' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.817 0.341 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.71 ' OD2' ' HB1' ' A' ' 73' ' ' ALA . 2.2 m-20 -72.86 -170.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -121.15 87.73 2.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -98.48 164.79 12.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.544 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.492 ' H ' ' HB2' ' A' ' 8' ' ' GLN . 4.6 p -97.98 162.84 13.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.494 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -47.35 -51.42 19.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.875 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -64.27 -27.72 69.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.991 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . 1.9 mm-40 -72.68 -51.36 19.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.707 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.725 HG22 HD21 ' A' ' 69' ' ' LEU . 36.7 pt -73.07 -28.74 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.895 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.34 -27.26 9.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 5.6 mm-40 -74.99 -28.39 60.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.227 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.6 ' CD1' ' HA ' ' A' ' 9' ' ' ILE . 3.2 m-85 -79.63 -58.33 3.24 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.293 0.568 . . . . 0.0 111.002 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.875 ' HA ' ' CD2' ' A' ' 16' ' ' PHE . 13.1 ptmt -54.41 -23.0 14.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.216 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 11' ' ' GLU . 0.9 OUTLIER -76.21 -28.28 57.15 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 19' ' ' PHE . . . -73.99 -39.81 63.4 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.07 177.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.875 ' CD2' ' HA ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -59.26 -52.04 67.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.806 0.812 . . . . 0.0 109.501 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -23.9 58.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.191 -1.368 . . . . 0.0 112.183 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.897 HD11 ' O ' ' A' ' 112' ' ' LEU . 2.4 tt -82.1 -25.09 34.78 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.273 0.558 . . . . 0.0 110.215 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.816 ' HB3' HD11 ' A' ' 27' ' ' ILE . 2.4 t80 -94.42 -0.27 54.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.47 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 26' ' ' THR . 28.7 t70 -103.87 144.88 30.92 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.959 0.885 . . . . 0.0 111.051 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.513 ' HG3' ' HG2' ' A' ' 31' ' ' GLU . 4.5 mmtt -61.13 -53.43 57.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.644 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -83.91 -5.94 59.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.814 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.13 45.31 57.24 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.451 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.9 p30 -90.47 17.23 7.6 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.832 0.348 . . . . 0.0 110.68 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.37 7.46 87.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.386 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 20' ' ' ASP . 69.0 p -150.38 148.23 28.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.816 HD11 ' HB3' ' A' ' 19' ' ' PHE . 3.7 mt -101.57 140.68 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.808 0.337 . . . . 0.0 111.829 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.703 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.5 t -85.52 179.37 7.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.117 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.781 HG21 ' CG ' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -70.43 -45.78 65.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 110.935 -179.201 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.629 ' HG3' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -54.36 -38.93 66.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.335 178.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.871 ' O ' HG23 ' A' ' 35' ' ' VAL . 3.4 mm-40 -71.64 -53.75 12.63 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.395 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.65 HD23 ' CD ' ' B' ' 9' ' ' LYS . 0.3 OUTLIER -56.11 -52.52 64.02 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.733 0.778 . . . . 0.0 109.51 178.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.82 -45.5 96.08 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.371 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 m -62.87 -35.88 81.46 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.917 0.389 . . . . 0.0 110.156 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 31' ' ' GLU . 60.1 t -61.76 -56.87 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.652 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.439 ' SD ' HG13 ' B' ' 5' ' ' VAL . 0.2 OUTLIER -71.6 -40.78 69.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.306 -179.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -41.2 99.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.377 . . . . 0.0 110.656 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 t -78.88 -10.08 59.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.629 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.542 ' C ' HD23 ' A' ' 39' ' ' LEU . 6.6 tt -88.76 -53.88 4.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.585 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.452 ' N ' HD23 ' A' ' 39' ' ' LEU . . . -177.04 34.59 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.819 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -135.86 -179.94 5.96 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.362 0.601 . . . . 0.0 111.306 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -159.75 56.5 0.87 Allowed Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.754 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 41' ' ' GLN . 96.0 Cg_endo -80.44 -173.58 1.91 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.527 2.151 . . . . 0.0 112.273 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.615 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 m -114.39 152.54 31.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.846 0.355 . . . . 0.0 110.166 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -57.68 -49.21 77.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.12 -31.17 71.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.742 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.569 ' H ' HG22 ' A' ' 44' ' ' THR . 1.3 mt-10 -67.16 -54.39 21.7 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.575 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.615 ' CD2' ' O ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -63.45 -37.84 88.84 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.209 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.781 ' CG ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -62.42 -49.9 73.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.842 0.353 . . . . 0.0 110.588 179.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -55.25 -46.25 76.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.496 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.412 ' HG3' ' CB ' ' B' ' 2' ' ' ARG . 1.4 mmt -74.74 -30.54 61.54 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.704 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.559 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -53.5 -38.0 31.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.498 -179.079 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -44.98 -28.59 0.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.373 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.461 ' CB ' ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -76.83 -39.58 50.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.944 0.402 . . . . 0.0 110.767 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.93 HG11 HG21 ' B' ' 6' ' ' ILE . 5.0 m -80.57 -11.96 12.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.099 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.534 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 39.4 t0 -103.69 155.15 18.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.74 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.502 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . . . -84.63 -28.86 26.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.152 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -116.46 -9.68 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.44 0.638 . . . . 0.0 110.468 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 56' ' ' ASP . . . 58.5 63.89 4.82 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.519 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -112.71 18.38 18.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.855 0.359 . . . . 0.0 110.133 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.88 19.93 56.79 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.467 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.703 HG22 ' HA ' ' A' ' 28' ' ' THR . 6.1 p -146.1 176.12 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.487 HG12 HG23 ' A' ' 55' ' ' VAL . 95.9 mt -115.21 136.38 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.551 0.215 . . . . 0.0 110.725 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 68' ' ' PHE . 11.4 m-20 -87.05 -178.17 6.2 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.16 0.505 . . . . 0.0 111.828 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.521 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.4 m-85 -67.97 -55.46 13.41 Favored Pre-proline 0 C--O 1.235 0.313 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.831 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.2 Cg_endo -65.72 -35.37 37.17 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.234 1.956 . . . . 0.0 111.348 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -63.84 -52.31 60.69 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.305 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.729 ' HE2' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -56.9 -56.78 17.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.834 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.725 HD21 HG22 ' A' ' 9' ' ' ILE . 0.3 OUTLIER -53.56 -49.51 67.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.83 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.788 ' OG1' ' HB2' ' A' ' 1' ' ' ALA . 80.6 m -58.57 -32.42 68.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.226 0.536 . . . . 0.0 109.685 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 1.004 ' HG2' HD13 ' B' ' 10' ' ' ILE . 2.7 tpp -67.19 -61.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.899 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.4 mtm -64.2 -29.12 70.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.68 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.71 ' HB1' ' OD2' ' A' ' 2' ' ' ASP . . . -54.01 -24.11 15.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.51 -28.08 52.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.008 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -58.99 -21.86 59.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.033 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.69 -23.06 26.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.325 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 45.14 1.24 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 111.193 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 t0 53.58 -165.55 0.08 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.22 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 69.15 155.67 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.022 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.18 30.71 13.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.096 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -77.55 -51.81 10.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.817 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -80.79 -29.15 36.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.006 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -52.24 -30.55 28.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.311 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.603 ' O ' HG11 ' B' ' 19' ' ' VAL . 1.1 mt-10 -70.54 -29.58 66.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.745 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.715 HG22 ' HE1' ' A' ' 138' ' ' TYR . 7.8 mt -79.45 -51.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 0.3 OUTLIER -75.27 -51.82 12.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.659 ' O ' HG23 ' A' ' 91' ' ' VAL . 8.9 tt0 -53.72 -25.53 18.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.884 0.373 . . . . 0.0 110.733 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.694 ' CB ' HG21 ' B' ' 19' ' ' VAL . . . -77.67 -37.13 50.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.204 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.592 ' CD2' ' HB2' ' A' ' 138' ' ' TYR . 23.2 t80 -68.04 -52.12 39.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.034 0.445 . . . . 0.0 110.087 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -54.77 -32.05 59.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.803 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 87' ' ' GLU . 54.3 t -88.63 -22.8 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.55 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.468 ' HB2' ' HA ' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -53.93 -32.96 55.32 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.114 -179.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -102.34 148.05 25.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.496 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -69.58 -37.21 76.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.351 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -112.16 -9.72 13.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.83 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.15 29.64 33.32 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.228 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -67.4 -13.93 62.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.079 0.439 . . . . 0.0 110.75 179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 89' ' ' PHE . . . 103.2 -12.23 55.3 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.992 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.478 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 21.1 m-85 -127.25 146.99 50.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.906 0.384 . . . . 0.0 111.378 -179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.864 HD13 HD13 ' A' ' 105' ' ' LEU . 1.1 pt -121.11 109.98 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.816 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.2 m -83.99 177.07 8.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.466 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -63.25 -30.09 71.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.097 0.475 . . . . 0.0 110.528 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.35 -57.11 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.205 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.754 ' O ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -76.32 -46.83 25.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.377 -179.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.864 HD13 HD13 ' A' ' 100' ' ' ILE . 30.2 tp -53.19 -31.23 41.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.938 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.845 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.6 ttt-85 -72.54 -49.15 34.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -59.22 -42.8 91.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.144 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 104' ' ' GLU . 2.2 t -72.95 -41.03 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.565 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.454 ' CE ' ' CD2' ' B' ' 20' ' ' PHE . 30.3 mmt -72.61 -54.17 9.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.536 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.743 HG23 ' HA ' ' A' ' 115' ' ' LYS . 4.4 m -57.12 -48.9 77.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.225 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -58.04 -29.9 65.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.796 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.897 ' O ' HD11 ' A' ' 18' ' ' LEU . 6.6 mp -121.58 37.13 4.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.822 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -171.35 -116.43 0.39 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.744 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.418 ' O ' HD23 ' A' ' 116' ' ' LEU . 7.8 pt-20 -131.02 168.72 16.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 110.835 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.743 ' HA ' HG23 ' A' ' 110' ' ' THR . 15.6 ttmt -73.71 100.11 3.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.262 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.971 HD12 ' CG2' ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.36 114.13 26.16 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.929 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -71.86 175.25 5.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.364 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.484 ' H ' HG22 ' A' ' 117' ' ' THR . 1.1 m-20 -48.04 -35.98 12.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.887 0.375 . . . . 0.0 110.779 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -77.36 -34.98 55.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -72.87 -33.03 65.82 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.973 0.415 . . . . 0.0 110.091 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.971 ' CG2' HD12 ' A' ' 116' ' ' LEU . 2.6 t -75.06 -48.76 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.817 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -58.81 -52.77 64.28 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.788 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -28.74 63.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.791 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.822 ' HG3' HD21 ' A' ' 105' ' ' LEU . 11.7 tpt -76.13 -37.77 57.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.135 0.493 . . . . 0.0 110.282 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.509 HD11 ' N ' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -68.23 -39.55 81.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.407 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -65.2 -41.41 94.56 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.489 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 124' ' ' MET . 6.2 pt-20 -82.62 -32.84 28.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 110.483 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.15 -35.87 78.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.484 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.718 ' HB2' HG22 ' A' ' 136' ' ' VAL . 20.1 t0 -105.83 148.6 27.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.974 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.569 HG13 ' OD1' ' A' ' 131' ' ' ASP . 17.8 pt -84.84 -40.8 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.024 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.569 ' OD1' HG13 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -68.94 -10.93 59.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.691 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 131' ' ' ASP . . . 42.0 32.83 1.08 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.445 ' CG ' ' HB2' ' A' ' 131' ' ' ASP . 44.4 p-10 -96.36 -12.79 23.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.291 -0.954 . . . . 0.0 112.451 -176.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.21 10.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.808 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -146.6 146.95 30.62 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.043 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' A' ' 129' ' ' ASP . 33.0 t -130.75 107.5 14.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.202 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 138' ' ' TYR . 3.1 t30 -80.35 174.16 11.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.327 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.715 ' HE1' HG22 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -45.88 -67.05 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.471 0.653 . . . . 0.0 111.433 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 142' ' ' VAL . 1.2 mt-10 -59.95 -32.58 70.94 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.045 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.509 ' HB3' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -56.13 -43.44 78.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.258 0.551 . . . . 0.0 109.65 179.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.806 ' CE1' HD23 ' B' ' 23' ' ' LEU . 0.0 OUTLIER -78.69 -31.76 46.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.213 178.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 138' ' ' TYR . 62.1 t -54.95 -51.83 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.683 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -56.87 -46.88 81.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.2 tpp -68.72 -31.09 69.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.8 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.427 ' HB2' ' CE1' ' A' ' 141' ' ' PHE . 11.3 ttp -61.61 -46.19 90.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.846 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.2 t -77.06 -30.96 55.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.59 154.24 18.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.956 ' O ' HG23 ' B' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.825 0.345 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.736 ' O ' HG13 ' B' ' 6' ' ' ILE . 7.2 mmm180 -52.24 -51.41 58.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.724 ' HA ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -50.73 -53.45 31.41 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.632 0.253 . . . . 0.0 111.391 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.81 -36.61 70.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.136 0.493 . . . . 0.0 110.09 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.956 HG23 ' O ' ' B' ' 1' ' ' ALA . 21.7 t -64.27 -34.3 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.32 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.93 HG21 HG11 ' A' ' 55' ' ' VAL . 2.8 mt -71.56 -49.79 44.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.235 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' B' ' 3' ' ' LYS . 21.9 mmm-85 -58.01 -33.14 68.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.119 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.07 -49.19 47.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.187 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.789 ' O ' HD12 ' B' ' 13' ' ' ILE . 1.6 ptpt -61.38 -50.52 72.52 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.657 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 1.004 HD13 ' HG2' ' A' ' 71' ' ' MET . 10.6 mt -51.29 -57.37 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.091 0.472 . . . . 0.0 110.766 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' B' ' 15' ' ' LYS . 0.0 OUTLIER -59.98 -50.79 72.37 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.93 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' B' ' 16' ' ' MET . . . -53.11 -39.97 63.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.892 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.789 HD12 ' O ' ' B' ' 9' ' ' LYS . 2.6 mt -54.51 -52.11 43.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.612 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.418 ' C ' ' HE2' ' B' ' 15' ' ' LYS . . . -62.74 -36.27 93.08 Favored Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.21 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.931 ' O ' HG13 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -64.96 -61.67 2.02 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.847 -0.676 . . . . 0.0 110.389 -178.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' MET . . . . . 0.664 ' O ' ' HB2' ' B' ' 20' ' ' PHE . 0.5 OUTLIER -62.43 -27.92 69.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.652 177.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' B' ' 13' ' ' ILE . . . -65.27 -51.55 60.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.209 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.761 ' HE ' HG12 ' B' ' 19' ' ' VAL . 0.5 OUTLIER -63.45 -43.56 97.02 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.931 HG13 ' O ' ' B' ' 15' ' ' LYS . 1.9 m -66.3 -32.36 57.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.599 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.667 ' O ' ' HG2' ' B' ' 24' ' ' ARG . 0.6 OUTLIER -71.73 -50.08 33.44 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.006 -179.115 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.448 ' HA ' ' CG ' ' B' ' 24' ' ' ARG . 54.7 p -58.49 -36.22 73.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.058 0.456 . . . . 0.0 110.765 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.486 HG22 ' C ' ' B' ' 19' ' ' VAL . 28.4 m -72.54 -45.01 60.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.071 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.806 HD23 ' CE1' ' A' ' 141' ' ' PHE . 3.0 pp -65.29 -27.53 68.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.022 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.667 ' HG2' ' O ' ' B' ' 20' ' ' PHE . 13.0 ptt180 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.921 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_